data_6fw4_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6fw4 _Structure_validation_residue.Date_analyzed 2019-03-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.86 -46.43 67.87 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.344 2.258 . . . . 0.0 113.395 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.48 -17.39 64.32 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.423 1.487 . . . . 0.0 113.97 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.39 -32.87 64.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.362 1.081 . . . . 0.0 111.993 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 pt -60.56 -28.18 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.735 0.698 . . . . 0.0 111.919 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -80.59 -58.89 2.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.359 1.064 . . . . 0.0 109.58 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 t -60.52 -35.4 75.87 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.75 1.22 . . . . 0.0 112.645 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -73.56 -32.38 64.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.459 1.104 . . . . 0.0 111.603 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -73.71 -32.65 64.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.871 0.759 . . . . 0.0 111.681 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.83 -56.46 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -65.2 -21.46 66.76 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.26 -9.26 59.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.72 -41.76 23.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.4 1.0 . . . . 0.0 111.374 163.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.99 86.39 2.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.232 1.413 . . . . 0.0 109.57 -173.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.76 39.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.052 1.741 . . . . 0.0 113.971 -173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.05 -60.01 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.957 0.903 . . . . 0.0 111.82 -166.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 72.73 -53.15 0.7 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.781 2.433 . . . . 0.0 114.148 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.47 -32.6 74.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 113.418 -171.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.8 p -96.6 5.64 50.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.093 1.357 . . . . 0.0 113.335 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.55 -27.4 13.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.232 1.813 . . . . 0.0 111.382 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -93.66 173.41 7.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.662 1.985 . . . . 0.0 112.657 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.66 -32.35 1.9 Allowed Glycine 0 N--CA 1.481 1.649 0 C-N-CA 125.811 1.672 . . . . 0.0 114.795 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -167.38 1.47 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.119 2.168 . . . . 0.0 110.675 165.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 158.63 38.03 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.28 -0.888 . . . . 0.0 110.442 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -156.46 150.16 24.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.612 1.165 . . . . 0.0 110.171 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.99 118.8 10.53 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.861 1.664 . . . . 0.0 110.589 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.38 171.05 14.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.413 1.085 . . . . 0.0 108.301 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.91 124.15 14.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.658 0.783 . . . . 0.0 110.402 -166.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.62 128.78 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.93 0.892 . . . . 0.0 109.074 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -117.6 105.9 12.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.379 1.472 . . . . 0.0 109.186 171.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.04 160.66 14.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.397 1.079 . . . . 0.0 111.397 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 pt -101.71 152.87 38.18 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.758 1.623 . . . . 0.0 110.2 167.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.73 151.76 46.73 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.175 2.583 . . . . 0.0 111.183 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -168.36 148.66 4.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.584 2.354 . . . . 0.0 108.273 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.63 74.7 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 -164.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -96.56 -6.06 37.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.579 1.552 . . . . 0.0 113.15 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.83 165.83 10.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.713 1.625 . . . . 0.0 111.598 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.64 161.4 20.55 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 117.959 0.879 . . . . 0.0 111.014 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.76 143.35 50.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.223 1.409 . . . . 0.0 111.159 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.3 109.59 0.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.88 -45.3 3.66 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.462 1.506 . . . . 0.0 110.938 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.4 m -156.06 146.33 21.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.344 1.058 . . . . 0.0 110.299 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.21 124.94 41.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.067 0.947 . . . . 0.0 109.927 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.9 m -104.77 121.49 43.73 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.006 1.323 . . . . 0.0 108.279 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.61 126.61 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 165.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.57 -40.44 6.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.048 0.539 . . . . 0.0 110.783 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -170.79 172.74 5.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.765 1.626 . . . . 0.0 111.462 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.57 172.33 17.57 Favored Glycine 0 N--CA 1.465 0.587 0 C-N-CA 125.981 1.753 . . . . 0.0 114.128 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -76.81 122.04 24.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.1 p -56.37 -27.42 56.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -157.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -56.68 -25.36 53.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.617 1.167 . . . . 0.0 113.865 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 tp -91.34 -59.57 2.11 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.066 1.303 . . . . 0.0 112.377 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.4 p -56.88 -31.79 65.19 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 121.137 1.789 . . . . 0.0 114.861 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.2 71.93 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.439 1.018 . . . . 0.0 112.658 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.37 -53.4 12.42 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.917 1.287 . . . . 0.0 112.006 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -54.55 -50.36 68.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.245 1.018 . . . . 0.0 110.608 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -51.14 -47.49 62.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.847 1.659 . . . . 0.0 111.755 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.98 -40.63 96.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 112.277 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.66 82.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.275 1.43 . . . . 0.0 112.453 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.01 -26.81 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.568 -1.332 . . . . 0.0 112.15 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.05 55.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.915 0.886 . . . . 0.0 112.991 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.54 -10.56 3.18 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.3 m -52.1 150.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.23 -50.13 49.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.017 0.927 . . . . 0.0 112.581 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p 168.67 147.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.459 2.704 . . . . 0.0 110.387 -173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -97.51 106.3 31.81 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.234 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.91 116.93 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.716 1.611 . . . . 0.0 110.647 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 142.43 28.48 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.043 1.337 . . . . 0.0 110.722 173.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.86 -24.17 11.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.34 2.693 . . . . 0.0 112.586 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.3 -179.93 6.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.39 1.476 . . . . 0.0 112.44 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -155.86 15.32 0.35 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.472 1.109 . . . . 0.0 113.086 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.28 129.09 32.85 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 120.637 -1.289 . . . . 0.0 108.967 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.64 -4.09 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.559 3.506 . . . . 0.0 115.801 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.51 -43.39 15.81 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.833 1.197 . . . . 0.0 112.141 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.12 -22.52 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.603 1.161 . . . . 0.0 112.609 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.3 t -55.2 -27.12 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.956 0.902 . . . . 0.0 110.903 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.65 -7.59 59.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.032 1.333 . . . . 0.0 113.81 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -45.69 6.14 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.046 -1.034 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.65 -23.19 60.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.998 0.919 . . . . 0.0 111.823 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -65.97 -22.12 66.45 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -125.52 79.34 1.81 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -102.19 158.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.48 1.112 . . . . 0.0 111.776 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.39 123.62 50.67 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 159.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.24 111.28 20.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -134.21 125.66 28.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.79 1.236 . . . . 0.0 108.931 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.76 149.88 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.727 1.611 . . . . 0.0 110.631 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 126.658 1.983 . . . . 0.0 111.201 -178.419 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.705 0.288 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.74 -43.09 65.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.431 1.892 . . . . 0.0 113.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.56 68.28 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.841 1.21 . . . . 0.0 114.011 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.07 70.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 111.366 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -59.6 -28.44 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.545 -0.722 . . . . 0.0 112.122 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -80.36 -58.86 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.968 1.307 . . . . 0.0 109.547 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -59.51 -35.53 74.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.553 1.141 . . . . 0.0 112.695 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -74.45 -30.27 61.8 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.726 1.21 . . . . 0.0 111.781 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -75.47 -34.49 60.9 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.531 1.059 . . . . 0.0 111.479 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.53 -44.44 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.295 1.038 . . . . 0.0 111.058 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.95 -14.37 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.884 0.874 . . . . 0.0 113.164 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -55.52 -35.53 65.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.268 0.227 . . . . 0.0 111.137 164.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.475 HD22 HG11 ' A' ' 96' ' ' VAL . 64.2 m-80 -81.7 -30.71 32.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 111.538 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 81.22 1.68 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.418 1.487 . . . . 0.0 109.531 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.48 38.09 0.18 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.413 1.485 . . . . 0.0 113.786 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.31 -51.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.97 0.908 . . . . 0.0 112.892 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 70.82 -59.01 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.779 2.432 . . . . 0.0 113.71 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.06 -34.34 77.84 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.076 -1.015 . . . . 0.0 113.464 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -87.8 -1.32 57.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 113.612 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -100.4 -24.4 14.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.774 1.629 . . . . 0.0 111.702 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -91.32 172.51 8.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.372 2.269 . . . . 0.0 111.373 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.47 -34.02 2.04 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -168.64 1.59 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.573 1.949 . . . . 0.0 110.748 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 160.6 32.75 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 110.703 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.6 t -157.46 149.02 21.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.506 1.122 . . . . 0.0 110.171 171.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 122.82 20.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.989 1.716 . . . . 0.0 110.368 167.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.54 163.11 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.591 1.156 . . . . 0.0 108.005 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.34 130.69 39.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.343 0.657 . . . . 0.0 112.128 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.44 129.76 46.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 110.084 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.47 103.82 11.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.424 1.489 . . . . 0.0 108.774 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.29 158.41 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.533 0.683 . . . . 0.0 111.757 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.16 140.09 21.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 109.861 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.85 125.42 9.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.436 2.091 . . . . 0.0 109.833 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.2 m -110.81 -31.0 7.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.695 1.198 . . . . 0.0 111.871 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.62 -117.04 0.7 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.191 1.377 . . . . 0.0 110.756 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -66.7 -4.98 10.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.393 1.477 . . . . 0.0 113.871 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.47 174.04 24.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.434 1.492 . . . . 0.0 114.27 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.57 163.87 12.16 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 111.717 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.78 147.15 50.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.435 1.894 . . . . 0.0 111.4 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.94 111.61 1.55 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.52 0.6 . . . . 0.0 112.133 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 -45.78 3.69 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.406 1.479 . . . . 0.0 111.15 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.4 m -157.33 152.86 26.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.747 1.219 . . . . 0.0 110.463 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.98 126.93 40.65 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.218 1.007 . . . . 0.0 110.214 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.7 m -106.8 120.87 43.18 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.638 1.975 . . . . 0.0 107.938 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -87.57 127.11 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.2 0.909 . . . . 0.0 108.779 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.29 -39.42 6.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.265 0.626 . . . . 0.0 110.896 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -170.25 168.83 8.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 111.849 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.8 173.84 19.9 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 125.283 1.421 . . . . 0.0 114.753 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.62 117.85 20.92 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.7 p -59.15 -19.76 47.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -159.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -55.85 -29.96 60.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.906 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.53 -52.31 5.64 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.84 1.2 . . . . 0.0 111.444 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 m -46.64 -46.8 20.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.741 1.155 . . . . 0.0 113.635 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.86 -42.3 67.05 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.009 0.822 . . . . 0.0 112.041 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.74 6.85 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.512 1.125 . . . . 0.0 112.531 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.1 t -57.64 -50.41 73.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.864 0.466 . . . . 0.0 110.168 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -51.74 -47.54 64.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.227 1.411 . . . . 0.0 111.876 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.02 -40.61 96.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.228 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.4 -49.3 74.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.763 1.225 . . . . 0.0 112.203 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.32 -24.06 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.633 -1.292 . . . . 0.0 111.723 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.78 -7.13 57.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 112.66 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -134.05 -12.74 2.5 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.475 HG11 HD22 ' A' ' 46' ' ' ASN . 11.0 m -58.45 146.56 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.231 1.013 . . . . 0.0 112.628 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -66.52 -46.05 77.45 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p 167.6 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.854 2.062 . . . . 0.0 111.0 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -96.24 109.38 47.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.666 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.05 132.0 14.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.424 2.083 . . . . 0.0 109.969 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.99 145.94 66.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.667 -173.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.66 -28.79 7.82 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.095 2.53 . . . . 0.0 111.181 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -140.42 150.58 44.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.925 2.09 . . . . 0.0 110.621 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -119.88 23.03 11.28 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.928 1.291 . . . . 0.0 112.888 -164.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -85.86 142.13 36.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.584 -1.323 . . . . 0.0 109.946 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -63.09 -4.57 6.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.484 2.789 . . . . 0.0 113.796 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.38 -33.44 19.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.597 1.159 . . . . 0.0 111.98 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 -24.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.202 1.001 . . . . 0.0 112.23 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.55 -25.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.23 1.012 . . . . 0.0 111.362 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -84.13 -7.36 59.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.978 1.311 . . . . 0.0 114.323 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 -46.52 5.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.905 0.882 . . . . 0.0 111.23 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.42 -20.33 60.08 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.571 1.548 . . . . 0.0 113.205 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -63.56 -23.9 67.58 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.699 -1.25 . . . . 0.0 113.354 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.34 80.09 1.92 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.985 1.314 . . . . 0.0 109.933 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -106.39 150.95 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.002 . . . . 0.0 111.828 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.82 130.57 44.07 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 160.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.84 111.95 23.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 156.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.0 m -134.6 126.45 29.25 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.704 1.202 . . . . 0.0 109.254 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.1 m -138.78 151.71 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.377 1.471 . . . . 0.0 110.495 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 126.26 1.824 . . . . 0.0 111.583 -178.021 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 120.773 0.32 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.58 -18.55 41.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 128.027 2.531 . . . . 0.0 116.219 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.66 -13.13 8.94 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.138 1.827 . . . . 0.0 113.945 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.37 -32.18 43.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.034 1.734 . . . . 0.0 110.755 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 pt -62.0 -28.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.186 -1.571 . . . . 0.0 112.15 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.75 -56.97 4.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.513 1.125 . . . . 0.0 110.098 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -58.83 -35.03 72.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.364 1.066 . . . . 0.0 112.641 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -70.31 -31.21 68.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.472 1.509 . . . . 0.0 112.307 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.0 tp -79.96 -35.24 37.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.605 0.362 . . . . 0.0 111.824 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 -53.11 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.777 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -59.06 -26.87 64.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.493 0.717 . . . . 0.0 112.289 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -15.16 60.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.453 HD22 HG11 ' A' ' 96' ' ' VAL . 56.7 m-80 -81.43 -40.1 23.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.039 0.836 . . . . 0.0 111.718 161.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.2 88.07 5.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 123.383 1.563 . . . . 0.0 111.607 -163.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 27.02 0.4 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.863 -1.517 . . . . 0.0 114.121 -175.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.45 -56.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.741 0.816 . . . . 0.0 112.563 -163.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.3 -57.59 0.63 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.001 2.521 . . . . 0.0 113.757 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.85 -24.13 62.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 112.937 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.6 m -84.06 -1.27 54.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.608 1.163 . . . . 0.0 113.623 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -117.5 -21.17 8.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.526 1.53 . . . . 0.0 113.179 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -85.44 152.1 23.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.315 1.846 . . . . 0.0 112.713 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 -8.49 28.3 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.365 1.459 . . . . 0.0 116.126 168.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 -179.55 4.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.149 1.779 . . . . 0.0 112.052 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 160.92 20.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.652 0.781 . . . . 0.0 111.29 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 49.0 t -159.51 144.19 15.29 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.449 1.1 . . . . 0.0 109.877 172.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.29 39.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.846 2.059 . . . . 0.0 110.031 168.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.25 175.08 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.277 1.031 . . . . 0.0 108.568 171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.08 126.76 20.45 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.941 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.75 128.75 53.89 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.128 0.971 . . . . 0.0 109.007 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -116.69 106.92 14.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.96 1.304 . . . . 0.0 109.117 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.28 157.77 16.16 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.605 1.162 . . . . 0.0 111.772 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.86 151.19 37.45 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.723 1.609 . . . . 0.0 110.154 167.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -72.52 150.42 51.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.137 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -166.47 148.17 6.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.487 2.315 . . . . 0.0 108.062 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.74 -17.66 71.42 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.776 1.071 . . . . 0.0 115.776 -165.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.3 p -97.14 -3.43 41.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.971 1.708 . . . . 0.0 113.127 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.26 165.42 11.45 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.161 1.363 . . . . 0.0 111.937 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 161.28 26.0 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.366 1.083 . . . . 0.0 111.115 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.21 144.58 51.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 111.127 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.65 112.2 1.91 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.427 0.558 . . . . 0.0 112.04 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.1 -46.11 3.16 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.026 1.298 . . . . 0.0 111.012 170.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.7 m -153.03 143.69 22.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.368 1.067 . . . . 0.0 110.682 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -119.21 121.86 40.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.258 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -104.8 118.31 36.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.405 1.482 . . . . 0.0 108.26 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 m -83.97 129.05 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 118.892 0.769 . . . . 0.0 109.732 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 mt -99.18 -54.32 3.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.009 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -177.87 164.8 1.96 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.721 2.008 . . . . 0.0 111.433 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.25 -173.71 39.44 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 125.57 1.557 . . . . 0.0 113.528 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.99 116.92 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.4 p -55.9 -26.31 46.83 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -150.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.83 -29.44 69.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.93 -47.37 16.54 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.722 1.147 . . . . 0.0 111.107 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 68.8 m -48.56 -45.07 37.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.632 1.106 . . . . 0.0 112.359 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.25 -47.93 75.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.628 1.171 . . . . 0.0 112.177 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.79 41.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.058 0.943 . . . . 0.0 113.266 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 t -56.8 -48.49 77.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.809 0.844 . . . . 0.0 110.845 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -48.71 -44.12 37.9 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.303 1.841 . . . . 0.0 111.953 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -70.57 -45.92 64.48 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.25 74.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.701 1.2 . . . . 0.0 111.161 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -67.08 -22.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.996 -1.065 . . . . 0.0 112.268 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -7.44 59.1 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.001 0.92 . . . . 0.0 112.538 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.18 -12.54 3.58 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 46' ' ' ASN . 9.6 m -56.52 145.56 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.485 1.114 . . . . 0.0 112.783 171.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.7 -44.68 77.13 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.0 p 165.59 142.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.214 2.205 . . . . 0.0 110.848 -169.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.21 111.27 51.13 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.693 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.18 128.85 10.85 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.217 1.945 . . . . 0.0 110.567 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.34 148.36 52.5 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.577 0.751 . . . . 0.0 112.118 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.06 -33.35 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.92 2.414 . . . . 0.0 111.075 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 153.78 45.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.161 2.184 . . . . 0.0 110.358 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -119.87 20.2 12.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.318 1.447 . . . . 0.0 113.406 -166.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -83.2 139.8 42.25 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 120.757 -1.214 . . . . 0.0 109.3 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.66 -15.74 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.461 2.774 . . . . 0.0 114.945 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.15 -28.62 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.973 1.309 . . . . 0.0 112.077 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.68 -26.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.582 1.553 . . . . 0.0 112.5 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.37 -26.27 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.49 1.116 . . . . 0.0 110.959 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.41 -11.49 59.68 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.233 1.413 . . . . 0.0 113.714 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -97.51 -46.52 6.01 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.914 0.779 . . . . 0.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.07 -22.52 60.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.796 1.238 . . . . 0.0 112.92 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.38 -23.93 66.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.07 82.35 2.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.006 0.923 . . . . 0.0 110.238 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.2 158.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.36 1.076 . . . . 0.0 111.968 178.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.06 126.09 52.33 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 157.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.59 112.47 21.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.5 m -132.1 125.84 32.31 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 109.054 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.24 149.99 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.251 1.82 . . . . 0.0 110.293 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 125.551 1.54 . . . . 0.0 112.197 -176.649 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 120.395 0.141 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' HH ' ' HB ' ' A' ' 108' ' ' VAL . 8.5 m-85 -49.89 -47.62 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.161 2.184 . . . . 0.0 114.038 -173.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.4 -16.14 62.87 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.052 1.31 . . . . 0.0 113.779 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.5 64.37 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.251 1.026 . . . . 0.0 111.645 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.03 -26.3 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.519 -0.738 . . . . 0.0 111.994 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -82.08 -59.87 2.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.494 1.118 . . . . 0.0 109.837 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -61.17 -35.14 76.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.254 1.022 . . . . 0.0 112.775 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -71.38 -43.02 67.66 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.165 0.986 . . . . 0.0 109.757 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.57 -30.33 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.672 0.669 . . . . 0.0 111.543 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -54.0 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.844 0.858 . . . . 0.0 110.915 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -68.05 -18.07 64.58 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -55.85 -36.45 67.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.256 0.48 . . . . 0.0 111.389 167.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.445 HD22 HG12 ' A' ' 96' ' ' VAL . 58.2 m-80 -77.51 -34.35 54.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -102.35 109.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.542 1.163 . . . . 0.0 111.14 -160.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.65 22.03 10.51 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 114.628 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.8 -62.56 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.332 0.653 . . . . 0.0 111.545 -166.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 72.86 -60.04 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.769 2.428 . . . . 0.0 113.506 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.6 -29.77 70.98 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.611 -1.305 . . . . 0.0 113.14 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -94.8 6.07 50.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.31 1.044 . . . . 0.0 113.655 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -105.31 -21.94 13.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 112.085 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -100.64 156.3 17.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.596 1.958 . . . . 0.0 111.905 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.48 -27.27 2.89 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.274 1.416 . . . . 0.0 114.556 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -174.68 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.494 1.918 . . . . 0.0 111.557 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 161.62 29.62 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.815 0.846 . . . . 0.0 110.643 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.443 ' HG ' HG22 ' A' ' 119' ' ' VAL . 0.5 OUTLIER -149.95 157.87 43.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.553 0.741 . . . . 0.0 111.433 160.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 126.03 31.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.84 1.656 . . . . 0.0 109.967 161.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.94 166.33 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.15 131.29 36.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.508 0.594 . . . . 0.0 112.065 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 132.18 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.159 0.984 . . . . 0.0 110.037 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -114.4 105.98 13.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.341 1.456 . . . . 0.0 109.147 171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.2 158.81 15.59 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.56 0.695 . . . . 0.0 111.748 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -99.3 133.43 22.03 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.126 1.37 . . . . 0.0 109.843 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.06 116.73 4.83 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.581 2.187 . . . . 0.0 109.207 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 m -106.14 -30.85 8.99 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.546 1.139 . . . . 0.0 112.095 -172.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.24 -112.33 0.49 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.852 1.215 . . . . 0.0 111.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -58.71 -25.28 62.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 112.34 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.76 179.04 20.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.757 1.17 . . . . 0.0 114.472 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.24 165.0 12.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.97 1.308 . . . . 0.0 111.515 170.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -132.82 147.22 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.151 1.781 . . . . 0.0 111.47 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.94 111.23 1.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.764 0.711 . . . . 0.0 112.656 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.35 -36.04 5.53 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.396 1.474 . . . . 0.0 111.668 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -167.26 153.39 7.94 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.266 1.426 . . . . 0.0 111.023 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -130.14 126.29 37.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.319 1.048 . . . . 0.0 109.873 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -105.17 132.98 50.71 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.402 1.881 . . . . 0.0 108.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.14 131.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.943 0.792 . . . . 0.0 109.102 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.56 -45.19 5.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.947 0.499 . . . . 0.0 110.073 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -172.58 167.91 5.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.986 1.715 . . . . 0.0 111.647 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.7 -177.84 27.59 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.893 1.235 . . . . 0.0 114.303 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.4 118.22 24.8 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 166.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.8 p -59.94 -21.27 60.94 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -158.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -60.88 -23.02 64.86 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.381 1.072 . . . . 0.0 113.669 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.44 -49.06 6.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.812 1.187 . . . . 0.0 111.414 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.8 m -49.99 -39.26 40.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.833 1.253 . . . . 0.0 114.322 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.2 56.86 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.04 0.836 . . . . 0.0 112.829 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -51.29 65.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.981 . . . . 0.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.4 t -57.46 -47.6 81.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.454 0.702 . . . . 0.0 110.235 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -57.19 -35.15 69.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.371 1.068 . . . . 0.0 112.157 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -71.26 -48.52 50.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.41 72.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.647 1.179 . . . . 0.0 111.749 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.1 -24.04 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.489 -1.382 . . . . 0.0 111.661 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -6.94 58.83 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -130.91 -12.14 3.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.445 HG12 HD22 ' A' ' 46' ' ' ASN . 9.7 m -58.76 145.91 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.395 1.078 . . . . 0.0 112.257 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.41 -42.1 83.78 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -173.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p 163.21 143.44 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.56 2.344 . . . . 0.0 111.048 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -98.13 105.32 27.61 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-O 117.527 -1.225 . . . . 0.0 109.948 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 134.35 17.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.817 2.344 . . . . 0.0 110.437 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 144.87 59.22 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.31 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.33 -28.67 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.241 2.627 . . . . 0.0 111.855 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -140.77 154.23 46.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.715 2.006 . . . . 0.0 110.482 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -133.49 48.1 2.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.175 0.99 . . . . 0.0 112.349 -165.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.9 141.2 22.84 Favored Pre-proline 0 C--O 1.243 0.733 0 O-C-N 121.35 -0.844 . . . . 0.0 108.802 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.17 -17.55 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.021 3.148 . . . . 0.0 115.182 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.76 -33.85 40.34 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.039 0.836 . . . . 0.0 112.335 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' HB ' ' HH ' ' A' ' 35' ' ' TYR . 21.5 m -97.26 -25.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.506 1.122 . . . . 0.0 112.611 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.33 -26.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.697 1.199 . . . . 0.0 110.951 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -81.38 -10.7 59.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.001 1.32 . . . . 0.0 114.031 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.77 -47.5 5.57 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.343 -0.848 . . . . 0.0 111.401 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.4 -21.07 61.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.188 . . . . 0.0 112.61 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -65.38 -24.95 67.36 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.726 -1.234 . . . . 0.0 113.42 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -129.92 78.78 1.87 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.044 1.338 . . . . 0.0 110.345 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.434 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.56 150.26 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.156 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.52 128.42 44.25 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 159.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.75 116.34 28.93 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.7 m -135.02 128.17 31.85 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.718 1.207 . . . . 0.0 109.679 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' A' ' 58' ' ' CYS . 5.7 m -139.65 156.56 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.421 1.488 . . . . 0.0 111.303 -168.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 127.431 2.293 . . . . 0.0 110.003 -175.76 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.475 ' HH ' ' HB ' ' A' ' 108' ' ' VAL . 5.2 m-85 -51.3 -42.74 61.38 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 126.837 2.055 . . . . 0.0 113.629 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.72 -17.5 67.91 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.393 1.473 . . . . 0.0 113.711 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.76 -30.27 51.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.794 1.297 . . . . 0.0 112.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -57.87 -29.0 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.098 -1.002 . . . . 0.0 111.065 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -79.16 -58.04 3.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.832 1.253 . . . . 0.0 110.161 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -60.36 -34.33 73.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.303 1.041 . . . . 0.0 112.56 -174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -72.73 -34.01 66.78 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.06 1.344 . . . . 0.0 111.984 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -70.64 -36.75 73.57 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.436 0.562 . . . . 0.0 111.378 172.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.01 -44.25 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.065 0.946 . . . . 0.0 111.333 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -12.04 59.9 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.083 0.953 . . . . 0.0 113.257 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -57.23 -37.14 71.81 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 161.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.445 HD22 HG12 ' A' ' 96' ' ' VAL . 26.1 m-80 -79.96 -49.25 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.625 0.726 . . . . 0.0 109.897 173.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 mt -89.0 75.33 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 123.341 1.543 . . . . 0.0 111.604 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.01 25.87 0.08 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.35 1.46 . . . . 0.0 114.729 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.99 -61.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.43 0.692 . . . . 0.0 112.408 -159.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 74.24 -47.66 0.64 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.732 2.413 . . . . 0.0 113.321 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.84 -28.43 68.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.967 1.307 . . . . 0.0 112.95 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -90.44 -3.41 57.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.927 1.691 . . . . 0.0 114.303 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -117.75 -29.83 5.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 113.726 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -92.59 164.82 13.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.975 1.31 . . . . 0.0 111.925 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.93 -42.61 2.52 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 125.777 1.656 . . . . 0.0 113.932 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -175.36 5.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.267 1.427 . . . . 0.0 111.438 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 162.46 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.615 -0.678 . . . . 0.0 111.315 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.8 t -157.99 146.16 18.79 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.636 1.175 . . . . 0.0 110.092 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 131.59 48.94 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.149 1.38 . . . . 0.0 111.123 164.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -144.01 171.88 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 120.781 -1.2 . . . . 0.0 108.175 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.72 132.31 40.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.346 -0.846 . . . . 0.0 112.176 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.12 131.08 54.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.938 0.895 . . . . 0.0 109.464 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.08 112.48 24.14 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.07 0.948 . . . . 0.0 109.49 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.14 159.22 15.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 111.204 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.8 pt -96.15 150.19 36.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 110.381 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.39 146.29 50.04 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.646 2.231 . . . . 0.0 110.247 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -165.21 147.33 7.82 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.561 1.944 . . . . 0.0 108.359 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.62 -18.59 72.17 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 124.444 1.021 . . . . 0.0 115.599 -168.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -94.13 3.16 55.67 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.409 1.884 . . . . 0.0 113.175 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.34 165.97 14.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.96 1.743 . . . . 0.0 111.335 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.26 22.12 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.001 0.901 . . . . 0.0 111.321 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -127.88 144.07 51.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.07 1.348 . . . . 0.0 111.182 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.27 113.7 2.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.623 0.647 . . . . 0.0 112.481 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.24 -43.05 2.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.676 1.608 . . . . 0.0 111.41 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -154.51 150.33 27.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.944 0.898 . . . . 0.0 111.434 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.37 131.02 53.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.526 1.131 . . . . 0.0 109.706 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -119.63 119.6 34.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.695 1.598 . . . . 0.0 108.694 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.16 137.23 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.053 0.842 . . . . 0.0 109.929 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -109.65 -50.37 2.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.144 0.578 . . . . 0.0 110.004 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -173.7 170.36 4.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.994 1.718 . . . . 0.0 111.78 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.63 32.73 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 125.326 1.441 . . . . 0.0 113.171 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.96 113.65 20.01 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -58.35 -19.94 39.42 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -153.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -49.61 -37.77 29.19 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.91 1.284 . . . . 0.0 112.681 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.11 -52.17 8.56 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.217 0.917 . . . . 0.0 110.722 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.2 m -46.46 -44.84 17.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.061 1.344 . . . . 0.0 113.421 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.38 82.73 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.925 0.89 . . . . 0.0 112.678 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.91 19.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.579 1.152 . . . . 0.0 112.83 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 t -57.37 -46.1 83.71 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.588 0.755 . . . . 0.0 110.617 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -50.29 -42.19 52.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.482 1.913 . . . . 0.0 111.723 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -69.78 -48.53 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.78 80.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.62 1.168 . . . . 0.0 111.693 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.69 -24.32 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.875 -1.141 . . . . 0.0 111.918 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.74 55.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.859 0.864 . . . . 0.0 112.869 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -134.68 -11.27 2.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.445 HG12 HD22 ' A' ' 46' ' ' ASN . 7.4 m -58.07 148.99 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.415 1.086 . . . . 0.0 112.776 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -70.51 -47.91 58.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 113.099 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 p 170.73 145.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.186 2.194 . . . . 0.0 110.355 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.62 108.49 42.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 117.771 -1.109 . . . . 0.0 110.363 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.13 136.28 19.94 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.248 1.965 . . . . 0.0 110.37 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.53 152.91 64.62 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.449 0.7 . . . . 0.0 112.329 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.46 -41.83 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.007 2.471 . . . . 0.0 110.277 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.47 149.28 50.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.023 2.129 . . . . 0.0 109.699 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.37 9.25 19.78 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -164.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.86 144.57 60.08 Favored Pre-proline 0 CA--C 1.539 0.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.98 -2.7 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.324 2.683 . . . . 0.0 113.584 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.863 0.865 . . . . 0.0 112.519 168.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HB ' ' HH ' ' A' ' 35' ' ' TYR . 16.4 m -97.76 -26.39 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.664 1.186 . . . . 0.0 112.654 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.38 -25.65 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.059 0.944 . . . . 0.0 111.028 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -83.12 -9.1 59.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.897 1.279 . . . . 0.0 113.995 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -42.43 6.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.068 . . . . 0.0 111.693 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.71 -20.13 59.97 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 124.867 1.267 . . . . 0.0 112.93 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -66.39 -25.56 66.84 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 113.163 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -128.82 81.96 2.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.031 0.932 . . . . 0.0 109.892 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.56 150.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 111.75 -178.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 130.86 35.94 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 153.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -85.3 129.09 34.88 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 157.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.0 m -146.15 127.07 14.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.82 157.25 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.335 1.454 . . . . 0.0 111.127 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.248 0 C-N-CA 126.272 1.829 . . . . 0.0 113.642 -179.389 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -54.38 -49.89 68.8 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.983 2.513 . . . . 0.0 113.915 -162.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.98 -15.43 65.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.969 1.747 . . . . 0.0 114.097 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.14 -30.4 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.647 1.223 . . . . 0.0 111.609 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.2 pt -62.62 -28.49 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.513 -1.367 . . . . 0.0 111.621 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.47 -57.06 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.924 1.289 . . . . 0.0 110.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -57.44 -36.04 70.88 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.064 0.946 . . . . 0.0 111.86 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.85 -38.03 82.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.929 1.292 . . . . 0.0 111.898 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 tp -76.52 -28.22 56.3 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.02 -54.42 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -25.56 67.69 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.278 0.631 . . . . 0.0 111.45 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.02 -14.54 61.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.449 HD22 HG11 ' A' ' 96' ' ' VAL . 70.1 m-80 -80.66 -33.85 35.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.472 1.033 . . . . 0.0 113.172 165.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.89 110.06 22.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.778 1.231 . . . . 0.0 111.47 -158.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.0 24.85 8.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.977 1.311 . . . . 0.0 114.14 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.8 -58.79 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.507 0.723 . . . . 0.0 112.12 -165.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 71.44 -64.11 0.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.612 2.365 . . . . 0.0 113.346 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -64.63 -35.34 80.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.761 1.225 . . . . 0.0 112.833 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -91.13 6.88 43.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.441 1.097 . . . . 0.0 113.448 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -104.29 -9.73 18.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.062 1.745 . . . . 0.0 112.491 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -114.58 159.43 20.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.004 1.722 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.348 1.451 . . . . 0.0 114.477 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 178.91 8.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.361 1.864 . . . . 0.0 112.354 -174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.17 19.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.294 1.037 . . . . 0.0 110.613 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.12 143.5 21.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.493 1.117 . . . . 0.0 110.768 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 129.56 46.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 110.403 163.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.87 172.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.14 131.18 30.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.705 -0.622 . . . . 0.0 112.345 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.84 130.19 51.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.161 0.984 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -114.19 105.11 12.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 109.214 171.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.43 157.6 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.736 0.779 . . . . 0.0 112.2 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.32 151.96 37.61 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 125.389 1.476 . . . . 0.0 110.488 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -72.37 147.83 47.72 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.264 2.643 . . . . 0.0 111.19 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -165.59 149.59 8.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.273 2.229 . . . . 0.0 108.493 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.87 -16.41 70.3 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.4 p -94.3 -4.84 47.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.215 1.806 . . . . 0.0 113.477 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.73 170.58 12.93 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.344 1.449 . . . . 0.0 111.755 -166.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.37 160.0 25.63 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.568 1.184 . . . . 0.0 111.323 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.07 145.96 51.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.147 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.99 109.85 1.19 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.172 0.589 . . . . 0.0 111.518 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.8 -47.34 3.44 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 125.204 1.383 . . . . 0.0 110.886 170.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 m -155.18 150.89 27.54 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.866 1.266 . . . . 0.0 111.218 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.4 129.08 49.15 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.833 1.253 . . . . 0.0 109.39 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 m -115.18 118.85 34.5 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.209 1.804 . . . . 0.0 108.093 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -81.87 134.63 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.286 0.948 . . . . 0.0 109.757 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.22 -48.93 3.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.213 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -171.21 170.26 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.525 1.53 . . . . 0.0 111.868 171.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.79 -178.93 29.65 Favored Glycine 0 N--CA 1.462 0.396 0 C-N-CA 125.314 1.435 . . . . 0.0 113.554 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.46 113.85 21.5 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 167.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -63.84 -17.58 63.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -149.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -56.17 -33.45 65.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.767 0.827 . . . . 0.0 112.225 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.86 -46.62 18.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.796 -1.097 . . . . 0.0 111.397 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -47.16 -46.08 23.24 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.773 1.229 . . . . 0.0 113.027 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.75 89.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.768 0.827 . . . . 0.0 112.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.76 -52.36 31.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 112.708 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.3 t -57.76 -48.25 80.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.586 0.755 . . . . 0.0 111.197 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -50.23 -44.71 53.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.469 1.508 . . . . 0.0 111.472 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.79 -45.06 65.37 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.697 0.799 . . . . 0.0 112.56 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.25 -49.76 75.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.385 1.074 . . . . 0.0 111.881 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.65 -22.8 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.828 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.4 -6.94 58.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 112.639 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.95 -12.2 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 46' ' ' ASN . 14.8 m -58.14 147.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.023 0.929 . . . . 0.0 112.35 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -71.61 -47.56 53.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p 171.14 142.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.723 2.009 . . . . 0.0 111.213 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -94.67 108.61 38.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.423 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 130.05 14.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.341 2.028 . . . . 0.0 110.111 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.04 148.29 74.84 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.491 0.716 . . . . 0.0 111.751 -171.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.98 -36.1 4.73 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.535 2.157 . . . . 0.0 110.879 168.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 153.51 41.31 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.439 2.295 . . . . 0.0 109.948 176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.15 8.56 19.98 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -165.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.16 144.38 62.74 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 118.988 0.813 . . . . 0.0 110.004 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.81 -4.01 6.6 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.424 2.749 . . . . 0.0 113.696 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.72 -38.26 19.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.98 0.809 . . . . 0.0 112.159 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.61 -26.66 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.225 1.01 . . . . 0.0 112.715 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -26.99 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.124 0.969 . . . . 0.0 110.906 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -78.72 -13.17 59.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.01 1.324 . . . . 0.0 113.222 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.06 -42.33 7.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.672 0.789 . . . . 0.0 111.71 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.39 -23.23 60.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.828 0.851 . . . . 0.0 112.488 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -68.96 -23.31 64.12 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.743 -1.223 . . . . 0.0 113.946 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -128.29 84.08 2.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.134 0.974 . . . . 0.0 110.057 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.446 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -112.11 155.31 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.479 1.111 . . . . 0.0 112.215 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -91.41 136.21 33.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 156.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.63 118.14 29.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 154.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -135.9 130.25 33.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.39 146.25 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.734 2.414 . . . . 0.0 108.493 -165.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 125.241 1.417 . . . . 0.0 111.628 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 120.342 0.115 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -63.82 -17.99 63.66 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.002 2.121 . . . . 0.0 116.057 -162.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.74 -13.35 11.45 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.923 2.201 . . . . 0.0 114.124 166.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.83 -30.17 40.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.117 1.367 . . . . 0.0 111.797 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -62.31 -27.77 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 120.646 -1.284 . . . . 0.0 111.946 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -80.01 -56.53 4.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.286 1.434 . . . . 0.0 110.682 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -58.11 -34.48 70.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.938 0.895 . . . . 0.0 112.01 -176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -67.92 -40.2 83.43 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.679 1.191 . . . . 0.0 110.881 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.36 -28.76 61.27 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.0 -54.12 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 110.441 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -23.29 67.29 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.043 0.537 . . . . 0.0 112.153 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.02 -15.6 60.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.434 HD22 HG13 ' A' ' 96' ' ' VAL . 69.1 m-80 -79.73 -39.9 30.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.845 1.202 . . . . 0.0 111.882 163.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.0 83.35 3.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.557 1.646 . . . . 0.0 112.243 -160.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 28.93 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.774 1.63 . . . . 0.0 114.232 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.71 -62.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.434 -0.791 . . . . 0.0 112.093 -163.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 72.54 -62.64 0.46 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.309 2.243 . . . . 0.0 113.51 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.12 -37.39 87.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.257 1.423 . . . . 0.0 112.554 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.2 m -85.56 -1.78 57.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -103.96 -22.64 13.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.983 1.713 . . . . 0.0 113.279 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 152.66 19.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.179 1.392 . . . . 0.0 112.911 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.6 2.16 90.6 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.083 1.325 . . . . 0.0 114.29 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.77 177.77 8.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.115 1.766 . . . . 0.0 112.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.59 160.48 25.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.826 1.25 . . . . 0.0 110.099 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 45.1 t -153.62 144.13 22.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.216 1.007 . . . . 0.0 110.215 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 127.76 38.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.293 1.437 . . . . 0.0 111.134 171.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.21 172.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.367 1.067 . . . . 0.0 108.335 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -137.02 131.67 33.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.588 0.755 . . . . 0.0 112.113 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -103.04 134.26 46.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.007 0.923 . . . . 0.0 110.38 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -118.09 103.47 9.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.187 1.395 . . . . 0.0 108.849 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -99.29 158.46 15.69 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.917 0.865 . . . . 0.0 112.149 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 pt -99.03 148.75 35.01 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.581 1.552 . . . . 0.0 110.183 166.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.56 147.92 41.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.302 2.668 . . . . 0.0 110.857 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -166.67 146.56 5.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.273 2.229 . . . . 0.0 108.479 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.95 -21.45 75.32 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.564 0.986 . . . . 0.0 115.564 -166.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -89.39 -5.22 57.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.979 1.712 . . . . 0.0 113.183 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.79 162.49 10.84 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.891 1.71 . . . . 0.0 111.421 -169.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.74 160.69 16.61 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 117.789 0.794 . . . . 0.0 111.596 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.84 143.32 50.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.332 1.453 . . . . 0.0 110.91 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.98 109.34 1.05 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.44 0.696 . . . . 0.0 111.623 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.92 -36.51 5.23 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.537 1.542 . . . . 0.0 111.925 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -163.85 155.68 16.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 111.127 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.43 129.94 39.94 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.091 1.357 . . . . 0.0 109.92 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.3 m -115.81 119.15 35.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.923 2.089 . . . . 0.0 108.448 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.0 137.1 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.098 0.863 . . . . 0.0 110.164 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.39 -47.37 3.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.933 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -174.12 166.77 4.2 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.998 2.119 . . . . 0.0 111.217 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.28 164.5 27.9 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.083 -1.011 . . . . 0.0 114.15 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.37 178.94 4.89 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.945 0.898 . . . . 0.0 110.363 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 t -30.24 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.73 2.412 . . . . 0.0 115.517 -162.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 31.6 mtm105 70.44 -1.21 2.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.199 2.2 . . . . 0.0 116.378 162.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.26 -46.58 70.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 122.429 2.377 . . . . 0.0 112.171 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.29 -28.08 51.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 166.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.18 -35.47 41.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.377 0.989 . . . . 0.0 112.382 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -51.02 15.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.63 1.572 . . . . 0.0 112.498 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.1 t -55.48 -48.9 73.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.854 0.861 . . . . 0.0 111.196 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -51.3 -44.7 61.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.786 1.634 . . . . 0.0 111.469 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -69.19 -44.55 71.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.028 0.931 . . . . 0.0 113.385 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.51 76.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.57 1.148 . . . . 0.0 111.48 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.9 -21.22 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.69 -1.256 . . . . 0.0 112.236 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.97 -6.92 59.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.066 0.947 . . . . 0.0 112.187 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.05 -12.73 4.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.434 HG13 HD22 ' A' ' 46' ' ' ASN . 16.7 m -58.14 146.05 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-N 119.394 0.997 . . . . 0.0 111.975 168.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -72.45 -46.12 56.46 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.1 p 172.78 141.94 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.36 1.864 . . . . 0.0 110.911 -168.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -94.37 106.74 25.01 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.292 1.037 . . . . 0.0 111.193 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.79 118.34 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.295 1.997 . . . . 0.0 109.968 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.03 148.71 37.42 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.461 1.104 . . . . 0.0 112.367 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.11 -29.93 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.924 2.416 . . . . 0.0 112.313 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -138.56 148.67 44.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.947 1.699 . . . . 0.0 110.495 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -120.66 22.0 11.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.555 1.542 . . . . 0.0 113.284 -167.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.8 142.17 32.26 Favored Pre-proline 0 C--O 1.242 0.668 0 O-C-N 120.627 -1.295 . . . . 0.0 110.731 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.02 -7.05 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 124.14 3.226 . . . . 0.0 116.177 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -87.95 -41.57 13.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.881 1.219 . . . . 0.0 112.343 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -92.57 -25.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.529 1.532 . . . . 0.0 113.365 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.49 -29.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.939 0.79 . . . . 0.0 110.935 170.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.402 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 33.0 mm-40 -77.0 -8.07 56.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.319 1.047 . . . . 0.0 113.766 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.38 -48.22 5.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.356 0.663 . . . . 0.0 112.203 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.8 -28.07 68.73 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.13 0.972 . . . . 0.0 112.679 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -72.51 -23.79 61.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.44 -1.413 . . . . 0.0 114.003 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -121.74 88.99 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.331 1.052 . . . . 0.0 111.086 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.449 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.63 156.34 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.435 1.094 . . . . 0.0 112.614 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.71 137.52 32.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.093 -0.379 . . . . 0.0 110.278 156.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.7 mt -91.4 112.91 25.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 153.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.8 m -134.83 125.43 26.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.916 0.887 . . . . 0.0 108.835 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.32 153.16 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.588 1.555 . . . . 0.0 110.734 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 125.466 1.506 . . . . 0.0 111.992 -175.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -51.02 -47.16 61.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 128.276 2.63 . . . . 0.0 113.699 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.95 -15.86 66.5 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.246 1.403 . . . . 0.0 113.366 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.75 60.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 1.119 . . . . 0.0 111.719 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -59.67 -27.01 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.9 0.773 . . . . 0.0 111.916 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -82.09 -58.64 2.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.122 1.369 . . . . 0.0 110.362 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -60.69 -33.4 72.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.003 0.921 . . . . 0.0 112.852 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -73.37 -35.4 65.93 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.994 0.918 . . . . 0.0 110.795 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.9 tp -73.39 -31.58 63.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.754 0.707 . . . . 0.0 112.059 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.24 -48.29 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.287 0.635 . . . . 0.0 110.71 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -67.78 -19.0 65.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -57.51 -36.53 71.66 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.128 0.571 . . . . 0.0 111.329 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.419 HD22 HG11 ' A' ' 96' ' ' VAL . 45.1 m-80 -78.24 -40.22 37.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.983 0.421 . . . . 0.0 112.098 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.72 88.4 3.81 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 123.149 1.452 . . . . 0.0 111.887 -163.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.96 31.02 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.338 -1.755 . . . . 0.0 113.781 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.68 -64.09 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.101 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 72.79 -63.84 0.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.892 2.077 . . . . 0.0 112.826 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.01 -45.33 61.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.667 1.187 . . . . 0.0 112.159 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.3 m -79.24 2.86 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -93.87 -10.46 33.88 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.834 1.653 . . . . 0.0 111.761 166.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -114.35 171.31 7.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.049 2.139 . . . . 0.0 111.107 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.02 -21.59 3.29 Favored Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.807 1.194 . . . . 0.0 114.372 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 -175.16 3.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.171 2.589 . . . . 0.0 111.616 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 164.98 23.21 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.449 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.2 t -159.97 144.74 14.91 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.448 1.099 . . . . 0.0 110.142 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.59 130.14 46.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.512 164.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.88 170.4 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.275 1.03 . . . . 0.0 108.333 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.0 131.18 32.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.348 0.594 . . . . 0.0 111.738 -173.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.13 132.85 45.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.967 0.907 . . . . 0.0 110.334 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -116.4 103.01 10.03 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 108.931 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.62 158.97 15.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.731 0.777 . . . . 0.0 111.906 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.1 pt -100.13 136.79 20.02 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.453 1.501 . . . . 0.0 110.219 167.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.95 129.62 17.71 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.585 2.19 . . . . 0.0 109.832 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 m -142.86 88.58 2.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.271 1.428 . . . . 0.0 108.548 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 -122.49 28.03 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.895 0.759 . . . . 0.0 112.12 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -81.6 3.5 24.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.209 1.803 . . . . 0.0 113.842 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.18 -166.6 10.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.257 1.408 . . . . 0.0 114.377 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.33 165.47 17.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.205 1.402 . . . . 0.0 110.918 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.62 148.51 52.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.144 1.778 . . . . 0.0 111.153 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.56 111.88 1.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.009 0.822 . . . . 0.0 112.28 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.54 -35.06 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.78 1.657 . . . . 0.0 112.125 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -167.2 153.18 7.86 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.365 1.466 . . . . 0.0 110.998 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -127.91 129.38 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.428 1.091 . . . . 0.0 109.874 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.3 m -113.28 118.87 35.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.236 1.815 . . . . 0.0 108.536 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.74 130.9 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.903 0.774 . . . . 0.0 109.81 169.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -101.98 -46.92 4.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.108 0.563 . . . . 0.0 110.04 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -170.47 169.48 7.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.119 1.768 . . . . 0.0 111.515 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.11 179.07 23.79 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 124.887 1.232 . . . . 0.0 114.527 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.23 119.79 25.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.79 -17.66 37.36 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -159.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.71 65.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.679 1.191 . . . . 0.0 112.07 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.3 tp -88.85 -49.23 6.94 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.673 1.124 . . . . 0.0 111.562 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 m -47.81 -43.09 27.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.537 1.062 . . . . 0.0 113.539 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.08 73.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.082 0.856 . . . . 0.0 112.573 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.14 -52.25 25.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.424 1.09 . . . . 0.0 112.191 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 t -57.85 -49.37 76.89 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.104 0.962 . . . . 0.0 110.355 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -51.27 -45.8 62.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -66.41 -47.02 74.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.518 0.727 . . . . 0.0 112.845 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.06 75.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 111.414 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.77 -23.29 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.579 -1.326 . . . . 0.0 111.518 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.78 -6.84 58.09 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.369 -0.832 . . . . 0.0 112.396 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.09 -11.97 3.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 46' ' ' ASN . 13.4 m -58.14 148.59 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.296 0.953 . . . . 0.0 112.55 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.48 -48.94 59.06 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 p 170.18 141.89 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.555 1.942 . . . . 0.0 111.414 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -98.99 110.38 57.5 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.311 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.18 134.34 12.84 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.842 2.361 . . . . 0.0 111.009 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.48 148.36 66.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.047 -0.502 . . . . 0.0 112.272 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 -36.17 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.482 2.788 . . . . 0.0 111.935 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 153.25 47.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.439 2.296 . . . . 0.0 110.526 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.11 7.69 18.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -163.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.03 142.91 44.96 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.937 -1.102 . . . . 0.0 110.431 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.34 0.35 2.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.807 3.005 . . . . 0.0 113.642 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.91 -38.72 17.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.927 0.891 . . . . 0.0 111.834 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 m -96.07 -26.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.571 1.148 . . . . 0.0 112.613 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.8 -28.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.435 1.094 . . . . 0.0 110.994 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -84.06 -5.44 59.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.237 1.015 . . . . 0.0 113.636 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -98.49 -51.36 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.013 -1.054 . . . . 0.0 111.192 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.98 -20.48 65.89 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.824 1.25 . . . . 0.0 113.874 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -69.74 -23.57 63.41 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.014 -1.054 . . . . 0.0 112.819 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -125.27 83.29 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.115 1.766 . . . . 0.0 111.119 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.449 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.43 153.42 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.319 1.047 . . . . 0.0 112.092 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.19 137.12 34.67 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.88 0.371 . . . . 0.0 110.125 158.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.33 120.68 33.89 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 155.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -136.77 129.1 29.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.384 1.074 . . . . 0.0 109.222 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 164.95 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.171 1.788 . . . . 0.0 110.742 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 112.958 -175.317 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -49.33 -45.84 46.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.597 2.359 . . . . 0.0 114.064 -172.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.71 -18.4 60.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.738 1.637 . . . . 0.0 113.746 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.51 63.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.375 1.088 . . . . 0.0 111.864 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -61.37 -27.07 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.125 -0.985 . . . . 0.0 112.347 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -82.37 -59.19 2.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 109.722 174.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -59.26 -35.33 73.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.034 0.934 . . . . 0.0 111.99 -171.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -71.54 -41.75 68.75 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.968 0.907 . . . . 0.0 110.867 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.63 -25.91 65.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.539 0.609 . . . . 0.0 112.035 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.46 -55.59 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.187 0.995 . . . . 0.0 110.253 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -22.46 66.11 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.668 0.387 . . . . 0.0 111.594 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.51 -13.16 61.72 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.642 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.437 HD22 HG12 ' A' ' 96' ' ' VAL . 71.7 m-80 -81.05 -36.69 30.18 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.947 1.248 . . . . 0.0 112.164 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 80.31 1.82 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.327 1.451 . . . . 0.0 109.821 -169.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 51.62 0.43 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.807 1.643 . . . . 0.0 112.492 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.66 -56.48 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 73.26 -51.71 0.7 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.063 2.545 . . . . 0.0 114.892 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.51 -31.75 32.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.382 1.473 . . . . 0.0 112.879 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -85.05 -13.38 50.61 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.836 0.854 . . . . 0.0 112.604 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -89.34 -8.17 53.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.014 1.326 . . . . 0.0 112.478 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -112.73 171.41 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.401 1.88 . . . . 0.0 113.099 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.3 -45.49 3.23 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.119 1.819 . . . . 0.0 112.371 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -170.89 3.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.61 1.564 . . . . 0.0 111.137 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.29 26.26 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.835 0.854 . . . . 0.0 110.985 168.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 38.8 t -151.61 145.04 24.82 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.691 1.196 . . . . 0.0 109.564 170.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.26 129.36 41.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.164 1.385 . . . . 0.0 110.615 170.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.69 172.07 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.87 1.268 . . . . 0.0 107.978 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -137.59 133.15 34.08 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.801 0.841 . . . . 0.0 111.722 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.98 140.35 36.39 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.387 0.675 . . . . 0.0 111.81 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -120.2 105.69 11.21 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.431 1.493 . . . . 0.0 108.92 170.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.74 159.37 15.24 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.397 -0.815 . . . . 0.0 111.843 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.68 139.96 20.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.924 1.689 . . . . 0.0 109.821 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.67 137.3 58.32 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.507 2.138 . . . . 0.0 111.624 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -143.97 162.89 35.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.28 2.232 . . . . 0.0 107.918 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.02 -22.24 70.38 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.005 -1.059 . . . . 0.0 115.561 -171.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -94.97 -19.61 20.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.783 1.633 . . . . 0.0 112.734 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.37 -174.37 34.86 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.649 2.071 . . . . 0.0 111.007 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 160.35 31.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.216 2.008 . . . . 0.0 110.15 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -132.43 143.7 49.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.304 1.442 . . . . 0.0 111.527 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.57 108.44 0.56 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.996 0.919 . . . . 0.0 112.261 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.51 -35.82 5.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.673 1.606 . . . . 0.0 111.632 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -166.01 150.04 7.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.901 1.28 . . . . 0.0 111.13 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.7 tt -123.07 130.44 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.955 1.702 . . . . 0.0 109.319 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -114.44 118.68 34.49 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.6 1.56 . . . . 0.0 108.358 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 m -83.63 136.19 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.803 0.729 . . . . 0.0 109.88 168.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.73 -45.79 3.77 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.3 0.64 . . . . 0.0 110.151 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -172.48 167.51 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.102 1.761 . . . . 0.0 111.348 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.83 170.11 36.17 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.526 -0.734 . . . . 0.0 114.552 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.36 -177.53 4.01 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.826 1.25 . . . . 0.0 111.047 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.259 59.3 p 51.52 -97.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.385 2.274 . . . . 0.0 113.018 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.33 -4.27 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 113.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -64.08 -43.91 93.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.926 1.694 . . . . 0.0 113.01 -157.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.0 p -56.95 -27.64 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.74 -40.73 13.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.799 1.239 . . . . 0.0 112.155 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.36 -53.74 50.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.77 1.228 . . . . 0.0 111.998 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.0 t -52.75 -46.65 67.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.894 0.878 . . . . 0.0 110.537 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.88 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.38 1.072 . . . . 0.0 113.438 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -73.35 -43.37 60.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.73 76.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.736 1.214 . . . . 0.0 112.024 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.86 -23.38 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.533 -1.354 . . . . 0.0 112.09 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.82 -6.96 55.9 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.35 -0.844 . . . . 0.0 112.727 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.31 -11.95 2.46 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG12 HD22 ' A' ' 46' ' ' ASN . 13.6 m -58.15 147.82 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.712 1.205 . . . . 0.0 112.734 171.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -75.3 -39.08 59.96 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 p 165.23 141.23 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 127.491 2.316 . . . . 0.0 111.501 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -95.04 112.26 57.68 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.269 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.44 120.7 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.306 2.004 . . . . 0.0 110.047 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 138.58 25.99 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.65 1.18 . . . . 0.0 111.743 -176.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.24 -47.58 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.421 2.748 . . . . 0.0 111.916 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -103.46 147.41 27.17 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.304 1.442 . . . . 0.0 110.868 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.31 12.79 11.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.874 1.27 . . . . 0.0 113.564 -163.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -78.88 140.56 58.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 O-C-N 120.825 -1.172 . . . . 0.0 109.392 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.87 -4.69 7.74 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.047 2.498 . . . . 0.0 113.419 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.43 -31.87 24.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.726 0.694 . . . . 0.0 112.403 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.97 -24.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.04 -28.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.264 1.026 . . . . 0.0 110.731 166.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.28 -9.86 59.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.501 1.52 . . . . 0.0 113.791 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.77 -43.83 5.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.279 1.032 . . . . 0.0 112.198 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.55 -22.33 61.77 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.973 0.909 . . . . 0.0 111.743 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -65.5 -22.95 66.78 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.63 -1.294 . . . . 0.0 113.918 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -123.74 80.12 1.77 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.41 1.084 . . . . 0.0 110.301 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.99 151.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.961 0.905 . . . . 0.0 111.83 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.3 128.04 41.82 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 159.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.05 111.18 21.85 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 160.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.8 m -135.45 123.94 23.49 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.589 1.155 . . . . 0.0 108.502 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.36 148.37 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.696 1.198 . . . . 0.0 111.175 -169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.397 0 C-N-CA 126.241 1.816 . . . . 0.0 114.388 175.327 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.61 -39.61 80.92 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 128.034 2.534 . . . . 0.0 113.761 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.78 63.73 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.377 1.465 . . . . 0.0 114.009 169.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -26.12 56.06 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.867 1.333 . . . . 0.0 112.065 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.18 -30.0 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.333 -1.479 . . . . 0.0 111.634 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' HH ' ' HB2' ' A' ' 112' ' ' LEU . 99.1 m-85 -77.8 -55.22 5.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.129 1.372 . . . . 0.0 110.095 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -57.33 -34.89 69.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.878 0.871 . . . . 0.0 112.297 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.64 -30.49 65.81 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.227 1.411 . . . . 0.0 112.628 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp -82.12 -31.48 30.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.674 0.67 . . . . 0.0 112.353 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.74 -46.86 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.761 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -21.76 66.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.284 1.034 . . . . 0.0 112.98 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -59.65 -36.73 77.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.516 0.727 . . . . 0.0 110.791 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.43 HD22 HG11 ' A' ' 96' ' ' VAL . 30.5 m-80 -78.35 -45.42 22.6 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 0.0 111.162 170.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.99 74.28 4.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 123.456 1.598 . . . . 0.0 112.298 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.03 29.06 0.06 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 113.791 -1.549 . . . . 0.0 114.048 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.6 -71.09 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 -163.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 74.15 -48.24 0.66 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.568 2.347 . . . . 0.0 114.119 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.26 -38.23 88.47 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.296 -1.503 . . . . 0.0 113.16 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.9 p -91.36 0.05 57.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.343 1.057 . . . . 0.0 113.662 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.7 m-30 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.543 1.537 . . . . 0.0 111.384 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -110.68 156.12 21.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.776 2.03 . . . . 0.0 111.223 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.12 -25.94 4.59 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.101 1.334 . . . . 0.0 113.795 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -106.29 -172.68 2.13 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.831 2.052 . . . . 0.0 110.741 167.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 164.31 28.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.273 1.029 . . . . 0.0 110.345 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.58 157.64 43.45 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.441 -0.787 . . . . 0.0 111.463 160.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.2 126.21 29.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.146 1.379 . . . . 0.0 110.069 162.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.59 166.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.58 131.72 36.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.042 0.837 . . . . 0.0 111.965 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.55 131.93 48.95 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.339 1.055 . . . . 0.0 110.164 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -113.52 107.71 16.18 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.318 1.447 . . . . 0.0 109.018 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.35 159.72 15.03 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.31 -0.869 . . . . 0.0 111.945 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 pt -102.34 148.38 35.35 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.987 1.715 . . . . 0.0 109.615 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.4 137.78 28.78 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.221 1.947 . . . . 0.0 110.08 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 m -148.66 93.92 2.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.115 1.366 . . . . 0.0 109.267 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.81 -113.66 5.81 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.82 0.724 . . . . 0.0 112.612 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.2 p -83.36 -2.79 56.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.755 2.022 . . . . 0.0 114.024 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.97 -164.85 11.34 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.585 1.084 . . . . 0.0 114.297 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.38 165.23 12.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.351 1.06 . . . . 0.0 110.649 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp -132.79 146.89 52.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.451 1.901 . . . . 0.0 111.666 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.05 111.63 1.77 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.53 0.732 . . . . 0.0 112.245 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.91 -34.22 5.52 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.387 1.47 . . . . 0.0 112.032 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.47 154.28 11.9 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.455 1.502 . . . . 0.0 110.994 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.82 128.44 34.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.509 1.124 . . . . 0.0 109.94 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 m -110.9 138.5 47.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.72 2.008 . . . . 0.0 108.349 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.72 133.8 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.781 0.719 . . . . 0.0 109.233 165.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -102.16 -42.92 5.89 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.479 0.712 . . . . 0.0 109.915 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -173.17 169.19 4.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.371 1.868 . . . . 0.0 111.476 171.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.18 -178.74 28.38 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 124.729 1.157 . . . . 0.0 114.509 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.4 116.64 26.77 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 m -58.68 -18.92 35.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -157.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -32.71 71.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.644 0.778 . . . . 0.0 112.564 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 tp -82.51 -46.83 12.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.62 1.1 . . . . 0.0 111.086 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.9 m -51.59 -42.92 62.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.382 0.992 . . . . 0.0 113.149 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.89 79.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.968 0.907 . . . . 0.0 112.364 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.2 58.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.541 0.737 . . . . 0.0 112.462 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.7 t -59.58 -47.68 84.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.652 0.781 . . . . 0.0 110.892 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -52.68 -42.42 64.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 111.138 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.25 -47.27 62.07 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.716 0.806 . . . . 0.0 112.914 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.97 78.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.87 -23.1 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.719 -1.238 . . . . 0.0 111.516 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.26 -6.71 59.17 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.46 -0.775 . . . . 0.0 112.676 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.89 -11.84 3.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 46' ' ' ASN . 11.6 m -57.79 145.11 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.148 0.979 . . . . 0.0 112.597 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.31 -41.28 81.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.6 p 166.04 144.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.437 2.695 . . . . 0.0 110.102 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.51 110.45 45.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.505 -1.236 . . . . 0.0 109.77 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.65 134.8 20.85 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.898 1.732 . . . . 0.0 109.831 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.24 148.35 70.78 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.073 0.549 . . . . 0.0 111.601 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.07 -33.36 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.745 2.297 . . . . 0.0 111.283 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 159.81 42.0 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.383 2.273 . . . . 0.0 109.808 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -125.98 31.3 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.756 1.222 . . . . 0.0 113.205 -160.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.0 144.5 28.5 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.108 -0.995 . . . . 0.0 110.365 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.48 -9.2 17.1 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.337 2.691 . . . . 0.0 113.417 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.06 -35.59 31.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.643 0.777 . . . . 0.0 112.11 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.52 -25.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.46 1.104 . . . . 0.0 112.473 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.44 -28.54 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 118.578 0.626 . . . . 0.0 110.915 168.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -78.89 -9.57 59.53 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.17 -46.88 6.59 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.61 0.719 . . . . 0.0 112.008 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.423 ' HB2' ' HH ' ' A' ' 39' ' ' TYR . 4.0 pp -68.26 -26.36 65.63 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.168 0.987 . . . . 0.0 112.438 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -71.51 -25.35 62.21 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.415 -1.428 . . . . 0.0 113.168 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.36 90.48 3.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 110.483 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.77 152.87 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.642 1.177 . . . . 0.0 112.525 178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -93.84 132.69 38.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.985 157.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.2 mt -91.27 117.32 29.54 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 156.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.9 m -135.31 128.28 31.48 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.1 155.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.405 1.482 . . . . 0.0 110.811 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.064 0 C-N-CA 125.91 1.684 . . . . 0.0 111.355 -178.39 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 121.027 0.442 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.88 -43.52 73.25 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 127.389 2.276 . . . . 0.0 113.212 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.46 -18.47 68.61 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.213 0.911 . . . . 0.0 113.44 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.93 -33.4 68.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.277 1.038 . . . . 0.0 111.592 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.5 pt -61.3 -28.13 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 120.953 -1.092 . . . . 0.0 111.889 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -80.56 -58.24 3.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.877 1.271 . . . . 0.0 109.581 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -60.13 -34.84 74.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 112.673 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -74.36 -28.11 60.98 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.772 1.229 . . . . 0.0 112.353 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.9 tp -76.4 -33.34 58.86 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.199 0.909 . . . . 0.0 111.684 171.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.11 -44.38 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.865 -1.147 . . . . 0.0 110.964 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.14 -13.6 61.6 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.262 1.025 . . . . 0.0 112.745 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.06 -38.38 73.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.485 HD22 HG13 ' A' ' 96' ' ' VAL . 37.0 m-80 -80.14 -37.39 33.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 0.0 111.989 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -99.49 103.9 15.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.62 1.2 . . . . 0.0 110.828 -164.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.94 20.71 7.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.98 -52.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.053 0.541 . . . . 0.0 112.237 -160.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 70.64 -62.55 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.867 2.467 . . . . 0.0 113.921 168.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.41 -35.41 80.34 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.635 -1.29 . . . . 0.0 111.946 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -77.09 -0.78 26.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -112.78 -12.49 13.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.612 1.965 . . . . 0.0 111.949 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -109.17 154.5 22.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 112.281 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.58 90.43 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.76 1.171 . . . . 0.0 114.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -178.61 5.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.747 2.019 . . . . 0.0 111.682 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.87 162.95 20.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.978 0.911 . . . . 0.0 110.462 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -157.4 147.2 20.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.446 1.099 . . . . 0.0 110.141 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.3 128.47 43.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.142 1.777 . . . . 0.0 110.372 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.17 167.42 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.58 1.152 . . . . 0.0 108.048 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -131.8 132.28 43.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.786 0.721 . . . . 0.0 111.95 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.68 130.13 49.5 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.139 0.975 . . . . 0.0 109.593 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -111.68 107.06 16.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.464 1.106 . . . . 0.0 109.227 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 158.69 15.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.913 0.863 . . . . 0.0 111.603 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -102.8 152.17 38.43 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.973 1.709 . . . . 0.0 110.506 168.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.05 147.27 29.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.143 2.562 . . . . 0.0 111.038 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -156.1 161.62 40.35 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.852 2.461 . . . . 0.0 108.338 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.3 -13.2 59.88 Favored Glycine 0 CA--C 1.54 1.649 0 O-C-N 120.737 -1.227 . . . . 0.0 115.187 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.9 p -99.77 -3.36 32.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.107 2.163 . . . . 0.0 113.919 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.97 -151.83 16.9 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.371 1.462 . . . . 0.0 111.078 -167.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.39 157.0 17.83 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.054 1.427 . . . . 0.0 111.949 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.0 144.45 51.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.269 1.828 . . . . 0.0 111.237 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.32 113.5 2.2 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.907 0.776 . . . . 0.0 112.182 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.81 4.69 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.68 1.61 . . . . 0.0 111.974 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.05 152.11 9.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.649 1.579 . . . . 0.0 111.295 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.37 134.29 49.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.247 1.019 . . . . 0.0 109.653 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.8 m -117.38 120.45 38.22 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.615 1.966 . . . . 0.0 108.707 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.23 133.97 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.312 0.96 . . . . 0.0 109.796 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -106.07 -49.93 3.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.298 0.639 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -173.03 170.23 4.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.166 1.786 . . . . 0.0 111.942 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.82 -175.21 32.97 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 125.054 1.311 . . . . 0.0 113.176 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.58 110.57 17.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 164.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 m -58.67 -17.91 26.44 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -52.45 -37.37 56.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.798 1.239 . . . . 0.0 112.357 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.19 -48.07 14.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.005 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -48.51 -46.22 38.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.565 1.146 . . . . 0.0 113.138 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.4 84.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.811 0.844 . . . . 0.0 112.296 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.22 23.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 112.629 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 t -57.44 -49.4 76.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.863 0.865 . . . . 0.0 110.508 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.29 -46.68 55.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.878 1.671 . . . . 0.0 111.258 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.9 -44.09 77.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.591 0.757 . . . . 0.0 112.833 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.78 -48.96 79.42 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.631 1.172 . . . . 0.0 112.173 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.5 -23.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.645 -1.284 . . . . 0.0 111.496 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.59 -6.63 57.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.689 0.796 . . . . 0.0 112.668 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -132.69 -12.0 3.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 46' ' ' ASN . 15.0 m -59.95 148.64 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.185 0.902 . . . . 0.0 112.456 171.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -71.33 -48.5 50.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 p 174.77 142.11 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.223 1.809 . . . . 0.0 111.884 -169.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.19 109.56 50.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 110.148 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.03 131.37 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.733 2.289 . . . . 0.0 110.417 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.83 150.83 75.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.573 0.749 . . . . 0.0 111.513 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.99 -40.84 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.321 2.014 . . . . 0.0 110.787 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -120.05 176.27 5.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.444 2.297 . . . . 0.0 111.278 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -152.64 49.43 0.75 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -112.83 135.66 21.63 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.11 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.73 -12.53 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.18 3.253 . . . . 0.0 115.585 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.0 -35.46 28.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 112.159 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -96.69 -24.16 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.209 1.004 . . . . 0.0 113.026 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.2 -25.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.592 0.757 . . . . 0.0 110.662 167.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -83.39 -7.77 59.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.03 -48.67 5.59 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.133 -0.98 . . . . 0.0 111.374 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.68 -20.95 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.648 1.179 . . . . 0.0 112.959 -175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.64 -25.24 67.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.987 0.915 . . . . 0.0 113.449 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -129.99 77.23 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.219 1.008 . . . . 0.0 110.102 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.57 148.33 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.62 123.48 36.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 157.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -84.63 110.03 18.43 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 160.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.7 m -132.32 127.55 35.82 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.85 1.26 . . . . 0.0 108.512 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 151.46 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -169.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 125.649 1.58 . . . . 0.0 111.425 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.341 0.591 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -55.27 -43.08 74.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.298 2.239 . . . . 0.0 112.803 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.62 66.76 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.197 1.38 . . . . 0.0 114.066 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.2 68.48 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.184 0.992 . . . . 0.0 111.608 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -60.59 -28.3 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.267 -0.896 . . . . 0.0 112.161 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.78 -58.44 3.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.114 1.366 . . . . 0.0 110.673 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -58.72 -36.84 74.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.49 1.116 . . . . 0.0 112.564 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -71.25 -32.58 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.701 1.2 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -76.05 -28.83 57.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.917 0.78 . . . . 0.0 112.271 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.27 -54.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.887 -1.133 . . . . 0.0 110.372 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -19.86 65.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.395 0.678 . . . . 0.0 112.495 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.17 -15.22 58.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.447 HD22 HG12 ' A' ' 96' ' ' VAL . 64.9 m-80 -78.76 -39.88 34.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.23 0.923 . . . . 0.0 111.992 161.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.81 96.34 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 123.436 1.589 . . . . 0.0 111.587 -160.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.54 24.44 1.2 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.098 -173.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.87 -72.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.163 0.985 . . . . 0.0 111.33 -167.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 75.0 -52.62 0.67 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 113.489 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.5 -36.84 85.11 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.005 -1.059 . . . . 0.0 111.905 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -83.66 0.33 47.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 113.743 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -102.83 -25.05 13.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.01 1.724 . . . . 0.0 112.805 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -87.52 162.65 17.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.504 2.321 . . . . 0.0 111.539 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.7 -5.36 69.95 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.788 1.185 . . . . 0.0 114.789 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 -173.89 4.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.277 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.61 162.05 25.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.766 0.826 . . . . 0.0 110.675 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.5 t -153.84 144.0 22.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.749 1.22 . . . . 0.0 110.381 169.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 130.55 48.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.729 1.212 . . . . 0.0 110.953 164.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.65 176.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.61 126.37 17.05 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.729 0.812 . . . . 0.0 110.572 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.69 131.4 52.18 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.94 0.896 . . . . 0.0 109.72 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -119.39 106.4 12.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 108.936 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -99.17 162.27 13.15 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.117 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.13 150.41 44.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.482 1.113 . . . . 0.0 110.677 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.31 134.19 17.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.668 2.245 . . . . 0.0 110.618 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -118.66 -33.73 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.252 1.421 . . . . 0.0 111.635 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.27 -121.84 0.8 Allowed Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.515 1.531 . . . . 0.0 111.274 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 p -63.69 -14.57 53.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.17 0.988 . . . . 0.0 113.088 167.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.17 153.52 16.82 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.887 1.708 . . . . 0.0 114.224 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.79 163.24 19.22 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.896 0.878 . . . . 0.0 110.292 161.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.13 147.68 52.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.393 1.877 . . . . 0.0 111.413 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.08 110.43 1.04 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.127 0.971 . . . . 0.0 112.033 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.65 -46.37 3.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.553 1.549 . . . . 0.0 110.591 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 m -155.41 149.59 25.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.338 1.055 . . . . 0.0 110.967 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.01 121.67 33.67 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.114 0.965 . . . . 0.0 109.546 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.3 m -103.66 118.7 37.32 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.448 1.499 . . . . 0.0 108.589 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.33 130.85 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.758 0.708 . . . . 0.0 109.207 167.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.17 -49.36 4.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.524 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -173.19 170.77 4.25 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.329 1.851 . . . . 0.0 111.796 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.93 -179.47 31.83 Favored Glycine 0 N--CA 1.461 0.359 0 C-N-CA 124.895 1.236 . . . . 0.0 113.55 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.19 113.95 20.37 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 165.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.7 p -61.3 -17.68 54.82 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -153.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -50.97 -35.58 34.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.548 1.139 . . . . 0.0 112.143 171.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -82.48 -51.04 8.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.086 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.3 m -45.74 -46.37 15.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.212 1.405 . . . . 0.0 113.203 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.98 82.43 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.038 0.835 . . . . 0.0 112.852 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.15 -52.88 14.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -56.68 -49.41 75.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.037 0.935 . . . . 0.0 110.58 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.64 -47.11 58.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.324 1.449 . . . . 0.0 111.303 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -68.5 -44.45 74.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.18 77.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.617 1.167 . . . . 0.0 111.23 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.3 -21.76 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.675 -1.266 . . . . 0.0 112.009 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.58 -7.44 59.25 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.569 0.748 . . . . 0.0 112.632 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -131.34 -11.84 3.58 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.447 HG12 HD22 ' A' ' 46' ' ' ASN . 7.8 m -55.78 147.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.05 0.94 . . . . 0.0 112.92 171.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.34 -49.85 65.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.5 p 167.9 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.228 2.611 . . . . 0.0 110.334 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.73 104.32 27.27 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 117.31 -1.329 . . . . 0.0 110.493 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -70.71 128.96 15.85 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.021 1.814 . . . . 0.0 111.512 -170.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 132.04 21.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.127 1.371 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.33 -52.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.186 2.591 . . . . 0.0 112.477 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.78 149.61 27.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.617 1.167 . . . . 0.0 110.045 167.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -128.03 21.01 6.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.288 1.435 . . . . 0.0 113.315 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -88.61 145.74 35.85 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 121.228 -0.92 . . . . 0.0 109.772 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.18 -23.58 6.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.563 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.2 -24.6 43.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.891 0.769 . . . . 0.0 112.862 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.2 m -98.22 -34.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.037 0.935 . . . . 0.0 111.97 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.27 -32.5 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.322 1.049 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.56 -11.74 59.87 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.129 0.972 . . . . 0.0 113.227 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.81 -34.05 8.68 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.179 -0.95 . . . . 0.0 113.289 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.84 -21.25 34.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.745 0.818 . . . . 0.0 112.913 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -69.44 -23.54 63.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.072 -1.017 . . . . 0.0 113.735 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.0 83.99 2.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.055 . . . . 0.0 110.146 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.46 159.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.81 126.91 55.12 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 160.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.8 121.9 32.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.9 m -134.12 129.76 36.38 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.097 0.959 . . . . 0.0 109.801 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.76 141.35 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 128.576 2.75 . . . . 0.0 107.885 -170.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 -174.928 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.399 0.142 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -60.08 -18.09 44.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.403 2.281 . . . . 0.0 116.429 -166.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.14 -13.83 9.66 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 126.896 2.188 . . . . 0.0 114.282 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.41 -34.41 54.77 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.381 1.472 . . . . 0.0 111.818 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.9 pt -59.33 -27.45 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.525 -0.735 . . . . 0.0 112.449 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.4 -58.59 2.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.949 1.3 . . . . 0.0 111.271 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -60.13 -33.33 72.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.618 1.167 . . . . 0.0 112.167 -172.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -74.05 -40.61 62.71 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.755 0.822 . . . . 0.0 110.464 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.52 -31.75 68.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.743 . . . . 0.0 111.361 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.59 -51.64 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -67.16 -19.94 65.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -57.08 -35.77 69.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.981 0.512 . . . . 0.0 111.245 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.421 HD22 HG13 ' A' ' 96' ' ' VAL . 65.3 m-80 -77.98 -32.7 51.46 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.36 109.15 20.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.621 1.201 . . . . 0.0 111.438 -160.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.08 25.01 5.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.72 1.608 . . . . 0.0 114.21 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.73 -64.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 0.0 111.385 -167.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 72.25 -68.3 0.23 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.217 2.207 . . . . 0.0 112.958 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.31 -27.86 68.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.982 1.313 . . . . 0.0 113.059 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.9 m -100.62 7.14 44.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.332 1.053 . . . . 0.0 113.21 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -100.08 -28.86 12.83 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.849 1.66 . . . . 0.0 112.161 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.993 1.717 . . . . 0.0 112.575 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.86 -23.6 3.64 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.199 1.38 . . . . 0.0 114.737 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 -169.77 1.53 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.081 2.153 . . . . 0.0 111.356 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 165.21 24.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 0.0 110.342 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 41.0 t -158.11 145.9 18.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 0.0 109.869 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 129.0 42.99 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.72 1.608 . . . . 0.0 111.003 165.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.99 169.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.18 132.21 33.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.236 -172.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -105.09 129.53 53.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.522 1.129 . . . . 0.0 109.725 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -112.36 111.14 21.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.999 0.92 . . . . 0.0 109.634 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -100.09 158.6 15.72 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.996 0.903 . . . . 0.0 111.715 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 pt -98.38 150.45 36.74 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 125.476 1.51 . . . . 0.0 110.036 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.35 150.89 37.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.17 2.58 . . . . 0.0 111.109 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -168.25 144.73 3.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.012 2.525 . . . . 0.0 107.98 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.0 -22.17 75.75 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -164.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.8 p -90.89 -9.6 45.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.488 1.515 . . . . 0.0 113.178 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.21 157.05 7.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.244 1.402 . . . . 0.0 112.635 -171.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.1 160.88 17.23 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 117.765 0.783 . . . . 0.0 110.767 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.19 144.93 51.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.072 1.349 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.05 110.25 1.16 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.461 0.704 . . . . 0.0 112.547 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.58 -37.28 4.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.882 1.705 . . . . 0.0 112.041 173.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -162.38 148.83 13.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.817 1.247 . . . . 0.0 111.0 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.35 125.78 39.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.347 1.059 . . . . 0.0 109.423 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.6 m -110.86 127.81 55.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.711 2.005 . . . . 0.0 108.133 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.57 133.33 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.608 1.094 . . . . 0.0 109.351 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 tp -104.51 -44.79 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.713 0.405 . . . . 0.0 110.287 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -172.48 168.86 5.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.646 1.578 . . . . 0.0 112.232 169.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.7 32.79 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.745 1.164 . . . . 0.0 113.573 169.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -85.68 114.73 22.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 166.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m -59.69 -19.82 52.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -151.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -58.43 -29.63 66.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.303 -0.856 . . . . 0.0 113.128 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -79.81 -48.58 13.31 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 120.228 1.376 . . . . 0.0 111.22 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 38.9 m -45.36 -47.3 13.4 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.694 1.134 . . . . 0.0 112.774 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.17 64.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.391 1.476 . . . . 0.0 114.486 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.04 -52.8 4.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.378 1.471 . . . . 0.0 111.975 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.0 t -56.05 -48.6 75.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 111.292 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -46.87 -47.21 21.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.427 1.891 . . . . 0.0 111.494 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -69.96 -43.25 71.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.08 71.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.694 1.197 . . . . 0.0 111.124 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.05 -22.02 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.82 -1.175 . . . . 0.0 112.645 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.71 -8.72 59.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.841 0.856 . . . . 0.0 112.455 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -128.85 -13.3 4.67 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG13 HD22 ' A' ' 46' ' ' ASN . 9.5 m -58.37 145.12 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.302 1.041 . . . . 0.0 111.984 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -69.46 -42.75 74.47 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -171.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.9 p 166.07 141.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.506 2.323 . . . . 0.0 110.192 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.61 112.55 52.4 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.538 -1.22 . . . . 0.0 110.388 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.96 127.02 9.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.33 2.02 . . . . 0.0 111.101 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -73.98 141.65 78.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.852 0.861 . . . . 0.0 111.43 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -44.16 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.891 2.394 . . . . 0.0 110.401 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -122.55 151.56 41.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.146 1.778 . . . . 0.0 109.507 160.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -108.43 10.61 27.38 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -165.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.68 144.31 56.11 Favored Pre-proline 0 C--O 1.24 0.569 0 O-C-N 120.872 -1.143 . . . . 0.0 109.947 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.68 -6.0 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.04 2.493 . . . . 0.0 113.957 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.44 -33.1 23.75 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.713 0.805 . . . . 0.0 112.875 169.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -97.44 -25.77 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 113.139 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.67 -25.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.742 0.817 . . . . 0.0 110.59 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.17 -11.44 59.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.277 1.431 . . . . 0.0 113.191 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -37.75 8.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 0.0 112.583 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.62 -23.94 53.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.778 1.231 . . . . 0.0 112.592 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -66.79 -22.83 66.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.5 91.01 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.942 0.897 . . . . 0.0 110.647 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -119.43 154.79 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.674 1.19 . . . . 0.0 113.067 -178.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -91.11 136.42 33.1 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.144 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.38 114.31 26.81 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 153.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.3 m -133.83 128.27 34.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.579 1.152 . . . . 0.0 109.34 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.57 156.7 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.783 1.633 . . . . 0.0 111.173 -171.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.107 0 C-N-CA 126.81 2.044 . . . . 0.0 110.629 -178.09 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -53.67 -44.0 69.33 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.096 1.759 . . . . 0.0 114.83 -162.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.56 -17.37 57.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.572 1.558 . . . . 0.0 114.03 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.06 -33.11 59.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.666 1.186 . . . . 0.0 111.547 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.9 pt -59.51 -25.79 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.136 0.88 . . . . 0.0 112.257 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.36 -59.88 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.122 0.969 . . . . 0.0 109.804 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 t -61.44 -35.25 77.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.472 1.109 . . . . 0.0 112.326 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -73.85 -27.5 61.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.718 1.207 . . . . 0.0 111.915 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -78.6 -32.27 47.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.252 0.933 . . . . 0.0 111.836 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.8 -43.54 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.891 1.276 . . . . 0.0 110.598 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -72.62 -13.99 61.5 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.961 0.904 . . . . 0.0 113.223 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -55.58 -38.43 69.36 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.457 0.303 . . . . 0.0 110.326 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.415 HD22 HG11 ' A' ' 96' ' ' VAL . 35.1 m-80 -81.25 -36.87 29.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -103.41 99.42 9.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.825 1.298 . . . . 0.0 111.869 -161.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.2 28.82 0.69 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.269 1.428 . . . . 0.0 113.625 -172.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.35 -40.5 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.599 0.759 . . . . 0.0 112.322 -165.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.57 -98.53 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.139 1.776 . . . . 0.0 112.95 164.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.69 -24.1 66.54 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.645 1.178 . . . . 0.0 113.605 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 m -92.83 1.42 57.3 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -88.64 -22.18 23.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.073 1.349 . . . . 0.0 111.575 156.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -86.4 170.92 11.56 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.581 1.952 . . . . 0.0 111.214 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 -9.72 28.46 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.095 1.331 . . . . 0.0 114.833 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 -176.94 5.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.714 2.406 . . . . 0.0 110.885 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.92 160.44 26.15 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.722 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -154.87 141.44 18.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.646 1.178 . . . . 0.0 109.538 168.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.06 131.6 53.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.397 1.479 . . . . 0.0 110.494 167.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.3 m -142.31 170.24 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -134.82 131.93 38.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.404 0.682 . . . . 0.0 111.5 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.38 133.33 48.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.222 1.009 . . . . 0.0 109.682 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -115.16 107.12 14.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.738 1.215 . . . . 0.0 109.709 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.92 158.47 15.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.08 148.2 34.78 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.61 1.564 . . . . 0.0 110.274 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.71 141.13 37.02 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.71 2.273 . . . . 0.0 110.853 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.8 m -133.43 156.94 46.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.277 1.831 . . . . 0.0 109.795 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.31 -26.47 61.68 Favored Glycine 0 N--CA 1.478 1.492 0 C-N-CA 123.55 0.595 . . . . 0.0 113.661 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -131.17 104.47 7.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.941 1.696 . . . . 0.0 108.331 161.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.58 -159.53 24.96 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.136 1.351 . . . . 0.0 114.442 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.72 162.45 14.75 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.344 1.057 . . . . 0.0 110.032 162.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.24 145.92 51.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.101 1.761 . . . . 0.0 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.14 112.74 1.81 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.759 0.708 . . . . 0.0 112.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.41 -36.37 5.16 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 125.796 1.665 . . . . 0.0 111.873 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -166.45 153.52 9.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.685 1.594 . . . . 0.0 111.201 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.25 131.65 48.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.44 1.096 . . . . 0.0 109.889 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.0 m -111.55 122.59 48.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.362 1.865 . . . . 0.0 107.878 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.56 130.79 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.96 0.8 . . . . 0.0 109.114 167.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.31 -49.88 3.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.315 0.646 . . . . 0.0 110.094 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.58 165.58 4.57 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.123 1.769 . . . . 0.0 111.865 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.95 179.62 38.33 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 124.543 1.068 . . . . 0.0 114.253 167.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.84 119.65 24.17 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -54.36 -31.64 55.09 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -144.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -54.79 -34.97 63.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.859 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.4 tp -78.92 -56.78 4.14 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.334 1.425 . . . . 0.0 111.678 -175.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 6.0 p -55.69 -32.62 63.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.42 -33.95 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.816 1.189 . . . . 0.0 113.414 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.52 -52.5 7.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.46 1.104 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.6 t -56.09 -46.63 78.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.25 1.02 . . . . 0.0 111.713 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -46.45 -45.74 18.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.393 1.877 . . . . 0.0 111.797 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -75.62 -43.1 49.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.393 1.077 . . . . 0.0 112.754 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.77 -48.44 81.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.815 1.246 . . . . 0.0 111.98 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.1 -24.42 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.859 -1.151 . . . . 0.0 111.235 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.35 -6.07 55.97 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.503 -0.748 . . . . 0.0 112.566 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -133.07 -12.05 2.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 46' ' ' ASN . 16.1 m -58.76 151.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.274 0.943 . . . . 0.0 113.238 169.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.65 -48.69 30.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 173.87 142.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.49 1.916 . . . . 0.0 111.835 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -97.12 113.79 63.66 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.902 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.5 127.95 6.74 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.868 2.379 . . . . 0.0 110.189 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.6 mt -83.42 146.73 51.22 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.754 0.821 . . . . 0.0 112.225 -172.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.27 -28.81 8.42 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.986 2.457 . . . . 0.0 111.892 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -140.76 156.84 46.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.76 2.024 . . . . 0.0 110.817 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -129.67 20.85 5.55 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -167.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -85.69 141.85 36.54 Favored Pre-proline 0 C--O 1.241 0.655 0 O-C-N 120.492 -1.38 . . . . 0.0 109.068 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.24 -5.41 8.01 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 113.399 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.52 -35.27 23.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.523 1.056 . . . . 0.0 112.124 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.0 m -100.34 -24.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.182 0.993 . . . . 0.0 113.278 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.54 -28.27 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.524 0.73 . . . . 0.0 110.379 167.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.409 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 31.7 mm-40 -79.8 -8.53 59.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.881 1.272 . . . . 0.0 113.981 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -93.1 -54.09 3.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.669 0.788 . . . . 0.0 111.311 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.81 -23.15 67.15 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 124.497 1.119 . . . . 0.0 113.17 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.409 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.9 ptmt -72.87 -23.91 60.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.721 -1.237 . . . . 0.0 113.292 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.7 83.08 2.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.124 1.369 . . . . 0.0 110.885 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.436 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.86 150.06 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.716 0.807 . . . . 0.0 112.199 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 126.55 39.83 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 157.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 mt -89.78 116.05 27.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 163.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -131.67 124.89 30.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.626 1.171 . . . . 0.0 109.345 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.89 139.95 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 128.333 2.653 . . . . 0.0 107.276 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 125.285 1.434 . . . . 0.0 111.514 -177.513 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -54.16 -43.97 71.07 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.801 2.04 . . . . 0.0 113.873 -171.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.05 68.22 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.123 1.344 . . . . 0.0 113.705 173.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.48 55.25 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.327 1.063 . . . . 0.0 112.074 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.35 -30.12 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.403 -1.436 . . . . 0.0 111.457 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -78.26 -56.09 4.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.405 1.482 . . . . 0.0 109.488 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -59.33 -33.95 71.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.845 0.858 . . . . 0.0 112.452 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -37.56 82.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.776 1.231 . . . . 0.0 111.672 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.23 -28.04 59.75 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.58 -52.5 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.224 -0.923 . . . . 0.0 110.622 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -23.91 67.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.638 0.775 . . . . 0.0 112.078 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.35 -14.16 60.46 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.428 HD22 HG13 ' A' ' 96' ' ' VAL . 62.0 m-80 -81.5 -45.19 16.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.182 0.901 . . . . 0.0 111.003 159.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.49 83.46 5.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 123.541 1.638 . . . . 0.0 112.081 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.34 28.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.813 1.645 . . . . 0.0 113.999 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.94 -69.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.462 -163.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 74.31 -49.78 0.67 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.982 2.513 . . . . 0.0 113.718 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.78 -44.74 92.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.621 1.168 . . . . 0.0 112.605 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.2 p -92.42 12.72 21.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -100.48 -17.92 16.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.59 1.556 . . . . 0.0 111.325 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -106.16 156.95 17.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.193 1.797 . . . . 0.0 111.813 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.39 -2.72 84.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.037 1.303 . . . . 0.0 114.804 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -178.97 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.032 2.133 . . . . 0.0 110.923 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 161.33 23.2 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.516 -0.74 . . . . 0.0 110.162 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -155.14 149.09 25.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.763 1.225 . . . . 0.0 110.403 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.27 117.64 9.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.733 1.613 . . . . 0.0 110.35 173.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.52 163.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -134.7 131.15 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.985 -0.447 . . . . 0.0 111.701 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.34 129.54 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.352 1.061 . . . . 0.0 109.885 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -114.29 103.81 11.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.511 1.524 . . . . 0.0 108.244 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.85 157.59 16.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.714 0.769 . . . . 0.0 112.085 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 pt -101.32 139.33 20.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.231 1.413 . . . . 0.0 110.159 168.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.42 126.23 10.8 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.526 2.151 . . . . 0.0 109.845 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 m -113.74 -33.72 5.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.272 1.029 . . . . 0.0 112.506 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.87 -110.16 0.37 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.487 1.041 . . . . 0.0 111.678 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -61.21 -23.74 65.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.19 0.996 . . . . 0.0 112.673 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.13 -178.43 16.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.268 1.413 . . . . 0.0 115.396 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 165.83 11.13 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.36 1.464 . . . . 0.0 111.833 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.26 146.49 52.33 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.385 1.874 . . . . 0.0 111.413 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.66 110.3 0.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.59 0.756 . . . . 0.0 112.038 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.45 -35.34 5.73 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.943 1.735 . . . . 0.0 111.703 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.8 152.51 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 0.0 111.556 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -126.0 125.06 42.06 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.532 1.133 . . . . 0.0 109.779 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.6 m -106.43 122.37 46.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.407 1.883 . . . . 0.0 108.19 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.81 129.55 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.125 0.875 . . . . 0.0 108.85 166.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -105.94 -41.54 5.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.405 0.682 . . . . 0.0 110.539 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.27 173.72 6.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.249 1.82 . . . . 0.0 111.503 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.36 169.41 13.08 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 125.778 1.656 . . . . 0.0 114.197 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.94 120.05 24.73 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 p -60.79 -20.85 62.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -154.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -52.69 -33.14 46.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.858 1.263 . . . . 0.0 112.976 171.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.09 -50.52 6.58 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.565 1.075 . . . . 0.0 111.053 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 m -46.22 -47.77 17.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.093 1.357 . . . . 0.0 113.922 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.61 80.45 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.72 0.808 . . . . 0.0 112.466 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.0 16.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.521 1.128 . . . . 0.0 112.068 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -58.68 -48.28 81.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.953 0.901 . . . . 0.0 110.734 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -49.25 -45.49 44.79 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.989 1.716 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.38 -47.39 61.12 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.23 77.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.289 1.036 . . . . 0.0 111.269 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.68 -22.55 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.86 -1.15 . . . . 0.0 112.013 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.08 -8.63 59.12 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.419 -0.801 . . . . 0.0 112.639 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.41 -11.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -173.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.428 HG13 HD22 ' A' ' 46' ' ' ASN . 13.8 m -56.92 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 112.387 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.33 -45.26 76.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 p 166.18 145.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 111.259 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -103.23 103.4 34.56 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.669 1.188 . . . . 0.0 109.426 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.11 132.24 25.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.308 2.006 . . . . 0.0 110.982 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.75 147.12 77.46 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 118.092 0.406 . . . . 0.0 110.941 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -42.01 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.92 1.747 . . . . 0.0 110.562 168.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 158.57 44.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.084 2.154 . . . . 0.0 111.276 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -126.64 19.14 7.34 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.389 1.076 . . . . 0.0 113.898 -162.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.69 140.41 40.98 Favored Pre-proline 0 C--O 1.24 0.589 0 O-C-N 120.508 -1.37 . . . . 0.0 109.442 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.45 -3.59 6.72 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.998 2.466 . . . . 0.0 113.523 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.84 -34.2 21.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.029 0.831 . . . . 0.0 111.985 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.94 -26.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.903 0.881 . . . . 0.0 112.978 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.58 -28.51 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.573 0.749 . . . . 0.0 110.623 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -79.62 -10.41 59.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.18 -53.31 4.41 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.518 -0.739 . . . . 0.0 111.133 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -65.2 -25.33 67.66 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 112.878 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.92 -24.74 60.86 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.01 -1.056 . . . . 0.0 113.337 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -125.81 81.1 1.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.796 1.638 . . . . 0.0 110.674 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.438 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.49 150.56 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.86 0.864 . . . . 0.0 112.415 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.36 129.24 43.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 160.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.94 109.69 19.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 156.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -133.85 125.83 29.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.769 1.228 . . . . 0.0 108.515 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.6 m -138.37 149.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.714 1.606 . . . . 0.0 110.321 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 125.627 1.571 . . . . 0.0 111.971 -177.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 111.377 0.14 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -49.62 -46.34 49.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.739 2.015 . . . . 0.0 114.741 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.54 -16.09 55.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.33 1.919 . . . . 0.0 114.097 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.2 -34.09 59.29 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.375 1.07 . . . . 0.0 111.863 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.0 pt -60.18 -24.72 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.54 0.736 . . . . 0.0 112.074 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -82.98 -59.7 2.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.599 1.16 . . . . 0.0 109.897 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -61.26 -34.66 75.53 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.448 1.099 . . . . 0.0 112.47 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -71.02 -43.94 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.471 1.108 . . . . 0.0 110.385 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.2 tp -67.41 -29.29 68.75 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.638 0.653 . . . . 0.0 111.631 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -53.42 24.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 O-C-N 121.498 -0.751 . . . . 0.0 110.862 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -67.54 -18.28 64.97 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.44 -36.36 66.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.84 0.456 . . . . 0.0 111.265 167.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.411 HD22 HG13 ' A' ' 96' ' ' VAL . 55.1 m-80 -78.17 -37.96 44.63 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 112.204 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.53 101.87 13.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.968 1.366 . . . . 0.0 111.57 -164.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 21.0 3.84 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.27 -60.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -162.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 73.31 -57.84 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.715 2.406 . . . . 0.0 113.198 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.4 -40.36 86.36 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.093 1.357 . . . . 0.0 112.05 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 m -79.73 0.87 28.78 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -112.29 -25.77 9.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.063 1.745 . . . . 0.0 112.955 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.69 156.49 16.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.119 1.367 . . . . 0.0 113.171 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.64 -24.11 4.56 Favored Glycine 0 N--CA 1.478 1.486 0 C-N-CA 125.376 1.465 . . . . 0.0 114.816 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -173.63 2.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.41 1.884 . . . . 0.0 111.532 171.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.1 27.59 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.245 -0.91 . . . . 0.0 111.594 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.9 t -160.36 146.68 15.49 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.936 1.294 . . . . 0.0 110.008 171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.23 129.81 42.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.184 1.794 . . . . 0.0 110.24 166.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.31 170.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.37 131.22 31.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.471 0.578 . . . . 0.0 112.02 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.46 127.93 49.29 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.177 0.991 . . . . 0.0 110.112 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mppt? -108.64 107.46 17.94 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.669 1.187 . . . . 0.0 109.277 165.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.4 160.45 14.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.994 0.902 . . . . 0.0 111.472 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.99 121.43 52.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.424 1.489 . . . . 0.0 109.504 166.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.62 121.84 10.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.96 2.44 . . . . 0.0 111.157 170.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.3 m -111.26 -29.54 7.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.132 1.373 . . . . 0.0 111.821 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.67 -52.99 0.71 Allowed Glycine 0 N--CA 1.476 1.324 0 C-N-CA 125.645 1.593 . . . . 0.0 112.415 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -70.03 -31.79 69.62 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.965 0.906 . . . . 0.0 111.378 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.15 -168.34 18.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 111.814 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.55 162.15 13.92 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 151.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.29 145.84 50.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.999 1.719 . . . . 0.0 111.16 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.94 112.2 1.58 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.644 -0.66 . . . . 0.0 112.402 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.13 -46.83 3.23 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.05 1.309 . . . . 0.0 110.68 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -156.64 148.28 22.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.609 1.164 . . . . 0.0 110.828 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.44 131.2 53.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.796 0.839 . . . . 0.0 109.574 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -115.22 117.17 29.75 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.142 1.777 . . . . 0.0 108.041 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -82.39 132.05 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.473 0.578 . . . . 0.0 109.631 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.86 -52.16 3.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.097 0.559 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -172.9 169.37 4.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.233 1.813 . . . . 0.0 112.119 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.03 -175.73 34.44 Favored Glycine 0 N--CA 1.465 0.581 0 C-N-CA 125.699 1.619 . . . . 0.0 113.843 168.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.63 116.63 19.94 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -25.53 39.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -152.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -55.08 -32.44 61.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.322 1.449 . . . . 0.0 112.834 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.76 -50.55 7.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.288 1.404 . . . . 0.0 112.404 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.1 p -60.74 -31.28 70.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.405 1.457 . . . . 0.0 113.26 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 -46.1 84.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.119 0.968 . . . . 0.0 112.75 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.07 -50.14 30.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.276 1.03 . . . . 0.0 113.206 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -56.87 -47.91 79.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.64 0.776 . . . . 0.0 110.521 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -48.79 -45.85 40.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.06 1.744 . . . . 0.0 111.818 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -69.14 -43.49 74.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.8 -49.13 78.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.724 1.21 . . . . 0.0 111.275 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.61 -23.03 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.5 -1.375 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.43 -6.05 57.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.97 0.908 . . . . 0.0 112.782 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.55 -12.27 3.46 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.411 HG13 HD22 ' A' ' 46' ' ' ASN . 14.1 m -60.0 146.62 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.416 1.087 . . . . 0.0 112.115 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -72.11 -46.57 56.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 172.89 138.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.162 1.785 . . . . 0.0 111.245 -168.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -93.53 111.39 52.16 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.099 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.38 116.21 4.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.892 1.728 . . . . 0.0 109.938 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.1 pt? -88.34 137.63 30.74 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.44 1.496 . . . . 0.0 111.848 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.61 -46.29 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.25 2.634 . . . . 0.0 112.35 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -99.3 168.16 10.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.053 1.341 . . . . 0.0 110.719 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -131.48 6.15 4.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -167.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.15 138.85 60.43 Favored Pre-proline 0 C--O 1.243 0.735 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.36 -0.97 4.0 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.872 2.381 . . . . 0.0 113.549 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.58 -40.39 16.32 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 111.773 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -93.02 -25.74 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.381 1.072 . . . . 0.0 112.412 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.51 -26.65 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.973 0.909 . . . . 0.0 110.799 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -84.55 -7.24 59.33 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.464 1.506 . . . . 0.0 113.826 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -92.68 -51.69 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.781 0.8 . . . . 0.0 111.876 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.06 -21.52 64.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.476 1.11 . . . . 0.0 112.345 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -62.37 -24.14 67.2 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.88 -1.138 . . . . 0.0 113.711 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -129.61 78.62 1.86 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.416 1.087 . . . . 0.0 110.401 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.84 151.86 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.306 1.042 . . . . 0.0 111.732 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.23 134.17 34.78 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 155.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.33 113.17 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.5 m -135.71 126.29 27.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.344 1.058 . . . . 0.0 109.165 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.26 151.31 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.84 1.656 . . . . 0.0 110.654 -171.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 125.979 1.712 . . . . 0.0 110.975 -176.328 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.911 0.386 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.96 -43.49 77.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.676 2.39 . . . . 0.0 113.335 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.73 -17.44 70.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.0 64.0 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.552 1.176 . . . . 0.0 111.632 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -61.97 -28.84 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.538 -0.726 . . . . 0.0 111.5 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.07 -59.0 2.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.554 1.542 . . . . 0.0 109.992 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -60.34 -34.16 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.025 0.93 . . . . 0.0 112.408 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -72.45 -31.47 65.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.078 0.951 . . . . 0.0 111.51 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.86 -30.18 61.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.548 0.613 . . . . 0.0 112.29 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -53.68 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.956 -1.09 . . . . 0.0 110.649 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -20.22 64.55 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.462 0.705 . . . . 0.0 112.53 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.59 -14.53 58.12 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.454 HD22 HG13 ' A' ' 96' ' ' VAL . 56.3 m-80 -79.81 -42.15 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.185 0.902 . . . . 0.0 111.324 159.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.81 84.61 4.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 123.412 1.577 . . . . 0.0 111.775 -163.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.6 27.07 0.13 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.581 1.553 . . . . 0.0 114.217 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.93 -69.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.047 0.939 . . . . 0.0 111.128 -165.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 77.34 -50.81 0.54 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.595 2.358 . . . . 0.0 113.67 162.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.47 -21.97 60.3 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.96 -1.087 . . . . 0.0 113.551 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 98.3 p -89.93 -6.65 55.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.712 1.205 . . . . 0.0 113.07 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.489 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.1 m-30 -98.31 -17.2 19.02 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.464 1.906 . . . . 0.0 112.277 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.72 159.78 14.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.875 2.07 . . . . 0.0 112.989 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.29 -43.08 2.45 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.698 1.618 . . . . 0.0 112.778 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -84.85 -176.79 6.37 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.21 1.404 . . . . 0.0 111.264 168.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 165.08 23.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.879 0.872 . . . . 0.0 111.313 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.41 158.24 43.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.123 0.569 . . . . 0.0 111.087 158.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 128.04 39.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.86 1.264 . . . . 0.0 109.883 159.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.3 178.19 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.57 124.98 13.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.288 0.635 . . . . 0.0 110.966 -166.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.07 131.9 49.72 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.945 0.898 . . . . 0.0 109.814 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -118.63 103.47 9.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.184 1.794 . . . . 0.0 109.38 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.79 160.39 14.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.374 1.083 . . . . 0.0 111.697 -175.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 pt -102.24 142.12 23.94 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.608 1.563 . . . . 0.0 109.879 166.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.07 126.11 9.06 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.793 2.329 . . . . 0.0 109.95 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.2 m -112.9 -27.9 7.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.229 1.412 . . . . 0.0 112.089 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.69 -39.59 2.82 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.652 1.596 . . . . 0.0 112.99 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.3 p -71.49 -34.73 70.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.748 1.219 . . . . 0.0 110.532 163.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.62 -165.61 15.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 112.061 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.05 164.14 15.19 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 122.014 -0.697 . . . . 0.0 109.376 151.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.94 145.79 51.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.593 1.557 . . . . 0.0 111.157 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.81 111.59 1.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.253 0.621 . . . . 0.0 112.474 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.4 -35.87 5.33 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.542 1.544 . . . . 0.0 111.683 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.48 151.91 8.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.857 1.663 . . . . 0.0 110.845 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -125.3 121.15 33.18 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.856 0.862 . . . . 0.0 110.02 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.6 m -101.1 135.68 42.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.722 1.609 . . . . 0.0 107.807 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.0 m -99.34 135.95 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.015 0.825 . . . . 0.0 109.006 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -103.82 -48.22 3.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.089 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -172.66 171.61 4.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 0.0 111.792 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.11 -175.1 30.95 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.394 1.474 . . . . 0.0 113.886 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.55 110.89 19.04 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -63.68 -15.32 58.09 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -153.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.78 -32.65 70.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.795 0.838 . . . . 0.0 112.196 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.02 -46.8 22.55 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 119.712 1.142 . . . . 0.0 110.775 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 54.4 m -51.84 -38.77 57.17 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.41 1.005 . . . . 0.0 113.603 173.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.26 -44.98 70.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.841 0.856 . . . . 0.0 112.27 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.22 -52.54 53.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 112.213 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.1 t -57.34 -50.31 73.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.801 0.84 . . . . 0.0 110.365 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -50.95 -46.84 61.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.442 1.497 . . . . 0.0 111.306 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -66.68 -44.22 82.35 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.78 80.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.857 1.263 . . . . 0.0 111.511 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.67 -22.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.5 -1.375 . . . . 0.0 111.947 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.83 -7.2 58.56 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.429 -0.794 . . . . 0.0 112.399 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.27 -12.08 3.19 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 46' ' ' ASN . 9.2 m -55.72 148.28 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.59 1.156 . . . . 0.0 113.017 171.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -73.46 -43.33 60.5 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.4 p 168.87 145.76 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.025 2.53 . . . . 0.0 111.141 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -95.56 110.68 52.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.439 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.69 114.85 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.527 1.485 . . . . 0.0 110.374 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.4 pt? -89.76 129.19 47.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.812 1.645 . . . . 0.0 110.397 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.93 -46.34 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.127 2.551 . . . . 0.0 111.043 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -94.26 167.17 11.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.17 1.388 . . . . 0.0 112.169 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.61 24.5 0.59 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.352 1.061 . . . . 0.0 113.027 -165.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.28 140.46 34.38 Favored Pre-proline 0 C--O 1.24 0.598 0 O-C-N 120.754 -1.217 . . . . 0.0 108.644 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.83 -15.26 2.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.961 3.107 . . . . 0.0 115.601 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.32 -35.7 30.65 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.273 0.942 . . . . 0.0 112.496 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -99.78 -27.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.523 1.129 . . . . 0.0 112.726 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.2 t -56.82 -32.5 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.564 1.146 . . . . 0.0 110.105 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -77.9 -7.83 57.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 113.462 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -99.19 -44.55 6.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 112.694 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.9 -28.14 67.25 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.771 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -73.01 -23.99 60.69 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.397 -1.439 . . . . 0.0 113.643 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -122.84 84.19 2.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.825 1.25 . . . . 0.0 110.445 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.59 155.92 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.147 0.979 . . . . 0.0 112.127 176.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 120.84 43.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.978 162.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.17 119.45 30.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -135.65 127.03 28.48 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.063 1.345 . . . . 0.0 108.56 -173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.49 157.32 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 111.606 -168.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 125.702 1.601 . . . . 0.0 115.265 175.131 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -51.48 -52.71 44.35 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 128.057 2.543 . . . . 0.0 113.7 -161.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.36 -15.01 65.04 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.052 1.786 . . . . 0.0 113.97 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.28 71.17 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.898 1.349 . . . . 0.0 110.551 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.5 pt -62.18 -26.97 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.476 -0.765 . . . . 0.0 112.223 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.2 -59.31 2.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.892 1.277 . . . . 0.0 109.927 174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -60.15 -35.58 75.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.881 1.272 . . . . 0.0 112.472 -173.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -77.4 -21.78 52.62 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.435 1.094 . . . . 0.0 112.779 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.93 -34.04 39.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.639 1.109 . . . . 0.0 111.416 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.75 -44.09 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 121.052 -1.03 . . . . 0.0 111.063 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -14.81 62.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.912 1.285 . . . . 0.0 112.911 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -59.99 -40.87 90.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.029 0.531 . . . . 0.0 109.962 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.46 HD22 HG13 ' A' ' 96' ' ' VAL . 34.0 m-80 -77.94 -44.06 28.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.952 0.882 . . . . 0.0 109.777 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.21 71.28 5.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.378 1.561 . . . . 0.0 111.512 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.12 28.95 0.05 Allowed 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.762 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.19 -70.68 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.991 . . . . 0.0 110.822 -163.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 75.82 -46.93 0.57 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.689 2.396 . . . . 0.0 113.201 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.09 -25.37 64.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.451 1.101 . . . . 0.0 113.067 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.6 m -86.02 -5.21 59.26 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.886 1.274 . . . . 0.0 113.336 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -110.47 -21.48 12.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 112.279 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -91.73 157.58 16.84 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.543 1.937 . . . . 0.0 113.334 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.03 -7.45 66.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 125.411 1.481 . . . . 0.0 114.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 -172.71 3.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.222 2.209 . . . . 0.0 110.955 176.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.18 165.91 21.36 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.458 -0.777 . . . . 0.0 110.593 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.8 t -154.99 142.05 19.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.001 0.92 . . . . 0.0 109.697 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.78 131.06 51.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.368 1.867 . . . . 0.0 110.677 166.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 170.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.461 1.104 . . . . 0.0 108.524 173.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.87 131.57 41.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.787 0.835 . . . . 0.0 112.068 -177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.28 134.25 44.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.044 0.938 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.89 102.89 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.162 1.385 . . . . 0.0 108.387 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.58 161.65 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.978 0.894 . . . . 0.0 111.493 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -100.59 121.01 54.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.273 1.429 . . . . 0.0 109.688 165.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.51 126.68 23.12 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.818 2.346 . . . . 0.0 110.994 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.2 m -143.52 92.45 2.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.276 1.431 . . . . 0.0 108.285 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.06 -123.95 32.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.977 0.799 . . . . 0.0 111.412 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.91 2.45 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.145 1.778 . . . . 0.0 114.199 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.71 -165.24 10.79 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.193 1.378 . . . . 0.0 114.726 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.15 165.73 19.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.838 1.255 . . . . 0.0 110.235 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.17 146.6 52.4 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.182 1.793 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.83 111.58 1.7 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.893 0.769 . . . . 0.0 112.419 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.61 -35.65 5.34 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.531 1.538 . . . . 0.0 112.287 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -166.43 153.87 9.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 111.06 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -129.58 129.13 44.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.261 1.024 . . . . 0.0 109.347 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.3 m -112.18 117.98 34.07 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.078 1.751 . . . . 0.0 108.229 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.61 132.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.708 0.685 . . . . 0.0 109.482 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -102.13 -53.13 2.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -179.1 162.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.666 1.987 . . . . 0.0 111.405 170.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.94 -176.54 40.69 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.368 0.985 . . . . 0.0 112.556 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 107.96 17.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 p -64.68 -13.95 56.33 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -147.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -57.1 -33.29 67.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.777 0.831 . . . . 0.0 112.604 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.35 -47.56 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.875 1.216 . . . . 0.0 111.855 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.7 m -45.68 -45.83 14.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.762 1.164 . . . . 0.0 112.802 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.54 71.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 0.0 112.427 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.81 66.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 t -58.85 -49.63 77.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.653 0.781 . . . . 0.0 110.477 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.39 -45.9 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.348 1.459 . . . . 0.0 111.518 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.71 -46.29 76.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.85 80.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.556 1.142 . . . . 0.0 111.622 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.06 -24.24 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.543 -1.348 . . . . 0.0 111.486 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.01 -7.22 58.71 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.348 -0.845 . . . . 0.0 112.368 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.75 -11.7 3.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.46 HG13 HD22 ' A' ' 46' ' ' ASN . 9.3 m -57.25 148.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.197 0.908 . . . . 0.0 112.869 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -68.57 -48.22 64.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.7 p 170.11 144.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.578 2.351 . . . . 0.0 110.56 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -97.18 110.66 55.21 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.466 -1.254 . . . . 0.0 109.482 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.87 129.93 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.447 2.098 . . . . 0.0 110.157 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.21 144.92 55.01 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.955 0.502 . . . . 0.0 110.745 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 -29.64 9.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.575 2.183 . . . . 0.0 111.656 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -114.66 -174.9 2.57 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.161 1.784 . . . . 0.0 111.864 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -151.96 21.15 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -95.52 132.29 27.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.89 -1.131 . . . . 0.0 109.457 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.69 -5.6 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.83 3.687 . . . . 0.0 116.857 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.75 -60.27 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.378 0.99 . . . . 0.0 110.266 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -74.97 -25.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.376 0.67 . . . . 0.0 112.273 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.25 -26.29 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 0.0 111.176 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -91.54 3.26 55.41 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.362 1.065 . . . . 0.0 113.711 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -98.33 -49.56 4.64 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.188 -0.945 . . . . 0.0 111.256 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.99 -22.37 65.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.014 1.725 . . . . 0.0 113.588 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.49 -25.1 64.8 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.921 -1.112 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -123.72 86.24 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.895 1.278 . . . . 0.0 111.041 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.446 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -110.55 150.29 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.898 1.279 . . . . 0.0 111.763 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.05 125.69 43.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 160.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.37 118.33 30.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 164.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -133.87 129.94 37.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.601 1.161 . . . . 0.0 109.321 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.36 153.67 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.534 1.534 . . . . 0.0 111.71 -171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.293 0 C-N-CA 125.734 1.614 . . . . 0.0 113.551 173.282 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.554 0.216 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HH ' ' HB ' ' A' ' 108' ' ' VAL . 6.7 m-85 -53.79 -45.31 70.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.29 2.236 . . . . 0.0 113.48 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.16 -17.2 69.99 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.111 1.339 . . . . 0.0 113.635 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.76 -31.93 63.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.612 1.206 . . . . 0.0 111.911 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.48 -27.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.157 -0.965 . . . . 0.0 111.61 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -81.83 -57.73 3.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.125 1.37 . . . . 0.0 110.23 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -58.08 -36.3 72.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.708 1.203 . . . . 0.0 112.444 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -73.21 -31.68 64.33 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.37 1.068 . . . . 0.0 111.484 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 tp -74.2 -34.33 63.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.071 0.851 . . . . 0.0 112.034 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.84 -44.82 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.591 -1.318 . . . . 0.0 110.927 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -72.15 -14.23 61.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -56.48 -39.24 72.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.442 0.297 . . . . 0.0 110.491 165.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.472 HD22 HG12 ' A' ' 96' ' ' VAL . 40.8 m-80 -79.27 -39.7 32.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.808 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -97.23 85.75 3.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 123.293 1.52 . . . . 0.0 112.031 -163.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.04 27.61 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.826 -1.534 . . . . 0.0 114.126 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 t -84.52 -52.82 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.346 0.658 . . . . 0.0 112.276 -163.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 69.78 -75.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.813 2.045 . . . . 0.0 112.554 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.29 -29.63 67.55 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.878 -1.138 . . . . 0.0 113.662 -167.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -81.55 0.75 36.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-30 -102.7 -17.57 15.58 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.704 2.001 . . . . 0.0 111.912 169.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -89.42 159.37 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.597 1.959 . . . . 0.0 112.18 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 -4.64 65.28 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.069 1.319 . . . . 0.0 114.873 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -140.06 -178.06 5.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.437 1.895 . . . . 0.0 111.882 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 164.01 21.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 109.75 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 t -156.79 144.54 19.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.942 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.11 128.85 45.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.11 1.364 . . . . 0.0 110.468 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -140.88 171.4 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 130.61 33.02 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.401 -0.812 . . . . 0.0 112.121 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.9 133.66 47.63 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.557 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -117.07 102.93 9.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.264 1.426 . . . . 0.0 109.245 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.17 160.67 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.98 0.895 . . . . 0.0 111.691 -176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.2 pt -101.69 122.35 47.91 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.809 1.644 . . . . 0.0 109.857 167.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 126.01 19.5 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.153 2.569 . . . . 0.0 110.88 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.3 m -118.71 -30.95 4.98 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.211 1.404 . . . . 0.0 111.967 -172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.75 -36.78 4.05 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 125.189 1.376 . . . . 0.0 113.716 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -71.48 -32.57 68.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.115 0.966 . . . . 0.0 110.527 161.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.05 -155.94 11.09 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 127.783 2.611 . . . . 0.0 110.897 172.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.43 163.61 13.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.205 1.003 . . . . 0.0 109.74 154.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.3 146.98 51.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 110.879 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.21 111.88 2.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.339 0.518 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.67 -46.78 3.11 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.304 1.43 . . . . 0.0 110.808 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.1 m -155.3 153.54 30.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.722 1.209 . . . . 0.0 111.452 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.25 132.16 45.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.618 1.167 . . . . 0.0 109.631 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 m -115.8 129.24 56.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.661 1.984 . . . . 0.0 107.494 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.79 136.49 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.397 0.999 . . . . 0.0 109.121 167.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.27 -49.7 3.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 119.083 -0.484 . . . . 0.0 109.996 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -171.39 170.3 5.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.32 1.848 . . . . 0.0 111.933 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.74 -175.32 32.11 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 124.731 1.158 . . . . 0.0 113.334 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.19 113.39 22.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 m -57.66 -20.19 31.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -155.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -54.32 -30.06 49.95 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 112.972 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.65 -50.59 7.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.202 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 m -45.09 -48.49 11.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.93 1.241 . . . . 0.0 113.604 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -29.29 69.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.427 1.091 . . . . 0.0 113.714 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.86 -52.05 5.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.403 1.481 . . . . 0.0 112.526 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 t -56.68 -48.3 77.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.057 0.943 . . . . 0.0 110.739 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -49.33 -47.28 47.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.589 1.556 . . . . 0.0 111.277 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -70.0 -44.48 69.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.809 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.443 1.019 . . . . 0.0 111.884 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.77 -23.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.599 -1.313 . . . . 0.0 111.556 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.88 -4.33 54.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.075 0.95 . . . . 0.0 112.735 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.06 -11.84 2.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 46' ' ' ASN . 13.0 m -58.34 149.41 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.577 1.081 . . . . 0.0 112.584 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -71.96 -46.27 58.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.4 p 170.29 144.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.708 2.003 . . . . 0.0 111.891 -173.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.74 110.44 58.96 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 110.184 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.98 131.11 10.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.381 2.054 . . . . 0.0 111.073 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.63 143.44 78.84 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.734 1.213 . . . . 0.0 112.324 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 -45.72 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.233 2.622 . . . . 0.0 111.24 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -126.63 154.53 43.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.722 2.009 . . . . 0.0 111.028 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -119.5 13.26 12.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 114.338 -161.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -80.35 143.45 55.92 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 120.814 -1.179 . . . . 0.0 109.741 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.61 -1.74 3.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.641 2.894 . . . . 0.0 114.159 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.2 -43.95 12.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.53 1.059 . . . . 0.0 111.652 167.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.409 ' HB ' ' HH ' ' A' ' 35' ' ' TYR . 21.1 m -87.84 -23.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.359 1.063 . . . . 0.0 112.902 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.76 -26.68 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.99 0.916 . . . . 0.0 110.468 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.2 -4.41 59.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.114 0.965 . . . . 0.0 113.506 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -96.02 -53.21 3.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.569 1.077 . . . . 0.0 111.296 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.47 -25.55 68.05 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.242 1.417 . . . . 0.0 113.009 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.42 -24.94 63.9 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.427 -1.421 . . . . 0.0 113.472 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -125.41 83.81 2.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.4 1.48 . . . . 0.0 110.76 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.63 156.19 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.948 1.299 . . . . 0.0 112.193 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.54 136.31 33.33 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 154.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.76 116.03 26.73 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 154.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -134.56 128.17 32.73 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 109.5 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.95 159.28 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.865 1.666 . . . . 0.0 110.889 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.108 0 C-N-CA 126.072 1.749 . . . . 0.0 111.401 -176.888 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.68 -42.13 67.63 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.081 2.152 . . . . 0.0 114.12 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.99 -17.3 59.67 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.68 1.61 . . . . 0.0 114.16 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.93 -31.26 56.52 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.706 1.253 . . . . 0.0 112.615 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -59.79 -26.87 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 111.969 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.01 -59.11 2.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.609 1.164 . . . . 0.0 110.176 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.746 1.219 . . . . 0.0 112.46 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.81 -42.89 69.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.487 1.115 . . . . 0.0 110.239 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.86 -29.88 69.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.798 0.726 . . . . 0.0 111.947 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.52 -52.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -17.74 63.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -55.26 -34.38 63.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.811 0.444 . . . . 0.0 111.648 165.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.479 HD22 HG13 ' A' ' 96' ' ' VAL . 68.0 m-80 -79.19 -33.4 43.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 81.2 1.87 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.004 1.321 . . . . 0.0 109.166 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.59 43.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.011 1.324 . . . . 0.0 112.829 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -78.25 -57.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.238 1.415 . . . . 0.0 111.802 -165.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 72.03 -50.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.954 2.501 . . . . 0.0 113.152 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.9 -32.62 73.93 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 113.728 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 m -89.9 0.35 57.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -111.8 -23.76 10.41 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.019 1.728 . . . . 0.0 112.267 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.52 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 112.804 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.16 -11.23 30.63 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.391 1.472 . . . . 0.0 114.925 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -170.2 2.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.053 2.141 . . . . 0.0 111.065 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.41 162.96 26.86 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.597 176.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.6 t -156.23 144.59 19.91 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 109.839 168.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.73 129.95 49.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.118 1.367 . . . . 0.0 110.648 165.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -142.8 170.19 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.905 1.282 . . . . 0.0 107.824 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -134.6 130.64 36.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.569 0.748 . . . . 0.0 111.66 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.6 132.43 47.26 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.225 1.01 . . . . 0.0 110.316 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.47 102.22 9.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.191 1.396 . . . . 0.0 108.903 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.25 159.84 14.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.26 1.029 . . . . 0.0 111.565 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.7 pt -103.87 146.6 32.83 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 126.111 1.764 . . . . 0.0 109.837 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.14 133.29 17.76 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 110.525 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -3.37 16.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.019 1.328 . . . . 0.0 113.121 175.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 -55.44 1.0 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 126.292 1.901 . . . . 0.0 112.441 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.6 p -79.94 -24.28 41.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.775 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.75 -159.11 10.11 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.086 1.803 . . . . 0.0 111.686 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -108.74 164.94 11.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.87 0.868 . . . . 0.0 110.871 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.73 145.3 49.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.592 1.957 . . . . 0.0 110.787 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.27 112.49 1.95 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.075 0.852 . . . . 0.0 112.135 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.72 -36.15 4.89 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.432 1.492 . . . . 0.0 112.034 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -164.83 154.44 13.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.408 1.483 . . . . 0.0 111.533 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -130.61 126.74 37.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.274 1.03 . . . . 0.0 109.791 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.8 m -110.62 118.73 37.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.946 1.698 . . . . 0.0 107.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.25 134.32 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.185 0.902 . . . . 0.0 109.632 170.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 mt -107.09 -49.21 3.32 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.997 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -173.38 166.24 4.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.65 1.58 . . . . 0.0 111.618 172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.76 -177.44 35.37 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 125.164 1.364 . . . . 0.0 114.011 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.31 116.69 21.92 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -56.28 -25.36 48.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -151.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -51.25 -38.18 51.23 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.917 1.287 . . . . 0.0 112.666 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.053 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.99 -28.66 67.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.5 1.5 . . . . 0.0 114.138 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 -44.26 69.16 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.895 0.77 . . . . 0.0 112.666 170.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.13 -54.61 12.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.66 1.184 . . . . 0.0 113.549 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -54.67 -48.52 72.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.506 0.723 . . . . 0.0 110.514 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -52.13 -45.75 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.658 1.583 . . . . 0.0 112.048 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.6 mtp-105 -63.81 -42.32 97.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.121 0.568 . . . . 0.0 112.019 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.81 74.76 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.83 -25.08 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.253 -1.529 . . . . 0.0 112.383 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.2 -7.7 57.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.728 0.811 . . . . 0.0 112.804 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -132.31 -12.74 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.479 HG13 HD22 ' A' ' 46' ' ' ASN . 6.8 m -58.09 146.68 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.415 1.086 . . . . 0.0 112.681 173.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -68.74 -41.98 78.2 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 p 163.41 139.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.448 2.299 . . . . 0.0 110.96 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -91.95 113.03 57.67 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.154 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.26 118.82 5.07 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.249 1.966 . . . . 0.0 109.926 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -93.17 140.28 23.27 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.909 1.284 . . . . 0.0 112.047 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.06 -31.2 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.271 2.647 . . . . 0.0 113.463 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.76 146.45 49.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.584 1.554 . . . . 0.0 110.049 176.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -102.78 8.13 39.44 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -166.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.02 136.33 57.89 Favored Pre-proline 0 C--O 1.241 0.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.366 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.61 -5.11 8.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.807 2.338 . . . . 0.0 113.465 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.32 -35.93 21.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.965 0.802 . . . . 0.0 112.063 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.18 -27.72 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.25 1.02 . . . . 0.0 112.814 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -57.26 -27.1 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.705 0.802 . . . . 0.0 110.874 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -82.07 -6.64 59.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.075 1.35 . . . . 0.0 114.094 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -92.54 -55.71 3.29 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.365 -0.834 . . . . 0.0 111.314 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.99 -27.62 65.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.885 1.274 . . . . 0.0 112.991 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -67.68 -23.07 65.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.063 -1.648 . . . . 0.0 114.048 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -122.68 86.28 2.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.45 1.1 . . . . 0.0 110.877 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -109.11 151.55 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.615 1.166 . . . . 0.0 111.978 175.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.72 129.52 36.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 154.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -86.03 111.77 20.61 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.7 m -131.8 126.32 34.07 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.06 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.89 151.83 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 126.486 1.914 . . . . 0.0 110.641 -178.752 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 77.19 -44.13 0.44 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.714 2.806 . . . . 0.0 113.766 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 77.07 5.61 3.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.416 2.286 . . . . 0.0 114.363 164.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -93.67 -20.71 19.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.501 0.721 . . . . 0.0 112.809 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.21 -23.07 0.34 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.626 1.57 . . . . 0.0 113.634 -166.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -55.84 -13.57 1.87 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -169.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -52.64 -29.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.949 0.9 . . . . 0.0 112.399 168.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 t -65.86 -24.89 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.924 1.29 . . . . 0.0 114.346 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.4 m -88.37 -31.53 18.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.522 0.729 . . . . 0.0 111.714 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.83 -33.79 72.79 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.404 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.55 -25.61 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.293 1.406 . . . . 0.0 111.231 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.05 70.25 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.22 1.867 . . . . 0.0 113.915 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -99.58 -55.77 2.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.194 1.497 . . . . 0.0 112.19 164.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.86 -46.43 67.87 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.344 2.258 . . . . 0.0 113.395 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.48 -17.39 64.32 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.423 1.487 . . . . 0.0 113.97 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.39 -32.87 64.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.362 1.081 . . . . 0.0 111.993 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 pt -60.56 -28.18 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.735 0.698 . . . . 0.0 111.919 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -80.59 -58.89 2.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.359 1.064 . . . . 0.0 109.58 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 t -60.52 -35.4 75.87 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.75 1.22 . . . . 0.0 112.645 -172.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -73.56 -32.38 64.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.459 1.104 . . . . 0.0 111.603 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -73.71 -32.65 64.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.871 0.759 . . . . 0.0 111.681 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.83 -56.46 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -65.2 -21.46 66.76 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.26 -9.26 59.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.72 -41.76 23.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.4 1.0 . . . . 0.0 111.374 163.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.99 86.39 2.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.232 1.413 . . . . 0.0 109.57 -173.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.76 39.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.052 1.741 . . . . 0.0 113.971 -173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.05 -60.01 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.957 0.903 . . . . 0.0 111.82 -166.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 72.73 -53.15 0.7 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.781 2.433 . . . . 0.0 114.148 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.47 -32.6 74.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 113.418 -171.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.8 p -96.6 5.64 50.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.093 1.357 . . . . 0.0 113.335 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.55 -27.4 13.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.232 1.813 . . . . 0.0 111.382 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -93.66 173.41 7.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.662 1.985 . . . . 0.0 112.657 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.66 -32.35 1.9 Allowed Glycine 0 N--CA 1.481 1.649 0 C-N-CA 125.811 1.672 . . . . 0.0 114.795 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -167.38 1.47 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.119 2.168 . . . . 0.0 110.675 165.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 158.63 38.03 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.28 -0.888 . . . . 0.0 110.442 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -156.46 150.16 24.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.612 1.165 . . . . 0.0 110.171 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.99 118.8 10.53 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.861 1.664 . . . . 0.0 110.589 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.38 171.05 14.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.413 1.085 . . . . 0.0 108.301 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.91 124.15 14.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.658 0.783 . . . . 0.0 110.402 -166.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.62 128.78 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.93 0.892 . . . . 0.0 109.074 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -117.6 105.9 12.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.379 1.472 . . . . 0.0 109.186 171.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.04 160.66 14.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.397 1.079 . . . . 0.0 111.397 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 pt -101.71 152.87 38.18 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.758 1.623 . . . . 0.0 110.2 167.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.73 151.76 46.73 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.175 2.583 . . . . 0.0 111.183 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -168.36 148.66 4.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.584 2.354 . . . . 0.0 108.273 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.63 74.7 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 -164.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -96.56 -6.06 37.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.579 1.552 . . . . 0.0 113.15 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.83 165.83 10.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.713 1.625 . . . . 0.0 111.598 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.64 161.4 20.55 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 117.959 0.879 . . . . 0.0 111.014 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.76 143.35 50.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.223 1.409 . . . . 0.0 111.159 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.3 109.59 0.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.88 -45.3 3.66 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.462 1.506 . . . . 0.0 110.938 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.4 m -156.06 146.33 21.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.344 1.058 . . . . 0.0 110.299 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.21 124.94 41.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.067 0.947 . . . . 0.0 109.927 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.9 m -104.77 121.49 43.73 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.006 1.323 . . . . 0.0 108.279 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.61 126.61 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 165.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.57 -40.44 6.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.048 0.539 . . . . 0.0 110.783 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -170.79 172.74 5.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.765 1.626 . . . . 0.0 111.462 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.57 172.33 17.57 Favored Glycine 0 N--CA 1.465 0.587 0 C-N-CA 125.981 1.753 . . . . 0.0 114.128 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -76.81 122.04 24.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.1 p -56.37 -27.42 56.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -157.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -56.68 -25.36 53.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.617 1.167 . . . . 0.0 113.865 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 tp -91.34 -59.57 2.11 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.066 1.303 . . . . 0.0 112.377 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.4 p -56.88 -31.79 65.19 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 121.137 1.789 . . . . 0.0 114.861 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.2 71.93 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.439 1.018 . . . . 0.0 112.658 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.37 -53.4 12.42 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.917 1.287 . . . . 0.0 112.006 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 t -54.55 -50.36 68.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.245 1.018 . . . . 0.0 110.608 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -51.14 -47.49 62.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.847 1.659 . . . . 0.0 111.755 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.98 -40.63 96.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 112.277 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.66 82.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.275 1.43 . . . . 0.0 112.453 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.01 -26.81 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.568 -1.332 . . . . 0.0 112.15 178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.05 55.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.915 0.886 . . . . 0.0 112.991 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.54 -10.56 3.18 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.3 m -52.1 150.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.23 -50.13 49.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.017 0.927 . . . . 0.0 112.581 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p 168.67 147.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.459 2.704 . . . . 0.0 110.387 -173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -97.51 106.3 31.81 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.234 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.91 116.93 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.716 1.611 . . . . 0.0 110.647 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 142.43 28.48 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.043 1.337 . . . . 0.0 110.722 173.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.86 -24.17 11.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.34 2.693 . . . . 0.0 112.586 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.3 -179.93 6.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.39 1.476 . . . . 0.0 112.44 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -155.86 15.32 0.35 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.472 1.109 . . . . 0.0 113.086 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.28 129.09 32.85 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 120.637 -1.289 . . . . 0.0 108.967 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.64 -4.09 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.559 3.506 . . . . 0.0 115.801 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.51 -43.39 15.81 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.833 1.197 . . . . 0.0 112.141 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.12 -22.52 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.603 1.161 . . . . 0.0 112.609 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.3 t -55.2 -27.12 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.956 0.902 . . . . 0.0 110.903 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.65 -7.59 59.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.032 1.333 . . . . 0.0 113.81 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -45.69 6.14 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.046 -1.034 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -72.65 -23.19 60.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.998 0.919 . . . . 0.0 111.823 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -65.97 -22.12 66.45 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -125.52 79.34 1.81 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -102.19 158.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.48 1.112 . . . . 0.0 111.776 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.39 123.62 50.67 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 159.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.24 111.28 20.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -134.21 125.66 28.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.79 1.236 . . . . 0.0 108.931 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.76 149.88 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.727 1.611 . . . . 0.0 110.631 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.01 165.0 5.99 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 126.658 1.983 . . . . 0.0 111.201 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.13 154.47 67.3 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.574 2.85 . . . . 0.0 112.781 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 125.11 1.364 . . . . 0.0 111.184 178.642 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.44 165.0 12.77 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -156.58 19.11 0.33 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.389 1.476 . . . . 0.0 113.336 -167.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -99.11 -20.76 16.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.473 . . . . 0.0 112.076 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.7 -17.21 0.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.052 1.741 . . . . 0.0 112.7 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.03 5.41 0.14 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.107 2.163 . . . . 0.0 116.035 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -57.18 -29.79 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.806 1.242 . . . . 0.0 112.661 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -57.97 -48.41 80.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.068 0.947 . . . . 0.0 111.878 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -63.29 -30.79 71.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.461 1.104 . . . . 0.0 112.159 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -72.03 -19.69 61.8 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.908 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.7 t -59.37 -31.44 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 121.643 2.02 . . . . 0.0 111.027 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.07 -9.29 66.54 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.44 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -105.2 -46.41 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.287 1.435 . . . . 0.0 110.943 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.74 -43.09 65.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.431 1.892 . . . . 0.0 113.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.56 68.28 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.841 1.21 . . . . 0.0 114.011 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.59 -35.07 70.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 111.366 178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -59.6 -28.44 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.545 -0.722 . . . . 0.0 112.122 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -80.36 -58.86 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.968 1.307 . . . . 0.0 109.547 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -59.51 -35.53 74.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.553 1.141 . . . . 0.0 112.695 -173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -74.45 -30.27 61.8 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.726 1.21 . . . . 0.0 111.781 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -75.47 -34.49 60.9 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.531 1.059 . . . . 0.0 111.479 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.53 -44.44 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.295 1.038 . . . . 0.0 111.058 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.95 -14.37 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.884 0.874 . . . . 0.0 113.164 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -55.52 -35.53 65.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.268 0.227 . . . . 0.0 111.137 164.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.475 HD22 HG11 ' A' ' 96' ' ' VAL . 64.2 m-80 -81.7 -30.71 32.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 111.538 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.95 81.22 1.68 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.418 1.487 . . . . 0.0 109.531 -172.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.48 38.09 0.18 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.413 1.485 . . . . 0.0 113.786 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.31 -51.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.97 0.908 . . . . 0.0 112.892 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 70.82 -59.01 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.779 2.432 . . . . 0.0 113.71 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.06 -34.34 77.84 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.076 -1.015 . . . . 0.0 113.464 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -87.8 -1.32 57.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 113.612 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -100.4 -24.4 14.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.774 1.629 . . . . 0.0 111.702 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -91.32 172.51 8.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.372 2.269 . . . . 0.0 111.373 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.47 -34.02 2.04 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -168.64 1.59 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.573 1.949 . . . . 0.0 110.748 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 160.6 32.75 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 110.703 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 44.6 t -157.46 149.02 21.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.506 1.122 . . . . 0.0 110.171 171.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 122.82 20.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.989 1.716 . . . . 0.0 110.368 167.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.54 163.11 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.591 1.156 . . . . 0.0 108.005 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.34 130.69 39.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.343 0.657 . . . . 0.0 112.128 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.44 129.76 46.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 110.084 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.47 103.82 11.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.424 1.489 . . . . 0.0 108.774 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.29 158.41 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.533 0.683 . . . . 0.0 111.757 -177.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.16 140.09 21.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 109.861 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.85 125.42 9.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.436 2.091 . . . . 0.0 109.833 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.2 m -110.81 -31.0 7.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.695 1.198 . . . . 0.0 111.871 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.62 -117.04 0.7 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.191 1.377 . . . . 0.0 110.756 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -66.7 -4.98 10.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.393 1.477 . . . . 0.0 113.871 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.47 174.04 24.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.434 1.492 . . . . 0.0 114.27 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.57 163.87 12.16 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 111.717 171.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.78 147.15 50.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.435 1.894 . . . . 0.0 111.4 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.94 111.61 1.55 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.52 0.6 . . . . 0.0 112.133 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 -45.78 3.69 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.406 1.479 . . . . 0.0 111.15 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.4 m -157.33 152.86 26.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.747 1.219 . . . . 0.0 110.463 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.98 126.93 40.65 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.218 1.007 . . . . 0.0 110.214 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.7 m -106.8 120.87 43.18 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.638 1.975 . . . . 0.0 107.938 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -87.57 127.11 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.2 0.909 . . . . 0.0 108.779 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.29 -39.42 6.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.265 0.626 . . . . 0.0 110.896 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -170.25 168.83 8.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 111.849 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.8 173.84 19.9 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 125.283 1.421 . . . . 0.0 114.753 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.62 117.85 20.92 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.7 p -59.15 -19.76 47.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -159.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -55.85 -29.96 60.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.906 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.53 -52.31 5.64 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.84 1.2 . . . . 0.0 111.444 171.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 m -46.64 -46.8 20.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.741 1.155 . . . . 0.0 113.635 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.86 -42.3 67.05 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.009 0.822 . . . . 0.0 112.041 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.69 -58.74 6.85 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.512 1.125 . . . . 0.0 112.531 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.1 t -57.64 -50.41 73.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.864 0.466 . . . . 0.0 110.168 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -51.74 -47.54 64.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.227 1.411 . . . . 0.0 111.876 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.02 -40.61 96.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.228 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.4 -49.3 74.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.763 1.225 . . . . 0.0 112.203 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.32 -24.06 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.633 -1.292 . . . . 0.0 111.723 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.78 -7.13 57.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 112.66 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -134.05 -12.74 2.5 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.475 HG11 HD22 ' A' ' 46' ' ' ASN . 11.0 m -58.45 146.56 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.231 1.013 . . . . 0.0 112.628 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -66.52 -46.05 77.45 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p 167.6 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.854 2.062 . . . . 0.0 111.0 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -96.24 109.38 47.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.666 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.05 132.0 14.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.424 2.083 . . . . 0.0 109.969 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.99 145.94 66.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.667 -173.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.66 -28.79 7.82 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.095 2.53 . . . . 0.0 111.181 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -140.42 150.58 44.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.925 2.09 . . . . 0.0 110.621 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -119.88 23.03 11.28 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.928 1.291 . . . . 0.0 112.888 -164.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -85.86 142.13 36.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.584 -1.323 . . . . 0.0 109.946 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -63.09 -4.57 6.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.484 2.789 . . . . 0.0 113.796 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.38 -33.44 19.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.597 1.159 . . . . 0.0 111.98 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 -24.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.202 1.001 . . . . 0.0 112.23 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.55 -25.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.23 1.012 . . . . 0.0 111.362 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -84.13 -7.36 59.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.978 1.311 . . . . 0.0 114.323 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 -46.52 5.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.905 0.882 . . . . 0.0 111.23 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.0 pp -74.42 -20.33 60.08 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.571 1.548 . . . . 0.0 113.205 -177.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -63.56 -23.9 67.58 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.699 -1.25 . . . . 0.0 113.354 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.34 80.09 1.92 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.985 1.314 . . . . 0.0 109.933 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -106.39 150.95 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.002 . . . . 0.0 111.828 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.82 130.57 44.07 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 160.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.84 111.95 23.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 156.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.0 m -134.6 126.45 29.25 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.704 1.202 . . . . 0.0 109.254 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.1 m -138.78 151.71 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.377 1.471 . . . . 0.0 110.495 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.06 165.08 5.91 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.26 1.824 . . . . 0.0 111.583 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.54 166.14 16.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.737 2.958 . . . . 0.0 112.331 171.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 . . . . . 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 111.938 -178.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.38 167.34 8.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.954 1.302 . . . . 0.0 111.537 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -166.64 19.9 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 113.187 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -105.37 -20.37 13.51 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 0.0 112.704 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.93 -9.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.146 1.379 . . . . 0.0 114.083 -166.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -72.43 1.33 8.15 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -157.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -54.82 -33.88 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.167 0.987 . . . . 0.0 112.044 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -59.25 -38.21 79.49 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.951 0.9 . . . . 0.0 112.584 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 t -78.23 -23.57 47.34 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.188 -0.945 . . . . 0.0 113.005 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -72.08 -33.95 68.29 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.327 -0.858 . . . . 0.0 111.981 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.4 t -66.6 -27.62 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 120.351 1.432 . . . . 0.0 110.712 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.85 1.44 30.96 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.196 1.379 . . . . 0.0 114.638 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -132.59 -64.79 0.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.714 1.606 . . . . 0.0 111.438 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.58 -18.55 41.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 128.027 2.531 . . . . 0.0 116.219 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.66 -13.13 8.94 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.138 1.827 . . . . 0.0 113.945 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.37 -32.18 43.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.034 1.734 . . . . 0.0 110.755 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 pt -62.0 -28.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.186 -1.571 . . . . 0.0 112.15 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.75 -56.97 4.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.513 1.125 . . . . 0.0 110.098 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -58.83 -35.03 72.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.364 1.066 . . . . 0.0 112.641 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -70.31 -31.21 68.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.472 1.509 . . . . 0.0 112.307 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.0 tp -79.96 -35.24 37.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.605 0.362 . . . . 0.0 111.824 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.22 -53.11 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.777 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -59.06 -26.87 64.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.493 0.717 . . . . 0.0 112.289 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -15.16 60.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.453 HD22 HG11 ' A' ' 96' ' ' VAL . 56.7 m-80 -81.43 -40.1 23.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.039 0.836 . . . . 0.0 111.718 161.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.2 88.07 5.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 123.383 1.563 . . . . 0.0 111.607 -163.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 27.02 0.4 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.863 -1.517 . . . . 0.0 114.121 -175.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.45 -56.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.741 0.816 . . . . 0.0 112.563 -163.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.3 -57.59 0.63 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.001 2.521 . . . . 0.0 113.757 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.85 -24.13 62.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 112.937 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.6 m -84.06 -1.27 54.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.608 1.163 . . . . 0.0 113.623 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -117.5 -21.17 8.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.526 1.53 . . . . 0.0 113.179 -175.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -85.44 152.1 23.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.315 1.846 . . . . 0.0 112.713 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 -8.49 28.3 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.365 1.459 . . . . 0.0 116.126 168.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.4 -179.55 4.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.149 1.779 . . . . 0.0 112.052 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 160.92 20.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.652 0.781 . . . . 0.0 111.29 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 49.0 t -159.51 144.19 15.29 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.449 1.1 . . . . 0.0 109.877 172.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.29 39.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.846 2.059 . . . . 0.0 110.031 168.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.25 175.08 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.277 1.031 . . . . 0.0 108.568 171.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.08 126.76 20.45 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.941 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.75 128.75 53.89 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.128 0.971 . . . . 0.0 109.007 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -116.69 106.92 14.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.96 1.304 . . . . 0.0 109.117 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.28 157.77 16.16 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.605 1.162 . . . . 0.0 111.772 -176.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.86 151.19 37.45 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.723 1.609 . . . . 0.0 110.154 167.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -72.52 150.42 51.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.137 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -166.47 148.17 6.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.487 2.315 . . . . 0.0 108.062 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.74 -17.66 71.42 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.776 1.071 . . . . 0.0 115.776 -165.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.3 p -97.14 -3.43 41.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.971 1.708 . . . . 0.0 113.127 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.26 165.42 11.45 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.161 1.363 . . . . 0.0 111.937 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.58 161.28 26.0 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.366 1.083 . . . . 0.0 111.115 -177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.21 144.58 51.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 111.127 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.65 112.2 1.91 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.427 0.558 . . . . 0.0 112.04 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.1 -46.11 3.16 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.026 1.298 . . . . 0.0 111.012 170.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.7 m -153.03 143.69 22.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.368 1.067 . . . . 0.0 110.682 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -119.21 121.86 40.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.258 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -104.8 118.31 36.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.405 1.482 . . . . 0.0 108.26 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 m -83.97 129.05 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 118.892 0.769 . . . . 0.0 109.732 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 mt -99.18 -54.32 3.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.009 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -177.87 164.8 1.96 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.721 2.008 . . . . 0.0 111.433 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.25 -173.71 39.44 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 125.57 1.557 . . . . 0.0 113.528 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.99 116.92 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.4 p -55.9 -26.31 46.83 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -150.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.83 -29.44 69.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.93 -47.37 16.54 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.722 1.147 . . . . 0.0 111.107 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 68.8 m -48.56 -45.07 37.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.632 1.106 . . . . 0.0 112.359 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.25 -47.93 75.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.628 1.171 . . . . 0.0 112.177 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.79 41.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.058 0.943 . . . . 0.0 113.266 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 t -56.8 -48.49 77.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.809 0.844 . . . . 0.0 110.845 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -48.71 -44.12 37.9 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.303 1.841 . . . . 0.0 111.953 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -70.57 -45.92 64.48 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.25 74.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.701 1.2 . . . . 0.0 111.161 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -67.08 -22.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.996 -1.065 . . . . 0.0 112.268 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -7.44 59.1 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.001 0.92 . . . . 0.0 112.538 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.18 -12.54 3.58 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.453 HG11 HD22 ' A' ' 46' ' ' ASN . 9.6 m -56.52 145.56 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.485 1.114 . . . . 0.0 112.783 171.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.7 -44.68 77.13 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.0 p 165.59 142.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.214 2.205 . . . . 0.0 110.848 -169.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -93.21 111.27 51.13 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.693 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.18 128.85 10.85 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.217 1.945 . . . . 0.0 110.567 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.34 148.36 52.5 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.577 0.751 . . . . 0.0 112.118 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.06 -33.35 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.92 2.414 . . . . 0.0 111.075 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 153.78 45.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.161 2.184 . . . . 0.0 110.358 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -119.87 20.2 12.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.318 1.447 . . . . 0.0 113.406 -166.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -83.2 139.8 42.25 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 120.757 -1.214 . . . . 0.0 109.3 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.66 -15.74 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.461 2.774 . . . . 0.0 114.945 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.15 -28.62 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.973 1.309 . . . . 0.0 112.077 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.68 -26.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.582 1.553 . . . . 0.0 112.5 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.37 -26.27 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.49 1.116 . . . . 0.0 110.959 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.41 -11.49 59.68 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.233 1.413 . . . . 0.0 113.714 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -97.51 -46.52 6.01 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.914 0.779 . . . . 0.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.07 -22.52 60.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.796 1.238 . . . . 0.0 112.92 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.38 -23.93 66.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.07 82.35 2.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.006 0.923 . . . . 0.0 110.238 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.424 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.2 158.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.36 1.076 . . . . 0.0 111.968 178.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.06 126.09 52.33 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 157.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.59 112.47 21.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.5 m -132.1 125.84 32.31 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 109.054 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.24 149.99 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.251 1.82 . . . . 0.0 110.293 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.89 156.63 8.58 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.551 1.54 . . . . 0.0 112.197 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.913 3.075 . . . . 0.0 111.517 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.244 0.799 0 C-N-CA 123.86 0.864 . . . . 0.0 111.68 177.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -165.29 -67.42 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.11 0.964 . . . . 0.0 111.525 -168.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 72.53 12.68 5.49 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.751 2.021 . . . . 0.0 114.101 171.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -94.42 -19.36 20.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.953 0.901 . . . . 0.0 113.118 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.95 -22.79 0.45 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.829 1.251 . . . . 0.0 113.966 -166.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.68 -16.97 18.74 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -166.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 m -56.26 -28.88 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.91 1.284 . . . . 0.0 112.806 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 t -58.23 -33.02 68.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.262 1.025 . . . . 0.0 112.965 171.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -80.96 -27.04 36.17 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.314 -0.867 . . . . 0.0 113.11 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.95 -34.99 77.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.338 0.972 . . . . 0.0 111.023 165.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.0 -28.25 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 119.889 1.222 . . . . 0.0 110.202 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.52 1.75 60.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.567 2.032 . . . . 0.0 114.07 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -111.42 -57.93 2.18 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.917 1.358 . . . . 0.0 111.112 162.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' HH ' ' HB ' ' A' ' 108' ' ' VAL . 8.5 m-85 -49.89 -47.62 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.161 2.184 . . . . 0.0 114.038 -173.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.4 -16.14 62.87 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.052 1.31 . . . . 0.0 113.779 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.92 -34.5 64.37 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.251 1.026 . . . . 0.0 111.645 178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -60.03 -26.3 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.519 -0.738 . . . . 0.0 111.994 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -82.08 -59.87 2.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.494 1.118 . . . . 0.0 109.837 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -61.17 -35.14 76.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.254 1.022 . . . . 0.0 112.775 -171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -71.38 -43.02 67.66 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.165 0.986 . . . . 0.0 109.757 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.57 -30.33 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.672 0.669 . . . . 0.0 111.543 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -54.0 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.844 0.858 . . . . 0.0 110.915 176.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -68.05 -18.07 64.58 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -55.85 -36.45 67.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.256 0.48 . . . . 0.0 111.389 167.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.445 HD22 HG12 ' A' ' 96' ' ' VAL . 58.2 m-80 -77.51 -34.35 54.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -102.35 109.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.542 1.163 . . . . 0.0 111.14 -160.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.65 22.03 10.51 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 114.628 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.8 -62.56 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.332 0.653 . . . . 0.0 111.545 -166.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 72.86 -60.04 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.769 2.428 . . . . 0.0 113.506 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.6 -29.77 70.98 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.611 -1.305 . . . . 0.0 113.14 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -94.8 6.07 50.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.31 1.044 . . . . 0.0 113.655 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -105.31 -21.94 13.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 112.085 173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -100.64 156.3 17.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.596 1.958 . . . . 0.0 111.905 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.48 -27.27 2.89 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.274 1.416 . . . . 0.0 114.556 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -174.68 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.494 1.918 . . . . 0.0 111.557 174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 161.62 29.62 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.815 0.846 . . . . 0.0 110.643 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.443 ' HG ' HG22 ' A' ' 119' ' ' VAL . 0.5 OUTLIER -149.95 157.87 43.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.553 0.741 . . . . 0.0 111.433 160.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 126.03 31.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.84 1.656 . . . . 0.0 109.967 161.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.94 166.33 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.15 131.29 36.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.508 0.594 . . . . 0.0 112.065 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 132.18 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.159 0.984 . . . . 0.0 110.037 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -114.4 105.98 13.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.341 1.456 . . . . 0.0 109.147 171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.2 158.81 15.59 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.56 0.695 . . . . 0.0 111.748 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -99.3 133.43 22.03 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.126 1.37 . . . . 0.0 109.843 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.06 116.73 4.83 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.581 2.187 . . . . 0.0 109.207 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 m -106.14 -30.85 8.99 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.546 1.139 . . . . 0.0 112.095 -172.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.24 -112.33 0.49 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.852 1.215 . . . . 0.0 111.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -58.71 -25.28 62.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 112.34 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.76 179.04 20.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.757 1.17 . . . . 0.0 114.472 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.24 165.0 12.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.97 1.308 . . . . 0.0 111.515 170.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -132.82 147.22 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.151 1.781 . . . . 0.0 111.47 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.94 111.23 1.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.764 0.711 . . . . 0.0 112.656 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.35 -36.04 5.53 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.396 1.474 . . . . 0.0 111.668 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -167.26 153.39 7.94 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.266 1.426 . . . . 0.0 111.023 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -130.14 126.29 37.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.319 1.048 . . . . 0.0 109.873 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -105.17 132.98 50.71 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.402 1.881 . . . . 0.0 108.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.14 131.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.943 0.792 . . . . 0.0 109.102 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.56 -45.19 5.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.947 0.499 . . . . 0.0 110.073 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -172.58 167.91 5.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.986 1.715 . . . . 0.0 111.647 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.7 -177.84 27.59 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.893 1.235 . . . . 0.0 114.303 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.4 118.22 24.8 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 166.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.8 p -59.94 -21.27 60.94 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -158.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -60.88 -23.02 64.86 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.381 1.072 . . . . 0.0 113.669 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.44 -49.06 6.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.812 1.187 . . . . 0.0 111.414 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.8 m -49.99 -39.26 40.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.833 1.253 . . . . 0.0 114.322 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.2 56.86 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.04 0.836 . . . . 0.0 112.829 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -51.29 65.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.981 . . . . 0.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.4 t -57.46 -47.6 81.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.454 0.702 . . . . 0.0 110.235 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -57.19 -35.15 69.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.371 1.068 . . . . 0.0 112.157 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -71.26 -48.52 50.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.41 72.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.647 1.179 . . . . 0.0 111.749 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.1 -24.04 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.489 -1.382 . . . . 0.0 111.661 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -6.94 58.83 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -130.91 -12.14 3.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.445 HG12 HD22 ' A' ' 46' ' ' ASN . 9.7 m -58.76 145.91 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.395 1.078 . . . . 0.0 112.257 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.41 -42.1 83.78 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -173.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p 163.21 143.44 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.56 2.344 . . . . 0.0 111.048 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -98.13 105.32 27.61 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-O 117.527 -1.225 . . . . 0.0 109.948 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 134.35 17.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.817 2.344 . . . . 0.0 110.437 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 144.87 59.22 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.31 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.33 -28.67 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.241 2.627 . . . . 0.0 111.855 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -140.77 154.23 46.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.715 2.006 . . . . 0.0 110.482 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -133.49 48.1 2.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.175 0.99 . . . . 0.0 112.349 -165.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.9 141.2 22.84 Favored Pre-proline 0 C--O 1.243 0.733 0 O-C-N 121.35 -0.844 . . . . 0.0 108.802 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.17 -17.55 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.021 3.148 . . . . 0.0 115.182 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.76 -33.85 40.34 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.039 0.836 . . . . 0.0 112.335 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' HB ' ' HH ' ' A' ' 35' ' ' TYR . 21.5 m -97.26 -25.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.506 1.122 . . . . 0.0 112.611 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.33 -26.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.697 1.199 . . . . 0.0 110.951 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -81.38 -10.7 59.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.001 1.32 . . . . 0.0 114.031 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.77 -47.5 5.57 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.343 -0.848 . . . . 0.0 111.401 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.4 -21.07 61.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.188 . . . . 0.0 112.61 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -65.38 -24.95 67.36 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.726 -1.234 . . . . 0.0 113.42 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -129.92 78.78 1.87 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.044 1.338 . . . . 0.0 110.345 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.434 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.56 150.26 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.156 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.52 128.42 44.25 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 159.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.75 116.34 28.93 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.7 m -135.02 128.17 31.85 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.718 1.207 . . . . 0.0 109.679 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.443 HG22 ' HG ' ' A' ' 58' ' ' CYS . 5.7 m -139.65 156.56 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.421 1.488 . . . . 0.0 111.303 -168.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.59 161.57 8.6 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 127.431 2.293 . . . . 0.0 110.003 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.76 163.39 37.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.083 2.522 . . . . 0.0 112.174 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.24 0.558 0 C-N-CA 125.246 1.418 . . . . 0.0 111.088 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.03 -72.08 0.48 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.973 1.309 . . . . 0.0 111.834 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 70.17 13.77 7.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.597 1.959 . . . . 0.0 114.832 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -94.98 -19.45 20.2 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -24.32 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.216 1.406 . . . . 0.0 112.984 -166.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -9.81 17.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -168.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.68 -26.8 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.574 1.55 . . . . 0.0 113.035 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 t -62.68 -24.1 67.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 113.153 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 t -85.35 -30.81 23.37 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.269 -0.894 . . . . 0.0 112.488 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -64.29 -38.18 90.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.753 1.16 . . . . 0.0 111.33 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.24 -24.99 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.305 1.412 . . . . 0.0 111.496 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.61 -8.5 72.06 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.471 1.986 . . . . 0.0 114.566 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -109.0 -47.68 3.4 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.392 1.877 . . . . 0.0 109.936 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.475 ' HH ' ' HB ' ' A' ' 108' ' ' VAL . 5.2 m-85 -51.3 -42.74 61.38 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 126.837 2.055 . . . . 0.0 113.629 176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.72 -17.5 67.91 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.393 1.473 . . . . 0.0 113.711 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.76 -30.27 51.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.794 1.297 . . . . 0.0 112.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -57.87 -29.0 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.098 -1.002 . . . . 0.0 111.065 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -79.16 -58.04 3.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.832 1.253 . . . . 0.0 110.161 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -60.36 -34.33 73.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.303 1.041 . . . . 0.0 112.56 -174.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -72.73 -34.01 66.78 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.06 1.344 . . . . 0.0 111.984 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -70.64 -36.75 73.57 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.436 0.562 . . . . 0.0 111.378 172.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.01 -44.25 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.065 0.946 . . . . 0.0 111.333 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -12.04 59.9 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.083 0.953 . . . . 0.0 113.257 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -57.23 -37.14 71.81 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 161.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.445 HD22 HG12 ' A' ' 96' ' ' VAL . 26.1 m-80 -79.96 -49.25 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.625 0.726 . . . . 0.0 109.897 173.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 mt -89.0 75.33 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 123.341 1.543 . . . . 0.0 111.604 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.01 25.87 0.08 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.35 1.46 . . . . 0.0 114.729 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.99 -61.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.43 0.692 . . . . 0.0 112.408 -159.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 74.24 -47.66 0.64 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.732 2.413 . . . . 0.0 113.321 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.84 -28.43 68.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.967 1.307 . . . . 0.0 112.95 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -90.44 -3.41 57.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.927 1.691 . . . . 0.0 114.303 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -117.75 -29.83 5.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 113.726 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -92.59 164.82 13.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.975 1.31 . . . . 0.0 111.925 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.93 -42.61 2.52 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 125.777 1.656 . . . . 0.0 113.932 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -175.36 5.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.267 1.427 . . . . 0.0 111.438 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 162.46 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.615 -0.678 . . . . 0.0 111.315 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.8 t -157.99 146.16 18.79 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.636 1.175 . . . . 0.0 110.092 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 131.59 48.94 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.149 1.38 . . . . 0.0 111.123 164.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -144.01 171.88 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 120.781 -1.2 . . . . 0.0 108.175 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.72 132.31 40.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.346 -0.846 . . . . 0.0 112.176 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.12 131.08 54.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.938 0.895 . . . . 0.0 109.464 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.08 112.48 24.14 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.07 0.948 . . . . 0.0 109.49 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -104.14 159.22 15.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 111.204 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.8 pt -96.15 150.19 36.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 110.381 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.39 146.29 50.04 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.646 2.231 . . . . 0.0 110.247 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -165.21 147.33 7.82 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.561 1.944 . . . . 0.0 108.359 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.62 -18.59 72.17 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 124.444 1.021 . . . . 0.0 115.599 -168.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -94.13 3.16 55.67 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.409 1.884 . . . . 0.0 113.175 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.34 165.97 14.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.96 1.743 . . . . 0.0 111.335 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.56 159.26 22.12 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.001 0.901 . . . . 0.0 111.321 -176.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -127.88 144.07 51.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.07 1.348 . . . . 0.0 111.182 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.27 113.7 2.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.623 0.647 . . . . 0.0 112.481 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.24 -43.05 2.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.676 1.608 . . . . 0.0 111.41 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -154.51 150.33 27.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.944 0.898 . . . . 0.0 111.434 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.37 131.02 53.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.526 1.131 . . . . 0.0 109.706 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -119.63 119.6 34.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.695 1.598 . . . . 0.0 108.694 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.16 137.23 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.053 0.842 . . . . 0.0 109.929 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -109.65 -50.37 2.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.144 0.578 . . . . 0.0 110.004 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -173.7 170.36 4.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.994 1.718 . . . . 0.0 111.78 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.63 32.73 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 125.326 1.441 . . . . 0.0 113.171 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.96 113.65 20.01 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -58.35 -19.94 39.42 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -153.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -49.61 -37.77 29.19 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.91 1.284 . . . . 0.0 112.681 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.11 -52.17 8.56 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.217 0.917 . . . . 0.0 110.722 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.2 m -46.46 -44.84 17.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.061 1.344 . . . . 0.0 113.421 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.38 82.73 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.925 0.89 . . . . 0.0 112.678 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.91 19.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.579 1.152 . . . . 0.0 112.83 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 t -57.37 -46.1 83.71 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.588 0.755 . . . . 0.0 110.617 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -50.29 -42.19 52.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.482 1.913 . . . . 0.0 111.723 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -69.78 -48.53 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.78 80.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.62 1.168 . . . . 0.0 111.693 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.69 -24.32 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.875 -1.141 . . . . 0.0 111.918 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.74 55.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.859 0.864 . . . . 0.0 112.869 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -134.68 -11.27 2.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.445 HG12 HD22 ' A' ' 46' ' ' ASN . 7.4 m -58.07 148.99 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.415 1.086 . . . . 0.0 112.776 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -70.51 -47.91 58.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 113.099 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 p 170.73 145.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.186 2.194 . . . . 0.0 110.355 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -96.62 108.49 42.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 117.771 -1.109 . . . . 0.0 110.363 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.13 136.28 19.94 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.248 1.965 . . . . 0.0 110.37 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.53 152.91 64.62 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.449 0.7 . . . . 0.0 112.329 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.46 -41.83 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.007 2.471 . . . . 0.0 110.277 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.47 149.28 50.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.023 2.129 . . . . 0.0 109.699 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.37 9.25 19.78 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -164.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.86 144.57 60.08 Favored Pre-proline 0 CA--C 1.539 0.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.98 -2.7 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.324 2.683 . . . . 0.0 113.584 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.863 0.865 . . . . 0.0 112.519 168.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.475 ' HB ' ' HH ' ' A' ' 35' ' ' TYR . 16.4 m -97.76 -26.39 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.664 1.186 . . . . 0.0 112.654 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.38 -25.65 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.059 0.944 . . . . 0.0 111.028 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -83.12 -9.1 59.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.897 1.279 . . . . 0.0 113.995 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -42.43 6.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.068 . . . . 0.0 111.693 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.71 -20.13 59.97 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 124.867 1.267 . . . . 0.0 112.93 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -66.39 -25.56 66.84 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 113.163 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -128.82 81.96 2.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.031 0.932 . . . . 0.0 109.892 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.423 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.56 150.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 111.75 -178.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 130.86 35.94 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 153.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -85.3 129.09 34.88 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 157.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.0 m -146.15 127.07 14.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.82 157.25 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.335 1.454 . . . . 0.0 111.127 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.76 -49.28 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.272 1.829 . . . . 0.0 113.642 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.0 167.48 76.76 Favored 'Cis proline' 0 C--N 1.356 0.938 0 CA-C-N 122.17 1.811 . . . . 0.0 112.158 -14.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--O 1.241 0.614 0 C-N-CA 124.16 0.984 . . . . 0.0 111.781 178.719 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -169.56 166.96 9.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.816 0.846 . . . . 0.0 112.926 -165.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 15.53 0.44 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.495 1.918 . . . . 0.0 113.66 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -97.97 -18.62 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.88 1.272 . . . . 0.0 112.066 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -22.6 0.42 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.44 1.896 . . . . 0.0 113.341 -163.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.81 -3.78 5.56 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -165.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -54.19 -30.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.726 1.211 . . . . 0.0 112.494 170.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.5 t -61.58 -48.53 80.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.857 0.863 . . . . 0.0 111.256 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -62.96 -30.91 71.94 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.386 1.074 . . . . 0.0 112.126 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.82 -26.8 62.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.674 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -24.2 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.655 1.57 . . . . 0.0 112.535 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.64 -6.76 44.47 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.035 1.779 . . . . 0.0 113.194 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -110.58 -70.92 0.78 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.012 1.725 . . . . 0.0 109.898 161.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -54.38 -49.89 68.8 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.983 2.513 . . . . 0.0 113.915 -162.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.98 -15.43 65.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.969 1.747 . . . . 0.0 114.097 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.14 -30.4 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.647 1.223 . . . . 0.0 111.609 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.2 pt -62.62 -28.49 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.513 -1.367 . . . . 0.0 111.621 176.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.47 -57.06 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.924 1.289 . . . . 0.0 110.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -57.44 -36.04 70.88 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.064 0.946 . . . . 0.0 111.86 -176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.85 -38.03 82.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.929 1.292 . . . . 0.0 111.898 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 tp -76.52 -28.22 56.3 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.02 -54.42 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -25.56 67.69 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.278 0.631 . . . . 0.0 111.45 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.02 -14.54 61.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.449 HD22 HG11 ' A' ' 96' ' ' VAL . 70.1 m-80 -80.66 -33.85 35.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.472 1.033 . . . . 0.0 113.172 165.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.89 110.06 22.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.778 1.231 . . . . 0.0 111.47 -158.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.0 24.85 8.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.977 1.311 . . . . 0.0 114.14 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.8 -58.79 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.507 0.723 . . . . 0.0 112.12 -165.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 71.44 -64.11 0.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.612 2.365 . . . . 0.0 113.346 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -64.63 -35.34 80.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.761 1.225 . . . . 0.0 112.833 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -91.13 6.88 43.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.441 1.097 . . . . 0.0 113.448 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -104.29 -9.73 18.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.062 1.745 . . . . 0.0 112.491 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -114.58 159.43 20.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.004 1.722 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.348 1.451 . . . . 0.0 114.477 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 178.91 8.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.361 1.864 . . . . 0.0 112.354 -174.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.17 19.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.294 1.037 . . . . 0.0 110.613 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.12 143.5 21.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.493 1.117 . . . . 0.0 110.768 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 129.56 46.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 110.403 163.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.87 172.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.14 131.18 30.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.705 -0.622 . . . . 0.0 112.345 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.84 130.19 51.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.161 0.984 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -114.19 105.11 12.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 109.214 171.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.43 157.6 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.736 0.779 . . . . 0.0 112.2 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.32 151.96 37.61 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 125.389 1.476 . . . . 0.0 110.488 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -72.37 147.83 47.72 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.264 2.643 . . . . 0.0 111.19 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -165.59 149.59 8.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.273 2.229 . . . . 0.0 108.493 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.87 -16.41 70.3 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.4 p -94.3 -4.84 47.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.215 1.806 . . . . 0.0 113.477 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.73 170.58 12.93 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.344 1.449 . . . . 0.0 111.755 -166.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.37 160.0 25.63 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.568 1.184 . . . . 0.0 111.323 -177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.07 145.96 51.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.147 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.99 109.85 1.19 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.172 0.589 . . . . 0.0 111.518 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.8 -47.34 3.44 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 125.204 1.383 . . . . 0.0 110.886 170.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 m -155.18 150.89 27.54 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.866 1.266 . . . . 0.0 111.218 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.4 129.08 49.15 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.833 1.253 . . . . 0.0 109.39 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 m -115.18 118.85 34.5 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.209 1.804 . . . . 0.0 108.093 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -81.87 134.63 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.286 0.948 . . . . 0.0 109.757 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.22 -48.93 3.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.213 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -171.21 170.26 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.525 1.53 . . . . 0.0 111.868 171.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.79 -178.93 29.65 Favored Glycine 0 N--CA 1.462 0.396 0 C-N-CA 125.314 1.435 . . . . 0.0 113.554 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.46 113.85 21.5 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 167.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -63.84 -17.58 63.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -149.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -56.17 -33.45 65.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.767 0.827 . . . . 0.0 112.225 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.86 -46.62 18.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.796 -1.097 . . . . 0.0 111.397 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -47.16 -46.08 23.24 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.773 1.229 . . . . 0.0 113.027 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.75 89.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.768 0.827 . . . . 0.0 112.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.76 -52.36 31.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 112.708 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.3 t -57.76 -48.25 80.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.586 0.755 . . . . 0.0 111.197 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -50.23 -44.71 53.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.469 1.508 . . . . 0.0 111.472 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.79 -45.06 65.37 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.697 0.799 . . . . 0.0 112.56 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.25 -49.76 75.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.385 1.074 . . . . 0.0 111.881 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.3 t -67.65 -22.8 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.828 -178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.4 -6.94 58.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 112.639 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.95 -12.2 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 46' ' ' ASN . 14.8 m -58.14 147.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.023 0.929 . . . . 0.0 112.35 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -71.61 -47.56 53.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p 171.14 142.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.723 2.009 . . . . 0.0 111.213 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -94.67 108.61 38.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.423 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 130.05 14.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.341 2.028 . . . . 0.0 110.111 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.04 148.29 74.84 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.491 0.716 . . . . 0.0 111.751 -171.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.98 -36.1 4.73 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.535 2.157 . . . . 0.0 110.879 168.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 153.51 41.31 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.439 2.295 . . . . 0.0 109.948 176.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.15 8.56 19.98 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -165.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.16 144.38 62.74 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 118.988 0.813 . . . . 0.0 110.004 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.81 -4.01 6.6 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.424 2.749 . . . . 0.0 113.696 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.72 -38.26 19.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.98 0.809 . . . . 0.0 112.159 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.61 -26.66 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.225 1.01 . . . . 0.0 112.715 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -26.99 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.124 0.969 . . . . 0.0 110.906 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -78.72 -13.17 59.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.01 1.324 . . . . 0.0 113.222 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.06 -42.33 7.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.672 0.789 . . . . 0.0 111.71 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.39 -23.23 60.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.828 0.851 . . . . 0.0 112.488 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -68.96 -23.31 64.12 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.743 -1.223 . . . . 0.0 113.946 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -128.29 84.08 2.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.134 0.974 . . . . 0.0 110.057 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.446 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -112.11 155.31 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.479 1.111 . . . . 0.0 112.215 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -91.41 136.21 33.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 156.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.63 118.14 29.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 154.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -135.9 130.25 33.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.39 146.25 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.734 2.414 . . . . 0.0 108.493 -165.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.56 161.09 30.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.241 1.417 . . . . 0.0 111.628 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.67 168.38 14.29 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.486 2.79 . . . . 0.0 111.65 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.241 0.638 0 C-N-CA 125.005 1.322 . . . . 0.0 111.612 179.095 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -153.01 -172.4 4.23 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.291 1.836 . . . . 0.0 111.67 -171.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 150.75 23.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 1 C-N-CA 133.106 4.562 . . . . 0.0 112.317 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -98.67 -17.71 18.44 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.141 1.376 . . . . 0.0 112.176 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.06 -29.97 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 113.614 -171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.9 1.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -165.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -55.5 -32.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.92 1.236 . . . . 0.0 111.512 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.9 t -67.39 -44.17 79.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.621 1.168 . . . . 0.0 112.674 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 m -59.85 -30.2 68.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 112.556 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.98 -23.39 64.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.368 -0.825 . . . . 0.0 113.093 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.84 -26.3 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 121.186 1.812 . . . . 0.0 111.531 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.95 -4.27 40.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.518 1.533 . . . . 0.0 114.238 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -111.0 -54.2 2.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.256 1.823 . . . . 0.0 111.115 164.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -63.82 -17.99 63.66 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.002 2.121 . . . . 0.0 116.057 -162.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.74 -13.35 11.45 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.923 2.201 . . . . 0.0 114.124 166.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.83 -30.17 40.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.117 1.367 . . . . 0.0 111.797 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -62.31 -27.77 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 120.646 -1.284 . . . . 0.0 111.946 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -80.01 -56.53 4.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.286 1.434 . . . . 0.0 110.682 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -58.11 -34.48 70.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.938 0.895 . . . . 0.0 112.01 -176.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -67.92 -40.2 83.43 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.679 1.191 . . . . 0.0 110.881 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.36 -28.76 61.27 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.0 -54.12 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 110.441 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -23.29 67.29 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.043 0.537 . . . . 0.0 112.153 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.02 -15.6 60.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.434 HD22 HG13 ' A' ' 96' ' ' VAL . 69.1 m-80 -79.73 -39.9 30.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.845 1.202 . . . . 0.0 111.882 163.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.0 83.35 3.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.557 1.646 . . . . 0.0 112.243 -160.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 28.93 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.774 1.63 . . . . 0.0 114.232 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.71 -62.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.434 -0.791 . . . . 0.0 112.093 -163.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 72.54 -62.64 0.46 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.309 2.243 . . . . 0.0 113.51 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.12 -37.39 87.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.257 1.423 . . . . 0.0 112.554 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.2 m -85.56 -1.78 57.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -103.96 -22.64 13.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.983 1.713 . . . . 0.0 113.279 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 152.66 19.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.179 1.392 . . . . 0.0 112.911 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.6 2.16 90.6 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.083 1.325 . . . . 0.0 114.29 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.77 177.77 8.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.115 1.766 . . . . 0.0 112.267 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.59 160.48 25.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.826 1.25 . . . . 0.0 110.099 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 45.1 t -153.62 144.13 22.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.216 1.007 . . . . 0.0 110.215 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 127.76 38.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.293 1.437 . . . . 0.0 111.134 171.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.21 172.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.367 1.067 . . . . 0.0 108.335 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -137.02 131.67 33.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.588 0.755 . . . . 0.0 112.113 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -103.04 134.26 46.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.007 0.923 . . . . 0.0 110.38 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -118.09 103.47 9.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.187 1.395 . . . . 0.0 108.849 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -99.29 158.46 15.69 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.917 0.865 . . . . 0.0 112.149 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 pt -99.03 148.75 35.01 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.581 1.552 . . . . 0.0 110.183 166.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.56 147.92 41.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.302 2.668 . . . . 0.0 110.857 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -166.67 146.56 5.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.273 2.229 . . . . 0.0 108.479 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.95 -21.45 75.32 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.564 0.986 . . . . 0.0 115.564 -166.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -89.39 -5.22 57.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.979 1.712 . . . . 0.0 113.183 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.79 162.49 10.84 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.891 1.71 . . . . 0.0 111.421 -169.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.74 160.69 16.61 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 117.789 0.794 . . . . 0.0 111.596 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.84 143.32 50.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.332 1.453 . . . . 0.0 110.91 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.98 109.34 1.05 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.44 0.696 . . . . 0.0 111.623 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.92 -36.51 5.23 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.537 1.542 . . . . 0.0 111.925 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -163.85 155.68 16.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 111.127 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.43 129.94 39.94 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.091 1.357 . . . . 0.0 109.92 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.3 m -115.81 119.15 35.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.923 2.089 . . . . 0.0 108.448 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.0 137.1 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.098 0.863 . . . . 0.0 110.164 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.39 -47.37 3.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.933 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -174.12 166.77 4.2 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.998 2.119 . . . . 0.0 111.217 169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.28 164.5 27.9 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.083 -1.011 . . . . 0.0 114.15 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.37 178.94 4.89 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.945 0.898 . . . . 0.0 110.363 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 t -30.24 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.73 2.412 . . . . 0.0 115.517 -162.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 31.6 mtm105 70.44 -1.21 2.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.199 2.2 . . . . 0.0 116.378 162.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.26 -46.58 70.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 122.429 2.377 . . . . 0.0 112.171 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.29 -28.08 51.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 166.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.18 -35.47 41.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.377 0.989 . . . . 0.0 112.382 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -51.02 15.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.63 1.572 . . . . 0.0 112.498 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.1 t -55.48 -48.9 73.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.854 0.861 . . . . 0.0 111.196 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -51.3 -44.7 61.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.786 1.634 . . . . 0.0 111.469 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -69.19 -44.55 71.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.028 0.931 . . . . 0.0 113.385 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.51 76.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.57 1.148 . . . . 0.0 111.48 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 t -67.9 -21.22 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.69 -1.256 . . . . 0.0 112.236 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.97 -6.92 59.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.066 0.947 . . . . 0.0 112.187 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.05 -12.73 4.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.434 HG13 HD22 ' A' ' 46' ' ' ASN . 16.7 m -58.14 146.05 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-N 119.394 0.997 . . . . 0.0 111.975 168.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -72.45 -46.12 56.46 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.1 p 172.78 141.94 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.36 1.864 . . . . 0.0 110.911 -168.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -94.37 106.74 25.01 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.292 1.037 . . . . 0.0 111.193 -175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.79 118.34 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.295 1.997 . . . . 0.0 109.968 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.03 148.71 37.42 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.461 1.104 . . . . 0.0 112.367 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.11 -29.93 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.924 2.416 . . . . 0.0 112.313 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -138.56 148.67 44.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.947 1.699 . . . . 0.0 110.495 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -120.66 22.0 11.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.555 1.542 . . . . 0.0 113.284 -167.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.8 142.17 32.26 Favored Pre-proline 0 C--O 1.242 0.668 0 O-C-N 120.627 -1.295 . . . . 0.0 110.731 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.02 -7.05 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 124.14 3.226 . . . . 0.0 116.177 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -87.95 -41.57 13.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.881 1.219 . . . . 0.0 112.343 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -92.57 -25.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.529 1.532 . . . . 0.0 113.365 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.49 -29.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.939 0.79 . . . . 0.0 110.935 170.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.402 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 33.0 mm-40 -77.0 -8.07 56.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.319 1.047 . . . . 0.0 113.766 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.38 -48.22 5.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.356 0.663 . . . . 0.0 112.203 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.8 -28.07 68.73 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.13 0.972 . . . . 0.0 112.679 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -72.51 -23.79 61.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.44 -1.413 . . . . 0.0 114.003 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -121.74 88.99 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.331 1.052 . . . . 0.0 111.086 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.449 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.63 156.34 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.435 1.094 . . . . 0.0 112.614 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.71 137.52 32.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.093 -0.379 . . . . 0.0 110.278 156.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.7 mt -91.4 112.91 25.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 153.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.8 m -134.83 125.43 26.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.916 0.887 . . . . 0.0 108.835 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.32 153.16 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.588 1.555 . . . . 0.0 110.734 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.37 158.07 15.39 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.466 1.506 . . . . 0.0 111.992 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.14 172.89 14.73 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.474 2.782 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.242 0.684 0 C-N-CA 125.274 1.43 . . . . 0.0 111.369 -177.489 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 69.91 167.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.883 2.473 . . . . 0.0 113.43 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -153.04 21.52 0.57 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.861 1.265 . . . . 0.0 114.067 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -106.61 -17.53 14.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.09 1.356 . . . . 0.0 112.671 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.16 -21.64 0.44 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.778 2.431 . . . . 0.0 112.753 -167.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -51.08 -15.85 0.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.299 2.64 . . . . 0.0 116.557 -172.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.24 -31.0 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.646 1.178 . . . . 0.0 112.402 171.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 t -57.6 -44.23 85.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.833 0.853 . . . . 0.0 112.092 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -69.48 -30.32 68.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.177 -0.952 . . . . 0.0 112.072 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.46 -29.22 67.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.699 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.62 -25.92 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 120.829 1.65 . . . . 0.0 110.418 172.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.59 -8.59 56.75 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.315 1.436 . . . . 0.0 114.043 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -111.39 -58.68 2.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.727 1.263 . . . . 0.0 111.868 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -51.02 -47.16 61.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 128.276 2.63 . . . . 0.0 113.699 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.95 -15.86 66.5 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.246 1.403 . . . . 0.0 113.366 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.73 -32.75 60.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 1.119 . . . . 0.0 111.719 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -59.67 -27.01 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.9 0.773 . . . . 0.0 111.916 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -82.09 -58.64 2.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.122 1.369 . . . . 0.0 110.362 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -60.69 -33.4 72.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.003 0.921 . . . . 0.0 112.852 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -73.37 -35.4 65.93 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.994 0.918 . . . . 0.0 110.795 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.9 tp -73.39 -31.58 63.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.754 0.707 . . . . 0.0 112.059 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.24 -48.29 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.287 0.635 . . . . 0.0 110.71 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -67.78 -19.0 65.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -57.51 -36.53 71.66 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.128 0.571 . . . . 0.0 111.329 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.419 HD22 HG11 ' A' ' 96' ' ' VAL . 45.1 m-80 -78.24 -40.22 37.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.983 0.421 . . . . 0.0 112.098 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.72 88.4 3.81 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 123.149 1.452 . . . . 0.0 111.887 -163.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.96 31.02 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.338 -1.755 . . . . 0.0 113.781 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.68 -64.09 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.101 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 72.79 -63.84 0.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.892 2.077 . . . . 0.0 112.826 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.01 -45.33 61.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.667 1.187 . . . . 0.0 112.159 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.3 m -79.24 2.86 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.2 m-30 -93.87 -10.46 33.88 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.834 1.653 . . . . 0.0 111.761 166.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -114.35 171.31 7.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.049 2.139 . . . . 0.0 111.107 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.02 -21.59 3.29 Favored Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.807 1.194 . . . . 0.0 114.372 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.46 -175.16 3.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.171 2.589 . . . . 0.0 111.616 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 164.98 23.21 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.449 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.2 t -159.97 144.74 14.91 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.448 1.099 . . . . 0.0 110.142 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.59 130.14 46.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.512 164.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.88 170.4 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.275 1.03 . . . . 0.0 108.333 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.0 131.18 32.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.348 0.594 . . . . 0.0 111.738 -173.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.13 132.85 45.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.967 0.907 . . . . 0.0 110.334 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -116.4 103.01 10.03 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 108.931 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.62 158.97 15.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.731 0.777 . . . . 0.0 111.906 -177.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.1 pt -100.13 136.79 20.02 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.453 1.501 . . . . 0.0 110.219 167.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.95 129.62 17.71 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.585 2.19 . . . . 0.0 109.832 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 m -142.86 88.58 2.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.271 1.428 . . . . 0.0 108.548 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 -122.49 28.03 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.895 0.759 . . . . 0.0 112.12 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -81.6 3.5 24.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.209 1.803 . . . . 0.0 113.842 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.18 -166.6 10.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.257 1.408 . . . . 0.0 114.377 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -124.33 165.47 17.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.205 1.402 . . . . 0.0 110.918 165.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.62 148.51 52.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.144 1.778 . . . . 0.0 111.153 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.56 111.88 1.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.009 0.822 . . . . 0.0 112.28 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.54 -35.06 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.78 1.657 . . . . 0.0 112.125 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -167.2 153.18 7.86 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.365 1.466 . . . . 0.0 110.998 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -127.91 129.38 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.428 1.091 . . . . 0.0 109.874 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.3 m -113.28 118.87 35.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.236 1.815 . . . . 0.0 108.536 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.74 130.9 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.903 0.774 . . . . 0.0 109.81 169.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -101.98 -46.92 4.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.108 0.563 . . . . 0.0 110.04 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -170.47 169.48 7.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.119 1.768 . . . . 0.0 111.515 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.11 179.07 23.79 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 124.887 1.232 . . . . 0.0 114.527 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.23 119.79 25.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.79 -17.66 37.36 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -159.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.71 65.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.679 1.191 . . . . 0.0 112.07 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.3 tp -88.85 -49.23 6.94 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.673 1.124 . . . . 0.0 111.562 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 m -47.81 -43.09 27.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.537 1.062 . . . . 0.0 113.539 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.08 73.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.082 0.856 . . . . 0.0 112.573 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.14 -52.25 25.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.424 1.09 . . . . 0.0 112.191 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.6 t -57.85 -49.37 76.89 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.104 0.962 . . . . 0.0 110.355 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -51.27 -45.8 62.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -66.41 -47.02 74.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.518 0.727 . . . . 0.0 112.845 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.06 75.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 111.414 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.77 -23.29 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.579 -1.326 . . . . 0.0 111.518 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.78 -6.84 58.09 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.369 -0.832 . . . . 0.0 112.396 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.09 -11.97 3.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 46' ' ' ASN . 13.4 m -58.14 148.59 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.296 0.953 . . . . 0.0 112.55 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.48 -48.94 59.06 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 p 170.18 141.89 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.555 1.942 . . . . 0.0 111.414 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -98.99 110.38 57.5 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.311 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.18 134.34 12.84 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.842 2.361 . . . . 0.0 111.009 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.48 148.36 66.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.047 -0.502 . . . . 0.0 112.272 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 -36.17 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.482 2.788 . . . . 0.0 111.935 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 153.25 47.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.439 2.296 . . . . 0.0 110.526 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.11 7.69 18.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -163.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.03 142.91 44.96 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.937 -1.102 . . . . 0.0 110.431 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.34 0.35 2.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.807 3.005 . . . . 0.0 113.642 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.91 -38.72 17.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.927 0.891 . . . . 0.0 111.834 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 m -96.07 -26.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.571 1.148 . . . . 0.0 112.613 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.8 -28.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.435 1.094 . . . . 0.0 110.994 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -84.06 -5.44 59.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.237 1.015 . . . . 0.0 113.636 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -98.49 -51.36 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.013 -1.054 . . . . 0.0 111.192 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.98 -20.48 65.89 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.824 1.25 . . . . 0.0 113.874 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -69.74 -23.57 63.41 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.014 -1.054 . . . . 0.0 112.819 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -125.27 83.29 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.115 1.766 . . . . 0.0 111.119 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.449 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.43 153.42 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.319 1.047 . . . . 0.0 112.092 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.19 137.12 34.67 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.88 0.371 . . . . 0.0 110.125 158.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.33 120.68 33.89 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 155.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -136.77 129.1 29.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.384 1.074 . . . . 0.0 109.222 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 164.95 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.171 1.788 . . . . 0.0 110.742 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.52 170.32 9.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 112.958 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -57.71 -28.81 83.34 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.513 2.808 . . . . 0.0 116.935 -161.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.239 0.539 0 C-N-CA 125.105 1.362 . . . . 0.0 110.935 -170.624 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.18 -73.48 0.12 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -165.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtp-105 72.92 14.68 4.78 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.13 2.172 . . . . 0.0 113.545 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -97.8 -19.42 18.18 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.03 -25.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.002 1.721 . . . . 0.0 112.606 -166.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -6.65 10.4 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.5 1.52 . . . . 0.0 114.455 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -55.69 -27.9 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.275 1.43 . . . . 0.0 113.039 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -59.17 -35.44 73.57 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.278 0.631 . . . . 0.0 112.142 171.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -78.87 -28.01 44.12 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.158 -0.964 . . . . 0.0 113.065 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.582 0.628 . . . . 0.0 110.656 165.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.61 -27.26 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.93 1.241 . . . . 0.0 110.951 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.45 -11.35 68.1 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.525 1.536 . . . . 0.0 114.004 171.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -106.15 -55.69 2.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.058 1.429 . . . . 0.0 111.876 169.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -49.33 -45.84 46.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.597 2.359 . . . . 0.0 114.064 -172.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.71 -18.4 60.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.738 1.637 . . . . 0.0 113.746 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.78 -32.51 63.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.375 1.088 . . . . 0.0 111.864 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -61.37 -27.07 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.125 -0.985 . . . . 0.0 112.347 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -82.37 -59.19 2.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 109.722 174.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -59.26 -35.33 73.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.034 0.934 . . . . 0.0 111.99 -171.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -71.54 -41.75 68.75 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.968 0.907 . . . . 0.0 110.867 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.63 -25.91 65.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.539 0.609 . . . . 0.0 112.035 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.46 -55.59 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.187 0.995 . . . . 0.0 110.253 174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -22.46 66.11 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.668 0.387 . . . . 0.0 111.594 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.51 -13.16 61.72 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.642 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.437 HD22 HG12 ' A' ' 96' ' ' VAL . 71.7 m-80 -81.05 -36.69 30.18 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.947 1.248 . . . . 0.0 112.164 168.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 80.31 1.82 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.327 1.451 . . . . 0.0 109.821 -169.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 51.62 0.43 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.807 1.643 . . . . 0.0 112.492 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.66 -56.48 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 73.26 -51.71 0.7 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.063 2.545 . . . . 0.0 114.892 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.51 -31.75 32.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.382 1.473 . . . . 0.0 112.879 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -85.05 -13.38 50.61 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.836 0.854 . . . . 0.0 112.604 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -89.34 -8.17 53.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.014 1.326 . . . . 0.0 112.478 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -112.73 171.41 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.401 1.88 . . . . 0.0 113.099 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.3 -45.49 3.23 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.119 1.819 . . . . 0.0 112.371 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -170.89 3.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.61 1.564 . . . . 0.0 111.137 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.29 26.26 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.835 0.854 . . . . 0.0 110.985 168.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 38.8 t -151.61 145.04 24.82 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.691 1.196 . . . . 0.0 109.564 170.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.26 129.36 41.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.164 1.385 . . . . 0.0 110.615 170.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.69 172.07 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.87 1.268 . . . . 0.0 107.978 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -137.59 133.15 34.08 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.801 0.841 . . . . 0.0 111.722 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.98 140.35 36.39 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.387 0.675 . . . . 0.0 111.81 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -120.2 105.69 11.21 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.431 1.493 . . . . 0.0 108.92 170.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -100.74 159.37 15.24 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.397 -0.815 . . . . 0.0 111.843 -178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.68 139.96 20.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.924 1.689 . . . . 0.0 109.821 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.67 137.3 58.32 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.507 2.138 . . . . 0.0 111.624 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -143.97 162.89 35.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.28 2.232 . . . . 0.0 107.918 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.02 -22.24 70.38 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.005 -1.059 . . . . 0.0 115.561 -171.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -94.97 -19.61 20.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.783 1.633 . . . . 0.0 112.734 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.37 -174.37 34.86 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.649 2.071 . . . . 0.0 111.007 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.45 160.35 31.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.216 2.008 . . . . 0.0 110.15 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -132.43 143.7 49.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.304 1.442 . . . . 0.0 111.527 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.57 108.44 0.56 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.996 0.919 . . . . 0.0 112.261 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.51 -35.82 5.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.673 1.606 . . . . 0.0 111.632 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -166.01 150.04 7.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.901 1.28 . . . . 0.0 111.13 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.7 tt -123.07 130.44 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.955 1.702 . . . . 0.0 109.319 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -114.44 118.68 34.49 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.6 1.56 . . . . 0.0 108.358 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 m -83.63 136.19 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.803 0.729 . . . . 0.0 109.88 168.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.73 -45.79 3.77 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.3 0.64 . . . . 0.0 110.151 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -172.48 167.51 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.102 1.761 . . . . 0.0 111.348 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.83 170.11 36.17 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.526 -0.734 . . . . 0.0 114.552 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.36 -177.53 4.01 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.826 1.25 . . . . 0.0 111.047 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.259 59.3 p 51.52 -97.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.385 2.274 . . . . 0.0 113.018 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.33 -4.27 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 113.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -64.08 -43.91 93.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.926 1.694 . . . . 0.0 113.01 -157.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.0 p -56.95 -27.64 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.74 -40.73 13.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.799 1.239 . . . . 0.0 112.155 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.36 -53.74 50.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.77 1.228 . . . . 0.0 111.998 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.0 t -52.75 -46.65 67.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.894 0.878 . . . . 0.0 110.537 172.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.88 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.38 1.072 . . . . 0.0 113.438 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -73.35 -43.37 60.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.73 76.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.736 1.214 . . . . 0.0 112.024 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.86 -23.38 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.533 -1.354 . . . . 0.0 112.09 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.82 -6.96 55.9 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.35 -0.844 . . . . 0.0 112.727 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.31 -11.95 2.46 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG12 HD22 ' A' ' 46' ' ' ASN . 13.6 m -58.15 147.82 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.712 1.205 . . . . 0.0 112.734 171.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -75.3 -39.08 59.96 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 p 165.23 141.23 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 127.491 2.316 . . . . 0.0 111.501 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -95.04 112.26 57.68 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.269 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.44 120.7 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.306 2.004 . . . . 0.0 110.047 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 138.58 25.99 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.65 1.18 . . . . 0.0 111.743 -176.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.24 -47.58 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.421 2.748 . . . . 0.0 111.916 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -103.46 147.41 27.17 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.304 1.442 . . . . 0.0 110.868 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.31 12.79 11.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.874 1.27 . . . . 0.0 113.564 -163.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -78.88 140.56 58.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 O-C-N 120.825 -1.172 . . . . 0.0 109.392 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.87 -4.69 7.74 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.047 2.498 . . . . 0.0 113.419 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.43 -31.87 24.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.726 0.694 . . . . 0.0 112.403 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.97 -24.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.04 -28.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.264 1.026 . . . . 0.0 110.731 166.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.28 -9.86 59.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.501 1.52 . . . . 0.0 113.791 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.77 -43.83 5.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.279 1.032 . . . . 0.0 112.198 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.55 -22.33 61.77 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.973 0.909 . . . . 0.0 111.743 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -65.5 -22.95 66.78 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.63 -1.294 . . . . 0.0 113.918 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -123.74 80.12 1.77 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.41 1.084 . . . . 0.0 110.301 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.99 151.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.961 0.905 . . . . 0.0 111.83 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.3 128.04 41.82 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 159.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.05 111.18 21.85 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 160.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.8 m -135.45 123.94 23.49 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.589 1.155 . . . . 0.0 108.502 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.36 148.37 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.696 1.198 . . . . 0.0 111.175 -169.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -161.53 38.65 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.241 1.816 . . . . 0.0 114.388 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.69 140.87 52.77 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.32 2.013 . . . . 0.0 111.1 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 125.838 1.655 . . . . 0.0 112.199 -174.576 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.049 0 CA-C-O 117.692 -1.147 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 -44.15 9.11 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.374 3.07 . . . . 0.0 111.773 -7.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 75.84 3.58 3.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.394 2.278 . . . . 0.0 114.887 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -89.22 -19.6 25.2 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.203 0.601 . . . . 0.0 112.621 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.28 -27.45 0.24 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.009 1.323 . . . . 0.0 114.41 -166.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -17.7 6.65 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -166.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -55.17 -29.81 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.747 1.219 . . . . 0.0 112.664 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 t -58.49 -45.27 89.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.247 1.019 . . . . 0.0 112.191 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -64.37 -29.62 70.68 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.749 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -75.5 -17.59 60.07 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 117.558 -1.211 . . . . 0.0 112.996 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.12 -25.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.656 2.026 . . . . 0.0 111.09 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.96 -13.12 56.7 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.939 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -111.36 -57.26 2.27 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.033 1.417 . . . . 0.0 111.748 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.61 -39.61 80.92 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 128.034 2.534 . . . . 0.0 113.761 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.78 63.73 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.377 1.465 . . . . 0.0 114.009 169.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -26.12 56.06 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.867 1.333 . . . . 0.0 112.065 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.18 -30.0 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.333 -1.479 . . . . 0.0 111.634 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' HH ' ' HB2' ' A' ' 112' ' ' LEU . 99.1 m-85 -77.8 -55.22 5.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.129 1.372 . . . . 0.0 110.095 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -57.33 -34.89 69.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.878 0.871 . . . . 0.0 112.297 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.64 -30.49 65.81 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.227 1.411 . . . . 0.0 112.628 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp -82.12 -31.48 30.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.674 0.67 . . . . 0.0 112.353 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.74 -46.86 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.761 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -21.76 66.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.284 1.034 . . . . 0.0 112.98 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -59.65 -36.73 77.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.516 0.727 . . . . 0.0 110.791 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.43 HD22 HG11 ' A' ' 96' ' ' VAL . 30.5 m-80 -78.35 -45.42 22.6 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 0.0 111.162 170.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.99 74.28 4.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 123.456 1.598 . . . . 0.0 112.298 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.03 29.06 0.06 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 113.791 -1.549 . . . . 0.0 114.048 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.6 -71.09 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 -163.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 74.15 -48.24 0.66 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.568 2.347 . . . . 0.0 114.119 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.26 -38.23 88.47 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.296 -1.503 . . . . 0.0 113.16 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.9 p -91.36 0.05 57.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.343 1.057 . . . . 0.0 113.662 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.7 m-30 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.543 1.537 . . . . 0.0 111.384 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -110.68 156.12 21.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.776 2.03 . . . . 0.0 111.223 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.12 -25.94 4.59 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.101 1.334 . . . . 0.0 113.795 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -106.29 -172.68 2.13 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.831 2.052 . . . . 0.0 110.741 167.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 164.31 28.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.273 1.029 . . . . 0.0 110.345 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.58 157.64 43.45 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.441 -0.787 . . . . 0.0 111.463 160.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.2 126.21 29.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.146 1.379 . . . . 0.0 110.069 162.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.59 166.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.58 131.72 36.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.042 0.837 . . . . 0.0 111.965 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.55 131.93 48.95 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.339 1.055 . . . . 0.0 110.164 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -113.52 107.71 16.18 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.318 1.447 . . . . 0.0 109.018 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.35 159.72 15.03 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.31 -0.869 . . . . 0.0 111.945 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 pt -102.34 148.38 35.35 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.987 1.715 . . . . 0.0 109.615 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.4 137.78 28.78 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.221 1.947 . . . . 0.0 110.08 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 m -148.66 93.92 2.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.115 1.366 . . . . 0.0 109.267 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.81 -113.66 5.81 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.82 0.724 . . . . 0.0 112.612 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.2 p -83.36 -2.79 56.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.755 2.022 . . . . 0.0 114.024 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.97 -164.85 11.34 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.585 1.084 . . . . 0.0 114.297 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.38 165.23 12.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.351 1.06 . . . . 0.0 110.649 165.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp -132.79 146.89 52.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.451 1.901 . . . . 0.0 111.666 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.05 111.63 1.77 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.53 0.732 . . . . 0.0 112.245 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.91 -34.22 5.52 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.387 1.47 . . . . 0.0 112.032 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.47 154.28 11.9 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.455 1.502 . . . . 0.0 110.994 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.82 128.44 34.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.509 1.124 . . . . 0.0 109.94 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 m -110.9 138.5 47.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.72 2.008 . . . . 0.0 108.349 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.72 133.8 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.781 0.719 . . . . 0.0 109.233 165.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -102.16 -42.92 5.89 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.479 0.712 . . . . 0.0 109.915 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -173.17 169.19 4.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.371 1.868 . . . . 0.0 111.476 171.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.18 -178.74 28.38 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 124.729 1.157 . . . . 0.0 114.509 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.4 116.64 26.77 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 m -58.68 -18.92 35.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -157.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -32.71 71.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.644 0.778 . . . . 0.0 112.564 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 tp -82.51 -46.83 12.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.62 1.1 . . . . 0.0 111.086 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.9 m -51.59 -42.92 62.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.382 0.992 . . . . 0.0 113.149 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.89 79.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.968 0.907 . . . . 0.0 112.364 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.2 58.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.541 0.737 . . . . 0.0 112.462 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.7 t -59.58 -47.68 84.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.652 0.781 . . . . 0.0 110.892 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -52.68 -42.42 64.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 111.138 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.25 -47.27 62.07 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.716 0.806 . . . . 0.0 112.914 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.97 78.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 t -66.87 -23.1 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.719 -1.238 . . . . 0.0 111.516 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.26 -6.71 59.17 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.46 -0.775 . . . . 0.0 112.676 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.89 -11.84 3.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.43 HG11 HD22 ' A' ' 46' ' ' ASN . 11.6 m -57.79 145.11 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.148 0.979 . . . . 0.0 112.597 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.31 -41.28 81.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.6 p 166.04 144.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.437 2.695 . . . . 0.0 110.102 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.51 110.45 45.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.505 -1.236 . . . . 0.0 109.77 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.65 134.8 20.85 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.898 1.732 . . . . 0.0 109.831 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.24 148.35 70.78 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.073 0.549 . . . . 0.0 111.601 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.07 -33.36 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.745 2.297 . . . . 0.0 111.283 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 159.81 42.0 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.383 2.273 . . . . 0.0 109.808 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -125.98 31.3 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.756 1.222 . . . . 0.0 113.205 -160.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.0 144.5 28.5 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.108 -0.995 . . . . 0.0 110.365 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.48 -9.2 17.1 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.337 2.691 . . . . 0.0 113.417 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.06 -35.59 31.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.643 0.777 . . . . 0.0 112.11 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.52 -25.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.46 1.104 . . . . 0.0 112.473 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.44 -28.54 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 118.578 0.626 . . . . 0.0 110.915 168.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -78.89 -9.57 59.53 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.17 -46.88 6.59 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.61 0.719 . . . . 0.0 112.008 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.423 ' HB2' ' HH ' ' A' ' 39' ' ' TYR . 4.0 pp -68.26 -26.36 65.63 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.168 0.987 . . . . 0.0 112.438 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -71.51 -25.35 62.21 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.415 -1.428 . . . . 0.0 113.168 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.36 90.48 3.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 110.483 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.432 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.77 152.87 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.642 1.177 . . . . 0.0 112.525 178.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -93.84 132.69 38.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.985 157.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.2 mt -91.27 117.32 29.54 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 156.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.9 m -135.31 128.28 31.48 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.1 155.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.405 1.482 . . . . 0.0 110.811 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.43 168.2 7.57 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.91 1.684 . . . . 0.0 111.355 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.25 159.07 41.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.694 2.929 . . . . 0.0 112.827 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 C--O 1.241 0.638 0 C-N-CA 123.86 0.864 . . . . 0.0 111.963 177.202 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -163.26 -104.94 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.895 1.678 . . . . 0.0 112.162 -169.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 66.1 27.78 10.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.808 2.043 . . . . 0.0 113.675 -171.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -103.17 -21.34 13.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.169 0.988 . . . . 0.0 113.494 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -15.2 0.75 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.327 1.451 . . . . 0.0 113.871 -165.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -62.94 -13.06 29.96 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 m -56.08 -27.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.032 1.333 . . . . 0.0 112.853 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 t -56.94 -37.5 71.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.82 0.848 . . . . 0.0 112.607 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -73.8 -26.99 60.91 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.972 -1.08 . . . . 0.0 112.862 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.26 -31.19 68.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.754 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.78 -31.51 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 120.972 1.714 . . . . 0.0 110.845 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -12.24 69.68 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.585 1.088 . . . . 0.0 114.031 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -104.77 -46.46 4.31 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.369 1.467 . . . . 0.0 110.546 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.88 -43.52 73.25 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 127.389 2.276 . . . . 0.0 113.212 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.46 -18.47 68.61 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.213 0.911 . . . . 0.0 113.44 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.93 -33.4 68.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.277 1.038 . . . . 0.0 111.592 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.5 pt -61.3 -28.13 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 120.953 -1.092 . . . . 0.0 111.889 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -80.56 -58.24 3.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.877 1.271 . . . . 0.0 109.581 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -60.13 -34.84 74.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 112.673 -174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -74.36 -28.11 60.98 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.772 1.229 . . . . 0.0 112.353 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.9 tp -76.4 -33.34 58.86 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.199 0.909 . . . . 0.0 111.684 171.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.11 -44.38 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.865 -1.147 . . . . 0.0 110.964 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.14 -13.6 61.6 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.262 1.025 . . . . 0.0 112.745 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.06 -38.38 73.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.485 HD22 HG13 ' A' ' 96' ' ' VAL . 37.0 m-80 -80.14 -37.39 33.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 0.0 111.989 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -99.49 103.9 15.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.62 1.2 . . . . 0.0 110.828 -164.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.94 20.71 7.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.98 -52.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.053 0.541 . . . . 0.0 112.237 -160.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 70.64 -62.55 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.867 2.467 . . . . 0.0 113.921 168.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.41 -35.41 80.34 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.635 -1.29 . . . . 0.0 111.946 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -77.09 -0.78 26.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -112.78 -12.49 13.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.612 1.965 . . . . 0.0 111.949 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -109.17 154.5 22.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 112.281 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.58 90.43 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.76 1.171 . . . . 0.0 114.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -178.61 5.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.747 2.019 . . . . 0.0 111.682 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.87 162.95 20.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.978 0.911 . . . . 0.0 110.462 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -157.4 147.2 20.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.446 1.099 . . . . 0.0 110.141 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.3 128.47 43.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.142 1.777 . . . . 0.0 110.372 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.17 167.42 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.58 1.152 . . . . 0.0 108.048 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -131.8 132.28 43.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.786 0.721 . . . . 0.0 111.95 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.68 130.13 49.5 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.139 0.975 . . . . 0.0 109.593 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -111.68 107.06 16.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.464 1.106 . . . . 0.0 109.227 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.02 158.69 15.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.913 0.863 . . . . 0.0 111.603 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -102.8 152.17 38.43 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.973 1.709 . . . . 0.0 110.506 168.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.05 147.27 29.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.143 2.562 . . . . 0.0 111.038 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -156.1 161.62 40.35 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.852 2.461 . . . . 0.0 108.338 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.3 -13.2 59.88 Favored Glycine 0 CA--C 1.54 1.649 0 O-C-N 120.737 -1.227 . . . . 0.0 115.187 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.9 p -99.77 -3.36 32.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.107 2.163 . . . . 0.0 113.919 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.97 -151.83 16.9 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.371 1.462 . . . . 0.0 111.078 -167.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.39 157.0 17.83 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.054 1.427 . . . . 0.0 111.949 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.0 144.45 51.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.269 1.828 . . . . 0.0 111.237 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.32 113.5 2.2 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.907 0.776 . . . . 0.0 112.182 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.81 4.69 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.68 1.61 . . . . 0.0 111.974 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.05 152.11 9.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.649 1.579 . . . . 0.0 111.295 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.37 134.29 49.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.247 1.019 . . . . 0.0 109.653 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.8 m -117.38 120.45 38.22 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.615 1.966 . . . . 0.0 108.707 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.23 133.97 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.312 0.96 . . . . 0.0 109.796 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -106.07 -49.93 3.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.298 0.639 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -173.03 170.23 4.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.166 1.786 . . . . 0.0 111.942 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.82 -175.21 32.97 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 125.054 1.311 . . . . 0.0 113.176 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.58 110.57 17.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 164.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 m -58.67 -17.91 26.44 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -52.45 -37.37 56.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.798 1.239 . . . . 0.0 112.357 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.19 -48.07 14.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.005 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -48.51 -46.22 38.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.565 1.146 . . . . 0.0 113.138 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.4 84.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.811 0.844 . . . . 0.0 112.296 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.22 23.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 112.629 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.2 t -57.44 -49.4 76.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.863 0.865 . . . . 0.0 110.508 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.29 -46.68 55.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.878 1.671 . . . . 0.0 111.258 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.9 -44.09 77.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.591 0.757 . . . . 0.0 112.833 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.78 -48.96 79.42 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.631 1.172 . . . . 0.0 112.173 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.5 -23.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.645 -1.284 . . . . 0.0 111.496 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.59 -6.63 57.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.689 0.796 . . . . 0.0 112.668 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -132.69 -12.0 3.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 46' ' ' ASN . 15.0 m -59.95 148.64 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.185 0.902 . . . . 0.0 112.456 171.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -71.33 -48.5 50.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 p 174.77 142.11 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.223 1.809 . . . . 0.0 111.884 -169.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.19 109.56 50.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 110.148 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.03 131.37 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.733 2.289 . . . . 0.0 110.417 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.83 150.83 75.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.573 0.749 . . . . 0.0 111.513 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.99 -40.84 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.321 2.014 . . . . 0.0 110.787 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -120.05 176.27 5.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.444 2.297 . . . . 0.0 111.278 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -152.64 49.43 0.75 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -112.83 135.66 21.63 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.11 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.73 -12.53 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.18 3.253 . . . . 0.0 115.585 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.0 -35.46 28.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 112.159 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -96.69 -24.16 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.209 1.004 . . . . 0.0 113.026 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.2 -25.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.592 0.757 . . . . 0.0 110.662 167.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -83.39 -7.77 59.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.03 -48.67 5.59 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.133 -0.98 . . . . 0.0 111.374 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.68 -20.95 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.648 1.179 . . . . 0.0 112.959 -175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.64 -25.24 67.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.987 0.915 . . . . 0.0 113.449 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -129.99 77.23 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.219 1.008 . . . . 0.0 110.102 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.57 148.33 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.62 123.48 36.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 157.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -84.63 110.03 18.43 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 160.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.7 m -132.32 127.55 35.82 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.85 1.26 . . . . 0.0 108.512 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 151.46 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -169.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.42 160.72 14.09 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.649 1.58 . . . . 0.0 111.425 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -64.39 -34.53 54.13 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.056 2.504 . . . . 0.0 113.616 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 126.481 1.913 . . . . 0.0 111.692 -179.448 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 119.88 -0.105 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 82.43 104.13 0.06 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 130.439 3.495 . . . . 0.0 112.239 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.83 3.55 2.52 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.664 -164.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -88.54 -22.73 23.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.262 1.825 . . . . 0.0 111.636 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.54 -7.65 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -49.97 -19.81 0.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 m -55.42 -29.12 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.734 1.214 . . . . 0.0 112.689 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 t -58.73 -36.21 73.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.967 0.907 . . . . 0.0 112.098 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -78.03 -30.38 49.91 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.836 0.854 . . . . 0.0 112.527 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.89 -38.81 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.348 168.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.44 -30.08 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 119.653 1.115 . . . . 0.0 110.203 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.29 -14.53 74.27 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.355 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -96.51 -49.14 5.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.098 1.949 . . . . 0.0 112.003 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -55.27 -43.08 74.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.298 2.239 . . . . 0.0 112.803 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.62 66.76 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.197 1.38 . . . . 0.0 114.066 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.09 -34.2 68.48 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.184 0.992 . . . . 0.0 111.608 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -60.59 -28.3 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.267 -0.896 . . . . 0.0 112.161 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.78 -58.44 3.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.114 1.366 . . . . 0.0 110.673 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -58.72 -36.84 74.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.49 1.116 . . . . 0.0 112.564 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -71.25 -32.58 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.701 1.2 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -76.05 -28.83 57.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.917 0.78 . . . . 0.0 112.271 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -75.27 -54.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.887 -1.133 . . . . 0.0 110.372 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -19.86 65.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.395 0.678 . . . . 0.0 112.495 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.17 -15.22 58.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.447 HD22 HG12 ' A' ' 96' ' ' VAL . 64.9 m-80 -78.76 -39.88 34.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.23 0.923 . . . . 0.0 111.992 161.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.81 96.34 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 123.436 1.589 . . . . 0.0 111.587 -160.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.54 24.44 1.2 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.098 -173.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.87 -72.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.163 0.985 . . . . 0.0 111.33 -167.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 75.0 -52.62 0.67 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 113.489 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.5 -36.84 85.11 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.005 -1.059 . . . . 0.0 111.905 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -83.66 0.33 47.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 113.743 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -102.83 -25.05 13.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.01 1.724 . . . . 0.0 112.805 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -87.52 162.65 17.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.504 2.321 . . . . 0.0 111.539 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.7 -5.36 69.95 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.788 1.185 . . . . 0.0 114.789 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 -173.89 4.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.277 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.61 162.05 25.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.766 0.826 . . . . 0.0 110.675 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 40.5 t -153.84 144.0 22.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.749 1.22 . . . . 0.0 110.381 169.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 130.55 48.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.729 1.212 . . . . 0.0 110.953 164.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.65 176.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.61 126.37 17.05 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.729 0.812 . . . . 0.0 110.572 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.69 131.4 52.18 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.94 0.896 . . . . 0.0 109.72 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -119.39 106.4 12.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 108.936 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -99.17 162.27 13.15 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.117 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.13 150.41 44.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.482 1.113 . . . . 0.0 110.677 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.31 134.19 17.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.668 2.245 . . . . 0.0 110.618 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -118.66 -33.73 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.252 1.421 . . . . 0.0 111.635 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.27 -121.84 0.8 Allowed Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.515 1.531 . . . . 0.0 111.274 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 p -63.69 -14.57 53.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.17 0.988 . . . . 0.0 113.088 167.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.17 153.52 16.82 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.887 1.708 . . . . 0.0 114.224 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.79 163.24 19.22 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.896 0.878 . . . . 0.0 110.292 161.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.13 147.68 52.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.393 1.877 . . . . 0.0 111.413 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.08 110.43 1.04 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.127 0.971 . . . . 0.0 112.033 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.65 -46.37 3.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.553 1.549 . . . . 0.0 110.591 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 m -155.41 149.59 25.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.338 1.055 . . . . 0.0 110.967 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.01 121.67 33.67 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.114 0.965 . . . . 0.0 109.546 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.3 m -103.66 118.7 37.32 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.448 1.499 . . . . 0.0 108.589 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.33 130.85 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.758 0.708 . . . . 0.0 109.207 167.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.17 -49.36 4.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.524 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -173.19 170.77 4.25 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.329 1.851 . . . . 0.0 111.796 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.93 -179.47 31.83 Favored Glycine 0 N--CA 1.461 0.359 0 C-N-CA 124.895 1.236 . . . . 0.0 113.55 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.19 113.95 20.37 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 165.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.7 p -61.3 -17.68 54.82 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -153.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -50.97 -35.58 34.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.548 1.139 . . . . 0.0 112.143 171.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -82.48 -51.04 8.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.086 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.3 m -45.74 -46.37 15.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.212 1.405 . . . . 0.0 113.203 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.98 82.43 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.038 0.835 . . . . 0.0 112.852 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.15 -52.88 14.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.5 t -56.68 -49.41 75.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.037 0.935 . . . . 0.0 110.58 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.64 -47.11 58.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.324 1.449 . . . . 0.0 111.303 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -68.5 -44.45 74.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.18 77.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.617 1.167 . . . . 0.0 111.23 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.3 -21.76 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.675 -1.266 . . . . 0.0 112.009 -178.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.58 -7.44 59.25 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.569 0.748 . . . . 0.0 112.632 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -131.34 -11.84 3.58 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.447 HG12 HD22 ' A' ' 46' ' ' ASN . 7.8 m -55.78 147.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.05 0.94 . . . . 0.0 112.92 171.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.34 -49.85 65.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.5 p 167.9 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.228 2.611 . . . . 0.0 110.334 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -99.73 104.32 27.27 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 117.31 -1.329 . . . . 0.0 110.493 -174.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -70.71 128.96 15.85 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.021 1.814 . . . . 0.0 111.512 -170.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 132.04 21.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.127 1.371 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.33 -52.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.186 2.591 . . . . 0.0 112.477 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.78 149.61 27.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.617 1.167 . . . . 0.0 110.045 167.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -128.03 21.01 6.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.288 1.435 . . . . 0.0 113.315 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -88.61 145.74 35.85 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 121.228 -0.92 . . . . 0.0 109.772 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.18 -23.58 6.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.563 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.2 -24.6 43.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.891 0.769 . . . . 0.0 112.862 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.2 m -98.22 -34.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.037 0.935 . . . . 0.0 111.97 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.27 -32.5 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.322 1.049 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.56 -11.74 59.87 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.129 0.972 . . . . 0.0 113.227 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.81 -34.05 8.68 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.179 -0.95 . . . . 0.0 113.289 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.84 -21.25 34.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.745 0.818 . . . . 0.0 112.913 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -69.44 -23.54 63.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.072 -1.017 . . . . 0.0 113.735 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.0 83.99 2.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.055 . . . . 0.0 110.146 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.46 159.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.81 126.91 55.12 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 160.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.8 121.9 32.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.9 m -134.12 129.76 36.38 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.097 0.959 . . . . 0.0 109.801 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.76 141.35 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 128.576 2.75 . . . . 0.0 107.885 -170.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.528 ' H ' ' HD2' ' A' ' 121' ' ' PRO . . . -168.62 -35.37 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.528 ' HD2' ' H ' ' A' ' 120' ' ' ALA . 71.6 Cg_endo -75.55 162.5 35.62 Favored 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 122.852 2.054 . . . . 0.0 112.217 -172.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.718 1.207 . . . . 0.0 110.834 -173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.22 131.5 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 111.672 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 mtp180 -136.41 16.8 3.16 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.713 2.005 . . . . 0.0 111.671 -171.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -88.11 -33.23 18.33 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.748 1.619 . . . . 0.0 111.561 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.8 14.52 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -62.53 -13.99 36.98 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.7 m -57.31 -26.44 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.115 1.766 . . . . 0.0 113.523 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -57.27 -35.48 69.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.205 1.002 . . . . 0.0 112.519 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -24.36 56.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.043 -1.035 . . . . 0.0 112.889 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -67.98 -34.18 76.06 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 167.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -66.11 -28.15 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.704 -1.248 . . . . 0.0 110.805 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.51 3.41 41.59 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.697 1.618 . . . . 0.0 114.626 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -125.63 -64.98 1.03 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.977 1.711 . . . . 0.0 110.781 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -60.08 -18.09 44.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.403 2.281 . . . . 0.0 116.429 -166.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.14 -13.83 9.66 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 126.896 2.188 . . . . 0.0 114.282 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.41 -34.41 54.77 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.381 1.472 . . . . 0.0 111.818 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.9 pt -59.33 -27.45 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.525 -0.735 . . . . 0.0 112.449 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.4 -58.59 2.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.949 1.3 . . . . 0.0 111.271 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 t -60.13 -33.33 72.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.618 1.167 . . . . 0.0 112.167 -172.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -74.05 -40.61 62.71 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.755 0.822 . . . . 0.0 110.464 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.52 -31.75 68.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.743 . . . . 0.0 111.361 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.59 -51.64 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -67.16 -19.94 65.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -57.08 -35.77 69.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.981 0.512 . . . . 0.0 111.245 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.421 HD22 HG13 ' A' ' 96' ' ' VAL . 65.3 m-80 -77.98 -32.7 51.46 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.36 109.15 20.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.621 1.201 . . . . 0.0 111.438 -160.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.08 25.01 5.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.72 1.608 . . . . 0.0 114.21 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.73 -64.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 0.0 111.385 -167.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 72.25 -68.3 0.23 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.217 2.207 . . . . 0.0 112.958 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.31 -27.86 68.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.982 1.313 . . . . 0.0 113.059 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.9 m -100.62 7.14 44.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.332 1.053 . . . . 0.0 113.21 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -100.08 -28.86 12.83 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.849 1.66 . . . . 0.0 112.161 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.993 1.717 . . . . 0.0 112.575 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.86 -23.6 3.64 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.199 1.38 . . . . 0.0 114.737 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 -169.77 1.53 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.081 2.153 . . . . 0.0 111.356 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 165.21 24.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 0.0 110.342 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 41.0 t -158.11 145.9 18.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 0.0 109.869 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 129.0 42.99 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.72 1.608 . . . . 0.0 111.003 165.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.99 169.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.18 132.21 33.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.236 -172.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -105.09 129.53 53.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.522 1.129 . . . . 0.0 109.725 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -112.36 111.14 21.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.999 0.92 . . . . 0.0 109.634 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -100.09 158.6 15.72 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.996 0.903 . . . . 0.0 111.715 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 pt -98.38 150.45 36.74 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 125.476 1.51 . . . . 0.0 110.036 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.35 150.89 37.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.17 2.58 . . . . 0.0 111.109 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -168.25 144.73 3.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.012 2.525 . . . . 0.0 107.98 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.0 -22.17 75.75 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -164.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.8 p -90.89 -9.6 45.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.488 1.515 . . . . 0.0 113.178 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.21 157.05 7.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.244 1.402 . . . . 0.0 112.635 -171.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.1 160.88 17.23 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 117.765 0.783 . . . . 0.0 110.767 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.19 144.93 51.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.072 1.349 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.05 110.25 1.16 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.461 0.704 . . . . 0.0 112.547 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.58 -37.28 4.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.882 1.705 . . . . 0.0 112.041 173.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -162.38 148.83 13.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.817 1.247 . . . . 0.0 111.0 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.35 125.78 39.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.347 1.059 . . . . 0.0 109.423 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.6 m -110.86 127.81 55.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.711 2.005 . . . . 0.0 108.133 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.57 133.33 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.608 1.094 . . . . 0.0 109.351 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 tp -104.51 -44.79 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.713 0.405 . . . . 0.0 110.287 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -172.48 168.86 5.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.646 1.578 . . . . 0.0 112.232 169.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.7 32.79 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.745 1.164 . . . . 0.0 113.573 169.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -85.68 114.73 22.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 166.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m -59.69 -19.82 52.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -151.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -58.43 -29.63 66.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.303 -0.856 . . . . 0.0 113.128 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -79.81 -48.58 13.31 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 120.228 1.376 . . . . 0.0 111.22 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 38.9 m -45.36 -47.3 13.4 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.694 1.134 . . . . 0.0 112.774 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.17 64.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.391 1.476 . . . . 0.0 114.486 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.04 -52.8 4.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.378 1.471 . . . . 0.0 111.975 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.0 t -56.05 -48.6 75.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 111.292 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -46.87 -47.21 21.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.427 1.891 . . . . 0.0 111.494 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -69.96 -43.25 71.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.08 71.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.694 1.197 . . . . 0.0 111.124 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.05 -22.02 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.82 -1.175 . . . . 0.0 112.645 -178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.71 -8.72 59.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.841 0.856 . . . . 0.0 112.455 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -128.85 -13.3 4.67 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG13 HD22 ' A' ' 46' ' ' ASN . 9.5 m -58.37 145.12 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.302 1.041 . . . . 0.0 111.984 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -69.46 -42.75 74.47 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -171.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.9 p 166.07 141.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.506 2.323 . . . . 0.0 110.192 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -89.61 112.55 52.4 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.538 -1.22 . . . . 0.0 110.388 -175.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.96 127.02 9.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.33 2.02 . . . . 0.0 111.101 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.525 ' H ' HD23 ' A' ' 101' ' ' LEU . 0.1 OUTLIER -73.98 141.65 78.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.852 0.861 . . . . 0.0 111.43 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -44.16 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.891 2.394 . . . . 0.0 110.401 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -122.55 151.56 41.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.146 1.778 . . . . 0.0 109.507 160.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -108.43 10.61 27.38 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -165.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.68 144.31 56.11 Favored Pre-proline 0 C--O 1.24 0.569 0 O-C-N 120.872 -1.143 . . . . 0.0 109.947 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.68 -6.0 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.04 2.493 . . . . 0.0 113.957 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.44 -33.1 23.75 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.713 0.805 . . . . 0.0 112.875 169.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -97.44 -25.77 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 113.139 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.67 -25.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.742 0.817 . . . . 0.0 110.59 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.17 -11.44 59.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.277 1.431 . . . . 0.0 113.191 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -37.75 8.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 0.0 112.583 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.62 -23.94 53.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.778 1.231 . . . . 0.0 112.592 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -66.79 -22.83 66.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.5 91.01 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.942 0.897 . . . . 0.0 110.647 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -119.43 154.79 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.674 1.19 . . . . 0.0 113.067 -178.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -91.11 136.42 33.1 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.144 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.38 114.31 26.81 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 153.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.3 m -133.83 128.27 34.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.579 1.152 . . . . 0.0 109.34 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.57 156.7 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.783 1.633 . . . . 0.0 111.173 -171.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.42 167.86 9.84 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.81 2.044 . . . . 0.0 110.629 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -60.22 -31.23 92.78 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 123.395 2.73 . . . . 0.0 114.425 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.095 0.958 . . . . 0.0 109.699 175.738 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.01 -82.12 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 75.51 11.57 3.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.853 2.461 . . . . 0.0 114.117 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -96.25 -19.97 18.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.409 1.083 . . . . 0.0 112.817 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -12.0 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.189 1.796 . . . . 0.0 113.335 -169.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.22 -15.83 6.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.201 1.8 . . . . 0.0 115.598 -167.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 m -53.09 -26.74 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.396 1.478 . . . . 0.0 113.267 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 t -59.67 -47.69 84.62 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.672 0.789 . . . . 0.0 112.311 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -64.67 -31.74 73.1 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.145 0.978 . . . . 0.0 112.064 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.09 -24.54 67.48 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.728 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.86 -27.84 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 121.276 1.853 . . . . 0.0 111.272 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.64 -12.34 61.58 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.706 1.146 . . . . 0.0 113.889 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -105.41 -55.45 2.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.349 1.46 . . . . 0.0 112.466 165.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -53.67 -44.0 69.33 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.096 1.759 . . . . 0.0 114.83 -162.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.56 -17.37 57.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.572 1.558 . . . . 0.0 114.03 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.06 -33.11 59.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.666 1.186 . . . . 0.0 111.547 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.9 pt -59.51 -25.79 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.136 0.88 . . . . 0.0 112.257 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.36 -59.88 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.122 0.969 . . . . 0.0 109.804 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 t -61.44 -35.25 77.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.472 1.109 . . . . 0.0 112.326 -171.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -73.85 -27.5 61.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.718 1.207 . . . . 0.0 111.915 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -78.6 -32.27 47.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.252 0.933 . . . . 0.0 111.836 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -68.8 -43.54 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.891 1.276 . . . . 0.0 110.598 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -72.62 -13.99 61.5 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.961 0.904 . . . . 0.0 113.223 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -55.58 -38.43 69.36 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.457 0.303 . . . . 0.0 110.326 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.415 HD22 HG11 ' A' ' 96' ' ' VAL . 35.1 m-80 -81.25 -36.87 29.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -103.41 99.42 9.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.825 1.298 . . . . 0.0 111.869 -161.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.2 28.82 0.69 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.269 1.428 . . . . 0.0 113.625 -172.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.35 -40.5 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.599 0.759 . . . . 0.0 112.322 -165.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.57 -98.53 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.139 1.776 . . . . 0.0 112.95 164.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.69 -24.1 66.54 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.645 1.178 . . . . 0.0 113.605 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 m -92.83 1.42 57.3 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -88.64 -22.18 23.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.073 1.349 . . . . 0.0 111.575 156.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -86.4 170.92 11.56 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.581 1.952 . . . . 0.0 111.214 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 -9.72 28.46 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.095 1.331 . . . . 0.0 114.833 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 -176.94 5.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.714 2.406 . . . . 0.0 110.885 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.92 160.44 26.15 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.722 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -154.87 141.44 18.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.646 1.178 . . . . 0.0 109.538 168.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.06 131.6 53.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.397 1.479 . . . . 0.0 110.494 167.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.3 m -142.31 170.24 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -134.82 131.93 38.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.404 0.682 . . . . 0.0 111.5 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.38 133.33 48.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.222 1.009 . . . . 0.0 109.682 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -115.16 107.12 14.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.738 1.215 . . . . 0.0 109.709 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.92 158.47 15.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.08 148.2 34.78 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.61 1.564 . . . . 0.0 110.274 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.71 141.13 37.02 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.71 2.273 . . . . 0.0 110.853 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.8 m -133.43 156.94 46.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.277 1.831 . . . . 0.0 109.795 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.31 -26.47 61.68 Favored Glycine 0 N--CA 1.478 1.492 0 C-N-CA 123.55 0.595 . . . . 0.0 113.661 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -131.17 104.47 7.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.941 1.696 . . . . 0.0 108.331 161.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.58 -159.53 24.96 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.136 1.351 . . . . 0.0 114.442 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -110.72 162.45 14.75 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.344 1.057 . . . . 0.0 110.032 162.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.24 145.92 51.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.101 1.761 . . . . 0.0 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.14 112.74 1.81 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.759 0.708 . . . . 0.0 112.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.41 -36.37 5.16 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 125.796 1.665 . . . . 0.0 111.873 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -166.45 153.52 9.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.685 1.594 . . . . 0.0 111.201 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.25 131.65 48.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.44 1.096 . . . . 0.0 109.889 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.0 m -111.55 122.59 48.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.362 1.865 . . . . 0.0 107.878 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.56 130.79 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.96 0.8 . . . . 0.0 109.114 167.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.31 -49.88 3.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.315 0.646 . . . . 0.0 110.094 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.58 165.58 4.57 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.123 1.769 . . . . 0.0 111.865 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.95 179.62 38.33 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 124.543 1.068 . . . . 0.0 114.253 167.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.84 119.65 24.17 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -54.36 -31.64 55.09 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -144.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -54.79 -34.97 63.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.859 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.4 tp -78.92 -56.78 4.14 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.334 1.425 . . . . 0.0 111.678 -175.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 6.0 p -55.69 -32.62 63.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.42 -33.95 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.816 1.189 . . . . 0.0 113.414 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.52 -52.5 7.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.46 1.104 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.6 t -56.09 -46.63 78.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.25 1.02 . . . . 0.0 111.713 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -46.45 -45.74 18.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.393 1.877 . . . . 0.0 111.797 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -75.62 -43.1 49.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.393 1.077 . . . . 0.0 112.754 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.77 -48.44 81.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.815 1.246 . . . . 0.0 111.98 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.1 -24.42 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.859 -1.151 . . . . 0.0 111.235 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.35 -6.07 55.97 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.503 -0.748 . . . . 0.0 112.566 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -133.07 -12.05 2.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.415 HG11 HD22 ' A' ' 46' ' ' ASN . 16.1 m -58.76 151.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.274 0.943 . . . . 0.0 113.238 169.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.65 -48.69 30.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 173.87 142.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.49 1.916 . . . . 0.0 111.835 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -97.12 113.79 63.66 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.902 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.5 127.95 6.74 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.868 2.379 . . . . 0.0 110.189 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.6 mt -83.42 146.73 51.22 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.754 0.821 . . . . 0.0 112.225 -172.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.27 -28.81 8.42 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.986 2.457 . . . . 0.0 111.892 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -140.76 156.84 46.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.76 2.024 . . . . 0.0 110.817 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -129.67 20.85 5.55 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -167.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -85.69 141.85 36.54 Favored Pre-proline 0 C--O 1.241 0.655 0 O-C-N 120.492 -1.38 . . . . 0.0 109.068 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.24 -5.41 8.01 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 113.399 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.52 -35.27 23.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.523 1.056 . . . . 0.0 112.124 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.0 m -100.34 -24.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.182 0.993 . . . . 0.0 113.278 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.54 -28.27 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.524 0.73 . . . . 0.0 110.379 167.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.409 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 31.7 mm-40 -79.8 -8.53 59.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.881 1.272 . . . . 0.0 113.981 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -93.1 -54.09 3.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.669 0.788 . . . . 0.0 111.311 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.81 -23.15 67.15 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 124.497 1.119 . . . . 0.0 113.17 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.409 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.9 ptmt -72.87 -23.91 60.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.721 -1.237 . . . . 0.0 113.292 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.7 83.08 2.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.124 1.369 . . . . 0.0 110.885 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.436 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.86 150.06 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.716 0.807 . . . . 0.0 112.199 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 126.55 39.83 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 157.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 mt -89.78 116.05 27.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 163.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -131.67 124.89 30.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.626 1.171 . . . . 0.0 109.345 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.89 139.95 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 128.333 2.653 . . . . 0.0 107.276 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.71 151.9 6.28 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.285 1.434 . . . . 0.0 111.514 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.3 158.36 29.66 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.742 2.961 . . . . 0.0 111.096 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.241 0.626 0 C-N-CA 123.807 0.843 . . . . 0.0 111.1 173.465 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -163.62 -66.25 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.987 0.915 . . . . 0.0 111.805 -170.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 72.68 12.13 5.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.178 2.191 . . . . 0.0 114.491 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -96.06 -22.11 17.55 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.049 0.94 . . . . 0.0 113.094 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.37 -24.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.965 1.706 . . . . 0.0 113.513 -165.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -58.79 -15.0 10.23 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.006 1.722 . . . . 0.0 114.42 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.99 -27.28 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.172 1.389 . . . . 0.0 113.117 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -57.95 -32.43 67.8 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.9 m -82.13 -27.66 32.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 0.0 112.434 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.0 -38.02 87.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.552 166.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.6 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.971 1.26 . . . . 0.0 111.063 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.68 -18.91 68.7 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.445 -1.197 . . . . 0.0 113.981 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -101.59 -48.85 4.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.976 1.388 . . . . 0.0 112.349 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -54.16 -43.97 71.07 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.801 2.04 . . . . 0.0 113.873 -171.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.05 68.22 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.123 1.344 . . . . 0.0 113.705 173.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.8 -27.48 55.25 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.327 1.063 . . . . 0.0 112.074 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.35 -30.12 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.403 -1.436 . . . . 0.0 111.457 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -78.26 -56.09 4.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.405 1.482 . . . . 0.0 109.488 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -59.33 -33.95 71.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.845 0.858 . . . . 0.0 112.452 -176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -37.56 82.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.776 1.231 . . . . 0.0 111.672 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.23 -28.04 59.75 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.58 -52.5 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.224 -0.923 . . . . 0.0 110.622 177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -23.91 67.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.638 0.775 . . . . 0.0 112.078 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.35 -14.16 60.46 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.428 HD22 HG13 ' A' ' 96' ' ' VAL . 62.0 m-80 -81.5 -45.19 16.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.182 0.901 . . . . 0.0 111.003 159.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.49 83.46 5.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 123.541 1.638 . . . . 0.0 112.081 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.34 28.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.813 1.645 . . . . 0.0 113.999 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.94 -69.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.462 -163.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 74.31 -49.78 0.67 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.982 2.513 . . . . 0.0 113.718 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.78 -44.74 92.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.621 1.168 . . . . 0.0 112.605 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.2 p -92.42 12.72 21.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -100.48 -17.92 16.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.59 1.556 . . . . 0.0 111.325 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -106.16 156.95 17.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.193 1.797 . . . . 0.0 111.813 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.39 -2.72 84.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.037 1.303 . . . . 0.0 114.804 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -178.97 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.032 2.133 . . . . 0.0 110.923 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 161.33 23.2 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.516 -0.74 . . . . 0.0 110.162 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -155.14 149.09 25.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.763 1.225 . . . . 0.0 110.403 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.27 117.64 9.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.733 1.613 . . . . 0.0 110.35 173.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.52 163.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -134.7 131.15 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.985 -0.447 . . . . 0.0 111.701 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.34 129.54 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.352 1.061 . . . . 0.0 109.885 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -114.29 103.81 11.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.511 1.524 . . . . 0.0 108.244 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.85 157.59 16.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.714 0.769 . . . . 0.0 112.085 -178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 pt -101.32 139.33 20.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.231 1.413 . . . . 0.0 110.159 168.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.42 126.23 10.8 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.526 2.151 . . . . 0.0 109.845 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 m -113.74 -33.72 5.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.272 1.029 . . . . 0.0 112.506 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.87 -110.16 0.37 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.487 1.041 . . . . 0.0 111.678 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -61.21 -23.74 65.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.19 0.996 . . . . 0.0 112.673 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.13 -178.43 16.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.268 1.413 . . . . 0.0 115.396 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -100.98 165.83 11.13 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.36 1.464 . . . . 0.0 111.833 171.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.26 146.49 52.33 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.385 1.874 . . . . 0.0 111.413 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.66 110.3 0.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.59 0.756 . . . . 0.0 112.038 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.45 -35.34 5.73 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.943 1.735 . . . . 0.0 111.703 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.8 152.51 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 0.0 111.556 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -126.0 125.06 42.06 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.532 1.133 . . . . 0.0 109.779 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.6 m -106.43 122.37 46.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.407 1.883 . . . . 0.0 108.19 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.81 129.55 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.125 0.875 . . . . 0.0 108.85 166.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -105.94 -41.54 5.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.405 0.682 . . . . 0.0 110.539 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.27 173.72 6.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.249 1.82 . . . . 0.0 111.503 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.36 169.41 13.08 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 125.778 1.656 . . . . 0.0 114.197 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.94 120.05 24.73 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 p -60.79 -20.85 62.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -154.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -52.69 -33.14 46.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.858 1.263 . . . . 0.0 112.976 171.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.09 -50.52 6.58 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.565 1.075 . . . . 0.0 111.053 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 m -46.22 -47.77 17.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.093 1.357 . . . . 0.0 113.922 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.61 80.45 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.72 0.808 . . . . 0.0 112.466 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.0 16.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.521 1.128 . . . . 0.0 112.068 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.6 t -58.68 -48.28 81.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.953 0.901 . . . . 0.0 110.734 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -49.25 -45.49 44.79 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.989 1.716 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.38 -47.39 61.12 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.23 77.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.289 1.036 . . . . 0.0 111.269 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.68 -22.55 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.86 -1.15 . . . . 0.0 112.013 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.08 -8.63 59.12 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.419 -0.801 . . . . 0.0 112.639 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.41 -11.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -173.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.428 HG13 HD22 ' A' ' 46' ' ' ASN . 13.8 m -56.92 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 112.387 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.33 -45.26 76.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 p 166.18 145.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 111.259 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -103.23 103.4 34.56 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.669 1.188 . . . . 0.0 109.426 -178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.11 132.24 25.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.308 2.006 . . . . 0.0 110.982 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.75 147.12 77.46 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 118.092 0.406 . . . . 0.0 110.941 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -42.01 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.92 1.747 . . . . 0.0 110.562 168.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 158.57 44.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.084 2.154 . . . . 0.0 111.276 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -126.64 19.14 7.34 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.389 1.076 . . . . 0.0 113.898 -162.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.69 140.41 40.98 Favored Pre-proline 0 C--O 1.24 0.589 0 O-C-N 120.508 -1.37 . . . . 0.0 109.442 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.45 -3.59 6.72 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.998 2.466 . . . . 0.0 113.523 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.84 -34.2 21.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.029 0.831 . . . . 0.0 111.985 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.94 -26.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.903 0.881 . . . . 0.0 112.978 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.58 -28.51 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.573 0.749 . . . . 0.0 110.623 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -79.62 -10.41 59.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.18 -53.31 4.41 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.518 -0.739 . . . . 0.0 111.133 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -65.2 -25.33 67.66 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 112.878 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -72.92 -24.74 60.86 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.01 -1.056 . . . . 0.0 113.337 -178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -125.81 81.1 1.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.796 1.638 . . . . 0.0 110.674 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.438 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.49 150.56 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.86 0.864 . . . . 0.0 112.415 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.36 129.24 43.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 160.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.94 109.69 19.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 156.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -133.85 125.83 29.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.769 1.228 . . . . 0.0 108.515 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.6 m -138.37 149.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.714 1.606 . . . . 0.0 110.321 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.36 154.82 11.26 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 125.627 1.571 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -77.67 163.49 29.12 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.731 2.954 . . . . 0.0 111.473 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.239 0.534 0 C-N-CA 125.302 1.441 . . . . 0.0 110.954 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.09 -110.13 0.21 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.961 0.904 . . . . 0.0 112.075 -168.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 68.13 30.23 5.89 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.674 1.99 . . . . 0.0 113.039 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -109.09 -19.64 13.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.457 1.503 . . . . 0.0 113.23 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.94 -11.32 0.99 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.982 1.713 . . . . 0.0 113.339 -163.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -70.36 0.4 6.6 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -166.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 m -54.13 -30.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.319 1.448 . . . . 0.0 113.157 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 t -58.85 -34.86 72.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.508 1.123 . . . . 0.0 112.716 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.5 t -73.21 -32.09 64.58 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.392 -0.818 . . . . 0.0 111.895 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.59 -26.99 65.66 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.714 -0.616 . . . . 0.0 112.636 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.59 -25.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.249 1.386 . . . . 0.0 110.743 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.56 0.7 54.92 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.648 1.594 . . . . 0.0 113.699 171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -115.3 -61.13 1.79 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.045 1.738 . . . . 0.0 111.377 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -49.62 -46.34 49.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.739 2.015 . . . . 0.0 114.741 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.54 -16.09 55.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.33 1.919 . . . . 0.0 114.097 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.2 -34.09 59.29 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.375 1.07 . . . . 0.0 111.863 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.0 pt -60.18 -24.72 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.54 0.736 . . . . 0.0 112.074 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -82.98 -59.7 2.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.599 1.16 . . . . 0.0 109.897 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -61.26 -34.66 75.53 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.448 1.099 . . . . 0.0 112.47 -170.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -71.02 -43.94 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.471 1.108 . . . . 0.0 110.385 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.2 tp -67.41 -29.29 68.75 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.638 0.653 . . . . 0.0 111.631 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -53.42 24.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 O-C-N 121.498 -0.751 . . . . 0.0 110.862 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -67.54 -18.28 64.97 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.44 -36.36 66.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.84 0.456 . . . . 0.0 111.265 167.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 HD22 HG13 ' A' ' 96' ' ' VAL . 55.1 m-80 -78.17 -37.96 44.63 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 112.204 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.53 101.87 13.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.968 1.366 . . . . 0.0 111.57 -164.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 21.0 3.84 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.27 -60.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -162.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 73.31 -57.84 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.715 2.406 . . . . 0.0 113.198 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.4 -40.36 86.36 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.093 1.357 . . . . 0.0 112.05 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 m -79.73 0.87 28.78 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -112.29 -25.77 9.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.063 1.745 . . . . 0.0 112.955 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.69 156.49 16.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.119 1.367 . . . . 0.0 113.171 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.64 -24.11 4.56 Favored Glycine 0 N--CA 1.478 1.486 0 C-N-CA 125.376 1.465 . . . . 0.0 114.816 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -173.63 2.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.41 1.884 . . . . 0.0 111.532 171.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.1 27.59 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.245 -0.91 . . . . 0.0 111.594 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.9 t -160.36 146.68 15.49 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.936 1.294 . . . . 0.0 110.008 171.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.23 129.81 42.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.184 1.794 . . . . 0.0 110.24 166.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.31 170.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.37 131.22 31.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.471 0.578 . . . . 0.0 112.02 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.46 127.93 49.29 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.177 0.991 . . . . 0.0 110.112 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mppt? -108.64 107.46 17.94 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.669 1.187 . . . . 0.0 109.277 165.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.4 160.45 14.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.994 0.902 . . . . 0.0 111.472 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.99 121.43 52.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.424 1.489 . . . . 0.0 109.504 166.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.62 121.84 10.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.96 2.44 . . . . 0.0 111.157 170.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.3 m -111.26 -29.54 7.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.132 1.373 . . . . 0.0 111.821 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.67 -52.99 0.71 Allowed Glycine 0 N--CA 1.476 1.324 0 C-N-CA 125.645 1.593 . . . . 0.0 112.415 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -70.03 -31.79 69.62 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.965 0.906 . . . . 0.0 111.378 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.15 -168.34 18.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 111.814 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.55 162.15 13.92 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 151.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.29 145.84 50.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.999 1.719 . . . . 0.0 111.16 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.94 112.2 1.58 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.644 -0.66 . . . . 0.0 112.402 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.13 -46.83 3.23 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.05 1.309 . . . . 0.0 110.68 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -156.64 148.28 22.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.609 1.164 . . . . 0.0 110.828 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.44 131.2 53.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.796 0.839 . . . . 0.0 109.574 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -115.22 117.17 29.75 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.142 1.777 . . . . 0.0 108.041 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -82.39 132.05 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.473 0.578 . . . . 0.0 109.631 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.86 -52.16 3.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.097 0.559 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -172.9 169.37 4.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.233 1.813 . . . . 0.0 112.119 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.03 -175.73 34.44 Favored Glycine 0 N--CA 1.465 0.581 0 C-N-CA 125.699 1.619 . . . . 0.0 113.843 168.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.63 116.63 19.94 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -25.53 39.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -152.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -55.08 -32.44 61.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.322 1.449 . . . . 0.0 112.834 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.76 -50.55 7.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.288 1.404 . . . . 0.0 112.404 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.1 p -60.74 -31.28 70.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.405 1.457 . . . . 0.0 113.26 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 -46.1 84.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.119 0.968 . . . . 0.0 112.75 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.07 -50.14 30.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.276 1.03 . . . . 0.0 113.206 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.3 t -56.87 -47.91 79.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.64 0.776 . . . . 0.0 110.521 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -48.79 -45.85 40.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.06 1.744 . . . . 0.0 111.818 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -69.14 -43.49 74.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.8 -49.13 78.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.724 1.21 . . . . 0.0 111.275 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.0 t -66.61 -23.03 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.5 -1.375 . . . . 0.0 112.172 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.43 -6.05 57.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.97 0.908 . . . . 0.0 112.782 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.55 -12.27 3.46 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.411 HG13 HD22 ' A' ' 46' ' ' ASN . 14.1 m -60.0 146.62 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.416 1.087 . . . . 0.0 112.115 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -72.11 -46.57 56.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 172.89 138.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.162 1.785 . . . . 0.0 111.245 -168.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -93.53 111.39 52.16 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.099 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.38 116.21 4.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.892 1.728 . . . . 0.0 109.938 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.537 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.1 pt? -88.34 137.63 30.74 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.44 1.496 . . . . 0.0 111.848 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.61 -46.29 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.25 2.634 . . . . 0.0 112.35 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -99.3 168.16 10.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.053 1.341 . . . . 0.0 110.719 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -131.48 6.15 4.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -167.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.15 138.85 60.43 Favored Pre-proline 0 C--O 1.243 0.735 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.36 -0.97 4.0 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.872 2.381 . . . . 0.0 113.549 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.58 -40.39 16.32 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 111.773 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -93.02 -25.74 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.381 1.072 . . . . 0.0 112.412 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.51 -26.65 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.973 0.909 . . . . 0.0 110.799 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -84.55 -7.24 59.33 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.464 1.506 . . . . 0.0 113.826 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -92.68 -51.69 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.781 0.8 . . . . 0.0 111.876 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.06 -21.52 64.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.476 1.11 . . . . 0.0 112.345 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -62.37 -24.14 67.2 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.88 -1.138 . . . . 0.0 113.711 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -129.61 78.62 1.86 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.416 1.087 . . . . 0.0 110.401 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.84 151.86 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.306 1.042 . . . . 0.0 111.732 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.23 134.17 34.78 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 155.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.33 113.17 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.5 m -135.71 126.29 27.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.344 1.058 . . . . 0.0 109.165 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.26 151.31 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.84 1.656 . . . . 0.0 110.654 -171.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.82 159.84 8.19 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.979 1.712 . . . . 0.0 110.975 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.46 -20.0 8.53 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.361 2.707 . . . . 0.0 113.51 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.502 0 C-N-CA 125.749 1.619 . . . . 0.0 109.919 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -166.06 -97.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.532 1.133 . . . . 0.0 112.079 -171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 68.6 24.41 6.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.38 2.272 . . . . 0.0 113.413 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -98.27 -18.24 18.49 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.57 1.148 . . . . 0.0 112.793 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.33 -23.87 0.67 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.621 1.968 . . . . 0.0 113.174 -166.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.52 -13.12 3.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.481 1.912 . . . . 0.0 116.051 -168.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 m -54.14 -31.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.141 0.882 . . . . 0.0 112.025 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -60.93 -34.88 75.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.439 1.096 . . . . 0.0 113.033 173.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -76.59 -32.66 58.24 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.777 0.831 . . . . 0.0 111.784 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.98 -28.17 66.37 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.532 -1.223 . . . . 0.0 112.351 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.17 -27.94 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 120.702 1.592 . . . . 0.0 110.885 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.31 65.63 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.044 1.307 . . . . 0.0 114.083 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -104.55 -51.78 3.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.324 1.562 . . . . 0.0 111.805 169.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.96 -43.49 77.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.676 2.39 . . . . 0.0 113.335 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.73 -17.44 70.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 172.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.0 64.0 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.552 1.176 . . . . 0.0 111.632 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -61.97 -28.84 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.538 -0.726 . . . . 0.0 111.5 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.07 -59.0 2.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.554 1.542 . . . . 0.0 109.992 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -60.34 -34.16 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.025 0.93 . . . . 0.0 112.408 -173.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -72.45 -31.47 65.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.078 0.951 . . . . 0.0 111.51 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.86 -30.18 61.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.548 0.613 . . . . 0.0 112.29 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -73.97 -53.68 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.956 -1.09 . . . . 0.0 110.649 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -20.22 64.55 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.462 0.705 . . . . 0.0 112.53 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.59 -14.53 58.12 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.454 HD22 HG13 ' A' ' 96' ' ' VAL . 56.3 m-80 -79.81 -42.15 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.185 0.902 . . . . 0.0 111.324 159.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.81 84.61 4.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 123.412 1.577 . . . . 0.0 111.775 -163.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.6 27.07 0.13 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.581 1.553 . . . . 0.0 114.217 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.93 -69.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.047 0.939 . . . . 0.0 111.128 -165.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 77.34 -50.81 0.54 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.595 2.358 . . . . 0.0 113.67 162.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.47 -21.97 60.3 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.96 -1.087 . . . . 0.0 113.551 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 98.3 p -89.93 -6.65 55.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.712 1.205 . . . . 0.0 113.07 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.489 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.1 m-30 -98.31 -17.2 19.02 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.464 1.906 . . . . 0.0 112.277 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.72 159.78 14.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.875 2.07 . . . . 0.0 112.989 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.29 -43.08 2.45 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.698 1.618 . . . . 0.0 112.778 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -84.85 -176.79 6.37 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.21 1.404 . . . . 0.0 111.264 168.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 165.08 23.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.879 0.872 . . . . 0.0 111.313 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.41 158.24 43.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.123 0.569 . . . . 0.0 111.087 158.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 128.04 39.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.86 1.264 . . . . 0.0 109.883 159.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.3 178.19 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.57 124.98 13.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.288 0.635 . . . . 0.0 110.966 -166.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.07 131.9 49.72 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.945 0.898 . . . . 0.0 109.814 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -118.63 103.47 9.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.184 1.794 . . . . 0.0 109.38 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.79 160.39 14.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.374 1.083 . . . . 0.0 111.697 -175.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 pt -102.24 142.12 23.94 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.608 1.563 . . . . 0.0 109.879 166.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.07 126.11 9.06 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.793 2.329 . . . . 0.0 109.95 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.2 m -112.9 -27.9 7.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.229 1.412 . . . . 0.0 112.089 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.69 -39.59 2.82 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.652 1.596 . . . . 0.0 112.99 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.3 p -71.49 -34.73 70.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.748 1.219 . . . . 0.0 110.532 163.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.62 -165.61 15.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 112.061 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.05 164.14 15.19 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 122.014 -0.697 . . . . 0.0 109.376 151.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.94 145.79 51.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.593 1.557 . . . . 0.0 111.157 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.81 111.59 1.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.253 0.621 . . . . 0.0 112.474 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.4 -35.87 5.33 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.542 1.544 . . . . 0.0 111.683 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.48 151.91 8.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.857 1.663 . . . . 0.0 110.845 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -125.3 121.15 33.18 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.856 0.862 . . . . 0.0 110.02 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.6 m -101.1 135.68 42.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.722 1.609 . . . . 0.0 107.807 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.0 m -99.34 135.95 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.015 0.825 . . . . 0.0 109.006 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -103.82 -48.22 3.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.089 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -172.66 171.61 4.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 0.0 111.792 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.11 -175.1 30.95 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.394 1.474 . . . . 0.0 113.886 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.55 110.89 19.04 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -63.68 -15.32 58.09 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -153.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.78 -32.65 70.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.795 0.838 . . . . 0.0 112.196 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.02 -46.8 22.55 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 119.712 1.142 . . . . 0.0 110.775 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 54.4 m -51.84 -38.77 57.17 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.41 1.005 . . . . 0.0 113.603 173.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.26 -44.98 70.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.841 0.856 . . . . 0.0 112.27 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.22 -52.54 53.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 112.213 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.1 t -57.34 -50.31 73.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.801 0.84 . . . . 0.0 110.365 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -50.95 -46.84 61.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.442 1.497 . . . . 0.0 111.306 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -66.68 -44.22 82.35 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.78 80.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.857 1.263 . . . . 0.0 111.511 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.67 -22.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.5 -1.375 . . . . 0.0 111.947 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.83 -7.2 58.56 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.429 -0.794 . . . . 0.0 112.399 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.27 -12.08 3.19 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 46' ' ' ASN . 9.2 m -55.72 148.28 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.59 1.156 . . . . 0.0 113.017 171.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -73.46 -43.33 60.5 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.4 p 168.87 145.76 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.025 2.53 . . . . 0.0 111.141 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -95.56 110.68 52.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.439 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.69 114.85 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.527 1.485 . . . . 0.0 110.374 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.4 pt? -89.76 129.19 47.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.812 1.645 . . . . 0.0 110.397 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.93 -46.34 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.127 2.551 . . . . 0.0 111.043 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -94.26 167.17 11.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.17 1.388 . . . . 0.0 112.169 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.61 24.5 0.59 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.352 1.061 . . . . 0.0 113.027 -165.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.28 140.46 34.38 Favored Pre-proline 0 C--O 1.24 0.598 0 O-C-N 120.754 -1.217 . . . . 0.0 108.644 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.83 -15.26 2.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.961 3.107 . . . . 0.0 115.601 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.32 -35.7 30.65 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.273 0.942 . . . . 0.0 112.496 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -99.78 -27.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.523 1.129 . . . . 0.0 112.726 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.2 t -56.82 -32.5 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.564 1.146 . . . . 0.0 110.105 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -77.9 -7.83 57.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 113.462 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -99.19 -44.55 6.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 112.694 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.9 -28.14 67.25 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.771 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -73.01 -23.99 60.69 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.397 -1.439 . . . . 0.0 113.643 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -122.84 84.19 2.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.825 1.25 . . . . 0.0 110.445 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.59 155.92 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.147 0.979 . . . . 0.0 112.127 176.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 120.84 43.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.978 162.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.17 119.45 30.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -135.65 127.03 28.48 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.063 1.345 . . . . 0.0 108.56 -173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.49 157.32 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 111.606 -168.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -161.3 -40.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.702 1.601 . . . . 0.0 115.265 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -67.82 -32.51 29.4 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.173 1.915 . . . . 0.0 114.003 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 125.514 1.526 . . . . 0.0 110.055 -170.039 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.77 -76.47 0.07 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.026 2.531 . . . . 0.0 111.776 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HA ' ' CD1' ' A' ' 27' ' ' PHE . 58.8 mtt180 73.41 14.16 4.46 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.362 2.265 . . . . 0.0 113.675 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -96.17 -21.64 17.78 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.19 -19.09 0.99 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 113.453 -167.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 24' ' ' ARG . 3.0 p90 -65.59 -2.14 3.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 m -54.4 -30.9 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.255 1.022 . . . . 0.0 112.468 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.4 t -66.86 -47.33 72.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.796 1.238 . . . . 0.0 112.021 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -59.8 -30.99 69.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.612 1.165 . . . . 0.0 112.567 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.37 -29.36 70.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.486 171.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.89 -28.73 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.931 1.696 . . . . 0.0 111.167 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.29 -8.16 69.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.767 1.175 . . . . 0.0 114.226 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -121.23 -76.73 0.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.076 2.15 . . . . 0.0 111.724 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -51.48 -52.71 44.35 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 128.057 2.543 . . . . 0.0 113.7 -161.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.36 -15.01 65.04 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.052 1.786 . . . . 0.0 113.97 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.53 -37.28 71.17 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.898 1.349 . . . . 0.0 110.551 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.5 pt -62.18 -26.97 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.476 -0.765 . . . . 0.0 112.223 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.2 -59.31 2.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.892 1.277 . . . . 0.0 109.927 174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -60.15 -35.58 75.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.881 1.272 . . . . 0.0 112.472 -173.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -77.4 -21.78 52.62 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.435 1.094 . . . . 0.0 112.779 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.93 -34.04 39.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.639 1.109 . . . . 0.0 111.416 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.75 -44.09 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 121.052 -1.03 . . . . 0.0 111.063 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -14.81 62.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.912 1.285 . . . . 0.0 112.911 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -59.99 -40.87 90.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.029 0.531 . . . . 0.0 109.962 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.46 HD22 HG13 ' A' ' 96' ' ' VAL . 34.0 m-80 -77.94 -44.06 28.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.952 0.882 . . . . 0.0 109.777 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.21 71.28 5.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.378 1.561 . . . . 0.0 111.512 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.12 28.95 0.05 Allowed 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.762 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.19 -70.68 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.991 . . . . 0.0 110.822 -163.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 75.82 -46.93 0.57 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.689 2.396 . . . . 0.0 113.201 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.09 -25.37 64.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.451 1.101 . . . . 0.0 113.067 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.6 m -86.02 -5.21 59.26 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.886 1.274 . . . . 0.0 113.336 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -110.47 -21.48 12.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 112.279 -174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -91.73 157.58 16.84 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.543 1.937 . . . . 0.0 113.334 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.03 -7.45 66.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 125.411 1.481 . . . . 0.0 114.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.78 -172.71 3.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.222 2.209 . . . . 0.0 110.955 176.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.18 165.91 21.36 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.458 -0.777 . . . . 0.0 110.593 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.8 t -154.99 142.05 19.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.001 0.92 . . . . 0.0 109.697 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.78 131.06 51.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.368 1.867 . . . . 0.0 110.677 166.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 170.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.461 1.104 . . . . 0.0 108.524 173.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.87 131.57 41.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.787 0.835 . . . . 0.0 112.068 -177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.28 134.25 44.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.044 0.938 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.89 102.89 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.162 1.385 . . . . 0.0 108.387 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.58 161.65 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.978 0.894 . . . . 0.0 111.493 -178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -100.59 121.01 54.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.273 1.429 . . . . 0.0 109.688 165.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.51 126.68 23.12 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.818 2.346 . . . . 0.0 110.994 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.2 m -143.52 92.45 2.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.276 1.431 . . . . 0.0 108.285 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.06 -123.95 32.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.977 0.799 . . . . 0.0 111.412 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.91 2.45 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.145 1.778 . . . . 0.0 114.199 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.71 -165.24 10.79 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.193 1.378 . . . . 0.0 114.726 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.15 165.73 19.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.838 1.255 . . . . 0.0 110.235 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.17 146.6 52.4 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.182 1.793 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.83 111.58 1.7 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.893 0.769 . . . . 0.0 112.419 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.61 -35.65 5.34 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.531 1.538 . . . . 0.0 112.287 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -166.43 153.87 9.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 111.06 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -129.58 129.13 44.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.261 1.024 . . . . 0.0 109.347 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.3 m -112.18 117.98 34.07 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.078 1.751 . . . . 0.0 108.229 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.61 132.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.708 0.685 . . . . 0.0 109.482 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -102.13 -53.13 2.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -179.1 162.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.666 1.987 . . . . 0.0 111.405 170.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.94 -176.54 40.69 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.368 0.985 . . . . 0.0 112.556 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 107.96 17.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 p -64.68 -13.95 56.33 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -147.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -57.1 -33.29 67.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.777 0.831 . . . . 0.0 112.604 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.35 -47.56 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.875 1.216 . . . . 0.0 111.855 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.7 m -45.68 -45.83 14.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.762 1.164 . . . . 0.0 112.802 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.54 71.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 0.0 112.427 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.81 66.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 11.6 t -58.85 -49.63 77.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.653 0.781 . . . . 0.0 110.477 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.39 -45.9 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.348 1.459 . . . . 0.0 111.518 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.71 -46.29 76.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.85 80.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.556 1.142 . . . . 0.0 111.622 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.06 -24.24 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.543 -1.348 . . . . 0.0 111.486 -179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.01 -7.22 58.71 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.348 -0.845 . . . . 0.0 112.368 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.75 -11.7 3.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.46 HG13 HD22 ' A' ' 46' ' ' ASN . 9.3 m -57.25 148.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.197 0.908 . . . . 0.0 112.869 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -68.57 -48.22 64.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.7 p 170.11 144.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.578 2.351 . . . . 0.0 110.56 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -97.18 110.66 55.21 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.466 -1.254 . . . . 0.0 109.482 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.87 129.93 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.447 2.098 . . . . 0.0 110.157 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.21 144.92 55.01 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.955 0.502 . . . . 0.0 110.745 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 -29.64 9.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.575 2.183 . . . . 0.0 111.656 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -114.66 -174.9 2.57 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.161 1.784 . . . . 0.0 111.864 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -151.96 21.15 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -95.52 132.29 27.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.89 -1.131 . . . . 0.0 109.457 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.69 -5.6 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.83 3.687 . . . . 0.0 116.857 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.75 -60.27 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.378 0.99 . . . . 0.0 110.266 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -74.97 -25.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.376 0.67 . . . . 0.0 112.273 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.25 -26.29 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 0.0 111.176 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -91.54 3.26 55.41 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.362 1.065 . . . . 0.0 113.711 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -98.33 -49.56 4.64 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.188 -0.945 . . . . 0.0 111.256 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.99 -22.37 65.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.014 1.725 . . . . 0.0 113.588 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.49 -25.1 64.8 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.921 -1.112 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -123.72 86.24 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.895 1.278 . . . . 0.0 111.041 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.446 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -110.55 150.29 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.898 1.279 . . . . 0.0 111.763 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.05 125.69 43.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 160.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.37 118.33 30.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 164.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -133.87 129.94 37.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.601 1.161 . . . . 0.0 109.321 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.36 153.67 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.534 1.534 . . . . 0.0 111.71 -171.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -158.12 52.24 0.53 Allowed Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 125.734 1.614 . . . . 0.0 113.551 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.14 146.72 36.92 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.866 2.378 . . . . 0.0 112.481 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 C--O 1.238 0.486 0 C-N-CA 124.536 1.134 . . . . 0.0 112.069 -178.309 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.37 -50.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.53 3.532 . . . . 0.0 113.013 7.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 72.85 8.98 5.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.805 2.442 . . . . 0.0 114.453 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -96.17 -20.27 18.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.93 -25.62 0.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 113.168 -164.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.75 -17.65 6.51 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.624 1.57 . . . . 0.0 114.622 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -52.97 -27.43 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.746 1.618 . . . . 0.0 112.77 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -58.01 -38.96 77.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.623 0.769 . . . . 0.0 112.469 171.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -74.54 -29.87 61.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.75 -1.218 . . . . 0.0 112.535 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.08 -26.44 62.16 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.992 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -29.27 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.209 1.368 . . . . 0.0 112.099 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.08 -9.73 64.02 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.355 1.931 . . . . 0.0 113.856 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 -105.91 -52.28 2.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.541 1.17 . . . . 0.0 111.057 166.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.409 ' HH ' ' HB ' ' A' ' 108' ' ' VAL . 6.7 m-85 -53.79 -45.31 70.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.29 2.236 . . . . 0.0 113.48 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.16 -17.2 69.99 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.111 1.339 . . . . 0.0 113.635 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.76 -31.93 63.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.612 1.206 . . . . 0.0 111.911 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.48 -27.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.157 -0.965 . . . . 0.0 111.61 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -81.83 -57.73 3.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.125 1.37 . . . . 0.0 110.23 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 t -58.08 -36.3 72.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.708 1.203 . . . . 0.0 112.444 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -73.21 -31.68 64.33 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.37 1.068 . . . . 0.0 111.484 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 tp -74.2 -34.33 63.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.071 0.851 . . . . 0.0 112.034 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.84 -44.82 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.591 -1.318 . . . . 0.0 110.927 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -72.15 -14.23 61.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -56.48 -39.24 72.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.442 0.297 . . . . 0.0 110.491 165.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.472 HD22 HG12 ' A' ' 96' ' ' VAL . 40.8 m-80 -79.27 -39.7 32.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.808 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -97.23 85.75 3.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 123.293 1.52 . . . . 0.0 112.031 -163.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.04 27.61 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.826 -1.534 . . . . 0.0 114.126 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 t -84.52 -52.82 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.346 0.658 . . . . 0.0 112.276 -163.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 69.78 -75.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.813 2.045 . . . . 0.0 112.554 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.29 -29.63 67.55 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.878 -1.138 . . . . 0.0 113.662 -167.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -81.55 0.75 36.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-30 -102.7 -17.57 15.58 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.704 2.001 . . . . 0.0 111.912 169.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -89.42 159.37 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.597 1.959 . . . . 0.0 112.18 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 -4.64 65.28 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.069 1.319 . . . . 0.0 114.873 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.406 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -140.06 -178.06 5.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.437 1.895 . . . . 0.0 111.882 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 164.01 21.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 109.75 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 t -156.79 144.54 19.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.942 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.11 128.85 45.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.11 1.364 . . . . 0.0 110.468 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -140.88 171.4 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 130.61 33.02 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.401 -0.812 . . . . 0.0 112.121 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.9 133.66 47.63 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.557 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -117.07 102.93 9.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.264 1.426 . . . . 0.0 109.245 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.17 160.67 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.98 0.895 . . . . 0.0 111.691 -176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.2 pt -101.69 122.35 47.91 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.809 1.644 . . . . 0.0 109.857 167.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 126.01 19.5 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.153 2.569 . . . . 0.0 110.88 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.3 m -118.71 -30.95 4.98 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.211 1.404 . . . . 0.0 111.967 -172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.75 -36.78 4.05 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 125.189 1.376 . . . . 0.0 113.716 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -71.48 -32.57 68.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.115 0.966 . . . . 0.0 110.527 161.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.05 -155.94 11.09 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 127.783 2.611 . . . . 0.0 110.897 172.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.43 163.61 13.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.205 1.003 . . . . 0.0 109.74 154.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.3 146.98 51.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 110.879 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.21 111.88 2.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.339 0.518 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.67 -46.78 3.11 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.304 1.43 . . . . 0.0 110.808 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.1 m -155.3 153.54 30.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.722 1.209 . . . . 0.0 111.452 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.25 132.16 45.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.618 1.167 . . . . 0.0 109.631 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 m -115.8 129.24 56.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.661 1.984 . . . . 0.0 107.494 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.79 136.49 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.397 0.999 . . . . 0.0 109.121 167.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.27 -49.7 3.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 119.083 -0.484 . . . . 0.0 109.996 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -171.39 170.3 5.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.32 1.848 . . . . 0.0 111.933 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.74 -175.32 32.11 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 124.731 1.158 . . . . 0.0 113.334 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.19 113.39 22.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 m -57.66 -20.19 31.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -155.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -54.32 -30.06 49.95 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 112.972 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.65 -50.59 7.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.202 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 m -45.09 -48.49 11.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.93 1.241 . . . . 0.0 113.604 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -29.29 69.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.427 1.091 . . . . 0.0 113.714 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.86 -52.05 5.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.403 1.481 . . . . 0.0 112.526 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.4 t -56.68 -48.3 77.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.057 0.943 . . . . 0.0 110.739 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -49.33 -47.28 47.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.589 1.556 . . . . 0.0 111.277 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -70.0 -44.48 69.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.809 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.443 1.019 . . . . 0.0 111.884 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.77 -23.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.599 -1.313 . . . . 0.0 111.556 -178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.88 -4.33 54.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.075 0.95 . . . . 0.0 112.735 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.06 -11.84 2.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 46' ' ' ASN . 13.0 m -58.34 149.41 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.577 1.081 . . . . 0.0 112.584 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -71.96 -46.27 58.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.4 p 170.29 144.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.708 2.003 . . . . 0.0 111.891 -173.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.74 110.44 58.96 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 110.184 -176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.98 131.11 10.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.381 2.054 . . . . 0.0 111.073 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.63 143.44 78.84 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.734 1.213 . . . . 0.0 112.324 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 -45.72 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.233 2.622 . . . . 0.0 111.24 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -126.63 154.53 43.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.722 2.009 . . . . 0.0 111.028 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -119.5 13.26 12.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 114.338 -161.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -80.35 143.45 55.92 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 120.814 -1.179 . . . . 0.0 109.741 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.61 -1.74 3.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.641 2.894 . . . . 0.0 114.159 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.2 -43.95 12.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.53 1.059 . . . . 0.0 111.652 167.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.409 ' HB ' ' HH ' ' A' ' 35' ' ' TYR . 21.1 m -87.84 -23.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.359 1.063 . . . . 0.0 112.902 -175.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.76 -26.68 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.99 0.916 . . . . 0.0 110.468 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.2 -4.41 59.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.114 0.965 . . . . 0.0 113.506 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -96.02 -53.21 3.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.569 1.077 . . . . 0.0 111.296 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 pp -62.47 -25.55 68.05 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.242 1.417 . . . . 0.0 113.009 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.42 -24.94 63.9 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.427 -1.421 . . . . 0.0 113.472 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -125.41 83.81 2.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.4 1.48 . . . . 0.0 110.76 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.63 156.19 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.948 1.299 . . . . 0.0 112.193 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.54 136.31 33.33 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 154.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.76 116.03 26.73 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 154.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -134.56 128.17 32.73 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 109.5 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.95 159.28 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.865 1.666 . . . . 0.0 110.889 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -162.94 160.66 19.07 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 126.072 1.749 . . . . 0.0 111.401 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.98 -12.28 9.67 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.822 2.348 . . . . 0.0 113.502 -171.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 . . . . . 0 C--O 1.24 0.596 0 C-N-CA 124.44 1.096 . . . . 0.0 110.917 178.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 77.86 -54.35 0.51 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.687 2.795 . . . . 0.0 112.012 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' HA ' ' CD1' ' A' ' 27' ' ' PHE . 75.6 mtt-85 74.99 9.81 3.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.43 2.292 . . . . 0.0 113.662 163.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -92.51 -18.99 22.45 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.065 0.946 . . . . 0.0 112.083 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.76 -26.77 0.45 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.752 1.621 . . . . 0.0 113.127 -169.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -61.3 -5.94 1.9 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -167.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 m -57.94 -30.69 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.837 -1.165 . . . . 0.0 112.681 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -67.19 -47.56 70.55 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.608 1.163 . . . . 0.0 112.025 171.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 m -59.17 -30.89 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.45 1.5 . . . . 0.0 112.445 177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.84 -27.75 67.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.782 172.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -64.87 -27.47 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 121.254 1.843 . . . . 0.0 110.253 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.71 -12.88 78.3 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.119 1.342 . . . . 0.0 114.692 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -107.92 -56.19 2.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.961 1.381 . . . . 0.0 112.999 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.68 -42.13 67.63 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.081 2.152 . . . . 0.0 114.12 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.99 -17.3 59.67 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.68 1.61 . . . . 0.0 114.16 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.93 -31.26 56.52 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.706 1.253 . . . . 0.0 112.615 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -59.79 -26.87 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 111.969 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.01 -59.11 2.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.609 1.164 . . . . 0.0 110.176 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.746 1.219 . . . . 0.0 112.46 -172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.81 -42.89 69.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.487 1.115 . . . . 0.0 110.239 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.86 -29.88 69.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.798 0.726 . . . . 0.0 111.947 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.52 -52.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -17.74 63.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -55.26 -34.38 63.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.811 0.444 . . . . 0.0 111.648 165.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.479 HD22 HG13 ' A' ' 96' ' ' VAL . 68.0 m-80 -79.19 -33.4 43.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 81.2 1.87 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.004 1.321 . . . . 0.0 109.166 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.59 43.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.011 1.324 . . . . 0.0 112.829 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -78.25 -57.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.238 1.415 . . . . 0.0 111.802 -165.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 72.03 -50.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.954 2.501 . . . . 0.0 113.152 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.9 -32.62 73.93 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 113.728 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 m -89.9 0.35 57.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -111.8 -23.76 10.41 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.019 1.728 . . . . 0.0 112.267 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.52 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 112.804 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.16 -11.23 30.63 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.391 1.472 . . . . 0.0 114.925 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -170.2 2.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.053 2.141 . . . . 0.0 111.065 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.41 162.96 26.86 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.597 176.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.6 t -156.23 144.59 19.91 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 109.839 168.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.73 129.95 49.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.118 1.367 . . . . 0.0 110.648 165.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -142.8 170.19 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.905 1.282 . . . . 0.0 107.824 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -134.6 130.64 36.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.569 0.748 . . . . 0.0 111.66 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.6 132.43 47.26 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.225 1.01 . . . . 0.0 110.316 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.47 102.22 9.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.191 1.396 . . . . 0.0 108.903 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.25 159.84 14.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.26 1.029 . . . . 0.0 111.565 -178.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.7 pt -103.87 146.6 32.83 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 126.111 1.764 . . . . 0.0 109.837 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.14 133.29 17.76 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 110.525 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -3.37 16.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.019 1.328 . . . . 0.0 113.121 175.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 -55.44 1.0 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 126.292 1.901 . . . . 0.0 112.441 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.6 p -79.94 -24.28 41.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.775 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.75 -159.11 10.11 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.086 1.803 . . . . 0.0 111.686 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -108.74 164.94 11.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.87 0.868 . . . . 0.0 110.871 164.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.73 145.3 49.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.592 1.957 . . . . 0.0 110.787 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.27 112.49 1.95 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.075 0.852 . . . . 0.0 112.135 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.72 -36.15 4.89 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.432 1.492 . . . . 0.0 112.034 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -164.83 154.44 13.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.408 1.483 . . . . 0.0 111.533 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -130.61 126.74 37.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.274 1.03 . . . . 0.0 109.791 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.8 m -110.62 118.73 37.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.946 1.698 . . . . 0.0 107.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.25 134.32 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.185 0.902 . . . . 0.0 109.632 170.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 mt -107.09 -49.21 3.32 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.997 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -173.38 166.24 4.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.65 1.58 . . . . 0.0 111.618 172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.76 -177.44 35.37 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 125.164 1.364 . . . . 0.0 114.011 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.31 116.69 21.92 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -56.28 -25.36 48.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -151.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -51.25 -38.18 51.23 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.917 1.287 . . . . 0.0 112.666 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.3 tp -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.053 -177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.99 -28.66 67.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.5 1.5 . . . . 0.0 114.138 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 -44.26 69.16 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.895 0.77 . . . . 0.0 112.666 170.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.13 -54.61 12.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.66 1.184 . . . . 0.0 113.549 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.7 t -54.67 -48.52 72.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.506 0.723 . . . . 0.0 110.514 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -52.13 -45.75 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.658 1.583 . . . . 0.0 112.048 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.6 mtp-105 -63.81 -42.32 97.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.121 0.568 . . . . 0.0 112.019 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.81 74.76 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.9 t -62.83 -25.08 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.253 -1.529 . . . . 0.0 112.383 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.2 -7.7 57.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.728 0.811 . . . . 0.0 112.804 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -132.31 -12.74 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG13 HD22 ' A' ' 46' ' ' ASN . 6.8 m -58.09 146.68 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.415 1.086 . . . . 0.0 112.681 173.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -68.74 -41.98 78.2 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 p 163.41 139.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.448 2.299 . . . . 0.0 110.96 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -91.95 113.03 57.67 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.154 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.26 118.82 5.07 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.249 1.966 . . . . 0.0 109.926 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.9 pp -93.17 140.28 23.27 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.909 1.284 . . . . 0.0 112.047 -176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.06 -31.2 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.271 2.647 . . . . 0.0 113.463 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.76 146.45 49.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.584 1.554 . . . . 0.0 110.049 176.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -102.78 8.13 39.44 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -166.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.02 136.33 57.89 Favored Pre-proline 0 C--O 1.241 0.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.366 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.61 -5.11 8.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.807 2.338 . . . . 0.0 113.465 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.32 -35.93 21.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.965 0.802 . . . . 0.0 112.063 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.18 -27.72 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.25 1.02 . . . . 0.0 112.814 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -57.26 -27.1 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.705 0.802 . . . . 0.0 110.874 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -82.07 -6.64 59.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.075 1.35 . . . . 0.0 114.094 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -92.54 -55.71 3.29 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.365 -0.834 . . . . 0.0 111.314 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.99 -27.62 65.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.885 1.274 . . . . 0.0 112.991 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -67.68 -23.07 65.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.063 -1.648 . . . . 0.0 114.048 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -122.68 86.28 2.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.45 1.1 . . . . 0.0 110.877 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.422 ' H ' HD12 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -109.11 151.55 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.615 1.166 . . . . 0.0 111.978 175.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.72 129.52 36.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 154.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -86.03 111.77 20.61 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.7 m -131.8 126.32 34.07 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.06 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.89 151.83 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.96 164.81 11.24 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.486 1.914 . . . . 0.0 110.641 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.46 -33.52 97.26 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.641 2.894 . . . . 0.0 114.05 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.239 0.504 0 C-N-CA 124.862 1.265 . . . . 0.0 110.527 172.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.86 -46.43 67.87 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.344 2.258 . . . . 0.0 113.395 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.48 -17.39 64.32 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.423 1.487 . . . . 0.0 113.97 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.39 -32.87 64.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.362 1.081 . . . . 0.0 111.993 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 pt -60.56 -28.18 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.735 0.698 . . . . 0.0 111.919 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -80.59 -58.89 2.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.359 1.064 . . . . 0.0 109.58 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -60.52 -35.4 75.87 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.75 1.22 . . . . 0.0 112.645 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -73.56 -32.38 64.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.459 1.104 . . . . 0.0 111.603 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -73.71 -32.65 64.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.871 0.759 . . . . 0.0 111.681 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.83 -56.46 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -65.2 -21.46 66.76 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.26 -9.26 59.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.72 -41.76 23.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.4 1.0 . . . . 0.0 111.374 163.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.99 86.39 2.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.232 1.413 . . . . 0.0 109.57 -173.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.76 39.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.052 1.741 . . . . 0.0 113.971 -173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.05 -60.01 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.957 0.903 . . . . 0.0 111.82 -166.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 72.73 -53.15 0.7 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.781 2.433 . . . . 0.0 114.148 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.47 -32.6 74.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 113.418 -171.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.8 p -96.6 5.64 50.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.093 1.357 . . . . 0.0 113.335 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.55 -27.4 13.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.232 1.813 . . . . 0.0 111.382 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -93.66 173.41 7.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.662 1.985 . . . . 0.0 112.657 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.66 -32.35 1.9 Allowed Glycine 0 N--CA 1.481 1.649 0 C-N-CA 125.811 1.672 . . . . 0.0 114.795 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -167.38 1.47 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.119 2.168 . . . . 0.0 110.675 165.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 158.63 38.03 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.28 -0.888 . . . . 0.0 110.442 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -156.46 150.16 24.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.612 1.165 . . . . 0.0 110.171 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.99 118.8 10.53 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.861 1.664 . . . . 0.0 110.589 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.38 171.05 14.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.413 1.085 . . . . 0.0 108.301 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.91 124.15 14.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.658 0.783 . . . . 0.0 110.402 -166.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.62 128.78 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.93 0.892 . . . . 0.0 109.074 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -117.6 105.9 12.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.379 1.472 . . . . 0.0 109.186 171.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.04 160.66 14.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.397 1.079 . . . . 0.0 111.397 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 pt -101.71 152.87 38.18 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.758 1.623 . . . . 0.0 110.2 167.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.73 151.76 46.73 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.175 2.583 . . . . 0.0 111.183 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -168.36 148.66 4.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.584 2.354 . . . . 0.0 108.273 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.63 74.7 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 -164.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -96.56 -6.06 37.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.579 1.552 . . . . 0.0 113.15 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.83 165.83 10.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.713 1.625 . . . . 0.0 111.598 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -65.64 161.4 20.55 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 117.959 0.879 . . . . 0.0 111.014 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.76 143.35 50.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.223 1.409 . . . . 0.0 111.159 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.3 109.59 0.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.88 -45.3 3.66 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.462 1.506 . . . . 0.0 110.938 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.4 m -156.06 146.33 21.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.344 1.058 . . . . 0.0 110.299 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.21 124.94 41.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.067 0.947 . . . . 0.0 109.927 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.9 m -104.77 121.49 43.73 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.006 1.323 . . . . 0.0 108.279 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.61 126.61 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 165.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.57 -40.44 6.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.048 0.539 . . . . 0.0 110.783 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -170.79 172.74 5.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.765 1.626 . . . . 0.0 111.462 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.57 172.33 17.57 Favored Glycine 0 N--CA 1.465 0.587 0 C-N-CA 125.981 1.753 . . . . 0.0 114.128 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -76.81 122.04 24.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.1 p -56.37 -27.42 56.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -157.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -56.68 -25.36 53.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.617 1.167 . . . . 0.0 113.865 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 tp -91.34 -59.57 2.11 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.066 1.303 . . . . 0.0 112.377 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.4 p -56.88 -31.79 65.19 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 121.137 1.789 . . . . 0.0 114.861 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.2 71.93 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.439 1.018 . . . . 0.0 112.658 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.37 -53.4 12.42 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.917 1.287 . . . . 0.0 112.006 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.5 t -54.55 -50.36 68.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.245 1.018 . . . . 0.0 110.608 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -51.14 -47.49 62.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.847 1.659 . . . . 0.0 111.755 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.98 -40.63 96.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 112.277 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.66 82.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.275 1.43 . . . . 0.0 112.453 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -63.01 -26.81 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.568 -1.332 . . . . 0.0 112.15 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.05 55.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.915 0.886 . . . . 0.0 112.991 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.56 3.18 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.3 m -52.1 150.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.23 -50.13 49.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.017 0.927 . . . . 0.0 112.581 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p 168.67 147.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.459 2.704 . . . . 0.0 110.387 -173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -97.51 106.3 31.81 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.234 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.91 116.93 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.716 1.611 . . . . 0.0 110.647 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 142.43 28.48 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.043 1.337 . . . . 0.0 110.722 173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.86 -24.17 11.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.34 2.693 . . . . 0.0 112.586 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.3 -179.93 6.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.39 1.476 . . . . 0.0 112.44 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -155.86 15.32 0.35 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.472 1.109 . . . . 0.0 113.086 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.28 129.09 32.85 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 120.637 -1.289 . . . . 0.0 108.967 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.64 -4.09 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.559 3.506 . . . . 0.0 115.801 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.51 -43.39 15.81 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.833 1.197 . . . . 0.0 112.141 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.12 -22.52 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.603 1.161 . . . . 0.0 112.609 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.3 t -55.2 -27.12 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.956 0.902 . . . . 0.0 110.903 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.65 -7.59 59.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.032 1.333 . . . . 0.0 113.81 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -45.69 6.14 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.046 -1.034 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -72.65 -23.19 60.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.998 0.919 . . . . 0.0 111.823 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -65.97 -22.12 66.45 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -125.52 79.34 1.81 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.605 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -102.19 158.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.48 1.112 . . . . 0.0 111.776 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -112.39 123.62 50.67 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 159.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.24 111.28 20.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -134.21 125.66 28.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.79 1.236 . . . . 0.0 108.931 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.76 149.88 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.727 1.611 . . . . 0.0 110.631 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 126.658 1.983 . . . . 0.0 111.201 -178.419 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.705 0.288 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.74 -43.09 65.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.431 1.892 . . . . 0.0 113.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.56 68.28 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.841 1.21 . . . . 0.0 114.011 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.59 -35.07 70.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 111.366 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -59.6 -28.44 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.545 -0.722 . . . . 0.0 112.122 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -80.36 -58.86 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.968 1.307 . . . . 0.0 109.547 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.51 -35.53 74.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.553 1.141 . . . . 0.0 112.695 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -74.45 -30.27 61.8 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.726 1.21 . . . . 0.0 111.781 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -75.47 -34.49 60.9 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.531 1.059 . . . . 0.0 111.479 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.53 -44.44 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.295 1.038 . . . . 0.0 111.058 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.95 -14.37 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.884 0.874 . . . . 0.0 113.164 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -55.52 -35.53 65.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.268 0.227 . . . . 0.0 111.137 164.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -81.7 -30.71 32.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 111.538 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -143.95 81.22 1.68 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.418 1.487 . . . . 0.0 109.531 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.48 38.09 0.18 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.413 1.485 . . . . 0.0 113.786 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.31 -51.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.97 0.908 . . . . 0.0 112.892 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 70.82 -59.01 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.779 2.432 . . . . 0.0 113.71 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.06 -34.34 77.84 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.076 -1.015 . . . . 0.0 113.464 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -87.8 -1.32 57.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 113.612 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -100.4 -24.4 14.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.774 1.629 . . . . 0.0 111.702 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -91.32 172.51 8.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.372 2.269 . . . . 0.0 111.373 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.47 -34.02 2.04 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -168.64 1.59 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.573 1.949 . . . . 0.0 110.748 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 160.6 32.75 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 110.703 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.429 ' HB3' HD23 ' A' ' 85' ' ' LEU . 44.6 t -157.46 149.02 21.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.506 1.122 . . . . 0.0 110.171 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 122.82 20.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.989 1.716 . . . . 0.0 110.368 167.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.54 163.11 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.591 1.156 . . . . 0.0 108.005 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -133.34 130.69 39.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.343 0.657 . . . . 0.0 112.128 -174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.44 129.76 46.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 110.084 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.47 103.82 11.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.424 1.489 . . . . 0.0 108.774 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.29 158.41 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.533 0.683 . . . . 0.0 111.757 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.16 140.09 21.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 109.861 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.85 125.42 9.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.436 2.091 . . . . 0.0 109.833 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.2 m -110.81 -31.0 7.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.695 1.198 . . . . 0.0 111.871 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.62 -117.04 0.7 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.191 1.377 . . . . 0.0 110.756 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -66.7 -4.98 10.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.393 1.477 . . . . 0.0 113.871 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.47 174.04 24.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.434 1.492 . . . . 0.0 114.27 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -104.57 163.87 12.16 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 111.717 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.78 147.15 50.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.435 1.894 . . . . 0.0 111.4 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.94 111.61 1.55 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.52 0.6 . . . . 0.0 112.133 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 -45.78 3.69 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.406 1.479 . . . . 0.0 111.15 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.4 m -157.33 152.86 26.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.747 1.219 . . . . 0.0 110.463 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.98 126.93 40.65 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.218 1.007 . . . . 0.0 110.214 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.7 m -106.8 120.87 43.18 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.638 1.975 . . . . 0.0 107.938 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -87.57 127.11 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.2 0.909 . . . . 0.0 108.779 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.29 -39.42 6.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.265 0.626 . . . . 0.0 110.896 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -170.25 168.83 8.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 111.849 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.8 173.84 19.9 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 125.283 1.421 . . . . 0.0 114.753 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.62 117.85 20.92 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.7 p -59.15 -19.76 47.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -159.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -55.85 -29.96 60.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.906 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 58' ' ' CYS . 18.0 tp -86.53 -52.31 5.64 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.84 1.2 . . . . 0.0 111.444 171.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 m -46.64 -46.8 20.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.741 1.155 . . . . 0.0 113.635 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.86 -42.3 67.05 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.009 0.822 . . . . 0.0 112.041 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' A' ' 47' ' ' LEU . . . -61.69 -58.74 6.85 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.512 1.125 . . . . 0.0 112.531 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.64 -50.41 73.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.864 0.466 . . . . 0.0 110.168 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -51.74 -47.54 64.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.227 1.411 . . . . 0.0 111.876 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.02 -40.61 96.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.228 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.4 -49.3 74.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.763 1.225 . . . . 0.0 112.203 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -64.32 -24.06 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.633 -1.292 . . . . 0.0 111.723 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.78 -7.13 57.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 112.66 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -12.74 2.5 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.0 m -58.45 146.56 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.231 1.013 . . . . 0.0 112.628 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -66.52 -46.05 77.45 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p 167.6 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.854 2.062 . . . . 0.0 111.0 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 29.4 m-85 -96.24 109.38 47.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.666 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.05 132.0 14.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.424 2.083 . . . . 0.0 109.969 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.99 145.94 66.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.667 -173.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.66 -28.79 7.82 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.095 2.53 . . . . 0.0 111.181 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -140.42 150.58 44.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.925 2.09 . . . . 0.0 110.621 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -119.88 23.03 11.28 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.928 1.291 . . . . 0.0 112.888 -164.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -85.86 142.13 36.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.584 -1.323 . . . . 0.0 109.946 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -63.09 -4.57 6.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.484 2.789 . . . . 0.0 113.796 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.38 -33.44 19.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.597 1.159 . . . . 0.0 111.98 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 -24.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.202 1.001 . . . . 0.0 112.23 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.55 -25.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.23 1.012 . . . . 0.0 111.362 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -84.13 -7.36 59.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.978 1.311 . . . . 0.0 114.323 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 -46.52 5.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.905 0.882 . . . . 0.0 111.23 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.0 pp -74.42 -20.33 60.08 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.571 1.548 . . . . 0.0 113.205 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -63.56 -23.9 67.58 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.699 -1.25 . . . . 0.0 113.354 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.34 80.09 1.92 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.985 1.314 . . . . 0.0 109.933 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -106.39 150.95 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.002 . . . . 0.0 111.828 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.82 130.57 44.07 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 160.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.84 111.95 23.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 156.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.0 m -134.6 126.45 29.25 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.704 1.202 . . . . 0.0 109.254 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.1 m -138.78 151.71 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.377 1.471 . . . . 0.0 110.495 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 126.26 1.824 . . . . 0.0 111.583 -178.021 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 120.773 0.32 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.58 -18.55 41.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 128.027 2.531 . . . . 0.0 116.219 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.66 -13.13 8.94 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.138 1.827 . . . . 0.0 113.945 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.37 -32.18 43.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.034 1.734 . . . . 0.0 110.755 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 pt -62.0 -28.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.186 -1.571 . . . . 0.0 112.15 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.75 -56.97 4.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.513 1.125 . . . . 0.0 110.098 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.83 -35.03 72.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.364 1.066 . . . . 0.0 112.641 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -70.31 -31.21 68.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.472 1.509 . . . . 0.0 112.307 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.0 tp -79.96 -35.24 37.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.605 0.362 . . . . 0.0 111.824 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -68.22 -53.11 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.777 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -59.06 -26.87 64.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.493 0.717 . . . . 0.0 112.289 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -15.16 60.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -81.43 -40.1 23.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.039 0.836 . . . . 0.0 111.718 161.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.2 88.07 5.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 123.383 1.563 . . . . 0.0 111.607 -163.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 27.02 0.4 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.863 -1.517 . . . . 0.0 114.121 -175.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.45 -56.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.741 0.816 . . . . 0.0 112.563 -163.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.3 -57.59 0.63 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.001 2.521 . . . . 0.0 113.757 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.85 -24.13 62.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 112.937 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.6 m -84.06 -1.27 54.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.608 1.163 . . . . 0.0 113.623 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-85 -117.5 -21.17 8.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.526 1.53 . . . . 0.0 113.179 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -85.44 152.1 23.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.315 1.846 . . . . 0.0 112.713 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 -8.49 28.3 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.365 1.459 . . . . 0.0 116.126 168.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.4 -179.55 4.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.149 1.779 . . . . 0.0 112.052 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 160.92 20.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.652 0.781 . . . . 0.0 111.29 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 49.0 t -159.51 144.19 15.29 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.449 1.1 . . . . 0.0 109.877 172.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.29 39.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.846 2.059 . . . . 0.0 110.031 168.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.25 175.08 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.277 1.031 . . . . 0.0 108.568 171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.08 126.76 20.45 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.941 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.75 128.75 53.89 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.128 0.971 . . . . 0.0 109.007 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -116.69 106.92 14.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.96 1.304 . . . . 0.0 109.117 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.28 157.77 16.16 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.605 1.162 . . . . 0.0 111.772 -176.211 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.86 151.19 37.45 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.723 1.609 . . . . 0.0 110.154 167.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -72.52 150.42 51.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.137 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -166.47 148.17 6.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.487 2.315 . . . . 0.0 108.062 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.74 -17.66 71.42 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.776 1.071 . . . . 0.0 115.776 -165.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.3 p -97.14 -3.43 41.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.971 1.708 . . . . 0.0 113.127 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.26 165.42 11.45 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.161 1.363 . . . . 0.0 111.937 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -67.58 161.28 26.0 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.366 1.083 . . . . 0.0 111.115 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.21 144.58 51.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 111.127 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.65 112.2 1.91 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.427 0.558 . . . . 0.0 112.04 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.1 -46.11 3.16 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.026 1.298 . . . . 0.0 111.012 170.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.7 m -153.03 143.69 22.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.368 1.067 . . . . 0.0 110.682 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -119.21 121.86 40.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.258 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -104.8 118.31 36.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.405 1.482 . . . . 0.0 108.26 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 m -83.97 129.05 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 118.892 0.769 . . . . 0.0 109.732 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 mt -99.18 -54.32 3.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.009 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -177.87 164.8 1.96 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.721 2.008 . . . . 0.0 111.433 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.25 -173.71 39.44 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 125.57 1.557 . . . . 0.0 113.528 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.99 116.92 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.4 p -55.9 -26.31 46.83 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -150.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.83 -29.44 69.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.93 -47.37 16.54 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.722 1.147 . . . . 0.0 111.107 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 68.8 m -48.56 -45.07 37.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.632 1.106 . . . . 0.0 112.359 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.25 -47.93 75.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.628 1.171 . . . . 0.0 112.177 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.79 41.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.058 0.943 . . . . 0.0 113.266 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -56.8 -48.49 77.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.809 0.844 . . . . 0.0 110.845 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -48.71 -44.12 37.9 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.303 1.841 . . . . 0.0 111.953 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -70.57 -45.92 64.48 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.25 74.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.701 1.2 . . . . 0.0 111.161 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -67.08 -22.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.996 -1.065 . . . . 0.0 112.268 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -7.44 59.1 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.001 0.92 . . . . 0.0 112.538 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.18 -12.54 3.58 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.6 m -56.52 145.56 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.485 1.114 . . . . 0.0 112.783 171.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.7 -44.68 77.13 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.0 p 165.59 142.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.214 2.205 . . . . 0.0 110.848 -169.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.0 m-85 -93.21 111.27 51.13 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.693 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.18 128.85 10.85 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.217 1.945 . . . . 0.0 110.567 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.34 148.36 52.5 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.577 0.751 . . . . 0.0 112.118 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.06 -33.35 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.92 2.414 . . . . 0.0 111.075 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 153.78 45.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.161 2.184 . . . . 0.0 110.358 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -119.87 20.2 12.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.318 1.447 . . . . 0.0 113.406 -166.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -83.2 139.8 42.25 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 120.757 -1.214 . . . . 0.0 109.3 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.66 -15.74 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.461 2.774 . . . . 0.0 114.945 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.15 -28.62 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.973 1.309 . . . . 0.0 112.077 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.68 -26.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.582 1.553 . . . . 0.0 112.5 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.37 -26.27 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.49 1.116 . . . . 0.0 110.959 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.41 -11.49 59.68 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.233 1.413 . . . . 0.0 113.714 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -97.51 -46.52 6.01 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.914 0.779 . . . . 0.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.1 pp -73.07 -22.52 60.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.796 1.238 . . . . 0.0 112.92 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.38 -23.93 66.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.07 82.35 2.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.006 0.923 . . . . 0.0 110.238 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.2 158.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.36 1.076 . . . . 0.0 111.968 178.522 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -108.06 126.09 52.33 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 157.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.59 112.47 21.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.5 m -132.1 125.84 32.31 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 109.054 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.24 149.99 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.251 1.82 . . . . 0.0 110.293 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 125.551 1.54 . . . . 0.0 112.197 -176.649 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 38' ' ' ILE . 46.5 mtt180 . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 120.395 0.141 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -49.89 -47.62 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.161 2.184 . . . . 0.0 114.038 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.4 -16.14 62.87 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.052 1.31 . . . . 0.0 113.779 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.64 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.92 -34.5 64.37 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.251 1.026 . . . . 0.0 111.645 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 3.7 pt -60.03 -26.3 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.519 -0.738 . . . . 0.0 111.994 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -82.08 -59.87 2.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.494 1.118 . . . . 0.0 109.837 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -61.17 -35.14 76.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.254 1.022 . . . . 0.0 112.775 -171.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -71.38 -43.02 67.66 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.165 0.986 . . . . 0.0 109.757 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.57 -30.33 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.672 0.669 . . . . 0.0 111.543 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -69.87 -54.0 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.844 0.858 . . . . 0.0 110.915 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -68.05 -18.07 64.58 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -55.85 -36.45 67.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.256 0.48 . . . . 0.0 111.389 167.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -77.51 -34.35 54.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -102.35 109.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.542 1.163 . . . . 0.0 111.14 -160.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.65 22.03 10.51 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 114.628 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.8 -62.56 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.332 0.653 . . . . 0.0 111.545 -166.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 72.86 -60.04 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.769 2.428 . . . . 0.0 113.506 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.6 -29.77 70.98 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.611 -1.305 . . . . 0.0 113.14 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -94.8 6.07 50.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.31 1.044 . . . . 0.0 113.655 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.4 m-30 -105.31 -21.94 13.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 112.085 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -100.64 156.3 17.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.596 1.958 . . . . 0.0 111.905 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.48 -27.27 2.89 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.274 1.416 . . . . 0.0 114.556 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -174.68 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.494 1.918 . . . . 0.0 111.557 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 161.62 29.62 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.815 0.846 . . . . 0.0 110.643 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.95 157.87 43.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.553 0.741 . . . . 0.0 111.433 160.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 126.03 31.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.84 1.656 . . . . 0.0 109.967 161.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.94 166.33 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.15 131.29 36.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.508 0.594 . . . . 0.0 112.065 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 132.18 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.159 0.984 . . . . 0.0 110.037 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -114.4 105.98 13.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.341 1.456 . . . . 0.0 109.147 171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -100.2 158.81 15.59 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.56 0.695 . . . . 0.0 111.748 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -99.3 133.43 22.03 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.126 1.37 . . . . 0.0 109.843 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.06 116.73 4.83 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.581 2.187 . . . . 0.0 109.207 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 m -106.14 -30.85 8.99 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.546 1.139 . . . . 0.0 112.095 -172.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.24 -112.33 0.49 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.852 1.215 . . . . 0.0 111.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -58.71 -25.28 62.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 112.34 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.76 179.04 20.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.757 1.17 . . . . 0.0 114.472 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -95.24 165.0 12.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.97 1.308 . . . . 0.0 111.515 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -132.82 147.22 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.151 1.781 . . . . 0.0 111.47 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.94 111.23 1.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.764 0.711 . . . . 0.0 112.656 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.35 -36.04 5.53 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.396 1.474 . . . . 0.0 111.668 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -167.26 153.39 7.94 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.266 1.426 . . . . 0.0 111.023 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -130.14 126.29 37.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.319 1.048 . . . . 0.0 109.873 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -105.17 132.98 50.71 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.402 1.881 . . . . 0.0 108.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.14 131.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.943 0.792 . . . . 0.0 109.102 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.56 -45.19 5.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.947 0.499 . . . . 0.0 110.073 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -172.58 167.91 5.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.986 1.715 . . . . 0.0 111.647 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.7 -177.84 27.59 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.893 1.235 . . . . 0.0 114.303 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.4 118.22 24.8 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 166.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.8 p -59.94 -21.27 60.94 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -158.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -60.88 -23.02 64.86 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.381 1.072 . . . . 0.0 113.669 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.44 -49.06 6.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.812 1.187 . . . . 0.0 111.414 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.8 m -49.99 -39.26 40.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.833 1.253 . . . . 0.0 114.322 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.2 56.86 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.04 0.836 . . . . 0.0 112.829 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -51.29 65.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.981 . . . . 0.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.4 t -57.46 -47.6 81.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.454 0.702 . . . . 0.0 110.235 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -57.19 -35.15 69.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.371 1.068 . . . . 0.0 112.157 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -71.26 -48.52 50.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.41 72.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.647 1.179 . . . . 0.0 111.749 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.1 -24.04 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.489 -1.382 . . . . 0.0 111.661 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -6.94 58.83 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -12.14 3.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.7 m -58.76 145.91 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.395 1.078 . . . . 0.0 112.257 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.41 -42.1 83.78 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -173.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p 163.21 143.44 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.56 2.344 . . . . 0.0 111.048 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 20.3 m-85 -98.13 105.32 27.61 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-O 117.527 -1.225 . . . . 0.0 109.948 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 134.35 17.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.817 2.344 . . . . 0.0 110.437 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 144.87 59.22 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.31 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.33 -28.67 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.241 2.627 . . . . 0.0 111.855 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -140.77 154.23 46.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.715 2.006 . . . . 0.0 110.482 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -133.49 48.1 2.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.175 0.99 . . . . 0.0 112.349 -165.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -108.9 141.2 22.84 Favored Pre-proline 0 C--O 1.243 0.733 0 O-C-N 121.35 -0.844 . . . . 0.0 108.802 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.17 -17.55 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.021 3.148 . . . . 0.0 115.182 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.76 -33.85 40.34 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.039 0.836 . . . . 0.0 112.335 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 m -97.26 -25.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.506 1.122 . . . . 0.0 112.611 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.33 -26.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.697 1.199 . . . . 0.0 110.951 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -81.38 -10.7 59.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.001 1.32 . . . . 0.0 114.031 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.77 -47.5 5.57 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.343 -0.848 . . . . 0.0 111.401 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.4 -21.07 61.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.188 . . . . 0.0 112.61 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -65.38 -24.95 67.36 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.726 -1.234 . . . . 0.0 113.42 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -129.92 78.78 1.87 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.044 1.338 . . . . 0.0 110.345 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.584 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.56 150.26 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.156 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.52 128.42 44.25 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 159.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.75 116.34 28.93 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.7 m -135.02 128.17 31.85 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.718 1.207 . . . . 0.0 109.679 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -139.65 156.56 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.421 1.488 . . . . 0.0 111.303 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 127.431 2.293 . . . . 0.0 110.003 -175.76 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -51.3 -42.74 61.38 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 126.837 2.055 . . . . 0.0 113.629 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.72 -17.5 67.91 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.393 1.473 . . . . 0.0 113.711 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.76 -30.27 51.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.794 1.297 . . . . 0.0 112.444 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -57.87 -29.0 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.098 -1.002 . . . . 0.0 111.065 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -79.16 -58.04 3.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.832 1.253 . . . . 0.0 110.161 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.36 -34.33 73.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.303 1.041 . . . . 0.0 112.56 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -72.73 -34.01 66.78 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.06 1.344 . . . . 0.0 111.984 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -70.64 -36.75 73.57 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.436 0.562 . . . . 0.0 111.378 172.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.01 -44.25 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.065 0.946 . . . . 0.0 111.333 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -12.04 59.9 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.083 0.953 . . . . 0.0 113.257 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -57.23 -37.14 71.81 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 161.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -79.96 -49.25 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.625 0.726 . . . . 0.0 109.897 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 mt -89.0 75.33 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 123.341 1.543 . . . . 0.0 111.604 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.01 25.87 0.08 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.35 1.46 . . . . 0.0 114.729 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.99 -61.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.43 0.692 . . . . 0.0 112.408 -159.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 74.24 -47.66 0.64 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.732 2.413 . . . . 0.0 113.321 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.84 -28.43 68.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.967 1.307 . . . . 0.0 112.95 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -90.44 -3.41 57.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.927 1.691 . . . . 0.0 114.303 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -117.75 -29.83 5.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 113.726 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -92.59 164.82 13.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.975 1.31 . . . . 0.0 111.925 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.93 -42.61 2.52 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 125.777 1.656 . . . . 0.0 113.932 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -175.36 5.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.267 1.427 . . . . 0.0 111.438 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 162.46 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.615 -0.678 . . . . 0.0 111.315 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.8 t -157.99 146.16 18.79 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.636 1.175 . . . . 0.0 110.092 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 131.59 48.94 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.149 1.38 . . . . 0.0 111.123 164.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -144.01 171.88 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 120.781 -1.2 . . . . 0.0 108.175 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.72 132.31 40.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.346 -0.846 . . . . 0.0 112.176 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.12 131.08 54.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.938 0.895 . . . . 0.0 109.464 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.08 112.48 24.14 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.07 0.948 . . . . 0.0 109.49 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -104.14 159.22 15.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 111.204 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.8 pt -96.15 150.19 36.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 110.381 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.39 146.29 50.04 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.646 2.231 . . . . 0.0 110.247 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -165.21 147.33 7.82 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.561 1.944 . . . . 0.0 108.359 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.62 -18.59 72.17 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 124.444 1.021 . . . . 0.0 115.599 -168.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -94.13 3.16 55.67 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.409 1.884 . . . . 0.0 113.175 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.34 165.97 14.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.96 1.743 . . . . 0.0 111.335 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.56 159.26 22.12 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.001 0.901 . . . . 0.0 111.321 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -127.88 144.07 51.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.07 1.348 . . . . 0.0 111.182 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.27 113.7 2.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.623 0.647 . . . . 0.0 112.481 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.24 -43.05 2.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.676 1.608 . . . . 0.0 111.41 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -154.51 150.33 27.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.944 0.898 . . . . 0.0 111.434 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.37 131.02 53.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.526 1.131 . . . . 0.0 109.706 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -119.63 119.6 34.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.695 1.598 . . . . 0.0 108.694 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.16 137.23 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.053 0.842 . . . . 0.0 109.929 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -109.65 -50.37 2.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.144 0.578 . . . . 0.0 110.004 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -173.7 170.36 4.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.994 1.718 . . . . 0.0 111.78 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.63 32.73 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 125.326 1.441 . . . . 0.0 113.171 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.96 113.65 20.01 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -58.35 -19.94 39.42 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -153.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -49.61 -37.77 29.19 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.91 1.284 . . . . 0.0 112.681 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.11 -52.17 8.56 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.217 0.917 . . . . 0.0 110.722 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.2 m -46.46 -44.84 17.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.061 1.344 . . . . 0.0 113.421 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.38 82.73 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.925 0.89 . . . . 0.0 112.678 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.91 19.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.579 1.152 . . . . 0.0 112.83 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.0 t -57.37 -46.1 83.71 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.588 0.755 . . . . 0.0 110.617 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -50.29 -42.19 52.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.482 1.913 . . . . 0.0 111.723 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -69.78 -48.53 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.78 80.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.62 1.168 . . . . 0.0 111.693 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.69 -24.32 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.875 -1.141 . . . . 0.0 111.918 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.74 55.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.859 0.864 . . . . 0.0 112.869 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -11.27 2.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.4 m -58.07 148.99 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.415 1.086 . . . . 0.0 112.776 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -70.51 -47.91 58.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 113.099 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 p 170.73 145.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.186 2.194 . . . . 0.0 110.355 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 43.7 m-85 -96.62 108.49 42.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 117.771 -1.109 . . . . 0.0 110.363 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.13 136.28 19.94 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.248 1.965 . . . . 0.0 110.37 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.53 152.91 64.62 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.449 0.7 . . . . 0.0 112.329 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.46 -41.83 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.007 2.471 . . . . 0.0 110.277 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.47 149.28 50.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.023 2.129 . . . . 0.0 109.699 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.37 9.25 19.78 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -164.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.86 144.57 60.08 Favored Pre-proline 0 CA--C 1.539 0.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.98 -2.7 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.324 2.683 . . . . 0.0 113.584 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.863 0.865 . . . . 0.0 112.519 168.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.76 -26.39 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.664 1.186 . . . . 0.0 112.654 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.38 -25.65 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.059 0.944 . . . . 0.0 111.028 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -83.12 -9.1 59.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.897 1.279 . . . . 0.0 113.995 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -42.43 6.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.068 . . . . 0.0 111.693 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.8 pp -74.71 -20.13 59.97 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 124.867 1.267 . . . . 0.0 112.93 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -66.39 -25.56 66.84 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 113.163 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -128.82 81.96 2.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.031 0.932 . . . . 0.0 109.892 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.555 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.56 150.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 111.75 -178.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.73 130.86 35.94 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 153.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -85.3 129.09 34.88 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 157.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.0 m -146.15 127.07 14.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.82 157.25 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.335 1.454 . . . . 0.0 111.127 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.248 0 C-N-CA 126.272 1.829 . . . . 0.0 113.642 -179.389 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.9 mmp_? . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -54.38 -49.89 68.8 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.983 2.513 . . . . 0.0 113.915 -162.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.98 -15.43 65.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.969 1.747 . . . . 0.0 114.097 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.14 -30.4 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.647 1.223 . . . . 0.0 111.609 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.2 pt -62.62 -28.49 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.513 -1.367 . . . . 0.0 111.621 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.47 -57.06 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.924 1.289 . . . . 0.0 110.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -57.44 -36.04 70.88 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.064 0.946 . . . . 0.0 111.86 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.85 -38.03 82.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.929 1.292 . . . . 0.0 111.898 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 tp -76.52 -28.22 56.3 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.02 -54.42 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -25.56 67.69 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.278 0.631 . . . . 0.0 111.45 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.02 -14.54 61.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.66 -33.85 35.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.472 1.033 . . . . 0.0 113.172 165.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.89 110.06 22.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.778 1.231 . . . . 0.0 111.47 -158.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.0 24.85 8.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.977 1.311 . . . . 0.0 114.14 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.8 -58.79 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.507 0.723 . . . . 0.0 112.12 -165.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 71.44 -64.11 0.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.612 2.365 . . . . 0.0 113.346 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -64.63 -35.34 80.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.761 1.225 . . . . 0.0 112.833 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -91.13 6.88 43.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.441 1.097 . . . . 0.0 113.448 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -104.29 -9.73 18.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.062 1.745 . . . . 0.0 112.491 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -114.58 159.43 20.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.004 1.722 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.348 1.451 . . . . 0.0 114.477 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 178.91 8.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.361 1.864 . . . . 0.0 112.354 -174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.17 19.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.294 1.037 . . . . 0.0 110.613 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.12 143.5 21.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.493 1.117 . . . . 0.0 110.768 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 129.56 46.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 110.403 163.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.87 172.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.14 131.18 30.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.705 -0.622 . . . . 0.0 112.345 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.84 130.19 51.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.161 0.984 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -114.19 105.11 12.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 109.214 171.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.43 157.6 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.736 0.779 . . . . 0.0 112.2 -176.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.32 151.96 37.61 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 125.389 1.476 . . . . 0.0 110.488 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -72.37 147.83 47.72 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.264 2.643 . . . . 0.0 111.19 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -165.59 149.59 8.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.273 2.229 . . . . 0.0 108.493 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.87 -16.41 70.3 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.4 p -94.3 -4.84 47.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.215 1.806 . . . . 0.0 113.477 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.73 170.58 12.93 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.344 1.449 . . . . 0.0 111.755 -166.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -66.37 160.0 25.63 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.568 1.184 . . . . 0.0 111.323 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.07 145.96 51.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.147 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.99 109.85 1.19 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.172 0.589 . . . . 0.0 111.518 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.8 -47.34 3.44 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 125.204 1.383 . . . . 0.0 110.886 170.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 m -155.18 150.89 27.54 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.866 1.266 . . . . 0.0 111.218 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.4 129.08 49.15 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.833 1.253 . . . . 0.0 109.39 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 m -115.18 118.85 34.5 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.209 1.804 . . . . 0.0 108.093 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -81.87 134.63 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.286 0.948 . . . . 0.0 109.757 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.22 -48.93 3.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.213 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -171.21 170.26 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.525 1.53 . . . . 0.0 111.868 171.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.79 -178.93 29.65 Favored Glycine 0 N--CA 1.462 0.396 0 C-N-CA 125.314 1.435 . . . . 0.0 113.554 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.46 113.85 21.5 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 167.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -63.84 -17.58 63.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -149.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -56.17 -33.45 65.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.767 0.827 . . . . 0.0 112.225 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.86 -46.62 18.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.796 -1.097 . . . . 0.0 111.397 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -47.16 -46.08 23.24 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.773 1.229 . . . . 0.0 113.027 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.75 89.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.768 0.827 . . . . 0.0 112.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.76 -52.36 31.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 112.708 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.3 t -57.76 -48.25 80.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.586 0.755 . . . . 0.0 111.197 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -50.23 -44.71 53.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.469 1.508 . . . . 0.0 111.472 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.79 -45.06 65.37 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.697 0.799 . . . . 0.0 112.56 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.25 -49.76 75.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.385 1.074 . . . . 0.0 111.881 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.3 t -67.65 -22.8 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.828 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.4 -6.94 58.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 112.639 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -12.2 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.8 m -58.14 147.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.023 0.929 . . . . 0.0 112.35 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -71.61 -47.56 53.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p 171.14 142.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.723 2.009 . . . . 0.0 111.213 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.8 m-85 -94.67 108.61 38.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.423 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 130.05 14.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.341 2.028 . . . . 0.0 110.111 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.04 148.29 74.84 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.491 0.716 . . . . 0.0 111.751 -171.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.98 -36.1 4.73 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.535 2.157 . . . . 0.0 110.879 168.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 153.51 41.31 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.439 2.295 . . . . 0.0 109.948 176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.15 8.56 19.98 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -165.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.16 144.38 62.74 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 118.988 0.813 . . . . 0.0 110.004 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.81 -4.01 6.6 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.424 2.749 . . . . 0.0 113.696 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.72 -38.26 19.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.98 0.809 . . . . 0.0 112.159 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.61 -26.66 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.225 1.01 . . . . 0.0 112.715 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -26.99 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.124 0.969 . . . . 0.0 110.906 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -78.72 -13.17 59.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.01 1.324 . . . . 0.0 113.222 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.06 -42.33 7.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.672 0.789 . . . . 0.0 111.71 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.39 -23.23 60.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.828 0.851 . . . . 0.0 112.488 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -68.96 -23.31 64.12 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.743 -1.223 . . . . 0.0 113.946 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -128.29 84.08 2.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.134 0.974 . . . . 0.0 110.057 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.544 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -112.11 155.31 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.479 1.111 . . . . 0.0 112.215 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -91.41 136.21 33.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 156.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.63 118.14 29.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 154.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -135.9 130.25 33.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.39 146.25 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.734 2.414 . . . . 0.0 108.493 -165.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 125.241 1.417 . . . . 0.0 111.628 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 120.342 0.115 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -63.82 -17.99 63.66 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.002 2.121 . . . . 0.0 116.057 -162.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.74 -13.35 11.45 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.923 2.201 . . . . 0.0 114.124 166.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.83 -30.17 40.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.117 1.367 . . . . 0.0 111.797 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -62.31 -27.77 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 120.646 -1.284 . . . . 0.0 111.946 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -80.01 -56.53 4.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.286 1.434 . . . . 0.0 110.682 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -58.11 -34.48 70.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.938 0.895 . . . . 0.0 112.01 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -67.92 -40.2 83.43 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.679 1.191 . . . . 0.0 110.881 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.36 -28.76 61.27 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.504 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.0 -54.12 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 110.441 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -23.29 67.29 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.043 0.537 . . . . 0.0 112.153 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.02 -15.6 60.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -79.73 -39.9 30.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.845 1.202 . . . . 0.0 111.882 163.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.0 83.35 3.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.557 1.646 . . . . 0.0 112.243 -160.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 28.93 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.774 1.63 . . . . 0.0 114.232 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.71 -62.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.434 -0.791 . . . . 0.0 112.093 -163.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 72.54 -62.64 0.46 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.309 2.243 . . . . 0.0 113.51 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.12 -37.39 87.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.257 1.423 . . . . 0.0 112.554 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.2 m -85.56 -1.78 57.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 14.1 m-30 -103.96 -22.64 13.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.983 1.713 . . . . 0.0 113.279 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 152.66 19.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.179 1.392 . . . . 0.0 112.911 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.6 2.16 90.6 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.083 1.325 . . . . 0.0 114.29 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -143.77 177.77 8.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.115 1.766 . . . . 0.0 112.267 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.59 160.48 25.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.826 1.25 . . . . 0.0 110.099 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 45.1 t -153.62 144.13 22.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.216 1.007 . . . . 0.0 110.215 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.48 127.76 38.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.293 1.437 . . . . 0.0 111.134 171.206 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.21 172.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.367 1.067 . . . . 0.0 108.335 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -137.02 131.67 33.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.588 0.755 . . . . 0.0 112.113 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -103.04 134.26 46.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.007 0.923 . . . . 0.0 110.38 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -118.09 103.47 9.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.187 1.395 . . . . 0.0 108.849 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.29 158.46 15.69 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.917 0.865 . . . . 0.0 112.149 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 pt -99.03 148.75 35.01 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.581 1.552 . . . . 0.0 110.183 166.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.56 147.92 41.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.302 2.668 . . . . 0.0 110.857 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -166.67 146.56 5.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.273 2.229 . . . . 0.0 108.479 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.95 -21.45 75.32 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.564 0.986 . . . . 0.0 115.564 -166.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -89.39 -5.22 57.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.979 1.712 . . . . 0.0 113.183 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.79 162.49 10.84 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.891 1.71 . . . . 0.0 111.421 -169.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -63.74 160.69 16.61 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 117.789 0.794 . . . . 0.0 111.596 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.84 143.32 50.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.332 1.453 . . . . 0.0 110.91 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.98 109.34 1.05 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.44 0.696 . . . . 0.0 111.623 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.92 -36.51 5.23 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.537 1.542 . . . . 0.0 111.925 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -163.85 155.68 16.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 111.127 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.43 129.94 39.94 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.091 1.357 . . . . 0.0 109.92 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.3 m -115.81 119.15 35.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.923 2.089 . . . . 0.0 108.448 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.0 137.1 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.098 0.863 . . . . 0.0 110.164 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.39 -47.37 3.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.933 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 24.2 t0 -174.12 166.77 4.2 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.998 2.119 . . . . 0.0 111.217 169.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.28 164.5 27.9 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.083 -1.011 . . . . 0.0 114.15 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.37 178.94 4.89 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.945 0.898 . . . . 0.0 110.363 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 t -30.24 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.73 2.412 . . . . 0.0 115.517 -162.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 31.6 mtm105 70.44 -1.21 2.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.199 2.2 . . . . 0.0 116.378 162.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.26 -46.58 70.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 122.429 2.377 . . . . 0.0 112.171 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.29 -28.08 51.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 166.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.18 -35.47 41.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.377 0.989 . . . . 0.0 112.382 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -51.02 15.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.63 1.572 . . . . 0.0 112.498 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -55.48 -48.9 73.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.854 0.861 . . . . 0.0 111.196 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -51.3 -44.7 61.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.786 1.634 . . . . 0.0 111.469 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -69.19 -44.55 71.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.028 0.931 . . . . 0.0 113.385 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.51 76.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.57 1.148 . . . . 0.0 111.48 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.4 t -67.9 -21.22 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.69 -1.256 . . . . 0.0 112.236 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.97 -6.92 59.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.066 0.947 . . . . 0.0 112.187 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 -12.73 4.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.7 m -58.14 146.05 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-N 119.394 0.997 . . . . 0.0 111.975 168.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -72.45 -46.12 56.46 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.1 p 172.78 141.94 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.36 1.864 . . . . 0.0 110.911 -168.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -94.37 106.74 25.01 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.292 1.037 . . . . 0.0 111.193 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.79 118.34 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.295 1.997 . . . . 0.0 109.968 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.03 148.71 37.42 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.461 1.104 . . . . 0.0 112.367 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.11 -29.93 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.924 2.416 . . . . 0.0 112.313 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -138.56 148.67 44.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.947 1.699 . . . . 0.0 110.495 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -120.66 22.0 11.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.555 1.542 . . . . 0.0 113.284 -167.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.8 142.17 32.26 Favored Pre-proline 0 C--O 1.242 0.668 0 O-C-N 120.627 -1.295 . . . . 0.0 110.731 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.02 -7.05 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 124.14 3.226 . . . . 0.0 116.177 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -87.95 -41.57 13.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.881 1.219 . . . . 0.0 112.343 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -92.57 -25.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.529 1.532 . . . . 0.0 113.365 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.49 -29.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.939 0.79 . . . . 0.0 110.935 170.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 33.0 mm-40 -77.0 -8.07 56.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.319 1.047 . . . . 0.0 113.766 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.38 -48.22 5.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.356 0.663 . . . . 0.0 112.203 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.8 -28.07 68.73 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.13 0.972 . . . . 0.0 112.679 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.428 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -72.51 -23.79 61.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.44 -1.413 . . . . 0.0 114.003 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -121.74 88.99 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.331 1.052 . . . . 0.0 111.086 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.499 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.63 156.34 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.435 1.094 . . . . 0.0 112.614 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -92.71 137.52 32.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.093 -0.379 . . . . 0.0 110.278 156.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.7 mt -91.4 112.91 25.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 153.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.8 m -134.83 125.43 26.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.916 0.887 . . . . 0.0 108.835 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.32 153.16 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.588 1.555 . . . . 0.0 110.734 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 125.466 1.506 . . . . 0.0 111.992 -175.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -51.02 -47.16 61.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 128.276 2.63 . . . . 0.0 113.699 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.95 -15.86 66.5 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.246 1.403 . . . . 0.0 113.366 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -75.73 -32.75 60.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 1.119 . . . . 0.0 111.719 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -59.67 -27.01 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.9 0.773 . . . . 0.0 111.916 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -82.09 -58.64 2.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.122 1.369 . . . . 0.0 110.362 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.69 -33.4 72.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.003 0.921 . . . . 0.0 112.852 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -73.37 -35.4 65.93 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.994 0.918 . . . . 0.0 110.795 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.9 tp -73.39 -31.58 63.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.754 0.707 . . . . 0.0 112.059 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -71.24 -48.29 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.287 0.635 . . . . 0.0 110.71 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -67.78 -19.0 65.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -57.51 -36.53 71.66 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.128 0.571 . . . . 0.0 111.329 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -78.24 -40.22 37.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.983 0.421 . . . . 0.0 112.098 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.72 88.4 3.81 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 123.149 1.452 . . . . 0.0 111.887 -163.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.96 31.02 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.338 -1.755 . . . . 0.0 113.781 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.68 -64.09 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.101 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 72.79 -63.84 0.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.892 2.077 . . . . 0.0 112.826 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.01 -45.33 61.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.667 1.187 . . . . 0.0 112.159 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.3 m -79.24 2.86 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.2 m-30 -93.87 -10.46 33.88 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.834 1.653 . . . . 0.0 111.761 166.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -114.35 171.31 7.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.049 2.139 . . . . 0.0 111.107 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.02 -21.59 3.29 Favored Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.807 1.194 . . . . 0.0 114.372 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.46 -175.16 3.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.171 2.589 . . . . 0.0 111.616 175.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 164.98 23.21 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.449 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.2 t -159.97 144.74 14.91 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.448 1.099 . . . . 0.0 110.142 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.59 130.14 46.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.512 164.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.88 170.4 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.275 1.03 . . . . 0.0 108.333 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.0 131.18 32.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.348 0.594 . . . . 0.0 111.738 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.13 132.85 45.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.967 0.907 . . . . 0.0 110.334 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -116.4 103.01 10.03 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 108.931 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -99.62 158.97 15.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.731 0.777 . . . . 0.0 111.906 -177.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.1 pt -100.13 136.79 20.02 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.453 1.501 . . . . 0.0 110.219 167.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.95 129.62 17.71 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.585 2.19 . . . . 0.0 109.832 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 m -142.86 88.58 2.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.271 1.428 . . . . 0.0 108.548 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 -122.49 28.03 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.895 0.759 . . . . 0.0 112.12 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -81.6 3.5 24.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.209 1.803 . . . . 0.0 113.842 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.18 -166.6 10.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.257 1.408 . . . . 0.0 114.377 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -124.33 165.47 17.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.205 1.402 . . . . 0.0 110.918 165.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.62 148.51 52.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.144 1.778 . . . . 0.0 111.153 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.56 111.88 1.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.009 0.822 . . . . 0.0 112.28 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.54 -35.06 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.78 1.657 . . . . 0.0 112.125 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -167.2 153.18 7.86 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.365 1.466 . . . . 0.0 110.998 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -127.91 129.38 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.428 1.091 . . . . 0.0 109.874 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.3 m -113.28 118.87 35.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.236 1.815 . . . . 0.0 108.536 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.74 130.9 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.903 0.774 . . . . 0.0 109.81 169.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -101.98 -46.92 4.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.108 0.563 . . . . 0.0 110.04 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -170.47 169.48 7.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.119 1.768 . . . . 0.0 111.515 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.11 179.07 23.79 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 124.887 1.232 . . . . 0.0 114.527 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.23 119.79 25.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.79 -17.66 37.36 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -159.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.71 65.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.679 1.191 . . . . 0.0 112.07 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.3 tp -88.85 -49.23 6.94 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.673 1.124 . . . . 0.0 111.562 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 m -47.81 -43.09 27.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.537 1.062 . . . . 0.0 113.539 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.08 73.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.082 0.856 . . . . 0.0 112.573 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.14 -52.25 25.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.424 1.09 . . . . 0.0 112.191 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.6 t -57.85 -49.37 76.89 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.104 0.962 . . . . 0.0 110.355 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -51.27 -45.8 62.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -66.41 -47.02 74.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.518 0.727 . . . . 0.0 112.845 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.06 75.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 111.414 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.77 -23.29 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.579 -1.326 . . . . 0.0 111.518 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.78 -6.84 58.09 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.369 -0.832 . . . . 0.0 112.396 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.09 -11.97 3.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.4 m -58.14 148.59 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.296 0.953 . . . . 0.0 112.55 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.48 -48.94 59.06 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 p 170.18 141.89 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.555 1.942 . . . . 0.0 111.414 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 10.5 m-85 -98.99 110.38 57.5 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.311 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.18 134.34 12.84 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.842 2.361 . . . . 0.0 111.009 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.48 148.36 66.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.047 -0.502 . . . . 0.0 112.272 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 -36.17 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.482 2.788 . . . . 0.0 111.935 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 153.25 47.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.439 2.296 . . . . 0.0 110.526 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.11 7.69 18.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -163.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.03 142.91 44.96 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.937 -1.102 . . . . 0.0 110.431 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.34 0.35 2.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.807 3.005 . . . . 0.0 113.642 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.91 -38.72 17.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.927 0.891 . . . . 0.0 111.834 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 m -96.07 -26.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.571 1.148 . . . . 0.0 112.613 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.8 -28.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.435 1.094 . . . . 0.0 110.994 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -84.06 -5.44 59.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.237 1.015 . . . . 0.0 113.636 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -98.49 -51.36 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.013 -1.054 . . . . 0.0 111.192 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.98 -20.48 65.89 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.824 1.25 . . . . 0.0 113.874 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -69.74 -23.57 63.41 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.014 -1.054 . . . . 0.0 112.819 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -125.27 83.29 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.115 1.766 . . . . 0.0 111.119 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.43 153.42 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.319 1.047 . . . . 0.0 112.092 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -95.19 137.12 34.67 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.88 0.371 . . . . 0.0 110.125 158.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.33 120.68 33.89 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 155.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -136.77 129.1 29.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.384 1.074 . . . . 0.0 109.222 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 164.95 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.171 1.788 . . . . 0.0 110.742 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 112.958 -175.317 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -49.33 -45.84 46.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.597 2.359 . . . . 0.0 114.064 -172.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.71 -18.4 60.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.738 1.637 . . . . 0.0 113.746 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.78 -32.51 63.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.375 1.088 . . . . 0.0 111.864 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -61.37 -27.07 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.125 -0.985 . . . . 0.0 112.347 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -82.37 -59.19 2.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 109.722 174.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.26 -35.33 73.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.034 0.934 . . . . 0.0 111.99 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -71.54 -41.75 68.75 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.968 0.907 . . . . 0.0 110.867 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.63 -25.91 65.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.539 0.609 . . . . 0.0 112.035 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.415 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.46 -55.59 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.187 0.995 . . . . 0.0 110.253 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -22.46 66.11 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.668 0.387 . . . . 0.0 111.594 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.51 -13.16 61.72 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.642 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -81.05 -36.69 30.18 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.947 1.248 . . . . 0.0 112.164 168.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 80.31 1.82 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.327 1.451 . . . . 0.0 109.821 -169.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 51.62 0.43 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.807 1.643 . . . . 0.0 112.492 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.66 -56.48 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 73.26 -51.71 0.7 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.063 2.545 . . . . 0.0 114.892 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.51 -31.75 32.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.382 1.473 . . . . 0.0 112.879 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -85.05 -13.38 50.61 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.836 0.854 . . . . 0.0 112.604 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -89.34 -8.17 53.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.014 1.326 . . . . 0.0 112.478 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -112.73 171.41 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.401 1.88 . . . . 0.0 113.099 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.3 -45.49 3.23 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.119 1.819 . . . . 0.0 112.371 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -170.89 3.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.61 1.564 . . . . 0.0 111.137 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.29 26.26 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.835 0.854 . . . . 0.0 110.985 168.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 38.8 t -151.61 145.04 24.82 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.691 1.196 . . . . 0.0 109.564 170.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.26 129.36 41.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.164 1.385 . . . . 0.0 110.615 170.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.69 172.07 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.87 1.268 . . . . 0.0 107.978 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -137.59 133.15 34.08 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.801 0.841 . . . . 0.0 111.722 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.98 140.35 36.39 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.387 0.675 . . . . 0.0 111.81 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -120.2 105.69 11.21 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.431 1.493 . . . . 0.0 108.92 170.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.74 159.37 15.24 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.397 -0.815 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.68 139.96 20.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.924 1.689 . . . . 0.0 109.821 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.67 137.3 58.32 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.507 2.138 . . . . 0.0 111.624 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -143.97 162.89 35.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.28 2.232 . . . . 0.0 107.918 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.02 -22.24 70.38 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.005 -1.059 . . . . 0.0 115.561 -171.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -94.97 -19.61 20.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.783 1.633 . . . . 0.0 112.734 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.37 -174.37 34.86 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.649 2.071 . . . . 0.0 111.007 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -73.45 160.35 31.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.216 2.008 . . . . 0.0 110.15 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -132.43 143.7 49.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.304 1.442 . . . . 0.0 111.527 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.57 108.44 0.56 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.996 0.919 . . . . 0.0 112.261 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.51 -35.82 5.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.673 1.606 . . . . 0.0 111.632 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -166.01 150.04 7.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.901 1.28 . . . . 0.0 111.13 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.7 tt -123.07 130.44 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.955 1.702 . . . . 0.0 109.319 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -114.44 118.68 34.49 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.6 1.56 . . . . 0.0 108.358 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 m -83.63 136.19 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.803 0.729 . . . . 0.0 109.88 168.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.73 -45.79 3.77 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.3 0.64 . . . . 0.0 110.151 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -172.48 167.51 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.102 1.761 . . . . 0.0 111.348 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.83 170.11 36.17 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.526 -0.734 . . . . 0.0 114.552 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.36 -177.53 4.01 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.826 1.25 . . . . 0.0 111.047 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.259 59.3 p 51.52 -97.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.385 2.274 . . . . 0.0 113.018 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.33 -4.27 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 113.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -64.08 -43.91 93.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.926 1.694 . . . . 0.0 113.01 -157.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.0 p -56.95 -27.64 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.74 -40.73 13.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.799 1.239 . . . . 0.0 112.155 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.36 -53.74 50.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.77 1.228 . . . . 0.0 111.998 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 t -52.75 -46.65 67.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.894 0.878 . . . . 0.0 110.537 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.88 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.38 1.072 . . . . 0.0 113.438 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -73.35 -43.37 60.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.73 76.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.736 1.214 . . . . 0.0 112.024 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.86 -23.38 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.533 -1.354 . . . . 0.0 112.09 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.82 -6.96 55.9 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.35 -0.844 . . . . 0.0 112.727 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -11.95 2.46 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.6 m -58.15 147.82 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.712 1.205 . . . . 0.0 112.734 171.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -75.3 -39.08 59.96 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 p 165.23 141.23 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 127.491 2.316 . . . . 0.0 111.501 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.04 112.26 57.68 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.269 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.44 120.7 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.306 2.004 . . . . 0.0 110.047 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 138.58 25.99 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.65 1.18 . . . . 0.0 111.743 -176.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.24 -47.58 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.421 2.748 . . . . 0.0 111.916 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -103.46 147.41 27.17 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.304 1.442 . . . . 0.0 110.868 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.31 12.79 11.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.874 1.27 . . . . 0.0 113.564 -163.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -78.88 140.56 58.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 O-C-N 120.825 -1.172 . . . . 0.0 109.392 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.87 -4.69 7.74 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.047 2.498 . . . . 0.0 113.419 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.43 -31.87 24.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.726 0.694 . . . . 0.0 112.403 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.97 -24.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.04 -28.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.264 1.026 . . . . 0.0 110.731 166.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.28 -9.86 59.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.501 1.52 . . . . 0.0 113.791 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.77 -43.83 5.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.279 1.032 . . . . 0.0 112.198 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -71.55 -22.33 61.77 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.973 0.909 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -65.5 -22.95 66.78 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.63 -1.294 . . . . 0.0 113.918 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -123.74 80.12 1.77 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.41 1.084 . . . . 0.0 110.301 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.99 151.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.961 0.905 . . . . 0.0 111.83 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.3 128.04 41.82 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 159.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.05 111.18 21.85 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 160.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.8 m -135.45 123.94 23.49 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.589 1.155 . . . . 0.0 108.502 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.36 148.37 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.696 1.198 . . . . 0.0 111.175 -169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.397 0 C-N-CA 126.241 1.816 . . . . 0.0 114.388 175.327 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.61 -39.61 80.92 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 128.034 2.534 . . . . 0.0 113.761 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.78 63.73 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.377 1.465 . . . . 0.0 114.009 169.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.12 -26.12 56.06 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.867 1.333 . . . . 0.0 112.065 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.18 -30.0 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.333 -1.479 . . . . 0.0 111.634 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -77.8 -55.22 5.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.129 1.372 . . . . 0.0 110.095 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -57.33 -34.89 69.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.878 0.871 . . . . 0.0 112.297 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.64 -30.49 65.81 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.227 1.411 . . . . 0.0 112.628 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp -82.12 -31.48 30.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.674 0.67 . . . . 0.0 112.353 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -68.74 -46.86 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.761 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -21.76 66.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.284 1.034 . . . . 0.0 112.98 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -59.65 -36.73 77.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.516 0.727 . . . . 0.0 110.791 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -78.35 -45.42 22.6 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 0.0 111.162 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.99 74.28 4.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 123.456 1.598 . . . . 0.0 112.298 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.03 29.06 0.06 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 113.791 -1.549 . . . . 0.0 114.048 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.6 -71.09 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 -163.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 74.15 -48.24 0.66 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.568 2.347 . . . . 0.0 114.119 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.26 -38.23 88.47 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.296 -1.503 . . . . 0.0 113.16 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.9 p -91.36 0.05 57.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.343 1.057 . . . . 0.0 113.662 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.568 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.7 m-30 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.543 1.537 . . . . 0.0 111.384 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -110.68 156.12 21.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.776 2.03 . . . . 0.0 111.223 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.12 -25.94 4.59 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.101 1.334 . . . . 0.0 113.795 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -106.29 -172.68 2.13 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.831 2.052 . . . . 0.0 110.741 167.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 164.31 28.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.273 1.029 . . . . 0.0 110.345 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.58 157.64 43.45 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.441 -0.787 . . . . 0.0 111.463 160.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.2 126.21 29.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.146 1.379 . . . . 0.0 110.069 162.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.59 166.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -135.58 131.72 36.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.042 0.837 . . . . 0.0 111.965 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.55 131.93 48.95 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.339 1.055 . . . . 0.0 110.164 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -113.52 107.71 16.18 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.318 1.447 . . . . 0.0 109.018 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.35 159.72 15.03 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.31 -0.869 . . . . 0.0 111.945 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 pt -102.34 148.38 35.35 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.987 1.715 . . . . 0.0 109.615 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.4 137.78 28.78 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.221 1.947 . . . . 0.0 110.08 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 m -148.66 93.92 2.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.115 1.366 . . . . 0.0 109.267 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.81 -113.66 5.81 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.82 0.724 . . . . 0.0 112.612 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.2 p -83.36 -2.79 56.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.755 2.022 . . . . 0.0 114.024 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.97 -164.85 11.34 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.585 1.084 . . . . 0.0 114.297 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -111.38 165.23 12.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.351 1.06 . . . . 0.0 110.649 165.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp -132.79 146.89 52.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.451 1.901 . . . . 0.0 111.666 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.05 111.63 1.77 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.53 0.732 . . . . 0.0 112.245 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.91 -34.22 5.52 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.387 1.47 . . . . 0.0 112.032 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.47 154.28 11.9 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.455 1.502 . . . . 0.0 110.994 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.82 128.44 34.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.509 1.124 . . . . 0.0 109.94 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 m -110.9 138.5 47.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.72 2.008 . . . . 0.0 108.349 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.72 133.8 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.781 0.719 . . . . 0.0 109.233 165.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -102.16 -42.92 5.89 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.479 0.712 . . . . 0.0 109.915 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -173.17 169.19 4.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.371 1.868 . . . . 0.0 111.476 171.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.18 -178.74 28.38 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 124.729 1.157 . . . . 0.0 114.509 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.4 116.64 26.77 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 m -58.68 -18.92 35.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -157.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -32.71 71.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.644 0.778 . . . . 0.0 112.564 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 tp -82.51 -46.83 12.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.62 1.1 . . . . 0.0 111.086 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.9 m -51.59 -42.92 62.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.382 0.992 . . . . 0.0 113.149 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.89 79.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.968 0.907 . . . . 0.0 112.364 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.2 58.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.541 0.737 . . . . 0.0 112.462 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 8.7 t -59.58 -47.68 84.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.652 0.781 . . . . 0.0 110.892 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -52.68 -42.42 64.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 111.138 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.25 -47.27 62.07 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.716 0.806 . . . . 0.0 112.914 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.97 78.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' THR . 2.9 t -66.87 -23.1 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.719 -1.238 . . . . 0.0 111.516 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.26 -6.71 59.17 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.46 -0.775 . . . . 0.0 112.676 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.89 -11.84 3.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.6 m -57.79 145.11 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.148 0.979 . . . . 0.0 112.597 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.31 -41.28 81.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.6 p 166.04 144.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.437 2.695 . . . . 0.0 110.102 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -92.51 110.45 45.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.505 -1.236 . . . . 0.0 109.77 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.65 134.8 20.85 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.898 1.732 . . . . 0.0 109.831 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.24 148.35 70.78 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.073 0.549 . . . . 0.0 111.601 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.07 -33.36 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.745 2.297 . . . . 0.0 111.283 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 159.81 42.0 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.383 2.273 . . . . 0.0 109.808 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -125.98 31.3 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.756 1.222 . . . . 0.0 113.205 -160.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -100.0 144.5 28.5 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.108 -0.995 . . . . 0.0 110.365 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.48 -9.2 17.1 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.337 2.691 . . . . 0.0 113.417 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.06 -35.59 31.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.643 0.777 . . . . 0.0 112.11 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.52 -25.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.46 1.104 . . . . 0.0 112.473 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.44 -28.54 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 118.578 0.626 . . . . 0.0 110.915 168.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.3 mm-40 -78.89 -9.57 59.53 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.17 -46.88 6.59 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.61 0.719 . . . . 0.0 112.008 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.26 -26.36 65.63 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.168 0.987 . . . . 0.0 112.438 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -71.51 -25.35 62.21 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.415 -1.428 . . . . 0.0 113.168 -175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.36 90.48 3.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 110.483 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.77 152.87 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.642 1.177 . . . . 0.0 112.525 178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -93.84 132.69 38.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.985 157.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.2 mt -91.27 117.32 29.54 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 156.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.9 m -135.31 128.28 31.48 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.1 155.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.405 1.482 . . . . 0.0 110.811 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.064 0 C-N-CA 125.91 1.684 . . . . 0.0 111.355 -178.39 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 121.027 0.442 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.88 -43.52 73.25 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 127.389 2.276 . . . . 0.0 113.212 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.46 -18.47 68.61 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.213 0.911 . . . . 0.0 113.44 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.93 -33.4 68.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.277 1.038 . . . . 0.0 111.592 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.5 pt -61.3 -28.13 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 120.953 -1.092 . . . . 0.0 111.889 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -80.56 -58.24 3.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.877 1.271 . . . . 0.0 109.581 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.13 -34.84 74.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 112.673 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -74.36 -28.11 60.98 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.772 1.229 . . . . 0.0 112.353 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.9 tp -76.4 -33.34 58.86 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.199 0.909 . . . . 0.0 111.684 171.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.11 -44.38 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.865 -1.147 . . . . 0.0 110.964 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.14 -13.6 61.6 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.262 1.025 . . . . 0.0 112.745 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.06 -38.38 73.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -80.14 -37.39 33.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 0.0 111.989 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -99.49 103.9 15.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.62 1.2 . . . . 0.0 110.828 -164.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.94 20.71 7.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.98 -52.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.053 0.541 . . . . 0.0 112.237 -160.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 70.64 -62.55 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.867 2.467 . . . . 0.0 113.921 168.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.41 -35.41 80.34 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.635 -1.29 . . . . 0.0 111.946 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -77.09 -0.78 26.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -112.78 -12.49 13.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.612 1.965 . . . . 0.0 111.949 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -109.17 154.5 22.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 112.281 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.58 90.43 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.76 1.171 . . . . 0.0 114.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -178.61 5.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.747 2.019 . . . . 0.0 111.682 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.87 162.95 20.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.978 0.911 . . . . 0.0 110.462 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -157.4 147.2 20.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.446 1.099 . . . . 0.0 110.141 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.3 128.47 43.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.142 1.777 . . . . 0.0 110.372 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.17 167.42 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.58 1.152 . . . . 0.0 108.048 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -131.8 132.28 43.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.786 0.721 . . . . 0.0 111.95 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.68 130.13 49.5 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.139 0.975 . . . . 0.0 109.593 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -111.68 107.06 16.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.464 1.106 . . . . 0.0 109.227 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -100.02 158.69 15.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.913 0.863 . . . . 0.0 111.603 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -102.8 152.17 38.43 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.973 1.709 . . . . 0.0 110.506 168.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.05 147.27 29.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.143 2.562 . . . . 0.0 111.038 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -156.1 161.62 40.35 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.852 2.461 . . . . 0.0 108.338 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.3 -13.2 59.88 Favored Glycine 0 CA--C 1.54 1.649 0 O-C-N 120.737 -1.227 . . . . 0.0 115.187 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.9 p -99.77 -3.36 32.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.107 2.163 . . . . 0.0 113.919 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.97 -151.83 16.9 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.371 1.462 . . . . 0.0 111.078 -167.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -90.39 157.0 17.83 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.054 1.427 . . . . 0.0 111.949 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.0 144.45 51.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.269 1.828 . . . . 0.0 111.237 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.32 113.5 2.2 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.907 0.776 . . . . 0.0 112.182 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.81 4.69 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.68 1.61 . . . . 0.0 111.974 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.05 152.11 9.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.649 1.579 . . . . 0.0 111.295 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.37 134.29 49.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.247 1.019 . . . . 0.0 109.653 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.8 m -117.38 120.45 38.22 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.615 1.966 . . . . 0.0 108.707 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.23 133.97 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.312 0.96 . . . . 0.0 109.796 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -106.07 -49.93 3.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.298 0.639 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -173.03 170.23 4.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.166 1.786 . . . . 0.0 111.942 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.82 -175.21 32.97 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 125.054 1.311 . . . . 0.0 113.176 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.58 110.57 17.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 164.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 m -58.67 -17.91 26.44 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -52.45 -37.37 56.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.798 1.239 . . . . 0.0 112.357 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.19 -48.07 14.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.005 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -48.51 -46.22 38.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.565 1.146 . . . . 0.0 113.138 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.4 84.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.811 0.844 . . . . 0.0 112.296 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.22 23.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 112.629 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -57.44 -49.4 76.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.863 0.865 . . . . 0.0 110.508 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.29 -46.68 55.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.878 1.671 . . . . 0.0 111.258 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.9 -44.09 77.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.591 0.757 . . . . 0.0 112.833 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.78 -48.96 79.42 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.631 1.172 . . . . 0.0 112.173 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -65.5 -23.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.645 -1.284 . . . . 0.0 111.496 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.59 -6.63 57.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.689 0.796 . . . . 0.0 112.668 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -12.0 3.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.454 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 15.0 m -59.95 148.64 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.185 0.902 . . . . 0.0 112.456 171.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -71.33 -48.5 50.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 p 174.77 142.11 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.223 1.809 . . . . 0.0 111.884 -169.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.2 m-85 -97.19 109.56 50.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 110.148 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.03 131.37 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.733 2.289 . . . . 0.0 110.417 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.83 150.83 75.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.573 0.749 . . . . 0.0 111.513 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.99 -40.84 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.321 2.014 . . . . 0.0 110.787 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -120.05 176.27 5.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.444 2.297 . . . . 0.0 111.278 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -152.64 49.43 0.75 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -112.83 135.66 21.63 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.11 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.73 -12.53 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.18 3.253 . . . . 0.0 115.585 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.0 -35.46 28.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 112.159 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -96.69 -24.16 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.209 1.004 . . . . 0.0 113.026 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.2 -25.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.592 0.757 . . . . 0.0 110.662 167.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -83.39 -7.77 59.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.03 -48.67 5.59 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.133 -0.98 . . . . 0.0 111.374 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.6 pp -69.68 -20.95 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.648 1.179 . . . . 0.0 112.959 -175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.64 -25.24 67.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.987 0.915 . . . . 0.0 113.449 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -129.99 77.23 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.219 1.008 . . . . 0.0 110.102 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.574 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.57 148.33 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 123.48 36.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 157.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -84.63 110.03 18.43 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 160.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.7 m -132.32 127.55 35.82 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.85 1.26 . . . . 0.0 108.512 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 151.46 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -169.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 125.649 1.58 . . . . 0.0 111.425 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.341 0.591 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -55.27 -43.08 74.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.298 2.239 . . . . 0.0 112.803 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.62 66.76 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.197 1.38 . . . . 0.0 114.066 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.582 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -72.09 -34.2 68.48 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.184 0.992 . . . . 0.0 111.608 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -60.59 -28.3 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.267 -0.896 . . . . 0.0 112.161 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.78 -58.44 3.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.114 1.366 . . . . 0.0 110.673 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.72 -36.84 74.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.49 1.116 . . . . 0.0 112.564 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -71.25 -32.58 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.701 1.2 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -76.05 -28.83 57.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.917 0.78 . . . . 0.0 112.271 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -75.27 -54.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.887 -1.133 . . . . 0.0 110.372 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -19.86 65.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.395 0.678 . . . . 0.0 112.495 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.17 -15.22 58.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -78.76 -39.88 34.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.23 0.923 . . . . 0.0 111.992 161.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.81 96.34 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 123.436 1.589 . . . . 0.0 111.587 -160.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.54 24.44 1.2 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.098 -173.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.87 -72.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.163 0.985 . . . . 0.0 111.33 -167.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 75.0 -52.62 0.67 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 113.489 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.5 -36.84 85.11 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.005 -1.059 . . . . 0.0 111.905 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -83.66 0.33 47.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 113.743 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -102.83 -25.05 13.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.01 1.724 . . . . 0.0 112.805 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -87.52 162.65 17.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.504 2.321 . . . . 0.0 111.539 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.7 -5.36 69.95 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.788 1.185 . . . . 0.0 114.789 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 -173.89 4.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.277 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.61 162.05 25.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.766 0.826 . . . . 0.0 110.675 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.442 ' HB3' HD23 ' A' ' 85' ' ' LEU . 40.5 t -153.84 144.0 22.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.749 1.22 . . . . 0.0 110.381 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 130.55 48.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.729 1.212 . . . . 0.0 110.953 164.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.65 176.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.61 126.37 17.05 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.729 0.812 . . . . 0.0 110.572 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.69 131.4 52.18 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.94 0.896 . . . . 0.0 109.72 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -119.39 106.4 12.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 108.936 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.17 162.27 13.15 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.117 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.13 150.41 44.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.482 1.113 . . . . 0.0 110.677 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.31 134.19 17.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.668 2.245 . . . . 0.0 110.618 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -118.66 -33.73 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.252 1.421 . . . . 0.0 111.635 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.27 -121.84 0.8 Allowed Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.515 1.531 . . . . 0.0 111.274 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 p -63.69 -14.57 53.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.17 0.988 . . . . 0.0 113.088 167.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.17 153.52 16.82 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.887 1.708 . . . . 0.0 114.224 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -84.79 163.24 19.22 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.896 0.878 . . . . 0.0 110.292 161.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.13 147.68 52.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.393 1.877 . . . . 0.0 111.413 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.08 110.43 1.04 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.127 0.971 . . . . 0.0 112.033 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.65 -46.37 3.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.553 1.549 . . . . 0.0 110.591 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 m -155.41 149.59 25.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.338 1.055 . . . . 0.0 110.967 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.01 121.67 33.67 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.114 0.965 . . . . 0.0 109.546 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.3 m -103.66 118.7 37.32 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.448 1.499 . . . . 0.0 108.589 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.33 130.85 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.758 0.708 . . . . 0.0 109.207 167.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.17 -49.36 4.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.524 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -173.19 170.77 4.25 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.329 1.851 . . . . 0.0 111.796 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.93 -179.47 31.83 Favored Glycine 0 N--CA 1.461 0.359 0 C-N-CA 124.895 1.236 . . . . 0.0 113.55 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.19 113.95 20.37 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 165.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.7 p -61.3 -17.68 54.82 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -153.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -50.97 -35.58 34.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.548 1.139 . . . . 0.0 112.143 171.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 58' ' ' CYS . 10.8 tp -82.48 -51.04 8.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.086 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.3 m -45.74 -46.37 15.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.212 1.405 . . . . 0.0 113.203 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.98 82.43 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.038 0.835 . . . . 0.0 112.852 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.15 -52.88 14.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t -56.68 -49.41 75.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.037 0.935 . . . . 0.0 110.58 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.64 -47.11 58.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.324 1.449 . . . . 0.0 111.303 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -68.5 -44.45 74.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.18 77.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.617 1.167 . . . . 0.0 111.23 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -68.3 -21.76 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.675 -1.266 . . . . 0.0 112.009 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.58 -7.44 59.25 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.569 0.748 . . . . 0.0 112.632 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.34 -11.84 3.58 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.8 m -55.78 147.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.05 0.94 . . . . 0.0 112.92 171.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.34 -49.85 65.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.5 p 167.9 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.228 2.611 . . . . 0.0 110.334 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 25.7 m-85 -99.73 104.32 27.27 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 117.31 -1.329 . . . . 0.0 110.493 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -70.71 128.96 15.85 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.021 1.814 . . . . 0.0 111.512 -170.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 132.04 21.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.127 1.371 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.33 -52.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.186 2.591 . . . . 0.0 112.477 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.78 149.61 27.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.617 1.167 . . . . 0.0 110.045 167.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -128.03 21.01 6.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.288 1.435 . . . . 0.0 113.315 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -88.61 145.74 35.85 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 121.228 -0.92 . . . . 0.0 109.772 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.18 -23.58 6.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.563 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.2 -24.6 43.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.891 0.769 . . . . 0.0 112.862 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.2 m -98.22 -34.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.037 0.935 . . . . 0.0 111.97 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.27 -32.5 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.322 1.049 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.56 -11.74 59.87 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.129 0.972 . . . . 0.0 113.227 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.81 -34.05 8.68 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.179 -0.95 . . . . 0.0 113.289 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -82.84 -21.25 34.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.745 0.818 . . . . 0.0 112.913 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -69.44 -23.54 63.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.072 -1.017 . . . . 0.0 113.735 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.0 83.99 2.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.055 . . . . 0.0 110.146 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.46 159.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -110.81 126.91 55.12 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 160.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.8 121.9 32.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.9 m -134.12 129.76 36.38 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.097 0.959 . . . . 0.0 109.801 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.76 141.35 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 128.576 2.75 . . . . 0.0 107.885 -170.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 -174.928 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.399 0.142 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -60.08 -18.09 44.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.403 2.281 . . . . 0.0 116.429 -166.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.14 -13.83 9.66 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 126.896 2.188 . . . . 0.0 114.282 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.41 -34.41 54.77 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.381 1.472 . . . . 0.0 111.818 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.9 pt -59.33 -27.45 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.525 -0.735 . . . . 0.0 112.449 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.4 -58.59 2.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.949 1.3 . . . . 0.0 111.271 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.13 -33.33 72.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.618 1.167 . . . . 0.0 112.167 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -74.05 -40.61 62.71 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.755 0.822 . . . . 0.0 110.464 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.52 -31.75 68.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.743 . . . . 0.0 111.361 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.59 -51.64 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -67.16 -19.94 65.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -57.08 -35.77 69.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.981 0.512 . . . . 0.0 111.245 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -77.98 -32.7 51.46 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.36 109.15 20.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.621 1.201 . . . . 0.0 111.438 -160.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.08 25.01 5.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.72 1.608 . . . . 0.0 114.21 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.73 -64.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 0.0 111.385 -167.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 72.25 -68.3 0.23 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.217 2.207 . . . . 0.0 112.958 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.31 -27.86 68.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.982 1.313 . . . . 0.0 113.059 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.9 m -100.62 7.14 44.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.332 1.053 . . . . 0.0 113.21 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -100.08 -28.86 12.83 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.849 1.66 . . . . 0.0 112.161 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.993 1.717 . . . . 0.0 112.575 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.86 -23.6 3.64 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.199 1.38 . . . . 0.0 114.737 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 -169.77 1.53 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.081 2.153 . . . . 0.0 111.356 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 165.21 24.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 0.0 110.342 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 41.0 t -158.11 145.9 18.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 0.0 109.869 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.1 129.0 42.99 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.72 1.608 . . . . 0.0 111.003 165.676 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.99 169.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -137.18 132.21 33.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.236 -172.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -105.09 129.53 53.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.522 1.129 . . . . 0.0 109.725 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -112.36 111.14 21.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.999 0.92 . . . . 0.0 109.634 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.3 mm? -100.09 158.6 15.72 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.996 0.903 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 pt -98.38 150.45 36.74 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 125.476 1.51 . . . . 0.0 110.036 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.35 150.89 37.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.17 2.58 . . . . 0.0 111.109 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -168.25 144.73 3.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.012 2.525 . . . . 0.0 107.98 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.0 -22.17 75.75 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -164.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.8 p -90.89 -9.6 45.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.488 1.515 . . . . 0.0 113.178 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.21 157.05 7.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.244 1.402 . . . . 0.0 112.635 -171.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.1 160.88 17.23 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 117.765 0.783 . . . . 0.0 110.767 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.19 144.93 51.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.072 1.349 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.05 110.25 1.16 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.461 0.704 . . . . 0.0 112.547 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.58 -37.28 4.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.882 1.705 . . . . 0.0 112.041 173.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -162.38 148.83 13.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.817 1.247 . . . . 0.0 111.0 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.35 125.78 39.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.347 1.059 . . . . 0.0 109.423 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.6 m -110.86 127.81 55.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.711 2.005 . . . . 0.0 108.133 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.57 133.33 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.608 1.094 . . . . 0.0 109.351 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 tp -104.51 -44.79 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.713 0.405 . . . . 0.0 110.287 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 3.8 t0 -172.48 168.86 5.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.646 1.578 . . . . 0.0 112.232 169.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.7 32.79 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.745 1.164 . . . . 0.0 113.573 169.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -85.68 114.73 22.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 166.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m -59.69 -19.82 52.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -151.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -58.43 -29.63 66.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.303 -0.856 . . . . 0.0 113.128 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -79.81 -48.58 13.31 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 120.228 1.376 . . . . 0.0 111.22 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 38.9 m -45.36 -47.3 13.4 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.694 1.134 . . . . 0.0 112.774 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.17 64.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.391 1.476 . . . . 0.0 114.486 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.04 -52.8 4.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.378 1.471 . . . . 0.0 111.975 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.0 t -56.05 -48.6 75.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 111.292 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -46.87 -47.21 21.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.427 1.891 . . . . 0.0 111.494 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -69.96 -43.25 71.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.08 71.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.694 1.197 . . . . 0.0 111.124 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.05 -22.02 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.82 -1.175 . . . . 0.0 112.645 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.71 -8.72 59.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.841 0.856 . . . . 0.0 112.455 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -13.3 4.67 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -175.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.5 m -58.37 145.12 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.302 1.041 . . . . 0.0 111.984 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -69.46 -42.75 74.47 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -171.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.9 p 166.07 141.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.506 2.323 . . . . 0.0 110.192 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 42.7 m-85 -89.61 112.55 52.4 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.538 -1.22 . . . . 0.0 110.388 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.96 127.02 9.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.33 2.02 . . . . 0.0 111.101 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -73.98 141.65 78.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.852 0.861 . . . . 0.0 111.43 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -44.16 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.891 2.394 . . . . 0.0 110.401 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -122.55 151.56 41.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.146 1.778 . . . . 0.0 109.507 160.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -108.43 10.61 27.38 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -165.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.68 144.31 56.11 Favored Pre-proline 0 C--O 1.24 0.569 0 O-C-N 120.872 -1.143 . . . . 0.0 109.947 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.68 -6.0 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.04 2.493 . . . . 0.0 113.957 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.44 -33.1 23.75 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.713 0.805 . . . . 0.0 112.875 169.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -97.44 -25.77 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 113.139 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.67 -25.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.742 0.817 . . . . 0.0 110.59 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.17 -11.44 59.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.277 1.431 . . . . 0.0 113.191 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -37.75 8.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 0.0 112.583 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.62 -23.94 53.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.778 1.231 . . . . 0.0 112.592 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -66.79 -22.83 66.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.5 91.01 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.942 0.897 . . . . 0.0 110.647 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.475 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -119.43 154.79 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.674 1.19 . . . . 0.0 113.067 -178.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -91.11 136.42 33.1 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.144 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.38 114.31 26.81 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 153.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.3 m -133.83 128.27 34.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.579 1.152 . . . . 0.0 109.34 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.57 156.7 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.783 1.633 . . . . 0.0 111.173 -171.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.107 0 C-N-CA 126.81 2.044 . . . . 0.0 110.629 -178.09 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -53.67 -44.0 69.33 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.096 1.759 . . . . 0.0 114.83 -162.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.56 -17.37 57.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.572 1.558 . . . . 0.0 114.03 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.657 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.06 -33.11 59.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.666 1.186 . . . . 0.0 111.547 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.9 pt -59.51 -25.79 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.136 0.88 . . . . 0.0 112.257 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.36 -59.88 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.122 0.969 . . . . 0.0 109.804 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -61.44 -35.25 77.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.472 1.109 . . . . 0.0 112.326 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -73.85 -27.5 61.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.718 1.207 . . . . 0.0 111.915 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -78.6 -32.27 47.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.252 0.933 . . . . 0.0 111.836 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 93' ' ' VAL . 1.5 mp -68.8 -43.54 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.891 1.276 . . . . 0.0 110.598 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -72.62 -13.99 61.5 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.961 0.904 . . . . 0.0 113.223 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -55.58 -38.43 69.36 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.457 0.303 . . . . 0.0 110.326 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -81.25 -36.87 29.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -103.41 99.42 9.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.825 1.298 . . . . 0.0 111.869 -161.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.2 28.82 0.69 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.269 1.428 . . . . 0.0 113.625 -172.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.35 -40.5 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.599 0.759 . . . . 0.0 112.322 -165.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.57 -98.53 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.139 1.776 . . . . 0.0 112.95 164.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.69 -24.1 66.54 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.645 1.178 . . . . 0.0 113.605 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 m -92.83 1.42 57.3 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -88.64 -22.18 23.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.073 1.349 . . . . 0.0 111.575 156.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -86.4 170.92 11.56 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.581 1.952 . . . . 0.0 111.214 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 -9.72 28.46 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.095 1.331 . . . . 0.0 114.833 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 -176.94 5.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.714 2.406 . . . . 0.0 110.885 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.92 160.44 26.15 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.722 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.406 ' HB3' HD23 ' A' ' 85' ' ' LEU . 54.1 t -154.87 141.44 18.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.646 1.178 . . . . 0.0 109.538 168.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.06 131.6 53.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.397 1.479 . . . . 0.0 110.494 167.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.3 m -142.31 170.24 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -134.82 131.93 38.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.404 0.682 . . . . 0.0 111.5 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.38 133.33 48.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.222 1.009 . . . . 0.0 109.682 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -115.16 107.12 14.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.738 1.215 . . . . 0.0 109.709 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.491 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.92 158.47 15.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.08 148.2 34.78 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.61 1.564 . . . . 0.0 110.274 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.71 141.13 37.02 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.71 2.273 . . . . 0.0 110.853 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.8 m -133.43 156.94 46.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.277 1.831 . . . . 0.0 109.795 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.31 -26.47 61.68 Favored Glycine 0 N--CA 1.478 1.492 0 C-N-CA 123.55 0.595 . . . . 0.0 113.661 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -131.17 104.47 7.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.941 1.696 . . . . 0.0 108.331 161.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.58 -159.53 24.96 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.136 1.351 . . . . 0.0 114.442 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -110.72 162.45 14.75 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.344 1.057 . . . . 0.0 110.032 162.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.24 145.92 51.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.101 1.761 . . . . 0.0 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.14 112.74 1.81 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.759 0.708 . . . . 0.0 112.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.41 -36.37 5.16 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 125.796 1.665 . . . . 0.0 111.873 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -166.45 153.52 9.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.685 1.594 . . . . 0.0 111.201 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.25 131.65 48.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.44 1.096 . . . . 0.0 109.889 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.0 m -111.55 122.59 48.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.362 1.865 . . . . 0.0 107.878 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.56 130.79 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.96 0.8 . . . . 0.0 109.114 167.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.31 -49.88 3.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.315 0.646 . . . . 0.0 110.094 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.58 165.58 4.57 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.123 1.769 . . . . 0.0 111.865 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.95 179.62 38.33 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 124.543 1.068 . . . . 0.0 114.253 167.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.84 119.65 24.17 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -54.36 -31.64 55.09 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -144.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -54.79 -34.97 63.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.859 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 58' ' ' CYS . 12.4 tp -78.92 -56.78 4.14 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.334 1.425 . . . . 0.0 111.678 -175.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 6.0 p -55.69 -32.62 63.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.42 -33.95 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.816 1.189 . . . . 0.0 113.414 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.52 -52.5 7.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.46 1.104 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.6 t -56.09 -46.63 78.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.25 1.02 . . . . 0.0 111.713 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -46.45 -45.74 18.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.393 1.877 . . . . 0.0 111.797 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -75.62 -43.1 49.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.393 1.077 . . . . 0.0 112.754 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.77 -48.44 81.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.815 1.246 . . . . 0.0 111.98 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' THR . 2.7 t -66.1 -24.42 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.859 -1.151 . . . . 0.0 111.235 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.35 -6.07 55.97 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.503 -0.748 . . . . 0.0 112.566 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -133.07 -12.05 2.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.1 m -58.76 151.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.274 0.943 . . . . 0.0 113.238 169.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.65 -48.69 30.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 173.87 142.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.49 1.916 . . . . 0.0 111.835 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.5 m-85 -97.12 113.79 63.66 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.902 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.5 127.95 6.74 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.868 2.379 . . . . 0.0 110.189 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.6 mt -83.42 146.73 51.22 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.754 0.821 . . . . 0.0 112.225 -172.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.27 -28.81 8.42 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.986 2.457 . . . . 0.0 111.892 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -140.76 156.84 46.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.76 2.024 . . . . 0.0 110.817 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -129.67 20.85 5.55 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -167.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -85.69 141.85 36.54 Favored Pre-proline 0 C--O 1.241 0.655 0 O-C-N 120.492 -1.38 . . . . 0.0 109.068 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.24 -5.41 8.01 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 113.399 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.52 -35.27 23.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.523 1.056 . . . . 0.0 112.124 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.0 m -100.34 -24.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.182 0.993 . . . . 0.0 113.278 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.54 -28.27 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.524 0.73 . . . . 0.0 110.379 167.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.439 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 31.7 mm-40 -79.8 -8.53 59.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.881 1.272 . . . . 0.0 113.981 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -93.1 -54.09 3.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.669 0.788 . . . . 0.0 111.311 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.81 -23.15 67.15 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 124.497 1.119 . . . . 0.0 113.17 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.9 ptmt -72.87 -23.91 60.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.721 -1.237 . . . . 0.0 113.292 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.7 83.08 2.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.124 1.369 . . . . 0.0 110.885 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.585 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.86 150.06 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.716 0.807 . . . . 0.0 112.199 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.48 126.55 39.83 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 157.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 mt -89.78 116.05 27.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 163.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -131.67 124.89 30.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.626 1.171 . . . . 0.0 109.345 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.89 139.95 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 128.333 2.653 . . . . 0.0 107.276 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 125.285 1.434 . . . . 0.0 111.514 -177.513 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -54.16 -43.97 71.07 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.801 2.04 . . . . 0.0 113.873 -171.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.05 68.22 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.123 1.344 . . . . 0.0 113.705 173.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.8 -27.48 55.25 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.327 1.063 . . . . 0.0 112.074 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.35 -30.12 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.403 -1.436 . . . . 0.0 111.457 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -78.26 -56.09 4.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.405 1.482 . . . . 0.0 109.488 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.33 -33.95 71.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.845 0.858 . . . . 0.0 112.452 -176.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -37.56 82.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.776 1.231 . . . . 0.0 111.672 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.23 -28.04 59.75 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.58 -52.5 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.224 -0.923 . . . . 0.0 110.622 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -23.91 67.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.638 0.775 . . . . 0.0 112.078 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.35 -14.16 60.46 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -81.5 -45.19 16.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.182 0.901 . . . . 0.0 111.003 159.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.49 83.46 5.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 123.541 1.638 . . . . 0.0 112.081 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.34 28.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.813 1.645 . . . . 0.0 113.999 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.94 -69.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.462 -163.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 74.31 -49.78 0.67 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.982 2.513 . . . . 0.0 113.718 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.78 -44.74 92.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.621 1.168 . . . . 0.0 112.605 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.2 p -92.42 12.72 21.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -100.48 -17.92 16.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.59 1.556 . . . . 0.0 111.325 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -106.16 156.95 17.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.193 1.797 . . . . 0.0 111.813 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.39 -2.72 84.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.037 1.303 . . . . 0.0 114.804 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -178.97 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.032 2.133 . . . . 0.0 110.923 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 161.33 23.2 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.516 -0.74 . . . . 0.0 110.162 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -155.14 149.09 25.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.763 1.225 . . . . 0.0 110.403 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.27 117.64 9.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.733 1.613 . . . . 0.0 110.35 173.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.52 163.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -134.7 131.15 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.985 -0.447 . . . . 0.0 111.701 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.34 129.54 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.352 1.061 . . . . 0.0 109.885 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -114.29 103.81 11.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.511 1.524 . . . . 0.0 108.244 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -100.85 157.59 16.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.714 0.769 . . . . 0.0 112.085 -178.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 pt -101.32 139.33 20.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.231 1.413 . . . . 0.0 110.159 168.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.42 126.23 10.8 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.526 2.151 . . . . 0.0 109.845 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 m -113.74 -33.72 5.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.272 1.029 . . . . 0.0 112.506 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.87 -110.16 0.37 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.487 1.041 . . . . 0.0 111.678 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -61.21 -23.74 65.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.19 0.996 . . . . 0.0 112.673 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.13 -178.43 16.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.268 1.413 . . . . 0.0 115.396 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -100.98 165.83 11.13 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.36 1.464 . . . . 0.0 111.833 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.26 146.49 52.33 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.385 1.874 . . . . 0.0 111.413 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.66 110.3 0.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.59 0.756 . . . . 0.0 112.038 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.45 -35.34 5.73 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.943 1.735 . . . . 0.0 111.703 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.8 152.51 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 0.0 111.556 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -126.0 125.06 42.06 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.532 1.133 . . . . 0.0 109.779 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.6 m -106.43 122.37 46.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.407 1.883 . . . . 0.0 108.19 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.81 129.55 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.125 0.875 . . . . 0.0 108.85 166.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -105.94 -41.54 5.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.405 0.682 . . . . 0.0 110.539 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.27 173.72 6.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.249 1.82 . . . . 0.0 111.503 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.36 169.41 13.08 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 125.778 1.656 . . . . 0.0 114.197 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.94 120.05 24.73 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 p -60.79 -20.85 62.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -154.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -52.69 -33.14 46.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.858 1.263 . . . . 0.0 112.976 171.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.09 -50.52 6.58 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.565 1.075 . . . . 0.0 111.053 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 m -46.22 -47.77 17.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.093 1.357 . . . . 0.0 113.922 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.61 80.45 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.72 0.808 . . . . 0.0 112.466 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.0 16.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.521 1.128 . . . . 0.0 112.068 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.6 t -58.68 -48.28 81.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.953 0.901 . . . . 0.0 110.734 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -49.25 -45.49 44.79 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.989 1.716 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.38 -47.39 61.12 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.23 77.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.289 1.036 . . . . 0.0 111.269 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.68 -22.55 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.86 -1.15 . . . . 0.0 112.013 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.08 -8.63 59.12 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.419 -0.801 . . . . 0.0 112.639 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -11.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.8 m -56.92 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 112.387 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.33 -45.26 76.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 p 166.18 145.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 111.259 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 13.3 m-85 -103.23 103.4 34.56 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.669 1.188 . . . . 0.0 109.426 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.11 132.24 25.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.308 2.006 . . . . 0.0 110.982 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.75 147.12 77.46 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 118.092 0.406 . . . . 0.0 110.941 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -42.01 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.92 1.747 . . . . 0.0 110.562 168.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 158.57 44.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.084 2.154 . . . . 0.0 111.276 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -126.64 19.14 7.34 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.389 1.076 . . . . 0.0 113.898 -162.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.69 140.41 40.98 Favored Pre-proline 0 C--O 1.24 0.589 0 O-C-N 120.508 -1.37 . . . . 0.0 109.442 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.45 -3.59 6.72 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.998 2.466 . . . . 0.0 113.523 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.84 -34.2 21.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.029 0.831 . . . . 0.0 111.985 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.94 -26.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.903 0.881 . . . . 0.0 112.978 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.58 -28.51 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.573 0.749 . . . . 0.0 110.623 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.9 mm-40 -79.62 -10.41 59.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.18 -53.31 4.41 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.518 -0.739 . . . . 0.0 111.133 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.3 pp -65.2 -25.33 67.66 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 112.878 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.2 ptmt -72.92 -24.74 60.86 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.01 -1.056 . . . . 0.0 113.337 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -125.81 81.1 1.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.796 1.638 . . . . 0.0 110.674 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.57 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.49 150.56 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.86 0.864 . . . . 0.0 112.415 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.36 129.24 43.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 160.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.94 109.69 19.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 156.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -133.85 125.83 29.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.769 1.228 . . . . 0.0 108.515 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.6 m -138.37 149.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.714 1.606 . . . . 0.0 110.321 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 125.627 1.571 . . . . 0.0 111.971 -177.735 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 111.377 0.14 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -49.62 -46.34 49.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.739 2.015 . . . . 0.0 114.741 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.54 -16.09 55.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.33 1.919 . . . . 0.0 114.097 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.2 -34.09 59.29 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.375 1.07 . . . . 0.0 111.863 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.0 pt -60.18 -24.72 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.54 0.736 . . . . 0.0 112.074 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -82.98 -59.7 2.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.599 1.16 . . . . 0.0 109.897 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -61.26 -34.66 75.53 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.448 1.099 . . . . 0.0 112.47 -170.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -71.02 -43.94 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.471 1.108 . . . . 0.0 110.385 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.2 tp -67.41 -29.29 68.75 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.638 0.653 . . . . 0.0 111.631 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -53.42 24.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 O-C-N 121.498 -0.751 . . . . 0.0 110.862 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -67.54 -18.28 64.97 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.44 -36.36 66.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.84 0.456 . . . . 0.0 111.265 167.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -78.17 -37.96 44.63 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 112.204 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.53 101.87 13.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.968 1.366 . . . . 0.0 111.57 -164.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 21.0 3.84 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.27 -60.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -162.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 73.31 -57.84 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.715 2.406 . . . . 0.0 113.198 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.4 -40.36 86.36 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.093 1.357 . . . . 0.0 112.05 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 m -79.73 0.87 28.78 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -112.29 -25.77 9.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.063 1.745 . . . . 0.0 112.955 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.69 156.49 16.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.119 1.367 . . . . 0.0 113.171 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.64 -24.11 4.56 Favored Glycine 0 N--CA 1.478 1.486 0 C-N-CA 125.376 1.465 . . . . 0.0 114.816 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -173.63 2.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.41 1.884 . . . . 0.0 111.532 171.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.14 161.1 27.59 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.245 -0.91 . . . . 0.0 111.594 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.9 t -160.36 146.68 15.49 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.936 1.294 . . . . 0.0 110.008 171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.23 129.81 42.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.184 1.794 . . . . 0.0 110.24 166.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.31 170.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -137.37 131.22 31.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.471 0.578 . . . . 0.0 112.02 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.46 127.93 49.29 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.177 0.991 . . . . 0.0 110.112 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mppt? -108.64 107.46 17.94 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.669 1.187 . . . . 0.0 109.277 165.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.4 160.45 14.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.994 0.902 . . . . 0.0 111.472 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.99 121.43 52.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.424 1.489 . . . . 0.0 109.504 166.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.62 121.84 10.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.96 2.44 . . . . 0.0 111.157 170.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.3 m -111.26 -29.54 7.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.132 1.373 . . . . 0.0 111.821 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.67 -52.99 0.71 Allowed Glycine 0 N--CA 1.476 1.324 0 C-N-CA 125.645 1.593 . . . . 0.0 112.415 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -70.03 -31.79 69.62 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.965 0.906 . . . . 0.0 111.378 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.15 -168.34 18.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 111.814 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.55 162.15 13.92 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 151.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.29 145.84 50.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.999 1.719 . . . . 0.0 111.16 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.94 112.2 1.58 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.644 -0.66 . . . . 0.0 112.402 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.13 -46.83 3.23 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.05 1.309 . . . . 0.0 110.68 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -156.64 148.28 22.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.609 1.164 . . . . 0.0 110.828 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.44 131.2 53.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.796 0.839 . . . . 0.0 109.574 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -115.22 117.17 29.75 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.142 1.777 . . . . 0.0 108.041 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -82.39 132.05 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.473 0.578 . . . . 0.0 109.631 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.86 -52.16 3.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.097 0.559 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -172.9 169.37 4.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.233 1.813 . . . . 0.0 112.119 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.03 -175.73 34.44 Favored Glycine 0 N--CA 1.465 0.581 0 C-N-CA 125.699 1.619 . . . . 0.0 113.843 168.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.63 116.63 19.94 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -25.53 39.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -152.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -55.08 -32.44 61.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.322 1.449 . . . . 0.0 112.834 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.76 -50.55 7.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.288 1.404 . . . . 0.0 112.404 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.1 p -60.74 -31.28 70.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.405 1.457 . . . . 0.0 113.26 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 -46.1 84.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.119 0.968 . . . . 0.0 112.75 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.07 -50.14 30.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.276 1.03 . . . . 0.0 113.206 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.3 t -56.87 -47.91 79.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.64 0.776 . . . . 0.0 110.521 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -48.79 -45.85 40.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.06 1.744 . . . . 0.0 111.818 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -69.14 -43.49 74.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.8 -49.13 78.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.724 1.21 . . . . 0.0 111.275 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.61 -23.03 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.5 -1.375 . . . . 0.0 112.172 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.43 -6.05 57.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.97 0.908 . . . . 0.0 112.782 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 -12.27 3.46 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.1 m -60.0 146.62 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.416 1.087 . . . . 0.0 112.115 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -72.11 -46.57 56.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 172.89 138.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.162 1.785 . . . . 0.0 111.245 -168.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.0 m-85 -93.53 111.39 52.16 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.099 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.38 116.21 4.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.892 1.728 . . . . 0.0 109.938 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.1 pt? -88.34 137.63 30.74 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.44 1.496 . . . . 0.0 111.848 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.61 -46.29 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.25 2.634 . . . . 0.0 112.35 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -99.3 168.16 10.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.053 1.341 . . . . 0.0 110.719 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -131.48 6.15 4.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -167.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.15 138.85 60.43 Favored Pre-proline 0 C--O 1.243 0.735 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.36 -0.97 4.0 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.872 2.381 . . . . 0.0 113.549 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.58 -40.39 16.32 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 111.773 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -93.02 -25.74 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.381 1.072 . . . . 0.0 112.412 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.51 -26.65 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.973 0.909 . . . . 0.0 110.799 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -84.55 -7.24 59.33 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.464 1.506 . . . . 0.0 113.826 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -92.68 -51.69 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.781 0.8 . . . . 0.0 111.876 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 112' ' ' LEU . 3.2 pp -69.06 -21.52 64.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.476 1.11 . . . . 0.0 112.345 -172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -62.37 -24.14 67.2 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.88 -1.138 . . . . 0.0 113.711 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -129.61 78.62 1.86 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.416 1.087 . . . . 0.0 110.401 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.84 151.86 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.306 1.042 . . . . 0.0 111.732 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -91.23 134.17 34.78 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 155.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.33 113.17 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.5 m -135.71 126.29 27.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.344 1.058 . . . . 0.0 109.165 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.26 151.31 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.84 1.656 . . . . 0.0 110.654 -171.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 125.979 1.712 . . . . 0.0 110.975 -176.328 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.911 0.386 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.96 -43.49 77.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.676 2.39 . . . . 0.0 113.335 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.73 -17.44 70.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 172.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.51 -32.0 64.0 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.552 1.176 . . . . 0.0 111.632 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -61.97 -28.84 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.538 -0.726 . . . . 0.0 111.5 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.07 -59.0 2.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.554 1.542 . . . . 0.0 109.992 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.34 -34.16 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.025 0.93 . . . . 0.0 112.408 -173.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -72.45 -31.47 65.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.078 0.951 . . . . 0.0 111.51 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.86 -30.18 61.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.548 0.613 . . . . 0.0 112.29 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -73.97 -53.68 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.956 -1.09 . . . . 0.0 110.649 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -20.22 64.55 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.462 0.705 . . . . 0.0 112.53 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.59 -14.53 58.12 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -79.81 -42.15 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.185 0.902 . . . . 0.0 111.324 159.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.81 84.61 4.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 123.412 1.577 . . . . 0.0 111.775 -163.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.6 27.07 0.13 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.581 1.553 . . . . 0.0 114.217 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.93 -69.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.047 0.939 . . . . 0.0 111.128 -165.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 77.34 -50.81 0.54 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.595 2.358 . . . . 0.0 113.67 162.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.47 -21.97 60.3 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.96 -1.087 . . . . 0.0 113.551 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -89.93 -6.65 55.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.712 1.205 . . . . 0.0 113.07 169.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.1 m-30 -98.31 -17.2 19.02 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.464 1.906 . . . . 0.0 112.277 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.72 159.78 14.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.875 2.07 . . . . 0.0 112.989 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.29 -43.08 2.45 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.698 1.618 . . . . 0.0 112.778 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -84.85 -176.79 6.37 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.21 1.404 . . . . 0.0 111.264 168.122 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 165.08 23.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.879 0.872 . . . . 0.0 111.313 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.41 158.24 43.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.123 0.569 . . . . 0.0 111.087 158.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 128.04 39.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.86 1.264 . . . . 0.0 109.883 159.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.3 178.19 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.57 124.98 13.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.288 0.635 . . . . 0.0 110.966 -166.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.07 131.9 49.72 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.945 0.898 . . . . 0.0 109.814 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -118.63 103.47 9.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.184 1.794 . . . . 0.0 109.38 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.473 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.79 160.39 14.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.374 1.083 . . . . 0.0 111.697 -175.079 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 pt -102.24 142.12 23.94 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.608 1.563 . . . . 0.0 109.879 166.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.07 126.11 9.06 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.793 2.329 . . . . 0.0 109.95 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.2 m -112.9 -27.9 7.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.229 1.412 . . . . 0.0 112.089 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.69 -39.59 2.82 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.652 1.596 . . . . 0.0 112.99 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.3 p -71.49 -34.73 70.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.748 1.219 . . . . 0.0 110.532 163.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.62 -165.61 15.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 112.061 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -89.05 164.14 15.19 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 122.014 -0.697 . . . . 0.0 109.376 151.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.94 145.79 51.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.593 1.557 . . . . 0.0 111.157 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.81 111.59 1.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.253 0.621 . . . . 0.0 112.474 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.4 -35.87 5.33 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.542 1.544 . . . . 0.0 111.683 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.48 151.91 8.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.857 1.663 . . . . 0.0 110.845 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -125.3 121.15 33.18 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.856 0.862 . . . . 0.0 110.02 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.6 m -101.1 135.68 42.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.722 1.609 . . . . 0.0 107.807 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.0 m -99.34 135.95 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.015 0.825 . . . . 0.0 109.006 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -103.82 -48.22 3.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.089 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -172.66 171.61 4.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 0.0 111.792 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.11 -175.1 30.95 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.394 1.474 . . . . 0.0 113.886 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.55 110.89 19.04 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -63.68 -15.32 58.09 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -153.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.78 -32.65 70.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.795 0.838 . . . . 0.0 112.196 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.02 -46.8 22.55 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 119.712 1.142 . . . . 0.0 110.775 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 54.4 m -51.84 -38.77 57.17 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.41 1.005 . . . . 0.0 113.603 173.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.26 -44.98 70.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.841 0.856 . . . . 0.0 112.27 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.22 -52.54 53.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 112.213 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.34 -50.31 73.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.801 0.84 . . . . 0.0 110.365 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -50.95 -46.84 61.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.442 1.497 . . . . 0.0 111.306 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -66.68 -44.22 82.35 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.78 80.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.857 1.263 . . . . 0.0 111.511 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.67 -22.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.5 -1.375 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.83 -7.2 58.56 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.429 -0.794 . . . . 0.0 112.399 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 -12.08 3.19 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -173.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.48 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.2 m -55.72 148.28 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.59 1.156 . . . . 0.0 113.017 171.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -73.46 -43.33 60.5 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.4 p 168.87 145.76 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.025 2.53 . . . . 0.0 111.141 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.56 110.68 52.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.439 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.69 114.85 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.527 1.485 . . . . 0.0 110.374 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.741 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.4 pt? -89.76 129.19 47.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.812 1.645 . . . . 0.0 110.397 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.93 -46.34 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.127 2.551 . . . . 0.0 111.043 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -94.26 167.17 11.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.17 1.388 . . . . 0.0 112.169 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.61 24.5 0.59 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.352 1.061 . . . . 0.0 113.027 -165.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.28 140.46 34.38 Favored Pre-proline 0 C--O 1.24 0.598 0 O-C-N 120.754 -1.217 . . . . 0.0 108.644 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.83 -15.26 2.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.961 3.107 . . . . 0.0 115.601 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.32 -35.7 30.65 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.273 0.942 . . . . 0.0 112.496 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -99.78 -27.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.523 1.129 . . . . 0.0 112.726 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.2 t -56.82 -32.5 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.564 1.146 . . . . 0.0 110.105 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 35.5 mm-40 -77.9 -7.83 57.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 113.462 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -99.19 -44.55 6.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 112.694 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.9 -28.14 67.25 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.771 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.3 ptmt -73.01 -23.99 60.69 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.397 -1.439 . . . . 0.0 113.643 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -122.84 84.19 2.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.825 1.25 . . . . 0.0 110.445 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.59 155.92 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.147 0.979 . . . . 0.0 112.127 176.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 120.84 43.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.978 162.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.17 119.45 30.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -135.65 127.03 28.48 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.063 1.345 . . . . 0.0 108.56 -173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.49 157.32 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 111.606 -168.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 125.702 1.601 . . . . 0.0 115.265 175.131 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.7 mmp_? . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -51.48 -52.71 44.35 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 128.057 2.543 . . . . 0.0 113.7 -161.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.36 -15.01 65.04 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.052 1.786 . . . . 0.0 113.97 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.53 -37.28 71.17 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.898 1.349 . . . . 0.0 110.551 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.5 pt -62.18 -26.97 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.476 -0.765 . . . . 0.0 112.223 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.2 -59.31 2.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.892 1.277 . . . . 0.0 109.927 174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -60.15 -35.58 75.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.881 1.272 . . . . 0.0 112.472 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -77.4 -21.78 52.62 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.435 1.094 . . . . 0.0 112.779 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.93 -34.04 39.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.639 1.109 . . . . 0.0 111.416 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.75 -44.09 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 121.052 -1.03 . . . . 0.0 111.063 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -14.81 62.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.912 1.285 . . . . 0.0 112.911 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -59.99 -40.87 90.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.029 0.531 . . . . 0.0 109.962 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.94 -44.06 28.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.952 0.882 . . . . 0.0 109.777 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.21 71.28 5.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.378 1.561 . . . . 0.0 111.512 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.12 28.95 0.05 Allowed 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.762 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.19 -70.68 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.991 . . . . 0.0 110.822 -163.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 75.82 -46.93 0.57 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.689 2.396 . . . . 0.0 113.201 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.09 -25.37 64.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.451 1.101 . . . . 0.0 113.067 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.6 m -86.02 -5.21 59.26 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.886 1.274 . . . . 0.0 113.336 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 15.8 m-30 -110.47 -21.48 12.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 112.279 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -91.73 157.58 16.84 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.543 1.937 . . . . 0.0 113.334 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.03 -7.45 66.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 125.411 1.481 . . . . 0.0 114.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -134.78 -172.71 3.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.222 2.209 . . . . 0.0 110.955 176.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.18 165.91 21.36 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.458 -0.777 . . . . 0.0 110.593 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.8 t -154.99 142.05 19.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.001 0.92 . . . . 0.0 109.697 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.78 131.06 51.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.368 1.867 . . . . 0.0 110.677 166.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 170.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.461 1.104 . . . . 0.0 108.524 173.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.87 131.57 41.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.787 0.835 . . . . 0.0 112.068 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.28 134.25 44.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.044 0.938 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.89 102.89 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.162 1.385 . . . . 0.0 108.387 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.58 161.65 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.978 0.894 . . . . 0.0 111.493 -178.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -100.59 121.01 54.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.273 1.429 . . . . 0.0 109.688 165.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.51 126.68 23.12 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.818 2.346 . . . . 0.0 110.994 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.2 m -143.52 92.45 2.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.276 1.431 . . . . 0.0 108.285 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.06 -123.95 32.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.977 0.799 . . . . 0.0 111.412 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.91 2.45 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.145 1.778 . . . . 0.0 114.199 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.71 -165.24 10.79 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.193 1.378 . . . . 0.0 114.726 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -127.15 165.73 19.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.838 1.255 . . . . 0.0 110.235 161.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.17 146.6 52.4 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.182 1.793 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.83 111.58 1.7 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.893 0.769 . . . . 0.0 112.419 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.61 -35.65 5.34 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.531 1.538 . . . . 0.0 112.287 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -166.43 153.87 9.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 111.06 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -129.58 129.13 44.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.261 1.024 . . . . 0.0 109.347 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.3 m -112.18 117.98 34.07 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.078 1.751 . . . . 0.0 108.229 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.61 132.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.708 0.685 . . . . 0.0 109.482 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -102.13 -53.13 2.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -179.1 162.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.666 1.987 . . . . 0.0 111.405 170.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.94 -176.54 40.69 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.368 0.985 . . . . 0.0 112.556 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 107.96 17.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 p -64.68 -13.95 56.33 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -147.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -57.1 -33.29 67.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.777 0.831 . . . . 0.0 112.604 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.35 -47.56 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.875 1.216 . . . . 0.0 111.855 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.7 m -45.68 -45.83 14.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.762 1.164 . . . . 0.0 112.802 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.54 71.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 0.0 112.427 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.81 66.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.6 t -58.85 -49.63 77.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.653 0.781 . . . . 0.0 110.477 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.39 -45.9 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.348 1.459 . . . . 0.0 111.518 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.71 -46.29 76.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.85 80.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.556 1.142 . . . . 0.0 111.622 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' THR . 2.6 t -66.06 -24.24 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.543 -1.348 . . . . 0.0 111.486 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.01 -7.22 58.71 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.348 -0.845 . . . . 0.0 112.368 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 -11.7 3.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.3 m -57.25 148.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.197 0.908 . . . . 0.0 112.869 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -68.57 -48.22 64.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.7 p 170.11 144.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.578 2.351 . . . . 0.0 110.56 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 22.8 m-85 -97.18 110.66 55.21 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.466 -1.254 . . . . 0.0 109.482 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.87 129.93 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.447 2.098 . . . . 0.0 110.157 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.21 144.92 55.01 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.955 0.502 . . . . 0.0 110.745 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 -29.64 9.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.575 2.183 . . . . 0.0 111.656 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -114.66 -174.9 2.57 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.161 1.784 . . . . 0.0 111.864 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -151.96 21.15 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -95.52 132.29 27.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.89 -1.131 . . . . 0.0 109.457 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.69 -5.6 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.83 3.687 . . . . 0.0 116.857 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.75 -60.27 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.378 0.99 . . . . 0.0 110.266 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -74.97 -25.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.376 0.67 . . . . 0.0 112.273 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.25 -26.29 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 0.0 111.176 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -91.54 3.26 55.41 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.362 1.065 . . . . 0.0 113.711 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -98.33 -49.56 4.64 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.188 -0.945 . . . . 0.0 111.256 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.99 -22.37 65.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.014 1.725 . . . . 0.0 113.588 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.49 -25.1 64.8 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.921 -1.112 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -123.72 86.24 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.895 1.278 . . . . 0.0 111.041 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -110.55 150.29 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.898 1.279 . . . . 0.0 111.763 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 125.69 43.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 160.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.37 118.33 30.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 164.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -133.87 129.94 37.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.601 1.161 . . . . 0.0 109.321 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.36 153.67 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.534 1.534 . . . . 0.0 111.71 -171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.293 0 C-N-CA 125.734 1.614 . . . . 0.0 113.551 173.282 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.554 0.216 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.79 -45.31 70.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.29 2.236 . . . . 0.0 113.48 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.16 -17.2 69.99 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.111 1.339 . . . . 0.0 113.635 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.76 -31.93 63.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.612 1.206 . . . . 0.0 111.911 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.48 -27.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.157 -0.965 . . . . 0.0 111.61 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -81.83 -57.73 3.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.125 1.37 . . . . 0.0 110.23 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.08 -36.3 72.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.708 1.203 . . . . 0.0 112.444 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -73.21 -31.68 64.33 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.37 1.068 . . . . 0.0 111.484 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 tp -74.2 -34.33 63.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.071 0.851 . . . . 0.0 112.034 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.84 -44.82 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.591 -1.318 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -72.15 -14.23 61.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -56.48 -39.24 72.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.442 0.297 . . . . 0.0 110.491 165.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -79.27 -39.7 32.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -97.23 85.75 3.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 123.293 1.52 . . . . 0.0 112.031 -163.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.04 27.61 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.826 -1.534 . . . . 0.0 114.126 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 t -84.52 -52.82 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.346 0.658 . . . . 0.0 112.276 -163.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 69.78 -75.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.813 2.045 . . . . 0.0 112.554 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.29 -29.63 67.55 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.878 -1.138 . . . . 0.0 113.662 -167.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -81.55 0.75 36.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-30 -102.7 -17.57 15.58 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.704 2.001 . . . . 0.0 111.912 169.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -89.42 159.37 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.597 1.959 . . . . 0.0 112.18 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 -4.64 65.28 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.069 1.319 . . . . 0.0 114.873 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -140.06 -178.06 5.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.437 1.895 . . . . 0.0 111.882 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 164.01 21.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 109.75 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 t -156.79 144.54 19.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.942 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.11 128.85 45.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.11 1.364 . . . . 0.0 110.468 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -140.88 171.4 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -136.39 130.61 33.02 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.401 -0.812 . . . . 0.0 112.121 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.9 133.66 47.63 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.557 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -117.07 102.93 9.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.264 1.426 . . . . 0.0 109.245 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.17 160.67 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.98 0.895 . . . . 0.0 111.691 -176.1 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.2 pt -101.69 122.35 47.91 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.809 1.644 . . . . 0.0 109.857 167.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 126.01 19.5 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.153 2.569 . . . . 0.0 110.88 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.3 m -118.71 -30.95 4.98 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.211 1.404 . . . . 0.0 111.967 -172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.75 -36.78 4.05 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 125.189 1.376 . . . . 0.0 113.716 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -71.48 -32.57 68.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.115 0.966 . . . . 0.0 110.527 161.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.05 -155.94 11.09 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 127.783 2.611 . . . . 0.0 110.897 172.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.43 163.61 13.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.205 1.003 . . . . 0.0 109.74 154.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.3 146.98 51.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 110.879 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.21 111.88 2.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.339 0.518 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.67 -46.78 3.11 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.304 1.43 . . . . 0.0 110.808 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.1 m -155.3 153.54 30.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.722 1.209 . . . . 0.0 111.452 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.25 132.16 45.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.618 1.167 . . . . 0.0 109.631 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 m -115.8 129.24 56.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.661 1.984 . . . . 0.0 107.494 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.79 136.49 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.397 0.999 . . . . 0.0 109.121 167.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.27 -49.7 3.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 119.083 -0.484 . . . . 0.0 109.996 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -171.39 170.3 5.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.32 1.848 . . . . 0.0 111.933 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.74 -175.32 32.11 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 124.731 1.158 . . . . 0.0 113.334 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.19 113.39 22.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 m -57.66 -20.19 31.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -155.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -54.32 -30.06 49.95 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 112.972 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.65 -50.59 7.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.202 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 m -45.09 -48.49 11.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.93 1.241 . . . . 0.0 113.604 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -29.29 69.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.427 1.091 . . . . 0.0 113.714 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.86 -52.05 5.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.403 1.481 . . . . 0.0 112.526 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.4 t -56.68 -48.3 77.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.057 0.943 . . . . 0.0 110.739 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -49.33 -47.28 47.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.589 1.556 . . . . 0.0 111.277 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -70.0 -44.48 69.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.809 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.443 1.019 . . . . 0.0 111.884 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -66.77 -23.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.599 -1.313 . . . . 0.0 111.556 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.88 -4.33 54.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.075 0.95 . . . . 0.0 112.735 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.06 -11.84 2.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.494 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.0 m -58.34 149.41 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.577 1.081 . . . . 0.0 112.584 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -71.96 -46.27 58.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.4 p 170.29 144.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.708 2.003 . . . . 0.0 111.891 -173.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.6 m-85 -99.74 110.44 58.96 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 110.184 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.98 131.11 10.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.381 2.054 . . . . 0.0 111.073 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.63 143.44 78.84 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.734 1.213 . . . . 0.0 112.324 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 -45.72 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.233 2.622 . . . . 0.0 111.24 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -126.63 154.53 43.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.722 2.009 . . . . 0.0 111.028 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -119.5 13.26 12.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 114.338 -161.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -80.35 143.45 55.92 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 120.814 -1.179 . . . . 0.0 109.741 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.61 -1.74 3.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.641 2.894 . . . . 0.0 114.159 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.2 -43.95 12.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.53 1.059 . . . . 0.0 111.652 167.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.84 -23.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.359 1.063 . . . . 0.0 112.902 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.76 -26.68 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.99 0.916 . . . . 0.0 110.468 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.2 -4.41 59.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.114 0.965 . . . . 0.0 113.506 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -96.02 -53.21 3.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.569 1.077 . . . . 0.0 111.296 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.8 pp -62.47 -25.55 68.05 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.242 1.417 . . . . 0.0 113.009 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.42 -24.94 63.9 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.427 -1.421 . . . . 0.0 113.472 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -125.41 83.81 2.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.4 1.48 . . . . 0.0 110.76 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.585 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.63 156.19 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.948 1.299 . . . . 0.0 112.193 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -92.54 136.31 33.33 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 154.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.76 116.03 26.73 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 154.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -134.56 128.17 32.73 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 109.5 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.95 159.28 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.865 1.666 . . . . 0.0 110.889 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.108 0 C-N-CA 126.072 1.749 . . . . 0.0 111.401 -176.888 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.68 -42.13 67.63 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.081 2.152 . . . . 0.0 114.12 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.99 -17.3 59.67 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.68 1.61 . . . . 0.0 114.16 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.93 -31.26 56.52 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.706 1.253 . . . . 0.0 112.615 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -59.79 -26.87 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 111.969 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.01 -59.11 2.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.609 1.164 . . . . 0.0 110.176 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.746 1.219 . . . . 0.0 112.46 -172.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.81 -42.89 69.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.487 1.115 . . . . 0.0 110.239 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.86 -29.88 69.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.798 0.726 . . . . 0.0 111.947 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.52 -52.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -17.74 63.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -55.26 -34.38 63.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.811 0.444 . . . . 0.0 111.648 165.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -79.19 -33.4 43.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 81.2 1.87 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.004 1.321 . . . . 0.0 109.166 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.59 43.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.011 1.324 . . . . 0.0 112.829 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -78.25 -57.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.238 1.415 . . . . 0.0 111.802 -165.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 72.03 -50.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.954 2.501 . . . . 0.0 113.152 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.9 -32.62 73.93 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 113.728 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 m -89.9 0.35 57.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -111.8 -23.76 10.41 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.019 1.728 . . . . 0.0 112.267 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.52 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 112.804 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.16 -11.23 30.63 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.391 1.472 . . . . 0.0 114.925 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -170.2 2.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.053 2.141 . . . . 0.0 111.065 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.41 162.96 26.86 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.597 176.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.425 ' HB3' HD23 ' A' ' 85' ' ' LEU . 52.6 t -156.23 144.59 19.91 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 109.839 168.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.73 129.95 49.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.118 1.367 . . . . 0.0 110.648 165.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -142.8 170.19 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.905 1.282 . . . . 0.0 107.824 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -134.6 130.64 36.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.569 0.748 . . . . 0.0 111.66 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.6 132.43 47.26 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.225 1.01 . . . . 0.0 110.316 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.47 102.22 9.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.191 1.396 . . . . 0.0 108.903 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.25 159.84 14.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.26 1.029 . . . . 0.0 111.565 -178.217 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.7 pt -103.87 146.6 32.83 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 126.111 1.764 . . . . 0.0 109.837 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.14 133.29 17.76 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 110.525 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -3.37 16.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.019 1.328 . . . . 0.0 113.121 175.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 -55.44 1.0 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 126.292 1.901 . . . . 0.0 112.441 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.6 p -79.94 -24.28 41.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.775 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.75 -159.11 10.11 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.086 1.803 . . . . 0.0 111.686 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -108.74 164.94 11.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.87 0.868 . . . . 0.0 110.871 164.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.73 145.3 49.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.592 1.957 . . . . 0.0 110.787 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.27 112.49 1.95 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.075 0.852 . . . . 0.0 112.135 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.72 -36.15 4.89 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.432 1.492 . . . . 0.0 112.034 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -164.83 154.44 13.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.408 1.483 . . . . 0.0 111.533 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -130.61 126.74 37.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.274 1.03 . . . . 0.0 109.791 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.8 m -110.62 118.73 37.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.946 1.698 . . . . 0.0 107.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.25 134.32 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.185 0.902 . . . . 0.0 109.632 170.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 mt -107.09 -49.21 3.32 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.997 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -173.38 166.24 4.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.65 1.58 . . . . 0.0 111.618 172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.76 -177.44 35.37 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 125.164 1.364 . . . . 0.0 114.011 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.31 116.69 21.92 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -56.28 -25.36 48.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -151.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -51.25 -38.18 51.23 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.917 1.287 . . . . 0.0 112.666 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 58' ' ' CYS . 15.3 tp -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.053 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.99 -28.66 67.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.5 1.5 . . . . 0.0 114.138 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 -44.26 69.16 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.895 0.77 . . . . 0.0 112.666 170.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.13 -54.61 12.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.66 1.184 . . . . 0.0 113.549 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.7 t -54.67 -48.52 72.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.506 0.723 . . . . 0.0 110.514 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -52.13 -45.75 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.658 1.583 . . . . 0.0 112.048 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.6 mtp-105 -63.81 -42.32 97.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.121 0.568 . . . . 0.0 112.019 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.81 74.76 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 89' ' ' THR . 1.9 t -62.83 -25.08 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.253 -1.529 . . . . 0.0 112.383 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.2 -7.7 57.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.728 0.811 . . . . 0.0 112.804 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.31 -12.74 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.8 m -58.09 146.68 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.415 1.086 . . . . 0.0 112.681 173.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -68.74 -41.98 78.2 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 p 163.41 139.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.448 2.299 . . . . 0.0 110.96 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 39.7 m-85 -91.95 113.03 57.67 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.154 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.26 118.82 5.07 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.249 1.966 . . . . 0.0 109.926 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 101' ' ' LEU . 1.9 pp -93.17 140.28 23.27 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.909 1.284 . . . . 0.0 112.047 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.06 -31.2 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.271 2.647 . . . . 0.0 113.463 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.76 146.45 49.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.584 1.554 . . . . 0.0 110.049 176.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -102.78 8.13 39.44 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -166.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.02 136.33 57.89 Favored Pre-proline 0 C--O 1.241 0.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.366 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.61 -5.11 8.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.807 2.338 . . . . 0.0 113.465 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.32 -35.93 21.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.965 0.802 . . . . 0.0 112.063 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.18 -27.72 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.25 1.02 . . . . 0.0 112.814 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -57.26 -27.1 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.705 0.802 . . . . 0.0 110.874 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 30.4 mm-40 -82.07 -6.64 59.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.075 1.35 . . . . 0.0 114.094 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -92.54 -55.71 3.29 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.365 -0.834 . . . . 0.0 111.314 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.99 -27.62 65.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.885 1.274 . . . . 0.0 112.991 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 ptmt -67.68 -23.07 65.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.063 -1.648 . . . . 0.0 114.048 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -122.68 86.28 2.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.45 1.1 . . . . 0.0 110.877 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.559 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -109.11 151.55 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.615 1.166 . . . . 0.0 111.978 175.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -90.72 129.52 36.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 154.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -86.03 111.77 20.61 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.7 m -131.8 126.32 34.07 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.06 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.89 151.83 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 126.486 1.914 . . . . 0.0 110.641 -178.752 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 77.19 -44.13 0.44 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.714 2.806 . . . . 0.0 113.766 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 77.07 5.61 3.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.416 2.286 . . . . 0.0 114.363 164.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -93.67 -20.71 19.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.501 0.721 . . . . 0.0 112.809 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.21 -23.07 0.34 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.626 1.57 . . . . 0.0 113.634 -166.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -55.84 -13.57 1.87 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -169.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -52.64 -29.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.949 0.9 . . . . 0.0 112.399 168.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 t -65.86 -24.89 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.924 1.29 . . . . 0.0 114.346 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.4 m -88.37 -31.53 18.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.522 0.729 . . . . 0.0 111.714 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.83 -33.79 72.79 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.404 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.55 -25.61 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.293 1.406 . . . . 0.0 111.231 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.05 70.25 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.22 1.867 . . . . 0.0 113.915 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -99.58 -55.77 2.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.194 1.497 . . . . 0.0 112.19 164.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.86 -46.43 67.87 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.344 2.258 . . . . 0.0 113.395 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.48 -17.39 64.32 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.423 1.487 . . . . 0.0 113.97 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.39 -32.87 64.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.362 1.081 . . . . 0.0 111.993 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 pt -60.56 -28.18 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.735 0.698 . . . . 0.0 111.919 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -80.59 -58.89 2.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.359 1.064 . . . . 0.0 109.58 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -60.52 -35.4 75.87 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.75 1.22 . . . . 0.0 112.645 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -73.56 -32.38 64.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.459 1.104 . . . . 0.0 111.603 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -73.71 -32.65 64.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.871 0.759 . . . . 0.0 111.681 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.83 -56.46 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -65.2 -21.46 66.76 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.26 -9.26 59.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.72 -41.76 23.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.4 1.0 . . . . 0.0 111.374 163.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.99 86.39 2.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.232 1.413 . . . . 0.0 109.57 -173.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.76 39.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.052 1.741 . . . . 0.0 113.971 -173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.05 -60.01 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.957 0.903 . . . . 0.0 111.82 -166.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 72.73 -53.15 0.7 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.781 2.433 . . . . 0.0 114.148 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.47 -32.6 74.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 113.418 -171.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.8 p -96.6 5.64 50.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.093 1.357 . . . . 0.0 113.335 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.55 -27.4 13.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.232 1.813 . . . . 0.0 111.382 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -93.66 173.41 7.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.662 1.985 . . . . 0.0 112.657 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.66 -32.35 1.9 Allowed Glycine 0 N--CA 1.481 1.649 0 C-N-CA 125.811 1.672 . . . . 0.0 114.795 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -167.38 1.47 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.119 2.168 . . . . 0.0 110.675 165.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 158.63 38.03 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.28 -0.888 . . . . 0.0 110.442 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -156.46 150.16 24.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.612 1.165 . . . . 0.0 110.171 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.99 118.8 10.53 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.861 1.664 . . . . 0.0 110.589 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.38 171.05 14.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.413 1.085 . . . . 0.0 108.301 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.91 124.15 14.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.658 0.783 . . . . 0.0 110.402 -166.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.62 128.78 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.93 0.892 . . . . 0.0 109.074 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -117.6 105.9 12.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.379 1.472 . . . . 0.0 109.186 171.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.04 160.66 14.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.397 1.079 . . . . 0.0 111.397 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 pt -101.71 152.87 38.18 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.758 1.623 . . . . 0.0 110.2 167.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.73 151.76 46.73 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.175 2.583 . . . . 0.0 111.183 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -168.36 148.66 4.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.584 2.354 . . . . 0.0 108.273 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.63 74.7 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 -164.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -96.56 -6.06 37.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.579 1.552 . . . . 0.0 113.15 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.83 165.83 10.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.713 1.625 . . . . 0.0 111.598 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -65.64 161.4 20.55 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 117.959 0.879 . . . . 0.0 111.014 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.76 143.35 50.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.223 1.409 . . . . 0.0 111.159 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.3 109.59 0.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.88 -45.3 3.66 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.462 1.506 . . . . 0.0 110.938 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.4 m -156.06 146.33 21.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.344 1.058 . . . . 0.0 110.299 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.21 124.94 41.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.067 0.947 . . . . 0.0 109.927 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.9 m -104.77 121.49 43.73 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.006 1.323 . . . . 0.0 108.279 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.61 126.61 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 165.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.57 -40.44 6.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.048 0.539 . . . . 0.0 110.783 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -170.79 172.74 5.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.765 1.626 . . . . 0.0 111.462 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.57 172.33 17.57 Favored Glycine 0 N--CA 1.465 0.587 0 C-N-CA 125.981 1.753 . . . . 0.0 114.128 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -76.81 122.04 24.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.1 p -56.37 -27.42 56.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -157.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -56.68 -25.36 53.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.617 1.167 . . . . 0.0 113.865 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 tp -91.34 -59.57 2.11 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.066 1.303 . . . . 0.0 112.377 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.4 p -56.88 -31.79 65.19 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 121.137 1.789 . . . . 0.0 114.861 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.2 71.93 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.439 1.018 . . . . 0.0 112.658 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.37 -53.4 12.42 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.917 1.287 . . . . 0.0 112.006 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.5 t -54.55 -50.36 68.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.245 1.018 . . . . 0.0 110.608 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -51.14 -47.49 62.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.847 1.659 . . . . 0.0 111.755 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.98 -40.63 96.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 112.277 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.66 82.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.275 1.43 . . . . 0.0 112.453 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -63.01 -26.81 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.568 -1.332 . . . . 0.0 112.15 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.05 55.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.915 0.886 . . . . 0.0 112.991 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.54 -10.56 3.18 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -175.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.3 m -52.1 150.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.23 -50.13 49.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.017 0.927 . . . . 0.0 112.581 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p 168.67 147.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.459 2.704 . . . . 0.0 110.387 -173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -97.51 106.3 31.81 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.234 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.91 116.93 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.716 1.611 . . . . 0.0 110.647 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 142.43 28.48 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.043 1.337 . . . . 0.0 110.722 173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.86 -24.17 11.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.34 2.693 . . . . 0.0 112.586 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.3 -179.93 6.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.39 1.476 . . . . 0.0 112.44 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -155.86 15.32 0.35 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.472 1.109 . . . . 0.0 113.086 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.28 129.09 32.85 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 120.637 -1.289 . . . . 0.0 108.967 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.64 -4.09 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.559 3.506 . . . . 0.0 115.801 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.51 -43.39 15.81 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.833 1.197 . . . . 0.0 112.141 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.12 -22.52 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.603 1.161 . . . . 0.0 112.609 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.3 t -55.2 -27.12 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.956 0.902 . . . . 0.0 110.903 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.65 -7.59 59.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.032 1.333 . . . . 0.0 113.81 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -45.69 6.14 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.046 -1.034 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -72.65 -23.19 60.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.998 0.919 . . . . 0.0 111.823 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -65.97 -22.12 66.45 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -125.52 79.34 1.81 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.605 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -102.19 158.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.48 1.112 . . . . 0.0 111.776 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 -112.39 123.62 50.67 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 159.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.24 111.28 20.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -134.21 125.66 28.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.79 1.236 . . . . 0.0 108.931 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.76 149.88 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.727 1.611 . . . . 0.0 110.631 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.01 165.0 5.99 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 126.658 1.983 . . . . 0.0 111.201 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.13 154.47 67.3 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.574 2.85 . . . . 0.0 112.781 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 125.11 1.364 . . . . 0.0 111.184 178.642 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.44 165.0 12.77 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -156.58 19.11 0.33 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.389 1.476 . . . . 0.0 113.336 -167.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -99.11 -20.76 16.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.473 . . . . 0.0 112.076 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.7 -17.21 0.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.052 1.741 . . . . 0.0 112.7 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.03 5.41 0.14 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.107 2.163 . . . . 0.0 116.035 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -57.18 -29.79 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.806 1.242 . . . . 0.0 112.661 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -57.97 -48.41 80.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.068 0.947 . . . . 0.0 111.878 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -63.29 -30.79 71.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.461 1.104 . . . . 0.0 112.159 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -72.03 -19.69 61.8 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.908 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.7 t -59.37 -31.44 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 121.643 2.02 . . . . 0.0 111.027 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.07 -9.29 66.54 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.44 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -105.2 -46.41 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.287 1.435 . . . . 0.0 110.943 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.74 -43.09 65.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.431 1.892 . . . . 0.0 113.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.56 68.28 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.841 1.21 . . . . 0.0 114.011 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.59 -35.07 70.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 111.366 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -59.6 -28.44 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.545 -0.722 . . . . 0.0 112.122 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -80.36 -58.86 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.968 1.307 . . . . 0.0 109.547 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.51 -35.53 74.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.553 1.141 . . . . 0.0 112.695 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -74.45 -30.27 61.8 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.726 1.21 . . . . 0.0 111.781 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -75.47 -34.49 60.9 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.531 1.059 . . . . 0.0 111.479 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.53 -44.44 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.295 1.038 . . . . 0.0 111.058 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.95 -14.37 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.884 0.874 . . . . 0.0 113.164 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -55.52 -35.53 65.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.268 0.227 . . . . 0.0 111.137 164.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -81.7 -30.71 32.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 111.538 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -143.95 81.22 1.68 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.418 1.487 . . . . 0.0 109.531 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.48 38.09 0.18 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.413 1.485 . . . . 0.0 113.786 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.31 -51.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.97 0.908 . . . . 0.0 112.892 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 70.82 -59.01 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.779 2.432 . . . . 0.0 113.71 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.06 -34.34 77.84 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.076 -1.015 . . . . 0.0 113.464 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -87.8 -1.32 57.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 113.612 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -100.4 -24.4 14.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.774 1.629 . . . . 0.0 111.702 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -91.32 172.51 8.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.372 2.269 . . . . 0.0 111.373 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.47 -34.02 2.04 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -168.64 1.59 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.573 1.949 . . . . 0.0 110.748 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 160.6 32.75 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 110.703 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.429 ' HB3' HD23 ' A' ' 85' ' ' LEU . 44.6 t -157.46 149.02 21.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.506 1.122 . . . . 0.0 110.171 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 122.82 20.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.989 1.716 . . . . 0.0 110.368 167.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.54 163.11 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.591 1.156 . . . . 0.0 108.005 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -133.34 130.69 39.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.343 0.657 . . . . 0.0 112.128 -174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.44 129.76 46.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 110.084 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.47 103.82 11.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.424 1.489 . . . . 0.0 108.774 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.29 158.41 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.533 0.683 . . . . 0.0 111.757 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.16 140.09 21.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 109.861 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.85 125.42 9.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.436 2.091 . . . . 0.0 109.833 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.2 m -110.81 -31.0 7.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.695 1.198 . . . . 0.0 111.871 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.62 -117.04 0.7 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.191 1.377 . . . . 0.0 110.756 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -66.7 -4.98 10.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.393 1.477 . . . . 0.0 113.871 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.47 174.04 24.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.434 1.492 . . . . 0.0 114.27 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -104.57 163.87 12.16 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 111.717 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.78 147.15 50.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.435 1.894 . . . . 0.0 111.4 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.94 111.61 1.55 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.52 0.6 . . . . 0.0 112.133 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 -45.78 3.69 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.406 1.479 . . . . 0.0 111.15 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.4 m -157.33 152.86 26.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.747 1.219 . . . . 0.0 110.463 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.98 126.93 40.65 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.218 1.007 . . . . 0.0 110.214 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.7 m -106.8 120.87 43.18 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.638 1.975 . . . . 0.0 107.938 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -87.57 127.11 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.2 0.909 . . . . 0.0 108.779 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.29 -39.42 6.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.265 0.626 . . . . 0.0 110.896 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -170.25 168.83 8.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 111.849 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.8 173.84 19.9 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 125.283 1.421 . . . . 0.0 114.753 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.62 117.85 20.92 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.7 p -59.15 -19.76 47.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -159.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -55.85 -29.96 60.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.906 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 58' ' ' CYS . 18.0 tp -86.53 -52.31 5.64 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.84 1.2 . . . . 0.0 111.444 171.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 m -46.64 -46.8 20.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.741 1.155 . . . . 0.0 113.635 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.86 -42.3 67.05 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.009 0.822 . . . . 0.0 112.041 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' A' ' 47' ' ' LEU . . . -61.69 -58.74 6.85 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.512 1.125 . . . . 0.0 112.531 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.64 -50.41 73.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.864 0.466 . . . . 0.0 110.168 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -51.74 -47.54 64.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.227 1.411 . . . . 0.0 111.876 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.02 -40.61 96.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.228 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.4 -49.3 74.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.763 1.225 . . . . 0.0 112.203 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -64.32 -24.06 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.633 -1.292 . . . . 0.0 111.723 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.78 -7.13 57.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 112.66 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -12.74 2.5 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.0 m -58.45 146.56 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.231 1.013 . . . . 0.0 112.628 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -66.52 -46.05 77.45 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p 167.6 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.854 2.062 . . . . 0.0 111.0 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 29.4 m-85 -96.24 109.38 47.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.666 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.05 132.0 14.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.424 2.083 . . . . 0.0 109.969 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.99 145.94 66.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.667 -173.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.66 -28.79 7.82 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.095 2.53 . . . . 0.0 111.181 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -140.42 150.58 44.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.925 2.09 . . . . 0.0 110.621 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -119.88 23.03 11.28 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.928 1.291 . . . . 0.0 112.888 -164.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -85.86 142.13 36.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.584 -1.323 . . . . 0.0 109.946 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -63.09 -4.57 6.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.484 2.789 . . . . 0.0 113.796 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.38 -33.44 19.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.597 1.159 . . . . 0.0 111.98 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 -24.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.202 1.001 . . . . 0.0 112.23 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.55 -25.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.23 1.012 . . . . 0.0 111.362 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -84.13 -7.36 59.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.978 1.311 . . . . 0.0 114.323 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 -46.52 5.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.905 0.882 . . . . 0.0 111.23 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.0 pp -74.42 -20.33 60.08 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.571 1.548 . . . . 0.0 113.205 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -63.56 -23.9 67.58 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.699 -1.25 . . . . 0.0 113.354 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.34 80.09 1.92 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.985 1.314 . . . . 0.0 109.933 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -106.39 150.95 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.002 . . . . 0.0 111.828 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.82 130.57 44.07 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 160.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.84 111.95 23.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 156.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.0 m -134.6 126.45 29.25 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.704 1.202 . . . . 0.0 109.254 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.1 m -138.78 151.71 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.377 1.471 . . . . 0.0 110.495 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.06 165.08 5.91 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.26 1.824 . . . . 0.0 111.583 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.54 166.14 16.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.737 2.958 . . . . 0.0 112.331 171.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 . . . . . 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 111.938 -178.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.38 167.34 8.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.954 1.302 . . . . 0.0 111.537 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -166.64 19.9 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 113.187 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -105.37 -20.37 13.51 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 0.0 112.704 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.93 -9.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.146 1.379 . . . . 0.0 114.083 -166.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -72.43 1.33 8.15 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -157.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -54.82 -33.88 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.167 0.987 . . . . 0.0 112.044 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -59.25 -38.21 79.49 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.951 0.9 . . . . 0.0 112.584 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 t -78.23 -23.57 47.34 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.188 -0.945 . . . . 0.0 113.005 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -72.08 -33.95 68.29 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.327 -0.858 . . . . 0.0 111.981 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.4 t -66.6 -27.62 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 120.351 1.432 . . . . 0.0 110.712 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.85 1.44 30.96 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.196 1.379 . . . . 0.0 114.638 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -132.59 -64.79 0.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.714 1.606 . . . . 0.0 111.438 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.58 -18.55 41.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 128.027 2.531 . . . . 0.0 116.219 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.66 -13.13 8.94 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.138 1.827 . . . . 0.0 113.945 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.37 -32.18 43.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.034 1.734 . . . . 0.0 110.755 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 pt -62.0 -28.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.186 -1.571 . . . . 0.0 112.15 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.75 -56.97 4.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.513 1.125 . . . . 0.0 110.098 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.83 -35.03 72.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.364 1.066 . . . . 0.0 112.641 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -70.31 -31.21 68.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.472 1.509 . . . . 0.0 112.307 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.0 tp -79.96 -35.24 37.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.605 0.362 . . . . 0.0 111.824 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -68.22 -53.11 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.777 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -59.06 -26.87 64.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.493 0.717 . . . . 0.0 112.289 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -15.16 60.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -81.43 -40.1 23.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.039 0.836 . . . . 0.0 111.718 161.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.2 88.07 5.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 123.383 1.563 . . . . 0.0 111.607 -163.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 27.02 0.4 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.863 -1.517 . . . . 0.0 114.121 -175.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.45 -56.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.741 0.816 . . . . 0.0 112.563 -163.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.3 -57.59 0.63 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.001 2.521 . . . . 0.0 113.757 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.85 -24.13 62.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 112.937 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.6 m -84.06 -1.27 54.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.608 1.163 . . . . 0.0 113.623 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-85 -117.5 -21.17 8.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.526 1.53 . . . . 0.0 113.179 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -85.44 152.1 23.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.315 1.846 . . . . 0.0 112.713 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 -8.49 28.3 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.365 1.459 . . . . 0.0 116.126 168.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.4 -179.55 4.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.149 1.779 . . . . 0.0 112.052 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 160.92 20.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.652 0.781 . . . . 0.0 111.29 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 49.0 t -159.51 144.19 15.29 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.449 1.1 . . . . 0.0 109.877 172.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.29 39.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.846 2.059 . . . . 0.0 110.031 168.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.25 175.08 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.277 1.031 . . . . 0.0 108.568 171.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.08 126.76 20.45 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.941 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.75 128.75 53.89 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.128 0.971 . . . . 0.0 109.007 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -116.69 106.92 14.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.96 1.304 . . . . 0.0 109.117 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.28 157.77 16.16 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.605 1.162 . . . . 0.0 111.772 -176.211 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.86 151.19 37.45 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.723 1.609 . . . . 0.0 110.154 167.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -72.52 150.42 51.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.137 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -166.47 148.17 6.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.487 2.315 . . . . 0.0 108.062 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.74 -17.66 71.42 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.776 1.071 . . . . 0.0 115.776 -165.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.3 p -97.14 -3.43 41.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.971 1.708 . . . . 0.0 113.127 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.26 165.42 11.45 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.161 1.363 . . . . 0.0 111.937 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -67.58 161.28 26.0 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.366 1.083 . . . . 0.0 111.115 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.21 144.58 51.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 111.127 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.65 112.2 1.91 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.427 0.558 . . . . 0.0 112.04 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.1 -46.11 3.16 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.026 1.298 . . . . 0.0 111.012 170.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.7 m -153.03 143.69 22.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.368 1.067 . . . . 0.0 110.682 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -119.21 121.86 40.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.258 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -104.8 118.31 36.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.405 1.482 . . . . 0.0 108.26 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 m -83.97 129.05 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 118.892 0.769 . . . . 0.0 109.732 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 mt -99.18 -54.32 3.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.009 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -177.87 164.8 1.96 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.721 2.008 . . . . 0.0 111.433 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.25 -173.71 39.44 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 125.57 1.557 . . . . 0.0 113.528 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.99 116.92 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.4 p -55.9 -26.31 46.83 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -150.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.83 -29.44 69.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.93 -47.37 16.54 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.722 1.147 . . . . 0.0 111.107 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 68.8 m -48.56 -45.07 37.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.632 1.106 . . . . 0.0 112.359 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.25 -47.93 75.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.628 1.171 . . . . 0.0 112.177 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.79 41.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.058 0.943 . . . . 0.0 113.266 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -56.8 -48.49 77.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.809 0.844 . . . . 0.0 110.845 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -48.71 -44.12 37.9 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.303 1.841 . . . . 0.0 111.953 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -70.57 -45.92 64.48 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.25 74.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.701 1.2 . . . . 0.0 111.161 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -67.08 -22.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.996 -1.065 . . . . 0.0 112.268 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -7.44 59.1 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.001 0.92 . . . . 0.0 112.538 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.18 -12.54 3.58 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.6 m -56.52 145.56 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.485 1.114 . . . . 0.0 112.783 171.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.7 -44.68 77.13 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.0 p 165.59 142.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.214 2.205 . . . . 0.0 110.848 -169.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.0 m-85 -93.21 111.27 51.13 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.693 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.18 128.85 10.85 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.217 1.945 . . . . 0.0 110.567 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.34 148.36 52.5 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.577 0.751 . . . . 0.0 112.118 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.06 -33.35 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.92 2.414 . . . . 0.0 111.075 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 153.78 45.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.161 2.184 . . . . 0.0 110.358 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -119.87 20.2 12.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.318 1.447 . . . . 0.0 113.406 -166.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -83.2 139.8 42.25 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 120.757 -1.214 . . . . 0.0 109.3 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.66 -15.74 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.461 2.774 . . . . 0.0 114.945 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.15 -28.62 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.973 1.309 . . . . 0.0 112.077 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.68 -26.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.582 1.553 . . . . 0.0 112.5 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.37 -26.27 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.49 1.116 . . . . 0.0 110.959 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.41 -11.49 59.68 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.233 1.413 . . . . 0.0 113.714 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -97.51 -46.52 6.01 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.914 0.779 . . . . 0.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.1 pp -73.07 -22.52 60.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.796 1.238 . . . . 0.0 112.92 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.38 -23.93 66.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.07 82.35 2.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.006 0.923 . . . . 0.0 110.238 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.2 158.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.36 1.076 . . . . 0.0 111.968 178.522 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 -108.06 126.09 52.33 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 157.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.59 112.47 21.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.5 m -132.1 125.84 32.31 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 109.054 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.24 149.99 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.251 1.82 . . . . 0.0 110.293 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.89 156.63 8.58 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.551 1.54 . . . . 0.0 112.197 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.913 3.075 . . . . 0.0 111.517 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.244 0.799 0 C-N-CA 123.86 0.864 . . . . 0.0 111.68 177.904 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -165.29 -67.42 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.11 0.964 . . . . 0.0 111.525 -168.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 72.53 12.68 5.49 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.751 2.021 . . . . 0.0 114.101 171.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -94.42 -19.36 20.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.953 0.901 . . . . 0.0 113.118 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.95 -22.79 0.45 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.829 1.251 . . . . 0.0 113.966 -166.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.68 -16.97 18.74 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -166.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 m -56.26 -28.88 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.91 1.284 . . . . 0.0 112.806 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 t -58.23 -33.02 68.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.262 1.025 . . . . 0.0 112.965 171.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -80.96 -27.04 36.17 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.314 -0.867 . . . . 0.0 113.11 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.95 -34.99 77.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.338 0.972 . . . . 0.0 111.023 165.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.0 -28.25 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 119.889 1.222 . . . . 0.0 110.202 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.52 1.75 60.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.567 2.032 . . . . 0.0 114.07 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 38' ' ' ILE . 46.5 mtt180 -111.42 -57.93 2.18 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.917 1.358 . . . . 0.0 111.112 162.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -49.89 -47.62 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.161 2.184 . . . . 0.0 114.038 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.4 -16.14 62.87 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.052 1.31 . . . . 0.0 113.779 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.64 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.92 -34.5 64.37 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.251 1.026 . . . . 0.0 111.645 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 3.7 pt -60.03 -26.3 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.519 -0.738 . . . . 0.0 111.994 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -82.08 -59.87 2.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.494 1.118 . . . . 0.0 109.837 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -61.17 -35.14 76.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.254 1.022 . . . . 0.0 112.775 -171.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -71.38 -43.02 67.66 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.165 0.986 . . . . 0.0 109.757 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.57 -30.33 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.672 0.669 . . . . 0.0 111.543 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -69.87 -54.0 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.844 0.858 . . . . 0.0 110.915 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -68.05 -18.07 64.58 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -55.85 -36.45 67.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.256 0.48 . . . . 0.0 111.389 167.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -77.51 -34.35 54.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -102.35 109.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.542 1.163 . . . . 0.0 111.14 -160.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.65 22.03 10.51 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 114.628 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.8 -62.56 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.332 0.653 . . . . 0.0 111.545 -166.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 72.86 -60.04 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.769 2.428 . . . . 0.0 113.506 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.6 -29.77 70.98 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.611 -1.305 . . . . 0.0 113.14 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -94.8 6.07 50.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.31 1.044 . . . . 0.0 113.655 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.4 m-30 -105.31 -21.94 13.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 112.085 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -100.64 156.3 17.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.596 1.958 . . . . 0.0 111.905 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.48 -27.27 2.89 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.274 1.416 . . . . 0.0 114.556 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -174.68 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.494 1.918 . . . . 0.0 111.557 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 161.62 29.62 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.815 0.846 . . . . 0.0 110.643 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.95 157.87 43.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.553 0.741 . . . . 0.0 111.433 160.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 126.03 31.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.84 1.656 . . . . 0.0 109.967 161.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.94 166.33 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -135.15 131.29 36.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.508 0.594 . . . . 0.0 112.065 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 132.18 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.159 0.984 . . . . 0.0 110.037 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -114.4 105.98 13.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.341 1.456 . . . . 0.0 109.147 171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -100.2 158.81 15.59 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.56 0.695 . . . . 0.0 111.748 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -99.3 133.43 22.03 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.126 1.37 . . . . 0.0 109.843 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.06 116.73 4.83 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.581 2.187 . . . . 0.0 109.207 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 m -106.14 -30.85 8.99 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.546 1.139 . . . . 0.0 112.095 -172.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.24 -112.33 0.49 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.852 1.215 . . . . 0.0 111.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -58.71 -25.28 62.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 112.34 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.76 179.04 20.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.757 1.17 . . . . 0.0 114.472 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -95.24 165.0 12.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.97 1.308 . . . . 0.0 111.515 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -132.82 147.22 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.151 1.781 . . . . 0.0 111.47 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.94 111.23 1.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.764 0.711 . . . . 0.0 112.656 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.35 -36.04 5.53 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.396 1.474 . . . . 0.0 111.668 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -167.26 153.39 7.94 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.266 1.426 . . . . 0.0 111.023 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -130.14 126.29 37.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.319 1.048 . . . . 0.0 109.873 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -105.17 132.98 50.71 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.402 1.881 . . . . 0.0 108.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.14 131.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.943 0.792 . . . . 0.0 109.102 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.56 -45.19 5.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.947 0.499 . . . . 0.0 110.073 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -172.58 167.91 5.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.986 1.715 . . . . 0.0 111.647 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.7 -177.84 27.59 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.893 1.235 . . . . 0.0 114.303 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.4 118.22 24.8 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 166.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.8 p -59.94 -21.27 60.94 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -158.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -60.88 -23.02 64.86 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.381 1.072 . . . . 0.0 113.669 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.44 -49.06 6.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.812 1.187 . . . . 0.0 111.414 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.8 m -49.99 -39.26 40.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.833 1.253 . . . . 0.0 114.322 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.2 56.86 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.04 0.836 . . . . 0.0 112.829 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -51.29 65.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.981 . . . . 0.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.4 t -57.46 -47.6 81.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.454 0.702 . . . . 0.0 110.235 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -57.19 -35.15 69.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.371 1.068 . . . . 0.0 112.157 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -71.26 -48.52 50.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.41 72.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.647 1.179 . . . . 0.0 111.749 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.1 -24.04 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.489 -1.382 . . . . 0.0 111.661 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -6.94 58.83 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.91 -12.14 3.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.7 m -58.76 145.91 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.395 1.078 . . . . 0.0 112.257 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.41 -42.1 83.78 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -173.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p 163.21 143.44 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.56 2.344 . . . . 0.0 111.048 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 20.3 m-85 -98.13 105.32 27.61 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-O 117.527 -1.225 . . . . 0.0 109.948 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 134.35 17.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.817 2.344 . . . . 0.0 110.437 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 144.87 59.22 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.31 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.33 -28.67 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.241 2.627 . . . . 0.0 111.855 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -140.77 154.23 46.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.715 2.006 . . . . 0.0 110.482 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -133.49 48.1 2.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.175 0.99 . . . . 0.0 112.349 -165.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -108.9 141.2 22.84 Favored Pre-proline 0 C--O 1.243 0.733 0 O-C-N 121.35 -0.844 . . . . 0.0 108.802 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.17 -17.55 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.021 3.148 . . . . 0.0 115.182 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.76 -33.85 40.34 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.039 0.836 . . . . 0.0 112.335 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 m -97.26 -25.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.506 1.122 . . . . 0.0 112.611 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.33 -26.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.697 1.199 . . . . 0.0 110.951 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -81.38 -10.7 59.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.001 1.32 . . . . 0.0 114.031 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.77 -47.5 5.57 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.343 -0.848 . . . . 0.0 111.401 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.4 -21.07 61.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.188 . . . . 0.0 112.61 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -65.38 -24.95 67.36 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.726 -1.234 . . . . 0.0 113.42 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -129.92 78.78 1.87 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.044 1.338 . . . . 0.0 110.345 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.584 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.56 150.26 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.156 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -97.52 128.42 44.25 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 159.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.75 116.34 28.93 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.7 m -135.02 128.17 31.85 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.718 1.207 . . . . 0.0 109.679 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -139.65 156.56 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.421 1.488 . . . . 0.0 111.303 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.59 161.57 8.6 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 127.431 2.293 . . . . 0.0 110.003 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.76 163.39 37.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.083 2.522 . . . . 0.0 112.174 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.24 0.558 0 C-N-CA 125.246 1.418 . . . . 0.0 111.088 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.03 -72.08 0.48 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.973 1.309 . . . . 0.0 111.834 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 70.17 13.77 7.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.597 1.959 . . . . 0.0 114.832 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -94.98 -19.45 20.2 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -24.32 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.216 1.406 . . . . 0.0 112.984 -166.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -9.81 17.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -168.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.68 -26.8 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.574 1.55 . . . . 0.0 113.035 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 t -62.68 -24.1 67.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 113.153 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 t -85.35 -30.81 23.37 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.269 -0.894 . . . . 0.0 112.488 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -64.29 -38.18 90.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.753 1.16 . . . . 0.0 111.33 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.24 -24.99 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.305 1.412 . . . . 0.0 111.496 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.61 -8.5 72.06 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.471 1.986 . . . . 0.0 114.566 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -109.0 -47.68 3.4 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.392 1.877 . . . . 0.0 109.936 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -51.3 -42.74 61.38 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 126.837 2.055 . . . . 0.0 113.629 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.72 -17.5 67.91 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.393 1.473 . . . . 0.0 113.711 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.76 -30.27 51.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.794 1.297 . . . . 0.0 112.444 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -57.87 -29.0 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.098 -1.002 . . . . 0.0 111.065 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -79.16 -58.04 3.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.832 1.253 . . . . 0.0 110.161 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.36 -34.33 73.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.303 1.041 . . . . 0.0 112.56 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -72.73 -34.01 66.78 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.06 1.344 . . . . 0.0 111.984 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -70.64 -36.75 73.57 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.436 0.562 . . . . 0.0 111.378 172.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.01 -44.25 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.065 0.946 . . . . 0.0 111.333 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -12.04 59.9 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.083 0.953 . . . . 0.0 113.257 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -57.23 -37.14 71.81 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 161.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -79.96 -49.25 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.625 0.726 . . . . 0.0 109.897 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 mt -89.0 75.33 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 123.341 1.543 . . . . 0.0 111.604 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.01 25.87 0.08 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.35 1.46 . . . . 0.0 114.729 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.99 -61.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.43 0.692 . . . . 0.0 112.408 -159.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 74.24 -47.66 0.64 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.732 2.413 . . . . 0.0 113.321 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.84 -28.43 68.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.967 1.307 . . . . 0.0 112.95 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -90.44 -3.41 57.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.927 1.691 . . . . 0.0 114.303 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -117.75 -29.83 5.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 113.726 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -92.59 164.82 13.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.975 1.31 . . . . 0.0 111.925 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.93 -42.61 2.52 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 125.777 1.656 . . . . 0.0 113.932 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -175.36 5.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.267 1.427 . . . . 0.0 111.438 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 162.46 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.615 -0.678 . . . . 0.0 111.315 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.8 t -157.99 146.16 18.79 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.636 1.175 . . . . 0.0 110.092 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 131.59 48.94 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.149 1.38 . . . . 0.0 111.123 164.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -144.01 171.88 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 120.781 -1.2 . . . . 0.0 108.175 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.72 132.31 40.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.346 -0.846 . . . . 0.0 112.176 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.12 131.08 54.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.938 0.895 . . . . 0.0 109.464 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.08 112.48 24.14 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.07 0.948 . . . . 0.0 109.49 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -104.14 159.22 15.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 111.204 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.8 pt -96.15 150.19 36.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 110.381 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.39 146.29 50.04 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.646 2.231 . . . . 0.0 110.247 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -165.21 147.33 7.82 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.561 1.944 . . . . 0.0 108.359 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.62 -18.59 72.17 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 124.444 1.021 . . . . 0.0 115.599 -168.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -94.13 3.16 55.67 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.409 1.884 . . . . 0.0 113.175 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.34 165.97 14.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.96 1.743 . . . . 0.0 111.335 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.56 159.26 22.12 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.001 0.901 . . . . 0.0 111.321 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -127.88 144.07 51.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.07 1.348 . . . . 0.0 111.182 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.27 113.7 2.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.623 0.647 . . . . 0.0 112.481 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.24 -43.05 2.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.676 1.608 . . . . 0.0 111.41 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -154.51 150.33 27.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.944 0.898 . . . . 0.0 111.434 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.37 131.02 53.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.526 1.131 . . . . 0.0 109.706 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -119.63 119.6 34.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.695 1.598 . . . . 0.0 108.694 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.16 137.23 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.053 0.842 . . . . 0.0 109.929 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -109.65 -50.37 2.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.144 0.578 . . . . 0.0 110.004 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -173.7 170.36 4.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.994 1.718 . . . . 0.0 111.78 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.63 32.73 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 125.326 1.441 . . . . 0.0 113.171 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.96 113.65 20.01 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -58.35 -19.94 39.42 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -153.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -49.61 -37.77 29.19 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.91 1.284 . . . . 0.0 112.681 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.11 -52.17 8.56 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.217 0.917 . . . . 0.0 110.722 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.2 m -46.46 -44.84 17.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.061 1.344 . . . . 0.0 113.421 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.38 82.73 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.925 0.89 . . . . 0.0 112.678 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.91 19.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.579 1.152 . . . . 0.0 112.83 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.0 t -57.37 -46.1 83.71 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.588 0.755 . . . . 0.0 110.617 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -50.29 -42.19 52.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.482 1.913 . . . . 0.0 111.723 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -69.78 -48.53 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.78 80.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.62 1.168 . . . . 0.0 111.693 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.69 -24.32 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.875 -1.141 . . . . 0.0 111.918 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.74 55.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.859 0.864 . . . . 0.0 112.869 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.68 -11.27 2.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.4 m -58.07 148.99 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.415 1.086 . . . . 0.0 112.776 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -70.51 -47.91 58.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 113.099 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 p 170.73 145.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.186 2.194 . . . . 0.0 110.355 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 43.7 m-85 -96.62 108.49 42.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 117.771 -1.109 . . . . 0.0 110.363 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.13 136.28 19.94 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.248 1.965 . . . . 0.0 110.37 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.53 152.91 64.62 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.449 0.7 . . . . 0.0 112.329 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.46 -41.83 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.007 2.471 . . . . 0.0 110.277 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.47 149.28 50.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.023 2.129 . . . . 0.0 109.699 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.37 9.25 19.78 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -164.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.86 144.57 60.08 Favored Pre-proline 0 CA--C 1.539 0.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.98 -2.7 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.324 2.683 . . . . 0.0 113.584 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.863 0.865 . . . . 0.0 112.519 168.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.76 -26.39 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.664 1.186 . . . . 0.0 112.654 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.38 -25.65 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.059 0.944 . . . . 0.0 111.028 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -83.12 -9.1 59.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.897 1.279 . . . . 0.0 113.995 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -42.43 6.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.068 . . . . 0.0 111.693 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.8 pp -74.71 -20.13 59.97 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 124.867 1.267 . . . . 0.0 112.93 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -66.39 -25.56 66.84 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 113.163 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -128.82 81.96 2.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.031 0.932 . . . . 0.0 109.892 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.555 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.56 150.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 111.75 -178.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.73 130.86 35.94 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 153.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -85.3 129.09 34.88 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 157.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.0 m -146.15 127.07 14.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.82 157.25 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.335 1.454 . . . . 0.0 111.127 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.76 -49.28 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.272 1.829 . . . . 0.0 113.642 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.0 167.48 76.76 Favored 'Cis proline' 0 C--N 1.356 0.938 0 CA-C-N 122.17 1.811 . . . . 0.0 112.158 -14.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--O 1.241 0.614 0 C-N-CA 124.16 0.984 . . . . 0.0 111.781 178.719 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -169.56 166.96 9.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.816 0.846 . . . . 0.0 112.926 -165.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 15.53 0.44 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.495 1.918 . . . . 0.0 113.66 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -97.97 -18.62 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.88 1.272 . . . . 0.0 112.066 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -22.6 0.42 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.44 1.896 . . . . 0.0 113.341 -163.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.81 -3.78 5.56 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -165.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -54.19 -30.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.726 1.211 . . . . 0.0 112.494 170.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.5 t -61.58 -48.53 80.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.857 0.863 . . . . 0.0 111.256 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -62.96 -30.91 71.94 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.386 1.074 . . . . 0.0 112.126 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.82 -26.8 62.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.674 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -24.2 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.655 1.57 . . . . 0.0 112.535 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.64 -6.76 44.47 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.035 1.779 . . . . 0.0 113.194 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.9 mmp_? -110.58 -70.92 0.78 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.012 1.725 . . . . 0.0 109.898 161.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -54.38 -49.89 68.8 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.983 2.513 . . . . 0.0 113.915 -162.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.98 -15.43 65.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.969 1.747 . . . . 0.0 114.097 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.14 -30.4 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.647 1.223 . . . . 0.0 111.609 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.2 pt -62.62 -28.49 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.513 -1.367 . . . . 0.0 111.621 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.47 -57.06 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.924 1.289 . . . . 0.0 110.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -57.44 -36.04 70.88 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.064 0.946 . . . . 0.0 111.86 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.85 -38.03 82.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.929 1.292 . . . . 0.0 111.898 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 tp -76.52 -28.22 56.3 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.02 -54.42 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -25.56 67.69 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.278 0.631 . . . . 0.0 111.45 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.02 -14.54 61.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -80.66 -33.85 35.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.472 1.033 . . . . 0.0 113.172 165.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.89 110.06 22.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.778 1.231 . . . . 0.0 111.47 -158.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.0 24.85 8.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.977 1.311 . . . . 0.0 114.14 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.8 -58.79 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.507 0.723 . . . . 0.0 112.12 -165.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 71.44 -64.11 0.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.612 2.365 . . . . 0.0 113.346 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -64.63 -35.34 80.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.761 1.225 . . . . 0.0 112.833 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -91.13 6.88 43.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.441 1.097 . . . . 0.0 113.448 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -104.29 -9.73 18.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.062 1.745 . . . . 0.0 112.491 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -114.58 159.43 20.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.004 1.722 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.348 1.451 . . . . 0.0 114.477 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 178.91 8.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.361 1.864 . . . . 0.0 112.354 -174.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.17 19.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.294 1.037 . . . . 0.0 110.613 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.12 143.5 21.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.493 1.117 . . . . 0.0 110.768 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 129.56 46.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 110.403 163.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.87 172.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -138.14 131.18 30.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.705 -0.622 . . . . 0.0 112.345 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.84 130.19 51.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.161 0.984 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -114.19 105.11 12.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 109.214 171.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.43 157.6 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.736 0.779 . . . . 0.0 112.2 -176.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.32 151.96 37.61 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 125.389 1.476 . . . . 0.0 110.488 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -72.37 147.83 47.72 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.264 2.643 . . . . 0.0 111.19 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -165.59 149.59 8.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.273 2.229 . . . . 0.0 108.493 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.87 -16.41 70.3 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.4 p -94.3 -4.84 47.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.215 1.806 . . . . 0.0 113.477 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.73 170.58 12.93 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.344 1.449 . . . . 0.0 111.755 -166.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -66.37 160.0 25.63 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.568 1.184 . . . . 0.0 111.323 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.07 145.96 51.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.147 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.99 109.85 1.19 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.172 0.589 . . . . 0.0 111.518 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.8 -47.34 3.44 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 125.204 1.383 . . . . 0.0 110.886 170.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 m -155.18 150.89 27.54 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.866 1.266 . . . . 0.0 111.218 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.4 129.08 49.15 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.833 1.253 . . . . 0.0 109.39 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 m -115.18 118.85 34.5 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.209 1.804 . . . . 0.0 108.093 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -81.87 134.63 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.286 0.948 . . . . 0.0 109.757 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.22 -48.93 3.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.213 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -171.21 170.26 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.525 1.53 . . . . 0.0 111.868 171.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.79 -178.93 29.65 Favored Glycine 0 N--CA 1.462 0.396 0 C-N-CA 125.314 1.435 . . . . 0.0 113.554 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.46 113.85 21.5 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 167.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -63.84 -17.58 63.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -149.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -56.17 -33.45 65.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.767 0.827 . . . . 0.0 112.225 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.86 -46.62 18.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.796 -1.097 . . . . 0.0 111.397 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -47.16 -46.08 23.24 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.773 1.229 . . . . 0.0 113.027 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.75 89.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.768 0.827 . . . . 0.0 112.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.76 -52.36 31.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 112.708 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.3 t -57.76 -48.25 80.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.586 0.755 . . . . 0.0 111.197 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -50.23 -44.71 53.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.469 1.508 . . . . 0.0 111.472 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.79 -45.06 65.37 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.697 0.799 . . . . 0.0 112.56 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.25 -49.76 75.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.385 1.074 . . . . 0.0 111.881 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.3 t -67.65 -22.8 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.828 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.4 -6.94 58.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 112.639 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.95 -12.2 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.8 m -58.14 147.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.023 0.929 . . . . 0.0 112.35 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -71.61 -47.56 53.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p 171.14 142.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.723 2.009 . . . . 0.0 111.213 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.8 m-85 -94.67 108.61 38.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.423 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 130.05 14.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.341 2.028 . . . . 0.0 110.111 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.04 148.29 74.84 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.491 0.716 . . . . 0.0 111.751 -171.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.98 -36.1 4.73 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.535 2.157 . . . . 0.0 110.879 168.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 153.51 41.31 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.439 2.295 . . . . 0.0 109.948 176.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.15 8.56 19.98 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -165.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.16 144.38 62.74 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 118.988 0.813 . . . . 0.0 110.004 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.81 -4.01 6.6 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.424 2.749 . . . . 0.0 113.696 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.72 -38.26 19.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.98 0.809 . . . . 0.0 112.159 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.61 -26.66 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.225 1.01 . . . . 0.0 112.715 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -26.99 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.124 0.969 . . . . 0.0 110.906 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -78.72 -13.17 59.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.01 1.324 . . . . 0.0 113.222 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.06 -42.33 7.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.672 0.789 . . . . 0.0 111.71 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.39 -23.23 60.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.828 0.851 . . . . 0.0 112.488 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -68.96 -23.31 64.12 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.743 -1.223 . . . . 0.0 113.946 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -128.29 84.08 2.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.134 0.974 . . . . 0.0 110.057 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.544 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -112.11 155.31 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.479 1.111 . . . . 0.0 112.215 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -91.41 136.21 33.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 156.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.63 118.14 29.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 154.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -135.9 130.25 33.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.39 146.25 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.734 2.414 . . . . 0.0 108.493 -165.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.56 161.09 30.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.241 1.417 . . . . 0.0 111.628 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.67 168.38 14.29 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.486 2.79 . . . . 0.0 111.65 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.241 0.638 0 C-N-CA 125.005 1.322 . . . . 0.0 111.612 179.095 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -153.01 -172.4 4.23 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.291 1.836 . . . . 0.0 111.67 -171.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 150.75 23.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 1 C-N-CA 133.106 4.562 . . . . 0.0 112.317 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -98.67 -17.71 18.44 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.141 1.376 . . . . 0.0 112.176 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.06 -29.97 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 113.614 -171.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.9 1.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -165.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -55.5 -32.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.92 1.236 . . . . 0.0 111.512 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.9 t -67.39 -44.17 79.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.621 1.168 . . . . 0.0 112.674 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 m -59.85 -30.2 68.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 112.556 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.98 -23.39 64.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.368 -0.825 . . . . 0.0 113.093 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.84 -26.3 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 121.186 1.812 . . . . 0.0 111.531 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.95 -4.27 40.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.518 1.533 . . . . 0.0 114.238 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -111.0 -54.2 2.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.256 1.823 . . . . 0.0 111.115 164.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -63.82 -17.99 63.66 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.002 2.121 . . . . 0.0 116.057 -162.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.74 -13.35 11.45 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.923 2.201 . . . . 0.0 114.124 166.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.83 -30.17 40.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.117 1.367 . . . . 0.0 111.797 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -62.31 -27.77 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 120.646 -1.284 . . . . 0.0 111.946 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -80.01 -56.53 4.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.286 1.434 . . . . 0.0 110.682 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -58.11 -34.48 70.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.938 0.895 . . . . 0.0 112.01 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -67.92 -40.2 83.43 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.679 1.191 . . . . 0.0 110.881 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.36 -28.76 61.27 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.504 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.0 -54.12 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 110.441 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -23.29 67.29 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.043 0.537 . . . . 0.0 112.153 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.02 -15.6 60.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -79.73 -39.9 30.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.845 1.202 . . . . 0.0 111.882 163.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.0 83.35 3.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.557 1.646 . . . . 0.0 112.243 -160.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 28.93 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.774 1.63 . . . . 0.0 114.232 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.71 -62.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.434 -0.791 . . . . 0.0 112.093 -163.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 72.54 -62.64 0.46 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.309 2.243 . . . . 0.0 113.51 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.12 -37.39 87.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.257 1.423 . . . . 0.0 112.554 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.2 m -85.56 -1.78 57.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 14.1 m-30 -103.96 -22.64 13.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.983 1.713 . . . . 0.0 113.279 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 152.66 19.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.179 1.392 . . . . 0.0 112.911 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.6 2.16 90.6 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.083 1.325 . . . . 0.0 114.29 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -143.77 177.77 8.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.115 1.766 . . . . 0.0 112.267 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.59 160.48 25.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.826 1.25 . . . . 0.0 110.099 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 45.1 t -153.62 144.13 22.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.216 1.007 . . . . 0.0 110.215 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.48 127.76 38.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.293 1.437 . . . . 0.0 111.134 171.206 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.21 172.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.367 1.067 . . . . 0.0 108.335 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -137.02 131.67 33.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.588 0.755 . . . . 0.0 112.113 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -103.04 134.26 46.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.007 0.923 . . . . 0.0 110.38 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -118.09 103.47 9.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.187 1.395 . . . . 0.0 108.849 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.29 158.46 15.69 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.917 0.865 . . . . 0.0 112.149 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 pt -99.03 148.75 35.01 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.581 1.552 . . . . 0.0 110.183 166.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.56 147.92 41.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.302 2.668 . . . . 0.0 110.857 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -166.67 146.56 5.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.273 2.229 . . . . 0.0 108.479 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.95 -21.45 75.32 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.564 0.986 . . . . 0.0 115.564 -166.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -89.39 -5.22 57.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.979 1.712 . . . . 0.0 113.183 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.79 162.49 10.84 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.891 1.71 . . . . 0.0 111.421 -169.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -63.74 160.69 16.61 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 117.789 0.794 . . . . 0.0 111.596 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.84 143.32 50.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.332 1.453 . . . . 0.0 110.91 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.98 109.34 1.05 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.44 0.696 . . . . 0.0 111.623 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.92 -36.51 5.23 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.537 1.542 . . . . 0.0 111.925 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -163.85 155.68 16.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 111.127 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.43 129.94 39.94 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.091 1.357 . . . . 0.0 109.92 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.3 m -115.81 119.15 35.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.923 2.089 . . . . 0.0 108.448 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.0 137.1 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.098 0.863 . . . . 0.0 110.164 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.39 -47.37 3.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.933 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 24.2 t0 -174.12 166.77 4.2 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.998 2.119 . . . . 0.0 111.217 169.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.28 164.5 27.9 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.083 -1.011 . . . . 0.0 114.15 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.37 178.94 4.89 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.945 0.898 . . . . 0.0 110.363 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 t -30.24 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.73 2.412 . . . . 0.0 115.517 -162.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 31.6 mtm105 70.44 -1.21 2.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.199 2.2 . . . . 0.0 116.378 162.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.26 -46.58 70.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 122.429 2.377 . . . . 0.0 112.171 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.29 -28.08 51.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 166.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.18 -35.47 41.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.377 0.989 . . . . 0.0 112.382 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -51.02 15.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.63 1.572 . . . . 0.0 112.498 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -55.48 -48.9 73.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.854 0.861 . . . . 0.0 111.196 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -51.3 -44.7 61.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.786 1.634 . . . . 0.0 111.469 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -69.19 -44.55 71.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.028 0.931 . . . . 0.0 113.385 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.51 76.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.57 1.148 . . . . 0.0 111.48 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.4 t -67.9 -21.22 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.69 -1.256 . . . . 0.0 112.236 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.97 -6.92 59.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.066 0.947 . . . . 0.0 112.187 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.05 -12.73 4.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.7 m -58.14 146.05 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-N 119.394 0.997 . . . . 0.0 111.975 168.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -72.45 -46.12 56.46 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.1 p 172.78 141.94 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.36 1.864 . . . . 0.0 110.911 -168.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -94.37 106.74 25.01 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.292 1.037 . . . . 0.0 111.193 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.79 118.34 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.295 1.997 . . . . 0.0 109.968 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.03 148.71 37.42 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.461 1.104 . . . . 0.0 112.367 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.11 -29.93 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.924 2.416 . . . . 0.0 112.313 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -138.56 148.67 44.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.947 1.699 . . . . 0.0 110.495 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -120.66 22.0 11.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.555 1.542 . . . . 0.0 113.284 -167.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.8 142.17 32.26 Favored Pre-proline 0 C--O 1.242 0.668 0 O-C-N 120.627 -1.295 . . . . 0.0 110.731 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.02 -7.05 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 124.14 3.226 . . . . 0.0 116.177 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -87.95 -41.57 13.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.881 1.219 . . . . 0.0 112.343 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -92.57 -25.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.529 1.532 . . . . 0.0 113.365 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.49 -29.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.939 0.79 . . . . 0.0 110.935 170.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 33.0 mm-40 -77.0 -8.07 56.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.319 1.047 . . . . 0.0 113.766 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.38 -48.22 5.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.356 0.663 . . . . 0.0 112.203 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.8 -28.07 68.73 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.13 0.972 . . . . 0.0 112.679 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.428 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -72.51 -23.79 61.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.44 -1.413 . . . . 0.0 114.003 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -121.74 88.99 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.331 1.052 . . . . 0.0 111.086 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.499 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.63 156.34 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.435 1.094 . . . . 0.0 112.614 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -92.71 137.52 32.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.093 -0.379 . . . . 0.0 110.278 156.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.7 mt -91.4 112.91 25.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 153.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.8 m -134.83 125.43 26.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.916 0.887 . . . . 0.0 108.835 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.32 153.16 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.588 1.555 . . . . 0.0 110.734 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.37 158.07 15.39 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.466 1.506 . . . . 0.0 111.992 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.14 172.89 14.73 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.474 2.782 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.242 0.684 0 C-N-CA 125.274 1.43 . . . . 0.0 111.369 -177.489 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 69.91 167.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.883 2.473 . . . . 0.0 113.43 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -153.04 21.52 0.57 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.861 1.265 . . . . 0.0 114.067 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -106.61 -17.53 14.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.09 1.356 . . . . 0.0 112.671 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.16 -21.64 0.44 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.778 2.431 . . . . 0.0 112.753 -167.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -51.08 -15.85 0.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.299 2.64 . . . . 0.0 116.557 -172.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.24 -31.0 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.646 1.178 . . . . 0.0 112.402 171.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 t -57.6 -44.23 85.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.833 0.853 . . . . 0.0 112.092 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -69.48 -30.32 68.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.177 -0.952 . . . . 0.0 112.072 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.46 -29.22 67.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.699 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.62 -25.92 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 120.829 1.65 . . . . 0.0 110.418 172.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.59 -8.59 56.75 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.315 1.436 . . . . 0.0 114.043 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -111.39 -58.68 2.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.727 1.263 . . . . 0.0 111.868 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -51.02 -47.16 61.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 128.276 2.63 . . . . 0.0 113.699 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.95 -15.86 66.5 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.246 1.403 . . . . 0.0 113.366 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -75.73 -32.75 60.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 1.119 . . . . 0.0 111.719 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -59.67 -27.01 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.9 0.773 . . . . 0.0 111.916 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -82.09 -58.64 2.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.122 1.369 . . . . 0.0 110.362 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.69 -33.4 72.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.003 0.921 . . . . 0.0 112.852 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -73.37 -35.4 65.93 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.994 0.918 . . . . 0.0 110.795 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.9 tp -73.39 -31.58 63.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.754 0.707 . . . . 0.0 112.059 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -71.24 -48.29 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.287 0.635 . . . . 0.0 110.71 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -67.78 -19.0 65.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -57.51 -36.53 71.66 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.128 0.571 . . . . 0.0 111.329 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -78.24 -40.22 37.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.983 0.421 . . . . 0.0 112.098 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.72 88.4 3.81 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 123.149 1.452 . . . . 0.0 111.887 -163.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.96 31.02 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.338 -1.755 . . . . 0.0 113.781 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.68 -64.09 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.101 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 72.79 -63.84 0.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.892 2.077 . . . . 0.0 112.826 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.01 -45.33 61.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.667 1.187 . . . . 0.0 112.159 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.3 m -79.24 2.86 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.2 m-30 -93.87 -10.46 33.88 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.834 1.653 . . . . 0.0 111.761 166.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -114.35 171.31 7.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.049 2.139 . . . . 0.0 111.107 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.02 -21.59 3.29 Favored Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.807 1.194 . . . . 0.0 114.372 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.46 -175.16 3.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.171 2.589 . . . . 0.0 111.616 175.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 164.98 23.21 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.449 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.2 t -159.97 144.74 14.91 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.448 1.099 . . . . 0.0 110.142 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.59 130.14 46.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.512 164.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.88 170.4 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.275 1.03 . . . . 0.0 108.333 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -137.0 131.18 32.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.348 0.594 . . . . 0.0 111.738 -173.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.13 132.85 45.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.967 0.907 . . . . 0.0 110.334 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -116.4 103.01 10.03 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 108.931 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -99.62 158.97 15.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.731 0.777 . . . . 0.0 111.906 -177.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.1 pt -100.13 136.79 20.02 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.453 1.501 . . . . 0.0 110.219 167.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.95 129.62 17.71 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.585 2.19 . . . . 0.0 109.832 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 m -142.86 88.58 2.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.271 1.428 . . . . 0.0 108.548 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 -122.49 28.03 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.895 0.759 . . . . 0.0 112.12 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -81.6 3.5 24.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.209 1.803 . . . . 0.0 113.842 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.18 -166.6 10.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.257 1.408 . . . . 0.0 114.377 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -124.33 165.47 17.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.205 1.402 . . . . 0.0 110.918 165.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.62 148.51 52.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.144 1.778 . . . . 0.0 111.153 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.56 111.88 1.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.009 0.822 . . . . 0.0 112.28 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.54 -35.06 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.78 1.657 . . . . 0.0 112.125 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -167.2 153.18 7.86 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.365 1.466 . . . . 0.0 110.998 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -127.91 129.38 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.428 1.091 . . . . 0.0 109.874 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.3 m -113.28 118.87 35.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.236 1.815 . . . . 0.0 108.536 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.74 130.9 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.903 0.774 . . . . 0.0 109.81 169.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -101.98 -46.92 4.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.108 0.563 . . . . 0.0 110.04 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -170.47 169.48 7.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.119 1.768 . . . . 0.0 111.515 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.11 179.07 23.79 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 124.887 1.232 . . . . 0.0 114.527 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.23 119.79 25.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.79 -17.66 37.36 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -159.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.71 65.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.679 1.191 . . . . 0.0 112.07 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.3 tp -88.85 -49.23 6.94 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.673 1.124 . . . . 0.0 111.562 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 m -47.81 -43.09 27.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.537 1.062 . . . . 0.0 113.539 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.08 73.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.082 0.856 . . . . 0.0 112.573 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.14 -52.25 25.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.424 1.09 . . . . 0.0 112.191 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.6 t -57.85 -49.37 76.89 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.104 0.962 . . . . 0.0 110.355 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -51.27 -45.8 62.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -66.41 -47.02 74.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.518 0.727 . . . . 0.0 112.845 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.06 75.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 111.414 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.77 -23.29 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.579 -1.326 . . . . 0.0 111.518 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.78 -6.84 58.09 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.369 -0.832 . . . . 0.0 112.396 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.09 -11.97 3.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.4 m -58.14 148.59 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.296 0.953 . . . . 0.0 112.55 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.48 -48.94 59.06 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 p 170.18 141.89 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.555 1.942 . . . . 0.0 111.414 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 10.5 m-85 -98.99 110.38 57.5 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.311 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.18 134.34 12.84 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.842 2.361 . . . . 0.0 111.009 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.48 148.36 66.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.047 -0.502 . . . . 0.0 112.272 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 -36.17 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.482 2.788 . . . . 0.0 111.935 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 153.25 47.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.439 2.296 . . . . 0.0 110.526 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.11 7.69 18.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -163.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.03 142.91 44.96 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.937 -1.102 . . . . 0.0 110.431 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.34 0.35 2.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.807 3.005 . . . . 0.0 113.642 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.91 -38.72 17.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.927 0.891 . . . . 0.0 111.834 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 m -96.07 -26.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.571 1.148 . . . . 0.0 112.613 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.8 -28.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.435 1.094 . . . . 0.0 110.994 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -84.06 -5.44 59.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.237 1.015 . . . . 0.0 113.636 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -98.49 -51.36 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.013 -1.054 . . . . 0.0 111.192 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.98 -20.48 65.89 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.824 1.25 . . . . 0.0 113.874 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -69.74 -23.57 63.41 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.014 -1.054 . . . . 0.0 112.819 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -125.27 83.29 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.115 1.766 . . . . 0.0 111.119 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.43 153.42 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.319 1.047 . . . . 0.0 112.092 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -95.19 137.12 34.67 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.88 0.371 . . . . 0.0 110.125 158.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.33 120.68 33.89 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 155.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -136.77 129.1 29.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.384 1.074 . . . . 0.0 109.222 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 164.95 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.171 1.788 . . . . 0.0 110.742 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.52 170.32 9.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 112.958 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -57.71 -28.81 83.34 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.513 2.808 . . . . 0.0 116.935 -161.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.239 0.539 0 C-N-CA 125.105 1.362 . . . . 0.0 110.935 -170.624 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.18 -73.48 0.12 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -165.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtp-105 72.92 14.68 4.78 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.13 2.172 . . . . 0.0 113.545 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -97.8 -19.42 18.18 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.03 -25.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.002 1.721 . . . . 0.0 112.606 -166.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -6.65 10.4 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.5 1.52 . . . . 0.0 114.455 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -55.69 -27.9 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.275 1.43 . . . . 0.0 113.039 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -59.17 -35.44 73.57 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.278 0.631 . . . . 0.0 112.142 171.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -78.87 -28.01 44.12 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.158 -0.964 . . . . 0.0 113.065 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.582 0.628 . . . . 0.0 110.656 165.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.61 -27.26 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.93 1.241 . . . . 0.0 110.951 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.45 -11.35 68.1 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.525 1.536 . . . . 0.0 114.004 171.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -106.15 -55.69 2.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.058 1.429 . . . . 0.0 111.876 169.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -49.33 -45.84 46.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.597 2.359 . . . . 0.0 114.064 -172.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.71 -18.4 60.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.738 1.637 . . . . 0.0 113.746 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.78 -32.51 63.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.375 1.088 . . . . 0.0 111.864 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -61.37 -27.07 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.125 -0.985 . . . . 0.0 112.347 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -82.37 -59.19 2.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 109.722 174.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.26 -35.33 73.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.034 0.934 . . . . 0.0 111.99 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -71.54 -41.75 68.75 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.968 0.907 . . . . 0.0 110.867 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.63 -25.91 65.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.539 0.609 . . . . 0.0 112.035 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.415 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.46 -55.59 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.187 0.995 . . . . 0.0 110.253 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -22.46 66.11 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.668 0.387 . . . . 0.0 111.594 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.51 -13.16 61.72 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.642 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -81.05 -36.69 30.18 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.947 1.248 . . . . 0.0 112.164 168.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 80.31 1.82 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.327 1.451 . . . . 0.0 109.821 -169.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 51.62 0.43 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.807 1.643 . . . . 0.0 112.492 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.66 -56.48 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 73.26 -51.71 0.7 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.063 2.545 . . . . 0.0 114.892 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.51 -31.75 32.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.382 1.473 . . . . 0.0 112.879 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -85.05 -13.38 50.61 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.836 0.854 . . . . 0.0 112.604 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -89.34 -8.17 53.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.014 1.326 . . . . 0.0 112.478 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -112.73 171.41 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.401 1.88 . . . . 0.0 113.099 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.3 -45.49 3.23 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.119 1.819 . . . . 0.0 112.371 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -170.89 3.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.61 1.564 . . . . 0.0 111.137 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.29 26.26 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.835 0.854 . . . . 0.0 110.985 168.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 38.8 t -151.61 145.04 24.82 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.691 1.196 . . . . 0.0 109.564 170.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.26 129.36 41.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.164 1.385 . . . . 0.0 110.615 170.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.69 172.07 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.87 1.268 . . . . 0.0 107.978 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -137.59 133.15 34.08 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.801 0.841 . . . . 0.0 111.722 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.98 140.35 36.39 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.387 0.675 . . . . 0.0 111.81 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -120.2 105.69 11.21 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.431 1.493 . . . . 0.0 108.92 170.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.74 159.37 15.24 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.397 -0.815 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.68 139.96 20.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.924 1.689 . . . . 0.0 109.821 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.67 137.3 58.32 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.507 2.138 . . . . 0.0 111.624 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -143.97 162.89 35.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.28 2.232 . . . . 0.0 107.918 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.02 -22.24 70.38 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.005 -1.059 . . . . 0.0 115.561 -171.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -94.97 -19.61 20.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.783 1.633 . . . . 0.0 112.734 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.37 -174.37 34.86 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.649 2.071 . . . . 0.0 111.007 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -73.45 160.35 31.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.216 2.008 . . . . 0.0 110.15 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -132.43 143.7 49.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.304 1.442 . . . . 0.0 111.527 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.57 108.44 0.56 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.996 0.919 . . . . 0.0 112.261 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.51 -35.82 5.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.673 1.606 . . . . 0.0 111.632 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -166.01 150.04 7.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.901 1.28 . . . . 0.0 111.13 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.7 tt -123.07 130.44 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.955 1.702 . . . . 0.0 109.319 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -114.44 118.68 34.49 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.6 1.56 . . . . 0.0 108.358 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 m -83.63 136.19 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.803 0.729 . . . . 0.0 109.88 168.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.73 -45.79 3.77 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.3 0.64 . . . . 0.0 110.151 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -172.48 167.51 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.102 1.761 . . . . 0.0 111.348 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.83 170.11 36.17 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.526 -0.734 . . . . 0.0 114.552 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.36 -177.53 4.01 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.826 1.25 . . . . 0.0 111.047 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.259 59.3 p 51.52 -97.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.385 2.274 . . . . 0.0 113.018 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.33 -4.27 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 113.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -64.08 -43.91 93.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.926 1.694 . . . . 0.0 113.01 -157.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.0 p -56.95 -27.64 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.74 -40.73 13.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.799 1.239 . . . . 0.0 112.155 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.36 -53.74 50.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.77 1.228 . . . . 0.0 111.998 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 t -52.75 -46.65 67.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.894 0.878 . . . . 0.0 110.537 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.88 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.38 1.072 . . . . 0.0 113.438 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -73.35 -43.37 60.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.73 76.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.736 1.214 . . . . 0.0 112.024 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.86 -23.38 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.533 -1.354 . . . . 0.0 112.09 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.82 -6.96 55.9 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.35 -0.844 . . . . 0.0 112.727 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -11.95 2.46 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -173.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.6 m -58.15 147.82 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.712 1.205 . . . . 0.0 112.734 171.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -75.3 -39.08 59.96 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 p 165.23 141.23 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 127.491 2.316 . . . . 0.0 111.501 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.04 112.26 57.68 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.269 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.44 120.7 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.306 2.004 . . . . 0.0 110.047 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 138.58 25.99 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.65 1.18 . . . . 0.0 111.743 -176.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.24 -47.58 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.421 2.748 . . . . 0.0 111.916 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -103.46 147.41 27.17 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.304 1.442 . . . . 0.0 110.868 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.31 12.79 11.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.874 1.27 . . . . 0.0 113.564 -163.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -78.88 140.56 58.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 O-C-N 120.825 -1.172 . . . . 0.0 109.392 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.87 -4.69 7.74 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.047 2.498 . . . . 0.0 113.419 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.43 -31.87 24.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.726 0.694 . . . . 0.0 112.403 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.97 -24.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.04 -28.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.264 1.026 . . . . 0.0 110.731 166.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.28 -9.86 59.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.501 1.52 . . . . 0.0 113.791 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.77 -43.83 5.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.279 1.032 . . . . 0.0 112.198 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -71.55 -22.33 61.77 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.973 0.909 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -65.5 -22.95 66.78 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.63 -1.294 . . . . 0.0 113.918 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -123.74 80.12 1.77 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.41 1.084 . . . . 0.0 110.301 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.535 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.99 151.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.961 0.905 . . . . 0.0 111.83 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.3 128.04 41.82 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 159.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.05 111.18 21.85 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 160.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.8 m -135.45 123.94 23.49 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.589 1.155 . . . . 0.0 108.502 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.36 148.37 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.696 1.198 . . . . 0.0 111.175 -169.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -161.53 38.65 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.241 1.816 . . . . 0.0 114.388 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.69 140.87 52.77 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.32 2.013 . . . . 0.0 111.1 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 125.838 1.655 . . . . 0.0 112.199 -174.576 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.049 0 CA-C-O 117.692 -1.147 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 -44.15 9.11 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.374 3.07 . . . . 0.0 111.773 -7.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 75.84 3.58 3.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.394 2.278 . . . . 0.0 114.887 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -89.22 -19.6 25.2 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.203 0.601 . . . . 0.0 112.621 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.28 -27.45 0.24 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.009 1.323 . . . . 0.0 114.41 -166.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -17.7 6.65 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -166.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -55.17 -29.81 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.747 1.219 . . . . 0.0 112.664 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 t -58.49 -45.27 89.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.247 1.019 . . . . 0.0 112.191 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -64.37 -29.62 70.68 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.749 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -75.5 -17.59 60.07 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 117.558 -1.211 . . . . 0.0 112.996 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.12 -25.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.656 2.026 . . . . 0.0 111.09 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.96 -13.12 56.7 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.939 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -111.36 -57.26 2.27 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.033 1.417 . . . . 0.0 111.748 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.61 -39.61 80.92 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 128.034 2.534 . . . . 0.0 113.761 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.78 63.73 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.377 1.465 . . . . 0.0 114.009 169.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.12 -26.12 56.06 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.867 1.333 . . . . 0.0 112.065 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.18 -30.0 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.333 -1.479 . . . . 0.0 111.634 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -77.8 -55.22 5.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.129 1.372 . . . . 0.0 110.095 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -57.33 -34.89 69.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.878 0.871 . . . . 0.0 112.297 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.64 -30.49 65.81 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.227 1.411 . . . . 0.0 112.628 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp -82.12 -31.48 30.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.674 0.67 . . . . 0.0 112.353 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -68.74 -46.86 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.761 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -21.76 66.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.284 1.034 . . . . 0.0 112.98 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -59.65 -36.73 77.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.516 0.727 . . . . 0.0 110.791 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -78.35 -45.42 22.6 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 0.0 111.162 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.99 74.28 4.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 123.456 1.598 . . . . 0.0 112.298 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.03 29.06 0.06 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 113.791 -1.549 . . . . 0.0 114.048 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.6 -71.09 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 -163.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 74.15 -48.24 0.66 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.568 2.347 . . . . 0.0 114.119 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.26 -38.23 88.47 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.296 -1.503 . . . . 0.0 113.16 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.9 p -91.36 0.05 57.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.343 1.057 . . . . 0.0 113.662 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.568 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.7 m-30 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.543 1.537 . . . . 0.0 111.384 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -110.68 156.12 21.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.776 2.03 . . . . 0.0 111.223 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.12 -25.94 4.59 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.101 1.334 . . . . 0.0 113.795 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -106.29 -172.68 2.13 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.831 2.052 . . . . 0.0 110.741 167.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 164.31 28.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.273 1.029 . . . . 0.0 110.345 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.58 157.64 43.45 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.441 -0.787 . . . . 0.0 111.463 160.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.2 126.21 29.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.146 1.379 . . . . 0.0 110.069 162.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.59 166.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -135.58 131.72 36.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.042 0.837 . . . . 0.0 111.965 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.55 131.93 48.95 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.339 1.055 . . . . 0.0 110.164 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -113.52 107.71 16.18 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.318 1.447 . . . . 0.0 109.018 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.35 159.72 15.03 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.31 -0.869 . . . . 0.0 111.945 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 pt -102.34 148.38 35.35 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.987 1.715 . . . . 0.0 109.615 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.4 137.78 28.78 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.221 1.947 . . . . 0.0 110.08 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 m -148.66 93.92 2.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.115 1.366 . . . . 0.0 109.267 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.81 -113.66 5.81 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.82 0.724 . . . . 0.0 112.612 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.2 p -83.36 -2.79 56.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.755 2.022 . . . . 0.0 114.024 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.97 -164.85 11.34 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.585 1.084 . . . . 0.0 114.297 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -111.38 165.23 12.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.351 1.06 . . . . 0.0 110.649 165.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp -132.79 146.89 52.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.451 1.901 . . . . 0.0 111.666 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.05 111.63 1.77 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.53 0.732 . . . . 0.0 112.245 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.91 -34.22 5.52 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.387 1.47 . . . . 0.0 112.032 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.47 154.28 11.9 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.455 1.502 . . . . 0.0 110.994 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.82 128.44 34.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.509 1.124 . . . . 0.0 109.94 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 m -110.9 138.5 47.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.72 2.008 . . . . 0.0 108.349 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.72 133.8 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.781 0.719 . . . . 0.0 109.233 165.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -102.16 -42.92 5.89 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.479 0.712 . . . . 0.0 109.915 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -173.17 169.19 4.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.371 1.868 . . . . 0.0 111.476 171.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.18 -178.74 28.38 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 124.729 1.157 . . . . 0.0 114.509 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.4 116.64 26.77 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 m -58.68 -18.92 35.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -157.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -32.71 71.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.644 0.778 . . . . 0.0 112.564 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 tp -82.51 -46.83 12.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.62 1.1 . . . . 0.0 111.086 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.9 m -51.59 -42.92 62.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.382 0.992 . . . . 0.0 113.149 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.89 79.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.968 0.907 . . . . 0.0 112.364 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.2 58.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.541 0.737 . . . . 0.0 112.462 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 8.7 t -59.58 -47.68 84.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.652 0.781 . . . . 0.0 110.892 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -52.68 -42.42 64.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 111.138 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.25 -47.27 62.07 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.716 0.806 . . . . 0.0 112.914 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.97 78.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' THR . 2.9 t -66.87 -23.1 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.719 -1.238 . . . . 0.0 111.516 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.26 -6.71 59.17 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.46 -0.775 . . . . 0.0 112.676 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.89 -11.84 3.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.6 m -57.79 145.11 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.148 0.979 . . . . 0.0 112.597 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.31 -41.28 81.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.6 p 166.04 144.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.437 2.695 . . . . 0.0 110.102 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -92.51 110.45 45.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.505 -1.236 . . . . 0.0 109.77 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.65 134.8 20.85 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.898 1.732 . . . . 0.0 109.831 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.24 148.35 70.78 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.073 0.549 . . . . 0.0 111.601 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.07 -33.36 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.745 2.297 . . . . 0.0 111.283 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 159.81 42.0 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.383 2.273 . . . . 0.0 109.808 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -125.98 31.3 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.756 1.222 . . . . 0.0 113.205 -160.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -100.0 144.5 28.5 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.108 -0.995 . . . . 0.0 110.365 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.48 -9.2 17.1 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.337 2.691 . . . . 0.0 113.417 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.06 -35.59 31.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.643 0.777 . . . . 0.0 112.11 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.52 -25.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.46 1.104 . . . . 0.0 112.473 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.44 -28.54 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 118.578 0.626 . . . . 0.0 110.915 168.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.3 mm-40 -78.89 -9.57 59.53 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.17 -46.88 6.59 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.61 0.719 . . . . 0.0 112.008 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.26 -26.36 65.63 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.168 0.987 . . . . 0.0 112.438 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -71.51 -25.35 62.21 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.415 -1.428 . . . . 0.0 113.168 -175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.36 90.48 3.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 110.483 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.508 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.77 152.87 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.642 1.177 . . . . 0.0 112.525 178.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -93.84 132.69 38.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.985 157.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.2 mt -91.27 117.32 29.54 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 156.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.9 m -135.31 128.28 31.48 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.1 155.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.405 1.482 . . . . 0.0 110.811 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.43 168.2 7.57 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.91 1.684 . . . . 0.0 111.355 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.25 159.07 41.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.694 2.929 . . . . 0.0 112.827 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 C--O 1.241 0.638 0 C-N-CA 123.86 0.864 . . . . 0.0 111.963 177.202 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -163.26 -104.94 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.895 1.678 . . . . 0.0 112.162 -169.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 66.1 27.78 10.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.808 2.043 . . . . 0.0 113.675 -171.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -103.17 -21.34 13.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.169 0.988 . . . . 0.0 113.494 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -15.2 0.75 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.327 1.451 . . . . 0.0 113.871 -165.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -62.94 -13.06 29.96 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 m -56.08 -27.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.032 1.333 . . . . 0.0 112.853 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 t -56.94 -37.5 71.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.82 0.848 . . . . 0.0 112.607 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -73.8 -26.99 60.91 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.972 -1.08 . . . . 0.0 112.862 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.26 -31.19 68.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.754 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.78 -31.51 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 120.972 1.714 . . . . 0.0 110.845 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -12.24 69.68 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.585 1.088 . . . . 0.0 114.031 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -104.77 -46.46 4.31 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.369 1.467 . . . . 0.0 110.546 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.88 -43.52 73.25 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 127.389 2.276 . . . . 0.0 113.212 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.46 -18.47 68.61 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.213 0.911 . . . . 0.0 113.44 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.93 -33.4 68.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.277 1.038 . . . . 0.0 111.592 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.5 pt -61.3 -28.13 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 120.953 -1.092 . . . . 0.0 111.889 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -80.56 -58.24 3.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.877 1.271 . . . . 0.0 109.581 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.13 -34.84 74.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 112.673 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -74.36 -28.11 60.98 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.772 1.229 . . . . 0.0 112.353 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.9 tp -76.4 -33.34 58.86 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.199 0.909 . . . . 0.0 111.684 171.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.11 -44.38 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.865 -1.147 . . . . 0.0 110.964 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.14 -13.6 61.6 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.262 1.025 . . . . 0.0 112.745 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.06 -38.38 73.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -80.14 -37.39 33.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 0.0 111.989 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -99.49 103.9 15.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.62 1.2 . . . . 0.0 110.828 -164.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.94 20.71 7.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.98 -52.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.053 0.541 . . . . 0.0 112.237 -160.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 70.64 -62.55 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.867 2.467 . . . . 0.0 113.921 168.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.41 -35.41 80.34 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.635 -1.29 . . . . 0.0 111.946 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -77.09 -0.78 26.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -112.78 -12.49 13.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.612 1.965 . . . . 0.0 111.949 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -109.17 154.5 22.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 112.281 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.58 90.43 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.76 1.171 . . . . 0.0 114.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -178.61 5.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.747 2.019 . . . . 0.0 111.682 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.87 162.95 20.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.978 0.911 . . . . 0.0 110.462 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -157.4 147.2 20.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.446 1.099 . . . . 0.0 110.141 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.3 128.47 43.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.142 1.777 . . . . 0.0 110.372 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.17 167.42 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.58 1.152 . . . . 0.0 108.048 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -131.8 132.28 43.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.786 0.721 . . . . 0.0 111.95 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.68 130.13 49.5 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.139 0.975 . . . . 0.0 109.593 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -111.68 107.06 16.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.464 1.106 . . . . 0.0 109.227 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -100.02 158.69 15.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.913 0.863 . . . . 0.0 111.603 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -102.8 152.17 38.43 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.973 1.709 . . . . 0.0 110.506 168.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.05 147.27 29.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.143 2.562 . . . . 0.0 111.038 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -156.1 161.62 40.35 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.852 2.461 . . . . 0.0 108.338 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.3 -13.2 59.88 Favored Glycine 0 CA--C 1.54 1.649 0 O-C-N 120.737 -1.227 . . . . 0.0 115.187 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.9 p -99.77 -3.36 32.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.107 2.163 . . . . 0.0 113.919 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.97 -151.83 16.9 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.371 1.462 . . . . 0.0 111.078 -167.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -90.39 157.0 17.83 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.054 1.427 . . . . 0.0 111.949 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.0 144.45 51.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.269 1.828 . . . . 0.0 111.237 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.32 113.5 2.2 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.907 0.776 . . . . 0.0 112.182 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.81 4.69 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.68 1.61 . . . . 0.0 111.974 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.05 152.11 9.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.649 1.579 . . . . 0.0 111.295 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.37 134.29 49.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.247 1.019 . . . . 0.0 109.653 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.8 m -117.38 120.45 38.22 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.615 1.966 . . . . 0.0 108.707 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.23 133.97 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.312 0.96 . . . . 0.0 109.796 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -106.07 -49.93 3.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.298 0.639 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -173.03 170.23 4.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.166 1.786 . . . . 0.0 111.942 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.82 -175.21 32.97 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 125.054 1.311 . . . . 0.0 113.176 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.58 110.57 17.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 164.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 m -58.67 -17.91 26.44 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -52.45 -37.37 56.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.798 1.239 . . . . 0.0 112.357 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.19 -48.07 14.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.005 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -48.51 -46.22 38.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.565 1.146 . . . . 0.0 113.138 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.4 84.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.811 0.844 . . . . 0.0 112.296 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.22 23.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 112.629 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -57.44 -49.4 76.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.863 0.865 . . . . 0.0 110.508 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.29 -46.68 55.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.878 1.671 . . . . 0.0 111.258 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.9 -44.09 77.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.591 0.757 . . . . 0.0 112.833 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.78 -48.96 79.42 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.631 1.172 . . . . 0.0 112.173 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -65.5 -23.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.645 -1.284 . . . . 0.0 111.496 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.59 -6.63 57.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.689 0.796 . . . . 0.0 112.668 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.69 -12.0 3.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.454 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 15.0 m -59.95 148.64 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.185 0.902 . . . . 0.0 112.456 171.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -71.33 -48.5 50.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 p 174.77 142.11 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.223 1.809 . . . . 0.0 111.884 -169.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.2 m-85 -97.19 109.56 50.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 110.148 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.03 131.37 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.733 2.289 . . . . 0.0 110.417 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.83 150.83 75.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.573 0.749 . . . . 0.0 111.513 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.99 -40.84 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.321 2.014 . . . . 0.0 110.787 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -120.05 176.27 5.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.444 2.297 . . . . 0.0 111.278 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -152.64 49.43 0.75 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -112.83 135.66 21.63 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.11 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.73 -12.53 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.18 3.253 . . . . 0.0 115.585 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.0 -35.46 28.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 112.159 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -96.69 -24.16 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.209 1.004 . . . . 0.0 113.026 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.2 -25.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.592 0.757 . . . . 0.0 110.662 167.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -83.39 -7.77 59.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.03 -48.67 5.59 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.133 -0.98 . . . . 0.0 111.374 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.6 pp -69.68 -20.95 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.648 1.179 . . . . 0.0 112.959 -175.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.64 -25.24 67.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.987 0.915 . . . . 0.0 113.449 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -129.99 77.23 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.219 1.008 . . . . 0.0 110.102 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.574 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.57 148.33 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 123.48 36.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 157.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -84.63 110.03 18.43 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 160.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.7 m -132.32 127.55 35.82 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.85 1.26 . . . . 0.0 108.512 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 151.46 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -169.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.42 160.72 14.09 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.649 1.58 . . . . 0.0 111.425 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -64.39 -34.53 54.13 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.056 2.504 . . . . 0.0 113.616 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 126.481 1.913 . . . . 0.0 111.692 -179.448 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 119.88 -0.105 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 82.43 104.13 0.06 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 130.439 3.495 . . . . 0.0 112.239 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.83 3.55 2.52 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.664 -164.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -88.54 -22.73 23.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.262 1.825 . . . . 0.0 111.636 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.54 -7.65 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -49.97 -19.81 0.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 m -55.42 -29.12 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.734 1.214 . . . . 0.0 112.689 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 t -58.73 -36.21 73.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.967 0.907 . . . . 0.0 112.098 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -78.03 -30.38 49.91 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.836 0.854 . . . . 0.0 112.527 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.89 -38.81 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.348 168.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.44 -30.08 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 119.653 1.115 . . . . 0.0 110.203 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.29 -14.53 74.27 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.355 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -96.51 -49.14 5.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.098 1.949 . . . . 0.0 112.003 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -55.27 -43.08 74.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.298 2.239 . . . . 0.0 112.803 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.62 66.76 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.197 1.38 . . . . 0.0 114.066 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.582 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -72.09 -34.2 68.48 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.184 0.992 . . . . 0.0 111.608 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -60.59 -28.3 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.267 -0.896 . . . . 0.0 112.161 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.78 -58.44 3.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.114 1.366 . . . . 0.0 110.673 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.72 -36.84 74.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.49 1.116 . . . . 0.0 112.564 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -71.25 -32.58 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.701 1.2 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -76.05 -28.83 57.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.917 0.78 . . . . 0.0 112.271 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -75.27 -54.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.887 -1.133 . . . . 0.0 110.372 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -19.86 65.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.395 0.678 . . . . 0.0 112.495 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.17 -15.22 58.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m120 -78.76 -39.88 34.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.23 0.923 . . . . 0.0 111.992 161.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.81 96.34 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 123.436 1.589 . . . . 0.0 111.587 -160.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.54 24.44 1.2 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.098 -173.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.87 -72.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.163 0.985 . . . . 0.0 111.33 -167.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 75.0 -52.62 0.67 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 113.489 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.5 -36.84 85.11 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.005 -1.059 . . . . 0.0 111.905 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -83.66 0.33 47.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 113.743 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -102.83 -25.05 13.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.01 1.724 . . . . 0.0 112.805 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -87.52 162.65 17.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.504 2.321 . . . . 0.0 111.539 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.7 -5.36 69.95 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.788 1.185 . . . . 0.0 114.789 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 -173.89 4.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.277 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.61 162.05 25.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.766 0.826 . . . . 0.0 110.675 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.442 ' HB3' HD23 ' A' ' 85' ' ' LEU . 40.5 t -153.84 144.0 22.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.749 1.22 . . . . 0.0 110.381 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 130.55 48.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.729 1.212 . . . . 0.0 110.953 164.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.65 176.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.61 126.37 17.05 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.729 0.812 . . . . 0.0 110.572 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.69 131.4 52.18 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.94 0.896 . . . . 0.0 109.72 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -119.39 106.4 12.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 108.936 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.17 162.27 13.15 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.117 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.13 150.41 44.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.482 1.113 . . . . 0.0 110.677 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.31 134.19 17.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.668 2.245 . . . . 0.0 110.618 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -118.66 -33.73 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.252 1.421 . . . . 0.0 111.635 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.27 -121.84 0.8 Allowed Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.515 1.531 . . . . 0.0 111.274 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 p -63.69 -14.57 53.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.17 0.988 . . . . 0.0 113.088 167.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.17 153.52 16.82 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.887 1.708 . . . . 0.0 114.224 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -84.79 163.24 19.22 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.896 0.878 . . . . 0.0 110.292 161.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.13 147.68 52.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.393 1.877 . . . . 0.0 111.413 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.08 110.43 1.04 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.127 0.971 . . . . 0.0 112.033 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.65 -46.37 3.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.553 1.549 . . . . 0.0 110.591 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 m -155.41 149.59 25.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.338 1.055 . . . . 0.0 110.967 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.01 121.67 33.67 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.114 0.965 . . . . 0.0 109.546 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.3 m -103.66 118.7 37.32 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.448 1.499 . . . . 0.0 108.589 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.33 130.85 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.758 0.708 . . . . 0.0 109.207 167.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.17 -49.36 4.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.524 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -173.19 170.77 4.25 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.329 1.851 . . . . 0.0 111.796 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.93 -179.47 31.83 Favored Glycine 0 N--CA 1.461 0.359 0 C-N-CA 124.895 1.236 . . . . 0.0 113.55 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.19 113.95 20.37 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 165.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.7 p -61.3 -17.68 54.82 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -153.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -50.97 -35.58 34.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.548 1.139 . . . . 0.0 112.143 171.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 58' ' ' CYS . 10.8 tp -82.48 -51.04 8.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.086 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.3 m -45.74 -46.37 15.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.212 1.405 . . . . 0.0 113.203 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.98 82.43 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.038 0.835 . . . . 0.0 112.852 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.15 -52.88 14.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t -56.68 -49.41 75.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.037 0.935 . . . . 0.0 110.58 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.64 -47.11 58.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.324 1.449 . . . . 0.0 111.303 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -68.5 -44.45 74.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.18 77.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.617 1.167 . . . . 0.0 111.23 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -68.3 -21.76 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.675 -1.266 . . . . 0.0 112.009 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.58 -7.44 59.25 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.569 0.748 . . . . 0.0 112.632 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.34 -11.84 3.58 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -174.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.8 m -55.78 147.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.05 0.94 . . . . 0.0 112.92 171.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.34 -49.85 65.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.5 p 167.9 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.228 2.611 . . . . 0.0 110.334 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 25.7 m-85 -99.73 104.32 27.27 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 117.31 -1.329 . . . . 0.0 110.493 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -70.71 128.96 15.85 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.021 1.814 . . . . 0.0 111.512 -170.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 132.04 21.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.127 1.371 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.33 -52.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.186 2.591 . . . . 0.0 112.477 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.78 149.61 27.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.617 1.167 . . . . 0.0 110.045 167.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -128.03 21.01 6.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.288 1.435 . . . . 0.0 113.315 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -88.61 145.74 35.85 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 121.228 -0.92 . . . . 0.0 109.772 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.18 -23.58 6.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.563 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.2 -24.6 43.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.891 0.769 . . . . 0.0 112.862 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.2 m -98.22 -34.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.037 0.935 . . . . 0.0 111.97 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.27 -32.5 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.322 1.049 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.56 -11.74 59.87 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.129 0.972 . . . . 0.0 113.227 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.81 -34.05 8.68 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.179 -0.95 . . . . 0.0 113.289 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.459 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -82.84 -21.25 34.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.745 0.818 . . . . 0.0 112.913 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -69.44 -23.54 63.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.072 -1.017 . . . . 0.0 113.735 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.0 83.99 2.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.055 . . . . 0.0 110.146 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.55 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.46 159.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -110.81 126.91 55.12 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 160.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.8 121.9 32.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.9 m -134.12 129.76 36.38 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.097 0.959 . . . . 0.0 109.801 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.76 141.35 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 128.576 2.75 . . . . 0.0 107.885 -170.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.622 ' H ' ' HD2' ' A' ' 121' ' ' PRO . . . -168.62 -35.37 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' A' ' 120' ' ' ALA . 71.6 Cg_endo -75.55 162.5 35.62 Favored 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 122.852 2.054 . . . . 0.0 112.217 -172.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.718 1.207 . . . . 0.0 110.834 -173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.22 131.5 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 111.672 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 mtp180 -136.41 16.8 3.16 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.713 2.005 . . . . 0.0 111.671 -171.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -88.11 -33.23 18.33 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.748 1.619 . . . . 0.0 111.561 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.8 14.52 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -62.53 -13.99 36.98 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.7 m -57.31 -26.44 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.115 1.766 . . . . 0.0 113.523 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -57.27 -35.48 69.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.205 1.002 . . . . 0.0 112.519 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -24.36 56.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.043 -1.035 . . . . 0.0 112.889 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -67.98 -34.18 76.06 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 167.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -66.11 -28.15 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.704 -1.248 . . . . 0.0 110.805 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.51 3.41 41.59 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.697 1.618 . . . . 0.0 114.626 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -125.63 -64.98 1.03 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.977 1.711 . . . . 0.0 110.781 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -60.08 -18.09 44.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.403 2.281 . . . . 0.0 116.429 -166.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.14 -13.83 9.66 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 126.896 2.188 . . . . 0.0 114.282 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.41 -34.41 54.77 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.381 1.472 . . . . 0.0 111.818 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.9 pt -59.33 -27.45 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.525 -0.735 . . . . 0.0 112.449 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.4 -58.59 2.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.949 1.3 . . . . 0.0 111.271 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.13 -33.33 72.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.618 1.167 . . . . 0.0 112.167 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -74.05 -40.61 62.71 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.755 0.822 . . . . 0.0 110.464 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.52 -31.75 68.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.743 . . . . 0.0 111.361 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.59 -51.64 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -67.16 -19.94 65.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -57.08 -35.77 69.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.981 0.512 . . . . 0.0 111.245 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -77.98 -32.7 51.46 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.36 109.15 20.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.621 1.201 . . . . 0.0 111.438 -160.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.08 25.01 5.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.72 1.608 . . . . 0.0 114.21 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.73 -64.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 0.0 111.385 -167.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 72.25 -68.3 0.23 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.217 2.207 . . . . 0.0 112.958 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.31 -27.86 68.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.982 1.313 . . . . 0.0 113.059 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.9 m -100.62 7.14 44.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.332 1.053 . . . . 0.0 113.21 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -100.08 -28.86 12.83 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.849 1.66 . . . . 0.0 112.161 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.993 1.717 . . . . 0.0 112.575 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.86 -23.6 3.64 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.199 1.38 . . . . 0.0 114.737 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 -169.77 1.53 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.081 2.153 . . . . 0.0 111.356 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 165.21 24.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 0.0 110.342 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 41.0 t -158.11 145.9 18.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 0.0 109.869 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.1 129.0 42.99 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.72 1.608 . . . . 0.0 111.003 165.676 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.99 169.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -137.18 132.21 33.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.236 -172.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -105.09 129.53 53.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.522 1.129 . . . . 0.0 109.725 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -112.36 111.14 21.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.999 0.92 . . . . 0.0 109.634 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.3 mm? -100.09 158.6 15.72 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.996 0.903 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 pt -98.38 150.45 36.74 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 125.476 1.51 . . . . 0.0 110.036 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.35 150.89 37.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.17 2.58 . . . . 0.0 111.109 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -168.25 144.73 3.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.012 2.525 . . . . 0.0 107.98 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.0 -22.17 75.75 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -164.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.8 p -90.89 -9.6 45.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.488 1.515 . . . . 0.0 113.178 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.21 157.05 7.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.244 1.402 . . . . 0.0 112.635 -171.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.1 160.88 17.23 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 117.765 0.783 . . . . 0.0 110.767 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.19 144.93 51.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.072 1.349 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.05 110.25 1.16 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.461 0.704 . . . . 0.0 112.547 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.58 -37.28 4.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.882 1.705 . . . . 0.0 112.041 173.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -162.38 148.83 13.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.817 1.247 . . . . 0.0 111.0 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.35 125.78 39.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.347 1.059 . . . . 0.0 109.423 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.6 m -110.86 127.81 55.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.711 2.005 . . . . 0.0 108.133 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.57 133.33 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.608 1.094 . . . . 0.0 109.351 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 tp -104.51 -44.79 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.713 0.405 . . . . 0.0 110.287 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 3.8 t0 -172.48 168.86 5.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.646 1.578 . . . . 0.0 112.232 169.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.7 32.79 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.745 1.164 . . . . 0.0 113.573 169.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -85.68 114.73 22.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 166.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m -59.69 -19.82 52.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -151.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -58.43 -29.63 66.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.303 -0.856 . . . . 0.0 113.128 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -79.81 -48.58 13.31 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 120.228 1.376 . . . . 0.0 111.22 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 38.9 m -45.36 -47.3 13.4 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.694 1.134 . . . . 0.0 112.774 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.17 64.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.391 1.476 . . . . 0.0 114.486 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.04 -52.8 4.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.378 1.471 . . . . 0.0 111.975 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.0 t -56.05 -48.6 75.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 111.292 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -46.87 -47.21 21.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.427 1.891 . . . . 0.0 111.494 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -69.96 -43.25 71.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.08 71.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.694 1.197 . . . . 0.0 111.124 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.05 -22.02 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.82 -1.175 . . . . 0.0 112.645 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.71 -8.72 59.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.841 0.856 . . . . 0.0 112.455 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -13.3 4.67 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -175.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.5 m -58.37 145.12 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.302 1.041 . . . . 0.0 111.984 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -69.46 -42.75 74.47 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -171.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.9 p 166.07 141.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.506 2.323 . . . . 0.0 110.192 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 42.7 m-85 -89.61 112.55 52.4 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.538 -1.22 . . . . 0.0 110.388 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.96 127.02 9.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.33 2.02 . . . . 0.0 111.101 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -73.98 141.65 78.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.852 0.861 . . . . 0.0 111.43 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -44.16 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.891 2.394 . . . . 0.0 110.401 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -122.55 151.56 41.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.146 1.778 . . . . 0.0 109.507 160.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -108.43 10.61 27.38 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -165.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.68 144.31 56.11 Favored Pre-proline 0 C--O 1.24 0.569 0 O-C-N 120.872 -1.143 . . . . 0.0 109.947 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.68 -6.0 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.04 2.493 . . . . 0.0 113.957 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.44 -33.1 23.75 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.713 0.805 . . . . 0.0 112.875 169.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -97.44 -25.77 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 113.139 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.67 -25.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.742 0.817 . . . . 0.0 110.59 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.17 -11.44 59.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.277 1.431 . . . . 0.0 113.191 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -37.75 8.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 0.0 112.583 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.62 -23.94 53.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.778 1.231 . . . . 0.0 112.592 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -66.79 -22.83 66.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.5 91.01 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.942 0.897 . . . . 0.0 110.647 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.475 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -119.43 154.79 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.674 1.19 . . . . 0.0 113.067 -178.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -91.11 136.42 33.1 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.144 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.38 114.31 26.81 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 153.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.3 m -133.83 128.27 34.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.579 1.152 . . . . 0.0 109.34 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.57 156.7 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.783 1.633 . . . . 0.0 111.173 -171.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.42 167.86 9.84 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.81 2.044 . . . . 0.0 110.629 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -60.22 -31.23 92.78 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 123.395 2.73 . . . . 0.0 114.425 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.095 0.958 . . . . 0.0 109.699 175.738 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.01 -82.12 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 75.51 11.57 3.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.853 2.461 . . . . 0.0 114.117 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -96.25 -19.97 18.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.409 1.083 . . . . 0.0 112.817 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -12.0 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.189 1.796 . . . . 0.0 113.335 -169.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.22 -15.83 6.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.201 1.8 . . . . 0.0 115.598 -167.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 m -53.09 -26.74 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.396 1.478 . . . . 0.0 113.267 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 t -59.67 -47.69 84.62 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.672 0.789 . . . . 0.0 112.311 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -64.67 -31.74 73.1 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.145 0.978 . . . . 0.0 112.064 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.09 -24.54 67.48 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.728 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.86 -27.84 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 121.276 1.853 . . . . 0.0 111.272 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.64 -12.34 61.58 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.706 1.146 . . . . 0.0 113.889 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -105.41 -55.45 2.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.349 1.46 . . . . 0.0 112.466 165.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -53.67 -44.0 69.33 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.096 1.759 . . . . 0.0 114.83 -162.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.56 -17.37 57.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.572 1.558 . . . . 0.0 114.03 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.657 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.06 -33.11 59.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.666 1.186 . . . . 0.0 111.547 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.9 pt -59.51 -25.79 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.136 0.88 . . . . 0.0 112.257 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.36 -59.88 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.122 0.969 . . . . 0.0 109.804 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -61.44 -35.25 77.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.472 1.109 . . . . 0.0 112.326 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -73.85 -27.5 61.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.718 1.207 . . . . 0.0 111.915 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -78.6 -32.27 47.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.252 0.933 . . . . 0.0 111.836 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 93' ' ' VAL . 1.5 mp -68.8 -43.54 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.891 1.276 . . . . 0.0 110.598 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -72.62 -13.99 61.5 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.961 0.904 . . . . 0.0 113.223 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -55.58 -38.43 69.36 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.457 0.303 . . . . 0.0 110.326 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -81.25 -36.87 29.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -103.41 99.42 9.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.825 1.298 . . . . 0.0 111.869 -161.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.2 28.82 0.69 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.269 1.428 . . . . 0.0 113.625 -172.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.35 -40.5 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.599 0.759 . . . . 0.0 112.322 -165.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.57 -98.53 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.139 1.776 . . . . 0.0 112.95 164.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.69 -24.1 66.54 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.645 1.178 . . . . 0.0 113.605 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 m -92.83 1.42 57.3 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -88.64 -22.18 23.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.073 1.349 . . . . 0.0 111.575 156.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -86.4 170.92 11.56 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.581 1.952 . . . . 0.0 111.214 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 -9.72 28.46 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.095 1.331 . . . . 0.0 114.833 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 -176.94 5.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.714 2.406 . . . . 0.0 110.885 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.92 160.44 26.15 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.722 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.406 ' HB3' HD23 ' A' ' 85' ' ' LEU . 54.1 t -154.87 141.44 18.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.646 1.178 . . . . 0.0 109.538 168.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.06 131.6 53.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.397 1.479 . . . . 0.0 110.494 167.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.3 m -142.31 170.24 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -134.82 131.93 38.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.404 0.682 . . . . 0.0 111.5 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.38 133.33 48.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.222 1.009 . . . . 0.0 109.682 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -115.16 107.12 14.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.738 1.215 . . . . 0.0 109.709 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.92 158.47 15.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.08 148.2 34.78 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.61 1.564 . . . . 0.0 110.274 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.71 141.13 37.02 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.71 2.273 . . . . 0.0 110.853 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.8 m -133.43 156.94 46.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.277 1.831 . . . . 0.0 109.795 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.31 -26.47 61.68 Favored Glycine 0 N--CA 1.478 1.492 0 C-N-CA 123.55 0.595 . . . . 0.0 113.661 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -131.17 104.47 7.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.941 1.696 . . . . 0.0 108.331 161.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.58 -159.53 24.96 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.136 1.351 . . . . 0.0 114.442 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -110.72 162.45 14.75 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.344 1.057 . . . . 0.0 110.032 162.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.24 145.92 51.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.101 1.761 . . . . 0.0 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.14 112.74 1.81 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.759 0.708 . . . . 0.0 112.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.41 -36.37 5.16 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 125.796 1.665 . . . . 0.0 111.873 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -166.45 153.52 9.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.685 1.594 . . . . 0.0 111.201 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.25 131.65 48.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.44 1.096 . . . . 0.0 109.889 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.0 m -111.55 122.59 48.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.362 1.865 . . . . 0.0 107.878 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.56 130.79 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.96 0.8 . . . . 0.0 109.114 167.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.31 -49.88 3.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.315 0.646 . . . . 0.0 110.094 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.58 165.58 4.57 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.123 1.769 . . . . 0.0 111.865 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.95 179.62 38.33 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 124.543 1.068 . . . . 0.0 114.253 167.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.84 119.65 24.17 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -54.36 -31.64 55.09 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -144.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -54.79 -34.97 63.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.859 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 58' ' ' CYS . 12.4 tp -78.92 -56.78 4.14 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.334 1.425 . . . . 0.0 111.678 -175.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 6.0 p -55.69 -32.62 63.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.42 -33.95 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.816 1.189 . . . . 0.0 113.414 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.52 -52.5 7.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.46 1.104 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.6 t -56.09 -46.63 78.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.25 1.02 . . . . 0.0 111.713 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -46.45 -45.74 18.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.393 1.877 . . . . 0.0 111.797 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -75.62 -43.1 49.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.393 1.077 . . . . 0.0 112.754 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.77 -48.44 81.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.815 1.246 . . . . 0.0 111.98 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' THR . 2.7 t -66.1 -24.42 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.859 -1.151 . . . . 0.0 111.235 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.35 -6.07 55.97 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.503 -0.748 . . . . 0.0 112.566 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -133.07 -12.05 2.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.1 m -58.76 151.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.274 0.943 . . . . 0.0 113.238 169.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.65 -48.69 30.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 173.87 142.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.49 1.916 . . . . 0.0 111.835 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.5 m-85 -97.12 113.79 63.66 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.902 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.5 127.95 6.74 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.868 2.379 . . . . 0.0 110.189 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.6 mt -83.42 146.73 51.22 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.754 0.821 . . . . 0.0 112.225 -172.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.27 -28.81 8.42 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.986 2.457 . . . . 0.0 111.892 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -140.76 156.84 46.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.76 2.024 . . . . 0.0 110.817 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -129.67 20.85 5.55 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -167.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -85.69 141.85 36.54 Favored Pre-proline 0 C--O 1.241 0.655 0 O-C-N 120.492 -1.38 . . . . 0.0 109.068 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.24 -5.41 8.01 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 113.399 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.52 -35.27 23.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.523 1.056 . . . . 0.0 112.124 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.0 m -100.34 -24.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.182 0.993 . . . . 0.0 113.278 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.54 -28.27 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.524 0.73 . . . . 0.0 110.379 167.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.439 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 31.7 mm-40 -79.8 -8.53 59.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.881 1.272 . . . . 0.0 113.981 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -93.1 -54.09 3.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.669 0.788 . . . . 0.0 111.311 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.81 -23.15 67.15 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 124.497 1.119 . . . . 0.0 113.17 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.9 ptmt -72.87 -23.91 60.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.721 -1.237 . . . . 0.0 113.292 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.7 83.08 2.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.124 1.369 . . . . 0.0 110.885 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.585 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.86 150.06 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.716 0.807 . . . . 0.0 112.199 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.48 126.55 39.83 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 157.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 mt -89.78 116.05 27.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 163.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -131.67 124.89 30.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.626 1.171 . . . . 0.0 109.345 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.89 139.95 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 128.333 2.653 . . . . 0.0 107.276 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.71 151.9 6.28 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.285 1.434 . . . . 0.0 111.514 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.3 158.36 29.66 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.742 2.961 . . . . 0.0 111.096 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.241 0.626 0 C-N-CA 123.807 0.843 . . . . 0.0 111.1 173.465 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -163.62 -66.25 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.987 0.915 . . . . 0.0 111.805 -170.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 72.68 12.13 5.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.178 2.191 . . . . 0.0 114.491 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -96.06 -22.11 17.55 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.049 0.94 . . . . 0.0 113.094 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.37 -24.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.965 1.706 . . . . 0.0 113.513 -165.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -58.79 -15.0 10.23 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.006 1.722 . . . . 0.0 114.42 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.99 -27.28 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.172 1.389 . . . . 0.0 113.117 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -57.95 -32.43 67.8 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.9 m -82.13 -27.66 32.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 0.0 112.434 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.0 -38.02 87.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.552 166.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.6 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.971 1.26 . . . . 0.0 111.063 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.68 -18.91 68.7 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.445 -1.197 . . . . 0.0 113.981 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -101.59 -48.85 4.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.976 1.388 . . . . 0.0 112.349 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -54.16 -43.97 71.07 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.801 2.04 . . . . 0.0 113.873 -171.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.05 68.22 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.123 1.344 . . . . 0.0 113.705 173.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.8 -27.48 55.25 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.327 1.063 . . . . 0.0 112.074 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.35 -30.12 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.403 -1.436 . . . . 0.0 111.457 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -78.26 -56.09 4.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.405 1.482 . . . . 0.0 109.488 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.33 -33.95 71.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.845 0.858 . . . . 0.0 112.452 -176.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -37.56 82.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.776 1.231 . . . . 0.0 111.672 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.23 -28.04 59.75 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.58 -52.5 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.224 -0.923 . . . . 0.0 110.622 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -23.91 67.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.638 0.775 . . . . 0.0 112.078 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.35 -14.16 60.46 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -81.5 -45.19 16.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.182 0.901 . . . . 0.0 111.003 159.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.49 83.46 5.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 123.541 1.638 . . . . 0.0 112.081 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.34 28.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.813 1.645 . . . . 0.0 113.999 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.94 -69.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.462 -163.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 74.31 -49.78 0.67 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.982 2.513 . . . . 0.0 113.718 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.78 -44.74 92.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.621 1.168 . . . . 0.0 112.605 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.2 p -92.42 12.72 21.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -100.48 -17.92 16.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.59 1.556 . . . . 0.0 111.325 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -106.16 156.95 17.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.193 1.797 . . . . 0.0 111.813 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.39 -2.72 84.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.037 1.303 . . . . 0.0 114.804 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -178.97 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.032 2.133 . . . . 0.0 110.923 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 161.33 23.2 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.516 -0.74 . . . . 0.0 110.162 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -155.14 149.09 25.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.763 1.225 . . . . 0.0 110.403 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.27 117.64 9.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.733 1.613 . . . . 0.0 110.35 173.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.52 163.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -134.7 131.15 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.985 -0.447 . . . . 0.0 111.701 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.34 129.54 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.352 1.061 . . . . 0.0 109.885 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -114.29 103.81 11.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.511 1.524 . . . . 0.0 108.244 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -100.85 157.59 16.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.714 0.769 . . . . 0.0 112.085 -178.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 pt -101.32 139.33 20.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.231 1.413 . . . . 0.0 110.159 168.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.42 126.23 10.8 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.526 2.151 . . . . 0.0 109.845 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 m -113.74 -33.72 5.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.272 1.029 . . . . 0.0 112.506 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.87 -110.16 0.37 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.487 1.041 . . . . 0.0 111.678 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -61.21 -23.74 65.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.19 0.996 . . . . 0.0 112.673 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.13 -178.43 16.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.268 1.413 . . . . 0.0 115.396 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -100.98 165.83 11.13 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.36 1.464 . . . . 0.0 111.833 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.26 146.49 52.33 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.385 1.874 . . . . 0.0 111.413 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.66 110.3 0.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.59 0.756 . . . . 0.0 112.038 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.45 -35.34 5.73 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.943 1.735 . . . . 0.0 111.703 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.8 152.51 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 0.0 111.556 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -126.0 125.06 42.06 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.532 1.133 . . . . 0.0 109.779 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.6 m -106.43 122.37 46.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.407 1.883 . . . . 0.0 108.19 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.81 129.55 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.125 0.875 . . . . 0.0 108.85 166.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -105.94 -41.54 5.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.405 0.682 . . . . 0.0 110.539 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.27 173.72 6.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.249 1.82 . . . . 0.0 111.503 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.36 169.41 13.08 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 125.778 1.656 . . . . 0.0 114.197 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.94 120.05 24.73 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 p -60.79 -20.85 62.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -154.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -52.69 -33.14 46.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.858 1.263 . . . . 0.0 112.976 171.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.09 -50.52 6.58 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.565 1.075 . . . . 0.0 111.053 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 m -46.22 -47.77 17.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.093 1.357 . . . . 0.0 113.922 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.61 80.45 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.72 0.808 . . . . 0.0 112.466 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.0 16.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.521 1.128 . . . . 0.0 112.068 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.6 t -58.68 -48.28 81.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.953 0.901 . . . . 0.0 110.734 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -49.25 -45.49 44.79 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.989 1.716 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.38 -47.39 61.12 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.23 77.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.289 1.036 . . . . 0.0 111.269 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.68 -22.55 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.86 -1.15 . . . . 0.0 112.013 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.08 -8.63 59.12 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.419 -0.801 . . . . 0.0 112.639 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.41 -11.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.8 m -56.92 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 112.387 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.33 -45.26 76.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 p 166.18 145.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 111.259 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 13.3 m-85 -103.23 103.4 34.56 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.669 1.188 . . . . 0.0 109.426 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.11 132.24 25.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.308 2.006 . . . . 0.0 110.982 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.75 147.12 77.46 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 118.092 0.406 . . . . 0.0 110.941 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -42.01 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.92 1.747 . . . . 0.0 110.562 168.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 158.57 44.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.084 2.154 . . . . 0.0 111.276 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -126.64 19.14 7.34 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.389 1.076 . . . . 0.0 113.898 -162.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.69 140.41 40.98 Favored Pre-proline 0 C--O 1.24 0.589 0 O-C-N 120.508 -1.37 . . . . 0.0 109.442 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.45 -3.59 6.72 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.998 2.466 . . . . 0.0 113.523 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.84 -34.2 21.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.029 0.831 . . . . 0.0 111.985 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.94 -26.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.903 0.881 . . . . 0.0 112.978 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.58 -28.51 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.573 0.749 . . . . 0.0 110.623 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.9 mm-40 -79.62 -10.41 59.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.18 -53.31 4.41 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.518 -0.739 . . . . 0.0 111.133 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.3 pp -65.2 -25.33 67.66 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 112.878 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.2 ptmt -72.92 -24.74 60.86 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.01 -1.056 . . . . 0.0 113.337 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -125.81 81.1 1.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.796 1.638 . . . . 0.0 110.674 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.57 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.49 150.56 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.86 0.864 . . . . 0.0 112.415 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -96.36 129.24 43.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 160.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.94 109.69 19.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 156.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -133.85 125.83 29.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.769 1.228 . . . . 0.0 108.515 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.6 m -138.37 149.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.714 1.606 . . . . 0.0 110.321 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.36 154.82 11.26 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 125.627 1.571 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -77.67 163.49 29.12 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.731 2.954 . . . . 0.0 111.473 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.239 0.534 0 C-N-CA 125.302 1.441 . . . . 0.0 110.954 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.09 -110.13 0.21 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.961 0.904 . . . . 0.0 112.075 -168.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 68.13 30.23 5.89 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.674 1.99 . . . . 0.0 113.039 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -109.09 -19.64 13.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.457 1.503 . . . . 0.0 113.23 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.94 -11.32 0.99 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.982 1.713 . . . . 0.0 113.339 -163.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -70.36 0.4 6.6 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -166.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 m -54.13 -30.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.319 1.448 . . . . 0.0 113.157 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 t -58.85 -34.86 72.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.508 1.123 . . . . 0.0 112.716 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.5 t -73.21 -32.09 64.58 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.392 -0.818 . . . . 0.0 111.895 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.59 -26.99 65.66 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.714 -0.616 . . . . 0.0 112.636 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.59 -25.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.249 1.386 . . . . 0.0 110.743 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.56 0.7 54.92 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.648 1.594 . . . . 0.0 113.699 171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -115.3 -61.13 1.79 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.045 1.738 . . . . 0.0 111.377 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -49.62 -46.34 49.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.739 2.015 . . . . 0.0 114.741 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.54 -16.09 55.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.33 1.919 . . . . 0.0 114.097 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.2 -34.09 59.29 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.375 1.07 . . . . 0.0 111.863 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.0 pt -60.18 -24.72 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.54 0.736 . . . . 0.0 112.074 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -82.98 -59.7 2.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.599 1.16 . . . . 0.0 109.897 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -61.26 -34.66 75.53 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.448 1.099 . . . . 0.0 112.47 -170.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -71.02 -43.94 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.471 1.108 . . . . 0.0 110.385 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.2 tp -67.41 -29.29 68.75 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.638 0.653 . . . . 0.0 111.631 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -53.42 24.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 O-C-N 121.498 -0.751 . . . . 0.0 110.862 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -67.54 -18.28 64.97 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.44 -36.36 66.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.84 0.456 . . . . 0.0 111.265 167.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -78.17 -37.96 44.63 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 112.204 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.53 101.87 13.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.968 1.366 . . . . 0.0 111.57 -164.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 21.0 3.84 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.27 -60.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -162.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 73.31 -57.84 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.715 2.406 . . . . 0.0 113.198 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.4 -40.36 86.36 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.093 1.357 . . . . 0.0 112.05 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 m -79.73 0.87 28.78 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -112.29 -25.77 9.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.063 1.745 . . . . 0.0 112.955 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.69 156.49 16.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.119 1.367 . . . . 0.0 113.171 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.64 -24.11 4.56 Favored Glycine 0 N--CA 1.478 1.486 0 C-N-CA 125.376 1.465 . . . . 0.0 114.816 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -173.63 2.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.41 1.884 . . . . 0.0 111.532 171.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.14 161.1 27.59 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.245 -0.91 . . . . 0.0 111.594 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.9 t -160.36 146.68 15.49 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.936 1.294 . . . . 0.0 110.008 171.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.23 129.81 42.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.184 1.794 . . . . 0.0 110.24 166.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.31 170.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -137.37 131.22 31.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.471 0.578 . . . . 0.0 112.02 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.46 127.93 49.29 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.177 0.991 . . . . 0.0 110.112 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mppt? -108.64 107.46 17.94 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.669 1.187 . . . . 0.0 109.277 165.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.4 160.45 14.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.994 0.902 . . . . 0.0 111.472 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.99 121.43 52.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.424 1.489 . . . . 0.0 109.504 166.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.62 121.84 10.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.96 2.44 . . . . 0.0 111.157 170.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.3 m -111.26 -29.54 7.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.132 1.373 . . . . 0.0 111.821 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.67 -52.99 0.71 Allowed Glycine 0 N--CA 1.476 1.324 0 C-N-CA 125.645 1.593 . . . . 0.0 112.415 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -70.03 -31.79 69.62 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.965 0.906 . . . . 0.0 111.378 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.15 -168.34 18.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 111.814 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.55 162.15 13.92 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 151.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.29 145.84 50.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.999 1.719 . . . . 0.0 111.16 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.94 112.2 1.58 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.644 -0.66 . . . . 0.0 112.402 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.13 -46.83 3.23 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.05 1.309 . . . . 0.0 110.68 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -156.64 148.28 22.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.609 1.164 . . . . 0.0 110.828 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.44 131.2 53.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.796 0.839 . . . . 0.0 109.574 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -115.22 117.17 29.75 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.142 1.777 . . . . 0.0 108.041 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -82.39 132.05 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.473 0.578 . . . . 0.0 109.631 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.86 -52.16 3.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.097 0.559 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -172.9 169.37 4.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.233 1.813 . . . . 0.0 112.119 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.03 -175.73 34.44 Favored Glycine 0 N--CA 1.465 0.581 0 C-N-CA 125.699 1.619 . . . . 0.0 113.843 168.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.63 116.63 19.94 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -25.53 39.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -152.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -55.08 -32.44 61.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.322 1.449 . . . . 0.0 112.834 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.76 -50.55 7.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.288 1.404 . . . . 0.0 112.404 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.1 p -60.74 -31.28 70.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.405 1.457 . . . . 0.0 113.26 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 -46.1 84.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.119 0.968 . . . . 0.0 112.75 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.07 -50.14 30.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.276 1.03 . . . . 0.0 113.206 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.3 t -56.87 -47.91 79.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.64 0.776 . . . . 0.0 110.521 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -48.79 -45.85 40.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.06 1.744 . . . . 0.0 111.818 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -69.14 -43.49 74.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.8 -49.13 78.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.724 1.21 . . . . 0.0 111.275 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.61 -23.03 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.5 -1.375 . . . . 0.0 112.172 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.43 -6.05 57.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.97 0.908 . . . . 0.0 112.782 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.55 -12.27 3.46 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.1 m -60.0 146.62 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.416 1.087 . . . . 0.0 112.115 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -72.11 -46.57 56.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 172.89 138.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.162 1.785 . . . . 0.0 111.245 -168.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.0 m-85 -93.53 111.39 52.16 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.099 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.38 116.21 4.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.892 1.728 . . . . 0.0 109.938 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.1 pt? -88.34 137.63 30.74 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.44 1.496 . . . . 0.0 111.848 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.61 -46.29 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.25 2.634 . . . . 0.0 112.35 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -99.3 168.16 10.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.053 1.341 . . . . 0.0 110.719 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -131.48 6.15 4.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -167.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.15 138.85 60.43 Favored Pre-proline 0 C--O 1.243 0.735 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.36 -0.97 4.0 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.872 2.381 . . . . 0.0 113.549 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.58 -40.39 16.32 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 111.773 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -93.02 -25.74 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.381 1.072 . . . . 0.0 112.412 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.51 -26.65 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.973 0.909 . . . . 0.0 110.799 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -84.55 -7.24 59.33 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.464 1.506 . . . . 0.0 113.826 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -92.68 -51.69 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.781 0.8 . . . . 0.0 111.876 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 112' ' ' LEU . 3.2 pp -69.06 -21.52 64.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.476 1.11 . . . . 0.0 112.345 -172.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -62.37 -24.14 67.2 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.88 -1.138 . . . . 0.0 113.711 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -129.61 78.62 1.86 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.416 1.087 . . . . 0.0 110.401 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.84 151.86 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.306 1.042 . . . . 0.0 111.732 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -91.23 134.17 34.78 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 155.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.33 113.17 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.5 m -135.71 126.29 27.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.344 1.058 . . . . 0.0 109.165 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.26 151.31 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.84 1.656 . . . . 0.0 110.654 -171.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.82 159.84 8.19 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.979 1.712 . . . . 0.0 110.975 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.46 -20.0 8.53 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.361 2.707 . . . . 0.0 113.51 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.502 0 C-N-CA 125.749 1.619 . . . . 0.0 109.919 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -166.06 -97.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.532 1.133 . . . . 0.0 112.079 -171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 68.6 24.41 6.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.38 2.272 . . . . 0.0 113.413 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -98.27 -18.24 18.49 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.57 1.148 . . . . 0.0 112.793 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.33 -23.87 0.67 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.621 1.968 . . . . 0.0 113.174 -166.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.52 -13.12 3.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.481 1.912 . . . . 0.0 116.051 -168.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 m -54.14 -31.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.141 0.882 . . . . 0.0 112.025 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -60.93 -34.88 75.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.439 1.096 . . . . 0.0 113.033 173.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -76.59 -32.66 58.24 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.777 0.831 . . . . 0.0 111.784 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.98 -28.17 66.37 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.532 -1.223 . . . . 0.0 112.351 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.17 -27.94 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 120.702 1.592 . . . . 0.0 110.885 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.31 65.63 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.044 1.307 . . . . 0.0 114.083 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -104.55 -51.78 3.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.324 1.562 . . . . 0.0 111.805 169.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.96 -43.49 77.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.676 2.39 . . . . 0.0 113.335 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.73 -17.44 70.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 172.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.51 -32.0 64.0 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.552 1.176 . . . . 0.0 111.632 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -61.97 -28.84 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.538 -0.726 . . . . 0.0 111.5 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.07 -59.0 2.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.554 1.542 . . . . 0.0 109.992 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.34 -34.16 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.025 0.93 . . . . 0.0 112.408 -173.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -72.45 -31.47 65.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.078 0.951 . . . . 0.0 111.51 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.86 -30.18 61.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.548 0.613 . . . . 0.0 112.29 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -73.97 -53.68 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.956 -1.09 . . . . 0.0 110.649 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -20.22 64.55 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.462 0.705 . . . . 0.0 112.53 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.59 -14.53 58.12 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -79.81 -42.15 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.185 0.902 . . . . 0.0 111.324 159.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.81 84.61 4.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 123.412 1.577 . . . . 0.0 111.775 -163.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.6 27.07 0.13 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.581 1.553 . . . . 0.0 114.217 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.93 -69.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.047 0.939 . . . . 0.0 111.128 -165.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 77.34 -50.81 0.54 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.595 2.358 . . . . 0.0 113.67 162.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.47 -21.97 60.3 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.96 -1.087 . . . . 0.0 113.551 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -89.93 -6.65 55.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.712 1.205 . . . . 0.0 113.07 169.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.1 m-30 -98.31 -17.2 19.02 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.464 1.906 . . . . 0.0 112.277 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.72 159.78 14.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.875 2.07 . . . . 0.0 112.989 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.29 -43.08 2.45 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.698 1.618 . . . . 0.0 112.778 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -84.85 -176.79 6.37 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.21 1.404 . . . . 0.0 111.264 168.122 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 165.08 23.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.879 0.872 . . . . 0.0 111.313 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.41 158.24 43.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.123 0.569 . . . . 0.0 111.087 158.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 128.04 39.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.86 1.264 . . . . 0.0 109.883 159.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.3 178.19 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.57 124.98 13.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.288 0.635 . . . . 0.0 110.966 -166.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.07 131.9 49.72 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.945 0.898 . . . . 0.0 109.814 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -118.63 103.47 9.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.184 1.794 . . . . 0.0 109.38 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.473 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.79 160.39 14.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.374 1.083 . . . . 0.0 111.697 -175.079 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 pt -102.24 142.12 23.94 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.608 1.563 . . . . 0.0 109.879 166.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.07 126.11 9.06 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.793 2.329 . . . . 0.0 109.95 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.2 m -112.9 -27.9 7.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.229 1.412 . . . . 0.0 112.089 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.69 -39.59 2.82 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.652 1.596 . . . . 0.0 112.99 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.3 p -71.49 -34.73 70.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.748 1.219 . . . . 0.0 110.532 163.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.62 -165.61 15.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 112.061 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -89.05 164.14 15.19 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 122.014 -0.697 . . . . 0.0 109.376 151.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.94 145.79 51.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.593 1.557 . . . . 0.0 111.157 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.81 111.59 1.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.253 0.621 . . . . 0.0 112.474 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.4 -35.87 5.33 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.542 1.544 . . . . 0.0 111.683 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.48 151.91 8.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.857 1.663 . . . . 0.0 110.845 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -125.3 121.15 33.18 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.856 0.862 . . . . 0.0 110.02 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.6 m -101.1 135.68 42.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.722 1.609 . . . . 0.0 107.807 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.0 m -99.34 135.95 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.015 0.825 . . . . 0.0 109.006 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -103.82 -48.22 3.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.089 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -172.66 171.61 4.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 0.0 111.792 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.11 -175.1 30.95 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.394 1.474 . . . . 0.0 113.886 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.55 110.89 19.04 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -63.68 -15.32 58.09 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -153.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.78 -32.65 70.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.795 0.838 . . . . 0.0 112.196 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.02 -46.8 22.55 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 119.712 1.142 . . . . 0.0 110.775 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 54.4 m -51.84 -38.77 57.17 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.41 1.005 . . . . 0.0 113.603 173.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.26 -44.98 70.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.841 0.856 . . . . 0.0 112.27 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.22 -52.54 53.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 112.213 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.34 -50.31 73.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.801 0.84 . . . . 0.0 110.365 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -50.95 -46.84 61.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.442 1.497 . . . . 0.0 111.306 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -66.68 -44.22 82.35 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.78 80.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.857 1.263 . . . . 0.0 111.511 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.67 -22.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.5 -1.375 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.83 -7.2 58.56 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.429 -0.794 . . . . 0.0 112.399 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.27 -12.08 3.19 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -173.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.48 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.2 m -55.72 148.28 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.59 1.156 . . . . 0.0 113.017 171.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -73.46 -43.33 60.5 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.4 p 168.87 145.76 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.025 2.53 . . . . 0.0 111.141 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.56 110.68 52.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.439 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.69 114.85 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.527 1.485 . . . . 0.0 110.374 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.741 ' H ' HD23 ' A' ' 101' ' ' LEU . 1.4 pt? -89.76 129.19 47.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.812 1.645 . . . . 0.0 110.397 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.93 -46.34 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.127 2.551 . . . . 0.0 111.043 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -94.26 167.17 11.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.17 1.388 . . . . 0.0 112.169 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.61 24.5 0.59 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.352 1.061 . . . . 0.0 113.027 -165.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.28 140.46 34.38 Favored Pre-proline 0 C--O 1.24 0.598 0 O-C-N 120.754 -1.217 . . . . 0.0 108.644 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.83 -15.26 2.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.961 3.107 . . . . 0.0 115.601 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.32 -35.7 30.65 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.273 0.942 . . . . 0.0 112.496 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -99.78 -27.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.523 1.129 . . . . 0.0 112.726 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.2 t -56.82 -32.5 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.564 1.146 . . . . 0.0 110.105 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 35.5 mm-40 -77.9 -7.83 57.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 113.462 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -99.19 -44.55 6.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 112.694 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.9 -28.14 67.25 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.771 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.3 ptmt -73.01 -23.99 60.69 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.397 -1.439 . . . . 0.0 113.643 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -122.84 84.19 2.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.825 1.25 . . . . 0.0 110.445 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.59 155.92 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.147 0.979 . . . . 0.0 112.127 176.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 120.84 43.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.978 162.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.17 119.45 30.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -135.65 127.03 28.48 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.063 1.345 . . . . 0.0 108.56 -173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.49 157.32 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 111.606 -168.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -161.3 -40.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.702 1.601 . . . . 0.0 115.265 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -67.82 -32.51 29.4 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.173 1.915 . . . . 0.0 114.003 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 125.514 1.526 . . . . 0.0 110.055 -170.039 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.77 -76.47 0.07 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.026 2.531 . . . . 0.0 111.776 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' CD1' ' A' ' 27' ' ' PHE . 58.8 mtt180 73.41 14.16 4.46 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.362 2.265 . . . . 0.0 113.675 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -96.17 -21.64 17.78 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.19 -19.09 0.99 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 113.453 -167.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 24' ' ' ARG . 3.0 p90 -65.59 -2.14 3.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 m -54.4 -30.9 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.255 1.022 . . . . 0.0 112.468 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.4 t -66.86 -47.33 72.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.796 1.238 . . . . 0.0 112.021 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -59.8 -30.99 69.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.612 1.165 . . . . 0.0 112.567 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.37 -29.36 70.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.486 171.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.89 -28.73 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.931 1.696 . . . . 0.0 111.167 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.29 -8.16 69.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.767 1.175 . . . . 0.0 114.226 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.7 mmp_? -121.23 -76.73 0.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.076 2.15 . . . . 0.0 111.724 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -51.48 -52.71 44.35 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 128.057 2.543 . . . . 0.0 113.7 -161.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.36 -15.01 65.04 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.052 1.786 . . . . 0.0 113.97 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.53 -37.28 71.17 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.898 1.349 . . . . 0.0 110.551 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.5 pt -62.18 -26.97 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.476 -0.765 . . . . 0.0 112.223 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.2 -59.31 2.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.892 1.277 . . . . 0.0 109.927 174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -60.15 -35.58 75.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.881 1.272 . . . . 0.0 112.472 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -77.4 -21.78 52.62 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.435 1.094 . . . . 0.0 112.779 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.93 -34.04 39.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.639 1.109 . . . . 0.0 111.416 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.75 -44.09 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 121.052 -1.03 . . . . 0.0 111.063 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -14.81 62.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.912 1.285 . . . . 0.0 112.911 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -59.99 -40.87 90.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.029 0.531 . . . . 0.0 109.962 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -77.94 -44.06 28.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.952 0.882 . . . . 0.0 109.777 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.21 71.28 5.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.378 1.561 . . . . 0.0 111.512 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.12 28.95 0.05 Allowed 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.762 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.19 -70.68 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.991 . . . . 0.0 110.822 -163.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 75.82 -46.93 0.57 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.689 2.396 . . . . 0.0 113.201 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.09 -25.37 64.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.451 1.101 . . . . 0.0 113.067 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.6 m -86.02 -5.21 59.26 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.886 1.274 . . . . 0.0 113.336 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 15.8 m-30 -110.47 -21.48 12.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 112.279 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -91.73 157.58 16.84 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.543 1.937 . . . . 0.0 113.334 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.03 -7.45 66.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 125.411 1.481 . . . . 0.0 114.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -134.78 -172.71 3.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.222 2.209 . . . . 0.0 110.955 176.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.18 165.91 21.36 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.458 -0.777 . . . . 0.0 110.593 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.8 t -154.99 142.05 19.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.001 0.92 . . . . 0.0 109.697 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.78 131.06 51.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.368 1.867 . . . . 0.0 110.677 166.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 170.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.461 1.104 . . . . 0.0 108.524 173.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -132.87 131.57 41.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.787 0.835 . . . . 0.0 112.068 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.28 134.25 44.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.044 0.938 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.89 102.89 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.162 1.385 . . . . 0.0 108.387 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.58 161.65 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.978 0.894 . . . . 0.0 111.493 -178.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -100.59 121.01 54.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.273 1.429 . . . . 0.0 109.688 165.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.51 126.68 23.12 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.818 2.346 . . . . 0.0 110.994 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.2 m -143.52 92.45 2.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.276 1.431 . . . . 0.0 108.285 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.06 -123.95 32.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.977 0.799 . . . . 0.0 111.412 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.91 2.45 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.145 1.778 . . . . 0.0 114.199 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.71 -165.24 10.79 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.193 1.378 . . . . 0.0 114.726 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -127.15 165.73 19.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.838 1.255 . . . . 0.0 110.235 161.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.17 146.6 52.4 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.182 1.793 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.83 111.58 1.7 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.893 0.769 . . . . 0.0 112.419 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.61 -35.65 5.34 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.531 1.538 . . . . 0.0 112.287 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -166.43 153.87 9.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 111.06 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -129.58 129.13 44.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.261 1.024 . . . . 0.0 109.347 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.3 m -112.18 117.98 34.07 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.078 1.751 . . . . 0.0 108.229 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.61 132.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.708 0.685 . . . . 0.0 109.482 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -102.13 -53.13 2.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -179.1 162.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.666 1.987 . . . . 0.0 111.405 170.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.94 -176.54 40.69 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.368 0.985 . . . . 0.0 112.556 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 107.96 17.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 p -64.68 -13.95 56.33 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -147.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -57.1 -33.29 67.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.777 0.831 . . . . 0.0 112.604 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.35 -47.56 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.875 1.216 . . . . 0.0 111.855 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.7 m -45.68 -45.83 14.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.762 1.164 . . . . 0.0 112.802 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.54 71.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 0.0 112.427 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.81 66.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.6 t -58.85 -49.63 77.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.653 0.781 . . . . 0.0 110.477 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.39 -45.9 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.348 1.459 . . . . 0.0 111.518 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.71 -46.29 76.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.85 80.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.556 1.142 . . . . 0.0 111.622 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' THR . 2.6 t -66.06 -24.24 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.543 -1.348 . . . . 0.0 111.486 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.01 -7.22 58.71 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.348 -0.845 . . . . 0.0 112.368 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.75 -11.7 3.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.3 m -57.25 148.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.197 0.908 . . . . 0.0 112.869 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -68.57 -48.22 64.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.7 p 170.11 144.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.578 2.351 . . . . 0.0 110.56 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 22.8 m-85 -97.18 110.66 55.21 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.466 -1.254 . . . . 0.0 109.482 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.87 129.93 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.447 2.098 . . . . 0.0 110.157 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.21 144.92 55.01 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.955 0.502 . . . . 0.0 110.745 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 -29.64 9.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.575 2.183 . . . . 0.0 111.656 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -114.66 -174.9 2.57 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.161 1.784 . . . . 0.0 111.864 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -151.96 21.15 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -95.52 132.29 27.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.89 -1.131 . . . . 0.0 109.457 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.69 -5.6 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.83 3.687 . . . . 0.0 116.857 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.75 -60.27 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.378 0.99 . . . . 0.0 110.266 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -74.97 -25.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.376 0.67 . . . . 0.0 112.273 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.25 -26.29 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 0.0 111.176 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -91.54 3.26 55.41 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.362 1.065 . . . . 0.0 113.711 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -98.33 -49.56 4.64 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.188 -0.945 . . . . 0.0 111.256 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.99 -22.37 65.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.014 1.725 . . . . 0.0 113.588 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.49 -25.1 64.8 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.921 -1.112 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -123.72 86.24 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.895 1.278 . . . . 0.0 111.041 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.568 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -110.55 150.29 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.898 1.279 . . . . 0.0 111.763 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 125.69 43.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 160.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.37 118.33 30.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 164.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -133.87 129.94 37.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.601 1.161 . . . . 0.0 109.321 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.36 153.67 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.534 1.534 . . . . 0.0 111.71 -171.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -158.12 52.24 0.53 Allowed Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 125.734 1.614 . . . . 0.0 113.551 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.14 146.72 36.92 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.866 2.378 . . . . 0.0 112.481 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 C--O 1.238 0.486 0 C-N-CA 124.536 1.134 . . . . 0.0 112.069 -178.309 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.37 -50.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.53 3.532 . . . . 0.0 113.013 7.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 72.85 8.98 5.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.805 2.442 . . . . 0.0 114.453 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -96.17 -20.27 18.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.93 -25.62 0.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 113.168 -164.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.75 -17.65 6.51 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.624 1.57 . . . . 0.0 114.622 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -52.97 -27.43 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.746 1.618 . . . . 0.0 112.77 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -58.01 -38.96 77.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.623 0.769 . . . . 0.0 112.469 171.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -74.54 -29.87 61.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.75 -1.218 . . . . 0.0 112.535 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.08 -26.44 62.16 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.992 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -29.27 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.209 1.368 . . . . 0.0 112.099 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.08 -9.73 64.02 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.355 1.931 . . . . 0.0 113.856 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 -105.91 -52.28 2.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.541 1.17 . . . . 0.0 111.057 166.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.79 -45.31 70.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.29 2.236 . . . . 0.0 113.48 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.16 -17.2 69.99 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.111 1.339 . . . . 0.0 113.635 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.76 -31.93 63.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.612 1.206 . . . . 0.0 111.911 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.48 -27.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.157 -0.965 . . . . 0.0 111.61 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -81.83 -57.73 3.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.125 1.37 . . . . 0.0 110.23 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.08 -36.3 72.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.708 1.203 . . . . 0.0 112.444 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -73.21 -31.68 64.33 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.37 1.068 . . . . 0.0 111.484 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 tp -74.2 -34.33 63.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.071 0.851 . . . . 0.0 112.034 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.84 -44.82 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.591 -1.318 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -72.15 -14.23 61.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -56.48 -39.24 72.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.442 0.297 . . . . 0.0 110.491 165.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -79.27 -39.7 32.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -97.23 85.75 3.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 123.293 1.52 . . . . 0.0 112.031 -163.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.04 27.61 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.826 -1.534 . . . . 0.0 114.126 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 t -84.52 -52.82 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.346 0.658 . . . . 0.0 112.276 -163.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 69.78 -75.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.813 2.045 . . . . 0.0 112.554 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.29 -29.63 67.55 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.878 -1.138 . . . . 0.0 113.662 -167.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -81.55 0.75 36.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-30 -102.7 -17.57 15.58 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.704 2.001 . . . . 0.0 111.912 169.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -89.42 159.37 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.597 1.959 . . . . 0.0 112.18 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 -4.64 65.28 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.069 1.319 . . . . 0.0 114.873 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -140.06 -178.06 5.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.437 1.895 . . . . 0.0 111.882 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 164.01 21.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 109.75 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 t -156.79 144.54 19.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.942 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.11 128.85 45.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.11 1.364 . . . . 0.0 110.468 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -140.88 171.4 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -136.39 130.61 33.02 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.401 -0.812 . . . . 0.0 112.121 -173.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.9 133.66 47.63 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.557 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -117.07 102.93 9.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.264 1.426 . . . . 0.0 109.245 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.17 160.67 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.98 0.895 . . . . 0.0 111.691 -176.1 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.2 pt -101.69 122.35 47.91 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.809 1.644 . . . . 0.0 109.857 167.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 126.01 19.5 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.153 2.569 . . . . 0.0 110.88 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.3 m -118.71 -30.95 4.98 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.211 1.404 . . . . 0.0 111.967 -172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.75 -36.78 4.05 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 125.189 1.376 . . . . 0.0 113.716 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -71.48 -32.57 68.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.115 0.966 . . . . 0.0 110.527 161.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.05 -155.94 11.09 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 127.783 2.611 . . . . 0.0 110.897 172.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.43 163.61 13.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.205 1.003 . . . . 0.0 109.74 154.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.3 146.98 51.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 110.879 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.21 111.88 2.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.339 0.518 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.67 -46.78 3.11 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.304 1.43 . . . . 0.0 110.808 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.1 m -155.3 153.54 30.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.722 1.209 . . . . 0.0 111.452 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.25 132.16 45.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.618 1.167 . . . . 0.0 109.631 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 m -115.8 129.24 56.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.661 1.984 . . . . 0.0 107.494 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.79 136.49 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.397 0.999 . . . . 0.0 109.121 167.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.27 -49.7 3.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 119.083 -0.484 . . . . 0.0 109.996 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -171.39 170.3 5.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.32 1.848 . . . . 0.0 111.933 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.74 -175.32 32.11 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 124.731 1.158 . . . . 0.0 113.334 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.19 113.39 22.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 m -57.66 -20.19 31.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -155.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -54.32 -30.06 49.95 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 112.972 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.65 -50.59 7.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.202 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 m -45.09 -48.49 11.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.93 1.241 . . . . 0.0 113.604 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -29.29 69.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.427 1.091 . . . . 0.0 113.714 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.86 -52.05 5.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.403 1.481 . . . . 0.0 112.526 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.4 t -56.68 -48.3 77.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.057 0.943 . . . . 0.0 110.739 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -49.33 -47.28 47.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.589 1.556 . . . . 0.0 111.277 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -70.0 -44.48 69.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.809 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.443 1.019 . . . . 0.0 111.884 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -66.77 -23.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.599 -1.313 . . . . 0.0 111.556 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.88 -4.33 54.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.075 0.95 . . . . 0.0 112.735 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.06 -11.84 2.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.494 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.0 m -58.34 149.41 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.577 1.081 . . . . 0.0 112.584 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -71.96 -46.27 58.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.4 p 170.29 144.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.708 2.003 . . . . 0.0 111.891 -173.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.6 m-85 -99.74 110.44 58.96 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 110.184 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.98 131.11 10.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.381 2.054 . . . . 0.0 111.073 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.63 143.44 78.84 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.734 1.213 . . . . 0.0 112.324 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 -45.72 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.233 2.622 . . . . 0.0 111.24 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -126.63 154.53 43.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.722 2.009 . . . . 0.0 111.028 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -119.5 13.26 12.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 114.338 -161.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -80.35 143.45 55.92 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 120.814 -1.179 . . . . 0.0 109.741 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.61 -1.74 3.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.641 2.894 . . . . 0.0 114.159 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.2 -43.95 12.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.53 1.059 . . . . 0.0 111.652 167.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.84 -23.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.359 1.063 . . . . 0.0 112.902 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.76 -26.68 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.99 0.916 . . . . 0.0 110.468 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.2 -4.41 59.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.114 0.965 . . . . 0.0 113.506 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -96.02 -53.21 3.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.569 1.077 . . . . 0.0 111.296 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.8 pp -62.47 -25.55 68.05 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.242 1.417 . . . . 0.0 113.009 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.42 -24.94 63.9 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.427 -1.421 . . . . 0.0 113.472 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -125.41 83.81 2.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.4 1.48 . . . . 0.0 110.76 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.585 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.63 156.19 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.948 1.299 . . . . 0.0 112.193 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -92.54 136.31 33.33 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 154.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.76 116.03 26.73 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 154.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -134.56 128.17 32.73 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 109.5 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.95 159.28 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.865 1.666 . . . . 0.0 110.889 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -162.94 160.66 19.07 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 126.072 1.749 . . . . 0.0 111.401 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.98 -12.28 9.67 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.822 2.348 . . . . 0.0 113.502 -171.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 . . . . . 0 C--O 1.24 0.596 0 C-N-CA 124.44 1.096 . . . . 0.0 110.917 178.885 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 77.86 -54.35 0.51 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.687 2.795 . . . . 0.0 112.012 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HA ' ' CD1' ' A' ' 27' ' ' PHE . 75.6 mtt-85 74.99 9.81 3.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.43 2.292 . . . . 0.0 113.662 163.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -92.51 -18.99 22.45 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.065 0.946 . . . . 0.0 112.083 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.76 -26.77 0.45 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.752 1.621 . . . . 0.0 113.127 -169.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -61.3 -5.94 1.9 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -167.356 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 m -57.94 -30.69 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.837 -1.165 . . . . 0.0 112.681 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -67.19 -47.56 70.55 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.608 1.163 . . . . 0.0 112.025 171.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 m -59.17 -30.89 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.45 1.5 . . . . 0.0 112.445 177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.84 -27.75 67.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.782 172.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -64.87 -27.47 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 121.254 1.843 . . . . 0.0 110.253 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.71 -12.88 78.3 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.119 1.342 . . . . 0.0 114.692 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -107.92 -56.19 2.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.961 1.381 . . . . 0.0 112.999 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.68 -42.13 67.63 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.081 2.152 . . . . 0.0 114.12 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.99 -17.3 59.67 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.68 1.61 . . . . 0.0 114.16 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.93 -31.26 56.52 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.706 1.253 . . . . 0.0 112.615 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -59.79 -26.87 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 111.969 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.01 -59.11 2.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.609 1.164 . . . . 0.0 110.176 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.746 1.219 . . . . 0.0 112.46 -172.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.81 -42.89 69.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.487 1.115 . . . . 0.0 110.239 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.86 -29.88 69.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.798 0.726 . . . . 0.0 111.947 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.52 -52.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -17.74 63.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -55.26 -34.38 63.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.811 0.444 . . . . 0.0 111.648 165.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.3 m120 -79.19 -33.4 43.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 81.2 1.87 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.004 1.321 . . . . 0.0 109.166 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.59 43.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.011 1.324 . . . . 0.0 112.829 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -78.25 -57.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.238 1.415 . . . . 0.0 111.802 -165.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 72.03 -50.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.954 2.501 . . . . 0.0 113.152 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.9 -32.62 73.93 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 113.728 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 m -89.9 0.35 57.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -111.8 -23.76 10.41 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.019 1.728 . . . . 0.0 112.267 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.52 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 112.804 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.16 -11.23 30.63 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.391 1.472 . . . . 0.0 114.925 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -170.2 2.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.053 2.141 . . . . 0.0 111.065 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.41 162.96 26.86 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.597 176.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.425 ' HB3' HD23 ' A' ' 85' ' ' LEU . 52.6 t -156.23 144.59 19.91 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 109.839 168.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.73 129.95 49.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.118 1.367 . . . . 0.0 110.648 165.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -142.8 170.19 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.905 1.282 . . . . 0.0 107.824 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -134.6 130.64 36.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.569 0.748 . . . . 0.0 111.66 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.6 132.43 47.26 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.225 1.01 . . . . 0.0 110.316 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.47 102.22 9.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.191 1.396 . . . . 0.0 108.903 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.25 159.84 14.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.26 1.029 . . . . 0.0 111.565 -178.217 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.7 pt -103.87 146.6 32.83 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 126.111 1.764 . . . . 0.0 109.837 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.14 133.29 17.76 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 110.525 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -3.37 16.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.019 1.328 . . . . 0.0 113.121 175.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 -55.44 1.0 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 126.292 1.901 . . . . 0.0 112.441 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.6 p -79.94 -24.28 41.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.775 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.75 -159.11 10.11 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.086 1.803 . . . . 0.0 111.686 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -108.74 164.94 11.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.87 0.868 . . . . 0.0 110.871 164.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.73 145.3 49.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.592 1.957 . . . . 0.0 110.787 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.27 112.49 1.95 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.075 0.852 . . . . 0.0 112.135 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.72 -36.15 4.89 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.432 1.492 . . . . 0.0 112.034 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -164.83 154.44 13.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.408 1.483 . . . . 0.0 111.533 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -130.61 126.74 37.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.274 1.03 . . . . 0.0 109.791 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.8 m -110.62 118.73 37.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.946 1.698 . . . . 0.0 107.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.25 134.32 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.185 0.902 . . . . 0.0 109.632 170.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 mt -107.09 -49.21 3.32 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.997 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -173.38 166.24 4.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.65 1.58 . . . . 0.0 111.618 172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.76 -177.44 35.37 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 125.164 1.364 . . . . 0.0 114.011 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.31 116.69 21.92 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -56.28 -25.36 48.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -151.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -51.25 -38.18 51.23 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.917 1.287 . . . . 0.0 112.666 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 58' ' ' CYS . 15.3 tp -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.053 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.99 -28.66 67.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.5 1.5 . . . . 0.0 114.138 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 -44.26 69.16 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.895 0.77 . . . . 0.0 112.666 170.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.13 -54.61 12.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.66 1.184 . . . . 0.0 113.549 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.7 t -54.67 -48.52 72.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.506 0.723 . . . . 0.0 110.514 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -52.13 -45.75 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.658 1.583 . . . . 0.0 112.048 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.6 mtp-105 -63.81 -42.32 97.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.121 0.568 . . . . 0.0 112.019 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.81 74.76 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 89' ' ' THR . 1.9 t -62.83 -25.08 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.253 -1.529 . . . . 0.0 112.383 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.2 -7.7 57.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.728 0.811 . . . . 0.0 112.804 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.31 -12.74 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.8 m -58.09 146.68 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.415 1.086 . . . . 0.0 112.681 173.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -68.74 -41.98 78.2 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 p 163.41 139.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.448 2.299 . . . . 0.0 110.96 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 39.7 m-85 -91.95 113.03 57.67 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.154 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.26 118.82 5.07 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.249 1.966 . . . . 0.0 109.926 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 101' ' ' LEU . 1.9 pp -93.17 140.28 23.27 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.909 1.284 . . . . 0.0 112.047 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.06 -31.2 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.271 2.647 . . . . 0.0 113.463 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.76 146.45 49.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.584 1.554 . . . . 0.0 110.049 176.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -102.78 8.13 39.44 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -166.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.02 136.33 57.89 Favored Pre-proline 0 C--O 1.241 0.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.366 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.61 -5.11 8.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.807 2.338 . . . . 0.0 113.465 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.32 -35.93 21.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.965 0.802 . . . . 0.0 112.063 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.18 -27.72 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.25 1.02 . . . . 0.0 112.814 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -57.26 -27.1 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.705 0.802 . . . . 0.0 110.874 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 30.4 mm-40 -82.07 -6.64 59.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.075 1.35 . . . . 0.0 114.094 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -92.54 -55.71 3.29 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.365 -0.834 . . . . 0.0 111.314 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.99 -27.62 65.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.885 1.274 . . . . 0.0 112.991 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 ptmt -67.68 -23.07 65.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.063 -1.648 . . . . 0.0 114.048 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -122.68 86.28 2.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.45 1.1 . . . . 0.0 110.877 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.559 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -109.11 151.55 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.615 1.166 . . . . 0.0 111.978 175.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -90.72 129.52 36.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 154.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -86.03 111.77 20.61 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.7 m -131.8 126.32 34.07 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.06 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.89 151.83 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.96 164.81 11.24 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.486 1.914 . . . . 0.0 110.641 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.46 -33.52 97.26 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.641 2.894 . . . . 0.0 114.05 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.239 0.504 0 C-N-CA 124.862 1.265 . . . . 0.0 110.527 172.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.86 -46.43 67.87 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.344 2.258 . . . . 0.0 113.395 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.48 -17.39 64.32 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.423 1.487 . . . . 0.0 113.97 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.39 -32.87 64.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.362 1.081 . . . . 0.0 111.993 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 pt -60.56 -28.18 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.735 0.698 . . . . 0.0 111.919 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -80.59 -58.89 2.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.359 1.064 . . . . 0.0 109.58 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -60.52 -35.4 75.87 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.75 1.22 . . . . 0.0 112.645 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -73.56 -32.38 64.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.459 1.104 . . . . 0.0 111.603 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -73.71 -32.65 64.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.871 0.759 . . . . 0.0 111.681 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.83 -56.46 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -65.2 -21.46 66.76 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.26 -9.26 59.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.72 -41.76 23.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.4 1.0 . . . . 0.0 111.374 163.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.99 86.39 2.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.232 1.413 . . . . 0.0 109.57 -173.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.76 39.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.052 1.741 . . . . 0.0 113.971 -173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.05 -60.01 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.957 0.903 . . . . 0.0 111.82 -166.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 72.73 -53.15 0.7 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.781 2.433 . . . . 0.0 114.148 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.47 -32.6 74.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 113.418 -171.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.8 p -96.6 5.64 50.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.093 1.357 . . . . 0.0 113.335 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.55 -27.4 13.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.232 1.813 . . . . 0.0 111.382 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -93.66 173.41 7.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.662 1.985 . . . . 0.0 112.657 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.66 -32.35 1.9 Allowed Glycine 0 N--CA 1.481 1.649 0 C-N-CA 125.811 1.672 . . . . 0.0 114.795 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -167.38 1.47 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.119 2.168 . . . . 0.0 110.675 165.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 158.63 38.03 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.28 -0.888 . . . . 0.0 110.442 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -156.46 150.16 24.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.612 1.165 . . . . 0.0 110.171 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.99 118.8 10.53 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.861 1.664 . . . . 0.0 110.589 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.38 171.05 14.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.413 1.085 . . . . 0.0 108.301 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.91 124.15 14.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.658 0.783 . . . . 0.0 110.402 -166.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.62 128.78 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.93 0.892 . . . . 0.0 109.074 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -117.6 105.9 12.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.379 1.472 . . . . 0.0 109.186 171.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.04 160.66 14.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.397 1.079 . . . . 0.0 111.397 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 pt -101.71 152.87 38.18 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.758 1.623 . . . . 0.0 110.2 167.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.73 151.76 46.73 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.175 2.583 . . . . 0.0 111.183 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -168.36 148.66 4.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.584 2.354 . . . . 0.0 108.273 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.63 74.7 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 -164.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -96.56 -6.06 37.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.579 1.552 . . . . 0.0 113.15 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.83 165.83 10.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.713 1.625 . . . . 0.0 111.598 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -65.64 161.4 20.55 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 117.959 0.879 . . . . 0.0 111.014 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.76 143.35 50.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.223 1.409 . . . . 0.0 111.159 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.3 109.59 0.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.88 -45.3 3.66 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.462 1.506 . . . . 0.0 110.938 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.4 m -156.06 146.33 21.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.344 1.058 . . . . 0.0 110.299 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.21 124.94 41.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.067 0.947 . . . . 0.0 109.927 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.9 m -104.77 121.49 43.73 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.006 1.323 . . . . 0.0 108.279 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.61 126.61 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 165.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.57 -40.44 6.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.048 0.539 . . . . 0.0 110.783 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -170.79 172.74 5.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.765 1.626 . . . . 0.0 111.462 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.57 172.33 17.57 Favored Glycine 0 N--CA 1.465 0.587 0 C-N-CA 125.981 1.753 . . . . 0.0 114.128 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -76.81 122.04 24.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.1 p -56.37 -27.42 56.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -157.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -56.68 -25.36 53.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.617 1.167 . . . . 0.0 113.865 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 tp -91.34 -59.57 2.11 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.066 1.303 . . . . 0.0 112.377 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.4 p -56.88 -31.79 65.19 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 121.137 1.789 . . . . 0.0 114.861 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.2 71.93 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.439 1.018 . . . . 0.0 112.658 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.37 -53.4 12.42 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.917 1.287 . . . . 0.0 112.006 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.5 t -54.55 -50.36 68.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.245 1.018 . . . . 0.0 110.608 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -51.14 -47.49 62.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.847 1.659 . . . . 0.0 111.755 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.98 -40.63 96.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 112.277 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.66 82.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.275 1.43 . . . . 0.0 112.453 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -63.01 -26.81 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.568 -1.332 . . . . 0.0 112.15 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.05 55.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.915 0.886 . . . . 0.0 112.991 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.54 -10.56 3.18 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.3 m -52.1 150.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.23 -50.13 49.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.017 0.927 . . . . 0.0 112.581 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p 168.67 147.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.459 2.704 . . . . 0.0 110.387 -173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -97.51 106.3 31.81 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.234 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.91 116.93 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.716 1.611 . . . . 0.0 110.647 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 142.43 28.48 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.043 1.337 . . . . 0.0 110.722 173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.86 -24.17 11.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.34 2.693 . . . . 0.0 112.586 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.3 -179.93 6.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.39 1.476 . . . . 0.0 112.44 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -155.86 15.32 0.35 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.472 1.109 . . . . 0.0 113.086 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.28 129.09 32.85 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 120.637 -1.289 . . . . 0.0 108.967 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.64 -4.09 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.559 3.506 . . . . 0.0 115.801 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.51 -43.39 15.81 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.833 1.197 . . . . 0.0 112.141 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.12 -22.52 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.603 1.161 . . . . 0.0 112.609 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.3 t -55.2 -27.12 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.956 0.902 . . . . 0.0 110.903 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.65 -7.59 59.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.032 1.333 . . . . 0.0 113.81 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -45.69 6.14 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.046 -1.034 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -72.65 -23.19 60.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.998 0.919 . . . . 0.0 111.823 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -65.97 -22.12 66.45 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -125.52 79.34 1.81 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.605 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -102.19 158.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.48 1.112 . . . . 0.0 111.776 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.39 123.62 50.67 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 159.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.24 111.28 20.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -134.21 125.66 28.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.79 1.236 . . . . 0.0 108.931 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.76 149.88 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.727 1.611 . . . . 0.0 110.631 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.898 0 C-N-CA 126.658 1.983 . . . . 0.0 111.201 -178.419 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.705 0.288 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.74 -43.09 65.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.431 1.892 . . . . 0.0 113.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.56 68.28 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.841 1.21 . . . . 0.0 114.011 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.59 -35.07 70.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 111.366 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -59.6 -28.44 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.545 -0.722 . . . . 0.0 112.122 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -80.36 -58.86 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.968 1.307 . . . . 0.0 109.547 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.51 -35.53 74.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.553 1.141 . . . . 0.0 112.695 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -74.45 -30.27 61.8 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.726 1.21 . . . . 0.0 111.781 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -75.47 -34.49 60.9 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.531 1.059 . . . . 0.0 111.479 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.53 -44.44 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.295 1.038 . . . . 0.0 111.058 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.95 -14.37 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.884 0.874 . . . . 0.0 113.164 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -55.52 -35.53 65.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.268 0.227 . . . . 0.0 111.137 164.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.404 HD21 HG12 ' A' ' 96' ' ' VAL . 64.2 m-80 -81.7 -30.71 32.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 111.538 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -143.95 81.22 1.68 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.418 1.487 . . . . 0.0 109.531 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.48 38.09 0.18 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.413 1.485 . . . . 0.0 113.786 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.31 -51.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.97 0.908 . . . . 0.0 112.892 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 70.82 -59.01 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.779 2.432 . . . . 0.0 113.71 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.06 -34.34 77.84 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.076 -1.015 . . . . 0.0 113.464 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -87.8 -1.32 57.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 113.612 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -100.4 -24.4 14.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.774 1.629 . . . . 0.0 111.702 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -91.32 172.51 8.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.372 2.269 . . . . 0.0 111.373 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.47 -34.02 2.04 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -168.64 1.59 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.573 1.949 . . . . 0.0 110.748 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 160.6 32.75 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 110.703 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.429 ' HB3' HD23 ' A' ' 85' ' ' LEU . 44.6 t -157.46 149.02 21.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.506 1.122 . . . . 0.0 110.171 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 122.82 20.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.989 1.716 . . . . 0.0 110.368 167.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.54 163.11 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.591 1.156 . . . . 0.0 108.005 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.34 130.69 39.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.343 0.657 . . . . 0.0 112.128 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.44 129.76 46.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 110.084 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.47 103.82 11.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.424 1.489 . . . . 0.0 108.774 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.29 158.41 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.533 0.683 . . . . 0.0 111.757 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.16 140.09 21.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 109.861 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.85 125.42 9.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.436 2.091 . . . . 0.0 109.833 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.2 m -110.81 -31.0 7.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.695 1.198 . . . . 0.0 111.871 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.62 -117.04 0.7 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.191 1.377 . . . . 0.0 110.756 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -66.7 -4.98 10.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.393 1.477 . . . . 0.0 113.871 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.47 174.04 24.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.434 1.492 . . . . 0.0 114.27 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -104.57 163.87 12.16 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 111.717 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.78 147.15 50.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.435 1.894 . . . . 0.0 111.4 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.94 111.61 1.55 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.52 0.6 . . . . 0.0 112.133 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 -45.78 3.69 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.406 1.479 . . . . 0.0 111.15 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.4 m -157.33 152.86 26.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.747 1.219 . . . . 0.0 110.463 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.98 126.93 40.65 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.218 1.007 . . . . 0.0 110.214 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.7 m -106.8 120.87 43.18 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.638 1.975 . . . . 0.0 107.938 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -87.57 127.11 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.2 0.909 . . . . 0.0 108.779 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.29 -39.42 6.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.265 0.626 . . . . 0.0 110.896 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -170.25 168.83 8.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 111.849 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.8 173.84 19.9 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 125.283 1.421 . . . . 0.0 114.753 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.62 117.85 20.92 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.7 p -59.15 -19.76 47.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -159.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -55.85 -29.96 60.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.906 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 58' ' ' CYS . 18.0 tp -86.53 -52.31 5.64 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.84 1.2 . . . . 0.0 111.444 171.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 m -46.64 -46.8 20.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.741 1.155 . . . . 0.0 113.635 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.86 -42.3 67.05 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.009 0.822 . . . . 0.0 112.041 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' A' ' 47' ' ' LEU . . . -61.69 -58.74 6.85 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.512 1.125 . . . . 0.0 112.531 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.64 -50.41 73.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.864 0.466 . . . . 0.0 110.168 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -51.74 -47.54 64.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.227 1.411 . . . . 0.0 111.876 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.02 -40.61 96.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.228 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.4 -49.3 74.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.763 1.225 . . . . 0.0 112.203 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -64.32 -24.06 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.633 -1.292 . . . . 0.0 111.723 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.78 -7.13 57.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 112.66 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -134.05 -12.74 2.5 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.0 m -58.45 146.56 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.231 1.013 . . . . 0.0 112.628 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -66.52 -46.05 77.45 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p 167.6 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.854 2.062 . . . . 0.0 111.0 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 29.4 m-85 -96.24 109.38 47.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.666 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.05 132.0 14.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.424 2.083 . . . . 0.0 109.969 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.99 145.94 66.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.667 -173.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.66 -28.79 7.82 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.095 2.53 . . . . 0.0 111.181 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -140.42 150.58 44.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.925 2.09 . . . . 0.0 110.621 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -119.88 23.03 11.28 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.928 1.291 . . . . 0.0 112.888 -164.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -85.86 142.13 36.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.584 -1.323 . . . . 0.0 109.946 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -63.09 -4.57 6.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.484 2.789 . . . . 0.0 113.796 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.38 -33.44 19.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.597 1.159 . . . . 0.0 111.98 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 -24.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.202 1.001 . . . . 0.0 112.23 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.55 -25.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.23 1.012 . . . . 0.0 111.362 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -84.13 -7.36 59.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.978 1.311 . . . . 0.0 114.323 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 -46.52 5.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.905 0.882 . . . . 0.0 111.23 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.0 pp -74.42 -20.33 60.08 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.571 1.548 . . . . 0.0 113.205 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -63.56 -23.9 67.58 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.699 -1.25 . . . . 0.0 113.354 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.34 80.09 1.92 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.985 1.314 . . . . 0.0 109.933 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -106.39 150.95 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.002 . . . . 0.0 111.828 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.82 130.57 44.07 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 160.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.84 111.95 23.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 156.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.0 m -134.6 126.45 29.25 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.704 1.202 . . . . 0.0 109.254 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.1 m -138.78 151.71 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.377 1.471 . . . . 0.0 110.495 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.987 0 C-N-CA 126.26 1.824 . . . . 0.0 111.583 -178.021 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 120.773 0.32 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.58 -18.55 41.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 128.027 2.531 . . . . 0.0 116.219 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.66 -13.13 8.94 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.138 1.827 . . . . 0.0 113.945 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.37 -32.18 43.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.034 1.734 . . . . 0.0 110.755 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 pt -62.0 -28.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.186 -1.571 . . . . 0.0 112.15 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.75 -56.97 4.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.513 1.125 . . . . 0.0 110.098 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.83 -35.03 72.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.364 1.066 . . . . 0.0 112.641 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -70.31 -31.21 68.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.472 1.509 . . . . 0.0 112.307 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.0 tp -79.96 -35.24 37.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.605 0.362 . . . . 0.0 111.824 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -68.22 -53.11 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.777 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -59.06 -26.87 64.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.493 0.717 . . . . 0.0 112.289 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -15.16 60.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.419 HD21 HG12 ' A' ' 96' ' ' VAL . 56.7 m-80 -81.43 -40.1 23.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.039 0.836 . . . . 0.0 111.718 161.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.2 88.07 5.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 123.383 1.563 . . . . 0.0 111.607 -163.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 27.02 0.4 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.863 -1.517 . . . . 0.0 114.121 -175.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.45 -56.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.741 0.816 . . . . 0.0 112.563 -163.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.3 -57.59 0.63 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.001 2.521 . . . . 0.0 113.757 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.85 -24.13 62.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 112.937 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.6 m -84.06 -1.27 54.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.608 1.163 . . . . 0.0 113.623 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.452 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-85 -117.5 -21.17 8.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.526 1.53 . . . . 0.0 113.179 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -85.44 152.1 23.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.315 1.846 . . . . 0.0 112.713 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 -8.49 28.3 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.365 1.459 . . . . 0.0 116.126 168.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.4 -179.55 4.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.149 1.779 . . . . 0.0 112.052 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 160.92 20.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.652 0.781 . . . . 0.0 111.29 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 49.0 t -159.51 144.19 15.29 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.449 1.1 . . . . 0.0 109.877 172.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.29 39.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.846 2.059 . . . . 0.0 110.031 168.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.25 175.08 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.277 1.031 . . . . 0.0 108.568 171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.08 126.76 20.45 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.941 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.75 128.75 53.89 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.128 0.971 . . . . 0.0 109.007 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -116.69 106.92 14.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.96 1.304 . . . . 0.0 109.117 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.28 157.77 16.16 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.605 1.162 . . . . 0.0 111.772 -176.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.86 151.19 37.45 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.723 1.609 . . . . 0.0 110.154 167.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -72.52 150.42 51.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.137 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -166.47 148.17 6.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.487 2.315 . . . . 0.0 108.062 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.74 -17.66 71.42 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.776 1.071 . . . . 0.0 115.776 -165.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.3 p -97.14 -3.43 41.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.971 1.708 . . . . 0.0 113.127 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.26 165.42 11.45 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.161 1.363 . . . . 0.0 111.937 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -67.58 161.28 26.0 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.366 1.083 . . . . 0.0 111.115 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.21 144.58 51.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 111.127 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.65 112.2 1.91 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.427 0.558 . . . . 0.0 112.04 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.1 -46.11 3.16 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.026 1.298 . . . . 0.0 111.012 170.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.7 m -153.03 143.69 22.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.368 1.067 . . . . 0.0 110.682 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -119.21 121.86 40.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.258 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -104.8 118.31 36.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.405 1.482 . . . . 0.0 108.26 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 m -83.97 129.05 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 118.892 0.769 . . . . 0.0 109.732 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 mt -99.18 -54.32 3.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.009 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -177.87 164.8 1.96 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.721 2.008 . . . . 0.0 111.433 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.25 -173.71 39.44 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 125.57 1.557 . . . . 0.0 113.528 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.99 116.92 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.4 p -55.9 -26.31 46.83 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -150.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.83 -29.44 69.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.93 -47.37 16.54 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.722 1.147 . . . . 0.0 111.107 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 68.8 m -48.56 -45.07 37.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.632 1.106 . . . . 0.0 112.359 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.25 -47.93 75.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.628 1.171 . . . . 0.0 112.177 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.79 41.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.058 0.943 . . . . 0.0 113.266 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -56.8 -48.49 77.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.809 0.844 . . . . 0.0 110.845 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -48.71 -44.12 37.9 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.303 1.841 . . . . 0.0 111.953 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -70.57 -45.92 64.48 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.25 74.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.701 1.2 . . . . 0.0 111.161 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -67.08 -22.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.996 -1.065 . . . . 0.0 112.268 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -7.44 59.1 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.001 0.92 . . . . 0.0 112.538 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.18 -12.54 3.58 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.6 m -56.52 145.56 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.485 1.114 . . . . 0.0 112.783 171.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.7 -44.68 77.13 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.0 p 165.59 142.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.214 2.205 . . . . 0.0 110.848 -169.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.0 m-85 -93.21 111.27 51.13 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.693 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.18 128.85 10.85 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.217 1.945 . . . . 0.0 110.567 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.34 148.36 52.5 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.577 0.751 . . . . 0.0 112.118 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.06 -33.35 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.92 2.414 . . . . 0.0 111.075 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 153.78 45.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.161 2.184 . . . . 0.0 110.358 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -119.87 20.2 12.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.318 1.447 . . . . 0.0 113.406 -166.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -83.2 139.8 42.25 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 120.757 -1.214 . . . . 0.0 109.3 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.66 -15.74 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.461 2.774 . . . . 0.0 114.945 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.15 -28.62 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.973 1.309 . . . . 0.0 112.077 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.68 -26.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.582 1.553 . . . . 0.0 112.5 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.37 -26.27 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.49 1.116 . . . . 0.0 110.959 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.41 -11.49 59.68 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.233 1.413 . . . . 0.0 113.714 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -97.51 -46.52 6.01 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.914 0.779 . . . . 0.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.1 pp -73.07 -22.52 60.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.796 1.238 . . . . 0.0 112.92 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.38 -23.93 66.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.07 82.35 2.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.006 0.923 . . . . 0.0 110.238 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.2 158.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.36 1.076 . . . . 0.0 111.968 178.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.06 126.09 52.33 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 157.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.59 112.47 21.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.5 m -132.1 125.84 32.31 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 109.054 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.24 149.99 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.251 1.82 . . . . 0.0 110.293 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 125.551 1.54 . . . . 0.0 112.197 -176.649 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 38' ' ' ILE . 46.5 mtt180 . . . . . 0 N--CA 1.472 0.64 0 CA-C-O 120.395 0.141 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -49.89 -47.62 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.161 2.184 . . . . 0.0 114.038 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.4 -16.14 62.87 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.052 1.31 . . . . 0.0 113.779 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.64 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.92 -34.5 64.37 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.251 1.026 . . . . 0.0 111.645 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 3.7 pt -60.03 -26.3 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.519 -0.738 . . . . 0.0 111.994 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -82.08 -59.87 2.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.494 1.118 . . . . 0.0 109.837 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -61.17 -35.14 76.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.254 1.022 . . . . 0.0 112.775 -171.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -71.38 -43.02 67.66 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.165 0.986 . . . . 0.0 109.757 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.57 -30.33 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.672 0.669 . . . . 0.0 111.543 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.454 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -69.87 -54.0 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.844 0.858 . . . . 0.0 110.915 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -68.05 -18.07 64.58 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -55.85 -36.45 67.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.256 0.48 . . . . 0.0 111.389 167.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -77.51 -34.35 54.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -102.35 109.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.542 1.163 . . . . 0.0 111.14 -160.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.65 22.03 10.51 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 114.628 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.8 -62.56 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.332 0.653 . . . . 0.0 111.545 -166.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 72.86 -60.04 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.769 2.428 . . . . 0.0 113.506 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.6 -29.77 70.98 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.611 -1.305 . . . . 0.0 113.14 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -94.8 6.07 50.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.31 1.044 . . . . 0.0 113.655 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.4 m-30 -105.31 -21.94 13.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 112.085 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -100.64 156.3 17.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.596 1.958 . . . . 0.0 111.905 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.48 -27.27 2.89 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.274 1.416 . . . . 0.0 114.556 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -174.68 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.494 1.918 . . . . 0.0 111.557 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 161.62 29.62 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.815 0.846 . . . . 0.0 110.643 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.95 157.87 43.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.553 0.741 . . . . 0.0 111.433 160.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 126.03 31.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.84 1.656 . . . . 0.0 109.967 161.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.94 166.33 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.15 131.29 36.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.508 0.594 . . . . 0.0 112.065 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 132.18 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.159 0.984 . . . . 0.0 110.037 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -114.4 105.98 13.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.341 1.456 . . . . 0.0 109.147 171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -100.2 158.81 15.59 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.56 0.695 . . . . 0.0 111.748 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -99.3 133.43 22.03 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.126 1.37 . . . . 0.0 109.843 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.06 116.73 4.83 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.581 2.187 . . . . 0.0 109.207 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 m -106.14 -30.85 8.99 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.546 1.139 . . . . 0.0 112.095 -172.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.24 -112.33 0.49 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.852 1.215 . . . . 0.0 111.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -58.71 -25.28 62.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 112.34 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.76 179.04 20.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.757 1.17 . . . . 0.0 114.472 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -95.24 165.0 12.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.97 1.308 . . . . 0.0 111.515 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -132.82 147.22 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.151 1.781 . . . . 0.0 111.47 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.94 111.23 1.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.764 0.711 . . . . 0.0 112.656 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.35 -36.04 5.53 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.396 1.474 . . . . 0.0 111.668 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -167.26 153.39 7.94 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.266 1.426 . . . . 0.0 111.023 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -130.14 126.29 37.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.319 1.048 . . . . 0.0 109.873 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -105.17 132.98 50.71 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.402 1.881 . . . . 0.0 108.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.14 131.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.943 0.792 . . . . 0.0 109.102 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.56 -45.19 5.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.947 0.499 . . . . 0.0 110.073 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -172.58 167.91 5.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.986 1.715 . . . . 0.0 111.647 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.7 -177.84 27.59 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.893 1.235 . . . . 0.0 114.303 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.4 118.22 24.8 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 166.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.8 p -59.94 -21.27 60.94 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -158.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -60.88 -23.02 64.86 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.381 1.072 . . . . 0.0 113.669 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.44 -49.06 6.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.812 1.187 . . . . 0.0 111.414 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.8 m -49.99 -39.26 40.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.833 1.253 . . . . 0.0 114.322 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.2 56.86 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.04 0.836 . . . . 0.0 112.829 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -51.29 65.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.981 . . . . 0.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.4 t -57.46 -47.6 81.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.454 0.702 . . . . 0.0 110.235 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -57.19 -35.15 69.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.371 1.068 . . . . 0.0 112.157 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -71.26 -48.52 50.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.41 72.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.647 1.179 . . . . 0.0 111.749 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.1 -24.04 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.489 -1.382 . . . . 0.0 111.661 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -6.94 58.83 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -130.91 -12.14 3.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.7 m -58.76 145.91 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.395 1.078 . . . . 0.0 112.257 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.41 -42.1 83.78 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -173.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p 163.21 143.44 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.56 2.344 . . . . 0.0 111.048 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 20.3 m-85 -98.13 105.32 27.61 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-O 117.527 -1.225 . . . . 0.0 109.948 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 134.35 17.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.817 2.344 . . . . 0.0 110.437 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 144.87 59.22 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.31 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.33 -28.67 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.241 2.627 . . . . 0.0 111.855 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -140.77 154.23 46.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.715 2.006 . . . . 0.0 110.482 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -133.49 48.1 2.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.175 0.99 . . . . 0.0 112.349 -165.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.9 141.2 22.84 Favored Pre-proline 0 C--O 1.243 0.733 0 O-C-N 121.35 -0.844 . . . . 0.0 108.802 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.17 -17.55 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.021 3.148 . . . . 0.0 115.182 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.76 -33.85 40.34 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.039 0.836 . . . . 0.0 112.335 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 m -97.26 -25.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.506 1.122 . . . . 0.0 112.611 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.33 -26.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.697 1.199 . . . . 0.0 110.951 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -81.38 -10.7 59.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.001 1.32 . . . . 0.0 114.031 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.77 -47.5 5.57 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.343 -0.848 . . . . 0.0 111.401 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.4 -21.07 61.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.188 . . . . 0.0 112.61 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -65.38 -24.95 67.36 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.726 -1.234 . . . . 0.0 113.42 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -129.92 78.78 1.87 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.044 1.338 . . . . 0.0 110.345 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.584 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.56 150.26 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.156 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.52 128.42 44.25 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 159.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.75 116.34 28.93 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.7 m -135.02 128.17 31.85 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.718 1.207 . . . . 0.0 109.679 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -139.65 156.56 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.421 1.488 . . . . 0.0 111.303 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.015 0 C-N-CA 127.431 2.293 . . . . 0.0 110.003 -175.76 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 . . . . . 0 N--CA 1.473 0.688 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -51.3 -42.74 61.38 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 126.837 2.055 . . . . 0.0 113.629 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.72 -17.5 67.91 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.393 1.473 . . . . 0.0 113.711 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.76 -30.27 51.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.794 1.297 . . . . 0.0 112.444 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -57.87 -29.0 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.098 -1.002 . . . . 0.0 111.065 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -79.16 -58.04 3.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.832 1.253 . . . . 0.0 110.161 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.36 -34.33 73.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.303 1.041 . . . . 0.0 112.56 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -72.73 -34.01 66.78 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.06 1.344 . . . . 0.0 111.984 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -70.64 -36.75 73.57 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.436 0.562 . . . . 0.0 111.378 172.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.01 -44.25 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.065 0.946 . . . . 0.0 111.333 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -12.04 59.9 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.083 0.953 . . . . 0.0 113.257 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -57.23 -37.14 71.81 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 161.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -79.96 -49.25 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.625 0.726 . . . . 0.0 109.897 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 mt -89.0 75.33 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 123.341 1.543 . . . . 0.0 111.604 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.01 25.87 0.08 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.35 1.46 . . . . 0.0 114.729 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.99 -61.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.43 0.692 . . . . 0.0 112.408 -159.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 74.24 -47.66 0.64 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.732 2.413 . . . . 0.0 113.321 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.84 -28.43 68.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.967 1.307 . . . . 0.0 112.95 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -90.44 -3.41 57.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.927 1.691 . . . . 0.0 114.303 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -117.75 -29.83 5.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 113.726 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -92.59 164.82 13.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.975 1.31 . . . . 0.0 111.925 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.93 -42.61 2.52 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 125.777 1.656 . . . . 0.0 113.932 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -175.36 5.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.267 1.427 . . . . 0.0 111.438 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 162.46 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.615 -0.678 . . . . 0.0 111.315 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.8 t -157.99 146.16 18.79 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.636 1.175 . . . . 0.0 110.092 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 131.59 48.94 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.149 1.38 . . . . 0.0 111.123 164.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -144.01 171.88 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 120.781 -1.2 . . . . 0.0 108.175 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.72 132.31 40.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.346 -0.846 . . . . 0.0 112.176 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.12 131.08 54.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.938 0.895 . . . . 0.0 109.464 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.08 112.48 24.14 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.07 0.948 . . . . 0.0 109.49 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -104.14 159.22 15.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 111.204 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.8 pt -96.15 150.19 36.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 110.381 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.39 146.29 50.04 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.646 2.231 . . . . 0.0 110.247 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -165.21 147.33 7.82 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.561 1.944 . . . . 0.0 108.359 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.62 -18.59 72.17 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 124.444 1.021 . . . . 0.0 115.599 -168.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -94.13 3.16 55.67 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.409 1.884 . . . . 0.0 113.175 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.34 165.97 14.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.96 1.743 . . . . 0.0 111.335 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.56 159.26 22.12 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.001 0.901 . . . . 0.0 111.321 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -127.88 144.07 51.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.07 1.348 . . . . 0.0 111.182 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.27 113.7 2.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.623 0.647 . . . . 0.0 112.481 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.24 -43.05 2.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.676 1.608 . . . . 0.0 111.41 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -154.51 150.33 27.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.944 0.898 . . . . 0.0 111.434 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.37 131.02 53.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.526 1.131 . . . . 0.0 109.706 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -119.63 119.6 34.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.695 1.598 . . . . 0.0 108.694 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.16 137.23 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.053 0.842 . . . . 0.0 109.929 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -109.65 -50.37 2.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.144 0.578 . . . . 0.0 110.004 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -173.7 170.36 4.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.994 1.718 . . . . 0.0 111.78 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.63 32.73 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 125.326 1.441 . . . . 0.0 113.171 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.96 113.65 20.01 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -58.35 -19.94 39.42 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -153.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -49.61 -37.77 29.19 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.91 1.284 . . . . 0.0 112.681 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.11 -52.17 8.56 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.217 0.917 . . . . 0.0 110.722 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.2 m -46.46 -44.84 17.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.061 1.344 . . . . 0.0 113.421 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.38 82.73 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.925 0.89 . . . . 0.0 112.678 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.91 19.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.579 1.152 . . . . 0.0 112.83 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.0 t -57.37 -46.1 83.71 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.588 0.755 . . . . 0.0 110.617 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -50.29 -42.19 52.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.482 1.913 . . . . 0.0 111.723 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -69.78 -48.53 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.78 80.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.62 1.168 . . . . 0.0 111.693 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.69 -24.32 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.875 -1.141 . . . . 0.0 111.918 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.74 55.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.859 0.864 . . . . 0.0 112.869 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -134.68 -11.27 2.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.4 m -58.07 148.99 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.415 1.086 . . . . 0.0 112.776 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -70.51 -47.91 58.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 113.099 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 p 170.73 145.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.186 2.194 . . . . 0.0 110.355 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 43.7 m-85 -96.62 108.49 42.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 117.771 -1.109 . . . . 0.0 110.363 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.13 136.28 19.94 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.248 1.965 . . . . 0.0 110.37 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.53 152.91 64.62 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.449 0.7 . . . . 0.0 112.329 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.46 -41.83 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.007 2.471 . . . . 0.0 110.277 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.47 149.28 50.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.023 2.129 . . . . 0.0 109.699 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.37 9.25 19.78 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -164.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.86 144.57 60.08 Favored Pre-proline 0 CA--C 1.539 0.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.98 -2.7 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.324 2.683 . . . . 0.0 113.584 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.863 0.865 . . . . 0.0 112.519 168.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.76 -26.39 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.664 1.186 . . . . 0.0 112.654 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.38 -25.65 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.059 0.944 . . . . 0.0 111.028 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -83.12 -9.1 59.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.897 1.279 . . . . 0.0 113.995 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -42.43 6.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.068 . . . . 0.0 111.693 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.8 pp -74.71 -20.13 59.97 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 124.867 1.267 . . . . 0.0 112.93 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -66.39 -25.56 66.84 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 113.163 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -128.82 81.96 2.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.031 0.932 . . . . 0.0 109.892 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.56 150.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 111.75 -178.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 130.86 35.94 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 153.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -85.3 129.09 34.88 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 157.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.0 m -146.15 127.07 14.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.82 157.25 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.335 1.454 . . . . 0.0 111.127 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.248 0 C-N-CA 126.272 1.829 . . . . 0.0 113.642 -179.389 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.9 mmp_? . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -54.38 -49.89 68.8 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.983 2.513 . . . . 0.0 113.915 -162.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.98 -15.43 65.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.969 1.747 . . . . 0.0 114.097 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.14 -30.4 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.647 1.223 . . . . 0.0 111.609 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.2 pt -62.62 -28.49 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.513 -1.367 . . . . 0.0 111.621 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.47 -57.06 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.924 1.289 . . . . 0.0 110.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -57.44 -36.04 70.88 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.064 0.946 . . . . 0.0 111.86 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.85 -38.03 82.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.929 1.292 . . . . 0.0 111.898 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 tp -76.52 -28.22 56.3 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.02 -54.42 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -25.56 67.69 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.278 0.631 . . . . 0.0 111.45 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.02 -14.54 61.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -80.66 -33.85 35.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.472 1.033 . . . . 0.0 113.172 165.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.89 110.06 22.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.778 1.231 . . . . 0.0 111.47 -158.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.0 24.85 8.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.977 1.311 . . . . 0.0 114.14 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.8 -58.79 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.507 0.723 . . . . 0.0 112.12 -165.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 71.44 -64.11 0.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.612 2.365 . . . . 0.0 113.346 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -64.63 -35.34 80.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.761 1.225 . . . . 0.0 112.833 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -91.13 6.88 43.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.441 1.097 . . . . 0.0 113.448 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -104.29 -9.73 18.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.062 1.745 . . . . 0.0 112.491 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -114.58 159.43 20.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.004 1.722 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.348 1.451 . . . . 0.0 114.477 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 178.91 8.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.361 1.864 . . . . 0.0 112.354 -174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.17 19.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.294 1.037 . . . . 0.0 110.613 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.12 143.5 21.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.493 1.117 . . . . 0.0 110.768 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 129.56 46.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 110.403 163.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.87 172.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.14 131.18 30.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.705 -0.622 . . . . 0.0 112.345 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.84 130.19 51.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.161 0.984 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -114.19 105.11 12.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 109.214 171.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.43 157.6 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.736 0.779 . . . . 0.0 112.2 -176.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.32 151.96 37.61 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 125.389 1.476 . . . . 0.0 110.488 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -72.37 147.83 47.72 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.264 2.643 . . . . 0.0 111.19 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -165.59 149.59 8.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.273 2.229 . . . . 0.0 108.493 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.87 -16.41 70.3 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.4 p -94.3 -4.84 47.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.215 1.806 . . . . 0.0 113.477 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.73 170.58 12.93 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.344 1.449 . . . . 0.0 111.755 -166.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -66.37 160.0 25.63 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.568 1.184 . . . . 0.0 111.323 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.07 145.96 51.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.147 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.99 109.85 1.19 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.172 0.589 . . . . 0.0 111.518 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.8 -47.34 3.44 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 125.204 1.383 . . . . 0.0 110.886 170.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 m -155.18 150.89 27.54 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.866 1.266 . . . . 0.0 111.218 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.4 129.08 49.15 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.833 1.253 . . . . 0.0 109.39 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 m -115.18 118.85 34.5 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.209 1.804 . . . . 0.0 108.093 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -81.87 134.63 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.286 0.948 . . . . 0.0 109.757 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.22 -48.93 3.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.213 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -171.21 170.26 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.525 1.53 . . . . 0.0 111.868 171.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.79 -178.93 29.65 Favored Glycine 0 N--CA 1.462 0.396 0 C-N-CA 125.314 1.435 . . . . 0.0 113.554 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.46 113.85 21.5 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 167.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -63.84 -17.58 63.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -149.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -56.17 -33.45 65.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.767 0.827 . . . . 0.0 112.225 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.86 -46.62 18.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.796 -1.097 . . . . 0.0 111.397 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -47.16 -46.08 23.24 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.773 1.229 . . . . 0.0 113.027 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.75 89.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.768 0.827 . . . . 0.0 112.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.76 -52.36 31.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 112.708 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.3 t -57.76 -48.25 80.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.586 0.755 . . . . 0.0 111.197 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -50.23 -44.71 53.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.469 1.508 . . . . 0.0 111.472 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.79 -45.06 65.37 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.697 0.799 . . . . 0.0 112.56 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.25 -49.76 75.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.385 1.074 . . . . 0.0 111.881 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.3 t -67.65 -22.8 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.828 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.4 -6.94 58.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 112.639 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.95 -12.2 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.8 m -58.14 147.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.023 0.929 . . . . 0.0 112.35 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -71.61 -47.56 53.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p 171.14 142.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.723 2.009 . . . . 0.0 111.213 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.8 m-85 -94.67 108.61 38.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.423 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 130.05 14.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.341 2.028 . . . . 0.0 110.111 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.04 148.29 74.84 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.491 0.716 . . . . 0.0 111.751 -171.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.98 -36.1 4.73 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.535 2.157 . . . . 0.0 110.879 168.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 153.51 41.31 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.439 2.295 . . . . 0.0 109.948 176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.15 8.56 19.98 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -165.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.16 144.38 62.74 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 118.988 0.813 . . . . 0.0 110.004 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.81 -4.01 6.6 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.424 2.749 . . . . 0.0 113.696 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.72 -38.26 19.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.98 0.809 . . . . 0.0 112.159 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.61 -26.66 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.225 1.01 . . . . 0.0 112.715 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -26.99 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.124 0.969 . . . . 0.0 110.906 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -78.72 -13.17 59.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.01 1.324 . . . . 0.0 113.222 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.06 -42.33 7.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.672 0.789 . . . . 0.0 111.71 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.39 -23.23 60.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.828 0.851 . . . . 0.0 112.488 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -68.96 -23.31 64.12 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.743 -1.223 . . . . 0.0 113.946 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -128.29 84.08 2.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.134 0.974 . . . . 0.0 110.057 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -112.11 155.31 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.479 1.111 . . . . 0.0 112.215 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -91.41 136.21 33.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 156.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.63 118.14 29.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 154.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -135.9 130.25 33.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.39 146.25 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.734 2.414 . . . . 0.0 108.493 -165.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 125.241 1.417 . . . . 0.0 111.628 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? . . . . . 0 N--CA 1.466 0.374 0 CA-C-O 120.342 0.115 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -63.82 -17.99 63.66 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.002 2.121 . . . . 0.0 116.057 -162.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.74 -13.35 11.45 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.923 2.201 . . . . 0.0 114.124 166.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.83 -30.17 40.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.117 1.367 . . . . 0.0 111.797 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -62.31 -27.77 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 120.646 -1.284 . . . . 0.0 111.946 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -80.01 -56.53 4.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.286 1.434 . . . . 0.0 110.682 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -58.11 -34.48 70.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.938 0.895 . . . . 0.0 112.01 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -67.92 -40.2 83.43 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.679 1.191 . . . . 0.0 110.881 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.36 -28.76 61.27 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.504 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.0 -54.12 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 110.441 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -23.29 67.29 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.043 0.537 . . . . 0.0 112.153 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.02 -15.6 60.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -79.73 -39.9 30.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.845 1.202 . . . . 0.0 111.882 163.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.0 83.35 3.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.557 1.646 . . . . 0.0 112.243 -160.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 28.93 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.774 1.63 . . . . 0.0 114.232 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.71 -62.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.434 -0.791 . . . . 0.0 112.093 -163.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 72.54 -62.64 0.46 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.309 2.243 . . . . 0.0 113.51 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.12 -37.39 87.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.257 1.423 . . . . 0.0 112.554 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.2 m -85.56 -1.78 57.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 14.1 m-30 -103.96 -22.64 13.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.983 1.713 . . . . 0.0 113.279 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 152.66 19.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.179 1.392 . . . . 0.0 112.911 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.6 2.16 90.6 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.083 1.325 . . . . 0.0 114.29 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -143.77 177.77 8.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.115 1.766 . . . . 0.0 112.267 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.59 160.48 25.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.826 1.25 . . . . 0.0 110.099 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 45.1 t -153.62 144.13 22.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.216 1.007 . . . . 0.0 110.215 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.48 127.76 38.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.293 1.437 . . . . 0.0 111.134 171.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.21 172.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.367 1.067 . . . . 0.0 108.335 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -137.02 131.67 33.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.588 0.755 . . . . 0.0 112.113 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -103.04 134.26 46.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.007 0.923 . . . . 0.0 110.38 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -118.09 103.47 9.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.187 1.395 . . . . 0.0 108.849 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.29 158.46 15.69 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.917 0.865 . . . . 0.0 112.149 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 pt -99.03 148.75 35.01 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.581 1.552 . . . . 0.0 110.183 166.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.56 147.92 41.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.302 2.668 . . . . 0.0 110.857 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -166.67 146.56 5.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.273 2.229 . . . . 0.0 108.479 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.95 -21.45 75.32 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.564 0.986 . . . . 0.0 115.564 -166.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -89.39 -5.22 57.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.979 1.712 . . . . 0.0 113.183 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.79 162.49 10.84 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.891 1.71 . . . . 0.0 111.421 -169.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -63.74 160.69 16.61 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 117.789 0.794 . . . . 0.0 111.596 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.84 143.32 50.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.332 1.453 . . . . 0.0 110.91 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.98 109.34 1.05 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.44 0.696 . . . . 0.0 111.623 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.92 -36.51 5.23 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.537 1.542 . . . . 0.0 111.925 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -163.85 155.68 16.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 111.127 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.43 129.94 39.94 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.091 1.357 . . . . 0.0 109.92 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.3 m -115.81 119.15 35.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.923 2.089 . . . . 0.0 108.448 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.0 137.1 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.098 0.863 . . . . 0.0 110.164 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.39 -47.37 3.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.933 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 24.2 t0 -174.12 166.77 4.2 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.998 2.119 . . . . 0.0 111.217 169.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.28 164.5 27.9 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.083 -1.011 . . . . 0.0 114.15 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.37 178.94 4.89 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.945 0.898 . . . . 0.0 110.363 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 t -30.24 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.73 2.412 . . . . 0.0 115.517 -162.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 31.6 mtm105 70.44 -1.21 2.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.199 2.2 . . . . 0.0 116.378 162.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.26 -46.58 70.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 122.429 2.377 . . . . 0.0 112.171 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.29 -28.08 51.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 166.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.18 -35.47 41.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.377 0.989 . . . . 0.0 112.382 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -51.02 15.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.63 1.572 . . . . 0.0 112.498 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -55.48 -48.9 73.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.854 0.861 . . . . 0.0 111.196 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -51.3 -44.7 61.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.786 1.634 . . . . 0.0 111.469 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -69.19 -44.55 71.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.028 0.931 . . . . 0.0 113.385 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.51 76.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.57 1.148 . . . . 0.0 111.48 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.4 t -67.9 -21.22 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.69 -1.256 . . . . 0.0 112.236 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.97 -6.92 59.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.066 0.947 . . . . 0.0 112.187 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.05 -12.73 4.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.7 m -58.14 146.05 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-N 119.394 0.997 . . . . 0.0 111.975 168.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -72.45 -46.12 56.46 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.1 p 172.78 141.94 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.36 1.864 . . . . 0.0 110.911 -168.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -94.37 106.74 25.01 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.292 1.037 . . . . 0.0 111.193 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.79 118.34 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.295 1.997 . . . . 0.0 109.968 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.03 148.71 37.42 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.461 1.104 . . . . 0.0 112.367 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.11 -29.93 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.924 2.416 . . . . 0.0 112.313 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -138.56 148.67 44.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.947 1.699 . . . . 0.0 110.495 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -120.66 22.0 11.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.555 1.542 . . . . 0.0 113.284 -167.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.8 142.17 32.26 Favored Pre-proline 0 C--O 1.242 0.668 0 O-C-N 120.627 -1.295 . . . . 0.0 110.731 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.02 -7.05 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 124.14 3.226 . . . . 0.0 116.177 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -87.95 -41.57 13.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.881 1.219 . . . . 0.0 112.343 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -92.57 -25.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.529 1.532 . . . . 0.0 113.365 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.49 -29.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.939 0.79 . . . . 0.0 110.935 170.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 33.0 mm-40 -77.0 -8.07 56.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.319 1.047 . . . . 0.0 113.766 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.38 -48.22 5.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.356 0.663 . . . . 0.0 112.203 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.8 -28.07 68.73 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.13 0.972 . . . . 0.0 112.679 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.428 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -72.51 -23.79 61.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.44 -1.413 . . . . 0.0 114.003 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -121.74 88.99 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.331 1.052 . . . . 0.0 111.086 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.63 156.34 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.435 1.094 . . . . 0.0 112.614 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.71 137.52 32.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.093 -0.379 . . . . 0.0 110.278 156.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.7 mt -91.4 112.91 25.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 153.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.8 m -134.83 125.43 26.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.916 0.887 . . . . 0.0 108.835 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.32 153.16 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.588 1.555 . . . . 0.0 110.734 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 125.466 1.506 . . . . 0.0 111.992 -175.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -51.02 -47.16 61.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 128.276 2.63 . . . . 0.0 113.699 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.95 -15.86 66.5 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.246 1.403 . . . . 0.0 113.366 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -75.73 -32.75 60.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 1.119 . . . . 0.0 111.719 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -59.67 -27.01 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.9 0.773 . . . . 0.0 111.916 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -82.09 -58.64 2.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.122 1.369 . . . . 0.0 110.362 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.69 -33.4 72.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.003 0.921 . . . . 0.0 112.852 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -73.37 -35.4 65.93 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.994 0.918 . . . . 0.0 110.795 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.9 tp -73.39 -31.58 63.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.754 0.707 . . . . 0.0 112.059 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -71.24 -48.29 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.287 0.635 . . . . 0.0 110.71 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -67.78 -19.0 65.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -57.51 -36.53 71.66 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.128 0.571 . . . . 0.0 111.329 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -78.24 -40.22 37.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.983 0.421 . . . . 0.0 112.098 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.72 88.4 3.81 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 123.149 1.452 . . . . 0.0 111.887 -163.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.96 31.02 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.338 -1.755 . . . . 0.0 113.781 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.68 -64.09 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.101 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 72.79 -63.84 0.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.892 2.077 . . . . 0.0 112.826 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.01 -45.33 61.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.667 1.187 . . . . 0.0 112.159 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.3 m -79.24 2.86 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.2 m-30 -93.87 -10.46 33.88 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.834 1.653 . . . . 0.0 111.761 166.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -114.35 171.31 7.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.049 2.139 . . . . 0.0 111.107 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.02 -21.59 3.29 Favored Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.807 1.194 . . . . 0.0 114.372 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.46 -175.16 3.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.171 2.589 . . . . 0.0 111.616 175.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 164.98 23.21 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.449 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.2 t -159.97 144.74 14.91 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.448 1.099 . . . . 0.0 110.142 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.59 130.14 46.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.512 164.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.88 170.4 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.275 1.03 . . . . 0.0 108.333 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.0 131.18 32.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.348 0.594 . . . . 0.0 111.738 -173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.13 132.85 45.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.967 0.907 . . . . 0.0 110.334 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -116.4 103.01 10.03 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 108.931 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -99.62 158.97 15.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.731 0.777 . . . . 0.0 111.906 -177.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.1 pt -100.13 136.79 20.02 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.453 1.501 . . . . 0.0 110.219 167.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.95 129.62 17.71 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.585 2.19 . . . . 0.0 109.832 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 m -142.86 88.58 2.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.271 1.428 . . . . 0.0 108.548 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 -122.49 28.03 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.895 0.759 . . . . 0.0 112.12 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -81.6 3.5 24.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.209 1.803 . . . . 0.0 113.842 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.18 -166.6 10.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.257 1.408 . . . . 0.0 114.377 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -124.33 165.47 17.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.205 1.402 . . . . 0.0 110.918 165.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.62 148.51 52.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.144 1.778 . . . . 0.0 111.153 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.56 111.88 1.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.009 0.822 . . . . 0.0 112.28 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.54 -35.06 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.78 1.657 . . . . 0.0 112.125 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -167.2 153.18 7.86 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.365 1.466 . . . . 0.0 110.998 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -127.91 129.38 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.428 1.091 . . . . 0.0 109.874 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.3 m -113.28 118.87 35.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.236 1.815 . . . . 0.0 108.536 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.74 130.9 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.903 0.774 . . . . 0.0 109.81 169.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -101.98 -46.92 4.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.108 0.563 . . . . 0.0 110.04 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -170.47 169.48 7.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.119 1.768 . . . . 0.0 111.515 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.11 179.07 23.79 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 124.887 1.232 . . . . 0.0 114.527 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.23 119.79 25.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.79 -17.66 37.36 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -159.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.71 65.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.679 1.191 . . . . 0.0 112.07 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.3 tp -88.85 -49.23 6.94 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.673 1.124 . . . . 0.0 111.562 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 m -47.81 -43.09 27.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.537 1.062 . . . . 0.0 113.539 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.08 73.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.082 0.856 . . . . 0.0 112.573 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.14 -52.25 25.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.424 1.09 . . . . 0.0 112.191 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.6 t -57.85 -49.37 76.89 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.104 0.962 . . . . 0.0 110.355 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -51.27 -45.8 62.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -66.41 -47.02 74.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.518 0.727 . . . . 0.0 112.845 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.06 75.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 111.414 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.77 -23.29 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.579 -1.326 . . . . 0.0 111.518 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.78 -6.84 58.09 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.369 -0.832 . . . . 0.0 112.396 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.09 -11.97 3.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.4 m -58.14 148.59 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.296 0.953 . . . . 0.0 112.55 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.48 -48.94 59.06 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 p 170.18 141.89 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.555 1.942 . . . . 0.0 111.414 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 10.5 m-85 -98.99 110.38 57.5 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.311 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.18 134.34 12.84 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.842 2.361 . . . . 0.0 111.009 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.48 148.36 66.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.047 -0.502 . . . . 0.0 112.272 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 -36.17 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.482 2.788 . . . . 0.0 111.935 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 153.25 47.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.439 2.296 . . . . 0.0 110.526 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.11 7.69 18.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -163.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.03 142.91 44.96 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.937 -1.102 . . . . 0.0 110.431 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.34 0.35 2.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.807 3.005 . . . . 0.0 113.642 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.91 -38.72 17.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.927 0.891 . . . . 0.0 111.834 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 m -96.07 -26.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.571 1.148 . . . . 0.0 112.613 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.8 -28.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.435 1.094 . . . . 0.0 110.994 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -84.06 -5.44 59.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.237 1.015 . . . . 0.0 113.636 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -98.49 -51.36 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.013 -1.054 . . . . 0.0 111.192 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.98 -20.48 65.89 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.824 1.25 . . . . 0.0 113.874 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -69.74 -23.57 63.41 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.014 -1.054 . . . . 0.0 112.819 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -125.27 83.29 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.115 1.766 . . . . 0.0 111.119 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.597 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.43 153.42 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.319 1.047 . . . . 0.0 112.092 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.19 137.12 34.67 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.88 0.371 . . . . 0.0 110.125 158.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.33 120.68 33.89 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 155.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -136.77 129.1 29.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.384 1.074 . . . . 0.0 109.222 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 164.95 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.171 1.788 . . . . 0.0 110.742 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 112.958 -175.317 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 . . . . . 0 N--CA 1.469 0.49 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -49.33 -45.84 46.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.597 2.359 . . . . 0.0 114.064 -172.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.71 -18.4 60.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.738 1.637 . . . . 0.0 113.746 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.78 -32.51 63.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.375 1.088 . . . . 0.0 111.864 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -61.37 -27.07 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.125 -0.985 . . . . 0.0 112.347 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -82.37 -59.19 2.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 109.722 174.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.26 -35.33 73.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.034 0.934 . . . . 0.0 111.99 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -71.54 -41.75 68.75 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.968 0.907 . . . . 0.0 110.867 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.63 -25.91 65.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.539 0.609 . . . . 0.0 112.035 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.415 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.46 -55.59 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.187 0.995 . . . . 0.0 110.253 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -22.46 66.11 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.668 0.387 . . . . 0.0 111.594 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.51 -13.16 61.72 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.642 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -81.05 -36.69 30.18 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.947 1.248 . . . . 0.0 112.164 168.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 80.31 1.82 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.327 1.451 . . . . 0.0 109.821 -169.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 51.62 0.43 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.807 1.643 . . . . 0.0 112.492 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.66 -56.48 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 73.26 -51.71 0.7 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.063 2.545 . . . . 0.0 114.892 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.51 -31.75 32.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.382 1.473 . . . . 0.0 112.879 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -85.05 -13.38 50.61 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.836 0.854 . . . . 0.0 112.604 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -89.34 -8.17 53.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.014 1.326 . . . . 0.0 112.478 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -112.73 171.41 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.401 1.88 . . . . 0.0 113.099 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.3 -45.49 3.23 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.119 1.819 . . . . 0.0 112.371 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -170.89 3.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.61 1.564 . . . . 0.0 111.137 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.29 26.26 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.835 0.854 . . . . 0.0 110.985 168.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 38.8 t -151.61 145.04 24.82 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.691 1.196 . . . . 0.0 109.564 170.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.26 129.36 41.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.164 1.385 . . . . 0.0 110.615 170.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.69 172.07 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.87 1.268 . . . . 0.0 107.978 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -137.59 133.15 34.08 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.801 0.841 . . . . 0.0 111.722 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.98 140.35 36.39 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.387 0.675 . . . . 0.0 111.81 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -120.2 105.69 11.21 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.431 1.493 . . . . 0.0 108.92 170.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.74 159.37 15.24 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.397 -0.815 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.68 139.96 20.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.924 1.689 . . . . 0.0 109.821 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.67 137.3 58.32 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.507 2.138 . . . . 0.0 111.624 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -143.97 162.89 35.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.28 2.232 . . . . 0.0 107.918 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.02 -22.24 70.38 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.005 -1.059 . . . . 0.0 115.561 -171.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -94.97 -19.61 20.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.783 1.633 . . . . 0.0 112.734 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.37 -174.37 34.86 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.649 2.071 . . . . 0.0 111.007 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -73.45 160.35 31.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.216 2.008 . . . . 0.0 110.15 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -132.43 143.7 49.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.304 1.442 . . . . 0.0 111.527 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.57 108.44 0.56 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.996 0.919 . . . . 0.0 112.261 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.51 -35.82 5.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.673 1.606 . . . . 0.0 111.632 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -166.01 150.04 7.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.901 1.28 . . . . 0.0 111.13 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.7 tt -123.07 130.44 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.955 1.702 . . . . 0.0 109.319 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -114.44 118.68 34.49 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.6 1.56 . . . . 0.0 108.358 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 m -83.63 136.19 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.803 0.729 . . . . 0.0 109.88 168.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.73 -45.79 3.77 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.3 0.64 . . . . 0.0 110.151 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -172.48 167.51 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.102 1.761 . . . . 0.0 111.348 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.83 170.11 36.17 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.526 -0.734 . . . . 0.0 114.552 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.36 -177.53 4.01 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.826 1.25 . . . . 0.0 111.047 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.259 59.3 p 51.52 -97.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.385 2.274 . . . . 0.0 113.018 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.33 -4.27 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 113.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -64.08 -43.91 93.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.926 1.694 . . . . 0.0 113.01 -157.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.0 p -56.95 -27.64 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.74 -40.73 13.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.799 1.239 . . . . 0.0 112.155 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.36 -53.74 50.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.77 1.228 . . . . 0.0 111.998 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 t -52.75 -46.65 67.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.894 0.878 . . . . 0.0 110.537 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.88 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.38 1.072 . . . . 0.0 113.438 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -73.35 -43.37 60.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.73 76.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.736 1.214 . . . . 0.0 112.024 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.86 -23.38 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.533 -1.354 . . . . 0.0 112.09 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.82 -6.96 55.9 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.35 -0.844 . . . . 0.0 112.727 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.31 -11.95 2.46 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.6 m -58.15 147.82 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.712 1.205 . . . . 0.0 112.734 171.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -75.3 -39.08 59.96 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 p 165.23 141.23 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 127.491 2.316 . . . . 0.0 111.501 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.04 112.26 57.68 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.269 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.44 120.7 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.306 2.004 . . . . 0.0 110.047 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 138.58 25.99 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.65 1.18 . . . . 0.0 111.743 -176.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.24 -47.58 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.421 2.748 . . . . 0.0 111.916 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -103.46 147.41 27.17 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.304 1.442 . . . . 0.0 110.868 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.31 12.79 11.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.874 1.27 . . . . 0.0 113.564 -163.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -78.88 140.56 58.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 O-C-N 120.825 -1.172 . . . . 0.0 109.392 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.87 -4.69 7.74 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.047 2.498 . . . . 0.0 113.419 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.43 -31.87 24.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.726 0.694 . . . . 0.0 112.403 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.97 -24.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.04 -28.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.264 1.026 . . . . 0.0 110.731 166.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.28 -9.86 59.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.501 1.52 . . . . 0.0 113.791 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.77 -43.83 5.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.279 1.032 . . . . 0.0 112.198 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -71.55 -22.33 61.77 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.973 0.909 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -65.5 -22.95 66.78 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.63 -1.294 . . . . 0.0 113.918 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -123.74 80.12 1.77 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.41 1.084 . . . . 0.0 110.301 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.99 151.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.961 0.905 . . . . 0.0 111.83 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.3 128.04 41.82 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 159.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.05 111.18 21.85 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 160.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.8 m -135.45 123.94 23.49 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.589 1.155 . . . . 0.0 108.502 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.36 148.37 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.696 1.198 . . . . 0.0 111.175 -169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.397 0 C-N-CA 126.241 1.816 . . . . 0.0 114.388 175.327 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 . . . . . 0 N--CA 1.47 0.566 0 CA-C-O 120.779 0.323 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.61 -39.61 80.92 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 128.034 2.534 . . . . 0.0 113.761 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.78 63.73 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.377 1.465 . . . . 0.0 114.009 169.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.12 -26.12 56.06 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.867 1.333 . . . . 0.0 112.065 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.18 -30.0 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.333 -1.479 . . . . 0.0 111.634 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -77.8 -55.22 5.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.129 1.372 . . . . 0.0 110.095 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -57.33 -34.89 69.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.878 0.871 . . . . 0.0 112.297 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.64 -30.49 65.81 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.227 1.411 . . . . 0.0 112.628 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp -82.12 -31.48 30.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.674 0.67 . . . . 0.0 112.353 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -68.74 -46.86 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.761 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -21.76 66.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.284 1.034 . . . . 0.0 112.98 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -59.65 -36.73 77.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.516 0.727 . . . . 0.0 110.791 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -78.35 -45.42 22.6 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 0.0 111.162 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.99 74.28 4.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 123.456 1.598 . . . . 0.0 112.298 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.03 29.06 0.06 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 113.791 -1.549 . . . . 0.0 114.048 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.6 -71.09 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 -163.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 74.15 -48.24 0.66 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.568 2.347 . . . . 0.0 114.119 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.26 -38.23 88.47 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.296 -1.503 . . . . 0.0 113.16 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.9 p -91.36 0.05 57.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.343 1.057 . . . . 0.0 113.662 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.568 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.7 m-30 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.543 1.537 . . . . 0.0 111.384 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -110.68 156.12 21.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.776 2.03 . . . . 0.0 111.223 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.12 -25.94 4.59 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.101 1.334 . . . . 0.0 113.795 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -106.29 -172.68 2.13 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.831 2.052 . . . . 0.0 110.741 167.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 164.31 28.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.273 1.029 . . . . 0.0 110.345 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.58 157.64 43.45 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.441 -0.787 . . . . 0.0 111.463 160.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.2 126.21 29.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.146 1.379 . . . . 0.0 110.069 162.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.59 166.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.58 131.72 36.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.042 0.837 . . . . 0.0 111.965 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.55 131.93 48.95 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.339 1.055 . . . . 0.0 110.164 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -113.52 107.71 16.18 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.318 1.447 . . . . 0.0 109.018 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.35 159.72 15.03 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.31 -0.869 . . . . 0.0 111.945 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 pt -102.34 148.38 35.35 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.987 1.715 . . . . 0.0 109.615 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.4 137.78 28.78 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.221 1.947 . . . . 0.0 110.08 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 m -148.66 93.92 2.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.115 1.366 . . . . 0.0 109.267 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.81 -113.66 5.81 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.82 0.724 . . . . 0.0 112.612 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.2 p -83.36 -2.79 56.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.755 2.022 . . . . 0.0 114.024 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.97 -164.85 11.34 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.585 1.084 . . . . 0.0 114.297 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -111.38 165.23 12.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.351 1.06 . . . . 0.0 110.649 165.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp -132.79 146.89 52.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.451 1.901 . . . . 0.0 111.666 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.05 111.63 1.77 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.53 0.732 . . . . 0.0 112.245 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.91 -34.22 5.52 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.387 1.47 . . . . 0.0 112.032 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.47 154.28 11.9 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.455 1.502 . . . . 0.0 110.994 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.82 128.44 34.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.509 1.124 . . . . 0.0 109.94 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 m -110.9 138.5 47.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.72 2.008 . . . . 0.0 108.349 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.72 133.8 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.781 0.719 . . . . 0.0 109.233 165.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -102.16 -42.92 5.89 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.479 0.712 . . . . 0.0 109.915 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -173.17 169.19 4.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.371 1.868 . . . . 0.0 111.476 171.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.18 -178.74 28.38 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 124.729 1.157 . . . . 0.0 114.509 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.4 116.64 26.77 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 m -58.68 -18.92 35.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -157.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -32.71 71.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.644 0.778 . . . . 0.0 112.564 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 tp -82.51 -46.83 12.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.62 1.1 . . . . 0.0 111.086 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.9 m -51.59 -42.92 62.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.382 0.992 . . . . 0.0 113.149 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.89 79.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.968 0.907 . . . . 0.0 112.364 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.2 58.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.541 0.737 . . . . 0.0 112.462 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 8.7 t -59.58 -47.68 84.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.652 0.781 . . . . 0.0 110.892 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -52.68 -42.42 64.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 111.138 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.25 -47.27 62.07 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.716 0.806 . . . . 0.0 112.914 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.97 78.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' THR . 2.9 t -66.87 -23.1 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.719 -1.238 . . . . 0.0 111.516 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.26 -6.71 59.17 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.46 -0.775 . . . . 0.0 112.676 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.89 -11.84 3.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.6 m -57.79 145.11 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.148 0.979 . . . . 0.0 112.597 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.31 -41.28 81.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.6 p 166.04 144.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.437 2.695 . . . . 0.0 110.102 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -92.51 110.45 45.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.505 -1.236 . . . . 0.0 109.77 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.65 134.8 20.85 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.898 1.732 . . . . 0.0 109.831 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.24 148.35 70.78 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.073 0.549 . . . . 0.0 111.601 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.07 -33.36 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.745 2.297 . . . . 0.0 111.283 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 159.81 42.0 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.383 2.273 . . . . 0.0 109.808 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -125.98 31.3 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.756 1.222 . . . . 0.0 113.205 -160.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.0 144.5 28.5 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.108 -0.995 . . . . 0.0 110.365 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.48 -9.2 17.1 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.337 2.691 . . . . 0.0 113.417 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.06 -35.59 31.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.643 0.777 . . . . 0.0 112.11 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.52 -25.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.46 1.104 . . . . 0.0 112.473 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.44 -28.54 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 118.578 0.626 . . . . 0.0 110.915 168.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.3 mm-40 -78.89 -9.57 59.53 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.17 -46.88 6.59 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.61 0.719 . . . . 0.0 112.008 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.26 -26.36 65.63 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.168 0.987 . . . . 0.0 112.438 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -71.51 -25.35 62.21 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.415 -1.428 . . . . 0.0 113.168 -175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.36 90.48 3.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 110.483 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.77 152.87 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.642 1.177 . . . . 0.0 112.525 178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -93.84 132.69 38.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.985 157.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.2 mt -91.27 117.32 29.54 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 156.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.9 m -135.31 128.28 31.48 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.1 155.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.405 1.482 . . . . 0.0 110.811 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.064 0 C-N-CA 125.91 1.684 . . . . 0.0 111.355 -178.39 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 . . . . . 0 N--CA 1.47 0.575 0 CA-C-O 121.027 0.442 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.88 -43.52 73.25 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 127.389 2.276 . . . . 0.0 113.212 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.46 -18.47 68.61 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.213 0.911 . . . . 0.0 113.44 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.93 -33.4 68.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.277 1.038 . . . . 0.0 111.592 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.5 pt -61.3 -28.13 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 120.953 -1.092 . . . . 0.0 111.889 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -80.56 -58.24 3.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.877 1.271 . . . . 0.0 109.581 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.13 -34.84 74.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 112.673 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -74.36 -28.11 60.98 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.772 1.229 . . . . 0.0 112.353 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.9 tp -76.4 -33.34 58.86 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.199 0.909 . . . . 0.0 111.684 171.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.11 -44.38 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.865 -1.147 . . . . 0.0 110.964 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.14 -13.6 61.6 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.262 1.025 . . . . 0.0 112.745 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.06 -38.38 73.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.408 HD21 HG12 ' A' ' 96' ' ' VAL . 37.0 m-80 -80.14 -37.39 33.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 0.0 111.989 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -99.49 103.9 15.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.62 1.2 . . . . 0.0 110.828 -164.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.94 20.71 7.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.98 -52.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.053 0.541 . . . . 0.0 112.237 -160.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 70.64 -62.55 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.867 2.467 . . . . 0.0 113.921 168.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.41 -35.41 80.34 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.635 -1.29 . . . . 0.0 111.946 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -77.09 -0.78 26.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -112.78 -12.49 13.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.612 1.965 . . . . 0.0 111.949 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -109.17 154.5 22.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 112.281 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.58 90.43 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.76 1.171 . . . . 0.0 114.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -178.61 5.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.747 2.019 . . . . 0.0 111.682 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.87 162.95 20.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.978 0.911 . . . . 0.0 110.462 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -157.4 147.2 20.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.446 1.099 . . . . 0.0 110.141 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.3 128.47 43.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.142 1.777 . . . . 0.0 110.372 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.17 167.42 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.58 1.152 . . . . 0.0 108.048 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -131.8 132.28 43.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.786 0.721 . . . . 0.0 111.95 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.68 130.13 49.5 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.139 0.975 . . . . 0.0 109.593 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -111.68 107.06 16.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.464 1.106 . . . . 0.0 109.227 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -100.02 158.69 15.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.913 0.863 . . . . 0.0 111.603 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -102.8 152.17 38.43 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.973 1.709 . . . . 0.0 110.506 168.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.05 147.27 29.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.143 2.562 . . . . 0.0 111.038 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -156.1 161.62 40.35 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.852 2.461 . . . . 0.0 108.338 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.3 -13.2 59.88 Favored Glycine 0 CA--C 1.54 1.649 0 O-C-N 120.737 -1.227 . . . . 0.0 115.187 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.9 p -99.77 -3.36 32.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.107 2.163 . . . . 0.0 113.919 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.97 -151.83 16.9 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.371 1.462 . . . . 0.0 111.078 -167.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -90.39 157.0 17.83 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.054 1.427 . . . . 0.0 111.949 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.0 144.45 51.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.269 1.828 . . . . 0.0 111.237 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.32 113.5 2.2 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.907 0.776 . . . . 0.0 112.182 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.81 4.69 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.68 1.61 . . . . 0.0 111.974 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.05 152.11 9.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.649 1.579 . . . . 0.0 111.295 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.37 134.29 49.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.247 1.019 . . . . 0.0 109.653 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.8 m -117.38 120.45 38.22 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.615 1.966 . . . . 0.0 108.707 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.23 133.97 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.312 0.96 . . . . 0.0 109.796 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -106.07 -49.93 3.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.298 0.639 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -173.03 170.23 4.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.166 1.786 . . . . 0.0 111.942 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.82 -175.21 32.97 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 125.054 1.311 . . . . 0.0 113.176 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.58 110.57 17.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 164.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 m -58.67 -17.91 26.44 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -52.45 -37.37 56.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.798 1.239 . . . . 0.0 112.357 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.19 -48.07 14.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.005 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -48.51 -46.22 38.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.565 1.146 . . . . 0.0 113.138 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.4 84.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.811 0.844 . . . . 0.0 112.296 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.22 23.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 112.629 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -57.44 -49.4 76.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.863 0.865 . . . . 0.0 110.508 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.29 -46.68 55.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.878 1.671 . . . . 0.0 111.258 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.9 -44.09 77.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.591 0.757 . . . . 0.0 112.833 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.78 -48.96 79.42 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.631 1.172 . . . . 0.0 112.173 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -65.5 -23.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.645 -1.284 . . . . 0.0 111.496 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.59 -6.63 57.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.689 0.796 . . . . 0.0 112.668 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -132.69 -12.0 3.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.454 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 15.0 m -59.95 148.64 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.185 0.902 . . . . 0.0 112.456 171.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -71.33 -48.5 50.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 p 174.77 142.11 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.223 1.809 . . . . 0.0 111.884 -169.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.2 m-85 -97.19 109.56 50.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 110.148 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.03 131.37 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.733 2.289 . . . . 0.0 110.417 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.83 150.83 75.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.573 0.749 . . . . 0.0 111.513 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.99 -40.84 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.321 2.014 . . . . 0.0 110.787 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -120.05 176.27 5.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.444 2.297 . . . . 0.0 111.278 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -152.64 49.43 0.75 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -112.83 135.66 21.63 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.11 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.73 -12.53 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.18 3.253 . . . . 0.0 115.585 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.0 -35.46 28.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 112.159 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -96.69 -24.16 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.209 1.004 . . . . 0.0 113.026 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.2 -25.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.592 0.757 . . . . 0.0 110.662 167.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -83.39 -7.77 59.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.03 -48.67 5.59 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.133 -0.98 . . . . 0.0 111.374 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.6 pp -69.68 -20.95 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.648 1.179 . . . . 0.0 112.959 -175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.64 -25.24 67.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.987 0.915 . . . . 0.0 113.449 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -129.99 77.23 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.219 1.008 . . . . 0.0 110.102 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.57 148.33 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.62 123.48 36.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 157.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -84.63 110.03 18.43 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 160.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.7 m -132.32 127.55 35.82 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.85 1.26 . . . . 0.0 108.512 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 151.46 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -169.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.917 0 C-N-CA 125.649 1.58 . . . . 0.0 111.425 -179.472 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 121.341 0.591 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -55.27 -43.08 74.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.298 2.239 . . . . 0.0 112.803 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.62 66.76 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.197 1.38 . . . . 0.0 114.066 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.582 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -72.09 -34.2 68.48 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.184 0.992 . . . . 0.0 111.608 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -60.59 -28.3 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.267 -0.896 . . . . 0.0 112.161 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.78 -58.44 3.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.114 1.366 . . . . 0.0 110.673 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.72 -36.84 74.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.49 1.116 . . . . 0.0 112.564 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -71.25 -32.58 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.701 1.2 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -76.05 -28.83 57.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.917 0.78 . . . . 0.0 112.271 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -75.27 -54.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.887 -1.133 . . . . 0.0 110.372 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -19.86 65.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.395 0.678 . . . . 0.0 112.495 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.17 -15.22 58.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -78.76 -39.88 34.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.23 0.923 . . . . 0.0 111.992 161.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.81 96.34 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 123.436 1.589 . . . . 0.0 111.587 -160.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.54 24.44 1.2 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.098 -173.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.87 -72.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.163 0.985 . . . . 0.0 111.33 -167.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 75.0 -52.62 0.67 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 113.489 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.5 -36.84 85.11 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.005 -1.059 . . . . 0.0 111.905 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -83.66 0.33 47.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 113.743 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -102.83 -25.05 13.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.01 1.724 . . . . 0.0 112.805 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -87.52 162.65 17.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.504 2.321 . . . . 0.0 111.539 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.7 -5.36 69.95 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.788 1.185 . . . . 0.0 114.789 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 -173.89 4.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.277 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.61 162.05 25.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.766 0.826 . . . . 0.0 110.675 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.442 ' HB3' HD23 ' A' ' 85' ' ' LEU . 40.5 t -153.84 144.0 22.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.749 1.22 . . . . 0.0 110.381 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 130.55 48.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.729 1.212 . . . . 0.0 110.953 164.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.65 176.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.61 126.37 17.05 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.729 0.812 . . . . 0.0 110.572 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.69 131.4 52.18 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.94 0.896 . . . . 0.0 109.72 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -119.39 106.4 12.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 108.936 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.17 162.27 13.15 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.117 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.13 150.41 44.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.482 1.113 . . . . 0.0 110.677 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.31 134.19 17.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.668 2.245 . . . . 0.0 110.618 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -118.66 -33.73 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.252 1.421 . . . . 0.0 111.635 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.27 -121.84 0.8 Allowed Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.515 1.531 . . . . 0.0 111.274 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 p -63.69 -14.57 53.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.17 0.988 . . . . 0.0 113.088 167.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.17 153.52 16.82 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.887 1.708 . . . . 0.0 114.224 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -84.79 163.24 19.22 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.896 0.878 . . . . 0.0 110.292 161.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.13 147.68 52.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.393 1.877 . . . . 0.0 111.413 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.08 110.43 1.04 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.127 0.971 . . . . 0.0 112.033 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.65 -46.37 3.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.553 1.549 . . . . 0.0 110.591 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 m -155.41 149.59 25.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.338 1.055 . . . . 0.0 110.967 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.01 121.67 33.67 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.114 0.965 . . . . 0.0 109.546 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.3 m -103.66 118.7 37.32 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.448 1.499 . . . . 0.0 108.589 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.33 130.85 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.758 0.708 . . . . 0.0 109.207 167.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.17 -49.36 4.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.524 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -173.19 170.77 4.25 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.329 1.851 . . . . 0.0 111.796 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.93 -179.47 31.83 Favored Glycine 0 N--CA 1.461 0.359 0 C-N-CA 124.895 1.236 . . . . 0.0 113.55 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.19 113.95 20.37 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 165.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.7 p -61.3 -17.68 54.82 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -153.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -50.97 -35.58 34.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.548 1.139 . . . . 0.0 112.143 171.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 58' ' ' CYS . 10.8 tp -82.48 -51.04 8.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.086 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.3 m -45.74 -46.37 15.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.212 1.405 . . . . 0.0 113.203 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.98 82.43 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.038 0.835 . . . . 0.0 112.852 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.15 -52.88 14.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t -56.68 -49.41 75.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.037 0.935 . . . . 0.0 110.58 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.64 -47.11 58.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.324 1.449 . . . . 0.0 111.303 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -68.5 -44.45 74.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.18 77.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.617 1.167 . . . . 0.0 111.23 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -68.3 -21.76 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.675 -1.266 . . . . 0.0 112.009 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.58 -7.44 59.25 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.569 0.748 . . . . 0.0 112.632 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -131.34 -11.84 3.58 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.8 m -55.78 147.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.05 0.94 . . . . 0.0 112.92 171.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.34 -49.85 65.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.5 p 167.9 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.228 2.611 . . . . 0.0 110.334 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 25.7 m-85 -99.73 104.32 27.27 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 117.31 -1.329 . . . . 0.0 110.493 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -70.71 128.96 15.85 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.021 1.814 . . . . 0.0 111.512 -170.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 132.04 21.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.127 1.371 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.33 -52.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.186 2.591 . . . . 0.0 112.477 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.78 149.61 27.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.617 1.167 . . . . 0.0 110.045 167.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -128.03 21.01 6.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.288 1.435 . . . . 0.0 113.315 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -88.61 145.74 35.85 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 121.228 -0.92 . . . . 0.0 109.772 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.18 -23.58 6.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.563 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.2 -24.6 43.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.891 0.769 . . . . 0.0 112.862 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.2 m -98.22 -34.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.037 0.935 . . . . 0.0 111.97 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.27 -32.5 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.322 1.049 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.56 -11.74 59.87 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.129 0.972 . . . . 0.0 113.227 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.81 -34.05 8.68 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.179 -0.95 . . . . 0.0 113.289 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 112' ' ' LEU . 3.6 pp -82.84 -21.25 34.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.745 0.818 . . . . 0.0 112.913 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -69.44 -23.54 63.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.072 -1.017 . . . . 0.0 113.735 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.0 83.99 2.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.055 . . . . 0.0 110.146 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.55 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.46 159.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.81 126.91 55.12 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 160.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.8 121.9 32.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.9 m -134.12 129.76 36.38 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.097 0.959 . . . . 0.0 109.801 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.76 141.35 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 128.576 2.75 . . . . 0.0 107.885 -170.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.111 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 -174.928 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.399 0.142 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -60.08 -18.09 44.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.403 2.281 . . . . 0.0 116.429 -166.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.14 -13.83 9.66 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 126.896 2.188 . . . . 0.0 114.282 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.41 -34.41 54.77 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.381 1.472 . . . . 0.0 111.818 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.9 pt -59.33 -27.45 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.525 -0.735 . . . . 0.0 112.449 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.4 -58.59 2.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.949 1.3 . . . . 0.0 111.271 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.13 -33.33 72.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.618 1.167 . . . . 0.0 112.167 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -74.05 -40.61 62.71 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.755 0.822 . . . . 0.0 110.464 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.52 -31.75 68.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.743 . . . . 0.0 111.361 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.59 -51.64 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -67.16 -19.94 65.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -57.08 -35.77 69.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.981 0.512 . . . . 0.0 111.245 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -77.98 -32.7 51.46 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.36 109.15 20.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.621 1.201 . . . . 0.0 111.438 -160.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.08 25.01 5.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.72 1.608 . . . . 0.0 114.21 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.73 -64.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 0.0 111.385 -167.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 72.25 -68.3 0.23 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.217 2.207 . . . . 0.0 112.958 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.31 -27.86 68.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.982 1.313 . . . . 0.0 113.059 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.9 m -100.62 7.14 44.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.332 1.053 . . . . 0.0 113.21 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -100.08 -28.86 12.83 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.849 1.66 . . . . 0.0 112.161 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.993 1.717 . . . . 0.0 112.575 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.86 -23.6 3.64 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.199 1.38 . . . . 0.0 114.737 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 -169.77 1.53 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.081 2.153 . . . . 0.0 111.356 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 165.21 24.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 0.0 110.342 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 41.0 t -158.11 145.9 18.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 0.0 109.869 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.1 129.0 42.99 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.72 1.608 . . . . 0.0 111.003 165.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.99 169.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.18 132.21 33.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.236 -172.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -105.09 129.53 53.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.522 1.129 . . . . 0.0 109.725 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -112.36 111.14 21.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.999 0.92 . . . . 0.0 109.634 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.3 mm? -100.09 158.6 15.72 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.996 0.903 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 pt -98.38 150.45 36.74 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 125.476 1.51 . . . . 0.0 110.036 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.35 150.89 37.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.17 2.58 . . . . 0.0 111.109 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -168.25 144.73 3.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.012 2.525 . . . . 0.0 107.98 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.0 -22.17 75.75 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -164.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.8 p -90.89 -9.6 45.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.488 1.515 . . . . 0.0 113.178 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.21 157.05 7.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.244 1.402 . . . . 0.0 112.635 -171.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.1 160.88 17.23 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 117.765 0.783 . . . . 0.0 110.767 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.19 144.93 51.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.072 1.349 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.05 110.25 1.16 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.461 0.704 . . . . 0.0 112.547 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.58 -37.28 4.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.882 1.705 . . . . 0.0 112.041 173.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -162.38 148.83 13.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.817 1.247 . . . . 0.0 111.0 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.35 125.78 39.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.347 1.059 . . . . 0.0 109.423 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.6 m -110.86 127.81 55.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.711 2.005 . . . . 0.0 108.133 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.57 133.33 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.608 1.094 . . . . 0.0 109.351 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 tp -104.51 -44.79 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.713 0.405 . . . . 0.0 110.287 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 3.8 t0 -172.48 168.86 5.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.646 1.578 . . . . 0.0 112.232 169.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.7 32.79 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.745 1.164 . . . . 0.0 113.573 169.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -85.68 114.73 22.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 166.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m -59.69 -19.82 52.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -151.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -58.43 -29.63 66.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.303 -0.856 . . . . 0.0 113.128 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -79.81 -48.58 13.31 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 120.228 1.376 . . . . 0.0 111.22 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 38.9 m -45.36 -47.3 13.4 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.694 1.134 . . . . 0.0 112.774 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.17 64.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.391 1.476 . . . . 0.0 114.486 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.04 -52.8 4.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.378 1.471 . . . . 0.0 111.975 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.0 t -56.05 -48.6 75.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 111.292 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -46.87 -47.21 21.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.427 1.891 . . . . 0.0 111.494 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -69.96 -43.25 71.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.08 71.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.694 1.197 . . . . 0.0 111.124 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.05 -22.02 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.82 -1.175 . . . . 0.0 112.645 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.71 -8.72 59.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.841 0.856 . . . . 0.0 112.455 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -128.85 -13.3 4.67 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.5 m -58.37 145.12 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.302 1.041 . . . . 0.0 111.984 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -69.46 -42.75 74.47 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -171.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.9 p 166.07 141.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.506 2.323 . . . . 0.0 110.192 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 42.7 m-85 -89.61 112.55 52.4 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.538 -1.22 . . . . 0.0 110.388 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.96 127.02 9.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.33 2.02 . . . . 0.0 111.101 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -73.98 141.65 78.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.852 0.861 . . . . 0.0 111.43 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -44.16 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.891 2.394 . . . . 0.0 110.401 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -122.55 151.56 41.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.146 1.778 . . . . 0.0 109.507 160.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -108.43 10.61 27.38 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -165.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.68 144.31 56.11 Favored Pre-proline 0 C--O 1.24 0.569 0 O-C-N 120.872 -1.143 . . . . 0.0 109.947 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.68 -6.0 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.04 2.493 . . . . 0.0 113.957 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.44 -33.1 23.75 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.713 0.805 . . . . 0.0 112.875 169.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -97.44 -25.77 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 113.139 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.67 -25.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.742 0.817 . . . . 0.0 110.59 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.17 -11.44 59.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.277 1.431 . . . . 0.0 113.191 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -37.75 8.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 0.0 112.583 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.62 -23.94 53.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.778 1.231 . . . . 0.0 112.592 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -66.79 -22.83 66.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.5 91.01 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.942 0.897 . . . . 0.0 110.647 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.475 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -119.43 154.79 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.674 1.19 . . . . 0.0 113.067 -178.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -91.11 136.42 33.1 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.144 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.38 114.31 26.81 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 153.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.3 m -133.83 128.27 34.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.579 1.152 . . . . 0.0 109.34 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.57 156.7 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.783 1.633 . . . . 0.0 111.173 -171.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.107 0 C-N-CA 126.81 2.044 . . . . 0.0 110.629 -178.09 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -53.67 -44.0 69.33 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.096 1.759 . . . . 0.0 114.83 -162.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.56 -17.37 57.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.572 1.558 . . . . 0.0 114.03 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.657 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.06 -33.11 59.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.666 1.186 . . . . 0.0 111.547 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.9 pt -59.51 -25.79 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.136 0.88 . . . . 0.0 112.257 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.36 -59.88 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.122 0.969 . . . . 0.0 109.804 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -61.44 -35.25 77.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.472 1.109 . . . . 0.0 112.326 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -73.85 -27.5 61.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.718 1.207 . . . . 0.0 111.915 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -78.6 -32.27 47.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.252 0.933 . . . . 0.0 111.836 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 93' ' ' VAL . 1.5 mp -68.8 -43.54 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.891 1.276 . . . . 0.0 110.598 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -72.62 -13.99 61.5 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.961 0.904 . . . . 0.0 113.223 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -55.58 -38.43 69.36 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.457 0.303 . . . . 0.0 110.326 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -81.25 -36.87 29.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -103.41 99.42 9.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.825 1.298 . . . . 0.0 111.869 -161.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.2 28.82 0.69 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.269 1.428 . . . . 0.0 113.625 -172.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.35 -40.5 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.599 0.759 . . . . 0.0 112.322 -165.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.57 -98.53 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.139 1.776 . . . . 0.0 112.95 164.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.69 -24.1 66.54 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.645 1.178 . . . . 0.0 113.605 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 m -92.83 1.42 57.3 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -88.64 -22.18 23.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.073 1.349 . . . . 0.0 111.575 156.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -86.4 170.92 11.56 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.581 1.952 . . . . 0.0 111.214 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 -9.72 28.46 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.095 1.331 . . . . 0.0 114.833 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 -176.94 5.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.714 2.406 . . . . 0.0 110.885 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.92 160.44 26.15 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.722 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.406 ' HB3' HD23 ' A' ' 85' ' ' LEU . 54.1 t -154.87 141.44 18.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.646 1.178 . . . . 0.0 109.538 168.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.06 131.6 53.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.397 1.479 . . . . 0.0 110.494 167.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.3 m -142.31 170.24 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -134.82 131.93 38.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.404 0.682 . . . . 0.0 111.5 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.38 133.33 48.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.222 1.009 . . . . 0.0 109.682 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -115.16 107.12 14.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.738 1.215 . . . . 0.0 109.709 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.491 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.92 158.47 15.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.08 148.2 34.78 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.61 1.564 . . . . 0.0 110.274 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.71 141.13 37.02 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.71 2.273 . . . . 0.0 110.853 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.8 m -133.43 156.94 46.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.277 1.831 . . . . 0.0 109.795 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.31 -26.47 61.68 Favored Glycine 0 N--CA 1.478 1.492 0 C-N-CA 123.55 0.595 . . . . 0.0 113.661 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -131.17 104.47 7.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.941 1.696 . . . . 0.0 108.331 161.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.58 -159.53 24.96 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.136 1.351 . . . . 0.0 114.442 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -110.72 162.45 14.75 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.344 1.057 . . . . 0.0 110.032 162.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.24 145.92 51.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.101 1.761 . . . . 0.0 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.14 112.74 1.81 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.759 0.708 . . . . 0.0 112.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.41 -36.37 5.16 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 125.796 1.665 . . . . 0.0 111.873 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -166.45 153.52 9.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.685 1.594 . . . . 0.0 111.201 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.25 131.65 48.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.44 1.096 . . . . 0.0 109.889 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.0 m -111.55 122.59 48.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.362 1.865 . . . . 0.0 107.878 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.56 130.79 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.96 0.8 . . . . 0.0 109.114 167.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.31 -49.88 3.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.315 0.646 . . . . 0.0 110.094 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.58 165.58 4.57 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.123 1.769 . . . . 0.0 111.865 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.95 179.62 38.33 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 124.543 1.068 . . . . 0.0 114.253 167.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.84 119.65 24.17 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -54.36 -31.64 55.09 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -144.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -54.79 -34.97 63.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.859 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 58' ' ' CYS . 12.4 tp -78.92 -56.78 4.14 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.334 1.425 . . . . 0.0 111.678 -175.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 6.0 p -55.69 -32.62 63.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.42 -33.95 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.816 1.189 . . . . 0.0 113.414 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.52 -52.5 7.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.46 1.104 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.6 t -56.09 -46.63 78.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.25 1.02 . . . . 0.0 111.713 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -46.45 -45.74 18.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.393 1.877 . . . . 0.0 111.797 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -75.62 -43.1 49.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.393 1.077 . . . . 0.0 112.754 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.77 -48.44 81.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.815 1.246 . . . . 0.0 111.98 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' THR . 2.7 t -66.1 -24.42 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.859 -1.151 . . . . 0.0 111.235 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.35 -6.07 55.97 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.503 -0.748 . . . . 0.0 112.566 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -133.07 -12.05 2.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.1 m -58.76 151.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.274 0.943 . . . . 0.0 113.238 169.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.65 -48.69 30.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 173.87 142.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.49 1.916 . . . . 0.0 111.835 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.5 m-85 -97.12 113.79 63.66 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.902 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.5 127.95 6.74 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.868 2.379 . . . . 0.0 110.189 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.6 mt -83.42 146.73 51.22 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.754 0.821 . . . . 0.0 112.225 -172.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.27 -28.81 8.42 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.986 2.457 . . . . 0.0 111.892 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -140.76 156.84 46.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.76 2.024 . . . . 0.0 110.817 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -129.67 20.85 5.55 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -167.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -85.69 141.85 36.54 Favored Pre-proline 0 C--O 1.241 0.655 0 O-C-N 120.492 -1.38 . . . . 0.0 109.068 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.24 -5.41 8.01 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 113.399 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.52 -35.27 23.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.523 1.056 . . . . 0.0 112.124 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.0 m -100.34 -24.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.182 0.993 . . . . 0.0 113.278 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.54 -28.27 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.524 0.73 . . . . 0.0 110.379 167.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.439 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 31.7 mm-40 -79.8 -8.53 59.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.881 1.272 . . . . 0.0 113.981 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -93.1 -54.09 3.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.669 0.788 . . . . 0.0 111.311 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.81 -23.15 67.15 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 124.497 1.119 . . . . 0.0 113.17 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.9 ptmt -72.87 -23.91 60.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.721 -1.237 . . . . 0.0 113.292 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.7 83.08 2.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.124 1.369 . . . . 0.0 110.885 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.86 150.06 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.716 0.807 . . . . 0.0 112.199 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 126.55 39.83 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 157.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 mt -89.78 116.05 27.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 163.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -131.67 124.89 30.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.626 1.171 . . . . 0.0 109.345 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.89 139.95 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 128.333 2.653 . . . . 0.0 107.276 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 125.285 1.434 . . . . 0.0 111.514 -177.513 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 112.349 0.499 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -54.16 -43.97 71.07 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.801 2.04 . . . . 0.0 113.873 -171.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.05 68.22 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.123 1.344 . . . . 0.0 113.705 173.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.8 -27.48 55.25 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.327 1.063 . . . . 0.0 112.074 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.35 -30.12 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.403 -1.436 . . . . 0.0 111.457 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -78.26 -56.09 4.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.405 1.482 . . . . 0.0 109.488 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.33 -33.95 71.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.845 0.858 . . . . 0.0 112.452 -176.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -37.56 82.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.776 1.231 . . . . 0.0 111.672 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.23 -28.04 59.75 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.58 -52.5 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.224 -0.923 . . . . 0.0 110.622 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -23.91 67.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.638 0.775 . . . . 0.0 112.078 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.35 -14.16 60.46 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -81.5 -45.19 16.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.182 0.901 . . . . 0.0 111.003 159.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.49 83.46 5.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 123.541 1.638 . . . . 0.0 112.081 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.34 28.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.813 1.645 . . . . 0.0 113.999 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.94 -69.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.462 -163.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 74.31 -49.78 0.67 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.982 2.513 . . . . 0.0 113.718 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.78 -44.74 92.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.621 1.168 . . . . 0.0 112.605 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.2 p -92.42 12.72 21.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -100.48 -17.92 16.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.59 1.556 . . . . 0.0 111.325 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -106.16 156.95 17.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.193 1.797 . . . . 0.0 111.813 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.39 -2.72 84.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.037 1.303 . . . . 0.0 114.804 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -178.97 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.032 2.133 . . . . 0.0 110.923 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 161.33 23.2 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.516 -0.74 . . . . 0.0 110.162 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -155.14 149.09 25.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.763 1.225 . . . . 0.0 110.403 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.27 117.64 9.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.733 1.613 . . . . 0.0 110.35 173.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.52 163.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -134.7 131.15 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.985 -0.447 . . . . 0.0 111.701 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.34 129.54 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.352 1.061 . . . . 0.0 109.885 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -114.29 103.81 11.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.511 1.524 . . . . 0.0 108.244 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -100.85 157.59 16.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.714 0.769 . . . . 0.0 112.085 -178.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 pt -101.32 139.33 20.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.231 1.413 . . . . 0.0 110.159 168.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.42 126.23 10.8 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.526 2.151 . . . . 0.0 109.845 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 m -113.74 -33.72 5.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.272 1.029 . . . . 0.0 112.506 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.87 -110.16 0.37 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.487 1.041 . . . . 0.0 111.678 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -61.21 -23.74 65.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.19 0.996 . . . . 0.0 112.673 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.13 -178.43 16.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.268 1.413 . . . . 0.0 115.396 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -100.98 165.83 11.13 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.36 1.464 . . . . 0.0 111.833 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.26 146.49 52.33 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.385 1.874 . . . . 0.0 111.413 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.66 110.3 0.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.59 0.756 . . . . 0.0 112.038 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.45 -35.34 5.73 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.943 1.735 . . . . 0.0 111.703 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.8 152.51 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 0.0 111.556 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -126.0 125.06 42.06 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.532 1.133 . . . . 0.0 109.779 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.6 m -106.43 122.37 46.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.407 1.883 . . . . 0.0 108.19 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.81 129.55 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.125 0.875 . . . . 0.0 108.85 166.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -105.94 -41.54 5.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.405 0.682 . . . . 0.0 110.539 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.27 173.72 6.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.249 1.82 . . . . 0.0 111.503 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.36 169.41 13.08 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 125.778 1.656 . . . . 0.0 114.197 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.94 120.05 24.73 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 p -60.79 -20.85 62.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -154.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -52.69 -33.14 46.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.858 1.263 . . . . 0.0 112.976 171.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.09 -50.52 6.58 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.565 1.075 . . . . 0.0 111.053 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 m -46.22 -47.77 17.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.093 1.357 . . . . 0.0 113.922 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.61 80.45 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.72 0.808 . . . . 0.0 112.466 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.0 16.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.521 1.128 . . . . 0.0 112.068 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.6 t -58.68 -48.28 81.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.953 0.901 . . . . 0.0 110.734 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -49.25 -45.49 44.79 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.989 1.716 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.38 -47.39 61.12 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.23 77.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.289 1.036 . . . . 0.0 111.269 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.68 -22.55 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.86 -1.15 . . . . 0.0 112.013 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.08 -8.63 59.12 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.419 -0.801 . . . . 0.0 112.639 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.41 -11.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.8 m -56.92 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 112.387 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.33 -45.26 76.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 p 166.18 145.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 111.259 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 13.3 m-85 -103.23 103.4 34.56 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.669 1.188 . . . . 0.0 109.426 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.11 132.24 25.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.308 2.006 . . . . 0.0 110.982 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.75 147.12 77.46 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 118.092 0.406 . . . . 0.0 110.941 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -42.01 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.92 1.747 . . . . 0.0 110.562 168.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 158.57 44.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.084 2.154 . . . . 0.0 111.276 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -126.64 19.14 7.34 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.389 1.076 . . . . 0.0 113.898 -162.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.69 140.41 40.98 Favored Pre-proline 0 C--O 1.24 0.589 0 O-C-N 120.508 -1.37 . . . . 0.0 109.442 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.45 -3.59 6.72 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.998 2.466 . . . . 0.0 113.523 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.84 -34.2 21.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.029 0.831 . . . . 0.0 111.985 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.94 -26.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.903 0.881 . . . . 0.0 112.978 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.58 -28.51 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.573 0.749 . . . . 0.0 110.623 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.9 mm-40 -79.62 -10.41 59.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.18 -53.31 4.41 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.518 -0.739 . . . . 0.0 111.133 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.3 pp -65.2 -25.33 67.66 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 112.878 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.2 ptmt -72.92 -24.74 60.86 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.01 -1.056 . . . . 0.0 113.337 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -125.81 81.1 1.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.796 1.638 . . . . 0.0 110.674 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.49 150.56 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.86 0.864 . . . . 0.0 112.415 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.36 129.24 43.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 160.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.94 109.69 19.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 156.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -133.85 125.83 29.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.769 1.228 . . . . 0.0 108.515 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.6 m -138.37 149.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.714 1.606 . . . . 0.0 110.321 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.759 0 C-N-CA 125.627 1.571 . . . . 0.0 111.971 -177.735 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 111.377 0.14 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -49.62 -46.34 49.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.739 2.015 . . . . 0.0 114.741 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.54 -16.09 55.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.33 1.919 . . . . 0.0 114.097 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.2 -34.09 59.29 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.375 1.07 . . . . 0.0 111.863 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.0 pt -60.18 -24.72 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.54 0.736 . . . . 0.0 112.074 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -82.98 -59.7 2.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.599 1.16 . . . . 0.0 109.897 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -61.26 -34.66 75.53 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.448 1.099 . . . . 0.0 112.47 -170.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -71.02 -43.94 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.471 1.108 . . . . 0.0 110.385 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.2 tp -67.41 -29.29 68.75 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.638 0.653 . . . . 0.0 111.631 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -53.42 24.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 O-C-N 121.498 -0.751 . . . . 0.0 110.862 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -67.54 -18.28 64.97 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.44 -36.36 66.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.84 0.456 . . . . 0.0 111.265 167.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -78.17 -37.96 44.63 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 112.204 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.53 101.87 13.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.968 1.366 . . . . 0.0 111.57 -164.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 21.0 3.84 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.27 -60.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -162.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 73.31 -57.84 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.715 2.406 . . . . 0.0 113.198 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.4 -40.36 86.36 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.093 1.357 . . . . 0.0 112.05 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 m -79.73 0.87 28.78 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -112.29 -25.77 9.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.063 1.745 . . . . 0.0 112.955 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.69 156.49 16.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.119 1.367 . . . . 0.0 113.171 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.64 -24.11 4.56 Favored Glycine 0 N--CA 1.478 1.486 0 C-N-CA 125.376 1.465 . . . . 0.0 114.816 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -173.63 2.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.41 1.884 . . . . 0.0 111.532 171.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.1 27.59 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.245 -0.91 . . . . 0.0 111.594 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.9 t -160.36 146.68 15.49 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.936 1.294 . . . . 0.0 110.008 171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.23 129.81 42.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.184 1.794 . . . . 0.0 110.24 166.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.31 170.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.37 131.22 31.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.471 0.578 . . . . 0.0 112.02 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.46 127.93 49.29 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.177 0.991 . . . . 0.0 110.112 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mppt? -108.64 107.46 17.94 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.669 1.187 . . . . 0.0 109.277 165.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.4 160.45 14.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.994 0.902 . . . . 0.0 111.472 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.99 121.43 52.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.424 1.489 . . . . 0.0 109.504 166.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.62 121.84 10.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.96 2.44 . . . . 0.0 111.157 170.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.3 m -111.26 -29.54 7.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.132 1.373 . . . . 0.0 111.821 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.67 -52.99 0.71 Allowed Glycine 0 N--CA 1.476 1.324 0 C-N-CA 125.645 1.593 . . . . 0.0 112.415 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -70.03 -31.79 69.62 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.965 0.906 . . . . 0.0 111.378 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.15 -168.34 18.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 111.814 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.55 162.15 13.92 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 151.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.29 145.84 50.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.999 1.719 . . . . 0.0 111.16 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.94 112.2 1.58 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.644 -0.66 . . . . 0.0 112.402 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.13 -46.83 3.23 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.05 1.309 . . . . 0.0 110.68 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -156.64 148.28 22.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.609 1.164 . . . . 0.0 110.828 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.44 131.2 53.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.796 0.839 . . . . 0.0 109.574 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -115.22 117.17 29.75 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.142 1.777 . . . . 0.0 108.041 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -82.39 132.05 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.473 0.578 . . . . 0.0 109.631 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.86 -52.16 3.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.097 0.559 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -172.9 169.37 4.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.233 1.813 . . . . 0.0 112.119 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.03 -175.73 34.44 Favored Glycine 0 N--CA 1.465 0.581 0 C-N-CA 125.699 1.619 . . . . 0.0 113.843 168.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.63 116.63 19.94 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -25.53 39.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -152.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -55.08 -32.44 61.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.322 1.449 . . . . 0.0 112.834 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.76 -50.55 7.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.288 1.404 . . . . 0.0 112.404 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.1 p -60.74 -31.28 70.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.405 1.457 . . . . 0.0 113.26 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 -46.1 84.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.119 0.968 . . . . 0.0 112.75 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.07 -50.14 30.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.276 1.03 . . . . 0.0 113.206 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.3 t -56.87 -47.91 79.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.64 0.776 . . . . 0.0 110.521 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -48.79 -45.85 40.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.06 1.744 . . . . 0.0 111.818 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -69.14 -43.49 74.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.8 -49.13 78.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.724 1.21 . . . . 0.0 111.275 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.61 -23.03 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.5 -1.375 . . . . 0.0 112.172 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.43 -6.05 57.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.97 0.908 . . . . 0.0 112.782 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.55 -12.27 3.46 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.1 m -60.0 146.62 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.416 1.087 . . . . 0.0 112.115 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -72.11 -46.57 56.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 172.89 138.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.162 1.785 . . . . 0.0 111.245 -168.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.0 m-85 -93.53 111.39 52.16 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.099 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.38 116.21 4.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.892 1.728 . . . . 0.0 109.938 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 101' ' ' LEU . 1.1 pt? -88.34 137.63 30.74 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.44 1.496 . . . . 0.0 111.848 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.61 -46.29 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.25 2.634 . . . . 0.0 112.35 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -99.3 168.16 10.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.053 1.341 . . . . 0.0 110.719 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -131.48 6.15 4.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -167.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.15 138.85 60.43 Favored Pre-proline 0 C--O 1.243 0.735 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.36 -0.97 4.0 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.872 2.381 . . . . 0.0 113.549 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.58 -40.39 16.32 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 111.773 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -93.02 -25.74 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.381 1.072 . . . . 0.0 112.412 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.51 -26.65 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.973 0.909 . . . . 0.0 110.799 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -84.55 -7.24 59.33 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.464 1.506 . . . . 0.0 113.826 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -92.68 -51.69 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.781 0.8 . . . . 0.0 111.876 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 112' ' ' LEU . 3.2 pp -69.06 -21.52 64.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.476 1.11 . . . . 0.0 112.345 -172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -62.37 -24.14 67.2 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.88 -1.138 . . . . 0.0 113.711 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -129.61 78.62 1.86 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.416 1.087 . . . . 0.0 110.401 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.84 151.86 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.306 1.042 . . . . 0.0 111.732 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.23 134.17 34.78 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 155.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.33 113.17 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.5 m -135.71 126.29 27.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.344 1.058 . . . . 0.0 109.165 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.26 151.31 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.84 1.656 . . . . 0.0 110.654 -171.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 125.979 1.712 . . . . 0.0 110.975 -176.328 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.911 0.386 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.96 -43.49 77.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.676 2.39 . . . . 0.0 113.335 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.73 -17.44 70.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 172.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.51 -32.0 64.0 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.552 1.176 . . . . 0.0 111.632 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -61.97 -28.84 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.538 -0.726 . . . . 0.0 111.5 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.07 -59.0 2.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.554 1.542 . . . . 0.0 109.992 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.34 -34.16 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.025 0.93 . . . . 0.0 112.408 -173.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -72.45 -31.47 65.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.078 0.951 . . . . 0.0 111.51 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.86 -30.18 61.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.548 0.613 . . . . 0.0 112.29 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -73.97 -53.68 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.956 -1.09 . . . . 0.0 110.649 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -20.22 64.55 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.462 0.705 . . . . 0.0 112.53 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.59 -14.53 58.12 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -79.81 -42.15 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.185 0.902 . . . . 0.0 111.324 159.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.81 84.61 4.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 123.412 1.577 . . . . 0.0 111.775 -163.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.6 27.07 0.13 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.581 1.553 . . . . 0.0 114.217 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.93 -69.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.047 0.939 . . . . 0.0 111.128 -165.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 77.34 -50.81 0.54 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.595 2.358 . . . . 0.0 113.67 162.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.47 -21.97 60.3 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.96 -1.087 . . . . 0.0 113.551 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -89.93 -6.65 55.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.712 1.205 . . . . 0.0 113.07 169.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.1 m-30 -98.31 -17.2 19.02 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.464 1.906 . . . . 0.0 112.277 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.72 159.78 14.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.875 2.07 . . . . 0.0 112.989 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.29 -43.08 2.45 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.698 1.618 . . . . 0.0 112.778 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -84.85 -176.79 6.37 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.21 1.404 . . . . 0.0 111.264 168.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 165.08 23.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.879 0.872 . . . . 0.0 111.313 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.41 158.24 43.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.123 0.569 . . . . 0.0 111.087 158.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 128.04 39.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.86 1.264 . . . . 0.0 109.883 159.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.3 178.19 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.57 124.98 13.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.288 0.635 . . . . 0.0 110.966 -166.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.07 131.9 49.72 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.945 0.898 . . . . 0.0 109.814 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -118.63 103.47 9.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.184 1.794 . . . . 0.0 109.38 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.473 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.79 160.39 14.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.374 1.083 . . . . 0.0 111.697 -175.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 pt -102.24 142.12 23.94 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.608 1.563 . . . . 0.0 109.879 166.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.07 126.11 9.06 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.793 2.329 . . . . 0.0 109.95 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.2 m -112.9 -27.9 7.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.229 1.412 . . . . 0.0 112.089 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.69 -39.59 2.82 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.652 1.596 . . . . 0.0 112.99 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.3 p -71.49 -34.73 70.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.748 1.219 . . . . 0.0 110.532 163.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.62 -165.61 15.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 112.061 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -89.05 164.14 15.19 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 122.014 -0.697 . . . . 0.0 109.376 151.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.94 145.79 51.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.593 1.557 . . . . 0.0 111.157 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.81 111.59 1.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.253 0.621 . . . . 0.0 112.474 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.4 -35.87 5.33 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.542 1.544 . . . . 0.0 111.683 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.48 151.91 8.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.857 1.663 . . . . 0.0 110.845 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -125.3 121.15 33.18 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.856 0.862 . . . . 0.0 110.02 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.6 m -101.1 135.68 42.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.722 1.609 . . . . 0.0 107.807 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.0 m -99.34 135.95 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.015 0.825 . . . . 0.0 109.006 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -103.82 -48.22 3.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.089 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -172.66 171.61 4.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 0.0 111.792 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.11 -175.1 30.95 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.394 1.474 . . . . 0.0 113.886 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.55 110.89 19.04 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -63.68 -15.32 58.09 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -153.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.78 -32.65 70.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.795 0.838 . . . . 0.0 112.196 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.02 -46.8 22.55 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 119.712 1.142 . . . . 0.0 110.775 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 54.4 m -51.84 -38.77 57.17 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.41 1.005 . . . . 0.0 113.603 173.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.26 -44.98 70.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.841 0.856 . . . . 0.0 112.27 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.22 -52.54 53.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 112.213 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.34 -50.31 73.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.801 0.84 . . . . 0.0 110.365 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -50.95 -46.84 61.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.442 1.497 . . . . 0.0 111.306 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -66.68 -44.22 82.35 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.78 80.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.857 1.263 . . . . 0.0 111.511 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.67 -22.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.5 -1.375 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.83 -7.2 58.56 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.429 -0.794 . . . . 0.0 112.399 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.27 -12.08 3.19 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.48 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.2 m -55.72 148.28 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.59 1.156 . . . . 0.0 113.017 171.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -73.46 -43.33 60.5 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.4 p 168.87 145.76 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.025 2.53 . . . . 0.0 111.141 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.56 110.68 52.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.439 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.69 114.85 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.527 1.485 . . . . 0.0 110.374 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 101' ' ' LEU . 1.4 pt? -89.76 129.19 47.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.812 1.645 . . . . 0.0 110.397 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.93 -46.34 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.127 2.551 . . . . 0.0 111.043 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -94.26 167.17 11.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.17 1.388 . . . . 0.0 112.169 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.61 24.5 0.59 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.352 1.061 . . . . 0.0 113.027 -165.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.28 140.46 34.38 Favored Pre-proline 0 C--O 1.24 0.598 0 O-C-N 120.754 -1.217 . . . . 0.0 108.644 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.83 -15.26 2.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.961 3.107 . . . . 0.0 115.601 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.32 -35.7 30.65 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.273 0.942 . . . . 0.0 112.496 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -99.78 -27.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.523 1.129 . . . . 0.0 112.726 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.2 t -56.82 -32.5 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.564 1.146 . . . . 0.0 110.105 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 35.5 mm-40 -77.9 -7.83 57.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 113.462 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -99.19 -44.55 6.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 112.694 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.9 -28.14 67.25 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.771 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.3 ptmt -73.01 -23.99 60.69 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.397 -1.439 . . . . 0.0 113.643 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -122.84 84.19 2.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.825 1.25 . . . . 0.0 110.445 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.59 155.92 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.147 0.979 . . . . 0.0 112.127 176.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 120.84 43.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.978 162.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.17 119.45 30.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -135.65 127.03 28.48 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.063 1.345 . . . . 0.0 108.56 -173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.49 157.32 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 111.606 -168.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.2 0 C-N-CA 125.702 1.601 . . . . 0.0 115.265 175.131 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.7 mmp_? . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -51.48 -52.71 44.35 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 128.057 2.543 . . . . 0.0 113.7 -161.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.36 -15.01 65.04 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.052 1.786 . . . . 0.0 113.97 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.53 -37.28 71.17 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.898 1.349 . . . . 0.0 110.551 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.5 pt -62.18 -26.97 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.476 -0.765 . . . . 0.0 112.223 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.2 -59.31 2.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.892 1.277 . . . . 0.0 109.927 174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -60.15 -35.58 75.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.881 1.272 . . . . 0.0 112.472 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -77.4 -21.78 52.62 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.435 1.094 . . . . 0.0 112.779 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.93 -34.04 39.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.639 1.109 . . . . 0.0 111.416 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.75 -44.09 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 121.052 -1.03 . . . . 0.0 111.063 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -14.81 62.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.912 1.285 . . . . 0.0 112.911 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -59.99 -40.87 90.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.029 0.531 . . . . 0.0 109.962 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -77.94 -44.06 28.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.952 0.882 . . . . 0.0 109.777 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.21 71.28 5.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.378 1.561 . . . . 0.0 111.512 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.12 28.95 0.05 Allowed 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.762 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.19 -70.68 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.991 . . . . 0.0 110.822 -163.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 75.82 -46.93 0.57 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.689 2.396 . . . . 0.0 113.201 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.09 -25.37 64.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.451 1.101 . . . . 0.0 113.067 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.6 m -86.02 -5.21 59.26 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.886 1.274 . . . . 0.0 113.336 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 15.8 m-30 -110.47 -21.48 12.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 112.279 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -91.73 157.58 16.84 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.543 1.937 . . . . 0.0 113.334 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.03 -7.45 66.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 125.411 1.481 . . . . 0.0 114.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -134.78 -172.71 3.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.222 2.209 . . . . 0.0 110.955 176.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.18 165.91 21.36 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.458 -0.777 . . . . 0.0 110.593 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.8 t -154.99 142.05 19.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.001 0.92 . . . . 0.0 109.697 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.78 131.06 51.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.368 1.867 . . . . 0.0 110.677 166.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 170.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.461 1.104 . . . . 0.0 108.524 173.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.87 131.57 41.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.787 0.835 . . . . 0.0 112.068 -177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.28 134.25 44.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.044 0.938 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.89 102.89 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.162 1.385 . . . . 0.0 108.387 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.58 161.65 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.978 0.894 . . . . 0.0 111.493 -178.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -100.59 121.01 54.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.273 1.429 . . . . 0.0 109.688 165.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.51 126.68 23.12 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.818 2.346 . . . . 0.0 110.994 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.2 m -143.52 92.45 2.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.276 1.431 . . . . 0.0 108.285 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.06 -123.95 32.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.977 0.799 . . . . 0.0 111.412 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.91 2.45 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.145 1.778 . . . . 0.0 114.199 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.71 -165.24 10.79 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.193 1.378 . . . . 0.0 114.726 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -127.15 165.73 19.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.838 1.255 . . . . 0.0 110.235 161.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.17 146.6 52.4 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.182 1.793 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.83 111.58 1.7 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.893 0.769 . . . . 0.0 112.419 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.61 -35.65 5.34 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.531 1.538 . . . . 0.0 112.287 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -166.43 153.87 9.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 111.06 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -129.58 129.13 44.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.261 1.024 . . . . 0.0 109.347 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.3 m -112.18 117.98 34.07 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.078 1.751 . . . . 0.0 108.229 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.61 132.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.708 0.685 . . . . 0.0 109.482 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -102.13 -53.13 2.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -179.1 162.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.666 1.987 . . . . 0.0 111.405 170.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.94 -176.54 40.69 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.368 0.985 . . . . 0.0 112.556 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 107.96 17.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 p -64.68 -13.95 56.33 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -147.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -57.1 -33.29 67.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.777 0.831 . . . . 0.0 112.604 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.35 -47.56 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.875 1.216 . . . . 0.0 111.855 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.7 m -45.68 -45.83 14.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.762 1.164 . . . . 0.0 112.802 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.54 71.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 0.0 112.427 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.81 66.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.6 t -58.85 -49.63 77.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.653 0.781 . . . . 0.0 110.477 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.39 -45.9 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.348 1.459 . . . . 0.0 111.518 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.71 -46.29 76.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.85 80.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.556 1.142 . . . . 0.0 111.622 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' THR . 2.6 t -66.06 -24.24 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.543 -1.348 . . . . 0.0 111.486 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.01 -7.22 58.71 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.348 -0.845 . . . . 0.0 112.368 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.75 -11.7 3.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.3 m -57.25 148.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.197 0.908 . . . . 0.0 112.869 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -68.57 -48.22 64.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.7 p 170.11 144.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.578 2.351 . . . . 0.0 110.56 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 22.8 m-85 -97.18 110.66 55.21 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.466 -1.254 . . . . 0.0 109.482 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.87 129.93 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.447 2.098 . . . . 0.0 110.157 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.21 144.92 55.01 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.955 0.502 . . . . 0.0 110.745 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 -29.64 9.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.575 2.183 . . . . 0.0 111.656 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -114.66 -174.9 2.57 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.161 1.784 . . . . 0.0 111.864 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -151.96 21.15 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -95.52 132.29 27.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.89 -1.131 . . . . 0.0 109.457 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.69 -5.6 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.83 3.687 . . . . 0.0 116.857 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.75 -60.27 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.378 0.99 . . . . 0.0 110.266 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -74.97 -25.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.376 0.67 . . . . 0.0 112.273 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.25 -26.29 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 0.0 111.176 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -91.54 3.26 55.41 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.362 1.065 . . . . 0.0 113.711 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -98.33 -49.56 4.64 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.188 -0.945 . . . . 0.0 111.256 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.99 -22.37 65.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.014 1.725 . . . . 0.0 113.588 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.49 -25.1 64.8 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.921 -1.112 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -123.72 86.24 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.895 1.278 . . . . 0.0 111.041 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -110.55 150.29 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.898 1.279 . . . . 0.0 111.763 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.05 125.69 43.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 160.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.37 118.33 30.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 164.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -133.87 129.94 37.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.601 1.161 . . . . 0.0 109.321 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.36 153.67 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.534 1.534 . . . . 0.0 111.71 -171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.293 0 C-N-CA 125.734 1.614 . . . . 0.0 113.551 173.282 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.554 0.216 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.79 -45.31 70.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.29 2.236 . . . . 0.0 113.48 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.16 -17.2 69.99 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.111 1.339 . . . . 0.0 113.635 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.76 -31.93 63.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.612 1.206 . . . . 0.0 111.911 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.48 -27.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.157 -0.965 . . . . 0.0 111.61 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -81.83 -57.73 3.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.125 1.37 . . . . 0.0 110.23 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.08 -36.3 72.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.708 1.203 . . . . 0.0 112.444 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -73.21 -31.68 64.33 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.37 1.068 . . . . 0.0 111.484 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 tp -74.2 -34.33 63.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.071 0.851 . . . . 0.0 112.034 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.84 -44.82 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.591 -1.318 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -72.15 -14.23 61.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -56.48 -39.24 72.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.442 0.297 . . . . 0.0 110.491 165.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -79.27 -39.7 32.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -97.23 85.75 3.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 123.293 1.52 . . . . 0.0 112.031 -163.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.04 27.61 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.826 -1.534 . . . . 0.0 114.126 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 t -84.52 -52.82 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.346 0.658 . . . . 0.0 112.276 -163.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 69.78 -75.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.813 2.045 . . . . 0.0 112.554 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.29 -29.63 67.55 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.878 -1.138 . . . . 0.0 113.662 -167.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -81.55 0.75 36.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-30 -102.7 -17.57 15.58 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.704 2.001 . . . . 0.0 111.912 169.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -89.42 159.37 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.597 1.959 . . . . 0.0 112.18 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 -4.64 65.28 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.069 1.319 . . . . 0.0 114.873 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -140.06 -178.06 5.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.437 1.895 . . . . 0.0 111.882 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 164.01 21.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 109.75 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 t -156.79 144.54 19.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.942 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.11 128.85 45.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.11 1.364 . . . . 0.0 110.468 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -140.88 171.4 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 130.61 33.02 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.401 -0.812 . . . . 0.0 112.121 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.9 133.66 47.63 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.557 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -117.07 102.93 9.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.264 1.426 . . . . 0.0 109.245 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.17 160.67 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.98 0.895 . . . . 0.0 111.691 -176.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.2 pt -101.69 122.35 47.91 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.809 1.644 . . . . 0.0 109.857 167.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 126.01 19.5 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.153 2.569 . . . . 0.0 110.88 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.3 m -118.71 -30.95 4.98 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.211 1.404 . . . . 0.0 111.967 -172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.75 -36.78 4.05 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 125.189 1.376 . . . . 0.0 113.716 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -71.48 -32.57 68.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.115 0.966 . . . . 0.0 110.527 161.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.05 -155.94 11.09 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 127.783 2.611 . . . . 0.0 110.897 172.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.43 163.61 13.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.205 1.003 . . . . 0.0 109.74 154.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.3 146.98 51.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 110.879 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.21 111.88 2.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.339 0.518 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.67 -46.78 3.11 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.304 1.43 . . . . 0.0 110.808 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.1 m -155.3 153.54 30.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.722 1.209 . . . . 0.0 111.452 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.25 132.16 45.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.618 1.167 . . . . 0.0 109.631 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 m -115.8 129.24 56.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.661 1.984 . . . . 0.0 107.494 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.79 136.49 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.397 0.999 . . . . 0.0 109.121 167.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.27 -49.7 3.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 119.083 -0.484 . . . . 0.0 109.996 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -171.39 170.3 5.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.32 1.848 . . . . 0.0 111.933 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.74 -175.32 32.11 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 124.731 1.158 . . . . 0.0 113.334 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.19 113.39 22.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 m -57.66 -20.19 31.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -155.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -54.32 -30.06 49.95 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 112.972 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.65 -50.59 7.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.202 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 m -45.09 -48.49 11.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.93 1.241 . . . . 0.0 113.604 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -29.29 69.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.427 1.091 . . . . 0.0 113.714 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.86 -52.05 5.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.403 1.481 . . . . 0.0 112.526 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.4 t -56.68 -48.3 77.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.057 0.943 . . . . 0.0 110.739 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -49.33 -47.28 47.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.589 1.556 . . . . 0.0 111.277 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -70.0 -44.48 69.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.809 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.443 1.019 . . . . 0.0 111.884 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -66.77 -23.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.599 -1.313 . . . . 0.0 111.556 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.88 -4.33 54.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.075 0.95 . . . . 0.0 112.735 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.06 -11.84 2.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.494 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.0 m -58.34 149.41 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.577 1.081 . . . . 0.0 112.584 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -71.96 -46.27 58.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.4 p 170.29 144.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.708 2.003 . . . . 0.0 111.891 -173.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.6 m-85 -99.74 110.44 58.96 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 110.184 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.98 131.11 10.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.381 2.054 . . . . 0.0 111.073 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.63 143.44 78.84 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.734 1.213 . . . . 0.0 112.324 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 -45.72 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.233 2.622 . . . . 0.0 111.24 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -126.63 154.53 43.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.722 2.009 . . . . 0.0 111.028 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -119.5 13.26 12.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 114.338 -161.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -80.35 143.45 55.92 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 120.814 -1.179 . . . . 0.0 109.741 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.61 -1.74 3.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.641 2.894 . . . . 0.0 114.159 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.2 -43.95 12.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.53 1.059 . . . . 0.0 111.652 167.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.84 -23.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.359 1.063 . . . . 0.0 112.902 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.76 -26.68 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.99 0.916 . . . . 0.0 110.468 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.2 -4.41 59.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.114 0.965 . . . . 0.0 113.506 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -96.02 -53.21 3.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.569 1.077 . . . . 0.0 111.296 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.8 pp -62.47 -25.55 68.05 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.242 1.417 . . . . 0.0 113.009 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.42 -24.94 63.9 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.427 -1.421 . . . . 0.0 113.472 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -125.41 83.81 2.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.4 1.48 . . . . 0.0 110.76 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.63 156.19 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.948 1.299 . . . . 0.0 112.193 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.54 136.31 33.33 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 154.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.76 116.03 26.73 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 154.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -134.56 128.17 32.73 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 109.5 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.95 159.28 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.865 1.666 . . . . 0.0 110.889 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.108 0 C-N-CA 126.072 1.749 . . . . 0.0 111.401 -176.888 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 . . . . . 0 N--CA 1.468 0.465 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.68 -42.13 67.63 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.081 2.152 . . . . 0.0 114.12 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.99 -17.3 59.67 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.68 1.61 . . . . 0.0 114.16 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.93 -31.26 56.52 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.706 1.253 . . . . 0.0 112.615 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -59.79 -26.87 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 111.969 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.01 -59.11 2.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.609 1.164 . . . . 0.0 110.176 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.746 1.219 . . . . 0.0 112.46 -172.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.81 -42.89 69.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.487 1.115 . . . . 0.0 110.239 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.86 -29.88 69.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.798 0.726 . . . . 0.0 111.947 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.52 -52.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -17.74 63.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -55.26 -34.38 63.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.811 0.444 . . . . 0.0 111.648 165.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.433 HD21 HG12 ' A' ' 96' ' ' VAL . 68.0 m-80 -79.19 -33.4 43.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 81.2 1.87 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.004 1.321 . . . . 0.0 109.166 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.59 43.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.011 1.324 . . . . 0.0 112.829 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -78.25 -57.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.238 1.415 . . . . 0.0 111.802 -165.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 72.03 -50.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.954 2.501 . . . . 0.0 113.152 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.9 -32.62 73.93 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 113.728 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 m -89.9 0.35 57.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -111.8 -23.76 10.41 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.019 1.728 . . . . 0.0 112.267 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.52 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 112.804 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.16 -11.23 30.63 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.391 1.472 . . . . 0.0 114.925 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -170.2 2.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.053 2.141 . . . . 0.0 111.065 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.41 162.96 26.86 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.597 176.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.425 ' HB3' HD23 ' A' ' 85' ' ' LEU . 52.6 t -156.23 144.59 19.91 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 109.839 168.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.73 129.95 49.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.118 1.367 . . . . 0.0 110.648 165.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -142.8 170.19 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.905 1.282 . . . . 0.0 107.824 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -134.6 130.64 36.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.569 0.748 . . . . 0.0 111.66 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.6 132.43 47.26 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.225 1.01 . . . . 0.0 110.316 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.47 102.22 9.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.191 1.396 . . . . 0.0 108.903 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.25 159.84 14.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.26 1.029 . . . . 0.0 111.565 -178.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.7 pt -103.87 146.6 32.83 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 126.111 1.764 . . . . 0.0 109.837 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.14 133.29 17.76 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 110.525 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -3.37 16.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.019 1.328 . . . . 0.0 113.121 175.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 -55.44 1.0 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 126.292 1.901 . . . . 0.0 112.441 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.6 p -79.94 -24.28 41.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.775 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.75 -159.11 10.11 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.086 1.803 . . . . 0.0 111.686 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -108.74 164.94 11.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.87 0.868 . . . . 0.0 110.871 164.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.73 145.3 49.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.592 1.957 . . . . 0.0 110.787 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.27 112.49 1.95 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.075 0.852 . . . . 0.0 112.135 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.72 -36.15 4.89 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.432 1.492 . . . . 0.0 112.034 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -164.83 154.44 13.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.408 1.483 . . . . 0.0 111.533 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -130.61 126.74 37.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.274 1.03 . . . . 0.0 109.791 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.8 m -110.62 118.73 37.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.946 1.698 . . . . 0.0 107.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.25 134.32 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.185 0.902 . . . . 0.0 109.632 170.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 mt -107.09 -49.21 3.32 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.997 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -173.38 166.24 4.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.65 1.58 . . . . 0.0 111.618 172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.76 -177.44 35.37 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 125.164 1.364 . . . . 0.0 114.011 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.31 116.69 21.92 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -56.28 -25.36 48.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -151.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -51.25 -38.18 51.23 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.917 1.287 . . . . 0.0 112.666 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 58' ' ' CYS . 15.3 tp -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.053 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.99 -28.66 67.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.5 1.5 . . . . 0.0 114.138 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 -44.26 69.16 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.895 0.77 . . . . 0.0 112.666 170.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.13 -54.61 12.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.66 1.184 . . . . 0.0 113.549 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.7 t -54.67 -48.52 72.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.506 0.723 . . . . 0.0 110.514 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -52.13 -45.75 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.658 1.583 . . . . 0.0 112.048 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.6 mtp-105 -63.81 -42.32 97.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.121 0.568 . . . . 0.0 112.019 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.81 74.76 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 89' ' ' THR . 1.9 t -62.83 -25.08 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.253 -1.529 . . . . 0.0 112.383 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.2 -7.7 57.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.728 0.811 . . . . 0.0 112.804 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -132.31 -12.74 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.8 m -58.09 146.68 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.415 1.086 . . . . 0.0 112.681 173.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -68.74 -41.98 78.2 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 p 163.41 139.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.448 2.299 . . . . 0.0 110.96 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 39.7 m-85 -91.95 113.03 57.67 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.154 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.26 118.82 5.07 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.249 1.966 . . . . 0.0 109.926 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 101' ' ' LEU . 1.9 pp -93.17 140.28 23.27 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.909 1.284 . . . . 0.0 112.047 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.06 -31.2 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.271 2.647 . . . . 0.0 113.463 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.76 146.45 49.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.584 1.554 . . . . 0.0 110.049 176.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -102.78 8.13 39.44 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -166.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.02 136.33 57.89 Favored Pre-proline 0 C--O 1.241 0.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.366 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.61 -5.11 8.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.807 2.338 . . . . 0.0 113.465 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.32 -35.93 21.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.965 0.802 . . . . 0.0 112.063 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.18 -27.72 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.25 1.02 . . . . 0.0 112.814 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -57.26 -27.1 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.705 0.802 . . . . 0.0 110.874 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 30.4 mm-40 -82.07 -6.64 59.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.075 1.35 . . . . 0.0 114.094 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -92.54 -55.71 3.29 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.365 -0.834 . . . . 0.0 111.314 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.99 -27.62 65.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.885 1.274 . . . . 0.0 112.991 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 ptmt -67.68 -23.07 65.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.063 -1.648 . . . . 0.0 114.048 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -122.68 86.28 2.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.45 1.1 . . . . 0.0 110.877 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -109.11 151.55 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.615 1.166 . . . . 0.0 111.978 175.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.72 129.52 36.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 154.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -86.03 111.77 20.61 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.7 m -131.8 126.32 34.07 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.06 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.89 151.83 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.996 0 C-N-CA 126.486 1.914 . . . . 0.0 110.641 -178.752 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 77.19 -44.13 0.44 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.714 2.806 . . . . 0.0 113.766 166.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 77.07 5.61 3.24 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.416 2.286 . . . . 0.0 114.363 164.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -93.67 -20.71 19.91 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.501 0.721 . . . . 0.0 112.809 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.21 -23.07 0.34 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.626 1.57 . . . . 0.0 113.634 -166.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -55.84 -13.57 1.87 Allowed 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -169.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -52.64 -29.05 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.949 0.9 . . . . 0.0 112.399 168.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 t -65.86 -24.89 66.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.924 1.29 . . . . 0.0 114.346 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.4 m -88.37 -31.53 18.83 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.522 0.729 . . . . 0.0 111.714 171.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -69.83 -33.79 72.79 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 118.575 -0.726 . . . . 0.0 111.404 173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -68.55 -25.61 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 120.293 1.406 . . . . 0.0 111.231 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.97 -14.05 70.25 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.22 1.867 . . . . 0.0 113.915 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -99.58 -55.77 2.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.194 1.497 . . . . 0.0 112.19 164.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.86 -46.43 67.87 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 127.344 2.258 . . . . 0.0 113.395 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.48 -17.39 64.32 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.423 1.487 . . . . 0.0 113.97 174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.39 -32.87 64.7 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.362 1.081 . . . . 0.0 111.993 178.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.5 pt -60.56 -28.18 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.735 0.698 . . . . 0.0 111.919 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -80.59 -58.89 2.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.359 1.064 . . . . 0.0 109.58 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.638 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -60.52 -35.4 75.87 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.75 1.22 . . . . 0.0 112.645 -172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -73.56 -32.38 64.14 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.459 1.104 . . . . 0.0 111.603 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -73.71 -32.65 64.01 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.871 0.759 . . . . 0.0 111.681 173.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.83 -56.46 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -65.2 -21.46 66.76 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.26 -9.26 59.15 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 175.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.72 -41.76 23.06 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.4 1.0 . . . . 0.0 111.374 163.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.99 86.39 2.43 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.232 1.413 . . . . 0.0 109.57 -173.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.76 39.95 0.14 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 126.052 1.741 . . . . 0.0 113.971 -173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.2 t -77.05 -60.01 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.957 0.903 . . . . 0.0 111.82 -166.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 72.73 -53.15 0.7 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 127.781 2.433 . . . . 0.0 114.148 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.47 -32.6 74.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.747 1.219 . . . . 0.0 113.418 -171.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.8 p -96.6 5.64 50.34 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.093 1.357 . . . . 0.0 113.335 172.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -101.55 -27.4 13.12 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.232 1.813 . . . . 0.0 111.382 172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -93.66 173.41 7.7 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.662 1.985 . . . . 0.0 112.657 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.66 -32.35 1.9 Allowed Glycine 0 N--CA 1.481 1.649 0 C-N-CA 125.811 1.672 . . . . 0.0 114.795 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -167.38 1.47 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.119 2.168 . . . . 0.0 110.675 165.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 158.63 38.03 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.28 -0.888 . . . . 0.0 110.442 176.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -156.46 150.16 24.79 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.612 1.165 . . . . 0.0 110.171 173.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.99 118.8 10.53 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 125.861 1.664 . . . . 0.0 110.589 174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.38 171.05 14.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 124.413 1.085 . . . . 0.0 108.301 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.91 124.15 14.59 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 123.658 0.783 . . . . 0.0 110.402 -166.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.62 128.78 52.75 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.93 0.892 . . . . 0.0 109.074 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.3 mtmt -117.6 105.9 12.55 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.379 1.472 . . . . 0.0 109.186 171.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.04 160.66 14.14 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.397 1.079 . . . . 0.0 111.397 -175.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 pt -101.71 152.87 38.18 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 125.758 1.623 . . . . 0.0 110.2 167.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.73 151.76 46.73 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.175 2.583 . . . . 0.0 111.183 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -168.36 148.66 4.73 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.584 2.354 . . . . 0.0 108.273 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.47 -19.63 74.7 Favored Glycine 0 N--CA 1.477 1.402 0 N-CA-C 115.471 0.949 . . . . 0.0 115.471 -164.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 56.2 p -96.56 -6.06 37.79 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.579 1.552 . . . . 0.0 113.15 176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.83 165.83 10.4 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.713 1.625 . . . . 0.0 111.598 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -65.64 161.4 20.55 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 117.959 0.879 . . . . 0.0 111.014 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.76 143.35 50.77 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.223 1.409 . . . . 0.0 111.159 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.3 109.59 0.9 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.88 -45.3 3.66 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.462 1.506 . . . . 0.0 110.938 171.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.4 m -156.06 146.33 21.58 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.344 1.058 . . . . 0.0 110.299 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.21 124.94 41.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.067 0.947 . . . . 0.0 109.927 171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.9 m -104.77 121.49 43.73 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.006 1.323 . . . . 0.0 108.279 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.7 m -88.61 126.61 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 165.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.57 -40.44 6.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.048 0.539 . . . . 0.0 110.783 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -170.79 172.74 5.56 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.765 1.626 . . . . 0.0 111.462 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.57 172.33 17.57 Favored Glycine 0 N--CA 1.465 0.587 0 C-N-CA 125.981 1.753 . . . . 0.0 114.128 169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -76.81 122.04 24.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 167.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.1 p -56.37 -27.42 56.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -157.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 49.9 tpt85 -56.68 -25.36 53.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.617 1.167 . . . . 0.0 113.865 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.7 tp -91.34 -59.57 2.11 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 120.066 1.303 . . . . 0.0 112.377 173.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.4 p -56.88 -31.79 65.19 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 121.137 1.789 . . . . 0.0 114.861 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.2 -39.2 71.93 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.439 1.018 . . . . 0.0 112.658 172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.37 -53.4 12.42 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.917 1.287 . . . . 0.0 112.006 -177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.588 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.5 t -54.55 -50.36 68.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.245 1.018 . . . . 0.0 110.608 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -51.14 -47.49 62.03 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.847 1.659 . . . . 0.0 111.755 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -63.98 -40.63 96.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.595 0.758 . . . . 0.0 112.277 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.66 82.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.275 1.43 . . . . 0.0 112.453 172.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -63.01 -26.81 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 120.568 -1.332 . . . . 0.0 112.15 178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.07 -6.05 55.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.915 0.886 . . . . 0.0 112.991 177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.54 -10.56 3.18 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.116 1.154 . . . . 0.0 114.116 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.3 m -52.1 150.19 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -69.23 -50.13 49.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.017 0.927 . . . . 0.0 112.581 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.7 p 168.67 147.24 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 128.459 2.704 . . . . 0.0 110.387 -173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.733 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -97.51 106.3 31.81 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.234 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.91 116.93 4.33 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.716 1.611 . . . . 0.0 110.647 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.23 142.43 28.48 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.043 1.337 . . . . 0.0 110.722 173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -75.86 -24.17 11.75 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.34 2.693 . . . . 0.0 112.586 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.3 -179.93 6.22 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.39 1.476 . . . . 0.0 112.44 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -155.86 15.32 0.35 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.472 1.109 . . . . 0.0 113.086 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -97.28 129.09 32.85 Favored Pre-proline 0 C--O 1.241 0.633 0 O-C-N 120.637 -1.289 . . . . 0.0 108.967 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.64 -4.09 0.5 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 124.559 3.506 . . . . 0.0 115.801 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -83.51 -43.39 15.81 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.833 1.197 . . . . 0.0 112.141 170.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -98.12 -22.52 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.603 1.161 . . . . 0.0 112.609 -173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.3 t -55.2 -27.12 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.956 0.902 . . . . 0.0 110.903 166.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.65 -7.59 59.18 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.032 1.333 . . . . 0.0 113.81 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.09 -45.69 6.14 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.046 -1.034 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -72.65 -23.19 60.87 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.998 0.919 . . . . 0.0 111.823 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -65.97 -22.12 66.45 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -125.52 79.34 1.81 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 121.211 -0.93 . . . . 0.0 110.118 -174.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.605 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -102.19 158.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.48 1.112 . . . . 0.0 111.776 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -112.39 123.62 50.67 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 159.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.7 mt -86.24 111.28 20.27 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 166.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.8 m -134.21 125.66 28.28 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.79 1.236 . . . . 0.0 108.931 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 m -137.76 149.88 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.727 1.611 . . . . 0.0 110.631 -168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.01 165.0 5.99 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 126.658 1.983 . . . . 0.0 111.201 -178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -63.13 154.47 67.3 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.574 2.85 . . . . 0.0 112.781 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 125.11 1.364 . . . . 0.0 111.184 178.642 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.44 165.0 12.77 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.497 1.119 . . . . 0.0 111.371 -166.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 -156.58 19.11 0.33 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.389 1.476 . . . . 0.0 113.336 -167.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 -99.11 -20.76 16.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.384 1.473 . . . . 0.0 112.076 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.7 -17.21 0.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.052 1.741 . . . . 0.0 112.7 -171.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.03 5.41 0.14 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.107 2.163 . . . . 0.0 116.035 -173.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -57.18 -29.79 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.806 1.242 . . . . 0.0 112.661 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -57.97 -48.41 80.06 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.068 0.947 . . . . 0.0 111.878 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.3 m -63.29 -30.79 71.87 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.461 1.104 . . . . 0.0 112.159 175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -72.03 -19.69 61.8 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.908 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.7 t -59.37 -31.44 46.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 121.643 2.02 . . . . 0.0 111.027 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.07 -9.29 66.54 Favored Glycine 0 CA--C 1.534 1.27 0 CA-C-O 118.679 -1.067 . . . . 0.0 114.44 175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -105.2 -46.41 4.25 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.287 1.435 . . . . 0.0 110.943 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -52.74 -43.09 65.49 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.431 1.892 . . . . 0.0 113.509 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.51 -18.56 68.28 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 124.841 1.21 . . . . 0.0 114.011 173.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.607 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.59 -35.07 70.42 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.991 0.916 . . . . 0.0 111.366 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -59.6 -28.44 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 121.545 -0.722 . . . . 0.0 112.122 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -80.36 -58.86 2.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.968 1.307 . . . . 0.0 109.547 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.607 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.51 -35.53 74.33 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.553 1.141 . . . . 0.0 112.695 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -74.45 -30.27 61.8 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.726 1.21 . . . . 0.0 111.781 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.7 tp -75.47 -34.49 60.9 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.531 1.059 . . . . 0.0 111.479 173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.53 -44.44 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.295 1.038 . . . . 0.0 111.058 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.7 ppt_? -72.95 -14.37 61.44 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.884 0.874 . . . . 0.0 113.164 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -55.52 -35.53 65.73 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 122.268 0.227 . . . . 0.0 111.137 164.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.404 HD21 HG12 ' A' ' 96' ' ' VAL . 64.2 m-80 -81.7 -30.71 32.47 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.875 0.369 . . . . 0.0 111.538 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD22 ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -143.95 81.22 1.68 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.418 1.487 . . . . 0.0 109.531 -172.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.48 38.09 0.18 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.413 1.485 . . . . 0.0 113.786 -176.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.8 t -77.31 -51.59 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.97 0.908 . . . . 0.0 112.892 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 70.82 -59.01 0.55 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.779 2.432 . . . . 0.0 113.71 174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -66.06 -34.34 77.84 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.076 -1.015 . . . . 0.0 113.464 -167.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -87.8 -1.32 57.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.972 1.309 . . . . 0.0 113.612 173.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -100.4 -24.4 14.51 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.774 1.629 . . . . 0.0 111.702 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -91.32 172.51 8.48 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 127.372 2.269 . . . . 0.0 111.373 172.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.47 -34.02 2.04 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -168.64 1.59 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.573 1.949 . . . . 0.0 110.748 166.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 160.6 32.75 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.31 -0.869 . . . . 0.0 110.703 176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.429 ' HB3' HD23 ' A' ' 85' ' ' LEU . 44.6 t -157.46 149.02 21.98 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.506 1.122 . . . . 0.0 110.171 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.77 122.82 20.28 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.989 1.716 . . . . 0.0 110.368 167.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 m -139.54 163.11 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.591 1.156 . . . . 0.0 108.005 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.34 130.69 39.17 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.343 0.657 . . . . 0.0 112.128 -174.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.44 129.76 46.44 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.405 1.082 . . . . 0.0 110.084 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -113.47 103.82 11.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.424 1.489 . . . . 0.0 108.774 174.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.29 158.41 15.72 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.533 0.683 . . . . 0.0 111.757 -177.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.16 140.09 21.0 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 125.43 1.492 . . . . 0.0 109.861 168.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.85 125.42 9.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.436 2.091 . . . . 0.0 109.833 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.2 m -110.81 -31.0 7.32 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.695 1.198 . . . . 0.0 111.871 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.62 -117.04 0.7 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 125.191 1.377 . . . . 0.0 110.756 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 p -66.7 -4.98 10.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.393 1.477 . . . . 0.0 113.871 168.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -144.47 174.04 24.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.434 1.492 . . . . 0.0 114.27 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -104.57 163.87 12.16 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.422 1.489 . . . . 0.0 111.717 171.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.78 147.15 50.76 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.435 1.894 . . . . 0.0 111.4 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.94 111.61 1.55 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 118.52 0.6 . . . . 0.0 112.133 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.36 -45.78 3.69 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 125.406 1.479 . . . . 0.0 111.15 171.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.4 m -157.33 152.86 26.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.747 1.219 . . . . 0.0 110.463 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.5 tt -128.98 126.93 40.65 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.218 1.007 . . . . 0.0 110.214 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.7 m -106.8 120.87 43.18 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.638 1.975 . . . . 0.0 107.938 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.7 m -87.57 127.11 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 CA-C-N 119.2 0.909 . . . . 0.0 108.779 166.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.29 -39.42 6.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.265 0.626 . . . . 0.0 110.896 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -170.25 168.83 8.0 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.414 1.486 . . . . 0.0 111.849 171.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.8 173.84 19.9 Favored Glycine 0 N--CA 1.463 0.464 0 C-N-CA 125.283 1.421 . . . . 0.0 114.753 168.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -79.62 117.85 20.92 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 166.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 62.7 p -59.15 -19.76 47.77 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.297 1.591 . . . . 0.0 115.297 -159.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -55.85 -29.96 60.7 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.906 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 58' ' ' CYS . 18.0 tp -86.53 -52.31 5.64 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.84 1.2 . . . . 0.0 111.444 171.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.9 m -46.64 -46.8 20.09 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.741 1.155 . . . . 0.0 113.635 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.86 -42.3 67.05 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.009 0.822 . . . . 0.0 112.041 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' HB1' HD22 ' A' ' 47' ' ' LEU . . . -61.69 -58.74 6.85 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.512 1.125 . . . . 0.0 112.531 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.64 -50.41 73.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.864 0.466 . . . . 0.0 110.168 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -51.74 -47.54 64.01 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.227 1.411 . . . . 0.0 111.876 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -64.02 -40.61 96.7 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.228 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.4 -49.3 74.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.763 1.225 . . . . 0.0 112.203 173.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -64.32 -24.06 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 O-C-N 120.633 -1.292 . . . . 0.0 111.723 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.78 -7.13 57.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.796 0.838 . . . . 0.0 112.66 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -134.05 -12.74 2.5 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.0 m -58.45 146.56 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.231 1.013 . . . . 0.0 112.628 173.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -66.52 -46.05 77.45 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -174.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.7 p 167.6 141.47 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.854 2.062 . . . . 0.0 111.0 -168.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 29.4 m-85 -96.24 109.38 47.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 117.669 -1.158 . . . . 0.0 109.666 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.05 132.0 14.86 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.424 2.083 . . . . 0.0 109.969 -176.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.9 mt -78.99 145.94 66.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 119.208 -0.425 . . . . 0.0 111.667 -173.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.66 -28.79 7.82 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.095 2.53 . . . . 0.0 111.181 173.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -140.42 150.58 44.03 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.925 2.09 . . . . 0.0 110.621 173.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -119.88 23.03 11.28 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.928 1.291 . . . . 0.0 112.888 -164.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -85.86 142.13 36.39 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.584 -1.323 . . . . 0.0 109.946 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -63.09 -4.57 6.44 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.484 2.789 . . . . 0.0 113.796 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -87.38 -33.44 19.13 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.597 1.159 . . . . 0.0 111.98 170.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 m -98.03 -24.06 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.202 1.001 . . . . 0.0 112.23 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.1 t -54.55 -25.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.23 1.012 . . . . 0.0 111.362 167.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -84.13 -7.36 59.39 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.978 1.311 . . . . 0.0 114.323 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 -46.52 5.17 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.905 0.882 . . . . 0.0 111.23 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.0 pp -74.42 -20.33 60.08 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.571 1.548 . . . . 0.0 113.205 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -63.56 -23.9 67.58 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.699 -1.25 . . . . 0.0 113.354 176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.34 80.09 1.92 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.985 1.314 . . . . 0.0 109.933 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -106.39 150.95 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.206 1.002 . . . . 0.0 111.828 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.82 130.57 44.07 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 160.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 74.5 mt -89.84 111.95 23.13 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 156.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.0 m -134.6 126.45 29.25 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.704 1.202 . . . . 0.0 109.254 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.1 m -138.78 151.71 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.377 1.471 . . . . 0.0 110.495 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -170.06 165.08 5.91 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.26 1.824 . . . . 0.0 111.583 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -63.54 166.14 16.21 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.737 2.958 . . . . 0.0 112.331 171.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 . . . . . 0 N--CA 1.472 0.674 0 C-N-CA 123.679 0.791 . . . . 0.0 111.938 -178.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -170.38 167.34 8.36 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.954 1.302 . . . . 0.0 111.537 -172.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.8 ptt85 -166.64 19.9 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.323 1.849 . . . . 0.0 113.187 -168.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -105.37 -20.37 13.51 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 0.0 112.704 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.93 -9.19 0.53 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.146 1.379 . . . . 0.0 114.083 -166.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -72.43 1.33 8.15 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 116.132 1.901 . . . . 0.0 116.132 -157.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 m -54.82 -33.88 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.167 0.987 . . . . 0.0 112.044 173.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -59.25 -38.21 79.49 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.951 0.9 . . . . 0.0 112.584 172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 t -78.23 -23.57 47.34 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.188 -0.945 . . . . 0.0 113.005 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -72.08 -33.95 68.29 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.327 -0.858 . . . . 0.0 111.981 165.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 45.4 t -66.6 -27.62 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 120.351 1.432 . . . . 0.0 110.712 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.85 1.44 30.96 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.196 1.379 . . . . 0.0 114.638 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.9 mtt180 -132.59 -64.79 0.74 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.714 1.606 . . . . 0.0 111.438 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -59.58 -18.55 41.94 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 128.027 2.531 . . . . 0.0 116.219 -168.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -115.66 -13.13 8.94 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.138 1.827 . . . . 0.0 113.945 167.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.37 -32.18 43.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.034 1.734 . . . . 0.0 110.755 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.8 pt -62.0 -28.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 120.186 -1.571 . . . . 0.0 112.15 176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -78.75 -56.97 4.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.513 1.125 . . . . 0.0 110.098 176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.83 -35.03 72.24 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.364 1.066 . . . . 0.0 112.641 -176.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -70.31 -31.21 68.43 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.472 1.509 . . . . 0.0 112.307 178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.0 tp -79.96 -35.24 37.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.605 0.362 . . . . 0.0 111.824 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -68.22 -53.11 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 120.921 -1.112 . . . . 0.0 110.777 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -59.06 -26.87 64.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.493 0.717 . . . . 0.0 112.289 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -15.16 60.05 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.419 HD21 HG12 ' A' ' 96' ' ' VAL . 56.7 m-80 -81.43 -40.1 23.89 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.039 0.836 . . . . 0.0 111.718 161.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.1 mt -94.2 88.07 5.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 123.383 1.563 . . . . 0.0 111.607 -163.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.97 27.02 0.4 Allowed 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.863 -1.517 . . . . 0.0 114.121 -175.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 t -88.45 -56.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.741 0.816 . . . . 0.0 112.563 -163.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.3 -57.59 0.63 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 128.001 2.521 . . . . 0.0 113.757 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -70.85 -24.13 62.46 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.423 1.089 . . . . 0.0 112.937 -174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 60.6 m -84.06 -1.27 54.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.608 1.163 . . . . 0.0 113.623 172.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.452 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-85 -117.5 -21.17 8.73 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.526 1.53 . . . . 0.0 113.179 -175.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -85.44 152.1 23.47 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.315 1.846 . . . . 0.0 112.713 -178.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 -8.49 28.3 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.365 1.459 . . . . 0.0 116.126 168.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.4 -179.55 4.37 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.149 1.779 . . . . 0.0 112.052 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.45 160.92 20.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.652 0.781 . . . . 0.0 111.29 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 49.0 t -159.51 144.19 15.29 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.449 1.1 . . . . 0.0 109.877 172.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.83 127.29 39.97 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.846 2.059 . . . . 0.0 110.031 168.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 m -142.25 175.08 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.277 1.031 . . . . 0.0 108.568 171.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.08 126.76 20.45 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.941 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.75 128.75 53.89 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.128 0.971 . . . . 0.0 109.007 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm -116.69 106.92 14.05 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.96 1.304 . . . . 0.0 109.117 170.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.28 157.77 16.16 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.605 1.162 . . . . 0.0 111.772 -176.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 15.3 pt -97.86 151.19 37.45 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 125.723 1.609 . . . . 0.0 110.154 167.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -72.52 150.42 51.47 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.847 2.365 . . . . 0.0 111.137 175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -166.47 148.17 6.52 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.487 2.315 . . . . 0.0 108.062 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.74 -17.66 71.42 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.776 1.071 . . . . 0.0 115.776 -165.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 46.3 p -97.14 -3.43 41.12 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.971 1.708 . . . . 0.0 113.127 176.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.26 165.42 11.45 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.161 1.363 . . . . 0.0 111.937 -167.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -67.58 161.28 26.0 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 118.366 1.083 . . . . 0.0 111.115 -177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.21 144.58 51.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.424 1.49 . . . . 0.0 111.127 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.65 112.2 1.91 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.427 0.558 . . . . 0.0 112.04 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.1 -46.11 3.16 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.026 1.298 . . . . 0.0 111.012 170.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.7 m -153.03 143.69 22.74 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.368 1.067 . . . . 0.0 110.682 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -119.21 121.86 40.65 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.473 0.709 . . . . 0.0 109.258 168.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -104.8 118.31 36.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.405 1.482 . . . . 0.0 108.26 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 m -83.97 129.05 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 118.892 0.769 . . . . 0.0 109.732 170.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.0 mt -99.18 -54.32 3.0 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.708 -0.663 . . . . 0.0 110.009 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -177.87 164.8 1.96 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 126.721 2.008 . . . . 0.0 111.433 172.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.25 -173.71 39.44 Favored Glycine 0 N--CA 1.463 0.455 0 C-N-CA 125.57 1.557 . . . . 0.0 113.528 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.99 116.92 21.18 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 165.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 98.4 p -55.9 -26.31 46.83 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -150.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -60.83 -29.44 69.49 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.7 tp -78.93 -47.37 16.54 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 119.722 1.147 . . . . 0.0 111.107 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 68.8 m -48.56 -45.07 37.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.632 1.106 . . . . 0.0 112.359 168.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.25 -47.93 75.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.628 1.171 . . . . 0.0 112.177 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.6 -50.79 41.12 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.058 0.943 . . . . 0.0 113.266 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.637 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -56.8 -48.49 77.83 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.809 0.844 . . . . 0.0 110.845 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm -48.71 -44.12 37.9 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 126.303 1.841 . . . . 0.0 111.953 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.1 mmm-85 -70.57 -45.92 64.48 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.25 74.48 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.701 1.2 . . . . 0.0 111.161 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -67.08 -22.71 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.996 -1.065 . . . . 0.0 112.268 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -7.44 59.1 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.001 0.92 . . . . 0.0 112.538 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.18 -12.54 3.58 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.6 m -56.52 145.56 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 124.485 1.114 . . . . 0.0 112.783 171.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.7 -44.68 77.13 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.0 p 165.59 142.47 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 127.214 2.205 . . . . 0.0 110.848 -169.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.0 m-85 -93.21 111.27 51.13 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.693 -176.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -76.18 128.85 10.85 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.217 1.945 . . . . 0.0 110.567 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -84.34 148.36 52.5 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.577 0.751 . . . . 0.0 112.118 -170.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.06 -33.35 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.92 2.414 . . . . 0.0 111.075 171.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 153.78 45.34 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.161 2.184 . . . . 0.0 110.358 174.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -119.87 20.2 12.26 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.318 1.447 . . . . 0.0 113.406 -166.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -83.2 139.8 42.25 Favored Pre-proline 0 CA--C 1.542 0.663 0 O-C-N 120.757 -1.214 . . . . 0.0 109.3 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.66 -15.74 3.13 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.461 2.774 . . . . 0.0 114.945 171.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -81.15 -28.62 35.0 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.973 1.309 . . . . 0.0 112.077 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -104.68 -26.46 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.582 1.553 . . . . 0.0 112.5 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.0 t -55.37 -26.27 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.49 1.116 . . . . 0.0 110.959 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -80.41 -11.49 59.68 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.233 1.413 . . . . 0.0 113.714 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -97.51 -46.52 6.01 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 118.914 0.779 . . . . 0.0 111.241 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.1 pp -73.07 -22.52 60.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.796 1.238 . . . . 0.0 112.92 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -66.38 -23.93 66.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -129.07 82.35 2.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.006 0.923 . . . . 0.0 110.238 -175.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.2 158.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 122.36 1.076 . . . . 0.0 111.968 178.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -108.06 126.09 52.33 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 157.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.6 mt -85.59 112.47 21.0 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 165.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 93.5 m -132.1 125.84 32.31 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.735 1.214 . . . . 0.0 109.054 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -134.24 149.99 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.251 1.82 . . . . 0.0 110.293 -172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.89 156.63 8.58 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 125.551 1.54 . . . . 0.0 112.197 -176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 164.17 36.33 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.913 3.075 . . . . 0.0 111.517 173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.244 0.799 0 C-N-CA 123.86 0.864 . . . . 0.0 111.68 177.904 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.393 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -165.29 -67.42 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.11 0.964 . . . . 0.0 111.525 -168.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 72.53 12.68 5.49 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 126.751 2.021 . . . . 0.0 114.101 171.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -94.42 -19.36 20.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.953 0.901 . . . . 0.0 113.118 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.95 -22.79 0.45 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.829 1.251 . . . . 0.0 113.966 -166.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -58.68 -16.97 18.74 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -166.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.8 m -56.26 -28.88 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.91 1.284 . . . . 0.0 112.806 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.5 t -58.23 -33.02 68.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.262 1.025 . . . . 0.0 112.965 171.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.2 m -80.96 -27.04 36.17 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 121.314 -0.867 . . . . 0.0 113.11 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -67.95 -34.99 77.63 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.338 0.972 . . . . 0.0 111.023 165.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.0 -28.25 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 119.889 1.222 . . . . 0.0 110.202 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.52 1.75 60.38 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 126.567 2.032 . . . . 0.0 114.07 171.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.4 ' O ' HG23 ' A' ' 38' ' ' ILE . 46.5 mtt180 -111.42 -57.93 2.18 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 118.917 1.358 . . . . 0.0 111.112 162.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -49.89 -47.62 51.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 127.161 2.184 . . . . 0.0 114.038 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.4 -16.14 62.87 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.052 1.31 . . . . 0.0 113.779 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.64 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.92 -34.5 64.37 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.251 1.026 . . . . 0.0 111.645 178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 34' ' ' ARG . 3.7 pt -60.03 -26.3 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 121.519 -0.738 . . . . 0.0 111.994 179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -82.08 -59.87 2.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.494 1.118 . . . . 0.0 109.837 174.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -61.17 -35.14 76.33 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.254 1.022 . . . . 0.0 112.775 -171.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -71.38 -43.02 67.66 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.165 0.986 . . . . 0.0 109.757 179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.8 tp -66.57 -30.33 70.6 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.672 0.669 . . . . 0.0 111.543 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.454 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -69.87 -54.0 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 123.844 0.858 . . . . 0.0 110.915 176.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -68.05 -18.07 64.58 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -55.85 -36.45 67.56 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.256 0.48 . . . . 0.0 111.389 167.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -77.51 -34.35 54.11 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.3 mt -102.35 109.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 122.542 1.163 . . . . 0.0 111.14 -160.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.65 22.03 10.51 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.214 -1.357 . . . . 0.0 114.628 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.9 t -80.8 -62.56 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.332 0.653 . . . . 0.0 111.545 -166.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 72.86 -60.04 0.55 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.769 2.428 . . . . 0.0 113.506 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.6 -29.77 70.98 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 120.611 -1.305 . . . . 0.0 113.14 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.6 m -94.8 6.07 50.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.31 1.044 . . . . 0.0 113.655 173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.4 m-30 -105.31 -21.94 13.14 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 112.085 173.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -100.64 156.3 17.39 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.596 1.958 . . . . 0.0 111.905 -175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.48 -27.27 2.89 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.274 1.416 . . . . 0.0 114.556 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -103.37 -174.68 2.6 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.494 1.918 . . . . 0.0 111.557 174.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.11 161.62 29.62 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.815 0.846 . . . . 0.0 110.643 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.95 157.87 43.6 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.553 0.741 . . . . 0.0 111.433 160.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.66 126.03 31.7 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.84 1.656 . . . . 0.0 109.967 161.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.94 166.33 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.15 131.29 36.64 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.508 0.594 . . . . 0.0 112.065 -174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -102.54 132.18 48.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.159 0.984 . . . . 0.0 110.037 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -114.4 105.98 13.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.341 1.456 . . . . 0.0 109.147 171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -100.2 158.81 15.59 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.56 0.695 . . . . 0.0 111.748 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -99.3 133.43 22.03 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.126 1.37 . . . . 0.0 109.843 167.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.06 116.73 4.83 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.581 2.187 . . . . 0.0 109.207 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.1 m -106.14 -30.85 8.99 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.546 1.139 . . . . 0.0 112.095 -172.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.24 -112.33 0.49 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 124.852 1.215 . . . . 0.0 111.76 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.4 m -58.71 -25.28 62.75 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.871 1.669 . . . . 0.0 112.34 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.76 179.04 20.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.757 1.17 . . . . 0.0 114.472 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -95.24 165.0 12.61 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.97 1.308 . . . . 0.0 111.515 170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -132.82 147.22 52.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.151 1.781 . . . . 0.0 111.47 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.94 111.23 1.4 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.764 0.711 . . . . 0.0 112.656 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.35 -36.04 5.53 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.396 1.474 . . . . 0.0 111.668 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -167.26 153.39 7.94 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.266 1.426 . . . . 0.0 111.023 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -130.14 126.29 37.14 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.319 1.048 . . . . 0.0 109.873 175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -105.17 132.98 50.71 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.402 1.881 . . . . 0.0 108.107 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -94.14 131.72 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.943 0.792 . . . . 0.0 109.102 164.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.5 mt -100.56 -45.19 5.61 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.947 0.499 . . . . 0.0 110.073 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -172.58 167.91 5.39 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.986 1.715 . . . . 0.0 111.647 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.7 -177.84 27.59 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.893 1.235 . . . . 0.0 114.303 170.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -85.4 118.22 24.8 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 166.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.8 p -59.94 -21.27 60.94 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -158.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.6 mmt-85 -60.88 -23.02 64.86 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.381 1.072 . . . . 0.0 113.669 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.2 tp -91.44 -49.06 6.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 119.812 1.187 . . . . 0.0 111.414 168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 40.8 m -49.99 -39.26 40.6 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.833 1.253 . . . . 0.0 114.322 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.38 -41.2 56.86 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.04 0.836 . . . . 0.0 112.829 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.82 -51.29 65.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.154 0.981 . . . . 0.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.4 t -57.46 -47.6 81.41 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.454 0.702 . . . . 0.0 110.235 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.0 ttmt -57.19 -35.15 69.24 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.371 1.068 . . . . 0.0 112.157 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -71.26 -48.52 50.53 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 -50.41 72.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.647 1.179 . . . . 0.0 111.749 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.1 -24.04 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 O-C-N 120.489 -1.382 . . . . 0.0 111.661 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.38 -6.94 58.83 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -130.91 -12.14 3.73 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.457 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.7 m -58.76 145.91 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.395 1.078 . . . . 0.0 112.257 173.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -67.41 -42.1 83.78 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -173.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.2 p 163.21 143.44 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.56 2.344 . . . . 0.0 111.048 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 20.3 m-85 -98.13 105.32 27.61 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-O 117.527 -1.225 . . . . 0.0 109.948 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.25 134.35 17.3 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.817 2.344 . . . . 0.0 110.437 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.0 mt -80.19 144.87 59.22 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-O 118.834 -0.603 . . . . 0.0 112.31 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.33 -28.67 8.45 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.241 2.627 . . . . 0.0 111.855 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -140.77 154.23 46.19 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.715 2.006 . . . . 0.0 110.482 173.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -133.49 48.1 2.41 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.175 0.99 . . . . 0.0 112.349 -165.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -108.9 141.2 22.84 Favored Pre-proline 0 C--O 1.243 0.733 0 O-C-N 121.35 -0.844 . . . . 0.0 108.802 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.17 -17.55 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.021 3.148 . . . . 0.0 115.182 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.76 -33.85 40.34 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.039 0.836 . . . . 0.0 112.335 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 m -97.26 -25.94 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.506 1.122 . . . . 0.0 112.611 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 55.9 t -54.33 -26.93 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.697 1.199 . . . . 0.0 110.951 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -81.38 -10.7 59.48 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.001 1.32 . . . . 0.0 114.031 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.77 -47.5 5.57 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 121.343 -0.848 . . . . 0.0 111.401 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.4 -21.07 61.32 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.671 1.188 . . . . 0.0 112.61 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -65.38 -24.95 67.36 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.726 -1.234 . . . . 0.0 113.42 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -129.92 78.78 1.87 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.044 1.338 . . . . 0.0 110.345 -173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.584 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.56 150.26 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.156 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.52 128.42 44.25 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 159.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 60.6 mt -92.75 116.34 28.93 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.7 m -135.02 128.17 31.85 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.718 1.207 . . . . 0.0 109.679 -176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -139.65 156.56 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.421 1.488 . . . . 0.0 111.303 -168.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.59 161.57 8.6 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 127.431 2.293 . . . . 0.0 110.003 -175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.76 163.39 37.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 123.083 2.522 . . . . 0.0 112.174 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.24 0.558 0 C-N-CA 125.246 1.418 . . . . 0.0 111.088 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.35 0.871 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.03 -72.08 0.48 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.973 1.309 . . . . 0.0 111.834 -166.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 70.17 13.77 7.7 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.597 1.959 . . . . 0.0 114.832 175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.3 mm-40 -94.98 -19.45 20.2 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.1 -24.32 0.61 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.216 1.406 . . . . 0.0 112.984 -166.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -63.89 -9.81 17.35 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -168.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 m -54.68 -26.8 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.574 1.55 . . . . 0.0 113.035 171.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.7 t -62.68 -24.1 67.46 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.55 1.14 . . . . 0.0 113.153 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.2 t -85.35 -30.81 23.37 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.269 -0.894 . . . . 0.0 112.488 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -64.29 -38.18 90.13 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.753 1.16 . . . . 0.0 111.33 170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 p -70.24 -24.99 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 CA-C-N 120.305 1.412 . . . . 0.0 111.496 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.61 -8.5 72.06 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 126.471 1.986 . . . . 0.0 114.566 171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.4 mtt-85 -109.0 -47.68 3.4 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.392 1.877 . . . . 0.0 109.936 175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -51.3 -42.74 61.38 Favored 'General case' 0 C--O 1.216 -0.688 0 C-N-CA 126.837 2.055 . . . . 0.0 113.629 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.72 -17.5 67.91 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.393 1.473 . . . . 0.0 113.711 172.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.76 -30.27 51.41 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.794 1.297 . . . . 0.0 112.444 178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 pt -57.87 -29.0 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.098 -1.002 . . . . 0.0 111.065 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -79.16 -58.04 3.43 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.832 1.253 . . . . 0.0 110.161 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.637 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.36 -34.33 73.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.303 1.041 . . . . 0.0 112.56 -174.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -72.73 -34.01 66.78 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 125.06 1.344 . . . . 0.0 111.984 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.7 tp -70.64 -36.75 73.57 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.436 0.562 . . . . 0.0 111.378 172.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.01 -44.25 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.065 0.946 . . . . 0.0 111.333 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -77.27 -12.04 59.9 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.083 0.953 . . . . 0.0 113.257 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -57.23 -37.14 71.81 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 161.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -79.96 -49.25 12.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.625 0.726 . . . . 0.0 109.897 173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 mt -89.0 75.33 8.0 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 123.341 1.543 . . . . 0.0 111.604 -174.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.01 25.87 0.08 Allowed 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 125.35 1.46 . . . . 0.0 114.729 -175.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -94.99 -61.91 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.43 0.692 . . . . 0.0 112.408 -159.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 74.24 -47.66 0.64 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.732 2.413 . . . . 0.0 113.321 176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -60.84 -28.43 68.81 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.967 1.307 . . . . 0.0 112.95 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.5 p -90.44 -3.41 57.69 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.927 1.691 . . . . 0.0 114.303 174.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -117.75 -29.83 5.61 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.123 1.369 . . . . 0.0 113.726 -172.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -92.59 164.82 13.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.975 1.31 . . . . 0.0 111.925 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.93 -42.61 2.52 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 125.777 1.656 . . . . 0.0 113.932 177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.68 -175.36 5.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.267 1.427 . . . . 0.0 111.438 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 162.46 22.33 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.615 -0.678 . . . . 0.0 111.315 177.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.8 t -157.99 146.16 18.79 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.636 1.175 . . . . 0.0 110.092 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 131.59 48.94 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.149 1.38 . . . . 0.0 111.123 164.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.5 m -144.01 171.88 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 120.781 -1.2 . . . . 0.0 108.175 172.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -133.72 132.31 40.46 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.346 -0.846 . . . . 0.0 112.176 -176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.3 mp -107.12 131.08 54.52 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.938 0.895 . . . . 0.0 109.464 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -112.08 112.48 24.14 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.07 0.948 . . . . 0.0 109.49 167.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.478 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -104.14 159.22 15.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 111.204 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 26.8 pt -96.15 150.19 36.89 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.223 1.409 . . . . 0.0 110.381 166.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -71.39 146.29 50.04 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.646 2.231 . . . . 0.0 110.247 172.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 m -165.21 147.33 7.82 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.561 1.944 . . . . 0.0 108.359 -177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.62 -18.59 72.17 Favored Glycine 0 N--CA 1.478 1.453 0 C-N-CA 124.444 1.021 . . . . 0.0 115.599 -168.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.9 p -94.13 3.16 55.67 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.409 1.884 . . . . 0.0 113.175 175.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 116.34 165.97 14.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.96 1.743 . . . . 0.0 111.335 -167.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.56 159.26 22.12 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 118.001 0.901 . . . . 0.0 111.321 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -127.88 144.07 51.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.07 1.348 . . . . 0.0 111.182 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.27 113.7 2.51 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.623 0.647 . . . . 0.0 112.481 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.24 -43.05 2.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.676 1.608 . . . . 0.0 111.41 171.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 m -154.51 150.33 27.68 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.944 0.898 . . . . 0.0 111.434 175.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 tt -125.37 131.02 53.05 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.526 1.131 . . . . 0.0 109.706 171.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.6 m -119.63 119.6 34.21 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.695 1.598 . . . . 0.0 108.694 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.6 m -81.16 137.23 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.053 0.842 . . . . 0.0 109.929 169.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.9 mt -109.65 -50.37 2.99 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.144 0.578 . . . . 0.0 110.004 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -173.7 170.36 4.03 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.994 1.718 . . . . 0.0 111.78 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.63 32.73 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 125.326 1.441 . . . . 0.0 113.171 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -81.96 113.65 20.01 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.2 m -58.35 -19.94 39.42 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -153.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -49.61 -37.77 29.19 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.91 1.284 . . . . 0.0 112.681 172.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 10.8 tp -79.11 -52.17 8.56 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.217 0.917 . . . . 0.0 110.722 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 61.2 m -46.46 -44.84 17.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.061 1.344 . . . . 0.0 113.421 174.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.55 -42.38 82.73 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.925 0.89 . . . . 0.0 112.678 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.91 19.38 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.579 1.152 . . . . 0.0 112.83 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.0 t -57.37 -46.1 83.71 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.588 0.755 . . . . 0.0 110.617 178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -50.29 -42.19 52.04 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.482 1.913 . . . . 0.0 111.723 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 13.0 mmt-85 -69.78 -48.53 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 173.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.78 80.33 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.62 1.168 . . . . 0.0 111.693 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.664 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.69 -24.32 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.875 -1.141 . . . . 0.0 111.918 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.66 -5.74 55.73 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.859 0.864 . . . . 0.0 112.869 175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -134.68 -11.27 2.37 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -174.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.506 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.4 m -58.07 148.99 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.415 1.086 . . . . 0.0 112.776 172.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -70.51 -47.91 58.17 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.894 0.878 . . . . 0.0 113.099 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.5 p 170.73 145.27 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.186 2.194 . . . . 0.0 110.355 -171.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 43.7 m-85 -96.62 108.49 42.9 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 117.771 -1.109 . . . . 0.0 110.363 -176.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.13 136.28 19.94 Favored 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.248 1.965 . . . . 0.0 110.37 -176.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.53 152.91 64.62 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 123.449 0.7 . . . . 0.0 112.329 -170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.46 -41.83 0.77 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.007 2.471 . . . . 0.0 110.277 167.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.47 149.28 50.71 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.023 2.129 . . . . 0.0 109.699 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -112.37 9.25 19.78 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 -164.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -79.86 144.57 60.08 Favored Pre-proline 0 CA--C 1.539 0.541 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.98 -2.7 5.9 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.324 2.683 . . . . 0.0 113.584 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -87.54 -33.21 19.02 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.863 0.865 . . . . 0.0 112.519 168.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.4 m -97.76 -26.39 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.664 1.186 . . . . 0.0 112.654 -177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -56.38 -25.65 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.059 0.944 . . . . 0.0 111.028 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -83.12 -9.1 59.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.897 1.279 . . . . 0.0 113.995 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.24 -42.43 6.67 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.371 1.068 . . . . 0.0 111.693 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.8 pp -74.71 -20.13 59.97 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 124.867 1.267 . . . . 0.0 112.93 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -66.39 -25.56 66.84 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 113.163 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -128.82 81.96 2.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.031 0.932 . . . . 0.0 109.892 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.555 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.56 150.67 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 111.75 -178.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 130.86 35.94 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 153.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.0 mt -85.3 129.09 34.88 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 157.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.0 m -146.15 127.07 14.5 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.82 157.25 42.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 125.335 1.454 . . . . 0.0 111.127 -171.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.76 -49.28 0.0 OUTLIER Pre-proline 0 CA--C 1.557 1.248 0 C-N-CA 126.272 1.829 . . . . 0.0 113.642 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.0 167.48 76.76 Favored 'Cis proline' 0 C--N 1.356 0.938 0 CA-C-N 122.17 1.811 . . . . 0.0 112.158 -14.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 . . . . . 0 C--O 1.241 0.614 0 C-N-CA 124.16 0.984 . . . . 0.0 111.781 178.719 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -169.56 166.96 9.94 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.816 0.846 . . . . 0.0 112.926 -165.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.69 15.53 0.44 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.495 1.918 . . . . 0.0 113.66 -172.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -97.97 -18.62 18.53 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.88 1.272 . . . . 0.0 112.066 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -22.6 0.42 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.44 1.896 . . . . 0.0 113.341 -163.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.81 -3.78 5.56 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -165.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -54.19 -30.49 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.726 1.211 . . . . 0.0 112.494 170.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.5 t -61.58 -48.53 80.55 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.857 0.863 . . . . 0.0 111.256 170.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -62.96 -30.91 71.94 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.386 1.074 . . . . 0.0 112.126 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.82 -26.8 62.54 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.604 -0.713 . . . . 0.0 112.674 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -24.2 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 120.655 1.57 . . . . 0.0 112.535 -175.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.64 -6.76 44.47 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 126.035 1.779 . . . . 0.0 113.194 171.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 38' ' ' ILE . 3.9 mmp_? -110.58 -70.92 0.78 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.012 1.725 . . . . 0.0 109.898 161.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -54.38 -49.89 68.8 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 127.983 2.513 . . . . 0.0 113.915 -162.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.98 -15.43 65.13 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 125.969 1.747 . . . . 0.0 114.097 171.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.602 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.14 -30.4 58.14 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.647 1.223 . . . . 0.0 111.609 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.2 pt -62.62 -28.49 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 120.513 -1.367 . . . . 0.0 111.621 176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -80.47 -57.06 3.76 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.924 1.289 . . . . 0.0 110.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -57.44 -36.04 70.88 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.064 0.946 . . . . 0.0 111.86 -176.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.85 -38.03 82.61 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.929 1.292 . . . . 0.0 111.898 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.6 tp -76.52 -28.22 56.3 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.02 -54.42 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 121.062 -1.024 . . . . 0.0 110.686 177.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -25.56 67.69 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.278 0.631 . . . . 0.0 111.45 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -74.02 -14.54 61.03 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -80.66 -33.85 35.28 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.472 1.033 . . . . 0.0 113.172 165.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 92.4 mt -103.89 110.06 22.05 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.778 1.231 . . . . 0.0 111.47 -158.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.0 24.85 8.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.977 1.311 . . . . 0.0 114.14 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.8 -58.79 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.507 0.723 . . . . 0.0 112.12 -165.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 71.44 -64.11 0.4 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.612 2.365 . . . . 0.0 113.346 171.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -64.63 -35.34 80.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.761 1.225 . . . . 0.0 112.833 -173.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.8 m -91.13 6.88 43.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.441 1.097 . . . . 0.0 113.448 172.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -104.29 -9.73 18.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.062 1.745 . . . . 0.0 112.491 169.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -114.58 159.43 20.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.004 1.722 . . . . 0.0 112.31 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.12 3.27 90.7 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 125.348 1.451 . . . . 0.0 114.477 -174.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.69 178.91 8.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.361 1.864 . . . . 0.0 112.354 -174.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.44 164.17 19.43 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.294 1.037 . . . . 0.0 110.613 176.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.12 143.5 21.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.493 1.117 . . . . 0.0 110.768 169.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 129.56 46.41 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.331 1.052 . . . . 0.0 110.403 163.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.2 m -139.87 172.45 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -138.14 131.18 30.04 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.705 -0.622 . . . . 0.0 112.345 -171.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp -103.84 130.19 51.39 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.161 0.984 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -114.19 105.11 12.8 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.938 1.295 . . . . 0.0 109.214 171.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.43 157.6 16.31 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.736 0.779 . . . . 0.0 112.2 -176.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.8 pt -99.32 151.96 37.61 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 125.389 1.476 . . . . 0.0 110.488 168.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -72.37 147.83 47.72 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.264 2.643 . . . . 0.0 111.19 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -165.59 149.59 8.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 127.273 2.229 . . . . 0.0 108.493 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.87 -16.41 70.3 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 115.927 1.131 . . . . 0.0 115.927 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 39.4 p -94.3 -4.84 47.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.215 1.806 . . . . 0.0 113.477 174.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.73 170.58 12.93 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.344 1.449 . . . . 0.0 111.755 -166.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -66.37 160.0 25.63 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.568 1.184 . . . . 0.0 111.323 -177.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.07 145.96 51.15 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.36 1.464 . . . . 0.0 111.147 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.99 109.85 1.19 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.172 0.589 . . . . 0.0 111.518 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.8 -47.34 3.44 Favored Glycine 0 C--N 1.342 0.875 0 C-N-CA 125.204 1.383 . . . . 0.0 110.886 170.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.0 m -155.18 150.89 27.54 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.866 1.266 . . . . 0.0 111.218 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -125.4 129.08 49.15 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.833 1.253 . . . . 0.0 109.39 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 70.5 m -115.18 118.85 34.5 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.209 1.804 . . . . 0.0 108.093 -177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.4 m -81.87 134.63 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 119.286 0.948 . . . . 0.0 109.757 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.22 -48.93 3.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.856 -0.592 . . . . 0.0 110.213 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -171.21 170.26 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.525 1.53 . . . . 0.0 111.868 171.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.79 -178.93 29.65 Favored Glycine 0 N--CA 1.462 0.396 0 C-N-CA 125.314 1.435 . . . . 0.0 113.554 171.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -84.46 113.85 21.5 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 167.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 p -63.84 -17.58 63.28 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -149.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -56.17 -33.45 65.27 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.767 0.827 . . . . 0.0 112.225 172.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -78.86 -46.62 18.19 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 117.796 -1.097 . . . . 0.0 111.397 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -47.16 -46.08 23.24 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.773 1.229 . . . . 0.0 113.027 168.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -43.75 89.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.768 0.827 . . . . 0.0 112.626 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.76 -52.36 31.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.069 0.948 . . . . 0.0 112.708 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.3 t -57.76 -48.25 80.18 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.586 0.755 . . . . 0.0 111.197 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -50.23 -44.71 53.45 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.469 1.508 . . . . 0.0 111.472 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.79 -45.06 65.37 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.697 0.799 . . . . 0.0 112.56 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.25 -49.76 75.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.385 1.074 . . . . 0.0 111.881 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.3 t -67.65 -22.8 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.828 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.4 -6.94 58.85 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 112.639 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.95 -12.2 3.71 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.8 m -58.14 147.36 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.023 0.929 . . . . 0.0 112.35 170.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -71.61 -47.56 53.79 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.8 p 171.14 142.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 126.723 2.009 . . . . 0.0 111.213 -169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 47.8 m-85 -94.67 108.61 38.39 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.423 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 130.05 14.47 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.341 2.028 . . . . 0.0 110.111 -173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.2 mt -78.04 148.29 74.84 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 123.491 0.716 . . . . 0.0 111.751 -171.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.98 -36.1 4.73 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.535 2.157 . . . . 0.0 110.879 168.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 153.51 41.31 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 127.439 2.295 . . . . 0.0 109.948 176.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -112.15 8.56 19.98 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -165.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.16 144.38 62.74 Favored Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 118.988 0.813 . . . . 0.0 110.004 -172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.81 -4.01 6.6 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 123.424 2.749 . . . . 0.0 113.696 179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -84.72 -38.26 19.93 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.98 0.809 . . . . 0.0 112.159 167.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -92.61 -26.66 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.225 1.01 . . . . 0.0 112.715 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.34 -26.99 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.124 0.969 . . . . 0.0 110.906 171.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -78.72 -13.17 59.96 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.01 1.324 . . . . 0.0 113.222 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.06 -42.33 7.93 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.672 0.789 . . . . 0.0 111.71 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -73.39 -23.23 60.15 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.828 0.851 . . . . 0.0 112.488 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -68.96 -23.31 64.12 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 120.743 -1.223 . . . . 0.0 113.946 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -128.29 84.08 2.21 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.134 0.974 . . . . 0.0 110.057 -175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -112.11 155.31 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.479 1.111 . . . . 0.0 112.215 -179.265 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -91.41 136.21 33.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 156.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.7 mt -90.63 118.14 29.84 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 154.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -135.9 130.25 33.53 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.172 0.989 . . . . 0.0 109.694 -174.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.6 t -136.39 146.25 29.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.734 2.414 . . . . 0.0 108.493 -165.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -155.56 161.09 30.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.241 1.417 . . . . 0.0 111.628 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.67 168.38 14.29 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.486 2.79 . . . . 0.0 111.65 -174.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 C--O 1.241 0.638 0 C-N-CA 125.005 1.322 . . . . 0.0 111.612 179.095 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -153.01 -172.4 4.23 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.291 1.836 . . . . 0.0 111.67 -171.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 150.75 23.81 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 1 C-N-CA 133.106 4.562 . . . . 0.0 112.317 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -98.67 -17.71 18.44 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.141 1.376 . . . . 0.0 112.176 -169.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.06 -29.97 0.53 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.557 1.543 . . . . 0.0 113.614 -171.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.9 1.05 0.12 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 118.661 2.838 . . . . 0.0 118.661 -165.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -55.5 -32.85 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.92 1.236 . . . . 0.0 111.512 172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.9 t -67.39 -44.17 79.53 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.621 1.168 . . . . 0.0 112.674 171.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.6 m -59.85 -30.2 68.8 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.702 1.201 . . . . 0.0 112.556 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.98 -23.39 64.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 118.368 -0.825 . . . . 0.0 113.093 171.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.6 t -62.84 -26.3 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 CA-C-N 121.186 1.812 . . . . 0.0 111.531 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.95 -4.27 40.61 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.518 1.533 . . . . 0.0 114.238 171.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -111.0 -54.2 2.63 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.256 1.823 . . . . 0.0 111.115 164.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -63.82 -17.99 63.66 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.002 2.121 . . . . 0.0 116.057 -162.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.74 -13.35 11.45 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.923 2.201 . . . . 0.0 114.124 166.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -79.83 -30.17 40.34 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.117 1.367 . . . . 0.0 111.797 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.0 pt -62.31 -27.77 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 O-C-N 120.646 -1.284 . . . . 0.0 111.946 175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -80.01 -56.53 4.18 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.286 1.434 . . . . 0.0 110.682 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -58.11 -34.48 70.25 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.938 0.895 . . . . 0.0 112.01 -176.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -67.92 -40.2 83.43 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.679 1.191 . . . . 0.0 110.881 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.36 -28.76 61.27 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.504 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.0 -54.12 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 123.721 0.808 . . . . 0.0 110.441 177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -23.29 67.29 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.043 0.537 . . . . 0.0 112.153 -176.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.02 -15.6 60.64 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -79.73 -39.9 30.08 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.845 1.202 . . . . 0.0 111.882 163.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.5 mt -96.0 83.35 3.64 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 123.557 1.646 . . . . 0.0 112.243 -160.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.2 28.93 0.12 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.774 1.63 . . . . 0.0 114.232 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.4 t -82.71 -62.21 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.434 -0.791 . . . . 0.0 112.093 -163.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 72.54 -62.64 0.46 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.309 2.243 . . . . 0.0 113.51 171.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -63.12 -37.39 87.04 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.257 1.423 . . . . 0.0 112.554 -174.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.2 m -85.56 -1.78 57.46 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 174.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.481 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 14.1 m-30 -103.96 -22.64 13.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.983 1.713 . . . . 0.0 113.279 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 152.66 19.64 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.179 1.392 . . . . 0.0 112.911 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.6 2.16 90.6 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.083 1.325 . . . . 0.0 114.29 -175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -143.77 177.77 8.28 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.115 1.766 . . . . 0.0 112.267 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.59 160.48 25.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.826 1.25 . . . . 0.0 110.099 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 45.1 t -153.62 144.13 22.44 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.216 1.007 . . . . 0.0 110.215 171.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -131.48 127.76 38.01 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.293 1.437 . . . . 0.0 111.134 171.206 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.21 172.16 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.367 1.067 . . . . 0.0 108.335 173.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -137.02 131.67 33.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.588 0.755 . . . . 0.0 112.113 -173.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -103.04 134.26 46.78 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.007 0.923 . . . . 0.0 110.38 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -118.09 103.47 9.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.187 1.395 . . . . 0.0 108.849 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.29 158.46 15.69 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.917 0.865 . . . . 0.0 112.149 -177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 pt -99.03 148.75 35.01 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.581 1.552 . . . . 0.0 110.183 166.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.56 147.92 41.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.302 2.668 . . . . 0.0 110.857 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.4 m -166.67 146.56 5.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.273 2.229 . . . . 0.0 108.479 -178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -68.95 -21.45 75.32 Favored Glycine 0 CA--C 1.537 1.457 0 N-CA-C 115.564 0.986 . . . . 0.0 115.564 -166.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 p -89.39 -5.22 57.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.979 1.712 . . . . 0.0 113.183 174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.79 162.49 10.84 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.891 1.71 . . . . 0.0 111.421 -169.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -63.74 160.69 16.61 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 117.789 0.794 . . . . 0.0 111.596 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.84 143.32 50.87 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.332 1.453 . . . . 0.0 110.91 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -60.98 109.34 1.05 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.44 0.696 . . . . 0.0 111.623 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.92 -36.51 5.23 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 125.537 1.542 . . . . 0.0 111.925 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -163.85 155.68 16.89 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.679 1.592 . . . . 0.0 111.127 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -132.43 129.94 39.94 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.091 1.357 . . . . 0.0 109.92 174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.3 m -115.81 119.15 35.08 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.923 2.089 . . . . 0.0 108.448 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -81.0 137.1 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.098 0.863 . . . . 0.0 110.164 170.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -106.39 -47.37 3.81 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.933 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 24.2 t0 -174.12 166.77 4.2 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.998 2.119 . . . . 0.0 111.217 169.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.28 164.5 27.9 Favored Glycine 0 CA--C 1.522 0.53 0 O-C-N 121.083 -1.011 . . . . 0.0 114.15 173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -98.37 178.94 4.89 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.945 0.898 . . . . 0.0 110.363 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 t -30.24 102.87 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.73 2.412 . . . . 0.0 115.517 -162.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 31.6 mtm105 70.44 -1.21 2.6 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.199 2.2 . . . . 0.0 116.378 162.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 21.2 tp -68.26 -46.58 70.05 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 122.429 2.377 . . . . 0.0 112.171 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 14.0 p -55.29 -28.08 51.11 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 166.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.18 -35.47 41.81 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.377 0.989 . . . . 0.0 112.382 176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.69 -51.02 15.43 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.63 1.572 . . . . 0.0 112.498 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -55.48 -48.9 73.82 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.854 0.861 . . . . 0.0 111.196 176.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -51.3 -44.7 61.95 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.786 1.634 . . . . 0.0 111.469 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.2 mtt85 -69.19 -44.55 71.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.028 0.931 . . . . 0.0 113.385 175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.51 76.38 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.57 1.148 . . . . 0.0 111.48 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 89' ' ' THR . 2.4 t -67.9 -21.22 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 120.69 -1.256 . . . . 0.0 112.236 -178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.97 -6.92 59.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.066 0.947 . . . . 0.0 112.187 173.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.05 -12.73 4.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.484 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.7 m -58.14 146.05 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 CA-C-N 119.394 0.997 . . . . 0.0 111.975 168.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -72.45 -46.12 56.46 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.1 p 172.78 141.94 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.36 1.864 . . . . 0.0 110.911 -168.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 52.9 m-85 -94.37 106.74 25.01 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 124.292 1.037 . . . . 0.0 111.193 -175.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -73.79 118.34 5.4 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.295 1.997 . . . . 0.0 109.968 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.03 148.71 37.42 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.461 1.104 . . . . 0.0 112.367 -175.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -78.11 -29.93 3.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.924 2.416 . . . . 0.0 112.313 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -138.56 148.67 44.47 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.947 1.699 . . . . 0.0 110.495 173.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -120.66 22.0 11.33 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.555 1.542 . . . . 0.0 113.284 -167.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -87.8 142.17 32.26 Favored Pre-proline 0 C--O 1.242 0.668 0 O-C-N 120.627 -1.295 . . . . 0.0 110.731 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.02 -7.05 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 124.14 3.226 . . . . 0.0 116.177 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -87.95 -41.57 13.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.881 1.219 . . . . 0.0 112.343 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -92.57 -25.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.529 1.532 . . . . 0.0 113.365 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.2 t -57.49 -29.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-N 118.939 0.79 . . . . 0.0 110.935 170.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.428 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 33.0 mm-40 -77.0 -8.07 56.76 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.319 1.047 . . . . 0.0 113.766 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.38 -48.22 5.96 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.356 0.663 . . . . 0.0 112.203 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -65.8 -28.07 68.73 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 124.13 0.972 . . . . 0.0 112.679 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.428 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -72.51 -23.79 61.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.44 -1.413 . . . . 0.0 114.003 -174.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -121.74 88.99 3.04 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.331 1.052 . . . . 0.0 111.086 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.63 156.34 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.435 1.094 . . . . 0.0 112.614 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.71 137.52 32.3 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.093 -0.379 . . . . 0.0 110.278 156.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.7 mt -91.4 112.91 25.02 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 153.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.8 m -134.83 125.43 26.82 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.916 0.887 . . . . 0.0 108.835 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.1 m -133.32 153.16 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.588 1.555 . . . . 0.0 110.734 -173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.37 158.07 15.39 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.466 1.506 . . . . 0.0 111.992 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.14 172.89 14.73 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.474 2.782 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.242 0.684 0 C-N-CA 125.274 1.43 . . . . 0.0 111.369 -177.489 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 69.91 167.43 0.29 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.883 2.473 . . . . 0.0 113.43 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -153.04 21.52 0.57 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.861 1.265 . . . . 0.0 114.067 -173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -106.61 -17.53 14.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.09 1.356 . . . . 0.0 112.671 -177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.16 -21.64 0.44 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.778 2.431 . . . . 0.0 112.753 -167.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -51.08 -15.85 0.39 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.299 2.64 . . . . 0.0 116.557 -172.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -53.24 -31.0 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.646 1.178 . . . . 0.0 112.402 171.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 t -57.6 -44.23 85.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.833 0.853 . . . . 0.0 112.092 170.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -69.48 -30.32 68.17 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.177 -0.952 . . . . 0.0 112.072 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -68.46 -29.22 67.81 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.732 -1.128 . . . . 0.0 112.699 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 75.7 t -64.62 -25.92 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 CA-C-N 120.829 1.65 . . . . 0.0 110.418 172.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.59 -8.59 56.75 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.315 1.436 . . . . 0.0 114.043 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 26.1 mtm105 -111.39 -58.68 2.08 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.727 1.263 . . . . 0.0 111.868 165.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -51.02 -47.16 61.69 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 128.276 2.63 . . . . 0.0 113.699 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.95 -15.86 66.5 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.246 1.403 . . . . 0.0 113.366 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.681 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -75.73 -32.75 60.14 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.437 1.119 . . . . 0.0 111.719 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 pt -59.67 -27.01 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-N 118.9 0.773 . . . . 0.0 111.916 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -82.09 -58.64 2.87 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.122 1.369 . . . . 0.0 110.362 174.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.681 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.69 -33.4 72.8 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.003 0.921 . . . . 0.0 112.852 -173.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -73.37 -35.4 65.93 Favored 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 123.994 0.918 . . . . 0.0 110.795 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 26.9 tp -73.39 -31.58 63.97 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.754 0.707 . . . . 0.0 112.059 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -71.24 -48.29 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 123.287 0.635 . . . . 0.0 110.71 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -67.78 -19.0 65.05 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -57.51 -36.53 71.66 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.128 0.571 . . . . 0.0 111.329 168.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -78.24 -40.22 37.93 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.983 0.421 . . . . 0.0 112.098 174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.9 mt -99.72 88.4 3.81 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 123.149 1.452 . . . . 0.0 111.887 -163.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.96 31.02 0.17 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.338 -1.755 . . . . 0.0 113.781 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -86.68 -64.09 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.469 0.708 . . . . 0.0 111.101 -166.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 72.79 -63.84 0.42 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.892 2.077 . . . . 0.0 112.826 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.01 -45.33 61.3 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.667 1.187 . . . . 0.0 112.159 -174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.3 m -79.24 2.86 19.69 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.2 m-30 -93.87 -10.46 33.88 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.834 1.653 . . . . 0.0 111.761 166.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -114.35 171.31 7.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.049 2.139 . . . . 0.0 111.107 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.02 -21.59 3.29 Favored Glycine 0 CA--C 1.542 1.741 0 C-N-CA 124.807 1.194 . . . . 0.0 114.372 -170.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -123.46 -175.16 3.13 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.171 2.589 . . . . 0.0 111.616 175.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 164.98 23.21 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.26 -0.9 . . . . 0.0 110.449 174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.2 t -159.97 144.74 14.91 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.448 1.099 . . . . 0.0 110.142 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.59 130.14 46.92 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.336 1.454 . . . . 0.0 110.512 164.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.9 m -139.88 170.4 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.275 1.03 . . . . 0.0 108.333 172.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -137.0 131.18 32.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.348 0.594 . . . . 0.0 111.738 -173.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.13 132.85 45.26 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 123.967 0.907 . . . . 0.0 110.334 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -116.4 103.01 10.03 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.497 1.519 . . . . 0.0 108.931 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -99.62 158.97 15.39 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.731 0.777 . . . . 0.0 111.906 -177.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.1 pt -100.13 136.79 20.02 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.453 1.501 . . . . 0.0 110.219 167.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.95 129.62 17.71 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.585 2.19 . . . . 0.0 109.832 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.0 m -142.86 88.58 2.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.271 1.428 . . . . 0.0 108.548 -169.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.72 -122.49 28.03 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.895 0.759 . . . . 0.0 112.12 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.2 p -81.6 3.5 24.94 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.209 1.803 . . . . 0.0 113.842 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -139.18 -166.6 10.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.257 1.408 . . . . 0.0 114.377 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.529 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -124.33 165.47 17.63 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.205 1.402 . . . . 0.0 110.918 165.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.62 148.51 52.61 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.144 1.778 . . . . 0.0 111.153 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.56 111.88 1.77 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 119.009 0.822 . . . . 0.0 112.28 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.54 -35.06 5.56 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.78 1.657 . . . . 0.0 112.125 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.6 m -167.2 153.18 7.86 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.365 1.466 . . . . 0.0 110.998 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.2 tt -127.91 129.38 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.428 1.091 . . . . 0.0 109.874 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 77.3 m -113.28 118.87 35.84 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.236 1.815 . . . . 0.0 108.536 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -81.74 130.9 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 118.903 0.774 . . . . 0.0 109.81 169.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -101.98 -46.92 4.73 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.108 0.563 . . . . 0.0 110.04 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -170.47 169.48 7.38 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.119 1.768 . . . . 0.0 111.515 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.11 179.07 23.79 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 124.887 1.232 . . . . 0.0 114.527 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.23 119.79 25.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 168.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.3 p -59.79 -17.66 37.36 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -159.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.71 65.31 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.679 1.191 . . . . 0.0 112.07 175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.3 tp -88.85 -49.23 6.94 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-N 119.673 1.124 . . . . 0.0 111.562 172.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.3 m -47.81 -43.09 27.52 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 119.537 1.062 . . . . 0.0 113.539 176.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.08 73.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.082 0.856 . . . . 0.0 112.573 177.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.14 -52.25 25.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.424 1.09 . . . . 0.0 112.191 -176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.6 t -57.85 -49.37 76.89 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.104 0.962 . . . . 0.0 110.355 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttmt -51.27 -45.8 62.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.677 1.591 . . . . 0.0 111.531 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -66.41 -47.02 74.61 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.518 0.727 . . . . 0.0 112.845 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.42 -50.06 75.06 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.619 1.168 . . . . 0.0 111.414 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -66.77 -23.29 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 120.579 -1.326 . . . . 0.0 111.518 -177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.78 -6.84 58.09 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.369 -0.832 . . . . 0.0 112.396 174.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.09 -11.97 3.27 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.432 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.4 m -58.14 148.59 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 119.296 0.953 . . . . 0.0 112.55 171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -69.48 -48.94 59.06 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.7 p 170.18 141.89 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.555 1.942 . . . . 0.0 111.414 -169.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 10.5 m-85 -98.99 110.38 57.5 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.311 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -78.18 134.34 12.84 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.842 2.361 . . . . 0.0 111.009 -176.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.48 148.36 66.06 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-O 119.047 -0.502 . . . . 0.0 112.272 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.59 -36.17 6.94 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.482 2.788 . . . . 0.0 111.935 171.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.71 153.25 47.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.439 2.296 . . . . 0.0 110.526 176.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.11 7.69 18.06 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -163.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.03 142.91 44.96 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.937 -1.102 . . . . 0.0 110.431 -171.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -65.34 0.35 2.85 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.807 3.005 . . . . 0.0 113.642 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.91 -38.72 17.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.927 0.891 . . . . 0.0 111.834 168.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 m -96.07 -26.4 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.571 1.148 . . . . 0.0 112.613 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.7 t -55.8 -28.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.435 1.094 . . . . 0.0 110.994 170.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -84.06 -5.44 59.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.237 1.015 . . . . 0.0 113.636 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -98.49 -51.36 3.97 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 121.013 -1.054 . . . . 0.0 111.192 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 pp -66.98 -20.48 65.89 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.824 1.25 . . . . 0.0 113.874 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -69.74 -23.57 63.41 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.014 -1.054 . . . . 0.0 112.819 177.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -125.27 83.29 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.115 1.766 . . . . 0.0 111.119 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.597 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -107.43 153.42 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 124.319 1.047 . . . . 0.0 112.092 177.472 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.19 137.12 34.67 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.88 0.371 . . . . 0.0 110.125 158.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.5 mt -93.33 120.68 33.89 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 155.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -136.77 129.1 29.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.384 1.074 . . . . 0.0 109.222 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.11 164.95 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 126.171 1.788 . . . . 0.0 110.742 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -157.52 170.32 9.14 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 125.799 1.64 . . . . 0.0 112.958 -175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -57.71 -28.81 83.34 Favored 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 123.513 2.808 . . . . 0.0 116.935 -161.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 C--O 1.239 0.539 0 C-N-CA 125.105 1.362 . . . . 0.0 110.935 -170.624 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.18 -73.48 0.12 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -165.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtp-105 72.92 14.68 4.78 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.13 2.172 . . . . 0.0 113.545 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -97.8 -19.42 18.18 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.03 -25.8 0.86 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 126.002 1.721 . . . . 0.0 112.606 -166.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.31 -6.65 10.4 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.5 1.52 . . . . 0.0 114.455 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -55.69 -27.9 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.275 1.43 . . . . 0.0 113.039 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.4 t -59.17 -35.44 73.57 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.278 0.631 . . . . 0.0 112.142 171.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.9 m -78.87 -28.01 44.12 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.158 -0.964 . . . . 0.0 113.065 175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.23 -37.96 88.89 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.582 0.628 . . . . 0.0 110.656 165.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.61 -27.26 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 119.93 1.241 . . . . 0.0 110.951 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.45 -11.35 68.1 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.525 1.536 . . . . 0.0 114.004 171.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -106.15 -55.69 2.29 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.058 1.429 . . . . 0.0 111.876 169.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -49.33 -45.84 46.0 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.597 2.359 . . . . 0.0 114.064 -172.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -85.71 -18.4 60.04 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.738 1.637 . . . . 0.0 113.746 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.645 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.78 -32.51 63.81 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.375 1.088 . . . . 0.0 111.864 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -61.37 -27.07 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.125 -0.985 . . . . 0.0 112.347 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -82.37 -59.19 2.62 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.634 1.174 . . . . 0.0 109.722 174.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.26 -35.33 73.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.034 0.934 . . . . 0.0 111.99 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -71.54 -41.75 68.75 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.968 0.907 . . . . 0.0 110.867 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.9 tp -68.63 -25.91 65.08 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.539 0.609 . . . . 0.0 112.035 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.415 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -76.46 -55.59 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 124.187 0.995 . . . . 0.0 110.253 174.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -22.46 66.11 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.668 0.387 . . . . 0.0 111.594 -173.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -71.51 -13.16 61.72 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.706 -0.664 . . . . 0.0 112.642 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -81.05 -36.69 30.18 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.947 1.248 . . . . 0.0 112.164 168.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.27 80.31 1.82 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.327 1.451 . . . . 0.0 109.821 -169.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.2 51.62 0.43 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.807 1.643 . . . . 0.0 112.492 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -71.66 -56.48 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 73.26 -51.71 0.7 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 128.063 2.545 . . . . 0.0 114.892 166.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -81.51 -31.75 32.68 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.382 1.473 . . . . 0.0 112.879 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -85.05 -13.38 50.61 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.836 0.854 . . . . 0.0 112.604 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -89.34 -8.17 53.77 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.014 1.326 . . . . 0.0 112.478 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -112.73 171.41 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.401 1.88 . . . . 0.0 113.099 -176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.3 -45.49 3.23 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 126.119 1.819 . . . . 0.0 112.371 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.45 -170.89 3.33 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.61 1.564 . . . . 0.0 111.137 166.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.69 164.29 26.26 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.835 0.854 . . . . 0.0 110.985 168.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 38.8 t -151.61 145.04 24.82 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.691 1.196 . . . . 0.0 109.564 170.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.26 129.36 41.47 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.164 1.385 . . . . 0.0 110.615 170.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.7 m -141.69 172.07 10.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 124.87 1.268 . . . . 0.0 107.978 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -137.59 133.15 34.08 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.801 0.841 . . . . 0.0 111.722 -176.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.98 140.35 36.39 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.387 0.675 . . . . 0.0 111.81 174.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -120.2 105.69 11.21 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.431 1.493 . . . . 0.0 108.92 170.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.507 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.2 mm? -100.74 159.37 15.24 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.397 -0.815 . . . . 0.0 111.843 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.6 pt -103.68 139.96 20.6 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.924 1.689 . . . . 0.0 109.821 168.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -63.67 137.3 58.32 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.507 2.138 . . . . 0.0 111.624 170.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 m -143.97 162.89 35.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 127.28 2.232 . . . . 0.0 107.918 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.02 -22.24 70.38 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 121.005 -1.059 . . . . 0.0 115.561 -171.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.8 m -94.97 -19.61 20.07 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.783 1.633 . . . . 0.0 112.734 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.37 -174.37 34.86 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 126.649 2.071 . . . . 0.0 111.007 -172.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -73.45 160.35 31.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.216 2.008 . . . . 0.0 110.15 170.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -132.43 143.7 49.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.304 1.442 . . . . 0.0 111.527 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -57.57 108.44 0.56 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.996 0.919 . . . . 0.0 112.261 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.51 -35.82 5.56 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.673 1.606 . . . . 0.0 111.632 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.3 m -166.01 150.04 7.91 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.901 1.28 . . . . 0.0 111.13 176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.7 tt -123.07 130.44 52.78 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.955 1.702 . . . . 0.0 109.319 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.6 m -114.44 118.68 34.49 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.6 1.56 . . . . 0.0 108.358 176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 m -83.63 136.19 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 118.803 0.729 . . . . 0.0 109.88 168.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.5 mt -108.73 -45.79 3.77 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.3 0.64 . . . . 0.0 110.151 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -172.48 167.51 5.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.102 1.761 . . . . 0.0 111.348 167.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.83 170.11 36.17 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.526 -0.734 . . . . 0.0 114.552 171.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -126.36 -177.53 4.01 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.826 1.25 . . . . 0.0 111.047 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . 0.259 59.3 p 51.52 -97.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.385 2.274 . . . . 0.0 113.018 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.3 mmt-85 -143.33 -4.27 0.9 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.073 1.749 . . . . 0.0 113.981 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -64.08 -43.91 93.98 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.926 1.694 . . . . 0.0 113.01 -157.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 11.0 p -56.95 -27.64 61.38 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -87.74 -40.73 13.85 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.799 1.239 . . . . 0.0 112.155 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.36 -53.74 50.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.77 1.228 . . . . 0.0 111.998 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.0 t -52.75 -46.65 67.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.894 0.878 . . . . 0.0 110.537 172.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -61.88 -29.89 70.5 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.38 1.072 . . . . 0.0 113.438 -174.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -73.35 -43.37 60.85 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 168.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.69 -49.73 76.32 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.736 1.214 . . . . 0.0 112.024 178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 89' ' ' THR . 2.1 t -65.86 -23.38 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 120.533 -1.354 . . . . 0.0 112.09 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.82 -6.96 55.9 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.35 -0.844 . . . . 0.0 112.727 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.31 -11.95 2.46 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.448 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.6 m -58.15 147.82 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.712 1.205 . . . . 0.0 112.734 171.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -75.3 -39.08 59.96 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.6 p 165.23 141.23 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 127.491 2.316 . . . . 0.0 111.501 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.04 112.26 57.68 Favored Pre-proline 0 N--CA 1.471 0.588 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.269 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.44 120.7 4.51 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.306 2.004 . . . . 0.0 110.047 -176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.99 138.58 25.99 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.65 1.18 . . . . 0.0 111.743 -176.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.24 -47.58 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.421 2.748 . . . . 0.0 111.916 -171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -103.46 147.41 27.17 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.304 1.442 . . . . 0.0 110.868 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -121.31 12.79 11.0 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.874 1.27 . . . . 0.0 113.564 -163.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -78.88 140.56 58.35 Favored Pre-proline 0 CA--C 1.539 0.547 0 O-C-N 120.825 -1.172 . . . . 0.0 109.392 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.87 -4.69 7.74 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.047 2.498 . . . . 0.0 113.419 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -84.43 -31.87 24.39 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.726 0.694 . . . . 0.0 112.403 170.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.5 m -103.97 -24.71 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -54.04 -28.61 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.264 1.026 . . . . 0.0 110.731 166.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -80.28 -9.86 59.74 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.501 1.52 . . . . 0.0 113.791 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.77 -43.83 5.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.279 1.032 . . . . 0.0 112.198 -176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.408 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.6 pp -71.55 -22.33 61.77 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.973 0.909 . . . . 0.0 111.743 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -65.5 -22.95 66.78 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 120.63 -1.294 . . . . 0.0 113.918 175.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -123.74 80.12 1.77 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.41 1.084 . . . . 0.0 110.301 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.99 151.44 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.961 0.905 . . . . 0.0 111.83 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.3 128.04 41.82 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 159.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 76.9 mt -89.05 111.18 21.85 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 160.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.8 m -135.45 123.94 23.49 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.589 1.155 . . . . 0.0 108.502 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.36 148.37 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 124.696 1.198 . . . . 0.0 111.175 -169.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -161.53 38.65 0.05 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.241 1.816 . . . . 0.0 114.388 175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.69 140.87 52.77 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.32 2.013 . . . . 0.0 111.1 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 . . . . . 0 N--CA 1.475 0.817 0 C-N-CA 125.838 1.655 . . . . 0.0 112.199 -174.576 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.049 0 CA-C-O 117.692 -1.147 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 -44.15 9.11 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 129.374 3.07 . . . . 0.0 111.773 -7.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 75.84 3.58 3.81 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.394 2.278 . . . . 0.0 114.887 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -89.22 -19.6 25.2 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.203 0.601 . . . . 0.0 112.621 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -150.28 -27.45 0.24 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.009 1.323 . . . . 0.0 114.41 -166.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -55.76 -17.7 6.65 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 -166.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.2 m -55.17 -29.81 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.747 1.219 . . . . 0.0 112.664 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.7 t -58.49 -45.27 89.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.247 1.019 . . . . 0.0 112.191 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -64.37 -29.62 70.68 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.749 176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -75.5 -17.59 60.07 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-O 117.558 -1.211 . . . . 0.0 112.996 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.12 -25.83 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 CA-C-N 121.656 2.026 . . . . 0.0 111.09 173.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.96 -13.12 56.7 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.939 171.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 56.6 mtt180 -111.36 -57.26 2.27 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.033 1.417 . . . . 0.0 111.748 168.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -58.61 -39.61 80.92 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 128.034 2.534 . . . . 0.0 113.761 -173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.38 -17.78 63.73 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.377 1.465 . . . . 0.0 114.009 169.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.12 -26.12 56.06 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.867 1.333 . . . . 0.0 112.065 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 pt -64.18 -30.0 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 120.333 -1.479 . . . . 0.0 111.634 174.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -77.8 -55.22 5.51 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.129 1.372 . . . . 0.0 110.095 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -57.33 -34.89 69.22 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.878 0.871 . . . . 0.0 112.297 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -71.64 -30.49 65.81 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.227 1.411 . . . . 0.0 112.628 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.3 tp -82.12 -31.48 30.63 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.674 0.67 . . . . 0.0 112.353 173.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.456 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -68.74 -46.86 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 O-C-N 121.271 -0.893 . . . . 0.0 110.761 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.96 -21.76 66.63 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.284 1.034 . . . . 0.0 112.98 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 5.6 mm100 -59.65 -36.73 77.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.516 0.727 . . . . 0.0 110.791 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -78.35 -45.42 22.6 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.523 0.678 . . . . 0.0 111.162 170.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 mt -92.99 74.28 4.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 123.456 1.598 . . . . 0.0 112.298 -170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.03 29.06 0.06 Allowed 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 113.791 -1.549 . . . . 0.0 114.048 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.6 -71.09 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.164 0.986 . . . . 0.0 111.812 -163.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 74.15 -48.24 0.66 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 127.568 2.347 . . . . 0.0 114.119 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.26 -38.23 88.47 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.296 -1.503 . . . . 0.0 113.16 -177.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 89.9 p -91.36 0.05 57.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.343 1.057 . . . . 0.0 113.662 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.568 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 18.7 m-30 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.543 1.537 . . . . 0.0 111.384 176.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -110.68 156.12 21.47 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.776 2.03 . . . . 0.0 111.223 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.12 -25.94 4.59 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.101 1.334 . . . . 0.0 113.795 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -106.29 -172.68 2.13 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.831 2.052 . . . . 0.0 110.741 167.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.65 164.31 28.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.273 1.029 . . . . 0.0 110.345 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.58 157.64 43.45 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.441 -0.787 . . . . 0.0 111.463 160.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.2 126.21 29.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.146 1.379 . . . . 0.0 110.069 162.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -141.59 166.37 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -135.58 131.72 36.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 119.042 0.837 . . . . 0.0 111.965 -174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.55 131.93 48.95 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.339 1.055 . . . . 0.0 110.164 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -113.52 107.71 16.18 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.318 1.447 . . . . 0.0 109.018 170.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.35 159.72 15.03 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.31 -0.869 . . . . 0.0 111.945 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.4 pt -102.34 148.38 35.35 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.987 1.715 . . . . 0.0 109.615 166.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.4 137.78 28.78 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.221 1.947 . . . . 0.0 110.08 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 m -148.66 93.92 2.2 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.115 1.366 . . . . 0.0 109.267 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 60.81 -113.66 5.81 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 123.82 0.724 . . . . 0.0 112.612 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.2 p -83.36 -2.79 56.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 126.755 2.022 . . . . 0.0 114.024 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -146.97 -164.85 11.34 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 119.585 1.084 . . . . 0.0 114.297 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -111.38 165.23 12.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 124.351 1.06 . . . . 0.0 110.649 165.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 tp -132.79 146.89 52.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.451 1.901 . . . . 0.0 111.666 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -61.05 111.63 1.77 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.53 0.732 . . . . 0.0 112.245 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.91 -34.22 5.52 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 125.387 1.47 . . . . 0.0 112.032 174.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.47 154.28 11.9 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.455 1.502 . . . . 0.0 110.994 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -133.82 128.44 34.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.509 1.124 . . . . 0.0 109.94 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.0 m -110.9 138.5 47.23 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.72 2.008 . . . . 0.0 108.349 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.72 133.8 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 118.781 0.719 . . . . 0.0 109.233 165.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -102.16 -42.92 5.89 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.479 0.712 . . . . 0.0 109.915 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -173.17 169.19 4.62 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.371 1.868 . . . . 0.0 111.476 171.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 151.18 -178.74 28.38 Favored Glycine 0 N--CA 1.463 0.499 0 C-N-CA 124.729 1.157 . . . . 0.0 114.509 171.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -88.4 116.64 26.77 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 166.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.2 m -58.68 -18.92 35.03 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -157.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.93 -32.71 71.04 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.644 0.778 . . . . 0.0 112.564 176.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.3 tp -82.51 -46.83 12.91 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.62 1.1 . . . . 0.0 111.086 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 51.9 m -51.59 -42.92 62.26 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 119.382 0.992 . . . . 0.0 113.149 175.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.89 79.41 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.968 0.907 . . . . 0.0 112.364 175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.77 -52.2 58.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.541 0.737 . . . . 0.0 112.462 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.729 ' O ' HG23 ' A' ' 93' ' ' VAL . 8.7 t -59.58 -47.68 84.63 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.652 0.781 . . . . 0.0 110.892 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -52.68 -42.42 64.75 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.251 1.02 . . . . 0.0 111.138 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -70.25 -47.27 62.07 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.716 0.806 . . . . 0.0 112.914 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -48.97 78.34 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.112 0.965 . . . . 0.0 111.899 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 89' ' ' THR . 2.9 t -66.87 -23.1 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 120.719 -1.238 . . . . 0.0 111.516 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.26 -6.71 59.17 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.46 -0.775 . . . . 0.0 112.676 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -130.89 -11.84 3.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 11.6 m -57.79 145.11 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.148 0.979 . . . . 0.0 112.597 171.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -68.31 -41.28 81.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.6 p 166.04 144.29 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 128.437 2.695 . . . . 0.0 110.102 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.518 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 40.2 m-85 -92.51 110.45 45.07 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.505 -1.236 . . . . 0.0 109.77 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.65 134.8 20.85 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.898 1.732 . . . . 0.0 109.831 -176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -79.24 148.35 70.78 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.073 0.549 . . . . 0.0 111.601 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.07 -33.36 4.57 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.745 2.297 . . . . 0.0 111.283 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.15 159.81 42.0 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.383 2.273 . . . . 0.0 109.808 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -125.98 31.3 5.49 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.756 1.222 . . . . 0.0 113.205 -160.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -100.0 144.5 28.5 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 121.108 -0.995 . . . . 0.0 110.365 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.48 -9.2 17.1 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.337 2.691 . . . . 0.0 113.417 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -81.06 -35.59 31.59 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.643 0.777 . . . . 0.0 112.11 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 20.0 m -94.52 -25.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.46 1.104 . . . . 0.0 112.473 -177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.6 t -55.44 -28.54 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-N 118.578 0.626 . . . . 0.0 110.915 168.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.3 mm-40 -78.89 -9.57 59.53 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -95.17 -46.88 6.59 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.61 0.719 . . . . 0.0 112.008 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 pp -68.26 -26.36 65.63 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.168 0.987 . . . . 0.0 112.438 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 19.7 ptmt -71.51 -25.35 62.21 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 120.415 -1.428 . . . . 0.0 113.168 -175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -124.36 90.48 3.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.533 1.133 . . . . 0.0 110.483 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.508 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -114.77 152.87 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.642 1.177 . . . . 0.0 112.525 178.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -93.84 132.69 38.0 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.985 157.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.2 mt -91.27 117.32 29.54 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 156.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.9 m -135.31 128.28 31.48 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 124.365 1.066 . . . . 0.0 108.851 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.1 155.6 29.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 125.405 1.482 . . . . 0.0 110.811 -173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -166.43 168.2 7.57 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.91 1.684 . . . . 0.0 111.355 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.25 159.07 41.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.694 2.929 . . . . 0.0 112.827 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 C--O 1.241 0.638 0 C-N-CA 123.86 0.864 . . . . 0.0 111.963 177.202 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.037 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -163.26 -104.94 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.895 1.678 . . . . 0.0 112.162 -169.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 66.1 27.78 10.43 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.808 2.043 . . . . 0.0 113.675 -171.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -103.17 -21.34 13.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.169 0.988 . . . . 0.0 113.494 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -15.2 0.75 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.327 1.451 . . . . 0.0 113.871 -165.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -62.94 -13.06 29.96 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 -167.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 m -56.08 -27.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.032 1.333 . . . . 0.0 112.853 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 t -56.94 -37.5 71.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.82 0.848 . . . . 0.0 112.607 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.4 m -73.8 -26.99 60.91 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.972 -1.08 . . . . 0.0 112.862 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.26 -31.19 68.45 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.754 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.78 -31.51 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-N 120.972 1.714 . . . . 0.0 110.845 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -12.24 69.68 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.585 1.088 . . . . 0.0 114.031 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -104.77 -46.46 4.31 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.369 1.467 . . . . 0.0 110.546 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -54.88 -43.52 73.25 Favored 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 127.389 2.276 . . . . 0.0 113.212 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.46 -18.47 68.61 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.213 0.911 . . . . 0.0 113.44 173.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.6 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.93 -33.4 68.22 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.277 1.038 . . . . 0.0 111.592 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.5 pt -61.3 -28.13 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 120.953 -1.092 . . . . 0.0 111.889 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -80.56 -58.24 3.21 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.877 1.271 . . . . 0.0 109.581 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.6 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.13 -34.84 74.09 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.478 1.111 . . . . 0.0 112.673 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -74.36 -28.11 60.98 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.772 1.229 . . . . 0.0 112.353 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.9 tp -76.4 -33.34 58.86 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.199 0.909 . . . . 0.0 111.684 171.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.11 -44.38 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 O-C-N 120.865 -1.147 . . . . 0.0 110.964 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -72.14 -13.6 61.6 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.262 1.025 . . . . 0.0 112.745 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -57.06 -38.38 73.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 165.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.408 HD21 HG12 ' A' ' 96' ' ' VAL . 37.0 m-80 -80.14 -37.39 33.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.123 0.487 . . . . 0.0 111.989 -179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 81.7 mt -99.49 103.9 15.68 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.62 1.2 . . . . 0.0 110.828 -164.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.94 20.71 7.43 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -174.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.98 -52.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.053 0.541 . . . . 0.0 112.237 -160.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 70.64 -62.55 0.44 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.867 2.467 . . . . 0.0 113.921 168.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.41 -35.41 80.34 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.635 -1.29 . . . . 0.0 111.946 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.8 m -77.09 -0.78 26.07 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 114.26 1.208 . . . . 0.0 114.26 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -112.78 -12.49 13.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.612 1.965 . . . . 0.0 111.949 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -109.17 154.5 22.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 112.281 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.94 2.58 90.43 Favored Glycine 0 N--CA 1.479 1.563 0 C-N-CA 124.76 1.171 . . . . 0.0 114.816 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.5 -178.61 5.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.747 2.019 . . . . 0.0 111.682 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.87 162.95 20.05 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.978 0.911 . . . . 0.0 110.462 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.2 t -157.4 147.2 20.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.446 1.099 . . . . 0.0 110.141 170.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.3 128.47 43.25 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.142 1.777 . . . . 0.0 110.372 163.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 m -141.17 167.42 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 124.58 1.152 . . . . 0.0 108.048 170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -131.8 132.28 43.61 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.786 0.721 . . . . 0.0 111.95 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.68 130.13 49.5 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.139 0.975 . . . . 0.0 109.593 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -111.68 107.06 16.05 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.464 1.106 . . . . 0.0 109.227 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -100.02 158.69 15.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.913 0.863 . . . . 0.0 111.603 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -102.8 152.17 38.43 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.973 1.709 . . . . 0.0 110.506 168.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.05 147.27 29.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.143 2.562 . . . . 0.0 111.038 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -156.1 161.62 40.35 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 127.852 2.461 . . . . 0.0 108.338 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.3 -13.2 59.88 Favored Glycine 0 CA--C 1.54 1.649 0 O-C-N 120.737 -1.227 . . . . 0.0 115.187 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 32.9 p -99.77 -3.36 32.95 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.107 2.163 . . . . 0.0 113.919 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.97 -151.83 16.9 Favored Glycine 0 N--CA 1.47 0.907 0 C-N-CA 125.371 1.462 . . . . 0.0 111.078 -167.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -90.39 157.0 17.83 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 119.054 1.427 . . . . 0.0 111.949 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -129.0 144.45 51.19 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.269 1.828 . . . . 0.0 111.237 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.32 113.5 2.2 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.907 0.776 . . . . 0.0 112.182 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.63 -36.81 4.69 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.68 1.61 . . . . 0.0 111.974 171.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.05 152.11 9.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.649 1.579 . . . . 0.0 111.295 175.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -127.37 134.29 49.95 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.247 1.019 . . . . 0.0 109.653 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 64.8 m -117.38 120.45 38.22 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.615 1.966 . . . . 0.0 108.707 -178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.23 133.97 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 119.312 0.96 . . . . 0.0 109.796 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 mt -106.07 -49.93 3.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.298 0.639 . . . . 0.0 110.133 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -173.03 170.23 4.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 126.166 1.786 . . . . 0.0 111.942 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.82 -175.21 32.97 Favored Glycine 0 N--CA 1.46 0.281 0 C-N-CA 125.054 1.311 . . . . 0.0 113.176 169.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -82.58 110.57 17.78 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 164.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.6 m -58.67 -17.91 26.44 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -153.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -52.45 -37.37 56.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.798 1.239 . . . . 0.0 112.357 172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -79.19 -48.07 14.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.005 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 35.6 m -48.51 -46.22 38.21 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.565 1.146 . . . . 0.0 113.138 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.4 84.34 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.811 0.844 . . . . 0.0 112.296 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.72 -51.22 23.97 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 112.629 -176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.2 t -57.44 -49.4 76.36 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.863 0.865 . . . . 0.0 110.508 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.29 -46.68 55.44 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.878 1.671 . . . . 0.0 111.258 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.9 -44.09 77.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.591 0.757 . . . . 0.0 112.833 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.78 -48.96 79.42 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.631 1.172 . . . . 0.0 112.173 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -65.5 -23.89 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 120.645 -1.284 . . . . 0.0 111.496 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.59 -6.63 57.46 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.689 0.796 . . . . 0.0 112.668 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -132.69 -12.0 3.03 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.454 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 15.0 m -59.95 148.64 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 119.185 0.902 . . . . 0.0 112.456 171.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -71.33 -48.5 50.05 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.6 p 174.77 142.11 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.223 1.809 . . . . 0.0 111.884 -169.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.2 m-85 -97.19 109.56 50.14 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 124.45 1.1 . . . . 0.0 110.148 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -77.03 131.37 11.95 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.733 2.289 . . . . 0.0 110.417 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -78.83 150.83 75.97 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 123.573 0.749 . . . . 0.0 111.513 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.99 -40.84 1.58 Allowed 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.321 2.014 . . . . 0.0 110.787 170.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -120.05 176.27 5.52 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.444 2.297 . . . . 0.0 111.278 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -152.64 49.43 0.75 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -170.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -112.83 135.66 21.63 Favored Pre-proline 0 CA--C 1.544 0.716 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.11 171.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -53.73 -12.53 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.18 3.253 . . . . 0.0 115.585 174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -82.0 -35.46 28.87 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.395 0.998 . . . . 0.0 112.159 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.3 m -96.69 -24.16 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.209 1.004 . . . . 0.0 113.026 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.2 -25.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.592 0.757 . . . . 0.0 110.662 167.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -83.39 -7.77 59.51 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.03 -48.67 5.59 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.133 -0.98 . . . . 0.0 111.374 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.441 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 2.6 pp -69.68 -20.95 63.55 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.648 1.179 . . . . 0.0 112.959 -175.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.64 -25.24 67.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.987 0.915 . . . . 0.0 113.449 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -129.99 77.23 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.219 1.008 . . . . 0.0 110.102 -172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.574 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.57 148.33 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.62 123.48 36.97 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 157.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 52.2 mt -84.63 110.03 18.43 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 160.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.7 m -132.32 127.55 35.82 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.85 1.26 . . . . 0.0 108.512 -175.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.69 151.46 27.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 125.981 1.712 . . . . 0.0 110.518 -169.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.42 160.72 14.09 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.649 1.58 . . . . 0.0 111.425 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -64.39 -34.53 54.13 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.056 2.504 . . . . 0.0 113.616 176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.47 0.564 0 C-N-CA 126.481 1.913 . . . . 0.0 111.692 -179.448 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 119.88 -0.105 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 82.43 104.13 0.06 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 130.439 3.495 . . . . 0.0 112.239 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -69.83 3.55 2.52 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 113.595 -1.639 . . . . 0.0 114.664 -164.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 -88.54 -22.73 23.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.262 1.825 . . . . 0.0 111.636 -177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.54 -7.65 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.671 2.1 . . . . 0.0 116.671 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -49.97 -19.81 0.79 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 m -55.42 -29.12 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.734 1.214 . . . . 0.0 112.689 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 t -58.73 -36.21 73.94 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.967 0.907 . . . . 0.0 112.098 170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.1 m -78.03 -30.38 49.91 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.836 0.854 . . . . 0.0 112.527 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -63.89 -38.81 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 119.131 -0.461 . . . . 0.0 110.348 168.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.44 -30.08 48.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 119.653 1.115 . . . . 0.0 110.203 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.29 -14.53 74.27 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 117.993 -1.448 . . . . 0.0 114.355 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -96.51 -49.14 5.26 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 120.098 1.949 . . . . 0.0 112.003 166.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -55.27 -43.08 74.39 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 127.298 2.239 . . . . 0.0 112.803 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.62 66.76 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.197 1.38 . . . . 0.0 114.066 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.582 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -72.09 -34.2 68.48 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.184 0.992 . . . . 0.0 111.608 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.4 pt -60.59 -28.3 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 121.267 -0.896 . . . . 0.0 112.161 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -80.78 -58.44 3.09 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.114 1.366 . . . . 0.0 110.673 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.582 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.72 -36.84 74.94 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.49 1.116 . . . . 0.0 112.564 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -71.25 -32.58 68.92 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.701 1.2 . . . . 0.0 111.812 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.1 tp -76.05 -28.83 57.8 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.917 0.78 . . . . 0.0 112.271 173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.509 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -75.27 -54.4 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 O-C-N 120.887 -1.133 . . . . 0.0 110.372 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -19.86 65.24 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.395 0.678 . . . . 0.0 112.495 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -79.17 -15.22 58.41 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -78.76 -39.88 34.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.23 0.923 . . . . 0.0 111.992 161.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -95.81 96.34 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 123.436 1.589 . . . . 0.0 111.587 -160.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.54 24.44 1.2 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 113.79 -1.55 . . . . 0.0 114.098 -173.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.87 -72.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.163 0.985 . . . . 0.0 111.33 -167.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 75.0 -52.62 0.67 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 127.84 2.456 . . . . 0.0 113.489 165.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.5 -36.84 85.11 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.005 -1.059 . . . . 0.0 111.905 176.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 20.3 m -83.66 0.33 47.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 113.743 173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -102.83 -25.05 13.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.01 1.724 . . . . 0.0 112.805 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -87.52 162.65 17.1 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 127.504 2.321 . . . . 0.0 111.539 173.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.7 -5.36 69.95 Favored Glycine 0 N--CA 1.477 1.433 0 C-N-CA 124.788 1.185 . . . . 0.0 114.789 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.41 -173.89 4.07 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.819 2.048 . . . . 0.0 111.277 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.61 162.05 25.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.766 0.826 . . . . 0.0 110.675 176.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.442 ' HB3' HD23 ' A' ' 85' ' ' LEU . 40.5 t -153.84 144.0 22.11 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.749 1.22 . . . . 0.0 110.381 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.99 130.55 48.54 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.729 1.212 . . . . 0.0 110.953 164.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -141.65 176.85 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -142.61 126.37 17.05 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.729 0.812 . . . . 0.0 110.572 -167.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.69 131.4 52.18 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.94 0.896 . . . . 0.0 109.72 178.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -119.39 106.4 12.24 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.932 1.293 . . . . 0.0 108.936 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.1 mm? -99.17 162.27 13.15 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.598 0.759 . . . . 0.0 111.117 -177.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.13 150.41 44.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 124.482 1.113 . . . . 0.0 110.677 167.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.31 134.19 17.01 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.668 2.245 . . . . 0.0 110.618 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.5 m -118.66 -33.73 4.18 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.252 1.421 . . . . 0.0 111.635 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.27 -121.84 0.8 Allowed Glycine 0 N--CA 1.467 0.752 0 C-N-CA 125.515 1.531 . . . . 0.0 111.274 177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 p -63.69 -14.57 53.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.17 0.988 . . . . 0.0 113.088 167.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -122.17 153.52 16.82 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.887 1.708 . . . . 0.0 114.224 174.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -84.79 163.24 19.22 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.896 0.878 . . . . 0.0 110.292 161.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.13 147.68 52.11 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.393 1.877 . . . . 0.0 111.413 177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.08 110.43 1.04 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.127 0.971 . . . . 0.0 112.033 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.65 -46.37 3.73 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 125.553 1.549 . . . . 0.0 110.591 170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.1 m -155.41 149.59 25.79 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.338 1.055 . . . . 0.0 110.967 179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.7 tt -126.01 121.67 33.67 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.114 0.965 . . . . 0.0 109.546 171.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.3 m -103.66 118.7 37.32 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.448 1.499 . . . . 0.0 108.589 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.2 m -80.33 130.85 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.758 0.708 . . . . 0.0 109.207 167.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.9 mt -101.17 -49.36 4.11 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.524 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -173.19 170.77 4.25 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.329 1.851 . . . . 0.0 111.796 171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.93 -179.47 31.83 Favored Glycine 0 N--CA 1.461 0.359 0 C-N-CA 124.895 1.236 . . . . 0.0 113.55 169.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.19 113.95 20.37 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 165.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 61.7 p -61.3 -17.68 54.82 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -153.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 81.5 mtt85 -50.97 -35.58 34.41 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.548 1.139 . . . . 0.0 112.143 171.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 58' ' ' CYS . 10.8 tp -82.48 -51.04 8.19 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 118.31 -0.852 . . . . 0.0 111.086 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 33.3 m -45.74 -46.37 15.06 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.212 1.405 . . . . 0.0 113.203 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.98 82.43 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.038 0.835 . . . . 0.0 112.852 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.15 -52.88 14.59 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.57 1.148 . . . . 0.0 111.964 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.701 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.5 t -56.68 -49.41 75.19 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.037 0.935 . . . . 0.0 110.58 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -50.64 -47.11 58.63 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.324 1.449 . . . . 0.0 111.303 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.1 mtp-105 -68.5 -44.45 74.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.93 -49.18 77.64 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.617 1.167 . . . . 0.0 111.23 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -68.3 -21.76 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 O-C-N 120.675 -1.266 . . . . 0.0 112.009 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.58 -7.44 59.25 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.569 0.748 . . . . 0.0 112.632 173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -131.34 -11.84 3.58 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 7.8 m -55.78 147.61 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.05 0.94 . . . . 0.0 112.92 171.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -66.34 -49.85 65.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.5 p 167.9 147.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 128.228 2.611 . . . . 0.0 110.334 -173.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.508 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 25.7 m-85 -99.73 104.32 27.27 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 117.31 -1.329 . . . . 0.0 110.493 -174.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -70.71 128.96 15.85 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.021 1.814 . . . . 0.0 111.512 -170.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.41 132.04 21.52 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 125.127 1.371 . . . . 0.0 110.306 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.33 -52.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.186 2.591 . . . . 0.0 112.477 -171.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.78 149.61 27.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.617 1.167 . . . . 0.0 110.045 167.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -128.03 21.01 6.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.288 1.435 . . . . 0.0 113.315 -166.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -88.61 145.74 35.85 Favored Pre-proline 0 C--O 1.242 0.66 0 O-C-N 121.228 -0.92 . . . . 0.0 109.772 -178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -49.18 -23.58 6.84 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.28 2.653 . . . . 0.0 114.563 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.2 -24.6 43.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 118.891 0.769 . . . . 0.0 112.862 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.2 m -98.22 -34.16 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.037 0.935 . . . . 0.0 111.97 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.27 -32.5 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.322 1.049 . . . . 0.0 111.137 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -79.56 -11.74 59.87 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.129 0.972 . . . . 0.0 113.227 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.81 -34.05 8.68 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.179 -0.95 . . . . 0.0 113.289 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.459 ' HG ' ' H ' ' A' ' 112' ' ' LEU . 3.6 pp -82.84 -21.25 34.47 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.745 0.818 . . . . 0.0 112.913 176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -69.44 -23.54 63.69 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.072 -1.017 . . . . 0.0 113.735 -174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.0 83.99 2.23 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.336 1.055 . . . . 0.0 110.146 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.55 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.46 159.66 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.607 1.163 . . . . 0.0 112.102 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -110.81 126.91 55.12 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 160.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 64.4 mt -89.8 121.9 32.37 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 168.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 85.9 m -134.12 129.76 36.38 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 124.097 0.959 . . . . 0.0 109.801 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.76 141.35 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 128.576 2.75 . . . . 0.0 107.885 -170.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.622 ' H ' ' HD2' ' A' ' 121' ' ' PRO . . . -168.62 -35.37 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 -174.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' A' ' 120' ' ' ALA . 71.6 Cg_endo -75.55 162.5 35.62 Favored 'Trans proline' 0 C--N 1.359 1.082 0 CA-C-N 122.852 2.054 . . . . 0.0 112.217 -172.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.718 1.207 . . . . 0.0 110.834 -173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.279 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.22 131.5 5.05 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.698 0.799 . . . . 0.0 111.672 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 mtp180 -136.41 16.8 3.16 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.713 2.005 . . . . 0.0 111.671 -171.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -88.11 -33.23 18.33 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.748 1.619 . . . . 0.0 111.561 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.8 14.52 0.07 Allowed 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -172.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -62.53 -13.99 36.98 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -170.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.7 m -57.31 -26.44 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.115 1.766 . . . . 0.0 113.523 -176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.8 t -57.27 -35.48 69.81 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.205 1.002 . . . . 0.0 112.519 171.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.4 t -75.72 -24.36 56.17 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.043 -1.035 . . . . 0.0 112.889 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -67.98 -34.18 76.06 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.126 -0.984 . . . . 0.0 111.18 167.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.1 t -66.11 -28.15 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 120.704 -1.248 . . . . 0.0 110.805 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.51 3.41 41.59 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.697 1.618 . . . . 0.0 114.626 171.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -125.63 -64.98 1.03 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.977 1.711 . . . . 0.0 110.781 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -60.08 -18.09 44.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 127.403 2.281 . . . . 0.0 116.429 -166.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -114.14 -13.83 9.66 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 126.896 2.188 . . . . 0.0 114.282 167.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.619 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -77.41 -34.41 54.77 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.381 1.472 . . . . 0.0 111.818 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.9 pt -59.33 -27.45 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 121.525 -0.735 . . . . 0.0 112.449 176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.4 -58.59 2.97 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.949 1.3 . . . . 0.0 111.271 174.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.619 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.4 t -60.13 -33.33 72.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.618 1.167 . . . . 0.0 112.167 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -74.05 -40.61 62.71 Favored 'General case' 0 CA--C 1.527 0.074 0 C-N-CA 123.755 0.822 . . . . 0.0 110.464 178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.52 -31.75 68.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 118.836 0.743 . . . . 0.0 111.361 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.59 -51.64 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 121.329 -0.857 . . . . 0.0 111.295 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -67.16 -19.94 65.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -57.08 -35.77 69.78 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.981 0.512 . . . . 0.0 111.245 169.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-80 -77.98 -32.7 51.46 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 87.1 mt -107.36 109.15 20.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 122.621 1.201 . . . . 0.0 111.438 -160.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.08 25.01 5.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.72 1.608 . . . . 0.0 114.21 -173.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.4 t -78.73 -64.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.852 0.861 . . . . 0.0 111.385 -167.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 72.25 -68.3 0.23 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.217 2.207 . . . . 0.0 112.958 170.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.31 -27.86 68.91 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.982 1.313 . . . . 0.0 113.059 -173.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.9 m -100.62 7.14 44.15 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.332 1.053 . . . . 0.0 113.21 173.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -100.08 -28.86 12.83 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.849 1.66 . . . . 0.0 112.161 167.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.9 162.3 16.19 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.993 1.717 . . . . 0.0 112.575 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.86 -23.6 3.64 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.199 1.38 . . . . 0.0 114.737 175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.23 -169.77 1.53 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.081 2.153 . . . . 0.0 111.356 171.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.01 165.21 24.47 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.557 1.143 . . . . 0.0 110.342 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 41.0 t -158.11 145.9 18.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 0.0 109.869 169.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -130.1 129.0 42.99 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.72 1.608 . . . . 0.0 111.003 165.676 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.3 m -141.99 169.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.18 132.21 33.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 123.388 0.675 . . . . 0.0 112.236 -172.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -105.09 129.53 53.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.522 1.129 . . . . 0.0 109.725 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -112.36 111.14 21.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.999 0.92 . . . . 0.0 109.634 166.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.496 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.3 mm? -100.09 158.6 15.72 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.996 0.903 . . . . 0.0 111.715 -179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.2 pt -98.38 150.45 36.74 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 125.476 1.51 . . . . 0.0 110.036 167.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.35 150.89 37.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.17 2.58 . . . . 0.0 111.109 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -168.25 144.73 3.91 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.012 2.525 . . . . 0.0 107.98 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.0 -22.17 75.75 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 115.198 0.839 . . . . 0.0 115.198 -164.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.8 p -90.89 -9.6 45.64 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.488 1.515 . . . . 0.0 113.178 174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.21 157.05 7.04 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.244 1.402 . . . . 0.0 112.635 -171.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -64.1 160.88 17.23 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 117.765 0.783 . . . . 0.0 110.767 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -131.19 144.93 51.71 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.072 1.349 . . . . 0.0 111.291 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -60.05 110.25 1.16 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.461 0.704 . . . . 0.0 112.547 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.58 -37.28 4.82 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.882 1.705 . . . . 0.0 112.041 173.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -162.38 148.83 13.14 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.817 1.247 . . . . 0.0 111.0 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.35 125.78 39.39 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.347 1.059 . . . . 0.0 109.423 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.6 m -110.86 127.81 55.56 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.711 2.005 . . . . 0.0 108.133 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.57 133.33 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 119.608 1.094 . . . . 0.0 109.351 167.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.9 tp -104.51 -44.79 4.81 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.713 0.405 . . . . 0.0 110.287 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 59' ' ' ARG . 3.8 t0 -172.48 168.86 5.33 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.646 1.578 . . . . 0.0 112.232 169.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.45 -178.7 32.79 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 124.745 1.164 . . . . 0.0 113.573 169.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -85.68 114.73 22.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 166.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.0 m -59.69 -19.82 52.17 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 115.906 1.817 . . . . 0.0 115.906 -151.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -58.43 -29.63 66.26 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.303 -0.856 . . . . 0.0 113.128 176.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.7 tp -79.81 -48.58 13.31 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-N 120.228 1.376 . . . . 0.0 111.22 174.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 38.9 m -45.36 -47.3 13.4 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 119.694 1.134 . . . . 0.0 112.774 169.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.25 -22.17 64.78 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.391 1.476 . . . . 0.0 114.486 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -94.04 -52.8 4.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.378 1.471 . . . . 0.0 111.975 -179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.627 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.0 t -56.05 -48.6 75.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.698 1.199 . . . . 0.0 111.292 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.7 ttmm -46.87 -47.21 21.39 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.427 1.891 . . . . 0.0 111.494 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -69.96 -43.25 71.91 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.055 0.942 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.93 -51.08 71.59 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.694 1.197 . . . . 0.0 111.124 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.05 -22.02 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.82 -1.175 . . . . 0.0 112.645 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -81.71 -8.72 59.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.841 0.856 . . . . 0.0 112.455 174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -128.85 -13.3 4.67 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.479 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.5 m -58.37 145.12 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.302 1.041 . . . . 0.0 111.984 173.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -69.46 -42.75 74.47 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -171.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.9 p 166.07 141.05 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.506 2.323 . . . . 0.0 110.192 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 42.7 m-85 -89.61 112.55 52.4 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 117.538 -1.22 . . . . 0.0 110.388 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.96 127.02 9.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.33 2.02 . . . . 0.0 111.101 -171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.654 HD22 ' H ' ' A' ' 101' ' ' LEU . 0.1 OUTLIER -73.98 141.65 78.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 123.852 0.861 . . . . 0.0 111.43 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -44.16 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.891 2.394 . . . . 0.0 110.401 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -122.55 151.56 41.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.146 1.778 . . . . 0.0 109.507 160.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -108.43 10.61 27.38 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -165.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.68 144.31 56.11 Favored Pre-proline 0 C--O 1.24 0.569 0 O-C-N 120.872 -1.143 . . . . 0.0 109.947 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -62.68 -6.0 8.22 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.04 2.493 . . . . 0.0 113.957 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -84.44 -33.1 23.75 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.713 0.805 . . . . 0.0 112.875 169.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.2 m -97.44 -25.77 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 113.139 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.2 t -58.67 -25.55 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 123.742 0.817 . . . . 0.0 110.59 170.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.17 -11.44 59.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.277 1.431 . . . . 0.0 113.191 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -37.75 8.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.232 1.013 . . . . 0.0 112.583 -176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.62 -23.94 53.37 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.778 1.231 . . . . 0.0 112.592 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.4 ptpt -66.79 -22.83 66.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -174.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.5 91.01 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.942 0.897 . . . . 0.0 110.647 -177.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.475 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -119.43 154.79 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.674 1.19 . . . . 0.0 113.067 -178.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -91.11 136.42 33.1 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.144 156.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.4 mt -91.38 114.31 26.81 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 153.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 97.3 m -133.83 128.27 34.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.579 1.152 . . . . 0.0 109.34 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.3 m -135.57 156.7 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.783 1.633 . . . . 0.0 111.173 -171.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -164.42 167.86 9.84 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.81 2.044 . . . . 0.0 110.629 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -60.22 -31.23 92.78 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 123.395 2.73 . . . . 0.0 114.425 -175.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.095 0.958 . . . . 0.0 109.699 175.738 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.01 -82.12 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.4 mtm-85 75.51 11.57 3.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 127.853 2.461 . . . . 0.0 114.117 176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -96.25 -19.97 18.9 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.409 1.083 . . . . 0.0 112.817 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.01 -12.0 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.189 1.796 . . . . 0.0 113.335 -169.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.22 -15.83 6.81 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.201 1.8 . . . . 0.0 115.598 -167.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.5 m -53.09 -26.74 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.396 1.478 . . . . 0.0 113.267 173.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.7 t -59.67 -47.69 84.62 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.672 0.789 . . . . 0.0 112.311 170.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -64.67 -31.74 73.1 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.145 0.978 . . . . 0.0 112.064 174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -65.09 -24.54 67.48 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 117.817 -1.087 . . . . 0.0 112.728 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.86 -27.84 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 CA-C-N 121.276 1.853 . . . . 0.0 111.272 173.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.64 -12.34 61.58 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 124.706 1.146 . . . . 0.0 113.889 173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -105.41 -55.45 2.32 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.349 1.46 . . . . 0.0 112.466 165.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -53.67 -44.0 69.33 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.096 1.759 . . . . 0.0 114.83 -162.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.56 -17.37 57.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.572 1.558 . . . . 0.0 114.03 171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.657 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.06 -33.11 59.57 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.666 1.186 . . . . 0.0 111.547 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.9 pt -59.51 -25.79 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.136 0.88 . . . . 0.0 112.257 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.36 -59.88 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.122 0.969 . . . . 0.0 109.804 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.657 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.1 t -61.44 -35.25 77.04 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.472 1.109 . . . . 0.0 112.326 -171.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -73.85 -27.5 61.12 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.718 1.207 . . . . 0.0 111.915 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -78.6 -32.27 47.49 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.252 0.933 . . . . 0.0 111.836 172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.466 HG12 HG22 ' A' ' 93' ' ' VAL . 1.5 mp -68.8 -43.54 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.891 1.276 . . . . 0.0 110.598 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -72.62 -13.99 61.5 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.961 0.904 . . . . 0.0 113.223 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -55.58 -38.43 69.36 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 122.457 0.303 . . . . 0.0 110.326 164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -81.25 -36.87 29.41 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -103.41 99.42 9.25 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.825 1.298 . . . . 0.0 111.869 -161.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.2 28.82 0.69 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.269 1.428 . . . . 0.0 113.625 -172.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 68.1 t -88.35 -40.5 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.599 0.759 . . . . 0.0 112.322 -165.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 59.57 -98.53 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.139 1.776 . . . . 0.0 112.95 164.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -61.69 -24.1 66.54 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.645 1.178 . . . . 0.0 113.605 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 44.4 m -92.83 1.42 57.3 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -88.64 -22.18 23.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.073 1.349 . . . . 0.0 111.575 156.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -86.4 170.92 11.56 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.581 1.952 . . . . 0.0 111.214 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.72 -9.72 28.46 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.095 1.331 . . . . 0.0 114.833 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.29 -176.94 5.02 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.714 2.406 . . . . 0.0 110.885 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.92 160.44 26.15 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.722 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.406 ' HB3' HD23 ' A' ' 85' ' ' LEU . 54.1 t -154.87 141.44 18.85 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.646 1.178 . . . . 0.0 109.538 168.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.06 131.6 53.57 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.397 1.479 . . . . 0.0 110.494 167.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.3 m -142.31 170.24 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -134.82 131.93 38.04 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.404 0.682 . . . . 0.0 111.5 -177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -103.38 133.33 48.62 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.222 1.009 . . . . 0.0 109.682 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -115.16 107.12 14.89 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.738 1.215 . . . . 0.0 109.709 169.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.92 158.47 15.79 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.691 0.758 . . . . 0.0 111.719 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 pt -101.08 148.2 34.78 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 125.61 1.564 . . . . 0.0 110.274 168.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.71 141.13 37.02 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.71 2.273 . . . . 0.0 110.853 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.8 m -133.43 156.94 46.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.277 1.831 . . . . 0.0 109.795 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.31 -26.47 61.68 Favored Glycine 0 N--CA 1.478 1.492 0 C-N-CA 123.55 0.595 . . . . 0.0 113.661 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 86.9 m -131.17 104.47 7.09 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.941 1.696 . . . . 0.0 108.331 161.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.58 -159.53 24.96 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.136 1.351 . . . . 0.0 114.442 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -110.72 162.45 14.75 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.344 1.057 . . . . 0.0 110.032 162.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.24 145.92 51.8 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.101 1.761 . . . . 0.0 110.845 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.14 112.74 1.81 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 118.759 0.708 . . . . 0.0 112.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.41 -36.37 5.16 Favored Glycine 0 N--CA 1.467 0.713 0 C-N-CA 125.796 1.665 . . . . 0.0 111.873 172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.9 m -166.45 153.52 9.41 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.685 1.594 . . . . 0.0 111.201 175.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -128.25 131.65 48.76 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.44 1.096 . . . . 0.0 109.889 172.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.0 m -111.55 122.59 48.23 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.362 1.865 . . . . 0.0 107.878 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.9 m -85.56 130.79 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 118.96 0.8 . . . . 0.0 109.114 167.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.8 mt -101.31 -49.88 3.93 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.315 0.646 . . . . 0.0 110.094 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -173.58 165.58 4.57 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.123 1.769 . . . . 0.0 111.865 171.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.95 179.62 38.33 Favored Glycine 0 N--CA 1.463 0.485 0 C-N-CA 124.543 1.068 . . . . 0.0 114.253 167.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -81.84 119.65 24.17 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 168.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.2 m -54.36 -31.64 55.09 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 -144.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -54.79 -34.97 63.34 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.929 -1.034 . . . . 0.0 112.859 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 58' ' ' CYS . 12.4 tp -78.92 -56.78 4.14 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.334 1.425 . . . . 0.0 111.678 -175.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 6.0 p -55.69 -32.62 63.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.42 -33.95 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 119.816 1.189 . . . . 0.0 113.414 174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -79.52 -52.5 7.95 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.46 1.104 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.6 t -56.09 -46.63 78.98 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.25 1.02 . . . . 0.0 111.713 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 ttmm -46.45 -45.74 18.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.393 1.877 . . . . 0.0 111.797 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -75.62 -43.1 49.66 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.393 1.077 . . . . 0.0 112.754 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.77 -48.44 81.68 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.815 1.246 . . . . 0.0 111.98 177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' THR . 2.7 t -66.1 -24.42 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 120.859 -1.151 . . . . 0.0 111.235 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.35 -6.07 55.97 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.503 -0.748 . . . . 0.0 112.566 175.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -133.07 -12.05 2.88 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.451 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 16.1 m -58.76 151.36 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.274 0.943 . . . . 0.0 113.238 169.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -73.65 -48.69 30.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 173.87 142.58 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.49 1.916 . . . . 0.0 111.835 -171.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 27.5 m-85 -97.12 113.79 63.66 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 117.64 -1.172 . . . . 0.0 109.902 -177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.5 127.95 6.74 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.868 2.379 . . . . 0.0 110.189 -176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 15.6 mt -83.42 146.73 51.22 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.754 0.821 . . . . 0.0 112.225 -172.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.27 -28.81 8.42 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.986 2.457 . . . . 0.0 111.892 172.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -140.76 156.84 46.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.76 2.024 . . . . 0.0 110.817 175.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -129.67 20.85 5.55 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -167.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -85.69 141.85 36.54 Favored Pre-proline 0 C--O 1.241 0.655 0 O-C-N 120.492 -1.38 . . . . 0.0 109.068 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -63.24 -5.41 8.01 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.566 2.844 . . . . 0.0 113.399 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.52 -35.27 23.0 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 119.523 1.056 . . . . 0.0 112.124 171.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.0 m -100.34 -24.24 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.182 0.993 . . . . 0.0 113.278 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.8 t -55.54 -28.27 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.524 0.73 . . . . 0.0 110.379 167.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.439 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 31.7 mm-40 -79.8 -8.53 59.32 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.881 1.272 . . . . 0.0 113.981 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -93.1 -54.09 3.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.669 0.788 . . . . 0.0 111.311 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.81 -23.15 67.15 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 124.497 1.119 . . . . 0.0 113.17 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.9 ptmt -72.87 -23.91 60.79 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.721 -1.237 . . . . 0.0 113.292 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -123.7 83.08 2.09 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.124 1.369 . . . . 0.0 110.885 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.86 150.06 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 123.716 0.807 . . . . 0.0 112.199 177.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -94.48 126.55 39.83 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 157.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 65.5 mt -89.78 116.05 27.59 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 163.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -131.67 124.89 30.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.626 1.171 . . . . 0.0 109.345 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 16.4 t -122.89 139.95 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 128.333 2.653 . . . . 0.0 107.276 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -167.71 151.9 6.28 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 125.285 1.434 . . . . 0.0 111.514 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -78.3 158.36 29.66 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.742 2.961 . . . . 0.0 111.096 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.241 0.626 0 C-N-CA 123.807 0.843 . . . . 0.0 111.1 173.465 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.635 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -163.62 -66.25 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.987 0.915 . . . . 0.0 111.805 -170.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 72.68 12.13 5.41 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.178 2.191 . . . . 0.0 114.491 171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -96.06 -22.11 17.55 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.049 0.94 . . . . 0.0 113.094 -176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.37 -24.21 0.66 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.965 1.706 . . . . 0.0 113.513 -165.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -58.79 -15.0 10.23 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.006 1.722 . . . . 0.0 114.42 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.99 -27.28 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.172 1.389 . . . . 0.0 113.117 171.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.2 t -57.95 -32.43 67.8 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 171.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.9 m -82.13 -27.66 32.65 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.807 0.843 . . . . 0.0 112.434 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -66.0 -38.02 87.42 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 118.75 -0.643 . . . . 0.0 110.552 166.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.5 t -63.6 -28.9 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 CA-C-N 119.971 1.26 . . . . 0.0 111.063 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.68 -18.91 68.7 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.445 -1.197 . . . . 0.0 113.981 172.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.1 mtm-85 -101.59 -48.85 4.19 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.976 1.388 . . . . 0.0 112.349 172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -54.16 -43.97 71.07 Favored 'General case' 0 C--O 1.22 -0.493 0 C-N-CA 126.801 2.04 . . . . 0.0 113.873 -171.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.02 -17.05 68.22 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 125.123 1.344 . . . . 0.0 113.705 173.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.629 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.8 -27.48 55.25 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.327 1.063 . . . . 0.0 112.074 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -63.35 -30.12 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 120.403 -1.436 . . . . 0.0 111.457 176.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -78.26 -56.09 4.74 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.405 1.482 . . . . 0.0 109.488 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.629 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -59.33 -33.95 71.76 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.845 0.858 . . . . 0.0 112.452 -176.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -67.72 -37.56 82.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.776 1.231 . . . . 0.0 111.672 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.3 tp -75.23 -28.04 59.75 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -77.58 -52.5 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 121.224 -0.923 . . . . 0.0 110.622 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -23.91 67.56 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.638 0.775 . . . . 0.0 112.078 -177.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -75.35 -14.16 60.46 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 175.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -81.5 -45.19 16.32 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.182 0.901 . . . . 0.0 111.003 159.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.49 83.46 5.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 123.541 1.638 . . . . 0.0 112.081 -163.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.34 28.56 0.12 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.813 1.645 . . . . 0.0 113.999 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.94 -69.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.867 0.867 . . . . 0.0 111.462 -163.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 74.31 -49.78 0.67 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 127.982 2.513 . . . . 0.0 113.718 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -63.78 -44.74 92.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.621 1.168 . . . . 0.0 112.605 -174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.2 p -92.42 12.72 21.8 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -100.48 -17.92 16.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.59 1.556 . . . . 0.0 111.325 169.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 91.3 mtm180 -106.16 156.95 17.93 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.193 1.797 . . . . 0.0 111.813 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.39 -2.72 84.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.037 1.303 . . . . 0.0 114.804 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -178.97 5.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.032 2.133 . . . . 0.0 110.923 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.05 161.33 23.2 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 121.516 -0.74 . . . . 0.0 110.162 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 54.1 t -155.14 149.09 25.67 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.763 1.225 . . . . 0.0 110.403 172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.27 117.64 9.65 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.733 1.613 . . . . 0.0 110.35 173.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.52 163.69 22.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -134.7 131.15 37.32 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.985 -0.447 . . . . 0.0 111.701 -172.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -100.34 129.54 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.352 1.061 . . . . 0.0 109.885 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -114.29 103.81 11.45 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.511 1.524 . . . . 0.0 108.244 174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.501 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -100.85 157.59 16.61 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.714 0.769 . . . . 0.0 112.085 -178.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 pt -101.32 139.33 20.35 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 125.231 1.413 . . . . 0.0 110.159 168.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.42 126.23 10.8 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.526 2.151 . . . . 0.0 109.845 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.9 m -113.74 -33.72 5.72 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.272 1.029 . . . . 0.0 112.506 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.87 -110.16 0.37 Allowed Glycine 0 C--N 1.341 0.82 0 C-N-CA 124.487 1.041 . . . . 0.0 111.678 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -61.21 -23.74 65.83 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.19 0.996 . . . . 0.0 112.673 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.13 -178.43 16.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 125.268 1.413 . . . . 0.0 115.396 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -100.98 165.83 11.13 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.36 1.464 . . . . 0.0 111.833 171.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.26 146.49 52.33 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.385 1.874 . . . . 0.0 111.413 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.66 110.3 0.97 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.59 0.756 . . . . 0.0 112.038 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -95.45 -35.34 5.73 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.943 1.735 . . . . 0.0 111.703 172.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.5 m -165.8 152.51 9.8 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.08 1.352 . . . . 0.0 111.556 173.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -126.0 125.06 42.06 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.532 1.133 . . . . 0.0 109.779 171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.6 m -106.43 122.37 46.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.407 1.883 . . . . 0.0 108.19 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.3 m -88.81 129.55 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 119.125 0.875 . . . . 0.0 108.85 166.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.4 tp -105.94 -41.54 5.37 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.405 0.682 . . . . 0.0 110.539 177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.27 173.72 6.52 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.249 1.82 . . . . 0.0 111.503 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.36 169.41 13.08 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 125.778 1.656 . . . . 0.0 114.197 174.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -81.94 120.05 24.73 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 170.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 68.1 p -60.79 -20.85 62.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -154.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -52.69 -33.14 46.15 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.858 1.263 . . . . 0.0 112.976 171.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.09 -50.52 6.58 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 119.565 1.075 . . . . 0.0 111.053 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 16.9 m -46.22 -47.77 17.87 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.093 1.357 . . . . 0.0 113.922 174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.61 80.45 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.72 0.808 . . . . 0.0 112.466 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.0 16.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.521 1.128 . . . . 0.0 112.068 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 14.6 t -58.68 -48.28 81.62 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.953 0.901 . . . . 0.0 110.734 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.0 ttmm -49.25 -45.49 44.79 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.989 1.716 . . . . 0.0 111.38 179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mtp85 -70.38 -47.39 61.12 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.23 77.03 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.289 1.036 . . . . 0.0 111.269 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.68 -22.55 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 O-C-N 120.86 -1.15 . . . . 0.0 112.013 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.08 -8.63 59.12 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.419 -0.801 . . . . 0.0 112.639 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.41 -11.88 3.55 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -173.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.437 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.8 m -56.92 145.07 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 112.387 169.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -67.33 -45.26 76.93 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -175.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.3 p 166.18 145.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.867 2.067 . . . . 0.0 111.259 -167.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 13.3 m-85 -103.23 103.4 34.56 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 124.669 1.188 . . . . 0.0 109.426 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -68.11 132.24 25.67 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.308 2.006 . . . . 0.0 110.982 -177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.75 147.12 77.46 Favored Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 118.092 0.406 . . . . 0.0 110.941 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.37 -42.01 2.15 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.92 1.747 . . . . 0.0 110.562 168.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.73 158.57 44.15 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.084 2.154 . . . . 0.0 111.276 -176.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -126.64 19.14 7.34 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.389 1.076 . . . . 0.0 113.898 -162.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -83.69 140.41 40.98 Favored Pre-proline 0 C--O 1.24 0.589 0 O-C-N 120.508 -1.37 . . . . 0.0 109.442 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.45 -3.59 6.72 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.998 2.466 . . . . 0.0 113.523 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.84 -34.2 21.11 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.029 0.831 . . . . 0.0 111.985 169.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -96.94 -26.48 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.903 0.881 . . . . 0.0 112.978 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.58 -28.51 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.573 0.749 . . . . 0.0 110.623 167.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 34.9 mm-40 -79.62 -10.41 59.79 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.46 1.282 . . . . 0.0 114.46 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.18 -53.31 4.41 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.518 -0.739 . . . . 0.0 111.133 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.3 pp -65.2 -25.33 67.66 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.581 1.152 . . . . 0.0 112.878 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.408 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.2 ptmt -72.92 -24.74 60.86 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.01 -1.056 . . . . 0.0 113.337 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -125.81 81.1 1.96 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.796 1.638 . . . . 0.0 110.674 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -103.49 150.56 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.86 0.864 . . . . 0.0 112.415 176.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -96.36 129.24 43.75 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 160.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.4 mt -86.94 109.69 19.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 156.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 90.0 m -133.85 125.83 29.21 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.769 1.228 . . . . 0.0 108.515 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.6 m -138.37 149.61 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 125.714 1.606 . . . . 0.0 110.321 -170.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.36 154.82 11.26 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 125.627 1.571 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -77.67 163.49 29.12 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.731 2.954 . . . . 0.0 111.473 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.239 0.534 0 C-N-CA 125.302 1.441 . . . . 0.0 110.954 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -135.09 -110.13 0.21 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.961 0.904 . . . . 0.0 112.075 -168.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.2 mtm180 68.13 30.23 5.89 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 126.674 1.99 . . . . 0.0 113.039 -175.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -109.09 -19.64 13.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.457 1.503 . . . . 0.0 113.23 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -140.94 -11.32 0.99 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.982 1.713 . . . . 0.0 113.339 -163.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -70.36 0.4 6.6 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.226 1.565 . . . . 0.0 115.226 -166.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.1 m -54.13 -30.79 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 125.319 1.448 . . . . 0.0 113.157 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 t -58.85 -34.86 72.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.508 1.123 . . . . 0.0 112.716 172.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.5 t -73.21 -32.09 64.58 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.392 -0.818 . . . . 0.0 111.895 174.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.59 -26.99 65.66 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.714 -0.616 . . . . 0.0 112.636 171.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.3 t -64.59 -25.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.249 1.386 . . . . 0.0 110.743 172.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.56 0.7 54.92 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.648 1.594 . . . . 0.0 113.699 171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 -115.3 -61.13 1.79 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.045 1.738 . . . . 0.0 111.377 168.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -49.62 -46.34 49.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.739 2.015 . . . . 0.0 114.741 -166.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.54 -16.09 55.72 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 126.33 1.919 . . . . 0.0 114.097 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.2 -34.09 59.29 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.375 1.07 . . . . 0.0 111.863 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.0 pt -60.18 -24.72 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 123.54 0.736 . . . . 0.0 112.074 177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -82.98 -59.7 2.4 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.599 1.16 . . . . 0.0 109.897 172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.669 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -61.26 -34.66 75.53 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.448 1.099 . . . . 0.0 112.47 -170.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -71.02 -43.94 66.88 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.471 1.108 . . . . 0.0 110.385 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.2 tp -67.41 -29.29 68.75 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.638 0.653 . . . . 0.0 111.631 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -69.87 -53.42 24.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 O-C-N 121.498 -0.751 . . . . 0.0 110.862 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -67.54 -18.28 64.97 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -55.44 -36.36 66.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.84 0.456 . . . . 0.0 111.265 167.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -78.17 -37.96 44.63 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.296 0.57 . . . . 0.0 112.204 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.5 mt -98.53 101.87 13.44 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.968 1.366 . . . . 0.0 111.57 -164.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.95 21.0 3.84 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -171.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.27 -60.92 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -162.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 73.31 -57.84 0.62 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 127.715 2.406 . . . . 0.0 113.198 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -59.4 -40.36 86.36 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.093 1.357 . . . . 0.0 112.05 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.8 m -79.73 0.87 28.78 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -112.29 -25.77 9.1 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.063 1.745 . . . . 0.0 112.955 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.69 156.49 16.81 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.119 1.367 . . . . 0.0 113.171 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.64 -24.11 4.56 Favored Glycine 0 N--CA 1.478 1.486 0 C-N-CA 125.376 1.465 . . . . 0.0 114.816 175.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.46 -173.63 2.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.41 1.884 . . . . 0.0 111.532 171.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.14 161.1 27.59 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.245 -0.91 . . . . 0.0 111.594 175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 52.9 t -160.36 146.68 15.49 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.936 1.294 . . . . 0.0 110.008 171.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.23 129.81 42.1 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.184 1.794 . . . . 0.0 110.24 166.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.31 170.9 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 169.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -137.37 131.22 31.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 118.471 0.578 . . . . 0.0 112.02 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.46 127.93 49.29 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.177 0.991 . . . . 0.0 110.112 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.1 mppt? -108.64 107.46 17.94 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.669 1.187 . . . . 0.0 109.277 165.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.4 160.45 14.27 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.994 0.902 . . . . 0.0 111.472 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 pt -100.99 121.43 52.31 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 125.424 1.489 . . . . 0.0 109.504 166.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -58.62 121.84 10.64 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.96 2.44 . . . . 0.0 111.157 170.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 69.3 m -111.26 -29.54 7.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.132 1.373 . . . . 0.0 111.821 -175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.67 -52.99 0.71 Allowed Glycine 0 N--CA 1.476 1.324 0 C-N-CA 125.645 1.593 . . . . 0.0 112.415 172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.4 t -70.03 -31.79 69.62 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.965 0.906 . . . . 0.0 111.378 167.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -155.15 -168.34 18.19 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 111.814 171.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.55 162.15 13.92 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 151.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.29 145.84 50.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.999 1.719 . . . . 0.0 111.16 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -58.94 112.2 1.58 Allowed 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.644 -0.66 . . . . 0.0 112.402 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.13 -46.83 3.23 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 125.05 1.309 . . . . 0.0 110.68 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.1 m -156.64 148.28 22.62 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.609 1.164 . . . . 0.0 110.828 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -123.44 131.2 53.57 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.796 0.839 . . . . 0.0 109.574 171.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.7 m -115.22 117.17 29.75 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 126.142 1.777 . . . . 0.0 108.041 -178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.4 m -82.39 132.05 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 118.473 0.578 . . . . 0.0 109.631 170.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.86 -52.16 3.02 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.097 0.559 . . . . 0.0 109.834 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -172.9 169.37 4.79 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.233 1.813 . . . . 0.0 112.119 174.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.03 -175.73 34.44 Favored Glycine 0 N--CA 1.465 0.581 0 C-N-CA 125.699 1.619 . . . . 0.0 113.843 168.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.63 116.63 19.94 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 164.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.5 m -55.61 -25.53 39.14 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -152.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -55.08 -32.44 61.95 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.322 1.449 . . . . 0.0 112.834 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 22.8 tp -84.76 -50.55 7.5 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 120.288 1.404 . . . . 0.0 112.404 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 30.1 p -60.74 -31.28 70.6 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 120.405 1.457 . . . . 0.0 113.26 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.61 -46.1 84.06 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.119 0.968 . . . . 0.0 112.75 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.07 -50.14 30.7 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.276 1.03 . . . . 0.0 113.206 -175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.3 t -56.87 -47.91 79.35 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.64 0.776 . . . . 0.0 110.521 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -48.79 -45.85 40.79 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.06 1.744 . . . . 0.0 111.818 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -69.14 -43.49 74.23 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 176.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.8 -49.13 78.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.724 1.21 . . . . 0.0 111.275 177.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.633 HG23 ' O ' ' A' ' 89' ' ' THR . 2.0 t -66.61 -23.03 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 O-C-N 120.5 -1.375 . . . . 0.0 112.172 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.43 -6.05 57.47 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.97 0.908 . . . . 0.0 112.782 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.55 -12.27 3.46 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 14.1 m -60.0 146.62 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.416 1.087 . . . . 0.0 112.115 172.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -72.11 -46.57 56.17 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.3 p 172.89 138.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.162 1.785 . . . . 0.0 111.245 -168.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.0 m-85 -93.53 111.39 52.16 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.099 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.38 116.21 4.28 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 121.892 1.728 . . . . 0.0 109.938 -178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 101' ' ' LEU . 1.1 pt? -88.34 137.63 30.74 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.44 1.496 . . . . 0.0 111.848 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.61 -46.29 0.21 Allowed 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 123.25 2.634 . . . . 0.0 112.35 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -99.3 168.16 10.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.053 1.341 . . . . 0.0 110.719 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -131.48 6.15 4.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -167.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.15 138.85 60.43 Favored Pre-proline 0 C--O 1.243 0.735 0 O-C-N 121.127 -0.983 . . . . 0.0 109.162 -173.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.36 -0.97 4.0 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.872 2.381 . . . . 0.0 113.549 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.58 -40.39 16.32 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.775 0.716 . . . . 0.0 111.773 167.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 m -93.02 -25.74 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.381 1.072 . . . . 0.0 112.412 -173.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.51 -26.65 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 123.973 0.909 . . . . 0.0 110.799 168.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -84.55 -7.24 59.33 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.464 1.506 . . . . 0.0 113.826 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -92.68 -51.69 4.98 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.781 0.8 . . . . 0.0 111.876 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 112' ' ' LEU . 3.2 pp -69.06 -21.52 64.08 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.476 1.11 . . . . 0.0 112.345 -172.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -62.37 -24.14 67.2 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.88 -1.138 . . . . 0.0 113.711 172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -129.61 78.62 1.86 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.416 1.087 . . . . 0.0 110.401 -173.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -104.84 151.86 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 124.306 1.042 . . . . 0.0 111.732 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -91.23 134.17 34.78 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 155.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -88.33 113.17 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.5 m -135.71 126.29 27.03 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.344 1.058 . . . . 0.0 109.165 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 m -136.26 151.31 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.84 1.656 . . . . 0.0 110.654 -171.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -168.82 159.84 8.19 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 125.979 1.712 . . . . 0.0 110.975 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -80.46 -20.0 8.53 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.361 2.707 . . . . 0.0 113.51 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.239 0.502 0 C-N-CA 125.749 1.619 . . . . 0.0 109.919 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -166.06 -97.08 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.532 1.133 . . . . 0.0 112.079 -171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 68.6 24.41 6.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.38 2.272 . . . . 0.0 113.413 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -98.27 -18.24 18.49 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.57 1.148 . . . . 0.0 112.793 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.33 -23.87 0.67 Allowed 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.621 1.968 . . . . 0.0 113.174 -166.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -57.52 -13.12 3.26 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.481 1.912 . . . . 0.0 116.051 -168.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 m -54.14 -31.9 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-N 119.141 0.882 . . . . 0.0 112.025 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -60.93 -34.88 75.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.439 1.096 . . . . 0.0 113.033 173.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 t -76.59 -32.66 58.24 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.777 0.831 . . . . 0.0 111.784 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -68.98 -28.17 66.37 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 117.532 -1.223 . . . . 0.0 112.351 172.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.17 -27.94 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 CA-C-N 120.702 1.592 . . . . 0.0 110.885 173.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.73 -16.31 65.63 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 125.044 1.307 . . . . 0.0 114.083 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 28.3 mtm105 -104.55 -51.78 3.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.324 1.562 . . . . 0.0 111.805 169.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -55.96 -43.49 77.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.676 2.39 . . . . 0.0 113.335 -173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.73 -17.44 70.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.955 1.264 . . . . 0.0 113.844 172.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.51 -32.0 64.0 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.552 1.176 . . . . 0.0 111.632 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -61.97 -28.84 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.538 -0.726 . . . . 0.0 111.5 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -80.07 -59.0 2.89 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.554 1.542 . . . . 0.0 109.992 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -60.34 -34.16 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.025 0.93 . . . . 0.0 112.408 -173.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -72.45 -31.47 65.48 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.078 0.951 . . . . 0.0 111.51 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 27.4 tp -74.86 -30.18 61.26 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.548 0.613 . . . . 0.0 112.29 172.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.7 mp -73.97 -53.68 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.956 -1.09 . . . . 0.0 110.649 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -20.22 64.55 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.462 0.705 . . . . 0.0 112.53 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.59 -14.53 58.12 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -79.81 -42.15 24.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.185 0.902 . . . . 0.0 111.324 159.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.8 mt -93.81 84.61 4.61 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 123.412 1.577 . . . . 0.0 111.775 -163.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.6 27.07 0.13 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.581 1.553 . . . . 0.0 114.217 -175.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.93 -69.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.047 0.939 . . . . 0.0 111.128 -165.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 77.34 -50.81 0.54 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 127.595 2.358 . . . . 0.0 113.67 162.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.47 -21.97 60.3 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 120.96 -1.087 . . . . 0.0 113.551 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 98.3 p -89.93 -6.65 55.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.712 1.205 . . . . 0.0 113.07 169.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 19.1 m-30 -98.31 -17.2 19.02 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.464 1.906 . . . . 0.0 112.277 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.72 159.78 14.72 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.875 2.07 . . . . 0.0 112.989 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.29 -43.08 2.45 Favored Glycine 0 N--CA 1.476 1.362 0 C-N-CA 125.698 1.618 . . . . 0.0 112.778 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.581 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -84.85 -176.79 6.37 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.21 1.404 . . . . 0.0 111.264 168.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.8 165.08 23.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.879 0.872 . . . . 0.0 111.313 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.41 158.24 43.98 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 123.123 0.569 . . . . 0.0 111.087 158.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.78 128.04 39.92 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.86 1.264 . . . . 0.0 109.883 159.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 26.3 m -140.3 178.19 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 175.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.57 124.98 13.07 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.288 0.635 . . . . 0.0 110.966 -166.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.07 131.9 49.72 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 123.945 0.898 . . . . 0.0 109.814 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -118.63 103.47 9.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.184 1.794 . . . . 0.0 109.38 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.473 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.79 160.39 14.52 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.374 1.083 . . . . 0.0 111.697 -175.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.8 pt -102.24 142.12 23.94 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 125.608 1.563 . . . . 0.0 109.879 166.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.07 126.11 9.06 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.793 2.329 . . . . 0.0 109.95 176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.2 m -112.9 -27.9 7.93 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.229 1.412 . . . . 0.0 112.089 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.69 -39.59 2.82 Favored Glycine 0 N--CA 1.477 1.39 0 C-N-CA 125.652 1.596 . . . . 0.0 112.99 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.3 p -71.49 -34.73 70.41 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.748 1.219 . . . . 0.0 110.532 163.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -157.62 -165.61 15.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 126.341 1.924 . . . . 0.0 112.061 168.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -89.05 164.14 15.19 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 122.014 -0.697 . . . . 0.0 109.376 151.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.94 145.79 51.71 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.593 1.557 . . . . 0.0 111.157 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -57.81 111.59 1.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.253 0.621 . . . . 0.0 112.474 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.4 -35.87 5.33 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.542 1.544 . . . . 0.0 111.683 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -166.48 151.91 8.22 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.857 1.663 . . . . 0.0 110.845 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 tt -125.3 121.15 33.18 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.856 0.862 . . . . 0.0 110.02 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.6 m -101.1 135.68 42.17 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.722 1.609 . . . . 0.0 107.807 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.0 m -99.34 135.95 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.015 0.825 . . . . 0.0 109.006 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -103.82 -48.22 3.99 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.089 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -172.66 171.61 4.44 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.576 1.95 . . . . 0.0 111.792 171.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.11 -175.1 30.95 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 125.394 1.474 . . . . 0.0 113.886 171.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -84.55 110.89 19.04 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 165.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.5 p -63.68 -15.32 58.09 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 -153.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -59.78 -32.65 70.8 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.795 0.838 . . . . 0.0 112.196 173.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -77.02 -46.8 22.55 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 119.712 1.142 . . . . 0.0 110.775 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 54.4 m -51.84 -38.77 57.17 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.41 1.005 . . . . 0.0 113.603 173.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.26 -44.98 70.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.841 0.856 . . . . 0.0 112.27 174.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.22 -52.54 53.97 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 112.213 -179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 93' ' ' VAL . 15.1 t -57.34 -50.31 73.36 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.801 0.84 . . . . 0.0 110.365 178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -50.95 -46.84 61.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.442 1.497 . . . . 0.0 111.306 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -66.68 -44.22 82.35 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.86 -48.78 80.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.857 1.263 . . . . 0.0 111.511 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 89' ' ' THR . 2.2 t -67.67 -22.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 O-C-N 120.5 -1.375 . . . . 0.0 111.947 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.83 -7.2 58.56 Favored 'General case' 0 CA--C 1.548 0.877 0 O-C-N 121.429 -0.794 . . . . 0.0 112.399 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -132.27 -12.08 3.19 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -173.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.48 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.2 m -55.72 148.28 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.59 1.156 . . . . 0.0 113.017 171.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -73.46 -43.33 60.5 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 41.4 p 168.87 145.76 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 128.025 2.53 . . . . 0.0 111.141 -177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.48 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 24.7 m-85 -95.56 110.68 52.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.439 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -75.69 114.85 4.04 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.527 1.485 . . . . 0.0 110.374 -174.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 101' ' ' LEU . 1.4 pt? -89.76 129.19 47.53 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 125.812 1.645 . . . . 0.0 110.397 174.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.93 -46.34 0.25 Allowed 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.127 2.551 . . . . 0.0 111.043 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -94.26 167.17 11.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.17 1.388 . . . . 0.0 112.169 170.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.61 24.5 0.59 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.352 1.061 . . . . 0.0 113.027 -165.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.28 140.46 34.38 Favored Pre-proline 0 C--O 1.24 0.598 0 O-C-N 120.754 -1.217 . . . . 0.0 108.644 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.83 -15.26 2.92 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.961 3.107 . . . . 0.0 115.601 174.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.32 -35.7 30.65 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.273 0.942 . . . . 0.0 112.496 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.0 m -99.78 -27.32 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.523 1.129 . . . . 0.0 112.726 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.2 t -56.82 -32.5 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.564 1.146 . . . . 0.0 110.105 170.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 35.5 mm-40 -77.9 -7.83 57.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.301 1.04 . . . . 0.0 113.462 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -99.19 -44.55 6.21 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.852 0.861 . . . . 0.0 112.694 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.9 -28.14 67.25 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 123.352 0.661 . . . . 0.0 112.771 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.413 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 18.3 ptmt -73.01 -23.99 60.69 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.397 -1.439 . . . . 0.0 113.643 -176.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -122.84 84.19 2.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.825 1.25 . . . . 0.0 110.445 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.56 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -105.59 155.92 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.147 0.979 . . . . 0.0 112.127 176.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -108.77 120.84 43.68 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.978 162.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 55.2 mt -90.17 119.45 30.51 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 170.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -135.65 127.03 28.48 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.063 1.345 . . . . 0.0 108.56 -173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -137.49 157.32 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.802 1.241 . . . . 0.0 111.606 -168.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -161.3 -40.42 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.702 1.601 . . . . 0.0 115.265 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -67.82 -32.51 29.4 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.173 1.915 . . . . 0.0 114.003 178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 125.514 1.526 . . . . 0.0 110.055 -170.039 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 72.77 -76.47 0.07 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.026 2.531 . . . . 0.0 111.776 -178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' CD1' ' A' ' 27' ' ' PHE . 58.8 mtt180 73.41 14.16 4.46 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.362 2.265 . . . . 0.0 113.675 171.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -96.17 -21.64 17.78 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -175.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.19 -19.09 0.99 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.045 1.338 . . . . 0.0 113.453 -167.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 24' ' ' ARG . 3.0 p90 -65.59 -2.14 3.23 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 116.531 2.048 . . . . 0.0 116.531 -167.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.0 m -54.4 -30.9 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.255 1.022 . . . . 0.0 112.468 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.4 t -66.86 -47.33 72.24 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.796 1.238 . . . . 0.0 112.021 170.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 m -59.8 -30.99 69.29 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.612 1.165 . . . . 0.0 112.567 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.37 -29.36 70.43 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 118.296 -0.859 . . . . 0.0 112.486 171.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.3 t -65.89 -28.73 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-N 120.931 1.696 . . . . 0.0 111.167 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.29 -8.16 69.67 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.767 1.175 . . . . 0.0 114.226 173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' O ' HG23 ' A' ' 38' ' ' ILE . 4.7 mmp_? -121.23 -76.73 0.58 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.076 2.15 . . . . 0.0 111.724 178.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -51.48 -52.71 44.35 Favored 'General case' 0 C--O 1.219 -0.553 0 C-N-CA 128.057 2.543 . . . . 0.0 113.7 -161.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.36 -15.01 65.04 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.052 1.786 . . . . 0.0 113.97 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -71.53 -37.28 71.17 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.898 1.349 . . . . 0.0 110.551 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.432 HG23 ' O ' ' A' ' 34' ' ' ARG . 4.5 pt -62.18 -26.97 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.476 -0.765 . . . . 0.0 112.223 -179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.2 -59.31 2.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.892 1.277 . . . . 0.0 109.927 174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -60.15 -35.58 75.63 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.881 1.272 . . . . 0.0 112.472 -173.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -77.4 -21.78 52.62 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.435 1.094 . . . . 0.0 112.779 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.0 tp -79.93 -34.04 39.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 119.639 1.109 . . . . 0.0 111.416 168.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.75 -44.09 89.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 121.052 -1.03 . . . . 0.0 111.063 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -14.81 62.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.912 1.285 . . . . 0.0 112.911 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -59.99 -40.87 90.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.029 0.531 . . . . 0.0 109.962 166.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -77.94 -44.06 28.0 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.952 0.882 . . . . 0.0 109.777 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.8 mt -92.21 71.28 5.34 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.378 1.561 . . . . 0.0 111.512 -172.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.12 28.95 0.05 Allowed 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 113.714 -1.584 . . . . 0.0 113.762 176.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.1 t -90.19 -70.68 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.176 0.991 . . . . 0.0 110.822 -163.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 75.82 -46.93 0.57 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.689 2.396 . . . . 0.0 113.201 169.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.09 -25.37 64.4 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.451 1.101 . . . . 0.0 113.067 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 67.6 m -86.02 -5.21 59.26 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.886 1.274 . . . . 0.0 113.336 170.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 15.8 m-30 -110.47 -21.48 12.15 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 112.279 -174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -91.73 157.58 16.84 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.543 1.937 . . . . 0.0 113.334 177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.03 -7.45 66.71 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 125.411 1.481 . . . . 0.0 114.648 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -134.78 -172.71 3.1 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 127.222 2.209 . . . . 0.0 110.955 176.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.18 165.91 21.36 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.458 -0.777 . . . . 0.0 110.593 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.8 t -154.99 142.05 19.28 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.001 0.92 . . . . 0.0 109.697 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.78 131.06 51.37 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.368 1.867 . . . . 0.0 110.677 166.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.35 170.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.461 1.104 . . . . 0.0 108.524 173.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.87 131.57 41.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.787 0.835 . . . . 0.0 112.068 -177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp -101.28 134.25 44.62 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.044 0.938 . . . . 0.0 110.15 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.89 102.89 9.76 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.162 1.385 . . . . 0.0 108.387 173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.502 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 0.9 OUTLIER -99.58 161.65 13.49 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.978 0.894 . . . . 0.0 111.493 -178.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.8 pt -100.59 121.01 54.42 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.273 1.429 . . . . 0.0 109.688 165.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.51 126.68 23.12 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.818 2.346 . . . . 0.0 110.994 171.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.2 m -143.52 92.45 2.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.276 1.431 . . . . 0.0 108.285 -168.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.06 -123.95 32.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.977 0.799 . . . . 0.0 111.412 -178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.8 p -80.91 2.45 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.145 1.778 . . . . 0.0 114.199 176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -134.71 -165.24 10.79 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.193 1.378 . . . . 0.0 114.726 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -127.15 165.73 19.02 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.838 1.255 . . . . 0.0 110.235 161.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -131.17 146.6 52.4 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.182 1.793 . . . . 0.0 111.137 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.83 111.58 1.7 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.893 0.769 . . . . 0.0 112.419 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.61 -35.65 5.34 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.531 1.538 . . . . 0.0 112.287 172.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -166.43 153.87 9.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.808 1.643 . . . . 0.0 111.06 175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -129.58 129.13 44.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.261 1.024 . . . . 0.0 109.347 174.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 58.3 m -112.18 117.98 34.07 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.078 1.751 . . . . 0.0 108.229 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.2 m -80.61 132.4 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 118.708 0.685 . . . . 0.0 109.482 170.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.4 mt -102.13 -53.13 2.99 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.63 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -179.1 162.33 1.21 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.666 1.987 . . . . 0.0 111.405 170.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.94 -176.54 40.69 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 124.368 0.985 . . . . 0.0 112.556 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -85.35 107.96 17.6 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 167.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 p -64.68 -13.95 56.33 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -147.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 47.8 ttt85 -57.1 -33.29 67.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.777 0.831 . . . . 0.0 112.604 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.7 tp -76.35 -47.56 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.875 1.216 . . . . 0.0 111.855 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 37.7 m -45.68 -45.83 14.39 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.762 1.164 . . . . 0.0 112.802 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.7 -48.54 71.65 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.083 0.953 . . . . 0.0 112.427 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.81 66.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.723 ' O ' HG23 ' A' ' 93' ' ' VAL . 11.6 t -58.85 -49.63 77.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.653 0.781 . . . . 0.0 110.477 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -51.39 -45.9 62.65 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.348 1.459 . . . . 0.0 111.518 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -66.71 -46.29 76.03 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 176.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.85 80.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.556 1.142 . . . . 0.0 111.622 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 89' ' ' THR . 2.6 t -66.06 -24.24 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.543 -1.348 . . . . 0.0 111.486 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.01 -7.22 58.71 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.348 -0.845 . . . . 0.0 112.368 175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -131.75 -11.7 3.42 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.503 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 9.3 m -57.25 148.55 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 119.197 0.908 . . . . 0.0 112.869 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -68.57 -48.22 64.79 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 24.7 p 170.11 144.95 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 127.578 2.351 . . . . 0.0 110.56 -173.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 22.8 m-85 -97.18 110.66 55.21 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 117.466 -1.254 . . . . 0.0 109.482 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.87 129.93 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.447 2.098 . . . . 0.0 110.157 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.2 mt -81.21 144.92 55.01 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.955 0.502 . . . . 0.0 110.745 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.37 -29.64 9.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.575 2.183 . . . . 0.0 111.656 173.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -114.66 -174.9 2.57 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.161 1.784 . . . . 0.0 111.864 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -151.96 21.15 0.68 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -95.52 132.29 27.85 Favored Pre-proline 0 CA--C 1.541 0.605 0 O-C-N 120.89 -1.131 . . . . 0.0 109.457 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -54.69 -5.6 0.48 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.83 3.687 . . . . 0.0 116.857 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -82.75 -60.27 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.378 0.99 . . . . 0.0 110.266 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.8 m -74.97 -25.01 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.376 0.67 . . . . 0.0 112.273 -174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 59.8 t -60.25 -26.29 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.967 0.907 . . . . 0.0 111.176 170.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -91.54 3.26 55.41 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.362 1.065 . . . . 0.0 113.711 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -98.33 -49.56 4.64 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.188 -0.945 . . . . 0.0 111.256 171.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.99 -22.37 65.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.014 1.725 . . . . 0.0 113.588 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -68.49 -25.1 64.8 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.921 -1.112 . . . . 0.0 112.954 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -123.72 86.24 2.54 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.895 1.278 . . . . 0.0 111.041 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -110.55 150.29 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 124.898 1.279 . . . . 0.0 111.763 178.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.05 125.69 43.13 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 160.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 39.9 mt -91.37 118.33 30.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 164.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 86.5 m -133.87 129.94 37.13 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.601 1.161 . . . . 0.0 109.321 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -136.36 153.67 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.534 1.534 . . . . 0.0 111.71 -171.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -158.12 52.24 0.53 Allowed Pre-proline 0 CA--C 1.559 1.293 0 C-N-CA 125.734 1.614 . . . . 0.0 113.551 173.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.14 146.72 36.92 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.866 2.378 . . . . 0.0 112.481 -173.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 . . . . . 0 C--O 1.238 0.486 0 C-N-CA 124.536 1.134 . . . . 0.0 112.069 -178.309 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -168.37 -50.79 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 130.53 3.532 . . . . 0.0 113.013 7.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 72.85 8.98 5.52 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.805 2.442 . . . . 0.0 114.453 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -96.17 -20.27 18.72 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -143.93 -25.62 0.55 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.212 1.405 . . . . 0.0 113.168 -164.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -55.75 -17.65 6.51 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.624 1.57 . . . . 0.0 114.622 -172.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 m -52.97 -27.43 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.746 1.618 . . . . 0.0 112.77 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -58.01 -38.96 77.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.623 0.769 . . . . 0.0 112.469 171.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.7 m -74.54 -29.87 61.54 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.75 -1.218 . . . . 0.0 112.535 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -72.08 -26.44 62.16 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 118.159 -0.924 . . . . 0.0 111.992 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.8 -29.27 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-N 120.209 1.368 . . . . 0.0 112.099 -175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.08 -9.73 64.02 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 126.355 1.931 . . . . 0.0 113.856 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 mtt85 -105.91 -52.28 2.84 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.541 1.17 . . . . 0.0 111.057 166.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -53.79 -45.31 70.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 127.29 2.236 . . . . 0.0 113.48 -176.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -82.16 -17.2 69.99 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.111 1.339 . . . . 0.0 113.635 173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -73.76 -31.93 63.56 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.612 1.206 . . . . 0.0 111.911 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pt -60.48 -27.99 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.157 -0.965 . . . . 0.0 111.61 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -81.83 -57.73 3.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.125 1.37 . . . . 0.0 110.23 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.2 t -58.08 -36.3 72.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.708 1.203 . . . . 0.0 112.444 -175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -73.21 -31.68 64.33 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 124.37 1.068 . . . . 0.0 111.484 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.6 tp -74.2 -34.33 63.7 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.071 0.851 . . . . 0.0 112.034 173.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 ' CG1' HG22 ' A' ' 93' ' ' VAL . 1.6 mp -66.84 -44.82 88.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 120.591 -1.318 . . . . 0.0 110.927 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -72.15 -14.23 61.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.935 0.894 . . . . 0.0 112.858 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -56.48 -39.24 72.91 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.442 0.297 . . . . 0.0 110.491 165.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -79.27 -39.7 32.37 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.465 0.65 . . . . 0.0 111.808 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.4 mt -97.23 85.75 3.76 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 123.293 1.52 . . . . 0.0 112.031 -163.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.04 27.61 0.14 Allowed 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.826 -1.534 . . . . 0.0 114.126 -177.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.9 t -84.52 -52.82 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.346 0.658 . . . . 0.0 112.276 -163.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 69.78 -75.14 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.813 2.045 . . . . 0.0 112.554 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -69.29 -29.63 67.55 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 120.878 -1.138 . . . . 0.0 113.662 -167.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 61.1 m -81.55 0.75 36.72 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 171.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 13.8 m-30 -102.7 -17.57 15.58 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.704 2.001 . . . . 0.0 111.912 169.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -89.42 159.37 17.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.597 1.959 . . . . 0.0 112.18 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.97 -4.64 65.28 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.069 1.319 . . . . 0.0 114.873 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -140.06 -178.06 5.28 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.437 1.895 . . . . 0.0 111.882 -179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 164.01 21.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.214 1.006 . . . . 0.0 109.75 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 t -156.79 144.54 19.22 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.942 170.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.11 128.85 45.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.11 1.364 . . . . 0.0 110.468 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.1 m -140.88 171.4 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.39 130.61 33.02 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.401 -0.812 . . . . 0.0 112.121 -173.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -102.9 133.66 47.63 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.09 0.956 . . . . 0.0 110.557 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -117.07 102.93 9.73 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.264 1.426 . . . . 0.0 109.245 173.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -101.17 160.67 14.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.98 0.895 . . . . 0.0 111.691 -176.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.2 pt -101.69 122.35 47.91 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.809 1.644 . . . . 0.0 109.857 167.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -59.51 126.01 19.5 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.153 2.569 . . . . 0.0 110.88 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 62.3 m -118.71 -30.95 4.98 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.211 1.404 . . . . 0.0 111.967 -172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 110.75 -36.78 4.05 Favored Glycine 0 N--CA 1.473 1.151 0 C-N-CA 125.189 1.376 . . . . 0.0 113.716 174.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.7 p -71.48 -32.57 68.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.115 0.966 . . . . 0.0 110.527 161.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -171.05 -155.94 11.09 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 127.783 2.611 . . . . 0.0 110.897 172.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -94.43 163.61 13.34 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 118.205 1.003 . . . . 0.0 109.74 154.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.3 146.98 51.97 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.983 1.713 . . . . 0.0 110.879 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.21 111.88 2.15 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.339 0.518 . . . . 0.0 112.004 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.67 -46.78 3.11 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.304 1.43 . . . . 0.0 110.808 171.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.1 m -155.3 153.54 30.72 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.722 1.209 . . . . 0.0 111.452 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.25 132.16 45.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.618 1.167 . . . . 0.0 109.631 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 82.4 m -115.8 129.24 56.36 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 126.661 1.984 . . . . 0.0 107.494 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -90.79 136.49 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.397 0.999 . . . . 0.0 109.121 167.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.1 mt -105.27 -49.7 3.4 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 119.083 -0.484 . . . . 0.0 109.996 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -171.39 170.3 5.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.32 1.848 . . . . 0.0 111.933 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.74 -175.32 32.11 Favored Glycine 0 N--CA 1.469 0.868 0 C-N-CA 124.731 1.158 . . . . 0.0 113.334 170.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.19 113.39 22.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 167.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.8 m -57.66 -20.19 31.83 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -155.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -54.32 -30.06 49.95 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.732 1.213 . . . . 0.0 112.972 173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.65 -50.59 7.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 117.88 -1.057 . . . . 0.0 111.202 174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 42.5 m -45.09 -48.49 11.97 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.93 1.241 . . . . 0.0 113.604 172.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.74 -29.29 69.23 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.427 1.091 . . . . 0.0 113.714 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -85.86 -52.05 5.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.403 1.481 . . . . 0.0 112.526 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.707 ' O ' HG23 ' A' ' 93' ' ' VAL . 13.4 t -56.68 -48.3 77.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.057 0.943 . . . . 0.0 110.739 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -49.33 -47.28 47.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.589 1.556 . . . . 0.0 111.277 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -70.0 -44.48 69.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.809 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.61 -48.29 81.49 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.443 1.019 . . . . 0.0 111.884 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 89' ' ' THR . 2.5 t -66.77 -23.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.599 -1.313 . . . . 0.0 111.556 -178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.88 -4.33 54.43 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.075 0.95 . . . . 0.0 112.735 175.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -134.06 -11.84 2.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -175.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.494 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 13.0 m -58.34 149.41 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 119.577 1.081 . . . . 0.0 112.584 172.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -71.96 -46.27 58.05 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.4 p 170.29 144.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.708 2.003 . . . . 0.0 111.891 -173.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.494 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 23.6 m-85 -99.74 110.44 58.96 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.372 1.069 . . . . 0.0 110.184 -176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.98 131.11 10.81 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 122.381 2.054 . . . . 0.0 111.073 -174.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -74.63 143.44 78.84 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.734 1.213 . . . . 0.0 112.324 -174.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.17 -45.72 0.26 Allowed 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 123.233 2.622 . . . . 0.0 111.24 174.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -126.63 154.53 43.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.722 2.009 . . . . 0.0 111.028 170.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -119.5 13.26 12.57 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.924 1.289 . . . . 0.0 114.338 -161.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -80.35 143.45 55.92 Favored Pre-proline 0 C--O 1.241 0.636 0 O-C-N 120.814 -1.179 . . . . 0.0 109.741 -176.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -63.61 -1.74 3.57 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.641 2.894 . . . . 0.0 114.159 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.2 -43.95 12.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.53 1.059 . . . . 0.0 111.652 167.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.1 m -87.84 -23.26 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 124.359 1.063 . . . . 0.0 112.902 -175.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -55.76 -26.68 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.99 0.916 . . . . 0.0 110.468 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -85.2 -4.41 59.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.114 0.965 . . . . 0.0 113.506 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -96.02 -53.21 3.74 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.569 1.077 . . . . 0.0 111.296 178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 112' ' ' LEU . 3.8 pp -62.47 -25.55 68.05 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.242 1.417 . . . . 0.0 113.009 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -69.42 -24.94 63.9 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.427 -1.421 . . . . 0.0 113.472 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -125.41 83.81 2.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.4 1.48 . . . . 0.0 110.76 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -108.63 156.19 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.948 1.299 . . . . 0.0 112.193 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -92.54 136.31 33.33 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 154.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.3 mt -88.76 116.03 26.73 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 154.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.9 m -134.56 128.17 32.73 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.148 0.979 . . . . 0.0 109.5 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.95 159.28 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.865 1.666 . . . . 0.0 110.889 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -162.94 160.66 19.07 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 126.072 1.749 . . . . 0.0 111.401 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.98 -12.28 9.67 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.822 2.348 . . . . 0.0 113.502 -171.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 . . . . . 0 C--O 1.24 0.596 0 C-N-CA 124.44 1.096 . . . . 0.0 110.917 178.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 77.86 -54.35 0.51 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 128.687 2.795 . . . . 0.0 112.012 176.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HA ' ' CD1' ' A' ' 27' ' ' PHE . 75.6 mtt-85 74.99 9.81 3.89 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.43 2.292 . . . . 0.0 113.662 163.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -92.51 -18.99 22.45 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.065 0.946 . . . . 0.0 112.083 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.76 -26.77 0.45 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.752 1.621 . . . . 0.0 113.127 -169.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' CD1' ' HA ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -61.3 -5.94 1.9 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 -167.356 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 m -57.94 -30.69 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 O-C-N 120.837 -1.165 . . . . 0.0 112.681 -175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -67.19 -47.56 70.55 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.608 1.163 . . . . 0.0 112.025 171.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.3 m -59.17 -30.89 68.51 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.45 1.5 . . . . 0.0 112.445 177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.84 -27.75 67.79 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 117.914 -1.041 . . . . 0.0 112.782 172.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 32.2 t -64.87 -27.47 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-N 121.254 1.843 . . . . 0.0 110.253 173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.71 -12.88 78.3 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.119 1.342 . . . . 0.0 114.692 172.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -107.92 -56.19 2.27 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.961 1.381 . . . . 0.0 112.999 172.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -53.68 -42.13 67.63 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 127.081 2.152 . . . . 0.0 114.12 -169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.99 -17.3 59.67 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.68 1.61 . . . . 0.0 114.16 172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 40' ' ' THR . . . -76.93 -31.26 56.52 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.706 1.253 . . . . 0.0 112.615 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.8 pt -59.79 -26.87 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.761 0.71 . . . . 0.0 111.969 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -81.01 -59.11 2.78 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.609 1.164 . . . . 0.0 110.176 174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.653 HG22 ' HA ' ' A' ' 37' ' ' ALA . 1.3 t -59.19 -35.57 73.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.746 1.219 . . . . 0.0 112.46 -172.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -70.81 -42.89 69.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.487 1.115 . . . . 0.0 110.239 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.6 tp -67.86 -29.88 69.11 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.798 0.726 . . . . 0.0 111.947 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mp -68.52 -52.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -17.74 63.67 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -175.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -55.26 -34.38 63.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.811 0.444 . . . . 0.0 111.648 165.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.433 HD21 HG12 ' A' ' 96' ' ' VAL . 68.0 m-80 -79.19 -33.4 43.91 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 81.2 1.87 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.004 1.321 . . . . 0.0 109.166 -172.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.59 43.81 0.26 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.011 1.324 . . . . 0.0 112.829 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 80.5 t -78.25 -57.68 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.238 1.415 . . . . 0.0 111.802 -165.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 72.03 -50.2 0.69 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 127.954 2.501 . . . . 0.0 113.152 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.9 -32.62 73.93 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 113.728 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 58.5 m -89.9 0.35 57.11 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 172.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 15.1 m-30 -111.8 -23.76 10.41 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.019 1.728 . . . . 0.0 112.267 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.43 161.52 16.24 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.859 2.064 . . . . 0.0 112.804 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.16 -11.23 30.63 Favored Glycine 0 N--CA 1.478 1.466 0 C-N-CA 125.391 1.472 . . . . 0.0 114.925 174.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -170.2 2.21 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.053 2.141 . . . . 0.0 111.065 177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.41 162.96 26.86 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.234 -0.916 . . . . 0.0 110.597 176.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.425 ' HB3' HD23 ' A' ' 85' ' ' LEU . 52.6 t -156.23 144.59 19.91 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.442 1.097 . . . . 0.0 109.839 168.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.73 129.95 49.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.118 1.367 . . . . 0.0 110.648 165.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.9 m -142.8 170.19 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.905 1.282 . . . . 0.0 107.824 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -134.6 130.64 36.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.569 0.748 . . . . 0.0 111.66 -175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.6 132.43 47.26 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.225 1.01 . . . . 0.0 110.316 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.47 102.22 9.31 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.191 1.396 . . . . 0.0 108.903 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.511 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -99.25 159.84 14.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 122.26 1.029 . . . . 0.0 111.565 -178.217 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.7 pt -103.87 146.6 32.83 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 126.111 1.764 . . . . 0.0 109.837 166.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.14 133.29 17.76 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.265 1.977 . . . . 0.0 110.525 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.09 -3.37 16.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.019 1.328 . . . . 0.0 113.121 175.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.83 -55.44 1.0 Allowed Glycine 0 N--CA 1.473 1.123 0 C-N-CA 126.292 1.901 . . . . 0.0 112.441 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.6 p -79.94 -24.28 41.13 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.06 1.344 . . . . 0.0 112.775 174.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -162.75 -159.11 10.11 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 126.086 1.803 . . . . 0.0 111.686 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 64' ' ' LEU . . . -108.74 164.94 11.93 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.87 0.868 . . . . 0.0 110.871 164.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.73 145.3 49.72 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.592 1.957 . . . . 0.0 110.787 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -60.27 112.49 1.95 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.075 0.852 . . . . 0.0 112.135 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -97.72 -36.15 4.89 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.432 1.492 . . . . 0.0 112.034 172.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 3.4 m -164.83 154.44 13.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.408 1.483 . . . . 0.0 111.533 175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.4 tt -130.61 126.74 37.44 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.274 1.03 . . . . 0.0 109.791 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 91.8 m -110.62 118.73 37.0 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.946 1.698 . . . . 0.0 107.992 -178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -85.25 134.32 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-N 119.185 0.902 . . . . 0.0 109.632 170.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 mt -107.09 -49.21 3.32 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 118.733 -0.651 . . . . 0.0 109.997 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -173.38 166.24 4.75 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.65 1.58 . . . . 0.0 111.618 172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.76 -177.44 35.37 Favored Glycine 0 N--CA 1.466 0.639 0 C-N-CA 125.164 1.364 . . . . 0.0 114.011 169.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -82.31 116.69 21.92 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 167.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.7 m -56.28 -25.36 48.03 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -151.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -51.25 -38.18 51.23 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.917 1.287 . . . . 0.0 112.666 175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 58' ' ' CYS . 15.3 tp -79.63 -53.9 6.4 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.354 0.979 . . . . 0.0 112.053 -177.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' CYS . . . . . . . . . . . . . 25.9 p -59.99 -28.66 67.87 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 120.5 1.5 . . . . 0.0 114.138 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.16 -44.26 69.16 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.895 0.77 . . . . 0.0 112.666 170.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -70.13 -54.61 12.21 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.66 1.184 . . . . 0.0 113.549 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 12.7 t -54.67 -48.52 72.26 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.506 0.723 . . . . 0.0 110.514 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -52.13 -45.75 65.11 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.658 1.583 . . . . 0.0 112.048 -177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.6 mtp-105 -63.81 -42.32 97.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.121 0.568 . . . . 0.0 112.019 176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.87 -49.81 74.76 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.753 1.221 . . . . 0.0 111.97 173.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 89' ' ' THR . 1.9 t -62.83 -25.08 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 120.253 -1.529 . . . . 0.0 112.383 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -78.2 -7.7 57.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.728 0.811 . . . . 0.0 112.804 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.3 pp0? -132.31 -12.74 3.12 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 99' ' ' PHE . 6.8 m -58.09 146.68 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.415 1.086 . . . . 0.0 112.681 173.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -68.74 -41.98 78.2 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -173.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.1 p 163.41 139.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 127.448 2.299 . . . . 0.0 110.96 -169.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 96' ' ' VAL . 39.7 m-85 -91.95 113.03 57.67 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.154 -175.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.26 118.82 5.07 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.249 1.966 . . . . 0.0 109.926 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' H ' ' HG ' ' A' ' 101' ' ' LEU . 1.9 pp -93.17 140.28 23.27 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 124.909 1.284 . . . . 0.0 112.047 -176.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.06 -31.2 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 123.271 2.647 . . . . 0.0 113.463 -168.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.76 146.45 49.77 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.584 1.554 . . . . 0.0 110.049 176.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -102.78 8.13 39.44 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -166.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -79.02 136.33 57.89 Favored Pre-proline 0 C--O 1.241 0.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.366 -170.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -63.61 -5.11 8.02 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.807 2.338 . . . . 0.0 113.465 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -85.32 -35.93 21.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 118.965 0.802 . . . . 0.0 112.063 170.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 m -93.18 -27.72 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.25 1.02 . . . . 0.0 112.814 -177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.4 t -57.26 -27.1 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.705 0.802 . . . . 0.0 110.874 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.418 ' HA ' ' CD ' ' A' ' 113' ' ' LYS . 30.4 mm-40 -82.07 -6.64 59.32 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.075 1.35 . . . . 0.0 114.094 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -92.54 -55.71 3.29 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.365 -0.834 . . . . 0.0 111.314 174.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.99 -27.62 65.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.885 1.274 . . . . 0.0 112.991 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.418 ' CD ' ' HA ' ' A' ' 110' ' ' GLU . 21.0 ptmt -67.68 -23.07 65.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.063 -1.648 . . . . 0.0 114.048 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -122.68 86.28 2.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.45 1.1 . . . . 0.0 110.877 176.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -109.11 151.55 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.615 1.166 . . . . 0.0 111.978 175.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -90.72 129.52 36.81 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 154.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.9 mt -86.03 111.77 20.61 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 156.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 94.7 m -131.8 126.32 34.07 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.531 1.132 . . . . 0.0 109.06 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.7 m -133.89 151.83 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.691 1.596 . . . . 0.0 110.445 -173.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -165.96 164.81 11.24 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 126.486 1.914 . . . . 0.0 110.641 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.46 -33.52 97.26 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.641 2.894 . . . . 0.0 114.05 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.239 0.504 0 C-N-CA 124.862 1.265 . . . . 0.0 110.527 172.833 . . . . . . . . 0 0 . 1 stop_ save_